<SEC-DOCUMENT>0000744825-21-000030.txt : 20210406
<SEC-HEADER>0000744825-21-000030.hdr.sgml : 20210406
<ACCEPTANCE-DATETIME>20210406164548
ACCESSION NUMBER:		0000744825-21-000030
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		85
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210406
DATE AS OF CHANGE:		20210406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN SHARED HOSPITAL SERVICES
		CENTRAL INDEX KEY:			0000744825
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				942918118
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08789
		FILM NUMBER:		21809608

	BUSINESS ADDRESS:	
		STREET 1:		2 EMBARCADERO CENTER
		STREET 2:		SUITE 410
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
		BUSINESS PHONE:		415-788-5300

	MAIL ADDRESS:	
		STREET 1:		2 EMBARCADERO CENTER
		STREET 2:		SUITE 410
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ams-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:4e6f91f2-1bf1-41c4-8e53-76168a3ee138,g:df8d0904-ed6f-4833-8eea-c587ca49bdb5,d:08eb1efc99dc4f408903b4769adc4b90--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ams="http://www.ashs.com/20201231" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ams-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF80L2ZyYWc6MmNjYTQ1NDE2ZjFkNDU0YmIwYzAxYmY0OTZkZmI3NDQvdGFibGU6YWMxYTAzZmRmMzBmNDNlZmIwMjVlZmE3MmQxOGY0OTkvdGFibGVyYW5nZTphYzFhMDNmZGYzMGY0M2VmYjAyNWVmYTcyZDE4ZjQ5OV8yLTEtMS0xLTA_b82fd032-1241-40ee-bf0a-d036b9693c52">false</ix:nonNumeric><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF80L2ZyYWc6MmNjYTQ1NDE2ZjFkNDU0YmIwYzAxYmY0OTZkZmI3NDQvdGFibGU6YWMxYTAzZmRmMzBmNDNlZmIwMjVlZmE3MmQxOGY0OTkvdGFibGVyYW5nZTphYzFhMDNmZGYzMGY0M2VmYjAyNWVmYTcyZDE4ZjQ5OV80LTEtMS0xLTA_ef4b0960-b7ff-44ca-9612-85f62b5008b7">2020</ix:nonNumeric><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF80L2ZyYWc6MmNjYTQ1NDE2ZjFkNDU0YmIwYzAxYmY0OTZkZmI3NDQvdGFibGU6YWMxYTAzZmRmMzBmNDNlZmIwMjVlZmE3MmQxOGY0OTkvdGFibGVyYW5nZTphYzFhMDNmZGYzMGY0M2VmYjAyNWVmYTcyZDE4ZjQ5OV81LTEtMS0xLTA_db48d250-0fc2-4917-818b-f0ded592cc33">FY</ix:nonNumeric><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF80L2ZyYWc6MmNjYTQ1NDE2ZjFkNDU0YmIwYzAxYmY0OTZkZmI3NDQvdGFibGU6YWMxYTAzZmRmMzBmNDNlZmIwMjVlZmE3MmQxOGY0OTkvdGFibGVyYW5nZTphYzFhMDNmZGYzMGY0M2VmYjAyNWVmYTcyZDE4ZjQ5OV83LTEtMS0xLTA_4be47c8a-f877-4a07-bdc1-d56b146665e9">0000744825</ix:nonNumeric><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF80L2ZyYWc6MmNjYTQ1NDE2ZjFkNDU0YmIwYzAxYmY0OTZkZmI3NDQvdGFibGU6YWMxYTAzZmRmMzBmNDNlZmIwMjVlZmE3MmQxOGY0OTkvdGFibGVyYW5nZTphYzFhMDNmZGYzMGY0M2VmYjAyNWVmYTcyZDE4ZjQ5OV84LTEtMS0xLTA_2e0a608b-18fc-4aed-8242-8ab6dda96308">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="ie52549c616fe4dc18135044ebe97c162_D20170905-20170905" name="us-gaap:LongtermPurchaseCommitmentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU4MTM_78bf16e5-2777-43c0-8b8e-f765c5397ed5">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ams-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ied252e58dda6439bb22835292add17c7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i1e22177dad944968a24a1d8af4b54161_I20210322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6687a8b13ec24af5990e629224319cec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i882bf9794e8244f388b36b7749f33ee3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80d152c66b98490fac1712dd5160d5b6_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f2c5098442b4ca0990024d0a044f71d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eb01d36262d48dab3093fa93a55a639_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieffba5f94e464f3c9847c0ba5b17a15d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eaabaa2b68f452d814855cd3337f66d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88d4659da27e48458ba86016aae09e94_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idce4f3d545f2476ebdc0f7f36157ebb5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5dfe6ce5ed7480b9e09f5b3476be864_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0811458740d6449891c3119d222599c5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0146f023f5af475e8c42899ccb2714bd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49250096dac54dbc9d6f411a7223e401_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1933947a2065450e947da821bf4a32d6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95945ee330d74bbe84786fe63dbd0fe7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i031366823611429984ba59da571f0cf4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63c0e34c40b84e128c70ede3ca6deb9b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaf32a31b8e945bca3c5332f1bd4ea42_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdb999bd1cf140c987a60e65653baa9d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c7ecb5b71704129a21136aa3a829d59_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90f32e02b365478c95091f9014bef961_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9a7f6cfe5f24a45b55dad44c8b94d99_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6742d6b210b4bc7b247bbd2b1bbcdcd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if300614914f840d5afcad30cf88400e1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d457b7646a4469d9fe2d92f4b9ba9dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedffb7791f4c42a8a3e5d969848aaeb4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02bbd8133d3c48bebba8d7203bfb8f52_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i890ba0391e8b420f8705f2e7726453b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i6422158328d64dee80e1ac0f4c7ef41f_I20200612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i795a789ed9064252be4a8f64e1390165_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-12</xbrli:startDate><xbrli:endDate>2020-06-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i410be01cd1af4746a125e7746f1d7df8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ams:Or21LlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40610f194f284cf08a0a82249bb51162_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ams:ArchitecturalDesignCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id972ed669aba469da1b189f82f5af5dc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e8116d241f44505a3ffdf0d7e29c59b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56e19fee70bc48ac882fd81a5a98bbfc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fd315d5d86b412e8a98e82bbe77f732_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i400c6be02aad4a9fafc38382c1213485_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3e0fe294ba6407abae7a2107d1721a7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28c7add148a045bb833ce1179113d93f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40f23635f374477d8f08757fc9c0b712_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie606429758a940aeb109be90c15f3903_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05ae369147604a31ac9acde67baf1fe0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ad83fb416a54f079b45eac2cfce2818_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57e5d37f53fe4fc2b7edcc04f231b5d7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:ProtonBeamRadiationTherapyPBRTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i298febcd82414e288d184f34830a1679_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:GammaKnifeAndRadiationTherapyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a373e6624244f4798fe5b5d28dbef2a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:GammaKnifeAndRadiationTherapyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="unit"><xbrli:measure>ams:unit</xbrli:measure></xbrli:unit><xbrli:context id="i284508e025b34d6d9f64d3b93def6455_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7279522e293b495db1b4d192e00ff1e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ea0bf1639814d3381a9b42a27326780_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cea93e95519466ca67288ae891587b5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40f6d3eb893e49dba2c9816815bdc0a1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ams:CarryingValuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd382747b25b4861a422a0f266d39f5d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i519145167b974aab9b393f963cdb8d7a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93ecdfacebdb44469bdc41efe4acc1dc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d629e14069b4f1ca36dd799f3eb6039_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ams:CarryingValuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5fff1c8944b46cb882c1df18912daf8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17d0a114a3a64f229fe1ddcdd3b7eb1c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71d12ecde1e645d39bc55a9ecf494e71_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:GammaKnifeCenterEcuadorSAGKCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f48202c104045e5af8b285017387f01_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifce03623ecd94f9a9f86454660e7a747_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>ams:customer</xbrli:measure></xbrli:unit><xbrli:unit id="site"><xbrli:measure>ams:site</xbrli:measure></xbrli:unit><xbrli:context id="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i279a2dc09a1e4d058baa0f82d26d3fec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i201f554e454a461689418aeaf993818a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i430692827c684c1ca5be2f83d2a702f5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacead3b29e7846bcac84408721d0ef98_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>ams:segment</xbrli:measure></xbrli:unit><xbrli:context id="ieeeee52fa85b4659bb8c93af9403c135_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:DomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d5ec3bfbd86448fa8f03c6346be0f99_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:DomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i673d3ab8cf484509b5a1f6277fa696b3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:ForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8922c16f8684389b3b97dd8f6e8ab60_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:ForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51994c25a7e04ee08bec394c54e6c3c0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc4a678d396245e9bf4323d16c22d03a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bf5e95df79b44f7a18e189b2382eb21_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:DomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ams:NetIncomeLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7934b69f46a945fba713a315452b7c67_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:DomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ams:NetIncomeLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10727c3b4215451ba7e2258b5cc61bdd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:ForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ams:NetIncomeLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6958c1fb3942499d88011d908e7f5162_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:ForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ams:NetIncomeLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i714b56581adc46f6942c585891e61544_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ams:NetIncomeLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d9c32da78d040efa62915a5cb124fe4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ams:NetIncomeLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7895e51adef4d9988611e06cb9a3c5c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:DomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i426af3a3d5514c93814df64d63f704ff_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:DomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i309db3889f874fdb939e6cc89fd12897_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:ForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida6822c327084e89b634c2f2b2084d15_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:ForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfd154d740fb4aa0a7b0a97723469ebb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia83787ee66d2452c9afe259fa7fe0fea_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e4c0e6386194ed79a0a74908a8481c4_D20200612-20200612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-12</xbrli:startDate><xbrli:endDate>2020-06-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75857421209a4a9a88a2265cd4aa4e0c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:MedicalEquipmentAndFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i510367b0210f42978fd2121a0200735d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:MedicalEquipmentAndFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37f3a64c6fb840d18f0efb0eaa318c44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice7b40f1c9e14f0b8d6cb5971b5d802c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d358d5eef3047409dc23e990ed19c02_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76faded4f4504bc18d38d7c6fa9479aa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7084175c89f34387ac3446f385b5e3e1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:DepositsTowardsPurchaseOfProtonBeamSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cb27f70c0184108b4804f5d0b9480eb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:DepositsTowardsPurchaseOfProtonBeamSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3035febde0194678b2773c7062226a54_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="deposit"><xbrli:measure>ams:deposit</xbrli:measure></xbrli:unit><xbrli:context id="i8f932b9ba0be489d8eb94b2f6d54477c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:UnitsRemovedFromServiceInPriorYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf316d9d1b244b2bade2edc301cde456_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:UnitsRemovedFromServiceInCurrentYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22e35e1d597d4b4399ba9a87a43dd7da_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:UnitsThatWillBeRemovedFromServiceInFutureYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id856a65ad9834e49b099b1d1d0c6aaa4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f30f61a17e747c2ad1bc8c1d865eb97_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c2842d69fdd4db49a077b810d27392c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:ProtonBeamRadiationTherapyPBRTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f7bc9edba63482baa71fc49aef7db07_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i205b91ae82344e9d8e528defe6019354_D20200612-20200612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-12</xbrli:startDate><xbrli:endDate>2020-06-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24fa28513d1d4cedb8ff3631c13643d4_D20200612-20200612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-12</xbrli:startDate><xbrli:endDate>2020-06-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i381af277ce4b42e2a421005e64fa2c53_D20200612-20200612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:MedicalEquipmentAndOtherFixedAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-12</xbrli:startDate><xbrli:endDate>2020-06-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5ace117998418a93ba873e84fcee06_D20200612-20200612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:MedicalEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-12</xbrli:startDate><xbrli:endDate>2020-06-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7107c47918d4072a7fa9c7ea3337757_D20200612-20200612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:OtherFixedAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-12</xbrli:startDate><xbrli:endDate>2020-06-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie13445cb0ba94819a5bcc00de48c6ac3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aed20455da74365bfd0779fe7c8fe53_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="note"><xbrli:measure>ams:note</xbrli:measure></xbrli:unit><xbrli:context id="iea6020aa13c8441883aae4fa8107203a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfa5f63042e644d5b31c703f3ac54c9a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf0485b3300f4c709015ee46dc45d199_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a19b56e39284cc2bd0fe2b1a910fdc9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>ams:lease</xbrli:measure></xbrli:unit><xbrli:context id="i3dfd28bb44084d2ab54958e2d4bfab65_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeda16fd19d5413fa54b8ddbc438d749_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i087b2dc2b4b54227989cfb9e793c3951_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9aab6c477354d8aabfd59fedcdc7f0c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:PeruDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic40a5c6d28184e559db2655dfa2504c5_I20100630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b2e49a8ba0e4110902423280570dd60_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7da1cbcaab824c258a3e435ef167afeb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75ab1b400ca446ebafefb5497cfcbe7f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:NonEmployeeDirectorsAndCorporateSecretaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i439999ffc655418594f79bcae4f8e02b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:NonEmployeeDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ams:RetainerFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i865f409e789f412d9649eea7a779efbf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ams:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>ams:employee</xbrli:measure></xbrli:unit><xbrli:context id="i8948e770c9f64598b68bf6a898112dab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ams:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5065887f6a4b4118b70267038309da91_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:ExecutiveEquityAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf66345370f4da19371bd488b60d7d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1ed81d1b3e0406887e3f7c0a942518d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1182cb262dd5404e857585d6453d5008_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75a3e8aadc8a42998ea1f668ddc598aa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1abe365945b24f1187e85f47a39fb40b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ams:RetainerFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a54847db3184f809b995f6ca5865dd9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdcf8f1e671343ef84efbcc784e706a6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:ExecutiveEquityAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a5840910bb84c9ab051118c87f6190d_D20200803-20200803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:ExecutiveEquityAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-03</xbrli:startDate><xbrli:endDate>2020-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcb7ef47ef694053b29237a21986aa43_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ams:SeniorVicePresidentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:ExecutiveEquityAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bdba3f703e740a8b387f2723b455d9a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:ExecutiveEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f1ddba4c6143a2b7471da1ecaeeeaa_D20170104-20170104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:PerformanceShareAwardAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-04</xbrli:startDate><xbrli:endDate>2017-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32da477d172646529ddc5afd23e6ed4d_D20170104-20170104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:PerformanceShareAwardAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-04</xbrli:startDate><xbrli:endDate>2017-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe8c67bc767f4ff48911673917d29035_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:PerformanceShareAwardAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f9e8e77770741a39de67b6d254f0f78_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:PerformanceShareAwardAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b626e312a7d4b85bdb7b11f21a56788_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa091c4ef68c4bb68bd7b854b530cc2c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ams:RSUsIssuedInLieuOfRetainerFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e761c88d6f049ee8b2df4c059245e51_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ams:AnnualRSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie00f50be40664dab98b855706c8871d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ams:ExecutiveCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id87939e5af644ee294503aa4bedb6bbc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i613b14d7d6ca4d3f82337708f6ffc78f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2672c01483e420db7e4c638ebae606e_I20011231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2001-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib40f3f2ed22f45ceb3ad41a1918f4939_D20160813-20160813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2016-08-13</xbrli:startDate><xbrli:endDate>2016-08-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="reload"><xbrli:measure>ams:reload</xbrli:measure></xbrli:unit><xbrli:unit id="install"><xbrli:measure>ams:install</xbrli:measure></xbrli:unit><xbrli:unit id="purchase"><xbrli:measure>ams:purchase</xbrli:measure></xbrli:unit><xbrli:context id="i5e5ea45669af4723953be698788c51f5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ams:LINACSystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i588196b8c9c6489fab6078ddb17065d6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ams:GammaKnifePerfexionSystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie52549c616fe4dc18135044ebe97c162_D20170905-20170905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ams:MaintenanceAndSupportAgreementTheMevionServiceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:MevionMedicalSystemsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-09-05</xbrli:startDate><xbrli:endDate>2017-09-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i160dbde260894a5d8df523d1c2359928_I20170905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ams:MaintenanceAndSupportAgreementTheMevionServiceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:MevionMedicalSystemsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-09-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i303d240dda61403d9ec1de771f26041e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ams:LINACSystemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i922a42f468f946e8b4a7d5f99e207fbf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ams:LINACSystemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e9d39e86c2548f0bf5e350d4df09116_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18863b680ebc4002ab41bd4bd5d80267_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">ams:FinanceLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c1a379a87884628a8b8200736f37e34_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7d6fa8d4f2d4414a11cd4e62eebfcc7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">ams:EquipmentServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i735df263f1544be9ab7b0ae62cd61c55_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">ams:AcquisitionWorkingCapitalPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf60e6023f1042189106a9ed43c03bcb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">ams:OperatingLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5032e2b4fc36495cbac498a4109a1461_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">ams:GkfSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24a2c7db33474c15b8617c78beae2b0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">ams:UsSubsidiaryOfElektaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="upgrade"><xbrli:measure>ams:upgrade</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div id="i08eb1efc99dc4f408903b4769adc4b90_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8xMTY_c5ad0a00-7540-4b27-9afd-15ed9e075dbd">10-K</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6Zjg3NjQ4NjA3YzkzNDNhOGJiYTAxOTc2NTdhYjZkNmMvdGFibGVyYW5nZTpmODc2NDg2MDdjOTM0M2E4YmJhMDE5NzY1N2FiNmQ2Y18wLTAtMS0xLTE0MTk_8a942da5-4a1e-4e0d-8b73-8b56230cac44">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NNUAL </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EPORT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">URSUANT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ECTION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> 13 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> 15(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">) O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ECURITIES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> E</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">XCHANGE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> 1934 </span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">FOR THE FISCAL YEAR ENDED <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyNzA2_18f63be1-5687-4556-97da-a546c5f0bc03"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyNzA2_dee5a09e-9251-42c5-bde9-8124aa80224a">DECEMBER&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6OGUyNzU2ZGQwNGM2NDYyN2JiYzEyM2E2NmY3NzRmZWUvdGFibGVyYW5nZTo4ZTI3NTZkZDA0YzY0NjI3YmJjMTIzYTY2Zjc3NGZlZV8wLTAtMS0xLTE0MjE_df9e9f81-a3d2-4e82-b07f-1fa31027a101">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RANSITION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EPORT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">URSUANT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> To S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ECTION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> 13 or 15(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">) O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ECURITIES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> E</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">XCHANGE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> 1934</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RANSITION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERIOD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> _______________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">_______________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</span></div></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8zMjk4NTM0ODg1ODQ1_3ffa0ed8-4aed-450a-8af1-82e4ab782966">1-08789</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yMDE_34193e0a-6190-4abc-ab66-a980183f47f4">American Shared Hospital Services</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6Y2VhNTIwMmI0MDk0NDBmODkzNjVmNTljN2QyYzcyMTAvdGFibGVyYW5nZTpjZWE1MjAyYjQwOTQ0MGY4OTM2NWY1OWM3ZDJjNzIxMF8wLTAtMS0xLTE4NjE_75ec161e-df4b-41ab-846f-7334f5bd7080">California</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6Y2VhNTIwMmI0MDk0NDBmODkzNjVmNTljN2QyYzcyMTAvdGFibGVyYW5nZTpjZWE1MjAyYjQwOTQ0MGY4OTM2NWY1OWM3ZDJjNzIxMF8wLTItMS0xLTE4NjY_faa7fc78-725e-45c0-aa2e-6960f3b931de">94-2918118</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or other jurisdiction of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.505%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6NjMwYWFiMzQ0OWIwNDMzOGI2NGExZDE2ZjVjOWMxZDQvdGFibGVyYW5nZTo2MzBhYWIzNDQ5YjA0MzM4YjY0YTFkMTZmNWM5YzFkNF8wLTAtMS0xLTQxMzE_307b5e23-fd23-425d-8169-7b1dd885a464">Two Embarcadero Center</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6NjMwYWFiMzQ0OWIwNDMzOGI2NGExZDE2ZjVjOWMxZDQvdGFibGVyYW5nZTo2MzBhYWIzNDQ5YjA0MzM4YjY0YTFkMTZmNWM5YzFkNF8wLTEtMS0xLTQxMzE_2010238d-723a-4cd4-b0e4-52907a45ba5e">Suite 410,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6NjMwYWFiMzQ0OWIwNDMzOGI2NGExZDE2ZjVjOWMxZDQvdGFibGVyYW5nZTo2MzBhYWIzNDQ5YjA0MzM4YjY0YTFkMTZmNWM5YzFkNF8wLTItMS0xLTQxMzE_31ad1c8e-7230-4f19-bfde-16a1cb8d5249">San Francisco,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6NjMwYWFiMzQ0OWIwNDMzOGI2NGExZDE2ZjVjOWMxZDQvdGFibGVyYW5nZTo2MzBhYWIzNDQ5YjA0MzM4YjY0YTFkMTZmNWM5YzFkNF8wLTMtMS0xLTQxMzE_56be4c4d-8228-4283-b958-5cdd41972e8e">California</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6NjMwYWFiMzQ0OWIwNDMzOGI2NGExZDE2ZjVjOWMxZDQvdGFibGVyYW5nZTo2MzBhYWIzNDQ5YjA0MzM4YjY0YTFkMTZmNWM5YzFkNF8wLTQtMS0xLTQxMzE_7c09316b-e2a6-4dd6-b81c-ad5efe62b7c1">94111-4107</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8zMjk4NTM0ODg1ODQ3_12cb4db5-f2d9-4223-b822-e334a579f9ef">415</ix:nonNumeric>) <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8zMjk4NTM0ODg1ODU2_deaaac84-ed01-461e-a2f0-5b544c3ff1a7">788-5300</ix:nonNumeric></span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:40.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.277%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.070%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6MWFmMTQyMWNiZWQ2NDMyZWE3NTdkM2U2ZmJkOWNlYjIvdGFibGVyYW5nZToxYWYxNDIxY2JlZDY0MzJlYTc1N2QzZTZmYmQ5Y2ViMl8xLTAtMS0xLTE5MjM_3f8970da-8096-4fc3-955d-14de6136c848">Common Stock No Par Value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6MWFmMTQyMWNiZWQ2NDMyZWE3NTdkM2U2ZmJkOWNlYjIvdGFibGVyYW5nZToxYWYxNDIxY2JlZDY0MzJlYTc1N2QzZTZmYmQ5Y2ViMl8xLTItMS0xLTE5MjU_8740f470-6469-4314-ab14-bab356765bfb">AMS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6MWFmMTQyMWNiZWQ2NDMyZWE3NTdkM2U2ZmJkOWNlYjIvdGFibGVyYW5nZToxYWYxNDIxY2JlZDY0MzJlYTc1N2QzZTZmYmQ5Y2ViMl8xLTQtMS0xLTE5Mjc_330adf03-6069-4f9a-873c-b9e98e2e4857">NYSEAMER</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyNzA5_4b4722af-3f0b-4be2-8159-0de1737a689b">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl83MTE_438851b9-a051-43a4-8c11-3192c03d76e2">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8xMDYz_de1177ee-4d35-4797-b5a3-16d55a8257cc">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8zMjk4NTM0ODg1ODU3_6800f245-6238-4c12-87e6-1bf2ec303dfa">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act:</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Large Accelerated Filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accelerated Filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyNjg1_07820e8f-0925-4ced-aaea-1dc6e7642986">Non-Accelerated Filer</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160; Smaller reporting company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyNjg2_89bf56af-2686-447f-b55d-a475d04d1986">&#9746;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging Growth Company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyNjg3_bcee887f-ccaa-4f98-a05f-5e709b1e4690">&#9744;</ix:nonNumeric></span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by registered public accounting firm that prepared or issued its audit report.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyMzgx_922e575f-d0de-49e3-84a0-38dd3fa8477a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8zMjk4NTM0ODg1ODYy_0202318a-02c0-4f0e-9169-77716e3fa8ce">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2020, the aggregate market value of the common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="ied252e58dda6439bb22835292add17c7_I20200630" decimals="-3" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yMjM1_33d64205-8209-45e3-9dd4-20ab1fc48a39">8,188,000</ix:nonFraction>.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Number of shares of common stock of the registrant outstanding as of March&#160;22, 2021: <ix:nonFraction unitRef="shares" contextRef="i1e22177dad944968a24a1d8af4b54161_I20210322" decimals="-3" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yMzEy_fe853f52-e918-4ca2-862f-2b445fb15d0e">5,801,000</ix:nonFraction>.</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcxOTkz_0bade264-92bf-474f-95ef-830c8304fdec" escape="true">Portions of the registrant&#8217;s definitive Proxy Statement for the 2021 Annual Meeting of Shareholders are incorporated by reference into Part III of this report.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_10">FORWARD-LOOKING STATEMENTS</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_16">PART I:</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_16">Item 1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_16">Business</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_19">Item 1A</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_19">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_19">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_22">Item 1B</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_22">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_22">16</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_25">Item 2</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_25">Properties</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_25">16</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_28">Item 3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_28">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_28">16</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_31">Item 4</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_31">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_31">16</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_34">PART II:</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_37">Item 5</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_37">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_37">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_43">Item 6</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_40">Selected Financial Data</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_40">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_43">Item 7</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_43">Management&#8217;s Discussion and Analysis of Financial Condition &#160;and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_43">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_82">Item 8</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_82">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_82">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_85">Item 9</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_85">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_85">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_88">Item 9A</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_88">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_88">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_91">Item 9B</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_91">Other Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_91">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_94">PART III:</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_97">Item 10</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_97">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_97">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_100">Item 11</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_100">Executive Compensation</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_100">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_103">Item 12</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_103">Security Ownership of Certain Beneficial Owners and Management &#160;and Related Stockholder Matters</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_103">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_106">Item 13</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_106">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_106">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_109">Item 14</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_109">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_109">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_112">PART IV:</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_115">Item 15</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_115">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_115">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_118">Item 16</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_118">Form 10-K Summary</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_118">30</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain matters discussed in this Annual Report on Form&#160;10-K other than statements of historical information are &#8220;forward-looking statements.&#8221; The Private Securities Litigation Reform Act of 1995 has established that these statements qualify for safe harbors from liability. Forward-looking statements may include words like we &#8220;believe&#8221;, &#8220;anticipate&#8221;, &#8220;target&#8221;, &#8220;expect&#8221;, &#8220;pro forma&#8221;, &#8220;estimate&#8221;, &#8220;intend&#8221;, &#8220;will&#8221;, &#8220;is designed to&#8221;, &#8220;plan&#8221; and words of similar meaning. Forward-looking statements describe our future plans, objectives, expectations or goals. Such statements address future events and conditions concerning and include, but are not limited to, such things as:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capital expenditures</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">earnings</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">liquidity and capital resources</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financing of our business</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">government programs and regulations</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">legislation affecting the health care industry</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expansion of our proton beam radiation therapy business</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accounting matters</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with debt covenants</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">customer concentration</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contractual obligations</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">timing of payments</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">technology</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interest rates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements involve known and unknown risks that may cause our actual results in future periods to differ materially from those expressed in any forward-looking statement. Factors that could cause or contribute to such differences include, but are not limited to, such things as:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our high level of debt</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the limited market for our capital-intensive services</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of lowered federal reimbursement rates</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of recent U.S. health care reform legislation</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition and alternatives to our services</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">technological advances and the risk of equipment obsolescence</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our significant investment in the proton beam radiation therapy business</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the small and illiquid market for our stock</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effects of public health crises, pandemics and epidemics, such as COVID-19</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These lists are not all-inclusive because it is not possible to predict all factors. A discussion of some of these factors is included in this document under the headings &#8220;Item 1A. Risk Factors&#8221; and &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; &#8220;&#8211;Application of Critical Accounting Policies&#8221; and &#8220;&#8211;Liquidity and Capital Resources.&#8221; This report should be read in its entirety. No one section of this report deals with all aspects of the subject matter. Any forward-looking statement speaks only as of the date such statement was made, and we are not obligated to update any forward-looking statement to reflect events or circumstances after the date on which such statement was made, except as required by applicable laws or regulations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_16"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. BUSINESS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Shared Hospital Services (&#8220;ASHS&#8221; and, together with its subsidiaries, the &#8220;Company&#8221;) provides stereotactic radiosurgery equipment and advanced radiation therapy and related equipment. The Company currently provides Gamma Knife units to thirteen 13 medical centers in twelve (12) states in the United States and Gamma Knife units at stand-alone facilities in Lima, Peru and Guayaquil, Ecuador as of March 1, 2021. The Company provides Gamma Knife services through its 81% indirect interest in GK Financing, LLC, a California limited liability company (&#8220;GKF&#8221;). The remaining 19% of GKF is owned by GKV Investments, Inc., a wholly-owned U.S. subsidiary of Elekta AG, a Swedish company (&#8220;Elekta&#8221;). Elekta is the manufacturer of the Leksell Gamma Knife&#174;  (the &#8220;Gamma Knife&#8221;). GKF is a non-exclusive provider of alternative financing services for Leksell Gamma Knife units.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company wholly-owns the subsidiaries American Shared Radiosurgery Services (&#8220;ASRS&#8221;), OR21, Inc. and MedLeader.com, Inc. (&#8220;MedLeader&#8221;). ASRS is the majority-owner of GKF.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GKF has established the wholly-owned subsidiaries Instituto de Gamma Knife del Pacifico S.A.C. (&#8220;GKPeru&#8221;) and HoldCo GKC S.A (&#8220;HoldCo&#8221;) for the purpose of providing similar Gamma Knife services in Peru and Ecuador, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GKF also owns a 51% interest in Albuquerque GK Equipment, LLC (&#8220;AGKE&#8221;) and Jacksonville GK Equipment, LLC (&#8220;JGKE&#8221;). The remaining 49% in each of these two companies is owned by radiation oncologists.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also the sole owner of PBRT Orlando, LLC (&#8220;Orlando&#8221;) and the majority owner of Long Beach Equipment, LLC (&#8220;LBE&#8221;) which were formed to provide proton beam radiation therapy services in Orlando, Florida and Long Beach, California. A 40% minority ownership in LBE is owned by radiation oncologists.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 12, 2020, GKF, through HoldCo, purchased approximately 98% of the total outstanding shares of Gamma Knife Center Ecuador S.A. (&#8220;GKCE&#8221;), from GKCE&#8217;s majority shareholders (the &#8220;Acquisition&#8221;). As of December&#160;31, 2020, the Company acquired additional shares that increased its ownership to approximately 99.3% of the total outstanding shares of GKCE and intends to acquire the remaining 0.7% at a later date. The base purchase price for the Acquisition, including acquisition of the minority shares was approximately $2,000,000. This purchase price was paid with $575,000 in cash and a $1,425,000 loan from the United States International Development Finance Corporation (&#8220;DFC&#8221;).  The purchase price is subject to certain post-closing adjustments, including adjustment for GKCE's working capital and excess cash.  The DFC loan is denominated in U.S. dollars, which is also the currency of Ecuador.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to develop its design and business model for &#8220;The Operating Room for the 21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Century&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through its 50% owned OR21, LLC (&#8220;OR21&#8221;). The remaining 50% of OR21 is owned by an architectural design company. OR21 is not expected to generate significant revenue within the next two years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was incorporated in the State of California in 1983 and its predecessor, Ernest A. Bates, M.D., Ltd. (d/b/a American Shared Hospital Services), a California limited partnership, was formed in June 1980.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPERATIONS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gamma Knife Operations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery and/or radiation therapy. It can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. Compared to conventional surgery, Gamma Knife radiosurgery usually is an out-patient procedure with lower risk of complications and can be provided at a lower cost. Typically, Gamma Knife patients resume their pre-surgical activities one or two days after treatment. The Gamma Knife Perfexion unit, which was introduced by Elekta in 2006, treats patients with 192 single doses of gamma rays that are focused with great precision on small and medium sized, well circumscribed and critically located structures in the brain. The Cobalt-60 sources converge at the target area and deliver a dose that is high enough to destroy the diseased tissue without damaging the surrounding healthy tissue. In 2015, Elekta introduced an upgrade to the Gamma Knife Perfexion unit called Icon. As of March 1, 2021, all of the Company&#8217;s thirteen (13) Gamma Knife units in the United States are Gamma Knife Perfexion units and two (2) of these Perfexion units have the Icon upgrade.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). Research is being conducted to determine whether the Gamma Knife can be effective in the treatment of epilepsy, tremors, and other functional disorders.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, there were approximately 116 Gamma Knife sites in the United States and 345 units in operation worldwide. Based on 2019 case mix data, an estimated percentage breakdown of Gamma Knife procedures performed in the U.S. by indications treated is as follows: malignant (65%) and benign (21%) brain tumors, vascular disorders (4%), and functional disorders (10%).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, as of March 1, 2021, had thirteen (13) operating Gamma Knife units located in the United States and two (2) in South America in Lima, Peru and Guayaquil, Ecuador, respectively. The Company&#8217;s first Gamma Knife commenced operation in September 1991. The Company&#8217;s Gamma Knife units performed 1,530 procedures in 2020 for a cumulative total of approximately 43,500 procedures from commencement through December&#160;31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As December&#160;31, 2020, the Company recognized a loss on the write down of impaired assets of $8,264,000.  The impaired assets included six (6) Gamma Knife units and related removal costs, and two (2) deposits towards the purchase of proton beam systems and related capitalized interest.  The six (6) Gamma Knife units that were impaired consisted of two (2) units that had been taken out of service in prior years, one (1) unit that was taken out of service in 2020 and three (3) units that have already, or the Company anticipates will be taken out of service in 2021, totaling $3,051,000.  In addition to this impairment write-off of $3,051,000 were estimated costs of de-install and removal (ARO) of four (4) of the Gamma Knife units of $1,350,000 (of which, the Company has paid $80,000) as of December&#160;31, 2020.  Total impairment related to the Gamma Knife business was $4,401,000 for the year ended December&#160;31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the carrying value of its long-lived assets for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value may not be recoverable.  The Company has reviewed its Gamma Knife equipment, in light of available information as of December&#160;31, 2020 and based on current customer prospects, the probability of future contract extensions or renewals, and the high turnover rate in contract terminations compared to the Company's historical contract termination rate, the Company determined that these six (6) Gamma Knife units were more-than temporarily impaired.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gamma Knife treatment was included in the Radiation Oncology Alternative Payment Model (&#8220;RO APM&#8221;).  However, for the Company's customers included in the RO APM, there does not appear to be a significant reimbursement impact.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Gamma Knife services for the Company during each of the last two (2) years ended December 31, and the percentage of total revenue of the Company represented by the Gamma Knife for each of the last two years, are set forth below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:42.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Gamma Knife</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue (in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gamma Knife % of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its Gamma Knife business through its 81% indirect interest in GKF. The remaining 19% interest is indirectly owned by Elekta. GKF, formed in October 1995, is managed by its policy committee. The policy committee is composed of one representative from the Company, Craig Tagawa, ASHS&#8217;s President, Chief Operating and Financial Officer, and one representative from Elekta. The policy committee sets the operating policy for GKF. The policy committee may act only with the unanimous approval of both of its members. The policy committee selects a manager to handle GKF&#8217;s daily operations. Craig K. Tagawa, Chief Executive Officer of GKF and President, Chief Operating and Financial Officer of ASHS, serves as GKF&#8217;s manager.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GKF&#8217;s profits and/or losses and any cash distributions are allocated based on membership interests. GKF&#8217;s operating agreement requires that it have a cash reserve of at least $50,000 before cash distributions are made to its members. From inception to December&#160;31, 2020, GKF has distributed $50,005,000 to the Company and $11,730,000 to Elekta.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advanced Radiation Therapy Equipment and Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is continuing its efforts to contract new radiation therapy customers both domestically and internationally.  The Company has increased its product offerings from standard linear accelerators to more advanced linear accelerators that incorporate Magnetic Resonance Imaging (&#8220;MRI&#8221;) and potentially Positron Emission Tomography (&#8220;PET&#8221;) imaging technologies.  The Company believes that these more advanced technologies, with a higher capital cost component, may be potentially a more receptive market segment for its business model.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s radiation therapy business consisted of one Image Guided Radiation Therapy (&#8220;IGRT&#8221;) system that began operation in September 2007 at an existing Gamma Knife customer site. This contract terminated in July 2020 and did not generate any revenue in 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information on our operations can be found in Item 7&#8211; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and Note 1 of our consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proton Beam Radiation Therapy Operations (&#8220;PBRT&#8221;)</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PBRT is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. PBRT, first clinically introduced in the 1950s, has physics advantages compared to photon-based systems which allow PBRT to deliver higher radiation doses to the tumor with less radiation to healthy tissue. PBRT currently treats prostate, brain, spine, head and neck, lung, breast, gastrointestinal tract and pediatric tumors. More than 200,000 patients have been treated with protons worldwide.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to December&#160;31, 2020, the Company had $2,250,000 in deposits toward the purchase of two MEVION S250i PBRT systems from Mevion. The Company reviews the carrying value of its deposits for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value may not be recoverable. The Company has reviewed the deposits, in light of available information, as of December&#160;31, 2020 and based on its current customer prospects, the impact that the COVID-19 pandemic has had on medical centers undertaking large capital expenditure projects for a limited patient base, and the length of time required to negotiate and implement a proton therapy project, the Company determined that its deposits of $2,250,000, related capitalized interest of and other charges of $1,613,000 were other-than temporarily impaired.  Total impairment related to the proton therapy business was $3,863,000.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Introduction of PBRT in the United States, until recently, has been limited due to the high capital costs of these projects. The Company believes that the current development of one and two treatment room PBRT systems at lower capital costs and the level of reimbursement for PBRT from the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) will help make this technology available to a larger segment of the market.  However, the introduction of the RO APM and the inclusion of PBRT in this model potentially limits the adoption of PBRT by medical centers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information on our operations can be found in Item 6&#8211; &#8220;Selected Financial Data&#8221;, Item 7&#8211; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and Note 1 of our consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUSTOMERS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s current business is the outsourcing of stereotactic radiosurgery services and radiation therapy services. The Company typically provides the equipment, as well as planning, installation, reimbursement and marketing support services. The majority of the Company&#8217;s customers pay the Company on a revenue sharing basis. The market for these services primarily consists of large and medium sized medical centers. The business is capital intensive; the total cost of a Gamma Knife facility usually ranges from $3.0 million to $5.5 million, including equipment, site construction and installation; the total cost of a single room PBRT system usually ranges from $30.0M to $40.0M, inclusive of equipment, site construction and installation. The Company pays for the equipment and the medical center generally pays for site and installation costs. The following is a listing of the Company&#8217;s sites as of March 1, 2021:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:50.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.318%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.318%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.321%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Customers (Gamma Knife except as noted)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Original Term of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Contract</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Began</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Payment</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Texas Methodist Hospital San Antonio, Texas</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1998</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee per use</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kettering Medical Center Kettering, Ohio</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1999</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue sharing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">University of Arkansas for Medical Sciences Little Rock, Arkansas</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1999</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue sharing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Mississippi Medical Center Jackson, Mississippi</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2001</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee per use</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OSF Saint Francis Medical Center Peoria, Illinois</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2001</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee per use</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albuquerque Regional Medical Center Albuquerque, New Mexico </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2003</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee per use</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northern Westchester Hospital Mt. Kisco, New York </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2005</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee per use</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USC University Hospital Los Angeles, California </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee per use</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Vincent&#8217;s Medical Center Jacksonville, Florida </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue Sharing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sacred Heart Medical Center Pensacola, Florida </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue Sharing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PeaceHealth Sacred Heart Medical Center at RiverBend Eugene, Oregon</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue Sharing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orlando Health &#8211; UF Health Cancer Center Orlando, Florida (PBRT)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue Sharing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bryan Medical Center Lincoln, Nebraska</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue Sharing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Methodist Hospital Merrillville, Indiana</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue Sharing</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s typical fee per use agreement is for a ten-year term. The fixed fee per use reimbursement amount that the Company receives from the customer is based on the Company&#8217;s cost to provide the service and the anticipated volume of the customer. The Gamma Knife contracts signed by the Company typically call for a fee ranging from $6,000 to $9,300 per procedure. There are no minimum volume guarantees required of the customer. In most cases, GKF is responsible for providing the Gamma Knife and related ongoing Gamma Knife equipment expenses (i.e., personal property taxes, insurance, and equipment maintenance) and helps fund the customer&#8217;s Gamma Knife marketing. The customer generally is obligated to pay site and installation costs and the costs of operating the Gamma Knife. The customer can either renew the agreement or terminate the agreement at the end of the contractual term. If the customer chooses to terminate the agreement, then GKF removes the equipment from the medical center for possible placement at another site.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s typical revenue sharing agreements (&#8220;retail&#8221;) are for a period of ten years. Instead of receiving a fixed fee, the Company receives all or a percentage of the reimbursement (exclusive of physician fees) received by the customer. The Company is at risk for any reimbursement rate changes for radiosurgery or radiation therapy services by the government or other third-party payors. There are no minimum volume guarantees required of the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One customer accounted for approximately 35% and 30% of the Company&#8217;s total revenue in 2020 and 2019, respectively. At December&#160;31, 2020, four customers each individually accounted for 11%, 11%, 11% and 20% of total accounts receivable, respectively. At December&#160;31, 2019, three customers each individually accounted for 12%, 15% and 30% of total accounts receivable, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARKETING</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company markets its Gamma Knife services through its preferred provider status with Elekta and a direct sales effort led by its Senior Vice President, its President, Chief Operating and Financial Officer, and its Chief Executive Officer. The Company markets its PBRT service through a direct sales effort led by its Senior Vice President, its President, Chief Operating and Financial Officer, and its Chief Executive Officer. The major advantages to a health care provider in contracting with the Company for its services include:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">The medical center avoids the high cost of owning the equipment. By not acquiring the equipment supplied by the Company, the medical center is able to allocate the funds otherwise required to purchase and/or finance the equipment to other projects.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">The Company does not have minimum volume requirements, so the medical center avoids the risk of equipment under-utilization. The medical center pays the Company only for each procedure performed on a patient.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">For contracts under revenue sharing arrangements, the Company assumes all or a portion of the risk of reimbursement rate changes. The medical center pays the Company only the contracted portion of revenue received from each procedure.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">The medical center transfers the risk of technological obsolescence to the Company. The medical center and its physicians are not under any obligation to utilize technologically obsolete equipment.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">The Company provides planning, installation, operating and marketing assistance and support to its customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCING</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Gamma Knife business is operated through GKF. GKF generally finances its U.S. Gamma Knife units, upgrades and additions with loans or finance leases from various finance companies for typically 100% of the cost of each Gamma Knife, plus any sales tax, customs, and duties. The financing is predominantly fully amortized over an 84-month period and is collateralized by the equipment, customer contracts and accounts receivable, and is generally without recourse to the Company and Elekta. The lease financing obtained by Orlando is guaranteed by the Company and collateralized by the equipment, customer contract and accounts receivable related to this project.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPETITION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conventional neurosurgery, radiation therapy and other radiosurgery devices are the primary competitors of Gamma Knife radiosurgery. Gamma Knife radiosurgery has gained acceptance as an alternative and/or adjunct to conventional surgery due to its more favorable morbidity outcomes for certain procedures as well as its non-invasiveness. Utilization of the Company&#8217;s Gamma Knife units is contingent on the acceptance of Gamma Knife radiosurgery by the customer&#8217;s neurosurgeons, radiation oncologists and referring physicians. In addition, the utilization of the Company&#8217;s Gamma Knife units is impacted by the proximity of competing Gamma Knife centers and providers using other radiosurgery devices.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conventional linear accelerator-based radiation therapy is the primary competitor of the Company&#8217;s proton therapy system at Orlando Health. Although proton beam radiation therapy has been available for many years, it is only recently emerging as a more clinically beneficial alternative to conventional linear accelerators for certain tumors. Utilization of the Company&#8217;s proton therapy system is dependent on the acceptance of this technology by Orlando Health&#8217;s radiation oncologists and referring physicians, as well as patient self-referrals. There are currently no competing proton therapy facilities near the Company&#8217;s site.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are several competing manufacturers of PBRT systems, including Mevion, IBA Particle Therapy Inc., Varian Medical Systems, Inc., Hitachi Ltd., ProNova Solutions, LLC, Sumitomo Heavy Industries, ProTom International, Inc. and Mitsubishi Electric. The Company has purchased one MEVION S250 and has made deposits towards the purchase of two additional MEVION S250i systems. The Mevion system, as well as single room proton therapy systems from other manufacturers, potentially provides cancer centers the opportunity to introduce single treatment room PBRT services with a cost in the range of approximately $30 to $40 million versus four and five PBRT treatment room programs costing in excess of $120 million. The MEVION S250 system received FDA approval in the second quarter of 2012 and the first clinical treatment occurred in December 2013 at Barnes-Jewish Hospital. The MEVION S250i (Hyperscan) unit, which includes pencil beam scanning, was FDA approved in December 2017. The Company&#8217;s first MEVION S250 system in operation at Orlando Health treated its first patient in April 2016. The Company currently does not have customer contracts for its second and third PBRT units.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the business model it has developed for use in its stereotactic radiosurgery equipment and advanced radiation therapy placements can be tailored for the PBRT market segment. The Company is targeting large, hospital-based cancer programs. The Company&#8217;s ability to develop a successful PBRT financing entity depends on the decision of cancer centers to self-fund or to fund the PBRT through conventional financing vehicles, the Company&#8217;s ability to capture market share from competing alternative PBRT financing entities, and the Company&#8217;s ability to raise capital to fund PBRT projects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s ability to secure additional customers for stereotactic radiosurgery equipment, advanced radiation therapy equipment and services and other proton beam radiation therapy services, or other equipment, is dependent on its ability to effectively compete against the manufacturers of these systems selling directly to potential customers and other companies that outsource these services. The Company does not have an exclusive relationship with any manufacturer and has previously lost sales to customers that chose to purchase equipment directly from manufacturers. The Company may continue to lose future sales to such customers and to the Company&#8217;s competitors.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT PROGRAMS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicare program is administered by CMS of the U.S. Department of Health and Human Services. Medicare is a health insurance program primarily for individuals 65 years of age and older, certain younger people with disabilities, and people with end-stage renal disease, and is provided without regard to income or assets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicare program is subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions, all of which could materially increase or decrease payments from these government programs in the future, as well as affect the cost of providing services to patients and the timing of payments to our client hospitals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Gamma Knife and PBRT customers receive payments for patient care from federal government and private insurer reimbursement programs. Currently in the United States, Gamma Knife and proton therapy services are performed primarily on an out-patient basis. Gamma Knife patients with Medicare as their primary insurer, treated on either an in-patient or out-patient basis, comprise an estimated 35%-45% of the total Gamma Knife patients treated nationwide. PBRT patients with Medicare as their primary insurer are treated primarily on an out-patient basis and comprise an estimated 45% to 50% of the total radiation therapy patients treated.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 18, 2020, CMS issued the final rule that would implement a new mandatory payment model for radiation oncology services: the RO APM. The RO APM is scheduled to commence January 1, 2022 and will be in effect for a five (5) year period.  The RO APM significantly alters CMS' payment methodology from a fee for service paradigm to a set reimbursement by cancer type methodology for radiation services provided within a 90 day episode of care. Under the RO APM, hospital based and free-standing radiation therapy providers are mandatorily required to participate in the model based on whether the radiation therapy provider is located within a randomly selected Core Based Statistical Area ("CBSA"). CMS projects that providers treating approximately 30% of radiation oncology patients have been selected to participate in the RO APM. The remaining providers not included in the RO APM will continue to receive reimbursement based on a fee-for-service methodology.  The RO APM includes but is not limited to PBRT and Gamma Knife services. Four (4) of the Company's Gamma Knife centers are scheduled to be included in the RO APM.  It is not anticipated that inclusion in the RO APM will have a significant impact on the Company's Gamma Knife revenues. The Company's PBRT center was not selected for inclusion in the RO APM. For centers not included in the RO APM proposed model, Medicare reimbursement in 2021 for the most commonly used PBRT delivery codes increases by approximately 4.1% and decreases by approximately 1.7% for Gamma Knife. See additional discussion under &#8220;Item 1A Risk Factors.&#8221;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average Medicare reimbursement rate trends from 2019 to 2021 are outlined below:</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Average Medicare Reimbursement Rate Trends - Gamma Knife</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:59.356%"><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:31.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average Medicare reimbursement rate trends for PBRT from 2019 to 2021 are outlined below. Patients typically undergo 25-40 delivery sessions.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Average Medicare Reimbursement Rate Trends - PBRT</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.877%"><tr><td style="width:1.0%"></td><td style="width:49.959%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.314%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.314%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.317%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Simple without Compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Simple with Compensation, Intermediate, or Complex</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are unable to predict the effect of future government health care funding policy changes on operations. If the rates paid by governmental payers are reduced, if the scope of services covered by governmental payers is limited, or if one or more of our hospital clients are excluded from participation in the Medicare program or any other government health care program, there could be a material adverse effect on our business.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Affordable Care Act and Subsequent Regulation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, (&#8220;Affordable Care Act&#8221;), which has resulted in significant changes to the health care industry. The primary goal of the legislation was to extend health care coverage to uninsured legal U.S. residents through both an expansion of public programs and reforms to private sector health insurance. The expansion of insurance coverage was expected to be funded in part by measures designed to promote quality and cost efficiency in health care delivery and by budgetary savings in the Medicare and Medicaid programs. Because the Company is not a health care provider, we were not directly affected by the law, but we could be indirectly affected principally as follows:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in the number of insured residents could potentially increase the number of patients seeking Gamma Knife or radiation therapy treatment.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s retail contracts are subject to reimbursement rate changes for radiosurgery or radiation therapy services by the government or other third-party payors. Any changes to Medicare or Medicaid reimbursement through the repeal or modification of the Affordable Care Act could affect revenue generated from these sites.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the provisions of the Affordable Care Act have yet to be fully implemented, while certain provisions have been subject to judicial and Congressional challenges. While Congress has not passed comprehensive repeal legislation, it has enacted laws that modify certain provisions of the Affordable Care Act such as removing penalties, starting January 1, 2019, for not complying with the Affordable Care Act&#8217;s individual mandate to carry health insurance and delaying the implementation of certain Affordable Care Act-mandated fees. On December 14, 2018, a U.S. District Court Judge in the Northern District of Texas, or Texas District Court Judge, ruled that the individual mandate is a critical and inseverable feature of the Affordable Care Act, and therefore, because it was repealed as part of the Tax Cuts and Jobs Act, the remaining provisions of the Affordable Care Act are invalid as well. While the Texas District Court Judge and CMS, have stated that the ruling will have no immediate effect, it is unclear how this decision, subsequent appeals, and other efforts to repeal and replace the Affordable Care Act will impact the Affordable Care Act.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other legislative changes have been proposed and adopted in the United States since the Affordable Care Act was enacted. On August 2, 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. This includes aggregate reductions to Medicare payments to providers of up to 2% per fiscal year, started in April 2013, and, due to subsequent legislative amendments, will stay in effect through 2027 unless additional Congressional action is taken. On January 2, 2013, the then-U.S. President signed into law the American Taxpayer Relief Act of 2012, which, among other things, also reduced Medicare payments to several providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. It is unclear what effect, if any, the shifting legislative and other governmental proposals would have on our business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT REGULATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payment of remuneration to induce the referral of health care business has been a subject of increasing governmental and regulatory focus in recent years. Section 1128B(b) of the Social Security Act (sometimes referred to as the &#8220;federal anti-kickback statute&#8221;) provides criminal penalties for individuals or entities that offer, pay, solicit or receive remuneration in order to induce referrals for items or services for which payment may be made under the Medicare and Medicaid programs and certain other government funded programs. The Affordable Care Act amended the anti-kickback statute to eliminate the requirement of actual knowledge, or specific intent to commit a violation, of the anti-kickback statute. The Social Security Act authorizes the Office of Inspector General through civil proceedings to exclude an individual or entity from participation in the Medicare and state health programs if it is determined any such party has violated Section 1128B(b) of the Social Security Act. However, the federal anti-kickback statute is subject to evolving interpretations. In the past, the government has enforced the federal anti-kickback statute to reach large settlements with healthcare companies based on sham consulting and other financial arrangements with physicians. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, the government may assert that a claim including items or services resulting from a violation of the federal anti-kickback statute constitutes a false or fraudulent claim for purposes of the False Claims Act. The Company believes that it is in compliance with the federal anti-kickback statute. Additionally, the majority of states also have anti-kickback laws, which establish similar prohibitions and, in some cases, may apply to items or services reimbursed by any third-party payor, including commercial insurers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Omnibus Budget Reconciliation Act of 1993, often referred to as &#8220;Stark II&#8221;, bans physician self-referrals to providers of designated health services with which the physician has a financial relationship. On September 5, 2007, the third and final phase of the Stark regulations (Phase III) was published. The term &#8220;designated health services&#8221; includes, among others, radiation therapy services and in-patient and out-patient hospital services. On January 1, 1995, the Physician Ownership and Referral Act of 1993 became effective in California. This legislation prohibits physician self-referrals for covered goods and services, including radiation oncology, if the physician (or the physician's immediate family) concurrently has a financial interest in the entity receiving the referral. The Company believes that it is in compliance with these rules and regulations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 19, 2008, the CMS published a final rule relating to inpatient hospital services paid under the Inpatient Prospective Payment System for discharges in the Fiscal Year 2009 (the &#8220;Final Rule&#8221;). Among other things, the Final Rule prohibits &#8220;per-click payments&#8221; to certain physician lessors for services rendered to patients who were referred by the physician lessor. This prohibition on per-click payments for leased equipment used in the treatment of a patient referred to a hospital lessee by a physician lessor applies regardless of whether the physician himself or herself is the lessor or whether the lessor is an entity in which the referring physician has an ownership or investment interest. The effective date of this prohibition was October 1, 2009. However, referrals made by a radiation oncologist for radiation therapy or ancillary services necessary for, and integral to, the provision of radiation therapy (such as Gamma Knife services) are not subject to this prohibition so long as certain conditions are met. GK Financing&#8217;s majority owned subsidiaries, AGKE and JGKE have minority ownership interests that are held solely by radiation oncologists, who are otherwise exempt from the referral prohibition under the Final Rule. The Company believes it is in compliance with the Final Rule.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A range of federal civil and criminal laws target false claims and fraudulent billing activities. One of the most significant is the Federal False Claims Act, which prohibits the submission of a false claim or the making of a false record or statement in order to secure a reimbursement from a government-sponsored program. In recent years, the federal government has launched several initiatives aimed at uncovering practices which violate false claims or fraudulent billing laws. Claims under these laws may be brought either by the government or by private individuals on behalf of the government, through a &#8220;whistleblower&#8221; or &#8220;qui tam&#8221; action. The Company believes that it is in compliance with the Federal False Claims Act; however, because such actions are filed under seal and may remain secret for years, there can be no assurance that the Company or one of its affiliates is not named in a material qui tam action.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislation in various jurisdictions requires that health facilities obtain a Certificate of Need (&#8220;CON&#8221;) prior to making expenditures for medical technology in excess of specified amounts. Four of the Company&#8217;s existing customers were required to obtain a CON or its equivalent. The CON procedure can be expensive and time consuming and may impact the length of time before Gamma Knife services commence. CON requirements vary from state to state in their application to the operations of both the Company and its customers. In some jurisdictions the Company is required to comply with CON procedures to provide its services and in other jurisdictions customers must comply with CON procedures before using the Company's services. The Company is unable to predict if any jurisdiction will eliminate or alter its CON requirements in a manner that will increase competition and, thereby, affect the Company's competitive position.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Gamma Knife units contain Cobalt 60 radioactive sources. The medical centers that house the Company's Gamma Knife units are responsible for obtaining possession and user's licenses for the Cobalt 60 source from the Nuclear Regulatory Commission. The Company&#8217;s Gamma Knife center in Peru was responsible for obtaining possession and user&#8217;s licenses for the Cobalt-60 sources from the Peruvian Regulatory Agencies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standard linear accelerator equipment utilized to treat patients is regulated by the FDA. The licensing is obtained by the individual medical center operating the equipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes it is in substantial compliance with the various rules and regulations that affect its businesses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INSURANCE AND INDEMNIFICATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts with equipment vendors generally do not contain indemnification provisions. The Company maintains a comprehensive insurance program covering the value of its property and equipment, subject to deductibles, which the Company believes are reasonable.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's customer contracts generally contain mutual indemnification provisions. The Company maintains general and professional liability insurance in the United States. The Company is not involved in the practice of medicine and therefore believes its present insurance coverage and indemnification agreements are adequate for its business. The Company&#8217;s Peruvian and Ecuadorian Gamma Knife centers are free-standing facilities operated by GKPeru and GKCE, respectively. The treating physicians and clinical staff are these facilities are independent contractors. The Company maintains general and professional liability insurance consistent with the operations of these facilities and believes its present coverage is adequate for its business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMPLOYEES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company employed ten (10) people on a full-time basis in the United States, five (5) people on a full-time basis in Lima, Peru, and six (6) people on a full-time basis in Guayaquil, Ecuador. None of these employees are subject to a collective bargaining agreement and there is no union representation within the Company. The Company maintains various employee benefit plans and believes that its employee relations are good.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OFFICERS OF THE COMPANY</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides current information concerning those persons who serve as executive officers of the Company. The executive officers were appointed by the Board of Directors and serve at the discretion of the Board of Directors.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:24.559%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Age:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raymond C. Stachowiak</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Craig K. Tagawa</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Chief Operating and Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ernest R. Bates</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President </span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Raymond C. Stachowiak has served as Chief Executive Officer of the Company since October 1, 2020.  Mr. Stachowiak served as Interim President and Chief Executive Officer effective as of May 4, 2020 through September 30, 2020.  Mr. Stachowiak joined the Board in 2009.  Mr. Stachowiak previously served as President and Chief Executive Officer of Shared Imaging, a preferred independent provider of CT, MRI and PET/CT equipment and services, from its inception in December 1991 until his retirement in March 2013.  In 2008, Mr. Stachowiak sold 50% of his interest in Shared Imaging to Lubar Equity Fund and remains a 50% owner of Shared Imaging.  Mr. Stachowiak is the sole owner of RCS Investments, Inc., and owner-manager of Stachowiak Equity Fund, both of which are private equity funds.  Mr. Stachowiak received a B.S. in Business and an M.B.A. from Indiana University.  He is a Certified Public Accountant (inactive), Certified Internal Auditor (inactive) and holds a Certification in Production and Inventory Management.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Craig K. Tagawa assumed the title of President on October 1, 2020 along with his duties as Chief Operating Officer since February 1999 and Chief Financial Officer since May 1996. Mr. Tagawa also served as Chief Financial Officer from January 1992 through October 1995. Previously a Vice President in such capacity, Mr.&#160;Tagawa became a Senior Vice President on February&#160;28,&#160;1993 and President on September 16, 2020. He is also the Chief Executive Officer and policy committee member of GKF. From September 1988 through January 1992, Mr.&#160;Tagawa served in various positions with the Company. Mr. Tagawa currently serves as Chief Financial Officer and Secretary of the Ernest Bates Foundation. He received his undergraduate degree from the University of California at Berkeley and his M.B.A. from Cornell University.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernest R. Bates joined the Company in January 2007 as Vice President of Sales and Business Development, and assumed the title of Senior Vice President of Sales and Business Development, International Operations on October 1, 2020. In October 2020, he was appointed to and currently serves as a member of AHMC Seton Medical Community Advisory Board. He was on the Board of Directors of the Company from 2004 through February 2007. Prior to joining the Company, he had been Managing Director, Institutional Fixed Income Sales of HSBC Securities (USA), Inc. since 2003. Mr. Bates has also served as Managing Director, Head of Asian Product for HSBC Securities (USA) Inc. from 1999 to 2003. From 1993 through 1999, Mr. Bates held various positions with Merrill Lynch, last serving as Vice President, European Syndicate for Merrill Lynch International. He received his undergraduate degree from Brown University and a M.B.A. degree from The Wharton Business School. Ernest R. Bates is the son of Chairman of the Board Dr. Ernest A. Bates, founder of the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVAILABLE INFORMATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Internet address is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.ashs.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We make available free of charge, through our Internet website under the &#8220;Investor Center&#8221; tab in the &#8220;Corporate&#8221; section, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, annual proxy reports, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;) as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC. The information contained on our Internet website is not part of this document.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_19"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the other information in this report, the following factors could affect our future business, results of operations, cash flows or financial position, and could cause future results to differ materially from those expressed in any of the forward-looking statements contained in this report.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Company, Industry and Economic Risk</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Impact of the COVID-19 pandemic and associated economic disruptions may continue to adversely affect the company&#8217;s business operations and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing novel coronavirus COVID-19 has spread across the globe, has been declared a national emergency in the United States and, during 2020, shut down many business operations around the globe. Many states and municipalities in the United States, including California, have recommended or mandated aggressive and unprecedented actions to reduce the spread of the disease, including limiting non-essential gatherings of people, ceasing all non-essential travel, ordering certain businesses and government agencies to cease non-essential operations at physical locations and issuing shelter-in-place&#8221; orders, which direct individuals to shelter at their places of residence (subject to limited exceptions). Across our operations, although most governmental restrictions on certain medical procedures have been lifted, the pandemic adversely impacted our business, as healthcare resources were being prioritized for the treatment and management of the outbreak in some cases. Consequently, there were and continue to be delays in delivering certain Gamma Knife and PBRT treatments and significant volatility or reductions in demand for such treatments may continue. The COVID-19 pandemic poses the risk that the Company or its employees, contractors, customers, government and third party payors and others may be prevented from conducting business activities at full capacity for an indefinite period of time, including due to spread of the disease within these groups or due to shutdowns that have been and may continue to be recommended or mandated by governmental authorities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A broad, sustained continuation of the COVID-19 pandemic could continue to negatively impact the Company for the following reasons: </span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operations at certain medical facilities, including medical professionals and other medical facility employees, may be subject to prolonged closure or shut down and may impact our ability to market and deliver Gamma Knife and PBRT treatments; </span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">medical facilities may defer certain Gamma Knife and PBRT treatments for non-urgent patient cases in order to allocate resources to the care of patients with COVID-19; </span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patients may continue to defer certain Gamma Knife and PBRT treatments due to real or perceived concerns about the potential spread of COVID-19 in a medical facility setting; </span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain deferred Gamma Knife and PBRT treatments may not be rescheduled for a later date; </span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there may be significant volatility or continued reductions in demand for Gamma Knife and PBRT treatments due to limitations on operations at medical facilities, including in geographies that continue to experience severe impacts of the pandemic; </span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the pandemic may materially impact the Company&#8217;s operations for a sustained period of time due to the current travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns, including at our corporate headquarters in San Francisco, California; </span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">and/or members of the board, management or employee team, some of whom are particularly at risk for the severe symptoms of COVID-19, or of our small number of other employees, may become ill or have family members who are ill and are absent as a result, or they may elect not to come to work due to the illness affecting others in our office or facilities.</span></div><div style="padding-left:13.5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any of the foregoing events could have a material adverse effect on our business, results of operations, financial condition, liquidity and cash flows. The COVID-19 pandemic and mitigation measures have had and may continue to have an adverse impact on global economic conditions and healthcare activity, which could have an adverse effect on the Company&#8217;s business and financial condition. The full impact of the COVID-19 pandemic remains unknown, including the impact on the global economy and the healthcare industry. The extent to which the COVID-19 outbreak impacts the Company&#8217;s results will depend on future developments that are highly uncertain and cannot be predicted, including new information that may emerge concerning the severity of the virus, the effectiveness and implementation of vaccinations to counter the virus, actions to contain its impact, the efficacy of the current governmental orders in slowing down the pandemic, the governments&#8217; changing calculations on the economic impact and the health implications of maintaining these orders, the progress in the healthcare industry&#8217;s ability to effectively combat the virus, and potential increase or decrease in healthcare demand, volatility and uncertainty resulting from COVID-19 responses, all of which are highly unpredictable. Likewise, the financial market as a whole has experienced extreme volatility as a result of the global economic impact of the COVID-19 pandemic, which has impacted, and may continue to impact, the Company&#8217;s stock price.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We refer you to &#8220;Management&#8217;s Discussion and Analysis of Financial Position and Results of Operations&#8221; for a more detailed discussions of the potential impact of the COVID-19 pandemic and associated economic disruptions, and the actual operational and financial impacts that we have experienced to date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If the Company is not successful at diversifying its business model, its revenues and profitability may decline.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has historically relied on Gamma Knife unit placement and a PBRT system to provide its revenues.  Currently, there is a limited market for Gamma Knife equipment and there are few prospects for PBRT systems. As a result, we plan to adapt our business model to place other types of stereotactic radiosurgery and advanced radiation therapy equipment in addition to Gamma Knife units and PBRT systems. This will constitute a reorientation for the Company and there can be no assurance that we can successfully adapt our historical business model to these new product offerings. If we are not successful, our revenues and profitability could decline substantially as existing contracts expire and are not renewed. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The Federal reimbursement rate for Gamma Knife treatments may not provide the Company with an adequate return on its investment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Congress enacted legislation in 2013 that significantly reduced the Medicare reimbursement rate for outpatient Gamma Knife treatment by setting it at the same amount paid for linear accelerator-based radiosurgery treatment. Gamma Knife treatment has been relatively stable during the last five years. There can be no assurance that CMS reimbursement levels will be maintained at levels providing the Company an adequate return on its investment. Any future reductions in the reimbursement rate would adversely affect the Company&#8217;s revenues and financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Introduction of the RO APM Reimbursement Model.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 18, 2020, CMS issued the final rule that would implement a new mandatory payment model for radiation oncology services: the Radiation Oncology Alternative Payment Model (&#8220;RO APM&#8221;). The RO APM is scheduled to commence January 1, 2022 and will be in effect for a five (5) year period.  The RO APM significantly alters CMS' payment methodology from a fee for service paradigm to a set reimbursement by cancer type methodology for radiation services provided within a 90 day episode of care. Under the RO APM, hospital based and free-standing radiation therapy providers are mandatorily required to participate in the model based on whether the radiation therapy provider is located within a randomly selected Core Based Statistical Area ("CBSA"). CMS projects that providers treating approximately 30% of radiation oncology patients have been selected to participate in the RO APM. The remaining providers not included in the RO APM will continue to receive reimbursement based on a fee-for-service methodology.  The RO APM includes but is not limited to PBRT and Gamma Knife services. Four (4) of the Company's Gamma Knife centers are scheduled to be included in the RO APM.  It is not anticipated that inclusion in the RO APM will have a significant impact on the Company's Gamma Knife revenues. The Company's PBRT center was not selected for inclusion in the RO APM. For centers not included in the RO APM proposed model, Medicare reimbursement in 2021 for the most commonly used PBRT delivery codes will increase by approximately 4.1% and decrease by approximately 1.7% for Gamma Knife.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The Company&#8217;s capital investment at each site is substantial and the Company may not be able to fully recover its costs or capital investment which could have a material negative impact on its revenues and financial results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Gamma Knife, PBRT or advanced LINEAR accelerator device requires a substantial capital investment. In some cases, we contribute additional funds for capital costs and/or annual operating and equipment related costs such as marketing, maintenance, insurance and property taxes. Due to the structure of our contracts with medical centers, there can be no assurance that these costs will be fully recovered or that we will earn a satisfactory return on our investment, which could have a material negative impact on our revenues and financial results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market for the Gamma Knife is limited and the Company may not be able to place additional Gamma Knife units which could negatively impact the Company's revenue and financial results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a limited market for the Gamma Knife, and the market in the United States may be mature. The Company has begun and continued operation at only seven (7) new Gamma Knife sites in the United States since 2011. Due to the substantial costs of acquiring a Gamma Knife unit, we must identify medical centers that possess neurosurgery and radiation oncology departments capable of performing a large number of Gamma Knife procedures. As of December&#160;31, 2020, there were approximately 116 operating Gamma Knife units in the United States, of which fourteen (14) units were owned by the Company. There can be no assurance that we will be successful in placing additional units at any sites in the future. The Company&#8217;s existing contracts with its customers are fixed in length and there can be no assurance that the customers will wish to extend the contract beyond the end of the term.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company has a high level of debt and may incur additional debt to finance its operations and if the Company is unable to secure additional credit in the future its operations and profits will be negatively impacted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business is capital intensive. The Company finances its Gamma Knife units through its GKF subsidiary. The amounts financed through GKF have been generally non-recourse to ASHS. The Company financed its first proton therapy unit through its wholly-owned subsidiary, Orlando, and guaranteed the lease financing. The Company&#8217;s combined long-term debt and finance leases totaled $13,516,000 as of December&#160;31, 2020 and is collateralized by its Gamma Knife, MEVION S250 and other assets, including accounts receivable and future proceeds from any contract between the Company and any end user of the financed equipment. Depending on the Company&#8217;s financing requirements and market conditions, the Company may seek to finance its operations by incurring additional long-term debt in the future. The Company&#8217;s current level of debt may adversely affect the Company&#8217;s ability to secure additional credit in the future, and as a result may affect operations and profitability. If a default on debt occurs in the future, the Company&#8217;s creditors would have the ability to accelerate the defaulted loan, to seize the Gamma Knife or MEVION S250 units or other equipment with respect to which default has occurred, and to apply any collateral they may have at the time to cure the default.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A small number of customers account for a major portion of our revenues and the loss of any one of theses significant customers could have a material adverse effect on the Company's business and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of customers have historically accounted for a substantial portion of the Company&#8217;s total revenue, and the Company expects such customer concentration to continue for the foreseeable future. For example, in 2020, four (4) customers in total accounted for approximately 50% of the Company&#8217;s revenue. The loss of a significant customer or a significant decline in the business from the Company&#8217;s largest customers could have a material adverse effect on the Company&#8217;s business and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market for the company&#8217;s services is competitive and if the Company is not able to compete its business and results of operations could be negatively impacted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates that there are two other companies that actively provide alternative, non-conventional Gamma Knife financing to potential customers. The Company&#8217;s relationship with Elekta, the manufacturer of the Leksell Gamma Knife unit, is non-exclusive, and in the past the Company has lost sales to customers that chose to purchase a Gamma Knife unit directly from Elekta. The Company also has several competitors in the financing of proton therapy projects. The Company&#8217;s business model differs from its competitors, but there can be no assurances that the Company will not lose placements to its competitors. In addition, the Company may continue to lose future sales to customers purchasing equipment directly from manufacturers. There can be no assurance that the Company will be able to successfully compete against others in placing future units and if the Company is not able to compete its business and results of operations could be negatively impacted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There are alternatives to the Gamma Knife and medical centers could choose to use other radiosurgery devices instead of the Gamma Knife.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other radiosurgery devices and conventional neurosurgery compete against the Gamma Knife. Each of the medical centers targeted by the Company could decide to acquire another radiosurgery device instead of a Gamma Knife to perform cranial radiosurgery. In addition, neurosurgeons who are responsible for referring patients for Gamma Knife surgery may not be willing to make such referrals for various reasons, instead opting for invasive surgery. Because of these competing technologies, there can be no assurance that the Company will be able to secure a sufficient number of future sites or Gamma Knife procedures to sustain its profitability and growth and accordingly there may be a material negative impact on the business and results of operations of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Operations </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">make the Company vulnerable to risks associated with doing business in foreign countries that can affect its business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company installed a Gamma Knife unit in Lima, Peru in 2017 and acquired a Gamma Knife unit operation in Guayaquil, Ecuador in 2020. International operations can be subject to exchange rate volatility, which could have an adverse effect on our financial results and cash flows. In addition, international operations can be subject to legal and regulatory uncertainty and political and economic instability, which could result in problems asserting property or contractual rights, potential tariffs, increased compliance costs, increased regulatory scrutiny, potential adverse tax consequences, the inability to repatriate funds to the United States, and the Company&#8217;s inability to operate in those locations.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New technology and products could result in making the Company's equipment obsolete which could have a material adverse impact on its business and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is constant change and innovation in the market for highly sophisticated medical equipment. New and improved medical equipment can be introduced that could make the Gamma Knife technology obsolete and that would make it uneconomical to operate. In 2006 Elekta introduced a new model of the Gamma Knife, the Perfexion, which the Company has implemented at all of its domestic sites. The Perfexion can perform procedures faster than previous Gamma Knife models and it involves less health care personnel intervention. In 2015, Elekta introduced the Leksell Gamma Knife Icon </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Perfexion is upgradeable to the Icon platforms which has enhanced imaging capabilities allowing for treatment without a head frame and the treatment of larger tumors. Existing model 4Cs of the Gamma Knife are not upgradeable to the Perfexion model. As of March 1, 2021, all the Company&#8217;s Gamma Knife units in the United States are Perfexion models and two (2) of these Perfexion units have the Icon upgrade. The Company's two (2) South American sites utilize the Model 4(C). The failure to acquire or use new technology and products could have a material adverse effect on our business and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company has invested in a Proton Beam business and is obligated to fund two additional proton beams systems; there is no assurance that the Company will be able to fund these additional proton systems and if the Company is unable to do so the may be a negative impact on the Company&#8217;s business and results of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have committed a substantial amount of our financial resources to next-generation proton beam technology. The first MEVION S250 system began treating patients in December 2013. The Company&#8217;s first MEVION S250 system began treating patients in April 2016. The Company has committed to purchase two (2) additional MEVION S250i systems and has already made deposits of $2,250,000 towards this commitment. There can be no assurance that we will be able to obtain additional customers or be able to finance the two additional systems. If we are unable to obtain additional customers or are unable to finance the two additional systems, the Company will lose its deposits and there may be a negative impact on the Company&#8217;s business and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Stock Ownership Risk</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Trading Volume of Our Common Stock is Low</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although our common stock is listed on the NYSE American, our common stock has historically experienced low trading volume. Reported average daily trading volume in our common stock for the three-month period ended December&#160;31, 2020 was approximately 105,000 shares. There is no reason to think that a further increase in an active trading market in our common stock will develop in the future. Limited trading volume subjects our common stock to greater price volatility and may make it difficult for you to sell your shares in a quantity or at a price that is attractive to you.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_22"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B. UNRESOLVED STAFF COMMENTS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_25"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. PROPERTIES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's corporate offices are located at Two Embarcadero Center, Suite 410, San Francisco, California, where it leases approximately 3,253 square feet for $20,747 per month with a lease expiration date in August 2023. The Company owns and operates a stand-alone Gamma Knife facility in Lima, Peru where it leases approximately 1,600 square feet for approximately $7,800 per month with a lease expiration date in January 2024.  The Company also owns and operates a stand-alone Gamma Knife facility in Guayaquil, Ecuador where it owns 864 square feet of condominium space in an office building and approximately 10,135 of related land and parking spaces.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_28"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. LEGAL PROCEEDINGS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no material pending legal proceedings involving the Company or any of its property. The Company knows of no legal or administrative proceedings against the Company contemplated by governmental authorities.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_31"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_37"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information and Dividend Policy</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's common shares, no par value (the &#8220;Common Shares&#8221;), are currently traded on the NYSE American. At December&#160;31, 2020, the Company had 5,791,000 issued and outstanding common shares, 417,000 common shares reserved for options, 13,000 unvested restricted stock units issued, and 210,000 vested restricted stock units.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates that there were approximately 1,100 beneficial holders of its Common Shares at December&#160;31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no dividends declared or paid during 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of 1,000,000 shares of its common stock on the open market from time to time at prevailing prices, and in 2008 the Board of Directors reaffirmed these authorizations. In 2020 and 2019 there were no shares repurchased by the Company. A total of approximately 928,000 shares have been repurchased in the open market pursuant to these authorizations at a cost of approximately $1,957,000. As of December&#160;31, 2020, there were approximately 72,000 shares remaining under the repurchase authorizations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plans</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 3,000 restricted stock units, 31,000 restricted stock units for deferred compensation, 100,000 shares for executive compensation, and 10,000 options were granted. Additional information regarding our equity compensation plans is incorporated herein by reference from the 2021 Proxy Statement. Also, see Note 9 - &#8220;Shareholders&#8217; Equity&#8221; to the Consolidated Financial Statements.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_40"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ITEM 6. SELECTED FINANCIAL DATA</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a smaller reporting company, as defined in Rule 10(f)(1) of Regulation S-K under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), the Company is not required to provide the information required by this item.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_43"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic, the resulting recession in the United States and its follow-on effects have impacted and will likely continue to impact business activity across industries, including the Company&#8217;s. During 2020, due to factors related to the COVID-19 pandemic such as delays in service at medical facilities and restrictions imposed by government agencies, and the Company&#8217;s customers in response to the spread of COVID-19, the Company experienced some delays in delivering certain Gamma Knife procedures and PBRT treatments. Similarly, the Company&#8217;s ability to conduct commercial efforts with its customers have been and are likely to continue to be disrupted as customers have turned their focus to dealing with the impact of the COVID-19 pandemic on their operations and have restricted access to their sites in efforts to contain the spread of the virus. The global nature of the pandemic has resulted in authorities implementing numerous measures designed to contain the virus, including travel bans and restrictions, border closures, quarantines, shelter-in-place orders, business limitations and shutdowns. The impact of the COVID-19 pandemic on the global economy and capital markets is significant, and on June 8, 2020 the National Bureau of Economic Research announced that the United States was in an economic recession. An extended economic recession in the United States or elsewhere could have a material adverse effect on the Company&#8217;s ability to conduct its business and to access financing, as well as on the Company&#8217;s results of operation, financial condition, liquidity and cash flows. The prioritization of COVID-19 treatment and containment has resulted in delays in decisions by the Company&#8217;s customers and their patients, obstacles to the Company&#8217;s ability to market and deliver its services, declines in treatment volumes and adverse impacts to revenues for both Gamma Knife procedures and PBRT treatments. As a result of the pandemic and related governmental actions, Gamma Knife procedures and PBRT treatments, which currently make up all of the Company&#8217;s revenue, may be impacted differently at each of the Company&#8217;s various locations and may take longer to recover than other areas of the economy, which may have a material impact on the Company's business. The Company&#8217;s Gamma Knife operations in Latin America have experienced a decline in procedures due to the COVID-19 pandemic. Our Gamma Knife and PBRT operations in the United States have also experienced negative impacts from the COVID-19 pandemic. As the COVID-19 pandemic continues to develop, additional impacts may arise that we are not aware of currently.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of the COVID-19 pandemic for the year ended December&#160;31, 2020 has varied by location based on the stage of containment and actions by government agencies. The impact on treatments and costs in the three-month period ended March 31, 2020 did not appear material. The impact of the COVID-19 pandemic has been greater for the three-month periods ended June 30, 2020, September 30, 2020, and December 31, 2020, including declines in patient volumes and corresponding reductions in Gamma Knife procedures and reduced PBRT fractions during the second and fourth quarters.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_46"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPLICATION OF CRITICAL ACCOUNTING POLICIES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated financial statements are prepared in accordance with generally accepted accounting principles and follow general practices within the industry in which it operates. Application of these principles requires management to make estimates, assumptions and judgments that affect the amounts reported in the financial statements and accompanying notes. These estimates, assumptions and judgments are based on information available as of the date of the financial statements; accordingly, as this information changes, the financial statements could reflect different estimates, assumptions and judgments. Certain policies inherently have a greater reliance on the use of estimates, assumptions and judgments and as such have a greater possibility of producing results that could be materially different than originally reported.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant accounting policies followed by the Company are presented in Note 2 to the consolidated financial statements. These policies along with the disclosures presented in the other financial statement notes and, in this discussion, and analysis, provide information on how significant assets and liabilities are valued in the financial statements and how those values are determined. Based on the valuation techniques used and the sensitivity of financial statement amounts, and the methods, assumptions and estimates underlying those amounts, management has identified revenue recognition and costs of sales for turn-key and revenue sharing arrangements, and the carrying value of fixed assets and useful lives, and as such could be most subject to revision as new information becomes available. The following are our critical accounting policies in which management&#8217;s estimates, assumptions and judgments most directly and materially affect the financial statements:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenues under Accounting Standards Codification (&#8220;ASC&#8221;) 842 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 842&#8221;) and ASC 606 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 606&#8221;). The Company had sixteen (16) Gamma Knife units and one (1) PBRT system in operation as of December&#160;31, 2020. Four (4) of the Company&#8217;s customer contracts are through subsidiaries where GKF or its subsidiary is the majority owner and managing partner. Six (6) of the Company&#8217;s sixteen (16) current Gamma Knife customers are under fee-per-use contracts, and eight (8) customers are under retail arrangements. The Company, through GKF, also owns and operates single-unit Gamma Knife facilities in Lima, Peru and Guayaquil, Ecuador. These units economically function similar to the Company&#8217;s turn-key retail arrangements. The Company&#8217;s PBRT system at Orlando Health &#8211; UF Health Cancer Center (&#8220;Orlando Health&#8221;), is also considered a retail arrangement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Rental Income from Medical Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenues under ASC 842 when services have been rendered and collectability is reasonably assured, on either a fee per use or revenue sharing basis. The terms of the contracts do not contain any guaranteed minimum payments. The Company&#8217;s contracts are typically for a ten-year term and are classified as either fee per use or retail. Retail arrangements are further classified as either turn-key or revenue sharing. Revenues from fee per use contracts is determined by each hospital&#8217;s contracted rate. Revenues are recognized at the time the procedures are performed, based on each hospital&#8217;s contracted rate and the number of procedures performed. Under revenue sharing arrangements, the Company receives a contracted percentage of the reimbursement received by the hospital. The amount the Company expects to receive is recorded as revenue and estimated based on historical experience. Revenue estimates are reviewed periodically and adjusted as necessary. Under turn-key arrangements, the Company receives payment from the hospital in the amount of the hospital&#8217;s reimbursement from third party payors, and the Company is responsible for paying all the operating costs of the equipment. Operating costs are determined primarily based on historical treatment protocols and cost schedules with the hospital. The Company records an estimate of operating costs which are reviewed on a regular basis and adjusted as necessary to more accurately reflect the actual operating costs. For turn-key sites, the Company also shares a percentage of net operating profit. The Company records an estimate of net operating profit based on estimated revenues, less estimated operating costs. The operating costs and estimated net operating profit are recorded as other direct operating costs in the consolidated statement of operations. As of December&#160;31, 2020 and 2019, the Company recognized revenues of approximately $16,204,000 and $19,396,000 under ASC 842, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from retail arrangements amounted to approximately 64% and 64% of total revenue for the years ended December&#160;31, 2020 and 2019, respectively. Because the revenue estimates are reviewed on a quarterly basis, any adjustments required for past revenue estimates would result in an increase or reduction in revenue during the current quarterly period.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Patient Income</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has stand-alone facilities in Lima, Peru and Guayaquil, Ecuador, where a contract exists between the Company&#8217;s facilities and the individual patient treated at the facility. Under ASC 606, the Company acts as the principal in this transaction and provides, at a point in time, a single performance obligation, in the form of a Gamma Knife treatment. Revenue related to a Gamma Knife treatment is recognized on a gross basis at the time when the patient receives treatment. There is no variable consideration present in the Company&#8217;s performance obligation and the transaction price is agreed upon per the stated contractual rate. GKPeru's payment terms are typically prepaid for self-pay patients and insurance provider payments are paid net 30 days. GKCE's patient population is primarily covered by a government payor and payments are paid approximately 30 to 60 days upon invoice. The Company did not capitalize any incremental costs related to the fulfillment of its customer contracts.  Accounts receivable earned by GKPeru were not significant for the year ended December&#160;31, 2020 and 2019. GKCE's accounts receivable were $467,000 for the year ended December&#160;31, 2020. As of December&#160;31, 2020 and 2019, the Company recognized revenues of approximately $1,633,000 and $1,209,000 under ASC 606, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Results</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, 65% of the Company&#8217;s revenue was derived from its Gamma Knife business and 35% was derived from the PBRT system. For the year ended December&#160;31, 2019, 66% of the Company&#8217;s revenue was derived from its Gamma Knife business, 30% was derived from the PBRT system, and the remaining 4% from its IGRT business. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TOTAL REVENUE</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue in 2020 decreased 13.4% compared to 2019 primarily due to a decrease in average reimbursement for Gamma Knife procedures and a decrease in PBRT fractions.  This decrease in volumes was partially attributable to the COVID-19 pandemic.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gamma Knife Revenue</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from Gamma Knife (in thousands)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Gamma Knife procedures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,498&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average revenue per procedure</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gamma Knife revenue for 2020 was $11,670,000 compared to $13,551,000 in 2019.  Gamma Knife revenue for 2020 decreased $1,881,000 compared to 2019 due to a lower average reimbursement at the Company's retail sites driven by an increase in patients with Medicare coverage and a decrease in patients with Commercial insurance.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of Gamma Knife procedures performed in 2020 increased 32 compared to 2019 due to the Company's acquisition of GKCE in June 2020.  This increase was offset by a Gamma Knife contract that terminated in October 2020 and due to the impact of the COVID-19 pandemic. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, an existing Gamma Knife customer contract expired.  The site operated on a month-to-month basis through October 2020, when the customer notified the Company of their intent to terminate.  Two additional existing Gamma Knife customers notified the Company of their intent to not renew their contract during the third and fourth quarters of 2020.  One of the contracts terminated in February 2021 and the second is set to expire in December 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue per procedure decreased by $1,283 and in 2020 compared to 2019.  For 2020, the decrease was due to lower average reimbursement at the Company's retail sites.   </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Proton Therapy Revenue</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from PBRT (in thousands)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of PBRT fractions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,868&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,018&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average revenue per fraction</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PBRT revenue for 2020 was $6,167,000 compared to $6,214,000 in 2019. The number of PBRT fractions performed in 2020 was 5,868 compared to 6,018 in 2019.  Revenue per fraction in 2020 was $1,051 compared to $1,033 in 2019. In 2020, the Company's PBRT revenue declined due to an impact on volumes in the second and fourth quarter from the COVID-19 pandemic.  The Company's proton therapy system also experienced some down-time for maintenance in the third quarter of 2020.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IGRT Revenue</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from IGRT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IGRT revenue for 2020 was $0 compared to $840,000 in 2019. IGRT revenue decreased for 2020 as the result of the winding down of the Company&#8217;s IGRT system, which was being used as a back-up system at the customer site.  The Company&#8217;s contract for its IGRT equipment expired in April 2020 and the Company agreed to sell the equipment to its existing customer for $150,000, which was equal to the equipment's salvage value. The Company sold the equipment in July 2020.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COSTS OF REVENUE</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's costs of revenue, consisting of maintenance and supplies, depreciation and amortization, and other operating expenses (such as insurance, property taxes, sales taxes, marketing costs and operating costs from the Company&#8217;s retail sites) decreased by $314,000 in 2020 compared to 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maintenance and supplies costs as a percentage of total revenue were 13.4% and 12.7% in 2020 and 2019. Maintenance and supplies costs decreased by $233,000 in 2020 compared to 2019. The decrease in 2020 compared to 2019 was due to a decrease in time and materials costs at the Company's existing sites.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization costs as a percentage of total revenue were 38.1% and 35.6% in 2020 and 2019. Depreciation and amortization costs decreased $552,000 in 2020 compared to 2019. The decrease in 2020 compared to 2019 was primarily due to depreciation incurred on the Company's Gamma Knife and IGRT equipment at its location in Boston, Massachusetts in 2019, offset by increased depreciation recognition at two of the Company's expiring Gamma Knife sites.  One of these contracts expired in October 2020 and the second expired in the first quarter of 2021.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other direct operating costs as a percentage of total revenue were 23.5% and 18.1% in 2020 and 2019. Other direct operating costs increased by $471,000 in 2020 compared to 2019. The increase in 2020 is primarily due to operating costs from the Company's acquisition of GKCE in June 2020. </span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_49"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SELLING AND ADMINISTRATIVE EXPENSE</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's selling and administrative costs increased $548,000 in 2020 compared to 2019. The increase in 2020 was due to legal and other fees, including, but not limited to the COVID-19 pandemic and the transition in senior management and tax, legal, and consulting fees related to the Company's acquisition of GKCE of approximately $162,000.  </span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_52"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEREST EXPENSE</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's interest expense decreased $261,000 in 2020 compared to 2019. The decrease in 2020 was primarily due to a lower average principal base for the Company&#8217;s lease and debt portfolio, effectively reducing interest expense. </span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_58"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(LOSS) ON WRITE DOWN OF IMPAIRED ASSETS AND ASSOCIATED REMOVAL COSTS</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) on write down of impaired assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Not meaningful</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company recognized a loss on the write down of impaired assets of $8,264,000.  The Company reviewed its long-lived assets and deposits during the fourth quarter of 2020 and concluded events and circumstances existed that indicated the value of these assets was more-than temporarily impaired. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impaired assets included six (6) Gamma Knife units and related removal costs, and two (2) deposits towards the purchase of proton beam systems and related capitalized interest. The six (6) Gamma Knife units that were impaired consisted of two (2) units that had been taken out of service in prior years, one (1) unit that was taken out of service in 2020 and three (3) units that have already been or the Company anticipates will be taken out of service in 2021.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_61"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEREST AND OTHER INCOME</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income decreased $6,000 in 2020 compared to 2019. Interest and other income is generally comprised of interest expense and interest earned, and increases or decreases generally reflect fluctuations in these amounts.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_64"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCOME TAX EXPENSE</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,737)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of income, after net income attributable to non-controlling interests, and before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Not meaningful</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense decreased $1,865,000 in 2020 compared to 2019.  The decrease in income tax benefit provision in 2020 was due to the loss on write-down of impaired assets recorded during the year ended December&#160;31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company anticipates that it will continue to record income tax expense if it operates profitably in the future. Currently there are state income tax payments required for most states in which the Company operates. At December 31, 2020, the Company exhausted the remainder of its net operating loss carryforward for federal income tax return purposes. The Company has net operating loss carryforwards for state income tax purposes.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NET INCOME ATTRIBUTABLE TO NON-CONTROLLING INTERESTS</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(658)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to non-controlling interests decreased $1,429,000 in 2020 compared to 2019. Net income attributable to non-controlling interests represents the pre-tax income earned by the 19% non-controlling interest in GKF, and the pre-tax income or losses of the non-controlling interests in various subsidiaries controlled by GKF. The decrease or increase in net income attributable to non-controlling interests reflects the relative profitability of GKF.  The decrease in 2020 compared to 2019 was due to the loss on write off of impaired assets. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NET INCOME ATTRIBUTABLE TO AMERICAN SHARED HOSPITAL SERVICES</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands,</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">except per share amounts)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to ASHS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,058)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share attributable to ASHS, diluted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(1.14)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Not meaningful</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (loss) attributable to American Shared Hospital Services was $7,058,000 in 2020 compared to net income of $659,000 in 2019. Net loss decreased $7,717,000 in 2020 compared to 2019 due primarily to the loss on write down of impaired assets. </span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_70"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had cash and cash equivalents of $4,325,000 at December&#160;31, 2020 compared to $1,779,000 at December&#160;31, 2019, an increase of $2,546,000. The Company&#8217;s expected primary cash needs on both a short and long-term basis are for capital expenditures, business expansion, working capital, and other general corporate purposes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities provided cash of $9,745,000 in 2020, which was driven by non-cash charges for depreciation and amortization of $6,970,000, stock-based compensation expense of $299,000, non-cash lease expense of $288,000, a loss on the write-down of impaired assets of $8,184,000, interest expense associated with lease liabilities of $65,000, changes in receivables of $2,966,000, changes in prepaid and other assets of $762,000, and changes in other accrued liabilities, income taxes payable of $179,000, and deferred revenue of $263,000. These were offset by a net loss of $7,716,000, an income tax benefit of $2,162,000, and net lease liabilities of $353,000.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s trade accounts receivable decreased by $2,591,000 to $4,303,000 at December&#160;31, 2020 from $6,894,000 at December&#160;31, 2019, primarily due to an outstanding payment related to a contractual Medicare adjustment for one of the Company's Gamma Knife contracts, which was collected in January 2020, and an increase in collections from the Company's proton therapy customer. The number of days revenue (sales) outstanding (&#8220;DSO&#8221;) in accounts receivable as of December&#160;31, 2020 decreased to 88 days compared to 122 days at December&#160;31, 2019. DSO can and does fluctuate depending on timing of customer payments received and the mix of fee per use versus retail customers. Retail sites generally have longer collection periods than fee per use sites.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities used $2,389,000 of cash in 2020 due to payments made towards the purchase of property and equipment of $455,000 and payment for the Acquisition of $2,084,000, offset by proceeds from the sale of equipment of $150,000.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities used $4,810,000 of cash during 2020, primarily due to principal payments on long-term debt of $1,726,000, principal payments towards finance leases of $3,199,000, principal payments on short-term financing of $519,000, and distributions to non-controlling interests of $761,000. These decreases were offset by long-term debt financing of the Acquisition of $1,425,000.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had a working capital deficit at December&#160;31, 2020 of $1,530,000 compared to working capital of $2,528,000 at December&#160;31, 2019. The $4,058,000 decrease in net working capital was due to an decrease in accounts receivable and other receivables of $2,488,000, an increase in accounts payable of $126,000, an increase in employee compensation and benefits of $171,000, an increase in accrued liabilities of $266,000, asset retirement obligations of $1,270,000, an increase in income taxes payable of $243,000, working capital payment due of $197,000, increase in lease liabilities of $26,000, and an increase in finance leases of $2,236,000. This was offset by an increase in cash and restricted cash of $2,546,000, increases in prepaid and other assets of $50,000, and a decrease in long term debt of $369,000. The Company believes that its cash flow from cash on hand, operations, and other cash resources are adequate to meet its scheduled debt and finance lease obligations during the next 12 months. See additional discussion below related to commitments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, in the past, has secured financing for its Gamma Knife and radiation therapy units. The Company has secured financing for its projects from several lenders and anticipates that it will be able to secure financing on future projects from these or other lending sources, but there can be no assurance that financing will continue to be available on acceptable terms.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_82"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the Index to Consolidated Financial Statements and Financial Statement Schedules included at page F-1 of this report.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_85"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_88"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A. CONTROLS AND PROCEDURES</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Evaluation of disclosure controls and procedures.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and our Chief Financial Officer, after evaluating the effectiveness of the Company&#8217;s &#8220;disclosure controls and procedures&#8221; (as defined in the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;) Rules&#160;13a-15(e) and 15d-15(e)) as of the end of the period covered by this annual report, have concluded that our disclosure controls and procedures are effective based on their evaluation of these controls and procedures required by paragraph&#160;(b) of Exchange Act Rules 13a-15 or 15d-15.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Management&#8217;s report on internal control over financial reporting.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting. The Company&#8217;s internal control system was designed to provide reasonable assurance to its management and Board of Directors regarding the preparation and fair presentation of published financial statements.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assessed the effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2020. In making this assessment, it used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control &#8211; Integrated Framework (2013). Based on this assessment management believes that, as of December&#160;31, 2020, the Company&#8217;s internal control over financial reporting is effective based on those criteria.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company acquired Gamma Knife Center Ecuador S.A. (&#8220;GKCE&#8221;).  Management excluded GKCE from its report on internal controls over financial reporting as of December&#160;31, 2020. GKCE's financial statements constitute 3.8% and 3.6% of the Company&#8217;s consolidated total assets (excluding $1,343,000 of goodwill and intangible assets and $19,000 of land, which were integrated into the Company&#8217;s control environment), and revenues, respectively.  The Company will include GKCE in its assessment of the effectiveness of internal controls over financial reporting in fiscal year 2021 annual management report, the annual management report following the first anniversary of the acquisition.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Changes in internal controls over financial reporting.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and our Chief Financial Officer have evaluated the changes to the Company&#8217;s internal control over financial reporting that occurred during our last fiscal quarter ended December&#160;31, 2020, as required by paragraph&#160;(d) of Exchange Act Rules&#160;13a-15 and 15d-15, and have concluded that there were no such changes that materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_91"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B. OTHER INFORMATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_94"></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_97"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding directors is incorporated herein by reference from the Company&#8217;s definitive Proxy Statement for the 2021 Annual Meeting of Shareholders (the &#8220;2021 Proxy Statement&#8221;). Information regarding executive officers of the Company, included herein under the caption &#8220;Executive Officers of the Company&#8221; in Part I, Item 1 above, is incorporated herein by reference.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning the identification of our standing audit committee required by this Item is incorporated by reference from the 2021 Proxy Statement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning our audit committee financial experts required by this Item is incorporated by reference from the 2021 Proxy Statement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning compliance with Section 16(a) of the Exchange Act required by this Item is incorporated by reference from the 2021 Proxy Statement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a Code of Ethics that is available on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.ashs.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The information on our website is not part of this report. You may also request a copy of this document free of charge by writing our Corporate Secretary.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_100"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11. EXECUTIVE COMPENSATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this Item is incorporated herein by reference from the 2021 Proxy Statement.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_103"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this Item is incorporated herein by reference from the 2021 Proxy Statement.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_106"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this Item is incorporated herein by reference from the 2021 Proxy Statement.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_109"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this Item is incorporated herein by reference from the 2021 Proxy Statement.</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_112"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_115"></div><div style="-sec-extract:summary;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Financial Statements and Schedules.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Financial Statements and Schedules are filed with this Report:</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audited Consolidated Financial Statements</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Operations</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statement of Shareholders' Equity</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Statement Schedules- no schedules are included since the required information is not present or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the financial statements and notes thereto.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:72pt"><span><br/></span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Exhibits.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Exhibits are filed with this Report.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:7.719%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.860%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by reference herein</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420417027370/v466285_ex3-1.htm">3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Articles of Incorporation of the Company.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/15/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420417016805/v461869_ex3-1.htm">3.1a</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Amendment to Articles of Incorporation of the Company.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/27/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000074482521000014/a4847-5193x82661xamerica.htm">3.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By-laws of the Company, as amended and restated dated as of January 27, 2021.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/>001-08789</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/2/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ashs10-kexhibit41.htm">4.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K<br/>001-08789</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/6/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Agreement for GK Financing, LLC dated as of October 17, 1995 between American Shared Radiosurgery Services, Inc. and GKV Investments, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">033-63721</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/26/1995</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1a</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment Agreement dated as of October 26, 1995 to the GK Financing, LLC Operating Agreement between American Shared Radiosurgery Services, Inc. and GKV Investments, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">033-63721</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/29/1996</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1b</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment Agreement dated as of December 20, 1995 to the GK Financing, LLC Operating Agreement between American Shared Radiosurgery Services, Inc. and GKV Investments, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">033-63721</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/29/1996</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1c</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Amendment Agreement dated as of October 16, 1996 to the GK Financing, LLC Operating Agreement between American Shared Radiosurgery Services, Inc. and GKV Investments, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13b</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/31/1998</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1d</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment Four Agreement dated as of March 31, 1998 to the GK Financing, LLC Operating Agreement between American Shared Radiosurgery Services, Inc. and GKV Investments, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/31/1999</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1e</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fifth Amendment Agreement dated as of March 31, 1998 to the GK Financing, LLC Operating Agreement between American Shared Radiosurgery Services, Inc. and GKV Investments, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/31/1999</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1f</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sixth Amendment Agreement dated as of June 5, 1998 to the GK Financing, LLC Operating Agreement between American Shared Radiosurgery Services, Inc. and GKV Investments, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/31/1999</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000095013407007237/f27578exv10w52.htm">10.1g</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seventh Amendment Agreement dated as of October 18, 2006 to the GK Financing, LLC Operating Agreement between American Shared Radiosurgery Services, Inc. and GKV Investments, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/2/2007</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-1h.htm">10.1h</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eighth Amendment Agreement dated as of April 28, 2010 to the GK Financing, LLC Operating Agreement between American Shared Radiosurgery Services, Inc. and GKV Investments, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1h</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-1i.htm">10.1i</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ninth Amendment Agreement dated as of May 16, 2011 to the GK Financing, LLC Operating Agreement between American Shared Radiosurgery Services, Inc. and GKV Investments, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1i</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:7.719%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-2.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease Agreement for a Gamma Knife Unit dated as of October 29, 1996 between GK Financing, LLC and Methodist Healthcare Systems of San Antonio, Ltd., dba Southwest Texas Methodist Hospital.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-2a.htm">10.2a</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum to Lease Agreement for a Gamma Knife Unit dated as of October 31, 1996 between GK Financing, LLC and Methodist Healthcare System of San Antonio, Ltd., dba Southwest Texas Methodist Hospital.&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2a</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-2b.htm">10.2b</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum Two to Lease Agreement for a Gamma Knife Unit dated as of October 16, 1997 between Methodist Healthcare System of San Antonio, Ltd., d.b.a. Southwest Texas Methodist Hospital and GK Financing, LLC.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2b</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-2c.htm">10.2c</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Lease Agreement for a Gamma Knife Unit dated as of December 13, 2003 between Methodist Healthcare Systems of San Antonio, Ltd., d/b/a Southwest Texas Methodist Hospital and GK Financing, LLC.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2c</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420410060491/v202286_ex10-18b.htm">10.2d</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment to Lease Agreement for a Gamma Knife Unit (Perfexion Upgrade) dated as of December 23, 2009 between GK Financing, LLC and Methodist Healthcare Systems of San Antonio, Ltd., d/b/a Southwest Texas Methodist Hospital.&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18b</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/15/2010</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416118323/v445336_ex10-1.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased Services Agreement (for a Gamma Knife Unit) dated as of November 19, 2008 between GK Financing, LLC and Kettering Medical Center.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/11/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416118323/v445336_ex10-1a.htm">10.4a</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment to Purchased Services Agreement (for a Gamma Knife Unit) dated as of June 11, 2009 between GK Financing, LLC and Kettering Medical Center.&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1a</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/11/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420415020527/v404375_ex10-21c.htm">10.4b</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment to Purchased Services Agreement (for a Gamma Knife Unit) dated as of February 27, 2014 between GK Financing, LLC and Kettering Medical Center.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21c</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2015</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000074482519000008/ex101.htm">10.4c</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Amendment to Purchased Services Agreement (for a Gamma Knife Unit) dated as of March 28, 2019 between GK Financing, LLC and Kettering Medical Center</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>001-08789</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/7/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420414019552/v371940_ex10-22b.htm">10.5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease Agreement for a Gamma Knife Unit (Perfexion Upgrade) dated as of July 30, 2013 between Tufts Medical Center, Inc. (FKA New England Medical Center Hospitals, Inc.) and GK Financing, LLC.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22b</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/31/2014</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000074482520000093/firstamendmentleaserev.htm">10.5a</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment to Lease Agreement for a Gamma Knife Unit (Perfexion Upgrade) dated as of April 23, 2020 between Tufts Medical Center, Inc. (FKA New England Medical Center Hospitals, Inc.) and GK Financing, LLC.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/14/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420415050745/v416332_ex10-4.htm">10.6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Equipment Lease Agreement (for a Gamma Knife Unit) dated as of December 12, 2014, between GK Financing, LLC and the Board of Trustees of the University of Arkansas on behalf of the University of Arkansas for Medical Sciences.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/19/2015</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-10.htm">10.10</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease Agreement for a Gamma Knife Unit dated as of November 1, 1999 between GK Financing, LLC and Jackson HMA, Inc. d/b/a Central Mississippi Medical Center.&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000095014901501163/f74683ex10-34.txt">10.10a</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum to Lease Agreement for a Gamma Knife Unit dated as of November 1, 1999 between Jackson HMA, Inc. dba Central Mississippi Medical Center and GK Financing, LLC.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/10/2001</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000095013407007237/f27578exv10w51.htm">10.10b</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum Two to Lease Agreement for a Gamma Knife Unit dated as of November 6, 2006 between GK Financing, LLC and Jackson HMA, Inc. d/b/a Central Mississippi Medical Center.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/2/2007</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:7.719%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-10c.htm">10.10c</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment Three to Lease Agreement for a Gamma Knife Unit dated as of February 23, 2010 between GK Financing, LLC and Jackson HMA, LLC d/b/a Central Mississippi Medical Center.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10c</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000074482520000042/exhibit101cmmceqleaseadd.htm">10.10d</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment Four to Lease Agreement for a Gamma Knife Unit dated as of May 1, 2019 between GK Financing, LLC and Jackson HMA, LLC d/b/a Central Mississippi Medical Center.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/11/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-11.htm">10.11</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease Agreement for a Gamma Knife Unit dated as of February 18, 2000 between GK Financing, LLC and OSF HealthCare System.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416118323/v445336_ex10-2.htm">10.11a</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum to Lease Agreement for a Gamma Knife Unit dated as of April 13, 2007, between GK Financing, LLC and OSF Healthcare System.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/11/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416118323/v445336_ex10-2a.htm">10.11b</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum Two to Lease Agreement for a Gamma Knife Unit dated as of October 31, 2012 between GK Financing, LLC and OSF Healthcare System.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2a</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/11/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416118323/v445336_ex10-2b.htm">10.11c</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum Three to Lease Agreement for a Gamma Knife Unit dated as of June 7, 2016 between GK Financing, LLC and OSF Healthcare System.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2b</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/11/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ashsex1011dfullyexecuted.htm">10.11d</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum Four to Lease Agreement for a Gamma Knife Unit dated as of February 6, 2020 between GK Financing, LLC and OSF Healthcare System.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K<br/>001-08789</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11d</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/6/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-13.htm">10.13</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment Lease Agreement (for a Gamma Knife Unit) dated as of February 13, 2003 between GK Financing, LLC and AHS Albuquerque Regional Medical Center, LLC.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420411047155/v229865_ex10-62.htm">10.13a</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Equipment Lease Agreement (Perfexion Upgrade) dated as of April 8, 2011 between GK Financing, LLC and Lovelace Health System, Inc., d/b/a Lovelace Medical Center.&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/15/2011</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420411047155/v229865_ex10-62a.htm">10.13b</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assignment and Assumption of Purchase and License Agreement dated as of February 2, 2011 between Elekta, Inc., GK Financing, LLC and Albuquerque GK Equipment, LLC.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62a</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/15/2011</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000074482520000117/ams09-30x2020101exhibit.htm">10.13c</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Icon Upgrade and Amendment Two to Equipment Lease Agreement for a Gamma Knife Unit dated as of October 15, 2019 between GK Financing, LLC and Lovelace Health System, Inc., d/b/a Lovelace Medical Center.&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/13/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-14.htm">10.14</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment Lease Agreement (for a Gamma Knife Unit) dated as of March 21, 2003 between GK Financing, LLC and Northern Westchester Hospital Center.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420413045791/v351829_ex10-46a.htm">10.14a</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Equipment Lease Agreement (Perfexion Upgrade) dated as of June 8, 2012 between GK Financing, LLC and Northern Westchester Hospital Center.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46a</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/14/2013</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000095013408009511/f40856exv10w57.htm">10.16</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased Services Agreement (for a Gamma Knife Unit) dated as of March 5, 2008 between GK Financing, LLC and USC University Hospital, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/14/2008</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000095012309035258/f53366exv10w57a.htm">10.16a</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment to Purchased Services Agreement (for a Gamma Knife Unit) dated as of April 1, 2009 between GK Financing, LLC and University of Southern California.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57a</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/14/2009</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420414050371/v385235_ex10-57b.htm">10.16b</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment to Purchased Services Agreement (for a Gamma Knife Unit) dated as of October 1, 2013 between GK Financing, LLC and University of Southern California.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57b</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/14/2014</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:7.719%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000074482520000117/ams09-30x2020exhibit102.htm">10.16c</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Amendment to Purchased Services Agreement dated as June 30, 2020 between GK Financing, LLC and University of Southern California.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/13/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420411030025/v222418_ex10-6.htm">10.17</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment Lease Agreement (for a Gamma Knife Unit) dated as of May 1, 2010 between GK Financing, LLC and Fort Sanders Regional Medical Center.&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.60</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/16/2011</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-17a.htm">10.17a</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Lease Agreement (for a Gamma Knife Unit) dated as of January 3, 2012 between GK Financing, LLC and Fort Sanders Regional Medical Center.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17a</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420417042064/v472429_ex10-2.htm">10.17b</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment to Equipment Lease Agreement (for a Gamma Knife Unit) dated as of June 1, 2017 between GK Financing, LLC and Fort Sanders Regional Medical Center</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/10/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420412018468/v307334_ex10-63.htm">10.18</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leksell Gamma Knife Perfexion Purchased Services Agreement dated as of August 5, 2011 between Jacksonville GK Equipment, LLC and St. Vincent&#8217;s Medical Center, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.63</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2012</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420412018468/v307334_ex10-63a.htm">10.18a</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment to the Leksell Gamma Knife Perfexion Purchased Services Agreement dated as of October 10, 2011 between Jacksonville GK Equipment, LLC and St. Vincent&#8217;s Medical Center, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.63a</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2012</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420413029263/v343713_ex10-65.htm">10.19</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leksell Gamma Knife Perfexion Purchased Services Agreement dated as of January 19, 2012 between GK Financing, LLC and Sacred Heart Health System, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.65</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/15/2013</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420415020527/v404375_ex10-67.htm">10.20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leksell Gamma Knife Perfexion Purchased Services Agreement dated as of March 27, 2014 between GK Financing, LLC and PeaceHealth doing business through its operating division PeaceHealth Sacred Heart Medical Center at RiverBend.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.67</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2015</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420417058307/tv478457_ex10-1.htm">10.21</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment Lease Agreement (for a Gamma Knife Unit) dated as of February 21, 2017 between Bryan Medical Center, and GK Financing, LLC.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/13/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420418027082/tv493110_ex10-1.htm">10.21a</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment to Equipment Lease Agreement (for a Gamma Knife unit) dated as of February 14, 2018 between Bryan Medical Center and GK Financing, LLC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/10/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416118323/v445336_ex10-3.htm">10.22</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proton Beam Radiation Therapy Lease Agreement dated as of October 18, 2006 between American Shared Hospital Services and Orlando Regional Healthcare System, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/11/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416118323/v445336_ex10-3a.htm">10.22a</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment One to Proton Beam Radiation Therapy Lease Agreement dated as of August 12, 2012 between American Shared Hospital Services and Orlando Health, Inc., formerly known as Orlando Regional Healthcare System, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3a</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/11/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420419025524/tv521049_ex10-1.htm">10.23</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment Lease Agreement (for a Gamma Knife Unit) dated as of May 8, 2018 between The Methodist Hospitals, Inc. and GK Financing, LLC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/>001-08789</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/13/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000162828019010692/ams08-05x2019xex101icplan.htm">10.24</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">American Shared Hospital Services Incentive Compensation Plan as Amended and Restated effective June 21, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/13/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420416091106/v434650_ex10-26.htm">10.25</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Indemnification Agreement between American Shared Hospital Services and members of its Board of Directors.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/30/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000114420417016805/v461869_ex10-25.htm">10.26</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of American Shared Hospital Services Incentive Compensation Plan Performance Share Award Agreement.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-08789</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/27/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/744825/000074482520000027/ashs-8xkexhibit991.htm">10.27</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offer Letter between the Company and Mr. Raymond C. Stachowiak dated April 22, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K 001-08789</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/22/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit211.htm">21.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries of American Shared Hospital Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ashs-2020consentexhibit231.htm">23.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:7.719%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.860%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ams-20201231xex311.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer pursuant to Rule 13a-14a/15d-14a, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ams-20201231xex312.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Financial Officer pursuant to Rule 13a-14a/15d-14a, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ams-20201231xex321.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#450;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File &#8211; the cover page XBRL tags are embedded within the Inline Instance XBRL Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#450;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended.&#160;&#160;Omitted information has been replaced with asterisks.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates management compensatory plan, contract, or arrangement.</span></td></tr></table></div><div><span><br/></span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_118"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ITEM 16. FORM 10-K SUMMARY</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Optional summary in Item 16 has not been included in this Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMERICAN SHARED HOSPITAL SERVICES</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 6, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Raymond C. Stachowiak</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raymond C. Stachowiak</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:30.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.382%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Raymond C. Stachowiak</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 6, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raymond C. Stachowiak</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ernest A. Bates</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 6, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ernest A. Bates, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel G. Kelly Jr.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 6, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel G. Kelly JR.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David A. Larson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 6, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David A. Larson, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sandra A. J. Lawrence</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 6, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandra A. J. Lawrence</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ S. Mert Ozyurek</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 6, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S. Mert Ozyurek</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Craig K. Tagawa</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Chief Operating Officer and<br/>Chief Financial Officer<br/>(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 6, 2021</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Craig K. Tagawa</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMERICAN SHARED HOSPITAL SERVICES</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS OF December&#160;31, 2020 and 2019,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE YEARS ENDED DECEMBER&#160;31, 2020</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.467%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONTENTS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_127">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_127">F- </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_127">3</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_133">Balance sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_133">F- </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_133">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_139">Statements of operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_139">F- </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_139">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_142">Statement of shareholders&#8217; equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_142">F- </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_142">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_145">Statements of cash flows</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_145">F- </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_145">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_148">Notes to financial statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_148">F- </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08eb1efc99dc4f408903b4769adc4b90_148">11</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Shared Hospital Services, Inc.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have audited the accompanying consolidated balance sheets of American Shared Hospital Services, Inc. (the &#8220;Company&#8221;) as of December 31, 2020 and 2019, and the related consolidated statements of operations, shareholders&#8217; equity and cash flows for the years then ended, and the related notes. In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2020 and 2019, and the consolidated results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our audits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">included performing procedures to assess the risks of material misstatement of the consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Critical Audit Matters </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which they relate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Retail Revenue Recognition &#8211; Estimates of Reimbursement Rates and Payor Mix</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 2 in the Company&#8217;s consolidated financial statements, retail revenue amounted to approximately $11,418,000, which was approximately 64% of total consolidated revenue, during the year ended December 31, 2020. The related accounts receivable balance for total retail sites accounted for 68% of total accounts receivable at December 31, 2020. The Company has retail customer revenue classified as either turn-key or revenue sharing that are recognized under Accounting Standards Codification (&#8220;ASC&#8221;) 842 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASC 842&#8221;). Under revenue sharing arrangements, the Company receives a contracted percentage of the reimbursement received by the hospital. Under turn-key arrangements, the Company receives payment from the hospital based on the amount of the hospital&#8217;s reimbursement from third party payors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We identified management&#8217;s estimates of reimbursement rates and payor mix to record retail revenue and related accounts receivable, as a critical audit matter.  Retail revenue and related accounts receivable involves significant judgment and estimation, including measurement uncertainty, by management based on the estimates and assumptions used and are subject to adjustments based on actual reimbursements received by the Company. In turn, auditing management&#8217;s judgments and estimates related to retail revenue and related accounts receivable involved a high degree of subjectivity, as they are based on estimates of reimbursement rates and payor mix.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The primary procedures we performed to address this critical audit matter included:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt">Obtaining management&#8217;s reconciliation of retail revenue and accounts receivable by site agreeing to supporting documentation related to the estimated reimbursement rates and payor mix used in the calculation.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt">Obtaining third party confirmations, confirming number of procedures, payment dates and amounts paid, and reconciling confirmed amounts to management&#8217;s reconciliation, in order to validate approximate rate per procedure.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt">Testing subsequent cash receipts and evaluating the reasonableness of the estimates through a look-back analysis over retail revenue as compared to accounts receivable balances previously recognized.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt">Developing an independent expectation of reimbursement rates per procedure based on historical trends, procedures, and payment amounts received through confirmation directly with the hospital, and comparing to management&#8217;s estimates.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Property and Equipment - Salvage Value on Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Note 2 to the consolidated financial statements, property and equipment are stated at cost less accumulated depreciation. Depreciation for Gamma Knife, and other equipment is determined using the straight-line method over the estimated useful lives of the assets, which for medical and office equipment is generally 3 &#8211; 10 years, and after accounting for salvage value on the equipment where indicated. Salvage value is based on the estimated fair value of the equipment at the end of its useful life. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We identified management&#8217;s estimates of salvage value including qualitative assessments of certain equipment as a critical audit matter.  Determination of salvage values involves significant judgment and estimation, involving measurement uncertainty, as there is no active resale market for the Gamma Knife units due to limited sellers and buyers and trade-ins for the equipment are not guaranteed. Trade-ins are highly dependent on future demand, values and the Company&#8217;s relationship with supplier, a related party of the Company.  In turn, auditing management&#8217;s judgments and estimates related to salvage value of certain equipment, involved a high degree of subjectivity. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The primary procedure we performed to address this critical audit matter included:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt">Evaluating management&#8217;s determination of salvage values by comparing determined salvages values with historical trade-in transactions and publicly available transaction information, which included reviewing relevant purchase agreements, supplier agreements and evaluating publicly available transaction information.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Valuation of Certain Tangible and Intangible Assets Acquired Through Business Combination</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Note 4 to the consolidated financial statements, the Company completed the acquisition of Gamma Knife Center Ecuador S.A. (&#8220;GKCE&#8221;) from GKCE&#8217;s selling majority shareholders in June 2020. The Company subsequently executed agreements to acquire 1.3% of the total outstanding shares in July 2020 and intends to acquire the remaining 0.7% at later date.  The total purchase consideration for 100% of the outstanding shares of GKCE was approximately $2,869,000, including a base purchase price of $2,000,000, subject to certain price adjustments for current assets and liabilities and tax withholding. The transaction was accounted for as a business combination using the acquisition method, whereby the total consideration transferred, identifiable assets acquired, and liabilities assumed are based on the respective acquisition-date fair values.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As part of the acquisition, the Company acquired tangible assets, including building, equipment and other property and equipment with a fair value of approximately $723,000 and intangible assets, consisting of the acquired entity&#8217;s trade name, with a fair value of approximately $78,000.  We identified the judgment and estimation of the methodologies and assumptions used in the valuation by management, in the determination of the fair value of these assets, as a critical audit matter.  Significant assumptions used to estimate the fair value of these tangible and intangible assets included discount rates, useful lives, expected future cash flows, internal rate of return, revenue forecast and growth rates.  Given these factors, the related audit effort in evaluating management&#8217;s estimates required a high degree of auditor judgment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The primary procedures we performed to address this critical audit matter included:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:9.68pt">Evaluating the appropriateness of the methodologies and assumptions used to estimate the fair value of certain tangible (real property and equipment) and intangible (trade name) assets, including involving valuation specialists, where specialized skill or knowledge was needed, to assist with our evaluation. Our valuation specialist assisted primarily in the evaluation of the qualification of the appraiser and valuation specialist used by management, consideration of methodologies used in the appraisal of real property, including review of market information utilized to determine fair value, and in relation to the valuation of trade name, review of the methodology, discount rate, royalty rate, useful life (indefinite), and internal rate of return. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:9.68pt">Evaluating assumptions and inputs used in projected financial information of the acquired entity, which primarily related to revenue growth rates, including testing the completeness and accuracy of the underlying data supporting the significant assumptions and estimates. Specifically, when evaluating the assumptions related to the revenue growth rates and changes in the business that would drive these forecasted growth rates, we compared the assumptions to industry trends and subsequent interim period results to evaluate management&#8217;s estimates as of the date of the transaction.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Moss Adams LLP</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Francisco, California</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;6, 2021</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2000.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 5</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_133"></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ALANCE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HEETS</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CURRENT ASSETS</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzYtMS0xLTEtMA_092806ca-702d-4ea1-a4db-e74b94172956">3,961,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzYtMy0xLTEtMA_7f7973a3-3cb0-4e44-81a6-b8ccb6006150">1,429,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzctMS0xLTEtMA_c934fc15-98c9-4069-900f-5fe5880d0d9c">364,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzctMy0xLTEtMA_0f1166b4-e86d-460f-a9dd-f2dfb0753677">350,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzgtMC0xLTEtMjY2My90ZXh0cmVnaW9uOmQ5Yjk2MTJmNWQzNzQzMjM4YzdkZWQ5ZTdiYzMxNzNiXzI3NDg3NzkwNjk1NzE_0429ca44-01ad-44ba-868c-ee23a45c00ab"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzgtMC0xLTEtMjY2My90ZXh0cmVnaW9uOmQ5Yjk2MTJmNWQzNzQzMjM4YzdkZWQ5ZTdiYzMxNzNiXzI3NDg3NzkwNjk1NzE_88febbbe-bc4b-47b6-847a-7433679dddeb">100,000</ix:nonFraction></ix:nonFraction> at December 31, 2020 and December 31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzgtMS0xLTEtMA_3c00ee99-e2ef-4cd8-8f5f-350ccdafa0f0">4,303,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzgtMy0xLTEtMA_3f928428-1fcb-4767-a180-778d154431a2">6,894,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzEwLTEtMS0xLTA_841e744f-0b2c-4536-bbfb-50d6bd866746">272,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzEwLTMtMS0xLTA_00dca547-464c-4ec3-afef-de60a8b3ee03">169,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzExLTEtMS0xLTA_30a5e906-4f81-48a8-92aa-41b9affab3e5">1,950,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzExLTMtMS0xLTA_f2763ff9-3742-4797-81ad-2aab14670a5d">1,900,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzEyLTEtMS0xLTA_1b383320-8562-4fec-82a2-11c0fb7feebb">10,850,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzEyLTMtMS0xLTA_8d050e4b-9574-4b85-99c8-84950a148bdf">10,742,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PROPERTY AND EQUIPMENT, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzEzLTEtMS0xLTA_6bd063b7-b4a9-4d93-ad31-ea2d2b1547c5">30,418,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzEzLTMtMS0xLTA_d164508d-832d-4f75-a56b-c3c1b0a09c62">41,480,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LAND</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Land" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE0LTEtMS0xLTE4_a25d47c3-c6ea-49d8-a03e-2a6e7cb0e552">19,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:Land" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE0LTMtMS0xLTE4_de480bef-dc6c-4816-aa26-deebd3739d75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GOODWILL</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE1LTEtMS0xLTE4_9d8a24c1-4fa7-4c12-a664-9d1f036bfb94">1,265,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:Goodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE1LTMtMS0xLTE4_815fb9d0-f592-46b6-b159-0ef1181ece91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INTANGIBLE ASSETS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE2LTEtMS0xLTE4_558836c3-8b79-4b00-9183-a5c304f51855">78,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE2LTMtMS0xLTE4_8c055011-0688-428c-86cc-476a3ecb92ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RIGHT OF USE ASSETS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE0LTEtMS0xLTA_f9cdfa60-a91d-43ef-a26a-09785e37c59a">886,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE0LTMtMS0xLTA_28b33269-42f4-4d50-84d0-a3c313ba52ae">1,106,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTHER ASSETS</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE1LTEtMS0xLTA_71cbca6f-ffc2-41c9-ba2b-161719f0b622">137,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE1LTMtMS0xLTA_2b780a75-71bb-462e-a532-9c2b3a64bed1">455,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL ASSETS</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE2LTEtMS0xLTA_27d471d0-4965-4426-9fa4-87e500e262b9">43,653,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE2LTMtMS0xLTA_d53aa3f0-e0e0-4fcb-a91b-c8154d70c5ad">53,783,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CURRENT LIABILITIES</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIwLTEtMS0xLTA_fb031434-2032-461d-b64f-04215eb32c38">683,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIwLTMtMS0xLTA_bd4ed85a-ecdf-4b6a-9732-12b041d153a1">557,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIxLTEtMS0xLTA_bdc2e922-1ddd-4d9c-a1e8-56d6514a3a10">405,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIxLTMtMS0xLTA_2899758b-6e88-4cdb-aac1-54392617b20e">234,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIyLTEtMS0xLTA_95bfae69-edc8-439e-b63c-7425463ef52c">2,045,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIyLTMtMS0xLTA_fcada92e-30f3-4798-be2a-daef4cc17c4d">1,779,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset retirement obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetRetirementObligationCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIzLTEtMS0xLTA_48283e14-2c63-4191-a141-ceb0c4d85c4a">1,270,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetRetirementObligationCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIzLTMtMS0xLTA_860adf6e-19aa-4757-8d6a-608d99cd4b93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI0LTEtMS0xLTA_6ab89680-a0c1-41ce-9004-b95662e68101">373,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI0LTMtMS0xLTA_73d50b92-4c7d-4ff8-89a8-7ba22387b03e">130,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital payment due</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:WorkingCapitalPaymentLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI1LTEtMS0xLTA_f43466cf-82d4-473f-9b26-d235af98a15f">197,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:zerodash" name="ams:WorkingCapitalPaymentLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI1LTMtMS0xLTA_2146c603-6763-4db4-8907-fcd3cd59abc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI2LTEtMS0xLTA_bd8b43aa-4967-4cc2-87fe-2d22f752ef45">305,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI2LTMtMS0xLTA_ded74b30-0810-49b0-b40f-9acc228d8bc5">279,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI3LTEtMS0xLTA_9baddc88-947c-4010-9596-31ee6f297dbe">1,157,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI3LTMtMS0xLTA_c095c964-8b98-49f1-94e4-adf388d7b8d7">1,526,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI4LTEtMS0xLTA_8233fbf7-fb05-4f91-8d3c-895df5ba19ea">5,945,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI4LTMtMS0xLTA_f6f440fc-0d8b-4048-8db4-6753caeddecf">3,709,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI5LTEtMS0xLTA_3c726980-921b-47c8-894f-8f110b8f3338">12,380,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI5LTMtMS0xLTA_833f2b43-c710-4d8f-b871-b905097f7236">8,214,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LONG-TERM LEASE LIABILITIES, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMwLTEtMS0xLTA_f5d5dc47-02bd-4599-ad33-00bdfc189c3d">581,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMwLTMtMS0xLTA_910cec93-2af1-4f48-bd64-6fea2560d203">827,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LONG-TERM DEBT, less current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMxLTEtMS0xLTA_331f8bac-a278-4087-a056-3a7c1b00968b">3,440,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMxLTMtMS0xLTA_c3414f0c-0c3a-4f6a-8c5d-077d17ebb64a">1,954,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LONG-TERM FINANCE LEASES, less current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMyLTEtMS0xLTA_7db5dcf1-3efd-4fec-861d-465460954ce1">2,974,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMyLTMtMS0xLTA_4b66b329-345b-4d55-a29c-5048ca1bd751">8,177,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEFERRED REVENUE, less current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMzLTEtMS0xLTA_ae870812-1f0b-4286-af29-df897d71909f">210,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMzLTMtMS0xLTA_5bff2c0d-edf5-4d39-ab35-a204784d1f52">286,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEFERRED INCOME TAXES</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM0LTEtMS0xLTA_02b08c63-3ab3-4a80-ac31-4498c19089d5">418,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM0LTMtMS0xLTA_f5bc53df-8a94-457a-8869-6182cb5235b2">2,514,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMMITMENTS AND CONTINGENCIES (See Note 12)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM1LTEtMS0xLTA_a6090ca0-38b8-427d-a8d4-d3c1e81b3f2e"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM1LTMtMS0xLTA_7844d93e-2c99-46ec-a8d8-40e3fc58fdbb"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SHAREHOLDERS&#8217; EQUITY</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, no par value</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, <ix:nonFraction unitRef="usdPerShare" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NTk5_ebf75eca-a045-44de-a943-46fa1e2bd7cf"><ix:nonFraction unitRef="usdPerShare" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NTk5_f914defb-57e7-445a-8443-be53460b5b53">no</ix:nonFraction></ix:nonFraction> par value (<ix:nonFraction unitRef="shares" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NjE1_73fb4fd6-06f0-4443-aa34-a7ab3929bc29"><ix:nonFraction unitRef="shares" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NjE1_f694fbe4-db78-4c61-ac60-4af15e7ec4b5">10,000,000</ix:nonFraction></ix:nonFraction> authorized;&#160;&#160;Issued and outstanding shares &#8211; <ix:nonFraction unitRef="shares" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NjI3_1a52923a-a261-4b93-ab48-52cbe1f1d2a0"><ix:nonFraction unitRef="shares" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NjI3_f40bb426-d6e9-42b9-8bd7-b995c95bd563">5,791,000</ix:nonFraction></ix:nonFraction> at December 31, 2020 and <ix:nonFraction unitRef="shares" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NjM5_1c0b362e-17d9-41da-acbf-70ec3e3de298"><ix:nonFraction unitRef="shares" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NjM5_4380a950-0f33-4a81-ba15-8852ab00c6b1">5,817,000</ix:nonFraction></ix:nonFraction> at December 31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTEtMS0xLTA_78fce6e7-e4f4-4d9f-89cc-abc0e13a04ae">10,753,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTMtMS0xLTA_4da90bd5-2de0-4296-a009-4c5c0870de91">10,753,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM5LTEtMS0xLTA_bc4fb771-26c8-42ca-931b-e128f7aa6c47">7,024,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM5LTMtMS0xLTA_94120501-4720-4ac1-95dc-e76f8afd3d2d">6,725,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQwLTEtMS0xLTA_71abb2df-813e-4bbb-b31f-6bf0451ea96f">1,497,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQwLTMtMS0xLTA_0e1507f6-d070-42b5-b6be-cfeef9d53e32">8,555,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity- American Shared Hospital Services</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQxLTEtMS0xLTA_c2650b12-e148-4c45-b284-83a2259b6a10">19,274,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQxLTMtMS0xLTA_f4180a09-5adc-43d5-96f5-fc3971c414f3">26,033,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interests in subsidiaries</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQyLTEtMS0xLTA_d08bfa14-a64f-4fc5-bb90-51008f86f144">4,376,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQyLTMtMS0xLTA_957f1c73-a5f0-4118-9ffd-01fb9fd1738d">5,778,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQzLTEtMS0xLTA_ad7fd597-d2ab-4617-9f96-f1766114b3fa">23,650,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQzLTMtMS0xLTA_b0822b7d-b939-453a-bb97-84c07e954339">31,811,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQ0LTEtMS0xLTA_72359ec0-65d0-49a3-a02c-e570d2803514">43,653,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQ0LTMtMS0xLTA_d56133d1-1896-4764-a1fb-5ce43ffab3c6">53,783,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ee accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 6</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONSOLIDATED </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">TATEMENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PERATIONS</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YEARS ENDED DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzUtMS0xLTEtMA_7443c910-8728-48f6-8de8-401e58e83516">17,837,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzUtMy0xLTEtMA_dfa411c6-d907-4ab1-83ac-c5d905a21cae">20,605,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzYtMS0xLTEtMA_227e61a8-1cdd-4ff9-8b9d-961855811d67">17,837,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzYtMy0xLTEtMA_4326c5a9-76e7-421c-9a2f-8d2a2d14afb9">20,605,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of revenue:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintenance and supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DirectOperatingMaintenanceSuppliesCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzgtMS0xLTEtMA_bd89200a-dc55-4509-aeb7-c8ce08eab5ee">2,385,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DirectOperatingMaintenanceSuppliesCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzgtMy0xLTEtMA_40eea2cb-20a2-45bc-963a-296d8341022b">2,618,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzktMS0xLTEtMA_1459d246-fe90-4b3e-8d8a-9db2573b3d0b">6,789,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzktMy0xLTEtMA_fc5a9801-f26d-4077-9a57-af9d96e56a91">7,341,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other direct operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherCostOfOperatingRevenue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzEwLTEtMS0xLTA_5c4ffc29-5115-4dad-a5d0-c3656b15539a">4,197,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherCostOfOperatingRevenue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzEwLTMtMS0xLTA_4c2dcfee-70a0-4d5d-8028-cea3ee5fcfe8">3,726,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzExLTEtMS0xLTA_67a8e5a8-6eed-4765-a7b1-6c497d12166b">13,371,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzExLTMtMS0xLTA_9692db23-8372-4015-b755-897349a4d871">13,685,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzEyLTEtMS0xLTA_e0411bf3-f1f8-4db3-b3e7-4d6b91763093">4,466,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzEyLTMtMS0xLTA_4e680b05-57a3-43c9-a28b-5dfab2874391">6,920,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzEzLTEtMS0xLTA_1a4296db-02a9-4d12-93c9-70d729c62101">4,608,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzEzLTMtMS0xLTA_d794d4d2-a286-4b0a-aeae-6dc9c5f114f7">4,060,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE0LTEtMS0xLTA_05820a0a-60d0-4f42-9c8f-8a3489c728c2">1,057,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE0LTMtMS0xLTA_33d99d3a-9235-48e9-8fa0-cbce9763785d">1,318,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on write down of impaired assets and associated removal costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE1LTEtMS0xLTUxNzk_9719ba06-9230-4b0f-8649-54256864f377">8,264,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE1LTMtMS0xLTUxNzk_0bbadc99-61e3-40f0-af4e-1c735895af77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE1LTEtMS0xLTA_15172400-7b98-4cbc-8e1d-4c2ab4e06726">9,463,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE1LTMtMS0xLTA_93fab3ff-cf21-4e4c-a56d-fac686a3d2c4">1,542,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndOtherIncome" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE5LTEtMS0xLTA_5546307f-6986-4462-bf26-e273970be272">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndOtherIncome" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE5LTMtMS0xLTA_0e7875a5-4c1d-465d-abc1-ec5912f044ae">16,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIwLTEtMS0xLTA_3a559130-b177-4b4a-937d-cbd5d550870a">9,453,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIwLTMtMS0xLTA_6db2da13-d314-4dcd-9828-ad514bf6aba9">1,558,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIxLTEtMS0xLTA_f32b30fb-3def-4eef-a1b9-34465e0ba455">1,737,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIxLTMtMS0xLTA_b01a6a80-ac64-41bd-b034-5ae631e4d351">128,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIyLTEtMS0xLTA_6be388ae-110a-40f5-8827-be36b6ee91bf">7,716,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIyLTMtMS0xLTA_487e5b5a-6ee6-4b93-8987-6ce9b5fb3536">1,430,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net loss (income) attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIzLTEtMS0xLTA_d18263ff-5214-4313-b68a-fdbabf00edf7">658,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIzLTMtMS0xLTA_e66c55ea-d15e-4e23-95d6-6ed6154fded1">771,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to American Shared Hospital Services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzI0LTEtMS0xLTA_f28b55e7-79fb-4bdf-8b98-69de8d81a909">7,058,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzI0LTMtMS0xLTA_64cfafbe-5fa1-437b-94ab-5f61bc73b7da">659,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share attributable to American Shared Hospital Services:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income per common share- basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzI3LTEtMS0xLTA_722ed7ff-92ab-4527-b905-dde89dd59c6f">1.14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzI3LTMtMS0xLTA_bbc47080-7216-4160-a042-dfcbbd51deb8">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income per common share- diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzI4LTEtMS0xLTA_a1d1abb4-b12f-475a-b30b-6b4af0871213">1.14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzI4LTMtMS0xLTA_21e8872c-f590-4999-974c-c03022cad30a">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ee accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 7</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="42" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HAREHOLDERS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8217; E</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">QUITY</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YEARS ENDED DECEMBER 31, 2020 AND 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid-in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sub-Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASHS</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interests in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiaries</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80d152c66b98490fac1712dd5160d5b6_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTEtMS0xLTA_23885de8-45f0-49bc-9458-0aab3e8dcddb">5,714,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i80d152c66b98490fac1712dd5160d5b6_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTMtMS0xLTA_a4519d03-85e3-4430-90bf-d5efed42fd3f">10,711,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6f2c5098442b4ca0990024d0a044f71d_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTUtMS0xLTA_498b21f6-a172-4dbc-bd31-c45d1a1eee35">6,495,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4eb01d36262d48dab3093fa93a55a639_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTctMS0xLTA_4681e222-57dd-4efb-9074-c5ee6f00d25b">7,896,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ieffba5f94e464f3c9847c0ba5b17a15d_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTktMS0xLTA_18df6782-5010-4fb9-8fb9-70b5dc46522c">25,102,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i1eaabaa2b68f452d814855cd3337f66d_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTExLTEtMS0w_fafd6955-2e1a-4dc3-9ceb-405bdf1c135e">5,946,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i88d4659da27e48458ba86016aae09e94_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTEzLTEtMS0w_e2a9e8a7-d15e-4d7b-ae3b-afa89ea92666">31,048,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idce4f3d545f2476ebdc0f7f36157ebb5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE1LTEtMS0xLTA_d07b95e7-96cf-4e4f-9783-ca00b736ed37">4,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5dfe6ce5ed7480b9e09f5b3476be864_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE1LTUtMS0xLTA_cd11d104-ad0c-48ab-9630-f47bbd8b2630">230,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0811458740d6449891c3119d222599c5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE1LTktMS0xLTA_c3a3c89b-0382-43fa-80f6-30362e67ac55">230,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE1LTEzLTEtMS0w_678580f5-2744-44a4-ab6f-8afd5fb0c787">230,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idce4f3d545f2476ebdc0f7f36157ebb5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE2LTEtMS0xLTA_11abaeee-b0e1-47b9-9f30-348310c190b7">16,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idce4f3d545f2476ebdc0f7f36157ebb5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE2LTMtMS0xLTA_b443e44d-a62c-447a-b686-799eeaa32bc6">42,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0811458740d6449891c3119d222599c5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE2LTktMS0xLTA_7d68d442-0ded-4fce-ac33-582d811ea773">42,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE2LTEzLTEtMS0w_c6b9b129-5b0d-424b-b4a7-fa6fb01734d4">42,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idce4f3d545f2476ebdc0f7f36157ebb5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE3LTEtMS0xLTA_74cdabe3-49ac-4ffb-b473-5ffb4ab9c338">83,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash distributions to non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0146f023f5af475e8c42899ccb2714bd_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE4LTExLTEtMS0w_f92669e1-1688-47fa-96b7-d87ffb494086">939,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE4LTEzLTEtMS0w_5d5f84eb-4e25-4d63-a1c1-961b5b813854">939,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49250096dac54dbc9d6f411a7223e401_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE5LTctMS0xLTA_d8578e43-f869-4149-a7cf-fdccb7931207">659,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0811458740d6449891c3119d222599c5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE5LTktMS0xLTA_a9c0bace-a411-4177-8124-e9a7904a7fb4">659,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0146f023f5af475e8c42899ccb2714bd_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE5LTExLTEtMS0w_0a000fe8-5737-42a0-9beb-a00b9103a17b">771,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE5LTEzLTEtMS0w_e21807ca-ed28-4540-b9cb-92248080ca75">1,430,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1933947a2065450e947da821bf4a32d6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTEtMS0xLTA_1a9d0939-bbfb-4188-afd4-e5c9729c7825">5,817,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1933947a2065450e947da821bf4a32d6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTMtMS0xLTA_88a0c18a-1dab-4849-b262-c213ced74d33">10,753,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95945ee330d74bbe84786fe63dbd0fe7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTUtMS0xLTA_388c2e77-7c7e-4807-9a2e-1593e96dc858">6,725,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i031366823611429984ba59da571f0cf4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTctMS0xLTA_a627a827-78be-4498-be7c-3c0d979c5f83">8,555,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c0e34c40b84e128c70ede3ca6deb9b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTktMS0xLTA_bb97b688-bf75-454d-a898-e6e8d1126d74">26,033,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaf32a31b8e945bca3c5332f1bd4ea42_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTExLTEtMS0w_cd42bebe-6831-4b41-8579-a93b8c09505e">5,778,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTEzLTEtMS0w_3a9ea9ef-1b38-4ec7-94d9-5f9db3a00a15">31,811,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdb999bd1cf140c987a60e65653baa9d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIxLTEtMS0xLTEzOA_378e2961-e52f-4f1e-8de0-900764db95f5">103,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c7ecb5b71704129a21136aa3a829d59_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIxLTUtMS0xLTEzOA_6a20acd6-71ab-4bc7-9f6b-1a68d8708df9">299,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90f32e02b365478c95091f9014bef961_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIxLTktMS0xLTEzOA_2418feed-4a0e-4389-9af8-b5b826b01d5e">299,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIxLTEzLTEtMS0xMzg_9d865349-3a3a-422f-b4f9-fa474e67b182">299,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash distributions to non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9a7f6cfe5f24a45b55dad44c8b94d99_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIyLTExLTEtMS0xMzg_5c2614e8-c647-450d-97a0-f062365a1760">761,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIyLTEzLTEtMS0xMzg_8dfbb1c7-73c5-4118-800c-b13c769f06e3">761,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NCI investment in acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9a7f6cfe5f24a45b55dad44c8b94d99_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIzLTExLTEtMS0xMzg_3aeb274f-248b-4c6f-a4ce-eb1c13a1bc5a">17,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIzLTEzLTEtMS0xMzg_b3f1e105-a623-4a64-9b30-11a2dd11fe74">17,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted common shares returned to plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI0LTEtMS0xLTEzOA_ba2f84f4-3da8-40a3-8022-f6805ed088d6">129,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6742d6b210b4bc7b247bbd2b1bbcdcd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI1LTctMS0xLTEzOA_d3a8202f-bbd5-4927-9d8c-2d02b56cc27d">7,058,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90f32e02b365478c95091f9014bef961_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI1LTktMS0xLTEzOA_313e4285-29eb-4e53-aa56-e41af355e486">7,058,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9a7f6cfe5f24a45b55dad44c8b94d99_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI1LTExLTEtMS0xMzg_bdce3a63-d3bd-4c14-b886-08984e3b917d">658,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI1LTEzLTEtMS0xMzg_9095e95c-f30e-4986-a7cc-dfb785a1b9f2">7,716,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if300614914f840d5afcad30cf88400e1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTEtMS0xLTEzOA_94855859-21f6-4db2-b770-0e605fe2223e">5,791,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if300614914f840d5afcad30cf88400e1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTMtMS0xLTEzOA_60458678-4b10-4b78-ab5e-986179c82d79">10,753,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d457b7646a4469d9fe2d92f4b9ba9dc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTUtMS0xLTEzOA_af86c758-04de-4081-8d7c-2b14fe8fe50b">7,024,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedffb7791f4c42a8a3e5d969848aaeb4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTctMS0xLTEzOA_ad6d4ef6-a244-4e11-9399-8b0ce12ddeb4">1,497,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02bbd8133d3c48bebba8d7203bfb8f52_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTktMS0xLTEzOA_72755649-eb38-4624-a2f7-4b9a67ae21b2">19,274,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890ba0391e8b420f8705f2e7726453b8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTExLTEtMS0xMzg_dcbf62d3-bb07-4e26-8e93-378556d99415">4,376,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTEzLTEtMS0xMzg_f1e9a6e5-8d0a-42b7-a513-b8dcdc385a70">23,650,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ee accompanying notes</span></div><div style="margin-top:10pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 8</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASH </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LOWS</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YEARS ENDED DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OPERATING ACTIVITIES</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzUtMS0xLTEtMA_8faf4301-e0ef-44ee-9bf0-8a0f547f5590">7,716,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzUtMy0xLTEtMA_5046d674-cc5a-4658-9e08-47b635d9b4b6">1,430,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash from operating activities (excluding assets acquired and liabilities assumed):</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzctMS0xLTEtMA_ab351ba6-5e6a-48f7-87dc-51507375a6a7">6,970,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzctMy0xLTEtMA_10b18e8c-fa44-42e2-bedd-b7872aeb92f3">7,411,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non cash lease expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:NonCashLeaseExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzktMS0xLTEtMA_cdab8824-5236-4433-9017-aebc6c9b0d83">288,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="ams:NonCashLeaseExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzktMy0xLTEtMA_8c7462e9-de06-4237-9351-c01486f5d2a2">256,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on write down impaired assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzExLTEtMS0xLTA_06614a17-2dca-4c52-90c5-f82702cf5f8c">8,184,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzExLTMtMS0xLTA_4155545e-3246-4e0c-a7f4-623201434e16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzEyLTEtMS0xLTA_4ea65335-61a9-4754-af2c-4a60da3a9a07">2,162,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzEyLTMtMS0xLTA_f9ad7509-3166-4171-957e-9d66a3270812">444,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest on lease financing</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="ams:InterestExpenseLeaseFinancing" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzEzLTEtMS0xLTA_16149612-dd8d-422f-96d5-26883714d1cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="ams:InterestExpenseLeaseFinancing" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzEzLTMtMS0xLTA_4e2132ea-2c96-47f5-9a5d-4a498f557e25">29,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE0LTEtMS0xLTA_c88df995-bd79-43e7-9368-691cb7e7aa65">299,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE0LTMtMS0xLTA_008f6512-ae53-4bd6-a63f-cb911c7e4917">230,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense associated with lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseInterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE1LTEtMS0xLTA_c427173e-490c-4c36-a80b-cb70fc2c3c88">65,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseInterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE1LTMtMS0xLTA_b2d5279d-0b77-43c6-97c1-ac27d221ca84">76,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE3LTEtMS0xLTA_7941462c-ceae-455e-ab03-5f48b10f7023">2,966,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE3LTMtMS0xLTA_837e9145-0919-4a38-88ef-b0b25ba00b5d">1,187,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE4LTEtMS0xLTA_e30bfd5a-1047-4fab-abac-af1c0aae5f1a">762,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE4LTMtMS0xLTA_90282408-4cb7-45a9-b9ec-5cec845a1780">260,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities and deferred revenue</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="ams:IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE5LTEtMS0xLTA_4760da30-a59b-42bd-bf64-51241301992a">263,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="ams:IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE5LTMtMS0xLTA_8b226a2b-2957-4d01-81ad-83a21bfc474b">28,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="ams:IncreaseDecreaseInLeaseLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIwLTEtMS0xLTA_fa0dafbe-41f9-46b7-80ba-874e8c885215">353,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="ams:IncreaseDecreaseInLeaseLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIwLTMtMS0xLTA_ac146585-e33e-4838-9049-45c53cb78e46">332,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIxLTEtMS0xLTA_af8550a3-f40b-4f12-91dc-34c8c6f161b2">179,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIxLTMtMS0xLTA_cd14f6d1-c794-4cea-8d7c-6995f0c775ea">130,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net insurance proceeds receivable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="ams:IncreaseDecreaseInOtherReceivableInsuranceSettlements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIyLTEtMS0xLTA_abf61b2c-5a23-4877-aef0-394eb2ce9c65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="ams:IncreaseDecreaseInOtherReceivableInsuranceSettlements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIyLTMtMS0xLTA_fcea387e-63f3-461c-bfa5-371368ec3c77">160,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash from operating activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIzLTEtMS0xLTA_beecc687-bf3f-4fd6-966a-421b89f32670">9,745,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIzLTMtMS0xLTA_d200ea4b-c41e-4980-b283-f574529cf33d">8,047,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">INVESTING ACTIVITIES</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for purchase of property and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI1LTEtMS0xLTA_c96057a7-2af4-43d4-89d8-b34bce355608">455,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI1LTMtMS0xLTA_bea55071-4cca-408b-a382-82a37a7ece6e">990,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI2LTEtMS0xLTIyMw_b6a1b83d-c3d7-43b3-9ffa-b70ce7fa1c1b">2,084,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI2LTMtMS0xLTIyMw_a94c7358-3bcb-4bde-9c3a-e3a312bbf359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfMachineryAndEquipment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI3LTEtMS0xLTA_388ea922-428b-4bfd-8eff-ff35376d057f">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleOfMachineryAndEquipment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI3LTMtMS0xLTA_2522d97b-a542-4f27-8487-db4ddec4fa42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) investing activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI4LTEtMS0xLTA_1ad51bdc-231b-4af4-86a8-e9c42dd49b9c">2,389,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI4LTMtMS0xLTA_f7900913-da91-44b1-a454-6ab6e34bd6c4">990,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FINANCING ACTIVITIES</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on long-term debt</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMwLTEtMS0xLTA_172c4586-51de-4757-a3bc-333d16f29927">1,726,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMwLTMtMS0xLTA_05563121-c001-4ebb-9e0c-9e8eb6fec0f6">1,980,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on finance leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:RepaymentsOfLongTermFinanceLeaseObligations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMxLTEtMS0xLTA_99b34724-fe90-46b6-a9ea-f2bf3aeef827">3,199,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="ams:RepaymentsOfLongTermFinanceLeaseObligations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMxLTMtMS0xLTA_08d12668-61ac-41bc-b5bf-d44e4f37abc8">4,142,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from financing from acquisition</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:ProceedsFromFinancingFromAcquisition" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMzLTEtMS0xLTIzNw_6a763bdd-8105-4be2-994a-134d96ca0381">1,425,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="ams:ProceedsFromFinancingFromAcquisition" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMzLTMtMS0xLTIzNw_820b4c00-38bc-4b6a-8e49-fba7e60be3a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions to non-controlling interests</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMyLTEtMS0xLTA_e3e25877-b36f-40af-bbe6-0711d6f5379c">761,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMyLTMtMS0xLTA_7fd8e08b-6c16-4d6c-aeb3-6f51c579ab33">939,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM0LTEtMS0xLTIzMA_f0499933-9b2d-4c30-a45b-8bb96f1dbcc9">30,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM0LTMtMS0xLTIzMA_31839de7-6474-4165-b3c3-14a0700cf45d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from warrants and options exercised</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromWarrantExercises" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMzLTEtMS0xLTA_3300ff4e-32de-4890-b45f-bf18cf0b9ebb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromWarrantExercises" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMzLTMtMS0xLTA_e89c5577-6bdc-45e8-8fd0-624707b669d6">42,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on short-term financing </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLongTermCapitalLeaseObligations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM0LTEtMS0xLTA_f654a360-d23d-4fb1-9e91-8ab173c9dfce">519,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLongTermCapitalLeaseObligations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM0LTMtMS0xLTA_4edef950-f459-49af-b394-1e0562bb5237">51,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM1LTEtMS0xLTA_d4ab6625-fc0e-48fe-a773-5c1599441bc2">4,810,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM1LTMtMS0xLTA_ac7de1b0-e784-4e5a-8593-79e591a76b6d">7,070,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents and restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM2LTEtMS0xLTA_f8bf15a3-e437-4bd4-9332-d0f89bea89ea">2,546,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM2LTMtMS0xLTA_0d31be1f-1e8e-43f5-8889-68f96cdd93e4">13,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of year</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM3LTEtMS0xLTA_8212e90b-04f8-430c-aacd-fbb89a8a7851">1,779,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88d4659da27e48458ba86016aae09e94_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM3LTMtMS0xLTA_eae9f06a-b8b0-4a18-9e7a-2331528271d0">1,792,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of year</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM4LTEtMS0xLTA_7ff09e56-fd5e-4d65-80ab-736f890c3726">4,325,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM4LTMtMS0xLTA_3817f54c-cc3f-41b9-93ba-e3f495a8a722">1,779,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SUPPLEMENTAL CASH FLOW DISCLOSURE</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQxLTEtMS0xLTA_140135d4-3875-4779-b62e-8114e89b13b9">938,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQxLTMtMS0xLTA_e2d36e24-d2bd-41fe-8b30-a99e77653065">1,318,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQyLTEtMS0xLTA_2c007dde-bfaf-4876-867f-f97a56b6e95b">339,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQyLTMtMS0xLTA_0af0a81f-c9fe-4895-ac28-1020d601cb7f">397,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease reassessment right of use assets and lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ4LTEtMS0xLTI0NA_f5804c7c-b9ef-4e80-8e91-745fcd8e29b0">67,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets and lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:NonCashRightOfUseAssetsAndLeaseLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ5LTEtMS0xLTI0OA_935cbe2a-459d-4b3a-955e-733d6a998c95">135,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="ams:NonCashRightOfUseAssetsAndLeaseLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ5LTMtMS0xLTI0OA_b9dcc3ee-12c3-4946-9815-e73c6ad840d1">1,362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest capitalized to property and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:InterestCapitalizedToPropertyAndEquipment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzUwLTEtMS0xLTI3MDA_33ecb4cb-7938-47df-852a-7f303091b190">119,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="ams:InterestCapitalizedToPropertyAndEquipment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzUwLTMtMS0xLTI3MDU_38d7f488-ddf4-4a68-95b5-7e3d7adee3e1">110,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of equipment with finance leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ1LTEtMS0xLTA_b265f6a7-553c-4a31-839a-3c28b27014c1">496,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ1LTMtMS0xLTA_e65c16d5-6760-4a7f-aef6-581cbaa4e607">1,293,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of equipment with long-term debt financing</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:AcquisitionOfEquipmentWithLongTermDebtFinancing" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ2LTEtMS0xLTA_dced186a-ad66-4893-989e-25f2631d9e94">1,184,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="ams:AcquisitionOfEquipmentWithLongTermDebtFinancing" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ2LTMtMS0xLTA_a0fc1536-2d56-446e-b1b9-4a130229f688">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of insurance with short-term financing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:AcquisitionOfInsuranceWithShortTermFinancing" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ3LTEtMS0xLTA_a72c2dca-184a-48f2-bc3e-b74e6bfe44a9">634,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="ams:AcquisitionOfInsuranceWithShortTermFinancing" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ3LTMtMS0xLTA_5e5a7713-327f-43c8-b5b5-d2df275307a9">526,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First working capital payment related to acquisition, withholding taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:PaymentsForWorkingCapital" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzU0LTEtMS0xLTI1Ng_1a29e144-e477-463c-b947-ddd3acebac9f">43,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated subsequent working capital payment for acquisition</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:SubsequentWorkingCapitalPaymentAccruedForAcquisition" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzU1LTEtMS0xLTI2Nw_882eaea4-0c7d-4fd5-9720-d3845f42f869">154,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ee accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 10</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_148"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.287%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div></div><div><span><br/></span></div><div id="i08eb1efc99dc4f408903b4769adc4b90_151"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 1 &#8211; <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzMwMDg_31dc4483-0996-4026-9197-d61d3a1cfb20" continuedAt="i2054a579cdf24ab9a775d2b0b8339faf" escape="true">B</ix:nonNumeric></span><ix:continuation id="i2054a579cdf24ab9a775d2b0b8339faf" continuedAt="i5494fc2e9f1e40c2b1d56cdda044f56c"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">USINESS AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ASIS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">RESENTATION</span></ix:continuation></div><ix:continuation id="i5494fc2e9f1e40c2b1d56cdda044f56c"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These consolidated financial statements include the accounts of American Shared Hospital Services and its subsidiaries (the &#8220;Company&#8221;) as follows: the Company wholly-owns the subsidiaries American Shared Radiosurgery Services (&#8220;ASRS&#8221;), PBRT Orlando, LLC (&#8220;Orlando&#8221;), OR21, Inc., and MedLeader.com, Inc. (&#8220;MedLeader&#8221;); the Company is the majority owner of Long Beach Equipment, LLC (&#8220;LBE&#8221;); ASRS is the majority-owner of GK Financing, LLC (&#8220;GKF&#8221;) which wholly-owns the subsidiary Instituto de Gamma Knife del Pacifico S.A.C. (&#8220;GKPeru&#8221;). GKF is the majority owner of the subsidiaries Albuquerque GK Equipment, LLC (&#8220;AGKE&#8221;) and Jacksonville GK Equipment, LLC (&#8220;JGKE&#8221;).  GKF formed HoldCo GKC S.A. (&#8220;HoldCo&#8221;) to acquire Gamma Knife Center Ecuador S.A. (&#8220;GKCE&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company (through ASRS) and Elekta AG (&#8220;Elekta&#8221;), the manufacturer of the Gamma Knife (through its wholly-owned United States subsidiary, GKV Investments, Inc.), entered into an operating agreement and formed GKF. During 2020 GKF provided Gamma Knife units to fifteen medical centers in the United States in the states of Arkansas, California, Florida, Illinois, Indiana, Massachusetts, Mississippi, Nebraska, New Mexico, New York, Ohio, Oregon, Tennessee, and Texas. GKF also owns and operates single-unit Gamma Knife facilities in Lima, Peru and Guayaquil, Ecuador. The Company through its wholly-owned subsidiary, Orlando, provided proton beam radiation therapy (&#8220;PBRT&#8221;) and related equipment to a customer in the United States. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company formed the subsidiary GKPeru and acquired GKCE for the purposes of expanding its business internationally; Orlando and LBE to provide PBRT equipment and services in Orlando, Florida and Long Beach, California, respectively; and AGKE and JGKE to provide Gamma Knife equipment and services in Albuquerque, New Mexico and Jacksonville, Florida, respectively. AGKE began operations in the second quarter of 2011 and JGKE began operations in the fourth quarter of 2011. Orlando treated its first patient in April 2016. GKPeru treated its first patient in July 2017. LBE is not expected to generate revenue within the next two years.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 12, 2020, GKF, through HoldCo, purchased approximately <ix:nonFraction unitRef="number" contextRef="i6422158328d64dee80e1ac0f4c7ef41f_I20200612" decimals="2" name="ams:AssetAcquisitionPercentageOfSharesAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzEwOTk1MTE2MzQyMjM_ed5c7eea-9179-48d8-a91e-2ef37a6e782a">98</ix:nonFraction>% of the total outstanding shares of GKCE, from GKCE&#8217;s majority shareholders (the &#8220;Acquisition&#8221;). As of December 31, 2020, the Company had acquired approximately <ix:nonFraction unitRef="number" contextRef="i795a789ed9064252be4a8f64e1390165_I20201231" decimals="3" name="ams:AssetAcquisitionPercentageOfSharesAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzEwOTk1MTE2MzQzODQ_6aaec314-8670-477e-9520-c07294e43b18">99.3</ix:nonFraction>% of the total outstanding shares of GKCE and intends to acquire the remaining <ix:nonFraction unitRef="number" contextRef="i6422158328d64dee80e1ac0f4c7ef41f_I20200612" decimals="3" name="ams:AssetAcquisitionPercentageOfSharesRemaining" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzEwOTk1MTE2MzQ0NjU_1f7296a2-bc46-409a-a9f6-0a6e4b69855c">0.7</ix:nonFraction>% at a later date. The base purchase price for the Acquisition, including acquisition of the minority shares was approximately $<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-6" format="ixt:numdotdecimal" name="ams:AssetAcquisitionConsiderationTransferred" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzEwOTk1MTE2MzQ1OTQ_02ad57f5-05a6-4c3d-858e-8592e5b4352c">2,000,000</ix:nonFraction>. This purchase price was paid with $<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:PaymentsForAssetAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzEwOTk1MTE2MzQ2MzM_3e10a72d-f775-4667-a6cf-dd3955856731">575,000</ix:nonFraction> in cash and a $<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionTransactionCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzEwOTk1MTE2MzQ2NTE_424bdd03-0fad-4364-9dce-071060dbdc60">1,425,000</ix:nonFraction> loan from the United States International Development Finance Corporation (&#8220;DFC&#8221;).  The purchase price is subject to certain post-closing adjustments, including adjustment for GKCE's working capital and excess cash.  The DFC loan is denominated in U.S. dollars, which is also the currency of Ecuador.  See &#8220;Note 4. GKCE Acquisition&#8221; for further discussion.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to develop its design and business model for The Operating Room for the 21st Century</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through its <ix:nonFraction unitRef="number" contextRef="i410be01cd1af4746a125e7746f1d7df8_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzI1NDk_bdb76607-46e7-4622-bc9a-ade1161f1421">50</ix:nonFraction>% owned OR21, LLC (&#8220;OR21&#8221;). The remaining <ix:nonFraction unitRef="number" contextRef="i40610f194f284cf08a0a82249bb51162_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzI1OTI_3f7dd106-1a52-4d15-b85f-910b4d02b077">50</ix:nonFraction>% of OR21 is owned by an architectural design company. OR21 is not expected to generate significant revenue within the next two years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MedLeader was formed to provide continuing medical education online and through videos for doctors, nurses, and other healthcare workers. This subsidiary is not operational at this time.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All significant intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks and uncertainties as a result of the COVID-19 pandemic and the extent and duration of the future impact on the Company's business is highly uncertain and difficult to predict. The COVID-19 pandemic has adversely impacted, and is likely to further adversely impact, nearly all aspects of the Company&#8217;s business and markets, including its employees, operations, contractors, customers, government and third party payors and others. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition will depend on future developments that are highly uncertain and difficult to predict.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 11</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_154"></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.715%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 2 &#8211; <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTgz_fec59777-864b-42e5-9886-7491a01a906d" continuedAt="i6f0e95c2f10b4a4180d28c685d02726c" escape="true">A</ix:nonNumeric></span><ix:continuation id="i6f0e95c2f10b4a4180d28c685d02726c" continuedAt="i624dbebc48af418ab8d9e5858ca18094"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OLICIES</span></ix:continuation></div><ix:continuation id="i624dbebc48af418ab8d9e5858ca18094" continuedAt="i692bb0c3685d42268de63bcdcd0e2d79"><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTg0_d36d8f61-a064-4f67-be17-258235e59709" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of estimates in the preparation of financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In preparing the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates reflected in the Company&#8217;s consolidated financial statements include the estimated useful lives of fixed assets and its salvage values, revenues and costs of sales for turn-key and revenue sharing arrangements.&#160; Actual results could differ from those estimates.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTk3_0319408e-908d-4e9f-86c7-7ec1dd2a9fc1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company expenses advertising costs as incurred. Advertising costs were $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzkyNQ_f7ced1f2-0435-4f6b-855e-915d34dea3b5">237,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzkyOQ_e9cad694-7f74-4cf0-8f7e-7da4c399589b">144,000</ix:nonFraction> during the years ended December&#160;31, 2020 and 2019. Advertising costs are recorded in other direct operating costs and sales and administrative costs in the consolidated statements of operations.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjAw_13fd9917-6f25-42b6-84e4-575ba5bbb30f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company considers all liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. Restricted cash is not considered a cash equivalent for purposes of the consolidated statements of cash flows.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjAx_eef58b10-a54b-4a7f-9a4f-23b66b506a89" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Restricted cash represents the minimum cash that must be maintained in GKF to fund operations, per the subsidiary&#8217;s operating agreement, the minimum cash that must be maintained by GKF per it&#8217;s financing agreement with DFC, and the minimum cash that must be maintained in Orlando per the subsidiary&#8217;s financing agreement.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="ams:BusinessAndCreditRiskPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTkw_76ec18de-8d5c-444a-9e02-016885fbc661" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business and credit risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company maintains its cash balances, which exceed federally insured limits, in financial institutions. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents. The Company monitors the financial condition of the financial institutions it uses on a regular basis.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s revenue was provided by eighteen and seventeen customers in 2020 and 2019. One customer accounted for approximately <ix:nonFraction unitRef="number" contextRef="id972ed669aba469da1b189f82f5af5dc_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzIxNDk_5fbfe811-01b8-4ff7-bb88-fd2780238d83">35</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i8e8116d241f44505a3ffdf0d7e29c59b_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzIxNTM_925c886e-9945-4cba-8625-76cfbeb3e44d">30</ix:nonFraction>% of the Company&#8217;s total revenue in 2020 and 2019. At December&#160;31, 2020, four customers each individually accounted for <ix:nonFraction unitRef="number" contextRef="i56e19fee70bc48ac882fd81a5a98bbfc_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0MjY_55b8d5c8-9366-42ba-a839-792d0d79aaa0">11</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i5fd315d5d86b412e8a98e82bbe77f732_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0MzE_9d52eb7c-e861-4c91-ac42-0ded5498881d">11</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i400c6be02aad4a9fafc38382c1213485_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0MzY_3c8a0bef-7df1-4ff6-af9c-b77848f75c7d">11</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ie3e0fe294ba6407abae7a2107d1721a7_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0NDE_03f69871-f838-4057-9a6b-486d73802296">20</ix:nonFraction>% of total accounts receivable, respectively. At December&#160;31, 2019, three customers each individually accounted for <ix:nonFraction unitRef="number" contextRef="i28c7add148a045bb833ce1179113d93f_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0NDY_bbca7065-bb78-4c30-b232-29519c502458">12</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i40f23635f374477d8f08757fc9c0b712_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0NTE_bf0d4378-3060-4e35-998c-1acf2ba0d4d8">15</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ie606429758a940aeb109be90c15f3903_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0NTY_8303e417-b09b-4a4f-938b-e560fe3ff37c">30</ix:nonFraction>% of total accounts receivable, respectively. The Company performs credit evaluations of its customers and generally does not require collateral. The Company has not experienced significant losses related to receivables from individual customers or groups of customers in any particular geographic area.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s radiosurgery devices have been purchased through Elekta, to date. However, there are other manufacturers that also make radiosurgery devices.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTkx_afa1b7ff-91e3-48ea-b91d-6f2ca2c2f6a5" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts receivable and doubtful accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Accounts receivable are recorded at net realizable value. An allowance for doubtful accounts is estimated based on historical collections plus an allowance for probable losses. Receivables are considered past due based on contractual terms and are charged off in the period that they are deemed uncollectible. Recoveries of receivables previously charged off are offset against bad debt expense when received.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="ams:NoncontrollingInterestsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTc3_9c16c1a7-8c2b-48e0-9e6f-532248cb26ec" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-controlling interests</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company reports its non-controlling interests as a separate component of shareholders&#8217; equity. The Company also presents the consolidated net income and the portion of the consolidated net income allocable to the non-controlling interests and to the shareholders of the Company separately in its consolidated statements of operations.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTky_b857888e-087e-4bf4-99a4-aea2291a663a" continuedAt="ia88193c565dd4b24853b6af73f974f21" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Property and equipment are stated at cost less accumulated depreciation. Depreciation for Gamma Knife, IGRT, and other equipment is determined using the straight-line method over the estimated useful lives of the assets, which for medical and office equipment is generally <ix:nonNumeric contextRef="i05ae369147604a31ac9acde67baf1fe0_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzM4ODU_489a8dc4-c32b-47da-8358-0e15385baa85">3</ix:nonNumeric> &#8211; <ix:nonNumeric contextRef="i6ad83fb416a54f079b45eac2cfce2818_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzM4OTA_be582d99-2281-4946-885b-9f6ce255ffb3">10</ix:nonNumeric> years, and after accounting for salvage value on the equipment where indicated. Salvage value is based on the estimated fair value of the equipment at the end of its useful life.  The Company acquired a building as part of the Acquisition in June 2020.  Depreciation for buildings is determined using the straight-line method over 20 years.</span></ix:nonNumeric></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.715%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 2 &#8211; A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OLICIES (CONTINUED)</span></div></div><ix:continuation id="i692bb0c3685d42268de63bcdcd0e2d79" continuedAt="i25f5d1db13e044a694c9c2bab0d34386"><ix:continuation id="ia88193c565dd4b24853b6af73f974f21"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation for PBRT and related equipment is determined using the modified units of production method, which is a function of both time and usage of the equipment. This depreciation method allocates costs considering the projected volume of usage through the useful life of the PBRT unit, which has been estimated at <ix:nonNumeric contextRef="i57e5d37f53fe4fc2b7edcc04f231b5d7_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQzODU_48a2e7f0-f771-45e0-8db7-e8f52d7882a9">20</ix:nonNumeric> years. The estimated useful life of the PBRT unit is consistent with the estimated economic life of <ix:nonNumeric contextRef="i57e5d37f53fe4fc2b7edcc04f231b5d7_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQ0ODI_26e84d24-9f9e-4736-8fe3-ea01e4cf60f5">20</ix:nonNumeric> years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes interest incurred on property and equipment that is under construction, for which deposits or progress payments have been made. When a rate is not readily available, imputed interest is calculated using the Company&#8217;s incremental borrowing rate. The interest capitalized for property and equipment is the portion of interest cost incurred during the acquisition periods that could have been avoided if expenditures for the equipment had not been made. The Company capitalized interest of $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQ5OTc_8f66be8e-3de5-47af-9307-c11c5c46c0b6">119,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzUwMDE_327452a3-6307-4166-ba17-ec3df060beb3">110,000</ix:nonFraction> in 2020 and 2019, respectively, as costs of medical equipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases Gamma Knife and radiation therapy equipment to its customers under arrangements accounted for as operating leases. At December&#160;31, 2020, the Company held equipment under operating lease contracts with customers with an original cost of $<ix:nonFraction unitRef="usd" contextRef="i298febcd82414e288d184f34830a1679_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzUzMjc_b150eee3-5c6d-4c1e-b619-c70d6bac24fe">75,241,000</ix:nonFraction> and accumulated depreciation of $<ix:nonFraction unitRef="usd" contextRef="i298febcd82414e288d184f34830a1679_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzUzNjI_961a063e-abfc-4eb5-8726-6022e7e6362f">45,416,000</ix:nonFraction>. At December&#160;31, 2019, the Company held equipment under operating lease contracts with customers with an original cost of $<ix:nonFraction unitRef="usd" contextRef="i8a373e6624244f4798fe5b5d28dbef2a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzU0NzI_ef2c7ab1-d722-42f3-98c7-c52d3f008466">92,135,000</ix:nonFraction> and accumulated depreciation of $<ix:nonFraction unitRef="usd" contextRef="i8a373e6624244f4798fe5b5d28dbef2a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzU1MDc_2ecaae17-e206-4239-aae9-56da63f4b7bb">55,148,000</ix:nonFraction>.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company recognized a loss on the write down of impaired assets of $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQ5NDc4MDIzNjk3ODc_9719ba06-9230-4b0f-8649-54256864f377">8,264,000</ix:nonFraction>.  The impaired assets included six (<ix:nonFraction unitRef="unit" contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231" decimals="INF" name="ams:NumberOfImpairedAssetUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMDkzMTk_a072cc61-7aa7-4ccd-88e9-2661b7467e40">6</ix:nonFraction>) Gamma Knife units and the Company's deposits towards purchase of proton beam systems and related capitalized interest.  See further discussion under Note 2 - Long-lived asset impairment and Note 3 - Property and Equipment for further discussion.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTkz_714de1d7-338d-42b8-9268-d0cace3adc3f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company&#8217;s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels. Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company&#8217;s own assumptions about the assumptions that market participants would use in pricing the asset or liability.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjA0_6da0fe00-1ab8-4262-9d2f-7be5e7f360bb" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s assets and liabilities as of December&#160;31, 2020 and 2019 were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:38.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7279522e293b495db1b4d192e00ff1e6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzMtMS0xLTEtMA_c44c110d-194f-4aa0-a607-a48e1c6e170d">4,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ea0bf1639814d3381a9b42a27326780_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzMtMy0xLTEtMA_1f80178c-8ff1-4a21-aaa3-694cef4b3c94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cea93e95519466ca67288ae891587b5_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzMtNS0xLTEtMA_9b66817c-18d4-416e-99a2-6ae597bb9820">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzMtNy0xLTEtMA_8909f28d-2aed-4c64-b4c6-2d43d6e380c7">4,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40f6d3eb893e49dba2c9816815bdc0a1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzMtOS0xLTEtMA_92933f52-759d-498a-acf7-2a08143ed425">4,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7279522e293b495db1b4d192e00ff1e6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzQtMS0xLTEtMA_53e14eed-d8fb-499d-8179-c924aeb515bd">4,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ea0bf1639814d3381a9b42a27326780_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzQtMy0xLTEtMA_3a0aa28c-c79d-4883-a4ed-52c5af2907cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cea93e95519466ca67288ae891587b5_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzQtNS0xLTEtMA_626354f6-1d3d-43df-b12e-71bbc2a685d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzQtNy0xLTEtMA_8fb3d78c-5d77-4ff3-b309-0ac8e020c5e6">4,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40f6d3eb893e49dba2c9816815bdc0a1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzQtOS0xLTEtMA_0f4fb04d-3aa2-411a-a32b-6669d0577b4f">4,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7279522e293b495db1b4d192e00ff1e6_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzctMS0xLTEtMA_97edb270-1714-4af0-bd35-b8095b7467cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ea0bf1639814d3381a9b42a27326780_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzctMy0xLTEtMA_242bc82a-df30-407e-bba1-22d211b63d35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cea93e95519466ca67288ae891587b5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzctNS0xLTEtMA_14983684-4c3c-4612-863a-adbc06288931">4,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzctNy0xLTEtMA_acf650e2-f5d4-4ef7-8aa7-280bf557299a">4,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40f6d3eb893e49dba2c9816815bdc0a1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzctOS0xLTEtMA_e1ddf535-1fc6-48a4-819f-63cadcb49067">4,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7279522e293b495db1b4d192e00ff1e6_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzgtMS0xLTEtMA_d1a7a2a6-b5e1-49b1-aa12-adc288c28f3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ea0bf1639814d3381a9b42a27326780_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzgtMy0xLTEtMA_767b6295-8a74-4891-a13a-857998a8171a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cea93e95519466ca67288ae891587b5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzgtNS0xLTEtMA_67a0f1f1-3a58-4373-9ac9-e255a64cae99">4,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzgtNy0xLTEtMA_3c9b3892-cac6-44bd-9c05-4ac7e6b4167d">4,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40f6d3eb893e49dba2c9816815bdc0a1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzgtOS0xLTEtMA_69cd4785-2716-4a53-8a02-33420519f4e7">4,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd382747b25b4861a422a0f266d39f5d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEyLTEtMS0xLTA_b35c2877-a6ae-4798-acc5-45449292f7b8">1,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i519145167b974aab9b393f963cdb8d7a_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEyLTMtMS0xLTA_ec3e2286-9de9-460a-990a-12902c9bbe3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ecdfacebdb44469bdc41efe4acc1dc_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEyLTUtMS0xLTA_133a254a-a17b-46e3-a495-f9786d8a702c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEyLTctMS0xLTA_91f57361-af13-4e01-9854-3a9b2b14b1a5">1,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d629e14069b4f1ca36dd799f3eb6039_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEyLTktMS0xLTA_39d683c9-3694-4869-9243-176d704cde5d">1,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd382747b25b4861a422a0f266d39f5d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEzLTEtMS0xLTA_00e2224c-faa1-4a4a-a65e-970c00c9eb1a">1,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i519145167b974aab9b393f963cdb8d7a_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEzLTMtMS0xLTA_1a634cdb-97f4-4f68-b525-3dee9747245b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ecdfacebdb44469bdc41efe4acc1dc_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEzLTUtMS0xLTA_bee8590e-af47-4687-8a84-cd6ca377e336">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEzLTctMS0xLTA_8fab7185-dc12-489e-ae6d-eac1724f2e56">1,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d629e14069b4f1ca36dd799f3eb6039_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEzLTktMS0xLTA_fec96ee5-0896-452b-b20f-2dca02dfce42">1,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd382747b25b4861a422a0f266d39f5d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE2LTEtMS0xLTA_562d1d11-1294-469b-82ad-89ffa5b6ffc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i519145167b974aab9b393f963cdb8d7a_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE2LTMtMS0xLTA_eabfc1ee-d236-430c-b69b-aa588b99c63e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ecdfacebdb44469bdc41efe4acc1dc_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE2LTUtMS0xLTA_cc1060a6-e20b-406b-9906-5ad769b83412">3,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE2LTctMS0xLTA_636dc3f9-74f7-487a-ac49-02d66ba1da4d">3,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d629e14069b4f1ca36dd799f3eb6039_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE2LTktMS0xLTA_1d4fce45-162e-49f9-9f54-f57a2e71c102">3,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd382747b25b4861a422a0f266d39f5d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE3LTEtMS0xLTA_0a80f3dc-3a9b-4b4b-9867-d7cb29f59e48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i519145167b974aab9b393f963cdb8d7a_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE3LTMtMS0xLTA_7cf27020-1b72-4299-9565-df53ca8c25a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ecdfacebdb44469bdc41efe4acc1dc_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE3LTUtMS0xLTA_51c54708-baf7-40cc-bb2c-6f802bb9bad6">3,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE3LTctMS0xLTA_77ef98e3-2969-45e3-a29a-fd000190c2e3">3,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d629e14069b4f1ca36dd799f3eb6039_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE3LTktMS0xLTA_7efb078d-d472-4d66-a1b4-63239295e779">3,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.715%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 2 &#8211; A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OLICIES (CONTINUED)</span></div></div><ix:continuation id="i25f5d1db13e044a694c9c2bab0d34386" continuedAt="i462896e0fe7849d9b4f8200c9e80d63a"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjA1_dc745c08-b5ff-4b56-8003-6164e1bfeeb7" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company recognizes revenues under ASC 842 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 842&#8221;) and ASC 606 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 606&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rental income from medical services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company recognizes revenues under ASC 842 when services have been rendered and collectability is reasonably assured, on either a fee per use or revenue sharing basis. The terms of the contracts do not contain any guaranteed minimum payments. The Company&#8217;s contracts are typically for a <ix:nonNumeric contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMDYyMzc_b0c673c8-2522-4a44-8922-3123bac5b65e">10</ix:nonNumeric>-year term and are classified as either fee per use or retail. Retail arrangements are further classified as either turn-key or revenue sharing. Revenues from fee per use contracts is determined by each hospital&#8217;s contracted rate. Revenues are recognized at the time the procedures are performed, based on each hospital&#8217;s contracted rate and the number of procedures performed. Under revenue sharing arrangements, the Company receives a contracted percentage of the reimbursement received by the hospital. The amount the Company expects to receive is recorded as revenue and estimated based on historical experience. Revenue estimates are reviewed periodically and adjusted as necessary. Under turn-key arrangements, the Company receives payment from the hospital in the amount of the hospital&#8217;s reimbursement from third party payors, and the Company is responsible for paying all the operating costs of the equipment. Operating costs are determined primarily based on historical treatment protocols and cost schedules with the hospital. The Company records an estimate of operating costs which are reviewed on a regular basis and adjusted as necessary to more accurately reflect the actual operating costs. For turn-key sites, the Company also shares a percentage of net operating profit. The Company records an estimate of net operating profit based on estimated revenues, less estimated operating costs. The operating costs and estimated net operating profit are recorded as other direct operating costs in the consolidated statement of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2020 and 2019, the Company recognized revenues of approximately $<ix:nonFraction unitRef="usd" contextRef="ic5fff1c8944b46cb882c1df18912daf8_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQ5NDc4MDIzNzAxNzc_0cfb9f91-290d-4df5-8aa3-2a825a780334">16,204,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i17d0a114a3a64f229fe1ddcdd3b7eb1c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTU0NDg_3d62b226-6bac-43f4-b791-a97d00e1ca89">19,396,000</ix:nonFraction> under ASC 842, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company has stand-alone facilities in Lima, Peru and Guayaquil, Ecuador, where a contract exists between the Company&#8217;s facilities and the individual patient treated at the facility. Under ASC 606, the Company acts as the principal in this transaction and provides, at a point in time, a single performance obligation, in the form of a Gamma Knife treatment. Revenue related to a Gamma Knife treatment is recognized on a gross basis at the time when the patient receives treatment. There is no variable consideration present in the Company&#8217;s performance obligation and the transaction price is agreed upon per the stated contractual rate. GKPeru's payment terms are typically prepaid for self-pay patients and insurance provider payments are paid net 30 days. GKCE's patient population is primarily covered by a government payor and payments are paid approximately 30 to 60 days upon invoice. The Company did not capitalize any incremental costs related to the fulfillment of its customer contracts.  Accounts receivable earned by GKPeru were not significant for the year ended December&#160;31, 2020 and 2019. GKCE's accounts receivable were $<ix:nonFraction unitRef="usd" contextRef="i71d12ecde1e645d39bc55a9ecf494e71_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedParties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NTUxNjI_0413149c-71b1-40a4-b563-1c79fea715e0">467,000</ix:nonFraction> for the year ended December&#160;31, 2020. As of December&#160;31, 2020 and 2019, the Company recognized revenues of approximately $<ix:nonFraction unitRef="usd" contextRef="i6f48202c104045e5af8b285017387f01_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQ5NDc4MDIzNzAzODE_a758cd8b-ab21-4079-9b06-ed21a460866c">1,633,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifce03623ecd94f9a9f86454660e7a747_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTU0NjE_a7df14b3-6f08-48da-af2f-79ffb0b8d89c">1,209,000</ix:nonFraction> under ASC 606, respectively.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTc5_a0a73d5f-1f09-4973-834f-68dd02b71fd1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company measures all stock-based compensation awards at fair value and records such expense in its consolidated financial statements over the requisite service period of the related award. See Note 9 for additional information on the Company&#8217;s stock-based compensation programs.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTg1_18a544fd-7014-4890-9613-a292bb06eee2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Costs of revenue &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's costs of revenue consist primarily of maintenance and supplies, depreciation and amortization, and other operating expenses (such as insurance, property taxes, sales taxes, marketing costs and operating costs from the Company&#8217;s retail sites). Costs of revenues are recognized as incurred.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTk0_c4fe7f42-3a82-4216-b348-c0380a91d715" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company markets its services through its preferred provider status with Elekta and a direct sales effort led by its Senior Vice President of Sales and Business Development, its President and Chief Financial and Operating Officer and its Chief Executive Officer (&#8220;CEO&#8221;). </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically provides the equipment, as well as planning, installation, reimbursement and marketing support services.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTg3_36a009b8-c52e-42d4-9f51-bcb21d73ad1d" continuedAt="id7ab107b3bfe434781206055190f6b2d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.</span></ix:nonNumeric></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.715%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 2 &#8211; A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OLICIES (CONTINUED)</span></div></div><ix:continuation id="i462896e0fe7849d9b4f8200c9e80d63a" continuedAt="idf45ba1b3a4b4106a8b9993e3738648c"><ix:continuation id="id7ab107b3bfe434781206055190f6b2d"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for uncertainty in income taxes as required by the provisions of ASC 740 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 740&#8221;), which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to estimate and measure the tax benefit as the largest amount that is more than <ix:nonFraction unitRef="number" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="2" name="ams:PercentageOfTaxBenefitRealizedUponSettlement" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEyODk0_f9081b3b-e557-4cee-b0e5-1768c5ea1da1">50</ix:nonFraction>% likely of being realized upon ultimate settlement. It is inherently difficult and subjective to estimate such amounts, as this requires the Company to determine the probability of various possible outcomes. The Company considers many factors when evaluating and estimating the Company&#8217;s tax positions and tax benefits, which may require periodic adjustments and may not accurately anticipate actual outcomes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 for further discussion on income taxes.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjAy_c664fe6a-8aca-484b-b40b-1f190dda25ab" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Functional currency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Based on guidance provided in accordance with ASC 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 830&#8221;), the Company analyzes its operations outside the United States to determine the functional currency of each operation. Management has determined that these operations are initially accounted for in U.S. dollars since the primary transactions incurred are in U.S. dollars and the Company provides significant funding towards the startup of the operation. When Management determines that an operation has become predominantly self-sufficient, the Company will change its accounting for the operation to the local currency from the U.S. dollar. The Company analyzed it&#8217;s Gamma Knife site in Peru under ASC 830 as of December&#160;31, 2020 and 2019 and concluded the functional currency was the U.S. dollar. As facts and circumstances change, the Company will revisit this conclusion.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="ams:AssetRetirementObligationsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTgw_2ad1b9e4-2eb1-43b6-89f1-8ee9161647fb" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Retirement Obligations &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Based on the guidance provided in ASC 410 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Retirement Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 410&#8221;), the Company analyzed its existing lease agreements and determined an asset retirement obligation (&#8220;ARO&#8221;) exists to remove the respective units at the end of the lease terms. As of December&#160;31, 2020, four (<ix:nonFraction unitRef="customer" contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231" decimals="INF" name="ams:NumberOfCustomersWithIntentToTerminateContract" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMDYyMTQ_fdba9b6f-5935-4214-857a-485fa9947f2f">4</ix:nonFraction>) of the Company's Gamma Knife customers notified the Company of their intent to terminate their contracts at the contract lease term.  The Company recorded an ARO liability for these four (<ix:nonFraction unitRef="site" contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231" decimals="INF" name="ams:AssetRetirementObligationNumberOfSites" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMDYyMTc_acb794ea-c713-4746-b5fb-a78225ca2e55">4</ix:nonFraction>) sites, using estimates from Elekta.  No liability has been recorded as of December&#160;31, 2020 for the remaining Gamma Knife sites, or as of December&#160;31, 2019, because it is uncertain these units will be removed and the Company historically has not removed the Gamma Knife equipment at the end of the lease term. The Company will re-evaluate the need to record additional ARO liabilities on a periodic basis when facts and circumstances change that could affect this conclusion.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTk4_1b88dd75-408a-4db9-9dfa-9a70f8cc34f0" continuedAt="i8f29308662d04a1581ca82c010ecf3a6" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the year. The fully vested restricted stock units not issued and outstanding, are also included therein. Diluted earnings per share reflect the potential dilution that could occur if common shares were issued pursuant to the exercise of options or warrants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Company reported a loss for the year ended December&#160;31, 2020, the potentially dilutive effects of approximately <ix:nonFraction unitRef="shares" contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NjkzMDg_59901d93-0298-4745-be2d-fabf789f27ab">13,000</ix:nonFraction>, of the Company's unvested restricted stock awards were not considered for the reporting periods. </span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8f29308662d04a1581ca82c010ecf3a6">On March 31, 2020, the Company&#8217;s Award Agreements (as defined below) expired and the unvested performance share awards were returned to the Company&#8217;s stock incentive plan - see Note 9 for further discussion.  Based on the guidance provided in accordance with ASC 260, the weighted average common shares for basic earnings per share, for the year ended December 31, 2019 excluded the weighted average impact of the unvested performance share awards. These awards were legally outstanding but not deemed participating securities and therefore were excluded from the calculation of basic earnings per share. The unvested shares were also excluded from the denominator for diluted earnings per share because they were considered contingent shares not deemed probable as of December 31, 2019.</ix:continuation>  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjA2_c7575923-9153-479b-b03e-98999c7df187" continuedAt="i84f28ee724d04a14aa3f1f068b93fa88" escape="true">The following table illustrates the computations of basic and diluted earnings per share for the years ended December&#160;31, 2020 and 2019.</ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.715%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 2 &#8211; A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OLICIES (CONTINUED)</span></div></div><ix:continuation id="idf45ba1b3a4b4106a8b9993e3738648c" continuedAt="id2fc23ae76004f638cf5a728b25fe7a8"><div style="margin-bottom:6pt"><ix:continuation id="i84f28ee724d04a14aa3f1f068b93fa88"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for basic and diluted (loss) earnings per share</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzEtMS0xLTEtMA_71e3f40c-7196-4616-a86c-49a50e9c776e">7,058,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzEtMy0xLTEtMA_86f1d953-b79a-4f5f-ae02-c760e0f5ef9b">659,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic and diluted (loss) earnings per share &#8211; weighted-average shares</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzMtMS0xLTEtMA_89e5531d-0ddb-448f-afe5-6a463519d29b">6,182,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzMtMy0xLTEtMA_06849fb9-3fc0-4c6e-aea2-6c0dda1e34ac">5,919,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities Employee stock options and restricted stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzQtMS0xLTEtMA_ca5db7a3-7157-4c17-a6fe-d764a4a83cbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzQtMy0xLTEtMA_3ec8f0e6-7ef2-4fb2-be4e-b6f643ce3170">11,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted (loss) earnings per share &#8211; adjusted weighted-average shares</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzUtMS0xLTEtMA_7885bea2-7150-40b2-b830-013aae782815">6,182,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzUtMy0xLTEtMA_8bb433b7-0589-4718-bfd0-df416375ae0d">5,930,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings per common share- basic</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzYtMS0xLTEtMA_f48d0ff5-96ff-4ca4-bde9-f88f0c8e1227">1.14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzYtMy0xLTEtMA_2b2d2e2a-d698-40ee-b248-c5c223533944">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings per common share- diluted</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzctMS0xLTEtMA_f68b9aeb-83a2-44bf-a90c-992a30285e7a">1.14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzctMy0xLTEtMA_355d2ce0-5425-40c4-b02f-f963745ea216">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, options outstanding to purchase <ix:nonFraction unitRef="shares" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1NDYx_10fd4c8a-491e-42cb-b617-2fd7f04d1fc8">406,000</ix:nonFraction> shares of common stock at an exercise price range of $<ix:nonFraction unitRef="usdPerShare" contextRef="i279a2dc09a1e4d058baa0f82d26d3fec_D20200101-20201231" decimals="2" name="ams:StockOptionExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1NTE3_5f1e852c-b376-47de-9912-d1eb4b851723">2.25</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i201f554e454a461689418aeaf993818a_D20200101-20201231" decimals="2" name="ams:StockOptionExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1NTIy_7cae83e6-c8c1-4f60-8954-266c0c7d81a9">3.90</ix:nonFraction> per share and <ix:nonFraction unitRef="shares" contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1NTM5_031969c6-a930-4383-bca8-81b5020414fb">13,000</ix:nonFraction> restricted stock units were not included in the calculation of diluted earnings per share because they would be anti-dilutive.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, options outstanding to purchase <ix:nonFraction unitRef="shares" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1NzA4_8bef095c-770b-4ca2-bed9-eb3735cb86ed">387,000</ix:nonFraction> shares of common stock at an exercise price range of $<ix:nonFraction unitRef="usdPerShare" contextRef="i430692827c684c1ca5be2f83d2a702f5_D20190101-20191231" decimals="2" name="ams:StockOptionExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1NzY3_b02d3ad2-7be7-417b-b2d6-42b7ce8471c0">2.68</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="iacead3b29e7846bcac84408721d0ef98_D20190101-20191231" decimals="2" name="ams:StockOptionExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1Nzcy_316c36fd-806a-4eef-b727-65918581b7d7">3.90</ix:nonFraction> per share and <ix:nonFraction unitRef="shares" contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1Nzg5_63bd8992-192c-49a0-9b83-b139c6b4c735">3,000</ix:nonFraction> restricted stock units were not included in the calculation of diluted earnings per share because they would be anti-dilutive.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTgy_44b81264-a964-4a78-afa6-6c9a97777081" continuedAt="ie196e15011804a70b443f9c0a8c20000" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business segment information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Based on the guidance provided in accordance with ASC 280 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie196e15011804a70b443f9c0a8c20000"> (&#8220;ASC 280&#8221;), the Company analyzed its subsidiaries which are all in the business of leasing radiosurgery and radiation therapy equipment to healthcare providers, and concluded there are <ix:nonFraction unitRef="segment" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMDYyMjY_91df8203-27f5-41bd-8ed8-317fce023dad">two</ix:nonFraction> reportable segments, domestic and foreign. The Company provides Gamma Knife and PBRT equipment to fifteen hospitals in the United States and owns and operates two single-unit facilities in Lima, Peru and Guayaquil, Ecuador as of December&#160;31, 2020. The Company determined <ix:nonFraction unitRef="segment" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NjkwMzE_91df8203-27f5-41bd-8ed8-317fce023dad">two</ix:nonFraction> reportable segments existed due to similarities in economics of business operations and geographic location. The operating results of the <ix:nonFraction unitRef="segment" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NjkwMzQ_91df8203-27f5-41bd-8ed8-317fce023dad">two</ix:nonFraction> reportable segments are reviewed by the Company&#8217;s CEO and President, Chief Operating and Financial Officer, who are also deemed the Company&#8217;s Chief Operating Decision Makers (&#8220;CODMs&#8221;).  As of December&#160;31, 2019, the Company had one reportable segment.  Following the Company's acquisition of GKCE in June 2020, the Company concluded it had <ix:nonFraction unitRef="segment" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NzQ2MjE_91df8203-27f5-41bd-8ed8-317fce023dad">two</ix:nonFraction> reportable segments.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="ams:ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjAz_4abcd9d2-34ca-409f-81e9-6783d13d586b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenues, profit or loss, and net property and equipment allocations for the Company's two reportable segments as of December&#160;31, 2020 consists of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.143%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeeee52fa85b4659bb8c93af9403c135_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToyMWU4OTdhYmQ3ODQ0NWYzYmEzMjkyZWMyMzVmODVlOC90YWJsZXJhbmdlOjIxZTg5N2FiZDc4NDQ1ZjNiYTMyOTJlYzIzNWY4NWU4XzItMS0xLTEtMA_6b3ba4de-aad3-4a6a-a3fe-823e64c297e4">16,204,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d5ec3bfbd86448fa8f03c6346be0f99_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToyMWU4OTdhYmQ3ODQ0NWYzYmEzMjkyZWMyMzVmODVlOC90YWJsZXJhbmdlOjIxZTg5N2FiZDc4NDQ1ZjNiYTMyOTJlYzIzNWY4NWU4XzItMy0xLTEtMA_2be7dd6a-fed9-48d2-bbd7-a218cfad23f0">19,396,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673d3ab8cf484509b5a1f6277fa696b3_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToyMWU4OTdhYmQ3ODQ0NWYzYmEzMjkyZWMyMzVmODVlOC90YWJsZXJhbmdlOjIxZTg5N2FiZDc4NDQ1ZjNiYTMyOTJlYzIzNWY4NWU4XzMtMS0xLTEtMA_01c8bd9f-9074-4eb9-ac0b-ea7fa0974130">1,633,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8922c16f8684389b3b97dd8f6e8ab60_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToyMWU4OTdhYmQ3ODQ0NWYzYmEzMjkyZWMyMzVmODVlOC90YWJsZXJhbmdlOjIxZTg5N2FiZDc4NDQ1ZjNiYTMyOTJlYzIzNWY4NWU4XzMtMy0xLTEtMA_ad8508df-b598-431d-887e-78602b2a498d">1,209,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51994c25a7e04ee08bec394c54e6c3c0_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToyMWU4OTdhYmQ3ODQ0NWYzYmEzMjkyZWMyMzVmODVlOC90YWJsZXJhbmdlOjIxZTg5N2FiZDc4NDQ1ZjNiYTMyOTJlYzIzNWY4NWU4XzQtMS0xLTEtMA_e87870fa-19d7-49be-b7d1-ebb0d1ca1285">17,837,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4a678d396245e9bf4323d16c22d03a_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToyMWU4OTdhYmQ3ODQ0NWYzYmEzMjkyZWMyMzVmODVlOC90YWJsZXJhbmdlOjIxZTg5N2FiZDc4NDQ1ZjNiYTMyOTJlYzIzNWY4NWU4XzQtMy0xLTEtMA_5a0dff1c-8ed1-4286-82fa-66e7d9eb8aa7">20,605,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit or (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bf5e95df79b44f7a18e189b2382eb21_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTo2YzVmZTU4NDk2ZjY0NjJjOGM0ZTA0YjAxMzgzNDFlNy90YWJsZXJhbmdlOjZjNWZlNTg0OTZmNjQ2MmM4YzRlMDRiMDEzODM0MWU3XzItMS0xLTEtNjExOA_de3522ab-10e3-4f17-b2dd-4a8ccc6200e7">7,082,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7934b69f46a945fba713a315452b7c67_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTo2YzVmZTU4NDk2ZjY0NjJjOGM0ZTA0YjAxMzgzNDFlNy90YWJsZXJhbmdlOjZjNWZlNTg0OTZmNjQ2MmM4YzRlMDRiMDEzODM0MWU3XzItMy0xLTEtNjExOA_2c4fc1a7-b783-4505-99d4-f6afe1a4bd50">769,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10727c3b4215451ba7e2258b5cc61bdd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTo2YzVmZTU4NDk2ZjY0NjJjOGM0ZTA0YjAxMzgzNDFlNy90YWJsZXJhbmdlOjZjNWZlNTg0OTZmNjQ2MmM4YzRlMDRiMDEzODM0MWU3XzMtMS0xLTEtNjExOA_6032ad35-289b-49e8-9306-d22c8dd73f74">24,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6958c1fb3942499d88011d908e7f5162_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTo2YzVmZTU4NDk2ZjY0NjJjOGM0ZTA0YjAxMzgzNDFlNy90YWJsZXJhbmdlOjZjNWZlNTg0OTZmNjQ2MmM4YzRlMDRiMDEzODM0MWU3XzMtMy0xLTEtNjExOA_aac8bf06-3d15-41b3-bdbc-a2c840e06393">110,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i714b56581adc46f6942c585891e61544_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTo2YzVmZTU4NDk2ZjY0NjJjOGM0ZTA0YjAxMzgzNDFlNy90YWJsZXJhbmdlOjZjNWZlNTg0OTZmNjQ2MmM4YzRlMDRiMDEzODM0MWU3XzQtMS0xLTEtNjExOA_b54a77a4-ca6d-4920-a2e9-9de69be7f549">7,058,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9c32da78d040efa62915a5cb124fe4_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTo2YzVmZTU4NDk2ZjY0NjJjOGM0ZTA0YjAxMzgzNDFlNy90YWJsZXJhbmdlOjZjNWZlNTg0OTZmNjQ2MmM4YzRlMDRiMDEzODM0MWU3XzQtMy0xLTEtNjExOA_1ef6b364-22a0-4d45-8b9c-ebcd3ea02c75">659,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.143%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7895e51adef4d9988611e06cb9a3c5c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmMWY1OGE2N2Y2YTQ0MjNmOGJjMzNjZTdhZWM3ZjllYS90YWJsZXJhbmdlOmYxZjU4YTY3ZjZhNDQyM2Y4YmMzM2NlN2FlYzdmOWVhXzItMS0xLTEtMA_46957341-07fe-4ceb-960d-b5bbca686f3d">27,223,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426af3a3d5514c93814df64d63f704ff_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmMWY1OGE2N2Y2YTQ0MjNmOGJjMzNjZTdhZWM3ZjllYS90YWJsZXJhbmdlOmYxZjU4YTY3ZjZhNDQyM2Y4YmMzM2NlN2FlYzdmOWVhXzItMy0xLTEtMA_26cd7c13-c642-495c-befe-00bb7fcb9e93">38,593,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i309db3889f874fdb939e6cc89fd12897_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmMWY1OGE2N2Y2YTQ0MjNmOGJjMzNjZTdhZWM3ZjllYS90YWJsZXJhbmdlOmYxZjU4YTY3ZjZhNDQyM2Y4YmMzM2NlN2FlYzdmOWVhXzMtMS0xLTEtMA_94e6b979-3c91-418e-af0f-b2a70d718bfc">3,195,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6822c327084e89b634c2f2b2084d15_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmMWY1OGE2N2Y2YTQ0MjNmOGJjMzNjZTdhZWM3ZjllYS90YWJsZXJhbmdlOmYxZjU4YTY3ZjZhNDQyM2Y4YmMzM2NlN2FlYzdmOWVhXzMtMy0xLTEtMA_b21e0c6a-b327-4273-b3d4-37a14f43534e">2,887,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfd154d740fb4aa0a7b0a97723469ebb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmMWY1OGE2N2Y2YTQ0MjNmOGJjMzNjZTdhZWM3ZjllYS90YWJsZXJhbmdlOmYxZjU4YTY3ZjZhNDQyM2Y4YmMzM2NlN2FlYzdmOWVhXzQtMS0xLTEtMA_d19e5100-3cef-4be2-9a3f-7625bedbe96d">30,418,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia83787ee66d2452c9afe259fa7fe0fea_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmMWY1OGE2N2Y2YTQ0MjNmOGJjMzNjZTdhZWM3ZjllYS90YWJsZXJhbmdlOmYxZjU4YTY3ZjZhNDQyM2Y4YmMzM2NlN2FlYzdmOWVhXzQtMy0xLTEtMA_a0f1ecbb-04ab-4fb9-adae-a363f956a6ec">41,480,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.715%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 2 &#8211; A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OLICIES (CONTINUED)</span></div></div><ix:continuation id="id2fc23ae76004f638cf5a728b25fe7a8"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTg4_e89bd3ad-d5ce-4b54-a879-46a300804852" continuedAt="ie38a7943fcaa49cca6b9e0d125591880" escape="true">Long lived asset impairment</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie38a7943fcaa49cca6b9e0d125591880"> &#8211; The Company assesses the recoverability of its long-lived assets when events or changes in circumstances indicate their carrying value may not be recoverable. Such events or changes in circumstances may include: a significant adverse change in the extent or manner in which a long-lived asset is being used, significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset, an accumulation of costs significantly in excess of the amount originally expected for the acquisition or development of a long-lived asset, current or future operating or cash flow losses that demonstrate continuing losses associated with the use of a long-lived asset, or a current expectation that, more likely than not, a long-lived asset will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company performs impairment testing at the asset group level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. The Company assesses recoverability of a long-lived asset by determining whether the carrying value of the asset group can be recovered through projected undiscounted cash flows over their remaining lives. If the carrying value of the asset group exceeds the forecasted undiscounted cash flows, an impairment loss is recognized, measured as the amount by which the carrying amount exceeds estimated fair value. An impairment loss is charged to the consolidated statement of operations in the period in which management determines such impairment. As of December&#160;31, 2020, the Company determined circumstances existed indicating its assets could be impaired, concluded an impairment existed, and recognized a loss on the write down of impaired assets of $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQ5NDc4MDIzNjk3OTM_9719ba06-9230-4b0f-8649-54256864f377">8,264,000</ix:nonFraction>.  <ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE4OTY2_8f49d677-63f0-466a-9431-682511e2523b">No</ix:nonFraction> such impairment has been noted as of  December&#160;31, 2019.  See Note 3 - Property and Equipment for further discussion.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMDgzMDE_bb079044-2218-4621-8800-12473b7fab1f" continuedAt="ie00d434ccf5b460685b5009a40d1c0fc" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and intangible assets - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded goodwill of $<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NjUxMjk_66ffde27-4bc2-4717-bb94-9ea22bc469b7">1,265,000</ix:nonFraction> and an intangible asset with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i0e4c0e6386194ed79a0a74908a8481c4_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NjUyMTc_0076888b-9ed5-4f32-a0df-76d3837ebaac">78,000</ix:nonFraction> as part of the Acquisition in June 2020.  The intangible asset identified was GKCE's trade name and the Company assigned an indefinite useful life to the asset.  Based on the guidance provided in accordance with ASC 350 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie00d434ccf5b460685b5009a40d1c0fc"> (&#8220;ASC 350&#8221;), the Company does not amortize the intangible asset because it has an indefinite life.  The Company assesses goodwill at the reporting unit level, which has been determined to be GKCE. Each reporting period, the Company assesses whether events or circumstances continue to support an indefinite useful life for the intangible asset.  Per ASC 350, the Company tests goodwill and intangibles for impairment annually or as events or circumstances change that indicate the fair value may be below the carrying amount.  As of December&#160;31, 2020, there has been no change to the Company's assessment of the value of intangible assets or goodwill.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTE5MDU_3c41fb74-cdf0-4936-a065-1c8f98b2a860" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company records acquisitions according to ASC 805 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 805&#8221;) using the acquisition method of accounting. Under the acquisition method of accounting, all assets acquired, including goodwill and other intangible assets, should be stated at fair value at the time of acquisition. The allocation of purchase price consideration is preliminary, pending the completion of the fair value of certain tangible, intangible assets, and residual goodwill.  During the measurement period, which can be no more than one year from the Closing Date, the Company expects to continue to obtain information to assist in determining the final fair value of assets acquired.  See Note 4 - GKCE Acquisition for further discussion on acquisitions.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTk1_51157c5d-de47-4089-943e-7a6f682c9e07" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Accounting pronouncement issued and adopted &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2018, the FASB issued ASU No. 2018-03 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Recognition and Measurement of Financial Assets and Financial Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2018-03&#8221;), which clarifies certain aspects of ASU 2016-1. These are: equity securities without a readily determinable fair value &#8211; discontinuation, equity securities without a readily determinable fair value &#8211; adjustments, forward contracts and purchased options, presentation requirements for certain fair value option liabilities, fair value option liabilities denominated in a foreign currency, and transition guidance for equity securities without a readily determinable fair value. In August 2018, the FASB issued ASU No. 2018-13 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Fair Value Measurement (Topic 820): Disclosure Framework &#8211; Changes to the Disclosure Requirements to Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2018-13&#8221;), which amended the effective date and other certain measurement aspects of ASU 2018-03. The new guidance is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The Company adopted ASU 2018-03 and ASU 2018-13 on January 1, 2020. There was no significant impact on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting pronouncement issued and not yet adopted &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2019, the FASB issued ASU 2019-12 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2019-12&#8221;) which removes specific exceptions to the general principles in Topic 740 and eliminates the need for an organization to analyze whether the following apply in a given period: exception to the incremental approach for intraperiod tax allocation; exceptions to accounting for basis differences when there are ownership changes in foreign investments; exception in interim period income tax accounting for year-to-date losses that exceed anticipated losses.  The new guidance is effective for fiscal years and interim periods beginning after December 15, 2020.  The Company is currently evaluating ASU 2019-12 to determine the impact it may have on its consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 17</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_157"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.287%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3 &#8211; <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzE3MTQ_088013a6-26cb-4016-9f74-094d06ed40f2" continuedAt="i17b248532a8d46868c3b589d67ff32c2" escape="true">P</ix:nonNumeric></span><ix:continuation id="i17b248532a8d46868c3b589d67ff32c2" continuedAt="i2d0becf9aca942599cc16e7292d4fa55"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ROPERTY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> E</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">QUIPMENT</span></ix:continuation></div><ix:continuation id="i2d0becf9aca942599cc16e7292d4fa55"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzE3MTU_912bdb2c-7310-4eff-8dce-948a199b458e" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consists of the following:</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment and facilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75857421209a4a9a88a2265cd4aa4e0c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzItMS0xLTEtMA_25353d86-5a6d-4502-ab71-72a08e5764d0">75,657,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i510367b0210f42978fd2121a0200735d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzItMy0xLTEtMA_3b7f1955-1902-4cc3-a8ef-72217145dbf5">92,132,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f3a64c6fb840d18f0efb0eaa318c44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzMtMS0xLTEtMA_9edae9c1-f66b-4481-a37a-fa909817d16f">330,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice7b40f1c9e14f0b8d6cb5971b5d802c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzMtMy0xLTEtMA_a9900305-5068-48dc-834f-3b2fc736f1a0">594,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d358d5eef3047409dc23e990ed19c02_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzQtMS0xLTEtMA_ce502bb1-65f2-4cf4-8bcd-4d8a74a24d96">170,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76faded4f4504bc18d38d7c6fa9479aa_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzQtMy0xLTEtMA_c9abe255-a16d-4361-8309-ddf3863e2d3c">1,965,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits towards purchase of proton beam systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7084175c89f34387ac3446f385b5e3e1_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzUtMS0xLTEtMA_9dbe29be-d5c1-455c-b50f-3638e80c9c42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cb27f70c0184108b4804f5d0b9480eb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzUtMy0xLTEtMA_67cb0bb4-7172-4f14-89c0-039d9b863976">2,250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzYtMS0xLTEtMA_5183e26d-146b-4d05-aa28-7a4fdf9e4e7a">76,157,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzYtMy0xLTEtMA_28980f86-52f9-4053-8ba0-542405343151">96,941,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzctMS0xLTEtMA_6df8f86c-c9c7-4125-8a52-f04d3437108a">45,739,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzctMy0xLTEtMA_1515eb1f-4c3a-4724-b72c-2a4aa1f8fdb0">55,461,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net property and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzgtMS0xLTEtMA_a9662cdb-75ea-45a4-bb27-9c27ee6b5c02">30,418,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzgtMy0xLTEtMA_d25cffd6-8e08-4d7b-a1a6-b40020b308dd">41,480,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, approximately $<ix:nonFraction unitRef="usd" contextRef="i3035febde0194678b2773c7062226a54_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzQ5NDc4MDIzMzc5MDU_67362ddd-37d2-41ec-bb95-a2e4033d3f93">3,195,000</ix:nonFraction> of the net property and equipment balance is outside of the United States. As December&#160;31, 2020, the Company recognized a loss on the write down of impaired assets of $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzQ5NDc4MDIzMzc3NzM_9719ba06-9230-4b0f-8649-54256864f377">8,264,000</ix:nonFraction>.  The impaired assets included six (<ix:nonFraction unitRef="unit" contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231" decimals="INF" name="ams:NumberOfImpairedAssetUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwMjk_a072cc61-7aa7-4ccd-88e9-2661b7467e40">6</ix:nonFraction>) Gamma Knife units and related removal costs, and two (<ix:nonFraction unitRef="deposit" contextRef="i7084175c89f34387ac3446f385b5e3e1_I20201231" decimals="INF" name="ams:NumberOfDeposits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwMzI_36fd4b86-524a-4fa0-b06d-4569b38838b2">2</ix:nonFraction>) deposits towards the purchase of proton beam systems and related capitalized interest.  The six (<ix:nonFraction unitRef="unit" contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231" decimals="INF" name="ams:NumberOfImpairedAssetUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwMjU_a072cc61-7aa7-4ccd-88e9-2661b7467e40">6</ix:nonFraction>) Gamma Knife units that were impaired consisted of two (<ix:nonFraction unitRef="unit" contextRef="i8f932b9ba0be489d8eb94b2f6d54477c_I20201231" decimals="INF" name="ams:NumberOfImpairedAssetUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwMzU_bc6eb77e-dd9a-45ab-835f-510697af9f9a">2</ix:nonFraction>) units that had been taken out of service in prior years, one (<ix:nonFraction unitRef="unit" contextRef="icf316d9d1b244b2bade2edc301cde456_I20201231" decimals="INF" name="ams:NumberOfImpairedAssetUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwMzg_52288b9c-d646-4976-ad0f-b0f8d232cbb5">1</ix:nonFraction>) unit that was taken out of service in 2020 and three (<ix:nonFraction unitRef="unit" contextRef="i22e35e1d597d4b4399ba9a87a43dd7da_I20201231" decimals="INF" name="ams:NumberOfImpairedAssetUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwNDE_aa0fafe6-ee0e-48ea-87a0-1d9ef4af2f13">3</ix:nonFraction>) units that have already been, or the Company anticipates will be, taken out of service in 2021</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">totaling $<ix:nonFraction unitRef="usd" contextRef="id856a65ad9834e49b099b1d1d0c6aaa4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODc3Njc_95276bee-222a-4576-8136-061f880ca1ce">3,051,000</ix:nonFraction>.  In addition to this impairment write-off of $<ix:nonFraction unitRef="usd" contextRef="id856a65ad9834e49b099b1d1d0c6aaa4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODc3ODk_95276bee-222a-4576-8136-061f880ca1ce">3,051,000</ix:nonFraction> were estimated costs of de-install and removal (ARO) of four (<ix:nonFraction unitRef="unit" contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231" decimals="INF" name="ams:AssetRetirementObligationNumberOfRemovedAssetUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwNDQ_c9d6872b-5100-48df-bdad-669c5004802f">4</ix:nonFraction>) of the Gamma Knife units of $<ix:nonFraction unitRef="usd" contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:AssetRetirementObligation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwNDc_83e4c7aa-529c-4874-8e68-d07c70ed3b70">1,350,000</ix:nonFraction> (of which, the Company has paid $<ix:nonFraction unitRef="usd" contextRef="id856a65ad9834e49b099b1d1d0c6aaa4_D20200101-20201231" decimals="-4" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwNjk_fcd7b96a-5d07-4c4c-9ffc-d9a0ed65688c">80,000</ix:nonFraction>) as of December&#160;31, 2020. Total impairment related to the Gamma Knife business was $<ix:nonFraction unitRef="usd" contextRef="id856a65ad9834e49b099b1d1d0c6aaa4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TangibleAssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODc3OTI_7a703fee-58eb-4a79-a1dc-dcee136acb53">4,401,000</ix:nonFraction> for the year ended December&#160;31, 2020.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the carrying value of its long-lived assets for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value may not be recoverable.  The Company has reviewed its Gamma Knife equipment, in light of available information as of December&#160;31, 2020 and based on current customer prospects, the probability of future contract extensions or renewals, and the high turnover rate in contract terminations compared to the Company's historical contract termination rate, the Company determined that these six (<ix:nonFraction unitRef="unit" contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231" decimals="INF" name="ams:NumberOfImpairedAssetUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIxODk_a072cc61-7aa7-4ccd-88e9-2661b7467e40">6</ix:nonFraction>) Gamma Knife units were more-than temporarily impaired.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to December&#160;31, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i8f30f61a17e747c2ad1bc8c1d865eb97_I20201231" decimals="-4" format="ixt:numdotdecimal" name="ams:LongTermPurchaseCommitmentDepositsForAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzQ5NDc4MDIzMzg3MjY_f33b260e-5148-41f8-8a90-59d8709a37ae">2,250,000</ix:nonFraction> in deposits toward the purchase of two MEVION S250i PBRT systems from Mevion. The Company reviews the carrying value of its deposits for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value may not be recoverable. The Company has reviewed the deposits, in light of available information, as of December&#160;31, 2020 and based on its current customer prospects, the impact that the COVID-19 pandemic has had on medical centers undertaking large capital expenditure projects for a limited patient base, and the length of time required to negotiate and implement a proton therapy project, the Company determined that its deposits of $<ix:nonFraction unitRef="usd" contextRef="i8f30f61a17e747c2ad1bc8c1d865eb97_I20201231" decimals="-4" format="ixt:numdotdecimal" name="ams:LongTermPurchaseCommitmentDepositsForAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzQ5NDc4MDIzMzkzOTE_f33b260e-5148-41f8-8a90-59d8709a37ae">2,250,000</ix:nonFraction>, related capitalized interest and other charges of $<ix:nonFraction unitRef="usd" contextRef="i8f30f61a17e747c2ad1bc8c1d865eb97_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedCapitalizedInterestCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODc4MDQ_5beb0624-fd88-4d72-b862-9a14e54d405f">1,613,000</ix:nonFraction> were other-than temporarily impaired.  Total impairment related to the proton therapy business was $<ix:nonFraction unitRef="usd" contextRef="i8c2842d69fdd4db49a077b810d27392c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TangibleAssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODc4MTY_df8b7029-c619-415c-9fb9-9b355a42045d">3,863,000</ix:nonFraction>.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 18</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_160"></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.701%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 4 - <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzMyOTg1MzQ4OTQyMjY_b1a0c792-17f7-4bae-9fa9-cfb94239a2b7" continuedAt="i6c7a8790e594496f9c131cc860dd0393" escape="true">GKCE ACQUISITION</ix:nonNumeric></span></div><ix:continuation id="i6c7a8790e594496f9c131cc860dd0393" continuedAt="icf4eebefbb434722847c3d651c826ae1"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">On June 18, 2019, the Company entered into a Stock Purchase Agreement to acquire Gamma Knife Center Ecuador S.A. (&#8220;GKCE&#8221;) from GKCE&#8217;s selling majority shareholders. GKCE is a well-established Gamma Knife operation founded in 2009 as a private clinic to introduce advanced stereotactic radiosurgery into Ecuador and continues to operate the only Gamma Knife unit in the country. The Company acquired GKCE for the continued expansion of its business internationally. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">On June 12, 2020 (the &#8220;Closing Date&#8221;), the Company acquired approximately <ix:nonFraction unitRef="number" contextRef="i6422158328d64dee80e1ac0f4c7ef41f_I20200612" decimals="2" name="ams:AssetAcquisitionPercentageOfSharesAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDY4MDI_72b7007e-8fb8-4414-98fc-69623fc23221">98</ix:nonFraction>% of the total outstanding shares of GKCE.  As of December&#160;31, 2020, the Company acquired approximately <ix:nonFraction unitRef="number" contextRef="i795a789ed9064252be4a8f64e1390165_I20201231" decimals="3" name="ams:AssetAcquisitionPercentageOfSharesAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDY5MDk_6aaec314-8670-477e-9520-c07294e43b18">99.3</ix:nonFraction>% of the total outstanding shares of GKCE and intends to acquire the remaining <ix:nonFraction unitRef="number" contextRef="i6422158328d64dee80e1ac0f4c7ef41f_I20200612" decimals="3" name="ams:AssetAcquisitionPercentageOfSharesRemaining" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDY5OTA_92858028-cb7e-4370-af3a-9e904462e041">0.7</ix:nonFraction>% at a later date. The fair value of the non-controlling interests (&#8220;NCI&#8221;) on the Closing Date was approximately $<ix:nonFraction unitRef="usd" contextRef="i6422158328d64dee80e1ac0f4c7ef41f_I20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDcxMDU_097300ee-da73-4ab0-92f8-2319cd9bb72a">58,000</ix:nonFraction>, which was consistent with the purchase price in the executed NCI agreements. The total purchase consideration for <ix:nonFraction unitRef="number" contextRef="i6422158328d64dee80e1ac0f4c7ef41f_I20200612" decimals="2" name="ams:AssetAcquisitionPercentageOfOutstandingShares" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDcyMjQ_21575d1a-01f7-4efc-af95-f6977c8cfe45">100</ix:nonFraction>% of the outstanding shares of GKCE was $<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionTotalConsiderationTransferred" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzQ5NDc4MDIzMzY5NjM_78527f09-99cd-4f14-94ed-68ed4c933b4b">2,883,000</ix:nonFraction>, including $<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-6" format="ixt:numdotdecimal" name="ams:AssetAcquisitionConsiderationTransferred" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDcyODE_f7a91ac8-3055-4774-a076-1f6162c3fe39">2,000,000</ix:nonFraction> of base purchase price, subject to certain price adjustments for current assets and liabilities and tax withholding. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The base purchase price of $<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-6" format="ixt:numdotdecimal" name="ams:AssetAcquisitionConsiderationTransferred" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDc0MzE_f7a91ac8-3055-4774-a076-1f6162c3fe39">2,000,000</ix:nonFraction> was paid with $<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:PaymentsForAssetAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDc0NDk_72d92dc6-b536-4f70-81d8-cf6240d9922a">575,000</ix:nonFraction> of cash and a $<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionTransactionCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDc0Njc_5a42daa5-9b25-4e40-aa0e-0432bde5fe13">1,425,000</ix:nonFraction> loan from the United States International Development Finance Corporation (&#8220;DFC&#8221;). The DFC loan is denominated in U.S. dollars, which is also the currency of Ecuador. The price adjustments will be paid by the Company in the post-closing period with the adjustments related to the amount of working capital that GKCE had as of the Closing Date.  The first price adjustment for working capital as of the Closing Date was approximately $<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:PaymentsForWorkingCapital" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDc5MDQ_e510f954-eafc-4d1c-ae2e-af61567022c0">515,000</ix:nonFraction>, which was paid by the Company in August 2020.  As of December&#160;31, 2020, the Company owed the withholding taxes related to this payment totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:PaymentsForWorkingCapital" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDgwNjg_c3c45449-6b33-4711-b9e8-08866d4ef8f7">43,000</ix:nonFraction>. The Company estimates an additional contingent consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionAdditionalConsiderationTransferred" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzQ5NDc4MDIzMzY5NTA_c5ba8dca-30cf-4937-b9a2-51548fed0a6a">368,000</ix:nonFraction> will be remitted to the seller based on the collection of Closing Date accounts receivable balances, net of related costs, during the three-month, six-month and twelve-month periods after the Closing Date. As of December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:PaymentsToAcquireAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzI3NDg3NzkwODEzODc_a343d88f-96f3-4e11-ac54-b984b4bd1f08">214,000</ix:nonFraction> of the contingent considerations had been paid and $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:SubsequentWorkingCapitalPaymentAccruedForAcquisition" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzEwOTk1MTE2Mzg5Njk_882eaea4-0c7d-4fd5-9720-d3845f42f869">154,000</ix:nonFraction> is estimated to be paid for the twelve-month period after the Closing Date. The Company reviewed historical patient treatments, invoice, and collection data from GKCE to determine an appropriate estimate of the contingent consideration at the Closing Date. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The acquisition has been accounted for according to ASC 805 using the acquisition method of accounting.  Under the acquisition method of accounting, all assets acquired, including goodwill and other intangible assets, should be stated at fair value at the time of acquisition.  The allocation of purchase price consideration is preliminary, pending the completion of the fair value of certain tangible, intangible assets, and residual goodwill.  During the measurement period, which can be no more than one year from the Closing Date, the Company expects to continue to obtain information to assist in determining the final fair value of assets acquired.  The assets acquired were recorded based on valuations derived from estimated fair value assessments and assumptions used by the Company.  Thus, the provisional measurements of fair value discussed below are subject to change.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">As of December&#160;31, 2020, accounting for the Closing Date accounts receivable balances, allowance on the uncollected accounts receivable balances, and related liabilities, was not complete.  The accounting for these amounts will be complete following the twelve-month period after the Closing Date, per the terms of the Stock Purchase Agreement. The Company expects to finalize the valuation as soon as practicable, but no later than one year from the Closing Date.  While the Company believes its estimates and assumptions underlying the valuations are reasonable, different estimates and assumptions could result in different valuations assigned to the individual assets acquired, and the resulting amount of goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">After the Acquisition date, the Company received additional information regarding the amounts recorded as accounts receivable as of June 12, 2020.  After reviewing the information obtained, the Company booked an additional $<ix:nonFraction unitRef="usd" contextRef="i7f7bc9edba63482baa71fc49aef7db07_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionAccountsReceivable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzEwOTk1MTE2Mzk2NDA_ded1c62e-ab67-4818-b340-d6f862c38909">27,000</ix:nonFraction> of accounts receivable as of December&#160;31, 2020.  As a result, related liabilities were increased by $<ix:nonFraction unitRef="usd" contextRef="i7f7bc9edba63482baa71fc49aef7db07_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionLiabilitiesAssumed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzEwOTk1MTE2Mzk2NTA_ab5e1b94-1571-4455-a743-fc22228d26ea">13,000</ix:nonFraction> and the contingent consideration increased by $<ix:nonFraction unitRef="usd" contextRef="i7f7bc9edba63482baa71fc49aef7db07_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzEwOTk1MTE2Mzk2NjA_eb356d34-1dca-4559-a75b-34b7605159ab">14,000</ix:nonFraction>.  There was no impact to goodwill or net loss as of December&#160;31, 2020. </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.701%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div></div><ix:continuation id="icf4eebefbb434722847c3d651c826ae1" continuedAt="i59235a73480e486ba11eed5ba748ad56"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:105%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:105%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:105%"> 4 - GKCE ACQUISITION (CONTINUED)</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzMyOTg1MzQ4OTQzMDM_9510b790-3c6c-45d3-980d-be27516cb555" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The fair value of assets acquired and liabilities assumed were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 12, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionCashAndCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzEtMy0xLTEtMTk3Mg_6b42217f-c7c6-420b-9efa-24bb3c23101b">432,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionAccountsReceivable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzItMy0xLTEtMTk3Mg_a03f9f3e-c6d2-4272-ac54-80a13d028c36">854,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expense and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionPrepaidExpenseAndOther" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzMtMy0xLTEtMTk3Mg_2b43bc84-1f04-401c-a8ca-27d0dad39944">22,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205b91ae82344e9d8e528defe6019354_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzQtMy0xLTEtMTk3Mg_a5b55453-aae6-4243-b34f-cadb5545f34f">385,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24fa28513d1d4cedb8ff3631c13643d4_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzUtMy0xLTEtMjQxMA_16108eb0-e82e-4e45-aa03-af6c37407d5b">19,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381af277ce4b42e2a421005e64fa2c53_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzUtMy0xLTEtMTk3Mg_fad19fea-5fe8-4608-894c-bb313ecea127">319,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4c0e6386194ed79a0a74908a8481c4_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzYtMy0xLTEtMTk3Mg_772a2024-cf32-4ed4-8bba-43c26eb0742c">78,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzctMy0xLTEtMTk3Mg_515e08e7-60c7-4e01-877f-7cf4319988a0">1,265,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionAssetsAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzgtMy0xLTEtMTk3Mg_fd848574-9b1b-4424-bbef-52e9effb4f8b">3,374,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionAccountsPayable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzEwLTMtMS0xLTE5NzI_3a7efcbc-7859-4d35-ba51-6110b491189c">193,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionIncomeTaxesPayable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzExLTMtMS0xLTE5NzI_27896274-2c39-4d42-99c1-1f42e4e2ceeb">141,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionDeferredIncomeTaxes" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzEyLTMtMS0xLTE5NzI_ee965866-3263-4b12-83f5-f0d7e8c006fe">66,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionEmployeeCompensationAndBenefits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzEzLTMtMS0xLTE5NzI_88fbd95e-d672-4da7-a0ba-dff8c7dbdc59">91,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionLiabilitiesAssumed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzE0LTMtMS0xLTE5NzI_7226fefc-47af-4d90-b17d-412bdab22b46">491,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consideration allocated to assets acquired and liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionTotalConsiderationTransferred" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzE1LTMtMS0xLTE5NzQ_78527f09-99cd-4f14-94ed-68ed4c933b4b">2,883,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First working capital payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:PaymentsForWorkingCapital" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzE3LTMtMS0xLTE5NzI_c7d4b4db-aec9-4d80-8801-8a1169a8c620">515,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated subsequent working capital payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionAdditionalConsiderationTransferred" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzE4LTMtMS0xLTE5NzI_c5ba8dca-30cf-4937-b9a2-51548fed0a6a">368,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base purchase consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="ams:AssetAcquisitionConsiderationTransferred" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzE5LTMtMS0xLTE5NzI_a8ba3c7e-4833-4535-ba7d-cb41cb9c6198">2,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The Company has allocated the purchase price of GKCE to the tangible assets, liabilities, and intangible asset acquired, based on their estimated fair values.  Goodwill represents the excess of the purchase price consideration over the fair value of the identifiable tangible and intangible assets assumed.  The Company believes the amount of goodwill resulting from the acquisition is primarily attributable to expected synergies from an assembled and trained workforce and enhanced opportunities for growth and innovation.  The goodwill resulting from the acquisition is not tax deductible.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="ams:ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzMyOTg1MzQ4OTQzMDQ_3696a234-a0ac-451a-be28-4ef96af5e92f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The preliminary value of the acquired tangible assets acquired are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Life (in Years)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205b91ae82344e9d8e528defe6019354_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzItMS0xLTEtNDY0_c4d954ed-740b-4669-b887-86320abd27a5">385,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i205b91ae82344e9d8e528defe6019354_D20200612-20200612" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzItMy0xLTEtNDY0_2bd0b18c-c35b-4dd8-957e-c032b422d6e8">20</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24fa28513d1d4cedb8ff3631c13643d4_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzMtMS0xLTEtMjQxOQ_fd9f59ed-f3a2-4a2b-9ba1-e133f5edcd6f">19,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5ace117998418a93ba873e84fcee06_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzMtMS0xLTEtNDY0_f3994350-a752-4bf9-bb85-c39ae3c7184d">302,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief5ace117998418a93ba873e84fcee06_D20200612-20200612" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzMtMy0xLTEtNDY0_659f2e7b-13cb-4bd4-b779-27f36865c619">2</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7107c47918d4072a7fa9c7ea3337757_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzQtMS0xLTEtNDY0_ff55a5a7-b6d6-4f31-9e3d-6378698ee9f9">17,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie7107c47918d4072a7fa9c7ea3337757_D20200612-20200612" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzQtMy0xLTEtNDY0_9482f541-e152-4432-b636-4bc3173084cb">2</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzUtMS0xLTEtNDY0_19a57ec7-f0f5-4b32-bc8d-3621d9b7a4ff">723,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The Company also acquired intangible assets with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i0e4c0e6386194ed79a0a74908a8481c4_D20200612-20200612" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NTEwODY_0076888b-9ed5-4f32-a0df-76d3837ebaac">78,000</ix:nonFraction>.  The intangible asset identified was GKCE's trade name and the Company assigned an indefinite useful life to the asset.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The Company incurred costs related to the acquisition of approximately $<ix:nonFraction unitRef="usd" contextRef="ie13445cb0ba94819a5bcc00de48c6ac3_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NTEyODM_18880fd5-6bc6-43a2-afc6-3dd691b357b5">93,000</ix:nonFraction> for the three-month period ended June 30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i9aed20455da74365bfd0779fe7c8fe53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NTEzMzg_4133fa21-513c-44b3-bf79-6a3038dfd8b7">69,000</ix:nonFraction> for the three-month period ended September&#160;30, 2020.  All acquisition related costs were expensed as incurred and have been recorded in selling and administrative expense in the Company's consolidated statement of operations. </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.701%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div></div><div style="text-align:justify"><ix:continuation id="i59235a73480e486ba11eed5ba748ad56" continuedAt="iba9595091dd544319b0c06adc3ffbe1b"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:105%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:105%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:105%"> 4 - GKCE ACQUISITION (CONTINUED)</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"><ix:continuation id="iba9595091dd544319b0c06adc3ffbe1b">The revenue and earnings of GKCE have been included in the Company&#8217;s consolidated results since the Closing Date and are not material to the Company&#8217;s consolidated financial results.  Historical financial statements and pro forma results of the operations of GKCE as if the Acquisition occurred earlier than the Closing Date have not been presented, as the applicable significance thresholds are not exceeded by the Acquisition and the corresponding requirements to provide historical financial statements and corresponding pro forma financial information are not applicable to the Acquisition. In addition, the Company believes that the financial impact of the Acquisition to the Company&#8217;s consolidated financial statements is not material and such historical financial information and pro forma financial information would not be meaningful for investors and financial statement users.</ix:continuation> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 21</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_163"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.701%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 5 - <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzgxNQ_9b594c2f-3806-4454-bce4-b316f446c5eb" continuedAt="ia60029d585634b59b6aaa205c68908ed" escape="true">LONG TERM DEBT</ix:nonNumeric></span></div><ix:continuation id="ia60029d585634b59b6aaa205c68908ed"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists primarily of <ix:nonFraction unitRef="note" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="ams:NumberOfDebtInstruments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzI3NDg3NzkwNzA2Nzg_d3c4fc1c-ad2d-42d2-9a0e-41b76297f759">seven</ix:nonFraction> notes with three financing companies collateralized by the Gamma Knife equipment having an aggregate net book value of $<ix:nonFraction unitRef="usd" contextRef="iea6020aa13c8441883aae4fa8107203a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCollateralAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzE4Nw_e44aedf8-a0d8-4fdb-811a-18342fbdd8af">11,023,000</ix:nonFraction>, the individual customer contracts, and related accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="iea6020aa13c8441883aae4fa8107203a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedParties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzE2NDkyNjc0NDI2MDg_3f1d49f7-3a3b-4d99-a029-fc5222d65c34">1,718,000</ix:nonFraction> at December&#160;31, 2020. These notes are predominantly payable in <ix:nonNumeric contextRef="i279a2dc09a1e4d058baa0f82d26d3fec_D20200101-20201231" format="ixt-sec:duryear" name="ams:LongTermDebtMonthlyInstallments" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzI5Nw_3c74e0b4-cf70-498a-9aa2-a302addfaa02">36</ix:nonNumeric> to <ix:nonNumeric contextRef="i201f554e454a461689418aeaf993818a_D20200101-20201231" format="ixt-sec:durmonth" name="ams:LongTermDebtMonthlyInstallments" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzMwMw_d65c13f1-7d3d-4122-8510-a024b01130a4">84</ix:nonNumeric> fully amortizing monthly installments, mature between January 2021 and September 2027. The notes accrue interest at fixed annual rates between <ix:nonFraction unitRef="number" contextRef="icfa5f63042e644d5b31c703f3ac54c9a_I20201231" decimals="4" name="us-gaap:LongTermDebtPercentageBearingVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzUwMw_2d6e8175-6df4-4e89-bb6a-375649fe2810">3.67</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ibf0485b3300f4c709015ee46dc45d199_I20201231" decimals="4" name="us-gaap:LongTermDebtPercentageBearingVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzUxMA_fe3d6585-68bd-4da0-bcbe-2058e40f0657">6.90</ix:nonFraction>%.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2019, the Company had <ix:nonFraction unitRef="note" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="ams:NumberOfDebtInstruments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzI3NDg3NzkwNzA2ODI_848c6152-ef84-4e3d-bf15-b8b0df2e5ab0">six</ix:nonFraction> notes with two financing companies collateralized by the Gamma Knife equipment having an aggregate net book value of $<ix:nonFraction unitRef="usd" contextRef="i2a19b56e39284cc2bd0fe2b1a910fdc9_I20191231" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCollateralAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzE2NDkyNjc0NDI4NDg_28ad0ccf-d199-48ce-9b30-da58aebde747">13,130,000</ix:nonFraction>, the individual customer contracts, and related accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="i2a19b56e39284cc2bd0fe2b1a910fdc9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedParties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzE2NDkyNjc0NDI4NDQ_33635bf8-b844-4949-ae39-c3384f837939">1,848,000</ix:nonFraction>. </span></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzgxNA_c87fcac5-16e3-4a83-9385-0196c2912760" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are contractual maturities of long-term debt by year at December&#160;31, 2020, excluding debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzE2NDkyNjc0NDI2MDI_5df757f7-8fe5-4eb5-ad35-1e1494996c83">27,000</ix:nonFraction>:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.331%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.751%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzEtMi0xLTEtMA_6d932243-939b-47f6-8ad2-d11e947feff5">1,157,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzItMi0xLTEtMA_10637805-f123-466b-9d95-3dd7198ec43d">768,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzMtMi0xLTEtMA_257f69f1-005f-4bcf-bc7f-ee37a63546d3">802,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzQtMi0xLTEtMA_55323cb4-e60e-490c-b1e4-cda3e9ecac25">839,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzUtMi0xLTEtMA_36574bde-9799-4ffe-92fa-c5cfabece04c">592,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzYtMi0xLTEtMA_1f873cf2-36ea-4a8f-9da1-8d87217ddabf">466,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzctMi0xLTEtMA_b37c3158-bd13-408d-8f63-5f6c5b59e622">4,624,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 22</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_166"></div><hr style="page-break-after:always"/><div style="min-height:60.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.701%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 6 - <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzk0OQ_1ab63aaf-1423-47f3-bba7-f651c41eb247" continuedAt="i5c320d538e1c490289f10c658266614e" escape="true">FINANCE LEASES</ix:nonNumeric></span></div><ix:continuation id="i5c320d538e1c490289f10c658266614e"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="lease" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="ams:NumberOfFinancingLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzE2NDkyNjc0NDI2MjI_09fa34ac-caab-434d-b0dc-7fda052c8bae">six</ix:nonFraction> finance lease obligations with two financing companies, collateralized by Gamma Knife and PBRT equipment having an aggregate net book value of $<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:FinanceLeaseObligations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzE5NA_173003dd-d222-44f5-8afd-fc11529c997d">18,093,000</ix:nonFraction>, the individual customer contracts, and related accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:FinanceLeaseAccountsReceivable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzE2NDkyNjc0NDI4MTc_619b7fc8-240c-43e3-ba61-d8e712cd4e46">1,892,000</ix:nonFraction> at December&#160;31, 2020. These obligations have imputed interest rates ranging between <ix:nonFraction unitRef="number" contextRef="icfa5f63042e644d5b31c703f3ac54c9a_I20201231" decimals="4" name="ams:FinanceLeaseObligationInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzMzOQ_b1cc98d0-0c63-4e86-b31d-4d14ba7ede98">4.73</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ibf0485b3300f4c709015ee46dc45d199_I20201231" decimals="4" name="ams:FinanceLeaseObligationInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzM0Ng_d04735b9-f406-4d31-b0ab-0d6266d5011e">13.00</ix:nonFraction>%, are predominantly payable in <ix:nonNumeric contextRef="i279a2dc09a1e4d058baa0f82d26d3fec_D20200101-20201231" format="ixt-sec:duryear" name="ams:FinanceLeaseObligationsMonthlyInstallments" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzM2NQ_a6cf93f1-481b-41ff-bbf3-38245d71e599">36</ix:nonNumeric> to <ix:nonNumeric contextRef="i201f554e454a461689418aeaf993818a_D20200101-20201231" format="ixt-sec:duryear" name="ams:FinanceLeaseObligationsMonthlyInstallments" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzM3MQ_87d22d54-c50b-41a1-af48-a893efc8efe7">84</ix:nonNumeric> monthly installments, and mature between November 2021 and September 2024. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2019, the Company had <ix:nonFraction unitRef="lease" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="ams:NumberOfFinancingLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzE2NDkyNjc0NDI2NTQ_39668c9a-7cec-4453-8270-56e63e37c35e">ten</ix:nonFraction> finance lease obligations with three financing companies, collateralized by Gamma Knife and PBRT equipment, having an aggregate net book value of $<ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-4" format="ixt:numdotdecimal" name="ams:FinanceLeaseObligations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzY5MQ_c3441839-293e-4101-85d3-e43831aec3c9">22,860,000</ix:nonFraction>, the individual customer contracts, and related accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-5" format="ixt:numdotdecimal" name="ams:FinanceLeaseAccountsReceivable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzE2NDkyNjc0NDI4MDc_01201402-cec6-4172-b22e-103d2bdb6a5a">4,600,000</ix:nonFraction>. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of each lease term, the Company has a bargain purchase option to purchase the equipment.</span></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzk1Mw_0e59b0cb-097c-47c2-b483-797b4b7485c5" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments, together with the present value of the net minimum lease payments under finance leases at December&#160;31, 2020, are summarized as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Present Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of Minimum</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Payments</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Year ending December 31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzItMS0xLTEtMA_d3385ac3-a3a7-486d-a8a7-ba77024b99a8">6,590,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzMtMS0xLTEtMA_ea7a251e-333c-4bd7-be02-9cfa7adc2c94">1,576,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzQtMS0xLTEtMA_336471c1-7573-4682-99e3-7cfd4b9e2390">1,083,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzUtMS0xLTEtMA_ba3a8183-fa0c-4f57-bdda-242d92d3c6b9">522,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzgtMS0xLTEtMA_07a50c54-3a83-483e-926f-4a3b6739be83">9,771,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzktMS0xLTEtMA_eceef4a8-1646-4971-85ab-39a9fd268c11">852,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzEwLTEtMS0xLTA_5aa2e8e9-816c-4edb-b2ff-15834319d39f">8,919,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzExLTEtMS0xLTA_144983cd-f7c9-4618-992a-73af99a899e9">5,945,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzEyLTEtMS0xLTA_2f9a6a15-4bff-4073-a108-916a98bda474">2,974,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 23</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_169"></div><hr style="page-break-after:always"/><div style="min-height:69.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.701%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 7 - <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzI1OTA_9add1bf8-36cd-4f59-97e0-4ae7f581e09a" continuedAt="i5ca83ca91dfc4e4b84b6e397f72088a2" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="i5ca83ca91dfc4e4b84b6e397f72088a2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract is a lease at inception. Under ASC 842, the Company is a lessor of equipment to various customers. Leases that commenced prior to ASC 842 adoption date were classified as operating leases under historical guidance. As the Company has elected the package of practical expedients allowing it to not reassess lease classification, these leases are classified as operating leases under ASC 842 as well. All of the Company&#8217;s lessor arrangements entered into after ASC 842 adoption are also classified as operating leases. Some of these lease terms have an option to extend the lease after the initial term, but do not contain the option to terminate early or purchase the asset at the end of the term.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Gamma Knife and PBRT contracts with hospitals are classified as operating leases under ASC 842. The related equipment is included in medical equipment and facilities on the Company&#8217;s consolidated balance sheets (see further discussion at Note 2). As all income from the Company&#8217;s lessor arrangements is solely based on procedure volume, all income is considered variable payments not dependent on an index or a rate. As such, the Company does not measure future operating lease receivables.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lessee operating leases are accounted for as right-of-use (&#8220;ROU&#8221;) assets, other current liabilities, and lease liabilities on the consolidated balance sheets. Operating lease ROU assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company&#8217;s operating lease contracts do not provide an implicit rate for calculating the present value of future lease payments, so the Company determined its incremental borrowing rate to be in the range of approximately <ix:nonFraction unitRef="number" contextRef="icfa5f63042e644d5b31c703f3ac54c9a_I20201231" decimals="2" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzE2NDkyNjc0NDQyOTQ_8ed1db44-3d6e-462b-9734-7ed0c8f205c6">4.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ibf0485b3300f4c709015ee46dc45d199_I20201231" decimals="2" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzE4MDY_5081b56e-b662-4029-aa2b-a090330302eb">6.0</ix:nonFraction>% by using available market rates and expected lease terms. The operating lease ROU assets and liabilities also include any lease payments made and excludes lease incentives and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company&#8217;s lessee operating lease agreements are for administrative office space and related equipment, and the agreement to lease clinic space for its stand-alone facility in Lima, Peru. These leases have remaining lease terms between <ix:nonNumeric contextRef="icfa5f63042e644d5b31c703f3ac54c9a_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzU0OTc1NTgxNDI0OTg_ef033dee-3d5d-4081-aa34-c1ad75b1f054">2</ix:nonNumeric> and <ix:nonNumeric contextRef="ibf0485b3300f4c709015ee46dc45d199_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzE2NDkyNjc0NDQzNDE_9561d5ec-e56a-4cd0-a226-9b77990eaf0d">3</ix:nonNumeric> years, some of which include options to renew or extend the lease. As of December&#160;31, 2020, operating ROU assets and liabilities were $<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzI0Nzk_21724a13-d867-4dd7-b25b-c6cd9044ccfa"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzI0Nzk_f23f1cf8-c53c-4dd8-b1b2-a6f040837acc">886,000</ix:nonFraction></ix:nonFraction>.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company elected to not renew its lease for a satellite office in Fairfield, California.  The Company previously included the renewal term in its assessment of the lease term for the ROU asset and liability. The Company accounted for this change as a lease reassessment under ASC 842. At the reassessment date, the remaining lease balance was not material to the Company's consolidated balance sheets and the Company wrote off the related ROU assets and liabilities of $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzE2NDkyNjc0NDQ4Njc_6bf81729-3ea6-4ba3-ad60-134b781003b3">67,000</ix:nonFraction>.  Also during the year ended December&#160;31, 2020, the Company agreed to a rent increase for its clinic space for its stand-alone facility in Lima, Peru.  The rent increase was effective as of January 1, 2020 and the Company increased the related ROU assets and liabilities by $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:NonCashRightOfUseAssetsAndLeaseLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzE2NDkyNjc0NDUxNTQ_eae76257-4d45-4418-bb30-7125b0936965">135,000</ix:nonFraction>.</span></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzI1OTE_6f1824ec-9c59-493e-943e-21da368f2a62" continuedAt="i2ab9893430d94c72899cbab88b298abc" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes maturities of lessee operating lease ROU assets and liabilities as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzItMS0xLTEtMA_7b19a2e5-0c3c-42be-9646-c05b2c9785dc">346,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzMtMS0xLTEtMA_cb34c068-3be7-47ee-966e-9e20b9460444">353,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzQtMS0xLTEtMA_83982e75-6c95-479d-9de5-1b67525d9010">248,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzUtMS0xLTEtMA_beda3f9a-5c60-4a95-b2a3-6ec76a33bfb5">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzgtMS0xLTEtMA_e9c5c06a-5c51-42e8-9ac5-2395f82f1736">955,000</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzktMS0xLTEtMA_eb9c9148-5d4d-4423-b473-9782ab0f8123">69,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzEwLTEtMS0xLTA_64b00e18-cb8e-4721-897c-006e9d747f9e">886,000</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 24</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_172"></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.550%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 8 &#8211; <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkyNTU_524a81ff-ba82-4afb-bd9d-0686298effc0" continuedAt="if44f362aaa8947c6942d5c776ffe0f63" escape="true">I</ix:nonNumeric></span><ix:continuation id="if44f362aaa8947c6942d5c776ffe0f63" continuedAt="i1d9cfa897b6443b8a2c742373caa01b1"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NCOME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AXES</span></ix:continuation></div><ix:continuation id="i1d9cfa897b6443b8a2c742373caa01b1" continuedAt="i85358bba5528404e8999a90ef85e6d6a"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and 2019 the Company recorded an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzEwMA_32ea63fb-5c5c-457e-89c1-255d81534e6f">1,737,000</ix:nonFraction> and income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzEwNA_082f93ad-b114-41f5-96e8-14fe988fb3b9">128,000</ix:nonFraction>, respectively.  The decrease in the Company&#8217;s provision for income taxes as of December&#160;31, 2020 is due to a loss on the write down of impaired assets.  </span></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkyNTA_18fe072d-36a2-4f9f-bb78-64c465646588" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision (benefit) for income taxes as of December&#160;31, 2020 and 2019 consist of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YEARS ENDED DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzMtMS0xLTEtMA_0fa2e7ce-be55-455f-beba-0144ed1ddd28">209,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzMtMy0xLTEtMA_6c682b8d-882a-4a13-8adf-432f8e0c0182">443,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzQtMS0xLTEtMA_05840d2c-befe-4d26-8b86-a77db3f94ee2"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzQtMS0xLTEtMA_99de5bd3-62c0-4447-bd9e-fc1668ef640e">88,000</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzQtMy0xLTEtMA_04c8a0f3-586f-4446-8597-f679916fface"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzQtMy0xLTEtMA_110a55e1-28aa-4ef3-9acb-7fe78b6fd730">207,000</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzUtMS0xLTEtMA_ef74da8f-f61c-4ec7-83ec-2a142122c971">117,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzUtMy0xLTEtMA_9a82fb2a-aef9-4e29-b212-027d6e84f879">130,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzYtMS0xLTEtMA_4d624101-d11b-434e-aaab-d71efe034ea3"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzYtMS0xLTEtMA_993122a4-1f2a-472c-a180-9db7fa6d8f87">414,000</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzYtMy0xLTEtMA_5864aa83-65a6-4255-a9d2-231e71f47eb8"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzYtMy0xLTEtMA_d63a10a7-00d6-4768-968e-c42ba135ca4b">780,000</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzktMS0xLTEtMA_032bfb00-0965-4605-984c-c8b9b687a4fe">1,909,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzktMy0xLTEtMA_f6979472-4815-4a2d-b99c-449d6217c762">311,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzEwLTEtMS0xLTA_4c173166-fd2f-4e61-8e9c-7214e02841e6">266,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzEwLTMtMS0xLTA_f00feac1-3359-44b9-b58c-9178c1852d3f">251,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzExLTEtMS0xLTA_13c29d03-ea33-4c73-86a8-cc70ad833b12">24,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzExLTMtMS0xLTA_9df9f0b8-2673-4a0d-9ae9-7838d3f8f613">90,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzEyLTEtMS0xLTA_2667e9df-ff4b-48dc-acd7-fe5b3b8bc0a0">2,151,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzEyLTMtMS0xLTA_61506470-a6df-4085-b0bd-c76638a471b4">652,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzE0LTEtMS0xLTA_00395d9b-dd64-46f5-a643-5af0788717a0">1,737,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzE0LTMtMS0xLTA_93518051-48bb-41be-a4ac-769ccb9a1be2">128,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkyNTE_31a636c1-f0c5-4eee-a05a-60d0ee6fde25" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the Company&#8217;s deferred tax liabilities and assets as of December&#160;31, 2020 and 2019 are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzMtMS0xLTEtMA_3ebe448c-0124-45a6-ae37-8ed47588df34">564,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzMtMy0xLTEtMA_96d5cf28-771b-47dd-a236-47fee9b3677e">3,112,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzUtMS0xLTEtMA_42a02325-3703-4b36-b232-db8121301a2b">564,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzUtMy0xLTEtMA_7b5009ea-63d2-482a-b100-76c786330525">3,112,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzgtMS0xLTEtMA_a1648294-c826-4815-80b5-7095bc9631e1">99,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzgtMy0xLTEtMA_32849272-e88d-4f42-bbed-ad2986be421f">117,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzktMS0xLTEtMA_88eb7d92-903b-449e-ac9c-8ca7e7e681de">43,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzktMy0xLTEtMA_a685bdff-df89-44fd-95d6-1a995fb7edee">248,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzEwLTEtMS0xLTA_e0281856-e018-41df-b82c-8111f4aeec58">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzEwLTMtMS0xLTA_837a20d7-5b10-44b7-9b97-3e6acc3c8d17">4,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8211; net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOther" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzExLTEtMS0xLTA_111fbfd4-125c-4623-8b3c-28fa5c4f0322">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOther" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzExLTMtMS0xLTA_744aec86-8970-4576-9769-903aaa736831">229,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryover</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzEyLTEtMS0xLTA_97f53847-f965-4899-8be1-bff10d55af1a">627,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzEyLTMtMS0xLTA_b81b23c7-ae3c-4bc8-9f0a-d51d0ed519a7">921,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzE0LTEtMS0xLTA_22845cb7-924d-4506-a6c1-726be61cc7d0">824,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzE0LTMtMS0xLTA_1dbb3c59-10fa-4310-a6e0-81d3615dae0f">1,519,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzE2LTEtMS0xLTA_79521325-e013-45e2-9130-c94fc879ff7e">678,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzE2LTMtMS0xLTA_89fffff4-2c7b-45b9-917f-bbffd108c872">921,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets net of valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzE4LTEtMS0xLTA_8fe2bd4b-6d7e-4d6e-8079-c786b1f68556">146,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzE4LTMtMS0xLTA_e55074b1-e48e-411f-8e93-66895872f305">598,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzIwLTEtMS0xLTA_292cef21-df40-4ef1-82b7-2fef84f0f845">418,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzIwLTMtMS0xLTA_f79a16cd-2e7b-4103-a16d-3b97a6df65f8">2,514,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.550%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 8 &#8211; I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NCOME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AXES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> (CONTINUED)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i85358bba5528404e8999a90ef85e6d6a" continuedAt="i81484e84aeb649e988b18264dc620cb8"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="ams:ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkyNTI_55ba8041-1713-40ee-b1a5-1048c1213a11" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts are presented in the financial statements as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes (non-current)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5ZjAyNmE2NzAzMDY0Yjk5YjI5YTBlZjc4NDEyNWZmNy90YWJsZXJhbmdlOjlmMDI2YTY3MDMwNjRiOTliMjlhMGVmNzg0MTI1ZmY3XzItMS0xLTEtMA_52bf260f-89ae-4597-8bab-b1e2b1305960">418,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5ZjAyNmE2NzAzMDY0Yjk5YjI5YTBlZjc4NDEyNWZmNy90YWJsZXJhbmdlOjlmMDI2YTY3MDMwNjRiOTliMjlhMGVmNzg0MTI1ZmY3XzItMy0xLTEtMA_d0d90b42-7bff-4161-bed6-63e22b21a4d2">2,514,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5ZjAyNmE2NzAzMDY0Yjk5YjI5YTBlZjc4NDEyNWZmNy90YWJsZXJhbmdlOjlmMDI2YTY3MDMwNjRiOTliMjlhMGVmNzg0MTI1ZmY3XzMtMS0xLTEtMA_74cbec7a-91a6-401d-b015-b013af3a0bab">418,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5ZjAyNmE2NzAzMDY0Yjk5YjI5YTBlZjc4NDEyNWZmNy90YWJsZXJhbmdlOjlmMDI2YTY3MDMwNjRiOTliMjlhMGVmNzg0MTI1ZmY3XzMtMy0xLTEtMA_3839a29e-3031-4a45-9436-c0873b3cc765">2,514,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkyNTM_784dd8ce-8554-47b1-964c-e725d99bb613" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The (benefit) provision for income taxes differs from the amount computed by applying the U.S. federal statutory tax rate (<ix:nonFraction unitRef="number" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzIxOTQ_7c83725e-d843-4a51-aff3-1fbfda2e4390"><ix:nonFraction unitRef="number" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzIxOTQ_9bcf070c-de98-4614-8999-941c09750173">21</ix:nonFraction></ix:nonFraction>% in 2020 and 2019) to income before taxes as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YEARS ENDED DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computed expected federal income tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzItMS0xLTEtMA_d44194e7-c3fd-466a-bcb9-3fa9029e849d">1,844,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzItMy0xLTEtMA_380af34c-9c6b-4bca-87c9-7b988ba4a5e2">167,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzMtMS0xLTEtMA_ecdd2cba-acd6-443a-bcea-56be0a4e18d5">199,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzMtMy0xLTEtMA_5f088dc8-2c24-4944-aa78-cbaa9f8e624a">80,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzQtMS0xLTEtMA_3e3b5030-b697-4a7f-9ace-5eae5eb91121">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzQtMy0xLTEtMA_37f7298f-635f-49a9-ae72-1601a3cd1b8d">29,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to Provision True-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzYtMS0xLTEtMA_a8bb5b92-a964-4e94-bf15-d09fc07a756d">22,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="ams:EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzYtMy0xLTEtMA_b29d0e11-9dde-4732-a8f7-db4a475f4daf">39,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain Tax Positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzctMS0xLTEtMA_3e1663e5-5de5-4db7-8215-8983900e254d">16,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="ams:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzctMy0xLTEtMA_35721ee2-6efd-44ec-bfb3-82b9d6e08c03">80,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryforward expiration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzgtMS0xLTEtNTg2NA_ce37750f-6c1e-42cd-89b0-6bec381a0b20">246,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="ams:EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzgtMy0xLTEtNTg2NA_9b7cfab5-8bdf-4577-b977-6941bae33eda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzgtMS0xLTEtMA_0a34f3ad-fc96-4354-914d-73bbf4e76e80">243,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzgtMy0xLTEtMA_74b8c31b-ad7a-4627-a8bf-c46ae84c1369">175,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred tax adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzktMS0xLTEtMA_2f298cfb-1f2d-4e6d-83af-213a906b02c7">259,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzktMy0xLTEtMA_71ccccd1-1649-4305-9eca-964e3f607639">68,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzExLTEtMS0xLTA_a7fde81f-152a-4ff2-99fa-598772f84d65">1,737,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzExLTMtMS0xLTA_501322a7-4edf-4270-8399-3429131a07c4">128,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company exhausted the remainder of its net operating loss carryforward for federal income tax return purposes. The Company has net operating loss carryforwards for state income tax purposes of approximately $<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzU0MDE_d5a68f0e-0e98-4683-837b-dadb384755b6">2,219,000</ix:nonFraction> that begin to expire in 2029. The Company has net operating loss carryforwards for its international subsidiaries of approximately $<ix:nonFraction unitRef="usd" contextRef="i3dfd28bb44084d2ab54958e2d4bfab65_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzU1MzU_fbb104ae-a235-40b9-a07a-dc984c0a19e9">32,000</ix:nonFraction>.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of the net operating loss and credit carryforwards may be subject to an annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), and similar state provisions. Any annual limitation may result in the expiration of net operating losses and credits before utilization.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company has a capital loss carryforward for federal income tax return purposes of approximately $<ix:nonFraction unitRef="usd" contextRef="ibeda16fd19d5413fa54b8ddbc438d749_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzU5OTc_1799e22f-ddf2-4986-8645-4cbe84db8603">2,586,000</ix:nonFraction> which starts to expire in 2021. The Company has capital loss carryforwards for state income tax purposes of approximately $<ix:nonFraction unitRef="usd" contextRef="i087b2dc2b4b54227989cfb9e793c3951_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzYxMjI_6c0a6470-477c-4bb7-830e-6dafe4c8274c">129,000</ix:nonFraction> which starts to expire in 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to uncertainty surrounding the realization of impairment losses, capital losses and foreign operating losses in future years, the Company has placed a valuation allowance against a portion of its net domestic and foreign deferred tax assets. The net valuation allowance decreased by $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzY0NDQ_24d9b032-4d3d-4627-a453-0bf68024c6b4">243,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzY0NjE_85c6e639-34f0-4329-aaa3-1a04a6761169">175,000</ix:nonFraction> for the tax years ended December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, the Company released the valuation allowance related to GKPeru deferred tax assets, which resulted in an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ie9aab6c477354d8aabfd59fedcdc7f0c_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzY3MDc_2d3bfc8f-36f1-4d30-9fd6-97938e155d52">104,000</ix:nonFraction>. The Company concluded, based upon the preponderance of positive evidence (i.e. cumulative profit before tax adjusted for permanent items over the previous twelve quarters, a history of taxable income in recent periods, and the current forecast of income before taxes for GKPeru going forward) over negative evidence and the anticipated ability to use the deferred tax assets, that it was more likely than not that the deferred tax assets will be realized. If there are unfavorable changes to actual operating results or to projections of future income, the Company may determine that it is more likely than not such deferred tax assets may not be realizable.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax return years 2016 through 2019 remain open to examination by the major domestic taxing jurisdictions to which the Company is subject. In 2019, the Company settled a New York State examination for tax years 2015 through 2017 with no material adjustments. Net operating losses generated on a tax return basis by the Company for calendar years 1999 through 2004, 2009, 2010, 2012, 2014, 2015, 2016, 2017 and 2018 remain open to examination by the major domestic taxing jurisdictions.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.550%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 8 &#8211; I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NCOME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AXES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> (CONTINUED)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i81484e84aeb649e988b18264dc620cb8"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted accounting standards which prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of uncertain tax positions taken or expected to be taken in a company's income tax return, and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. Additionally, these accounting standards specify that tax positions for which the timing of the ultimate resolution is uncertain should be recognized as long-term liabilities. The Company has made no reclassifications between current taxes payable and long term taxes payable under this guidance.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the unrecognized tax benefit was $<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzg2MDc_de99fc34-6fc7-4a35-a35e-87a074babbb6">275,000</ix:nonFraction> which, if recognized, will not affect the annual effective tax rate as these unrecognized tax benefits would increase deferred tax assets which would be subject to a full valuation allowance. <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkyNTQ_9e252b47-de2a-46c1-a7c0-0f12792b126e" continuedAt="ie27f0468d1784f40a3e92fe71f89dd12" escape="true">A reconciliation of the beginning and ending amount of unrecognized tax benefit is as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><ix:continuation id="ie27f0468d1784f40a3e92fe71f89dd12"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEARS ENDED DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTozYjQzNWU1MzI1ODc0YTllOWM0M2NhMWY5ZjE4NDNhZS90YWJsZXJhbmdlOjNiNDM1ZTUzMjU4NzRhOWU5YzQzY2ExZjlmMTg0M2FlXzItMS0xLTEtMA_36ef86a8-7eea-4ac6-8868-db44c62e35b4">259,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88d4659da27e48458ba86016aae09e94_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTozYjQzNWU1MzI1ODc0YTllOWM0M2NhMWY5ZjE4NDNhZS90YWJsZXJhbmdlOjNiNDM1ZTUzMjU4NzRhOWU5YzQzY2ExZjlmMTg0M2FlXzItMy0xLTEtMA_fec6055c-b19f-4dfc-abe8-db8d7ac89910">87,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTozYjQzNWU1MzI1ODc0YTllOWM0M2NhMWY5ZjE4NDNhZS90YWJsZXJhbmdlOjNiNDM1ZTUzMjU4NzRhOWU5YzQzY2ExZjlmMTg0M2FlXzQtMS0xLTEtMA_126c4d65-668f-4b91-a1d0-d597f7f6312d">16,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTozYjQzNWU1MzI1ODc0YTllOWM0M2NhMWY5ZjE4NDNhZS90YWJsZXJhbmdlOjNiNDM1ZTUzMjU4NzRhOWU5YzQzY2ExZjlmMTg0M2FlXzQtMy0xLTEtMA_4ba1b21a-12f3-4539-a789-52265279662d">172,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTozYjQzNWU1MzI1ODc0YTllOWM0M2NhMWY5ZjE4NDNhZS90YWJsZXJhbmdlOjNiNDM1ZTUzMjU4NzRhOWU5YzQzY2ExZjlmMTg0M2FlXzYtMS0xLTEtMA_3d897135-243c-4172-9717-447870b98779">275,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTozYjQzNWU1MzI1ODc0YTllOWM0M2NhMWY5ZjE4NDNhZS90YWJsZXJhbmdlOjNiNDM1ZTUzMjU4NzRhOWU5YzQzY2ExZjlmMTg0M2FlXzYtMy0xLTEtMA_eed87b1b-cfdc-4cae-8d28-469035be1085">259,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's policy for deducting interest and penalties is to treat interest as interest expense and penalties as taxes. As of December&#160;31, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkwNDg_5e713321-2942-465d-858d-1c7b513cc7d4">15,000</ix:nonFraction> accrued for the payment of penalties and zero interest related to unrecognized tax benefits. The Company does not expect any material changes to our uncertain tax positions within the next 12 months.</span></div></ix:continuation><div id="i08eb1efc99dc4f408903b4769adc4b90_175"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 9 &#8211; <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg3NjI_04bdade5-0507-403c-a9c2-e553e6cca5e2" continuedAt="i501db6d894b0484fb65371fc8746af07" escape="true">S</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:continuation id="i501db6d894b0484fb65371fc8746af07" continuedAt="ie61d06129a054a358dffeaad0ceace4a">TOCK-BASED COMPENSATION EXPENSE</ix:continuation></span></div><ix:continuation id="ie61d06129a054a358dffeaad0ceace4a" continuedAt="i4a1f7f2073ae49c48b67dd5549f868bb"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive Compensation Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2010 shareholders approved an amendment and restatement of the Company&#8217;s stock incentive plan, renaming it the Incentive Compensation Plan (the &#8220;Plan&#8221;), and among other things, increasing the number of shares of the Company&#8217;s common stock reserved for issuance under the Plan to <ix:nonFraction unitRef="shares" contextRef="ic40a5c6d28184e559db2655dfa2504c5_I20100630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzM1MA_be7949a7-2c29-4fa4-95e0-92b84677d6b2">1,630,000</ix:nonFraction>. The Plan provides that the shares reserved under the Plan are available for issuance to officers of the Company, other key employees, non- employee directors, and advisors. The Plan is a successor to the Company&#8217;s previous plans, and any shares awarded and outstanding under those plans were transferred to the Plan. No further grants or share issuances will be made under the previous plans. On June 21, 2019, the Company&#8217;s shareholders approved an amendment and restatement of the Plan in order to extend the term of the Plan by two years to February 22, 2022. As of December&#160;31, 2020, approximately <ix:nonFraction unitRef="shares" contextRef="i4b2e49a8ba0e4110902423280570dd60_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzk0MQ_6168fbc5-face-423f-8d71-84f310ae812d">437,000</ix:nonFraction> shares remain available for grant under the Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Plan, a total of <ix:nonFraction unitRef="shares" contextRef="i7da1cbcaab824c258a3e435ef167afeb_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI4Mjk_5d2f774e-ab3c-46df-84fc-e3ad3424deb0">456,000</ix:nonFraction> restricted stock units have been granted, consisting of <ix:nonFraction unitRef="shares" contextRef="i75ab1b400ca446ebafefb5497cfcbe7f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI4ODg_8ed6422e-83c8-472c-b6fb-bb7abb0243e8">43,000</ix:nonFraction> of annual automatic grants to non-employee directors and the corporate secretary, <ix:nonFraction unitRef="shares" contextRef="i439999ffc655418594f79bcae4f8e02b_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI5NzM_0be675a3-1a0b-4a0a-9c83-a84d3aa12e79">293,000</ix:nonFraction> of deferred retainer fees to non-employee members of the Board, <ix:nonFraction unitRef="shares" contextRef="i865f409e789f412d9649eea7a779efbf_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzMwNDQ_901df5ab-fbf9-4952-8165-88f08d7bbee3">20,000</ix:nonFraction> grants issued in lieu of commission, to two (<ix:nonFraction unitRef="employee" contextRef="i8948e770c9f64598b68bf6a898112dab_I20201231" decimals="INF" name="ams:NumberOfEmployees" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODA1NTY_9b6375d7-c364-4917-949e-716d8e25a2d2">2</ix:nonFraction>) employees of the Company and <ix:nonFraction unitRef="shares" contextRef="i5065887f6a4b4118b70267038309da91_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODA1NTk_0d933e8a-e6d9-4ac6-8f2f-5c2c70b6d0f9">100,000</ix:nonFraction> restricted stock units issued to the CEO during 2020, see further discussion below. Of the total restricted stock units granted under the Plan <ix:nonFraction unitRef="shares" contextRef="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzMxNzU_dc71f903-304c-46b3-8c6b-d81f765b27a4">210,000</ix:nonFraction> of them are fully vested but not yet deemed issued and outstanding, <ix:nonFraction unitRef="shares" contextRef="i8cf66345370f4da19371bd488b60d7d9_I20201231" decimals="INF" format="ixt:numdotdecimal" name="ams:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODA1Njc_d27d54a3-eacb-4860-9c9d-f97e7d557559">233,000</ix:nonFraction> are fully vested and outstanding, and <ix:nonFraction unitRef="shares" contextRef="if1ed81d1b3e0406887e3f7c0a942518d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2NDAyMDY_a7f339d5-0fc5-40d4-bfb8-61e29ca08e37">13,000</ix:nonFraction> are outstanding as of December&#160;31, 2020.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 9 &#8211; S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">TOCK-BASED COMPENSATION EXPENSE (CONTINUED)</span></div></div><ix:continuation id="i4a1f7f2073ae49c48b67dd5549f868bb" continuedAt="i8c969982c0a84c0586a0d49ecd5c66e3"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg3NjM_e0b37fc3-085d-458f-aab1-4b7a70cef17d" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in restricted stock units, consisting primarily of annual automatic grants, deferred compensation to non-employee directors, and restricted stock units awards to the CEO, under the Incentive Compensation Plans during 2020 and 2019 are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Units</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1182cb262dd5404e857585d6453d5008_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzEtMS0xLTEtMA_04930e4d-aa53-4e8f-91f8-f106d94a7686">4,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1182cb262dd5404e857585d6453d5008_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzEtMy0xLTEtMA_ee8901c4-f129-4db7-8395-aaf70407262d">2.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1182cb262dd5404e857585d6453d5008_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzEtNS0xLTEtMA_ff932b88-05d8-4be7-b41e-5d6b2aa933e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzItMS0xLTEtMA_83909586-047c-4616-9e9d-1569d92d4e7c">36,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzItMy0xLTEtMA_bce700ef-d8c8-489e-8171-3956c635e3aa">2.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzItNS0xLTEtMA_3c52b012-3246-4933-963e-dc9df30d086d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzMtMS0xLTEtMA_fda1c38d-a36e-4947-8a06-b95485fd9673">37,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzMtMy0xLTEtMA_3edafa42-3f94-40fd-99f9-f62783faf8e7">2.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzMtNS0xLTEtMA_4924cf69-6571-4200-a5ba-9ef4f0f5d41f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75a3e8aadc8a42998ea1f668ddc598aa_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzQtMS0xLTEtMA_dd826dd4-44c2-42e3-b9da-84301d7827ac">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i75a3e8aadc8a42998ea1f668ddc598aa_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzQtMy0xLTEtMA_16ebbaa4-127f-4e30-ad91-85482b875249">3.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i75a3e8aadc8a42998ea1f668ddc598aa_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzQtNS0xLTEtMA_4ea9bac6-b6d0-4126-8af5-d978c0097bce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzctMS0xLTEtMA_4cfb39dd-ed84-42fb-bef7-cc344bb4f1c1">144,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzctMy0xLTEtMA_9cd85730-6d52-439a-b035-6f17d77b897e">1.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzctNS0xLTEtMA_178b3edd-36f3-47b8-838e-ab1557ef2f63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzgtMS0xLTEtMA_a624f8db-4a05-4c92-9981-bfbd23173e90">134,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzgtMy0xLTEtMA_dd00b3f7-1ea7-474a-8afc-a887bf8bec4a">1.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzgtNS0xLTEtMA_5bfc97ad-d1ea-44c0-ab62-bb3a09e67a33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1ed81d1b3e0406887e3f7c0a942518d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzktMS0xLTEtMA_a7f339d5-0fc5-40d4-bfb8-61e29ca08e37">13,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if1ed81d1b3e0406887e3f7c0a942518d_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzktMy0xLTEtMA_6dea4b8e-7434-48a0-9973-0f383e0f7058">1.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if1ed81d1b3e0406887e3f7c0a942518d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzktNS0xLTEtMA_f044417c-d037-44b3-8331-d952f6d64576">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, total compensation expense recorded in the consolidated statements of operations related to restricted stock units in lieu of retainer fees was $<ix:nonFraction unitRef="usd" contextRef="i1abe365945b24f1187e85f47a39fb40b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzM2MzI_5f932f9a-74f3-493b-a550-f95a391098da">80,000</ix:nonFraction>. For the year ended December&#160;31, 2020, total compensation expense recorded in the consolidated statements of income for annual restricted stock units awarded was $<ix:nonFraction unitRef="usd" contextRef="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzM3ODI_62506e20-7465-4f0d-8533-93c956b2305d">7,000</ix:nonFraction>, with an offsetting tax benefit of $<ix:nonFraction unitRef="usd" contextRef="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:OffsettingTaxBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzM4MjA_94bbbc41-59e2-4f17-a005-f3ef0589b6e0">1,000</ix:nonFraction>, as this expense is deductible for income tax purposes. As of December&#160;31, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="i8cf66345370f4da19371bd488b60d7d9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzM4OTk_d4a4f8bb-0958-4f86-a62b-ae34b820dc39">2,000</ix:nonFraction> of total unrecognized compensation cost related to annual restricted stock units which is expected to be recognized over a period of <ix:nonNumeric contextRef="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzQwMzU_eb6cb7b2-86da-4a72-8c00-cb0377626364">0.5</ix:nonNumeric> years. During 2020 and 2019, shares of restricted stock units totaling <ix:nonFraction unitRef="shares" contextRef="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2Mzg4Mzc_f6efad20-230d-437e-baa4-df3cf72af59d">3,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i4a54847db3184f809b995f6ca5865dd9_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2Mzg4NDE_8b1a9810-c5df-4aa0-87a0-1a01dd477915">4,000</ix:nonFraction> each, respectively, with a fair value of approximately $<ix:nonFraction unitRef="usd" contextRef="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzQxNjE_ef5a7870-5202-4d76-b414-fbfe40e1fc0a">9,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4a54847db3184f809b995f6ca5865dd9_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzQxNjU_fc05d938-5970-4e6b-9e98-7d9c753cc281">11,000</ix:nonFraction>, respectively, vested and became unrestricted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Certain Executive Equity Awards</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective May 4, 2020, the Company appointed Raymond C. Stachowiak as Interim President and Chief Executive Officer (&#8220;Interim CEO&#8221;). As part of his Offer Letter, the Interim CEO was granted <ix:nonFraction unitRef="shares" contextRef="icdcf8f1e671343ef84efbcc784e706a6_D20200401-20200630" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2Mzc2Nzk_93d71a0e-3335-4a87-b764-0878b0537d3a">50,000</ix:nonFraction> restricted stock awards that vested in full on August 3, 2020.  The Interim CEO was granted additional restricted stock awards totaling <ix:nonFraction unitRef="shares" contextRef="i8a5840910bb84c9ab051118c87f6190d_D20200803-20200803" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2Mzc4OTQ_a19cd1f2-1acc-4823-8a5b-64f9495d49fa">10,000</ix:nonFraction> common shares per month, which vest in full at the end of each <ix:nonNumeric contextRef="i8a5840910bb84c9ab051118c87f6190d_D20200803-20200803" format="ixt-sec:durday" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODA1OTg_1cc632c0-e48f-42b7-a283-feb6c592ec1d">30</ix:nonNumeric>-day period following issuance. On October 1, 2020 the Interim CEO was appointed the CEO.  For the year ended December&#160;31, 2020, <ix:nonFraction unitRef="shares" contextRef="i5065887f6a4b4118b70267038309da91_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2NDAzOTE_0d933e8a-e6d9-4ac6-8f2f-5c2c70b6d0f9">100,000</ix:nonFraction> restricted stock awards were issued to the CEO and <ix:nonFraction unitRef="shares" contextRef="i5065887f6a4b4118b70267038309da91_D20200101-20201231" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODQxNjc_9136f2cb-281d-48ff-ae99-d78001e38547">90,000</ix:nonFraction> became fully vested. Additionally, Ernest R. Bates, Senior Vice President, Sales and Business Development, International Operations, was awarded <ix:nonFraction unitRef="shares" contextRef="idcb7ef47ef694053b29237a21986aa43_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2MzgzMzM_098e5d19-3b35-4269-827c-200dac9170d8">10,000</ix:nonFraction> restricted stock awards, which vested in full on December 31, 2020. For the year ended December&#160;31, 2020, total compensation expense recorded in the consolidated financial statements of operations related to executive equity awards was $<ix:nonFraction unitRef="usd" contextRef="i6bdba3f703e740a8b387f2723b455d9a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODQ0OTA_a37ce1e3-7336-4e67-a957-69179663b290">195,000</ix:nonFraction>.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2017, the Company entered into a Performance Share Award Agreement with three executive officers of the Company (the &#8220;Award Agreements&#8221;) for <ix:nonFraction unitRef="shares" contextRef="i54f1ddba4c6143a2b7471da1ecaeeeaa_D20170104-20170104" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzQzNzc_62789bdf-8dfc-4c12-87a2-929289f07518">161,766</ix:nonFraction> restricted stock awards which vest upon the achievement of certain performance metrics. The Award Agreements expired on March 31, 2020. Based on the guidance in ASC 718 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 718&#8221;), the Company concluded these were performance-based awards with vesting criteria tied to performance metrics. As of December 31, 2017, the Company achieved one of the certain performance metrics under the Award Agreements and recognized stock compensation expense of approximately $<ix:nonFraction unitRef="usd" contextRef="i32da477d172646529ddc5afd23e6ed4d_D20170104-20170104" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzQ4NjA_2ca8dbb5-4d03-4132-9e7d-0cfc49abe17d">108,000</ix:nonFraction> related to these awards. The unrecognized stock-based compensation expense for these awards was approximately $<ix:nonFraction unitRef="usd" contextRef="ibe8c67bc767f4ff48911673917d29035_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzUwNzQ_2ce6e273-38c5-4250-b672-12255f5ebc94">421,000</ix:nonFraction> and unvested restricted stock awards of approximately <ix:nonFraction unitRef="shares" contextRef="i9f9e8e77770741a39de67b6d254f0f78_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzUxMzM_15dc86dd-e4e9-431d-9a96-422d84df19f0">129,000</ix:nonFraction> were returned to the plan as of March 31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODQ3OTg_15cc6c78-e962-40e8-b4e8-94990fb76972" continuedAt="i7a5ef9c1ce5947358f21604149423cf1" escape="true">As of December&#160;31, 2020, stock compensation expense recorded in the consolidated financial statements is summarized as follows: </ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 9 &#8211; S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">TOCK-BASED COMPENSATION EXPENSE (CONTINUED)</span></div></div><ix:continuation id="i8c969982c0a84c0586a0d49ecd5c66e3" continuedAt="ia207cc449d6b4bbdba9530525b63fdee"><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><ix:continuation id="i7a5ef9c1ce5947358f21604149423cf1"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock-Based</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Award Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">and Vested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b626e312a7d4b85bdb7b11f21a56788_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzMtNC0xLTEtNjMxNQ_20d6f33b-6325-404b-8958-d0a7db75aadf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b626e312a7d4b85bdb7b11f21a56788_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzMtNi0xLTEtNjMxNQ_c3d60331-cfe9-456b-80ac-3be395dbf49b">17,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs Issued in Lieu of Retainer Fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa091c4ef68c4bb68bd7b854b530cc2c_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzQtNC0xLTEtNjMxNQ_04a99f17-2d1f-48aa-9708-66dfcede5ee1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa091c4ef68c4bb68bd7b854b530cc2c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzQtNi0xLTEtNjMxNQ_ad71d586-e284-4aba-afc4-67b743a29bc7">80,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual RSU Awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e761c88d6f049ee8b2df4c059245e51_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzUtNC0xLTEtNjMxNQ_474f6a91-6625-47a3-90ea-4866fd2ad935">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e761c88d6f049ee8b2df4c059245e51_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzUtNi0xLTEtNjMxNQ_2ad40ca1-50d7-4638-ab85-a509657e3925">7,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie00f50be40664dab98b855706c8871d1_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzYtNC0xLTEtNjMxNQ_0c9761d5-a3d1-42ed-8b1f-61b5164dac19">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie00f50be40664dab98b855706c8871d1_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzYtNi0xLTEtNjMxNQ_4314a814-7940-462e-9045-eb543638d1d7">195,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzctNC0xLTEtNjMxNQ_ff1cd4f2-1a44-4f51-9214-f5936330c34a">103,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzctNi0xLTEtNjMxNQ_f1531553-def1-48cf-a719-0d0aba35e52c">299,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Stock Options</span></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg3NjQ_7fd8cf48-6331-4e96-b5ed-716a498f4dff" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in stock options outstanding under the Incentive Compensation Plans during 2020 and 2019 are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:49.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of Options</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term (Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88d4659da27e48458ba86016aae09e94_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzItMi0xLTEtMA_a26eda31-96cd-4d86-ba55-01fa4b307e62">613,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88d4659da27e48458ba86016aae09e94_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzItNC0xLTEtMA_522c327e-0ce0-470c-9775-4d29193d16cf">2.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id87939e5af644ee294503aa4bedb6bbc_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzItNi0xLTEtMA_cb2a1ce9-1382-4ded-b4a4-aae0dcc36c6d">3.14</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88d4659da27e48458ba86016aae09e94_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzItOC0xLTEtMA_7d44a33f-1203-4fda-abcb-bca153c829fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzMtMi0xLTEtMA_b8668a31-4883-4a86-a2a8-c208dd599a35">18,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzMtNC0xLTEtMA_2d046973-8860-4747-a9d8-079d8e063672">2.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" format="ixt-sec:duryear" name="ams:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzMtNi0xLTEtMA_9db70f1e-dea9-4794-9df3-4b56167efd9d">7.00</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzQtMi0xLTEtMA_333b409e-5b93-47d3-8267-1d91d23ff74f">16,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzQtNC0xLTEtNzk3_aa1c30cb-d6cc-4769-9e1d-3d83ae1c6a05">2.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzUtMi0xLTEtMA_f77a5d1a-f4de-4b4e-ac23-3c7d1edb42dd">165,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzUtNC0xLTEtMA_f1abec16-3853-4448-ad44-995389437bfa">3.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzctMi0xLTEtMA_ad0dbcc8-5ab4-4d96-bfda-4e8f4f87ed95">450,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzctNC0xLTEtMA_7fcd053f-f654-4cd4-b858-41ac50ac20a5">2.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzctNi0xLTEtMA_6c2e5558-1276-4c8c-b996-4b11806567f3">2.44</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzctOC0xLTEtMA_47e55676-ce0d-462f-a5f1-2a53e28c7026">27,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzgtMi0xLTEtMA_99f879e4-1830-4390-91b1-30e03af15cc6">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzgtNC0xLTEtMA_87fd5776-144c-4783-8caa-1906bfbd91d8">1.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:duryear" name="ams:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzgtNi0xLTEtMA_46f26a20-bbd0-49ff-b653-1e5a5cd5d1cf">7.00</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzEwLTItMS0xLTA_e9cd83f4-9d61-48f1-b2ce-de75613b6483">43,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzEwLTQtMS0xLTA_07d523a3-7b6a-4521-98df-22c1c36ba95f">2.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzEyLTItMS0xLTA_0edadffd-fb21-430a-9dd2-435940eb7b2f">417,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzEyLTQtMS0xLTA_d3328896-e4cd-46cd-86e5-824ec81298ee">2.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzEyLTYtMS0xLTA_7505a701-1dfb-4923-8686-e47c62a31cf5">1.61</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzEyLTgtMS0xLTA_cd79d8d0-a5ba-40a7-a8cf-45b0f7a5e874">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE0LTItMS0xLTA_2ee43c2d-a7e2-4c00-9278-eace6b8286d2">425,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE0LTQtMS0xLTA_17df1ee9-e7a6-4c25-96e4-558f7bb7afcb">2.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE0LTYtMS0xLTA_8fc6c016-dc58-4bef-acc9-5ce0520a33db">2.25</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE0LTgtMS0xLTA_e78b794f-0bb3-45b5-8395-caaf0634dc7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE2LTItMS0xLTA_7c1a410f-db19-4970-850f-54bcdade2e44">405,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE2LTQtMS0xLTA_292ea7cb-d228-4749-9113-0705530a48c4">2.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE2LTYtMS0xLTA_a0f579d1-18b8-4adc-8607-80c1509f3467">1.48</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE2LTgtMS0xLTA_63685c88-c4fe-4bbe-a702-66811577326b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant-date fair value of the options granted during the years 2020 and 2019 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzU2NTY_2e3f2176-5a72-4a5e-ab02-36cf3a9223fb">0.78</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzU2NjA_b32c13ec-5dd7-4b41-9117-2cc65686d96a">1.54</ix:nonFraction>, respectively. There were <ix:nonFraction unitRef="shares" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODA2MTY_60505490-e016-4059-a34d-4d7c68100978">no</ix:nonFraction> options exercised and accordingly, no intrinsic value of options exercised during the year ended December&#160;31, 2020. There were <ix:nonFraction unitRef="shares" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzU2OTc_be5c46e7-f165-4a95-94c1-160277225fd3">16,000</ix:nonFraction> options exercised during the year ended December&#160;31, 2019. Total stock-based compensation expense recognized for stock options for the years ended December 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i8b626e312a7d4b85bdb7b11f21a56788_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzYwMzA_18f6c5b4-2a31-4cc7-b869-43757b6f6173">17,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i613b14d7d6ca4d3f82337708f6ffc78f_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzYwMzQ_eb0adf79-9af5-4ca8-8ebb-79494fe2175e">141,000</ix:nonFraction>, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was <ix:nonFraction unitRef="usd" contextRef="id87939e5af644ee294503aa4bedb6bbc_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2Mzk5MDM_406cb5d3-99d1-4354-9dfb-fa24994650f8"><ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2Mzk5MDM_f1e86171-1769-43cd-be98-8c479c942cc7">no</ix:nonFraction></ix:nonFraction> cash received from options exercised under any share-based payment arrangements for the year ended December&#160;31, 2020, and as a result, there was no actual tax benefit realized for tax deductions from option exercises in that year. The Company received approximately $<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzYwOTU_612a7b69-5783-4f84-9a35-839c5e2c805a">42,000</ix:nonFraction> from the exercise of <ix:nonFraction unitRef="shares" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzYxMTk_91ee1cd9-b727-4c7e-b35f-df24635423df">16,000</ix:nonFraction> options under the share-based arrangements for the year ended December 31, 2019. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 9 &#8211; S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">TOCK-BASED COMPENSATION EXPENSE (CONTINUED)</span></div></div><ix:continuation id="ia207cc449d6b4bbdba9530525b63fdee"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg3NjU_3d9c2d57-d10b-4955-ac1c-1621a71c3d05" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of the Company&#8217;s non-vested stock options as of December&#160;31, 2020 and 2019, and changes during the years ended December&#160;31, 2020 and 2019 is presented below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:74.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of Options</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant-Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88d4659da27e48458ba86016aae09e94_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzEtMi0xLTEtMA_3974a1d8-5fe8-4497-bc1f-f62ada6d23c1">125,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88d4659da27e48458ba86016aae09e94_I20181231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzEtNC0xLTEtMA_8eb82ce0-aead-4b3d-a6d6-df9f71741c72">1.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzItMi0xLTEtMA_052e8292-0a40-4877-880a-2b01d52753f9">18,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzItNC0xLTEtMA_c2469adc-d382-4298-ada1-438892f9ac7e">1.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzMtMi0xLTEtMA_b81c2558-0ced-48ec-b10d-566f67ad883c">118,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzMtNC0xLTEtMA_64d02e49-54ae-4f43-995c-926515acf196">1.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzYtMi0xLTEtMA_acc6f813-7a74-4c4d-994b-c81a9e52bb85">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzYtNC0xLTEtMA_e5862601-e9b3-4d86-a23b-872e55e0a191">1.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzctMi0xLTEtMA_18ff0001-f89e-4cfe-9a55-5a60775ebd16">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzctNC0xLTEtMA_e7384575-778e-4c41-8528-2f9f5bdbaadd">0.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzgtMi0xLTEtMA_aeea57d4-76dc-469c-9eb0-e63d32df562b">23,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzgtNC0xLTEtMA_b5100bf4-a750-4bec-a91d-37ef1ebd958e">1.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzEwLTItMS0xLTA_414e41b8-1f10-438f-b0ad-78edce2ab63d">12,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzEwLTQtMS0xLTA_f72eabe8-8ad9-4bd5-9b7a-981c683f7028">1.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, there was approximately $<ix:nonFraction unitRef="usd" contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzY3Nzc_1f9286fa-8e19-4f53-8aa2-800e5ec49ea2">12,000</ix:nonFraction> of unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Plan. This cost is expected to be recognized over a period of approximately <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzY5Njg_f58eef60-738f-4047-b5cc-12b6ccedf820">three  years</ix:nonNumeric>.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based awards to employees are calculated using the Black-Scholes options valuation model. The Black-Scholes model was developed for use in estimating the fair value of traded options which have no vesting restrictions and are fully transferable. In addition, the Black-Scholes model requires the input of highly subjective assumptions including the expected stock price volatility. The Company&#8217;s stock-based awards have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the present value estimates. For these reasons, management believes that the existing models do not necessarily provide a reliable single measure of the fair value of its stock-based awards to employees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s option grants issued during 2020 and 2019  were estimated using assumptions for expected life, volatility, dividend yield, forfeiture rate, and risk-free interest rate which are specific to each award as summarized in the following table. The estimated fair value of the Company&#8217;s options is amortized over the period during which the optionee is required to provide service in exchange for the award, usually the vesting period.</span></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg3NjA_4bd5d5f4-4ea0-4d63-9e8f-855dfc4959a5" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s option grants under the Plan in 2020 and 2019 was estimated using the following assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzEtMS0xLTEtMA_e6c014ca-f052-48ed-a7a6-767521c5949e">7.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzEtMy0xLTEtMA_60a625c1-01a4-494e-b6a7-110244ad0406">7.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected forfeiture rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="3" name="ams:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzItMS0xLTEtMA_66e1982a-da2f-49f2-9ce0-be8438f2d7ff">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="3" name="ams:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzItMy0xLTEtMA_c8c44961-995a-4f87-b5a5-aed889d631e9">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzMtMS0xLTEtMA_20c3e040-9146-44b3-93ea-b54c637496e9">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzMtMy0xLTEtMA_0c775a5f-ca1f-4c72-b8d4-6ab4697c1486">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzQtMS0xLTEtMA_b16cab71-4010-4293-ba0b-0f9a7580ff54">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzQtMy0xLTEtMA_2c38c03d-0ff5-4cac-b095-8b9302ff1fef">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzUtMS0xLTEtMA_f8b7b5d5-5b4f-48ea-a2dc-6b400911c6da">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzUtMy0xLTEtMA_c001c507-b78e-407a-b94d-5ac8d43de266">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Repurchase of Common Stock, Common Stock Warrants and Stock Options</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of <ix:nonFraction unitRef="shares" contextRef="ia2672c01483e420db7e4c638ebae606e_I20011231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg1Mjk_6d081961-8deb-49b1-a557-6b8c3ac2b7c3">1,000,000</ix:nonFraction> shares of its own stock on the open market, which the Board reaffirmed in 2008. There were no shares of the Company repurchased during 2020 or 2019. There are approximately <ix:nonFraction unitRef="shares" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg3MDU_b8851ac9-dd4b-43bc-8d73-2fcdfd5e780c">72,000</ix:nonFraction> shares remaining under this repurchase authorization.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 30</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_178"></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div><div style="margin-top:4pt"><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 10 &#8211; <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzgvZnJhZzoyYWZjYzIyNzgyODg0ZWJhYWEzYzgxMzE2NTEwOWFkYS90ZXh0cmVnaW9uOjJhZmNjMjI3ODI4ODRlYmFhYTNjODEzMTY1MTA5YWRhXzY4Nw_ce34cc31-40a3-4bf9-8ff7-75dd1d36d12f" continuedAt="i1610f12fbfe94e37a8b54bb5b3025589" escape="true">R</ix:nonNumeric></span><ix:continuation id="i1610f12fbfe94e37a8b54bb5b3025589" continuedAt="i346ac55a434d4b2ca0699805cf060859"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ETIREMENT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">LAN</span></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i346ac55a434d4b2ca0699805cf060859">The Company has a defined-contribution retirement plan (the &#8220;Retirement Plan&#8221;) that allows for a matching safe harbor contribution. For 2020, the Board of Directors elected to match participant deferred salary contributions up to a maximum of <ix:nonFraction unitRef="number" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzgvZnJhZzoyYWZjYzIyNzgyODg0ZWJhYWEzYzgxMzE2NTEwOWFkYS90ZXh0cmVnaW9uOjJhZmNjMjI3ODI4ODRlYmFhYTNjODEzMTY1MTA5YWRhXzI3Mg_13170196-fe04-4f14-9cf1-151cd1626b1b">4</ix:nonFraction>% of the participant&#8217;s annual compensation. Discretionary profit sharing contributions are allowed under the Retirement Plan in years that the Board does not elect a safe harbor match. The Company has accrued approximately $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzgvZnJhZzoyYWZjYzIyNzgyODg0ZWJhYWEzYzgxMzE2NTEwOWFkYS90ZXh0cmVnaW9uOjJhZmNjMjI3ODI4ODRlYmFhYTNjODEzMTY1MTA5YWRhXzQ5Ng_d11e39af-f244-4a4f-a120-7a7addceeab3">37,000</ix:nonFraction> for the estimated safe harbor matching contribution for the year ended December&#160;31, 2020. The Company contributed $<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzgvZnJhZzoyYWZjYzIyNzgyODg0ZWJhYWEzYzgxMzE2NTEwOWFkYS90ZXh0cmVnaW9uOjJhZmNjMjI3ODI4ODRlYmFhYTNjODEzMTY1MTA5YWRhXzU5OA_e4bf388e-9cd5-4592-b1bf-c49aa6b95b6b">38,000</ix:nonFraction> to the Retirement Plan for the safe harbor match for the year ended December&#160;31, 2019.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 31</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_181"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div><div><span><br/></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 11 &#8211; <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:OperatingLeasesOfLessorDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90ZXh0cmVnaW9uOmI5NzIzMWQ0MGEyMjRjNjdhMTQ5ZmRlZjI1NzJkNGYxXzEwODM_5555d5e6-0a83-43d0-9e87-16bc62b284ba" continuedAt="i7391aa2b16e74e4594de1f6306ab3714" escape="true">O</ix:nonNumeric></span><ix:continuation id="i7391aa2b16e74e4594de1f6306ab3714" continuedAt="i1621f3e6bf9548daa11dd0282bb386c8"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PERATING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> L</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">EASES</span></ix:continuation></div><ix:continuation id="i1621f3e6bf9548daa11dd0282bb386c8"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases office space and equipment under operating leases expiring at various dates through 2021 and 2024. On August 13, 2016, the Company entered into a <ix:nonNumeric contextRef="ib40f3f2ed22f45ceb3ad41a1918f4939_D20160813-20160813" format="ixt-sec:duryear" name="ams:LeaseExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90ZXh0cmVnaW9uOmI5NzIzMWQ0MGEyMjRjNjdhMTQ5ZmRlZjI1NzJkNGYxXzE5NQ_ce36e54b-1c61-4417-a303-1fdb23c365ef">7</ix:nonNumeric> year operating lease for an office space located in San Francisco, CA. The Company also owns and operates a stand-alone Gamma Knife facility in Lima, Peru where it leases approximately <ix:nonFraction unitRef="sqft" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:AreaOfLand" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90ZXh0cmVnaW9uOmI5NzIzMWQ0MGEyMjRjNjdhMTQ5ZmRlZjI1NzJkNGYxXzQ4MA_3c8f1500-e2bf-45ae-aede-42147b531ba4">1,600</ix:nonFraction> square feet for approximately $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-2" format="ixt:numdotdecimal" name="ams:OperatingLeaseMonthlyLeaseExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90ZXh0cmVnaW9uOmI5NzIzMWQ0MGEyMjRjNjdhMTQ5ZmRlZjI1NzJkNGYxXzUwMQ_c1b0c9e5-6772-45fe-9829-9ba6a28ca3ae">7,800</ix:nonFraction> per month with a lease expiration date in January 2024.</span></div><ix:continuation id="i2ab9893430d94c72899cbab88b298abc"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum payments under non-cancelable operating leases having initial terms of more than one year consisted of the following:</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31, </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90YWJsZTpiODc2ZDY1Nzk3NjA0Yjk4OTI2ZGY0NjI2ZTY0NTIyZC90YWJsZXJhbmdlOmI4NzZkNjU3OTc2MDRiOTg5MjZkZjQ2MjZlNjQ1MjJkXzItMS0xLTEtMA_be22b986-e988-4d8f-ab36-0b42b22663a5">350,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90YWJsZTpiODc2ZDY1Nzk3NjA0Yjk4OTI2ZGY0NjI2ZTY0NTIyZC90YWJsZXJhbmdlOmI4NzZkNjU3OTc2MDRiOTg5MjZkZjQ2MjZlNjQ1MjJkXzMtMS0xLTEtMA_37093f2f-5c1e-4a54-b224-c8d527f6cb6a">355,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90YWJsZTpiODc2ZDY1Nzk3NjA0Yjk4OTI2ZGY0NjI2ZTY0NTIyZC90YWJsZXJhbmdlOmI4NzZkNjU3OTc2MDRiOTg5MjZkZjQ2MjZlNjQ1MjJkXzQtMS0xLTEtMA_bc454b63-3ec7-4d8f-8e92-c5087f5bc4ed">259,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90YWJsZTpiODc2ZDY1Nzk3NjA0Yjk4OTI2ZGY0NjI2ZTY0NTIyZC90YWJsZXJhbmdlOmI4NzZkNjU3OTc2MDRiOTg5MjZkZjQ2MjZlNjQ1MjJkXzUtMS0xLTEtMA_155bc612-19ed-40e3-bb11-9bfee884baf9">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90YWJsZTpiODc2ZDY1Nzk3NjA0Yjk4OTI2ZGY0NjI2ZTY0NTIyZC90YWJsZXJhbmdlOmI4NzZkNjU3OTc2MDRiOTg5MjZkZjQ2MjZlNjQ1MjJkXzEwLTEtMS0xLTA_a7bb2658-d036-4248-a879-5cf705005f32">972,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments for repair and maintenance agreements incorporated in operating lease agreements are not included in the future minimum operating lease payments shown above.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net rent expense was $<ix:nonFraction unitRef="usd" contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90ZXh0cmVnaW9uOmI5NzIzMWQ0MGEyMjRjNjdhMTQ5ZmRlZjI1NzJkNGYxXzkxNw_78a59d8e-f355-4983-8028-703c5a1c1ac4">404,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90ZXh0cmVnaW9uOmI5NzIzMWQ0MGEyMjRjNjdhMTQ5ZmRlZjI1NzJkNGYxXzkyMQ_07c40f8c-9845-4fe5-b408-7d0630587750">380,000</ix:nonFraction> for the years ended December&#160;31, 2020 and 2019, respectively, and includes the above operating leases as well as month-to-month rental and certain executory costs.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 32</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_184"></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div></td></tr></table></div><div style="margin-top:4pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 12 &#8211; <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzM3Nzg_efd511c9-c460-4e7b-aba9-e1654fe3b63a" continuedAt="i02d3f0585ace432eb757dca263d793f5" escape="true">C</ix:nonNumeric></span><ix:continuation id="i02d3f0585ace432eb757dca263d793f5" continuedAt="i855194a37cbc46e9b3eb4734154372a4"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OMMITMENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ONTINGENCIES</span></ix:continuation></div><ix:continuation id="i855194a37cbc46e9b3eb4734154372a4"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 20, 2018, the Company signed Second Amendments to two System Build Agreements for the Company&#8217;s second and third Mevion PBRT units. The Company and Mevion have agreed to upgrade the second and third PBRT units for which the Company has purchase commitments. The Company is actively seeking sites for these units but, to date, has not entered into agreements with any party for either placement of a PBRT unit or the related financing. The Company projects that it will be required to commence delivery of the second and third PBRT units no later than 2023. In the event the Company is unable to enter into customer agreements within the requisite time frame or receive an extension from Mevion, the Company could forfeit its deposits, which are described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2020, the Company had commitments to perform three (<ix:nonFraction unitRef="reload" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="INF" name="ams:NumberOfCobalt60Reloads" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU3ODc_cfaaf55f-f3e1-4c1a-8a66-ee037f2b025a">3</ix:nonFraction>) Cobalt-60 reloads and install four (<ix:nonFraction unitRef="install" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="INF" name="ams:NumberOfLeksellGammaKnifeIconSystemInstalls" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU3ODk_f99c2e47-e71b-4981-968d-f440fb5d036e">4</ix:nonFraction>) Leksell Gamma Knife Icon Systems (&#8220;Icon&#8221;) at existing customer sites, and purchase two (<ix:nonFraction unitRef="purchase" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="INF" name="ams:NumberOfPurchaseCommitments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU3OTI_8ebd52e1-1d87-44b8-9235-97031fa52227">2</ix:nonFraction>) Linear Accelerator ("LINAC") systems, one to be placed at an existing customer site and one at a new customer site. The Company also has a commitment to upgrade the Gamma Knife unit at its stand-alone facility in Ecuador to a Perfexion. The Cobalt-60 reloads, Icon upgrades, and LINAC purchases are scheduled to occur between 2021 and 2022. The Company expects to upgrade the equipment in Ecuador in the second quarter of 2021. Total Gamma Knife and LINAC commitments as of December&#160;31, 2020 were $<ix:nonFraction unitRef="usd" contextRef="i5e5ea45669af4723953be698788c51f5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermPurchaseCommitmentAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzE1NTQ_0b1a28d4-23bd-48ad-9a4c-b2de8dcff59c"><ix:nonFraction unitRef="usd" contextRef="i588196b8c9c6489fab6078ddb17065d6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermPurchaseCommitmentAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzE1NTQ_70ea43c0-2502-47d5-96d4-a0c9e829f15b">12,210,000</ix:nonFraction></ix:nonFraction>.  There are no significant cash requirements, pending financing, for these commitments in the next 12 months. There can be no assurance that financing will be available for the Company&#8217;s current or future projects, or at terms that are acceptable to the Company.&#160;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 21, 2017, the Company entered into a Maintenance and Support Agreement (the &#8220;Mevion Service Agreement&#8221;) with Mevion, which provides for maintenance and support of the Company&#8217;s PBRT unit at Orlando Health. The Mevion Service Agreement began September 5, 2017, was amended in 2018, and renews annually over a five (<ix:nonNumeric contextRef="ie52549c616fe4dc18135044ebe97c162_D20170905-20170905" format="ixt-sec:duryear" name="ams:LongTermPurchaseCommitmentRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU3ODA_d4409c55-5a4d-4596-a591-f4f68cd61e3d">5</ix:nonNumeric>) year period. The agreement requires an annual prepayment of $<ix:nonFraction unitRef="usd" contextRef="i160dbde260894a5d8df523d1c2359928_I20170905" decimals="-3" format="ixt:numdotdecimal" name="ams:PurchaseAgreementAnnualPrepayment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU3OTU_61130d42-cebb-4be0-b441-186f76738a17">1,572,000</ix:nonFraction> for the current contractual period. This payment portion was recorded as a prepaid contract and will be amortized over the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU4MTM_78bf16e5-2777-43c0-8b8e-f765c5397ed5">one</span>-year service period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2020, the Company had commitments to service and maintain its Gamma Knife and PBRT equipment. The service commitments are carried out via contracts with Mevion, Elekta and Mobius Imaging, LLC. In addition, in April 2019, the Company signed agreements to service the Icon upgrades which will be installed at various dates between 2021 and 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s commitments to purchase two LINAC systems also include a <ix:nonNumeric contextRef="i303d240dda61403d9ec1de771f26041e_D20200101-20201231" format="ixt-sec:duryear" name="ams:LongTermServiceCommitmentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU4MjM_272228a1-c5a1-45af-b762-2b2bd05b5fea">9</ix:nonNumeric>-year and <ix:nonNumeric contextRef="i922a42f468f946e8b4a7d5f99e207fbf_D20200101-20201231" format="ixt-sec:duryear" name="ams:LongTermServiceCommitmentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU4MzA_11b9e6da-48cb-423d-8706-065af180dd74">5</ix:nonNumeric>-year agreement to service the equipment, respectively. Total service commitments as of December&#160;31, 2020 were $<ix:nonFraction unitRef="usd" contextRef="i5e5ea45669af4723953be698788c51f5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="ams:LongTermServiceCommitmentAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzM0Mjc_b8b9f34f-8ac1-4b7d-b902-86df965b2ddb">10,493,000</ix:nonFraction>. The Gamma Knife and certain other service contracts are paid monthly, as service is performed. The Company believes that cash flow from cash on hand and operations will be sufficient to cover these payments.</span></div><ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:LongTermPurchaseCommitmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzM3Nzk_58aa2138-489b-4e9c-844f-c174780b71af" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following commitments for each of the equipment systems, with expected timing of payments as follows as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.078%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts committed</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022-2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024-2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After 5&#160;years</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (includes interest)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e9d39e86c2548f0bf5e350d4df09116_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzItMi0xLTEtMA_4d5ed67c-592a-42d0-af73-c0af4c80d214">5,251,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e9d39e86c2548f0bf5e350d4df09116_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzItMy0xLTEtMA_bffc4a95-3184-461a-aa36-24034baa4bc9">1,373,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e9d39e86c2548f0bf5e350d4df09116_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInSecondAndThirdYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzItNC0xLTEtMA_339ae8a1-84d9-49e4-98b3-a41a644ec96a">1,854,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e9d39e86c2548f0bf5e350d4df09116_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInFourthAndFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzItNS0xLTEtMA_7834ae2d-44dd-48af-b7fb-40630205528d">1,543,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e9d39e86c2548f0bf5e350d4df09116_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueAfterFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzItNi0xLTEtMA_66f925b6-4a75-41ee-b713-23fab5e54064">481,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases (includes interest)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18863b680ebc4002ab41bd4bd5d80267_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzMtMi0xLTEtMA_bd7f15a2-849a-4caf-bb1a-f317e2fab84c">9,771,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18863b680ebc4002ab41bd4bd5d80267_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzMtMy0xLTEtMA_2d1d4cd9-7aed-4738-8d16-94079a9e4c19">6,590,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18863b680ebc4002ab41bd4bd5d80267_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInSecondAndThirdYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzMtNC0xLTEtMA_37c4df6b-a6c4-41f7-8e82-e22f9cf25d34">2,659,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18863b680ebc4002ab41bd4bd5d80267_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInFourthAndFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzMtNS0xLTEtMA_ef687377-7e96-484c-8ec7-2fd6d36bac4a">522,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18863b680ebc4002ab41bd4bd5d80267_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ContractualObligationDueAfterFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzMtNi0xLTEtMA_0a2492d9-de57-47a1-b44d-4154a70e6412">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Future equipment purchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c1a379a87884628a8b8200736f37e34_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzQtMi0xLTEtMA_3679221c-8995-436e-a18a-e5e49fe41a28">46,210,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c1a379a87884628a8b8200736f37e34_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzQtMy0xLTEtMA_08f8e2f8-d3be-40b2-a8c2-9a8b6414787c">2,175,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c1a379a87884628a8b8200736f37e34_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInSecondAndThirdYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzQtNC0xLTEtMA_c0ac10ad-e775-4bec-908c-b98c6e8ccd75">44,035,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c1a379a87884628a8b8200736f37e34_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ContractualObligationDueInFourthAndFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzQtNS0xLTEtMA_460e91f9-47b8-4ee9-8d79-c4e237a14c04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c1a379a87884628a8b8200736f37e34_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ContractualObligationDueAfterFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzQtNi0xLTEtMA_e5c70e2b-1f1f-465b-81e1-5326f106334f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment service contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7d6fa8d4f2d4414a11cd4e62eebfcc7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzUtMi0xLTEtMA_74498637-2b72-4244-9776-daa4541b186a">10,493,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7d6fa8d4f2d4414a11cd4e62eebfcc7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzUtMy0xLTEtMA_18c49cc1-15fd-4a6f-97db-5b086e888d4b">2,030,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7d6fa8d4f2d4414a11cd4e62eebfcc7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInSecondAndThirdYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzUtNC0xLTEtMA_a3128e2b-7129-4fe1-bac6-bbf3a7c5ada4">2,585,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7d6fa8d4f2d4414a11cd4e62eebfcc7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInFourthAndFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzUtNS0xLTEtMA_a856cf03-aab4-426b-a7ab-aceca02fcba9">2,999,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7d6fa8d4f2d4414a11cd4e62eebfcc7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueAfterFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzUtNi0xLTEtMA_10eeb730-26f8-4f09-ab4b-e4bc288d9a08">2,879,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition working capital payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735df263f1544be9ab7b0ae62cd61c55_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtMi0xLTEtODYz_e395b618-98a4-4361-abdf-e6497f9c5137">197,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735df263f1544be9ab7b0ae62cd61c55_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtMy0xLTEtODYz_f383b7e3-14cc-4e16-ad92-2c3b7235d6b7">197,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735df263f1544be9ab7b0ae62cd61c55_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ContractualObligationDueInSecondAndThirdYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtNC0xLTEtODYz_594a5687-9f53-4831-a7fc-0f5ba4364c68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735df263f1544be9ab7b0ae62cd61c55_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ContractualObligationDueInFourthAndFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtNS0xLTEtODYz_e0434b01-106c-4dec-b0cf-68bd87248f2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735df263f1544be9ab7b0ae62cd61c55_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ContractualObligationDueAfterFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtNi0xLTEtODYz_b53ac318-170c-4ade-a2e3-d4ca3676d1db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf60e6023f1042189106a9ed43c03bcb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtMi0xLTEtMA_bf65c6b7-bc45-4551-874c-04141846d395">972,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf60e6023f1042189106a9ed43c03bcb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtMy0xLTEtMA_cb161a42-0788-4c6d-897c-5d43d8fa0170">350,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf60e6023f1042189106a9ed43c03bcb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInSecondAndThirdYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtNC0xLTEtMA_c2d26947-1b7b-4d62-9622-15481fffbdc6">614,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf60e6023f1042189106a9ed43c03bcb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInFourthAndFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtNS0xLTEtMA_bb94f430-0387-4702-ab0b-39bdfd3f973a">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf60e6023f1042189106a9ed43c03bcb_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ContractualObligationDueAfterFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtNi0xLTEtMA_5515dfc6-30b2-4634-a890-7d591e9a34bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commitments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzgtMi0xLTEtMA_330fb0f1-498c-4200-91da-92c7958b819e">72,894,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzgtMy0xLTEtMA_c590230f-f7a3-415d-8325-13e202c026ea">12,715,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInSecondAndThirdYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzgtNC0xLTEtMA_9e7ad867-361f-4a95-989f-b6a646faf658">51,747,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInFourthAndFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzgtNS0xLTEtMA_91ee44ce-4809-43d1-96df-b3fc2a674e93">5,072,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueAfterFifthYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzgtNi0xLTEtMA_e672a814-0778-43e1-922b-21d203d111a9">3,360,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 33</span></div></div></div><div id="i08eb1efc99dc4f408903b4769adc4b90_187"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MERICAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">HARED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OSPITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ERVICES</span></div></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TATEMENTS</span></div><div><span><br/></span></div></td></tr></table></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 13 &#8211; <ix:nonNumeric contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODcvZnJhZzpmZmNhOTA5NjNmNDk0NDhhOThkYWMxYzJhMzMzYjhlNS90ZXh0cmVnaW9uOmZmY2E5MDk2M2Y0OTQ0OGE5OGRhYzFjMmEzMzNiOGU1XzEzNDI_f7083f99-d16f-4fff-9b8c-7009f1d0faa3" continuedAt="i03219d7e89704ee7b15b34a5fade7b59" escape="true">R</ix:nonNumeric></span><ix:continuation id="i03219d7e89704ee7b15b34a5fade7b59" continuedAt="i840392be7de44a839df6ad5fb1a7ceff"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ELATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ARTY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">RANSACTIONS</span></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i840392be7de44a839df6ad5fb1a7ceff">The Company&#8217;s Gamma Knife business is operated through its <ix:nonFraction unitRef="number" contextRef="i5032e2b4fc36495cbac498a4109a1461_I20201231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODcvZnJhZzpmZmNhOTA5NjNmNDk0NDhhOThkYWMxYzJhMzMzYjhlNS90ZXh0cmVnaW9uOmZmY2E5MDk2M2Y0OTQ0OGE5OGRhYzFjMmEzMzNiOGU1XzEwMQ_d7dab15b-c4f4-456f-b1ed-459d39044c9b">81</ix:nonFraction>% indirect interest in its GKF subsidiary. The remaining <ix:nonFraction unitRef="number" contextRef="i24a2c7db33474c15b8617c78beae2b0f_I20201231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODcvZnJhZzpmZmNhOTA5NjNmNDk0NDhhOThkYWMxYzJhMzMzYjhlNS90ZXh0cmVnaW9uOmZmY2E5MDk2M2Y0OTQ0OGE5OGRhYzFjMmEzMzNiOGU1XzE1OQ_7dcf8d42-c104-49c1-bfd5-b805df2b60d6">19</ix:nonFraction>% of GKF is owned by a wholly owned U.S. subsidiary of Elekta, which is the manufacturer of the Gamma Knife. Since the Company purchases its Gamma Knife units from Elekta, there are significant related party transactions with Elekta such as equipment purchases, commitments to purchase equipment, deposits for such equipment purchases, and costs to maintain the equipment. The Company believes that all its transactions with Elekta are arm&#8217;s-length transactions. At December&#160;31, 2020, the Company had commitments to purchase three (<ix:nonFraction unitRef="reload" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="INF" name="ams:NumberOfCobalt60Reloads" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODcvZnJhZzpmZmNhOTA5NjNmNDk0NDhhOThkYWMxYzJhMzMzYjhlNS90ZXh0cmVnaW9uOmZmY2E5MDk2M2Y0OTQ0OGE5OGRhYzFjMmEzMzNiOGU1XzI3NDg3NzkwNzE1MDE_c85b53c2-f31f-4310-9fca-ed587546b951">3</ix:nonFraction>) Cobalt-60 reloads, one (<ix:nonFraction unitRef="upgrade" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="INF" name="ams:NumberOfPerfexionUpgrades" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODcvZnJhZzpmZmNhOTA5NjNmNDk0NDhhOThkYWMxYzJhMzMzYjhlNS90ZXh0cmVnaW9uOmZmY2E5MDk2M2Y0OTQ0OGE5OGRhYzFjMmEzMzNiOGU1XzI3NDg3NzkwNzE1MDQ_a37becce-3fb0-4837-b84b-1c5ef38d4704">1</ix:nonFraction>) Perfexion upgrade, and install four (<ix:nonFraction unitRef="install" contextRef="i6687a8b13ec24af5990e629224319cec_I20201231" decimals="INF" name="ams:NumberOfLeksellGammaKnifeIconSystemInstalls" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODcvZnJhZzpmZmNhOTA5NjNmNDk0NDhhOThkYWMxYzJhMzMzYjhlNS90ZXh0cmVnaW9uOmZmY2E5MDk2M2Y0OTQ0OGE5OGRhYzFjMmEzMzNiOGU1XzI3NDg3NzkwNzE1MDc_f9432f46-c54e-44df-a6b5-2ab7e32157ac">4</ix:nonFraction>) Leksell Gamma Knife Icon Systems (&#8220;Icon&#8221;) and service the related equipment, as discussed in Note 12 &#8211; Commitments and Contingencies.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F- 34</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ashs10-kexhibit41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ibdb1946c529e47b7a95498fb791905ae_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 4.1</font></div><div style="padding-right:3.6pt;text-align:right"><font><br></font></div><div style="padding-right:3.6pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, American Shared Hospital Services, a California corporation (&#8220;ASHS&#8221;), had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended&#58;  common stock, no par value (&#8220;common stock&#8221;).  The following contains a description of our common stock, as well as certain related additional information.  This description is a summary only and does not purport to be complete.  We encourage you to read the complete text of ASHS&#8217;s articles of incorporation, as amended (the &#8220;articles of incorporation&#8221;) and amended and restated bylaws (the &#8220;bylaws&#8221;), which we have filed or incorporated by reference as exhibits to ASHS&#8217;s Annual Report on Form 10-K.  References to &#8220;we,&#8221; &#8220;our&#8221; and &#8220;us&#8221; refer to ASHS, unless the context otherwise requires.  References to &#8220;shareholders&#8221; refer to holders of our common stock, unless the context otherwise requires.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the articles of incorporation, we have the authority to issue 10,000,000 shares of common stock. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, 5,790,811 shares of our common stock were outstanding.  All of the outstanding shares of common stock are fully paid and nonassessable.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our bylaws, unless otherwise provided by law, our articles of incorporation or our bylaws, our shareholders are entitled to one vote for each share of common stock held on all matters voted upon by shareholders, including the election of directors. A majority of the shares entitled to vote at a meeting of the shareholders, represented in person or by proxy, shall constitute a quorum for the transaction of business thereat. The shareholders present at a duly called or held meeting at which a quorum is present may continue to transact business until adjournment notwithstanding the withdrawal of enough shareholders to leave less than a quorum, if any action taken (other than adjournment) is approved by at least a majority of the shares required to constitute a quorum.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our bylaws, unless the vote of a greater number is required by law or our articles of incorporation in connection with an election of directors, the affirmative vote of the majority of the shares represented and voting at a duly held meeting at which a quorum is present (which shares voting affirmatively also constitute at least a majority of the required quorum) shall be the act of the shareholders, Every shareholder entitled to vote at any election of directors may cumulate his votes and give one candidate a number of votes equal to the number of directors to be elected, multiplied by the number of votes to which his shares are normally entitled, or distribute his votes on the same principle among as many candidates as he thinks fit. However, no shareholder shall be entitled to cumulate his votes (i.e., cast for any candidate a number of votes greater than the number of votes which such shareholder normally is entitled to cast) unless the candidate's or candidates' names for which he desires to cumulate his votes have been placed in nomination prior to the voting and the shareholder has given notice at the meeting prior to the voting of his intention to cumulate his votes. If any one shareholder has given such notice, all shareholders may cumulate their votes for candidates in nomination. In any election of directors, the candidates receiving the highest number of affirmative votes of the shares entitled to be voted for them, up to the number of directors to be elected by such shares, are elected as directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Any action which may be taken at any annual or special meeting of the shareholders may be taken without a meeting, without a vote and without prior notice, if a consent in writing, setting forth the action so taken, is signed by the holders of outstanding shares having not less than the minimum number of votes which would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. Except for the election of a director by written consent to fill a vacancy (other than a vacancy created by removal), directors </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may be elected by written consent only by the unanimous written consent of all shares entitled to vote for the election of directors. In the case of an election of a director by written consent to fill a vacancy (other than a vacancy created by removal), any such election requires the consent of a majority of the outstanding shares entitled to vote for the election of directors.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Rights</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our shareholders are entitled to receive dividends as may be declared in the discretion of ASHS&#8217;s board of directors (the &#8220;board of directors&#8221;) out of funds legally available for the payment of dividends.  The declaration and amount of future dividends is at the discretion of our board  and will depend on our financial condition, results of operations, cash flows, prospects, industry conditions, capital requirements and other factors and restrictions our board of directors deems relevant.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidation Rights</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our shareholders are entitled to share equally and ratably in our net assets upon a liquidation or dissolution after the payment or provision for all liabilities.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">No Preemptive, Conversion or Redemption Rights</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our shareholders have no preemptive, subscription, conversion or redemption rights, and are not subject to further calls or assessments by us.  There are no sinking fund provisions applicable to our common stock.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Listing</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the New York Stock Exchange American under the symbol &#8220;AMS.&#8221;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effects of Certain Provisions of Our Bylaws </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our bylaws contain provisions that may deter or render more difficult nominating directors or advancing proposals a shareholder might consider to be in his or her best interest.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Special Meetings of Shareholders</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our bylaws provide that special meetings of shareholders may be called at any time only by our board of directors, the chairman of the board, the president or by the holders of shares entitled to vote not less than 10% of the votes entitled to vote on the record date.  The only business that may be conducted at a special meeting of shareholders is that business specified in the notice of the meeting and properly brought before the special meeting.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advance Notice Provisions</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our bylaws provide that proposals and director nominations made by a shareholder to be voted upon at any annual meeting or special meeting of shareholders may be taken only if such proposal or director nomination is &#8220;properly brought&#8221; at such meeting.  In order for any matter, as the case may be, to be considered &#8220;properly brought&#8221; at such meeting, a shareholder must comply with certain requirements regarding advance notice to us.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, in the case of nominations for directors at an annual meeting, shareholders must deliver to the secretary of ASHS a written notice between 60 and ninety 90 days prior to the date of the annual meeting.   If less than 70 days' notice of the meeting or prior public disclosure of the date of the meeting is given or made to shareholders, not later than the close of business on the tenth day following the day on which the notice of the meeting was mailed, or, if earlier, the day on which such public disclosure was made.  To nominate directors, the notice must include, as to each person whom the shareholder proposes to nominate for election as a director, the name, age, business address, residence address and principal occupation or employment of the nominee and certain information regarding the shares owned by the nominee and any other information relating to such person that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">would be required to be disclosed in solicitations of proxies for the election of such person as required by the Securities and Exchange Commission. Additionally, the notice must include information about the nominating shareholder including such shareholder&#8217;s  name and address, as they appear on the ASHS&#8217;s records and the class and number of shares of stock of ASHS which are beneficially owned by such shareholder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For business to be properly brought before an annual or special meeting by a shareholder, the shareholder must have given written notice thereof to the secretary, chairman of the board, president, any vice president or secretary, as applicable, delivered or mailed to and received at the principal executive offices of ASHS.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the case of an annual meeting such notice shall be sent to the secretary of ASHS in writing&#58; (x) not less than 60 days nor more than 90 days prior to the meeting, or (y) if less than 70 days' notice of the meeting or prior public disclosure of the date of the meeting is given or made to shareholders, not later than the close of business on the tenth day following the day on which the notice of the meeting was mailed or, if earlier, the day on which such public disclosure was made. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the case of a special meeting, called upon the request of holders of shares entitled to cast not less than 10 percent of the votes at such meeting, such notice shall be sent to the chairman of the board, president, any vice president or secretary in writing specifying the date and time of the meeting, which date shall be not less than 35 nor more than 60 days after receipt of the request.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A shareholder's notice for either a special or annual meeting shall set forth as to each item of business the shareholder proposes to bring before the meeting (1) a brief description of such item and the reasons for conducting such business at the meeting, (2) the name and address, as they appear on ASHS&#8217;s records, of the shareholder proposing such business, (3) the class and number of shares of stock of ASHS which are beneficially owned by the shareholder (for purposes of the regulations under Sections 13 and 14 of the Securities Exchange Act of 1934, as amended), and (4) any material interest of the shareholder in such business.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vacancies on the Board of Directors</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for a vacancy created by the removal of a director, vacancies on the board may be filled by a majority of the directors then in office, whether or not less than a quorum, or by a sole remaining director. A vacancy created by the removal of a director shall be filled only by a person elected by a majority of the shareholders entitled to vote at a duly held meeting at which there is a quorum present or by the unanimous written consent of the holders of the outstanding shares entitled to vote at such a meeting. The shareholders may elect a director at any time to fill any vacancy not filled by the directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ashsex1011dfullyexecuted.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ashsex1011dfullyexecuted</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1054;"><!-- ashsex1011dfullyexecuted001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ashsex1011dfullyexecuted001.jpg" title="slide1" width="1054" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>exhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i378b5ed01c764c5699ad68f20d1de2aa_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">The subsidiaries of American Shared Hospital Services are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MedLeader.com, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A California corporation</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR21, Inc. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A California corporation</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR21, LLC</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Washington limited liability company</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long Beach Equipment, LLC</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Delaware limited liability company</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Shared Radiosurgery Services</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A California corporation</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PBRT Orlando LLC</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Delaware limited liability company</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiaries of American Shared Radiosurgery Services</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GK Financing, LLC </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A California limited liability company</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiaries of GK Financing, LLC</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Albuquerque GK Equipment, LLC</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Delaware limited liability company</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jacksonville GK Equipment, LLC</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Delaware limited liability company</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instituto de Gamma Knife del Pacifico S.A.C.</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Peruvian company</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HoldCo GKC S.A.</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Ecuadorian company</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiaries of HoldCo GKC S. A.</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gamma Knife Center Ecuador S.A.</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Ecuadorian company</font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>ashs-2020consentexhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i4d153cb41aec4046882d8c34cf98f892_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;margin-top:72pt"><font style="color:#000000;font-family:'Georgia',serif;font-size:14pt;font-weight:700;line-height:133%">Consent of Independent Registered Public Accounting Firm</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We consent to the incorporation by reference in the Registration Statements (Form S-3 No. 333-204593, and Form S-8 No. 333-170650, No. 333-139446, No. 333-81138, No. 333-73172, No. 333-12879, and No. 333-08009) of our report dated  April&#160;6, 2021, relating to the consolidated financial statements appearing in the Annual Report on Form 10-K of American Shared Hospital Services for the year ended December&#160;31, 2020.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#47;s&#47; Moss Adams LLP</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">San Francisco, California</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">April&#160;6, 2021</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>ams-20201231xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7008a1fce643449a96432d4499e44373_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Raymond C. Stachowiak., as chief executive officer of American Shared Hospital Services, certify that&#58;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;I have reviewed this annual report on Form 10-K for the period ended December&#160;31, 2020 of American Shared Hospital Services&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;Disclosed in this report any changes in the registrant&#8217;s internal control over financial reporting that occurred during registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;6, 2021</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Raymond C. Stachowiak</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raymond C. Stachowiak<br>Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>ams-20201231xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib459fb66d8b948cbb635ef50b83df8e2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Craig K. Tagawa, as president, chief financial and operating officer of American Shared Hospital Services, certify that&#58;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;I have reviewed this annual report on Form 10-K for the period ended December&#160;31, 2020 of American Shared Hospital Services&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;Disclosed in this report any changes in the registrant&#8217;s internal control over financial reporting that occurred during registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;6, 2021</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:81.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Craig K. Tagawa</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Craig K. Tagawa<br>President, Chief Operating and Financial Officer</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>ams-20201231xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i0f515ad950004d9a9df75602e99f19e4_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;6, 2021 </font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities and Exchange Commission</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">450 Fifth Street, N.W</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Washington, D.C. 20549</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-top:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted to the Securities and Exchange Commission solely for the purpose of complying with Rule 13a-14(b) and Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. This certification is not to be deemed filed pursuant to the Exchange Act and does not constitute a part of the Annual Report on Form 10-K (the &#8220;Report&#8221;) accompanying this letter.</font></div><div style="margin-top:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raymond C. Stachowiak., the Chief Executive Officer and Craig K. Tagawa, the President, Chief Financial and Operating Officer of American Shared Hospital Services, each certifies that, to the best of his knowledge&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of American Shared Hospital Services.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Raymond C. Stachowiak</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raymond C. Stachowiak<br>Chief Executive Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Craig K. Tagawa</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Craig K. Tagawa<br>President, Chief Operating and Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>ams-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4e6f91f2-1bf1-41c4-8e53-76168a3ee138,g:df8d0904-ed6f-4833-8eea-c587ca49bdb5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ams="http://www.ashs.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ashs.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ams-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ams-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ams-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ams-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.ashs.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STATEMENTSOFOPERATIONS" roleURI="http://www.ashs.com/role/STATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" roleURI="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY">
        <link:definition>1004005 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSANDBASISOFPRESENTATION" roleURI="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATION">
        <link:definition>2101101 - Disclosure - BUSINESS AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSANDBASISOFPRESENTATIONNarrativeDetails" roleURI="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails">
        <link:definition>2402401 - Disclosure - BUSINESS AND BASIS OF PRESENTATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTINGPOLICIES" roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIES">
        <link:definition>2103102 - Disclosure - ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTINGPOLICIESPolicies" roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies">
        <link:definition>2204201 - Disclosure - ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTINGPOLICIESTables" roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESTables">
        <link:definition>2305301 - Disclosure - ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>2406402 - Disclosure - ACCOUNTING POLICIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTINGPOLICIESScheduleofFairValueDetails" roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails">
        <link:definition>2407403 - Disclosure - ACCOUNTING POLICIES - Schedule of Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTINGPOLICIESScheduleofEPSDetails" roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails">
        <link:definition>2408404 - Disclosure - ACCOUNTING POLICIES - Schedule of EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails" roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails">
        <link:definition>2409405 - Disclosure - ACCOUNTING POLICIES - Schedule of Domestic and Foreign Break out Percentages (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENT" roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENT">
        <link:definition>2110103 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTTables" roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENTTables">
        <link:definition>2311302 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTDetails" roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails">
        <link:definition>2412406 - Disclosure - PROPERTY AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNarrativeDetails" roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails">
        <link:definition>2413407 - Disclosure - PROPERTY AND EQUIPMENT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GKCEACQUISITION" roleURI="http://www.ashs.com/role/GKCEACQUISITION">
        <link:definition>2114104 - Disclosure - GKCE ACQUISITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GKCEACQUISITIONTables" roleURI="http://www.ashs.com/role/GKCEACQUISITIONTables">
        <link:definition>2315303 - Disclosure - GKCE ACQUISITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GKCEACQUISITIONNarrativeDetails" roleURI="http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails">
        <link:definition>2416408 - Disclosure - GKCE ACQUISITION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails" roleURI="http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails">
        <link:definition>2417409 - Disclosure - GKCE ACQUISITION - Schedule of Purchase Price Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails" roleURI="http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails">
        <link:definition>2418410 - Disclosure - GKCE ACQUISITION - Schedule of Tangible Assets Acquired as Part of Business Combination (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBT" roleURI="http://www.ashs.com/role/LONGTERMDEBT">
        <link:definition>2119105 - Disclosure - LONG TERM DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBTTables" roleURI="http://www.ashs.com/role/LONGTERMDEBTTables">
        <link:definition>2320304 - Disclosure - LONG TERM DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBTNarrativeDetails" roleURI="http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails">
        <link:definition>2421411 - Disclosure - LONG TERM DEBT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBTDetails" roleURI="http://www.ashs.com/role/LONGTERMDEBTDetails">
        <link:definition>2422412 - Disclosure - LONG TERM DEBT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCELEASES" roleURI="http://www.ashs.com/role/FINANCELEASES">
        <link:definition>2123106 - Disclosure - FINANCE LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCELEASESTables" roleURI="http://www.ashs.com/role/FINANCELEASESTables">
        <link:definition>2324305 - Disclosure - FINANCE LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCELEASESNarrativeDetails" roleURI="http://www.ashs.com/role/FINANCELEASESNarrativeDetails">
        <link:definition>2425413 - Disclosure - FINANCE LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCELEASESDetails" roleURI="http://www.ashs.com/role/FINANCELEASESDetails">
        <link:definition>2426414 - Disclosure - FINANCE LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCELEASESDetails_1" roleURI="http://www.ashs.com/role/FINANCELEASESDetails_1">
        <link:definition>2426414 - Disclosure - FINANCE LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.ashs.com/role/LEASES">
        <link:definition>2127107 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.ashs.com/role/LEASESTables">
        <link:definition>2328306 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativeDetails" roleURI="http://www.ashs.com/role/LEASESNarrativeDetails">
        <link:definition>2429415 - Disclosure - LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails" roleURI="http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails">
        <link:definition>2430416 - Disclosure - LEASES - Summary of Maturities of Lessee Operating Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails_1" roleURI="http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails_1">
        <link:definition>2430416 - Disclosure - LEASES - Summary of Maturities of Lessee Operating Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.ashs.com/role/INCOMETAXES">
        <link:definition>2131108 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.ashs.com/role/INCOMETAXESTables">
        <link:definition>2332307 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://www.ashs.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>2433417 - Disclosure - INCOME TAXES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails" roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails">
        <link:definition>2434418 - Disclosure - INCOME TAXES - Schedule of Components of Income Tax Expense (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>2435419 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails" roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails">
        <link:definition>2436420 - Disclosure - INCOME TAXES - Schedule of Amounts Presented in Financial Statements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails">
        <link:definition>2437421 - Disclosure - INCOME TAXES - Schedule of Effective Income Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails" roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails">
        <link:definition>2438422 - Disclosure - INCOME TAXES - Schedule of Unrecognized Tax Benefits Roll Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONEXPENSE" roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSE">
        <link:definition>2139109 - Disclosure - STOCK-BASED COMPENSATION EXPENSE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONEXPENSETables" roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables">
        <link:definition>2340308 - Disclosure - STOCK-BASED COMPENSATION EXPENSE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails" roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails">
        <link:definition>2441423 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails" roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails">
        <link:definition>2442424 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails" roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails">
        <link:definition>2443425 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails" roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails">
        <link:definition>2444426 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Share-based Compensation, Stock Options, Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails" roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails">
        <link:definition>2445427 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Schedule of Nonvested Share Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails" roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails">
        <link:definition>2446428 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLAN" roleURI="http://www.ashs.com/role/RETIREMENTPLAN">
        <link:definition>2147110 - Disclosure - RETIREMENT PLAN</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANDetailsTextual" roleURI="http://www.ashs.com/role/RETIREMENTPLANDetailsTextual">
        <link:definition>2448429 - Disclosure - RETIREMENT PLAN (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATINGLEASES" roleURI="http://www.ashs.com/role/OPERATINGLEASES">
        <link:definition>2149111 - Disclosure - OPERATING LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATINGLEASESTables" roleURI="http://www.ashs.com/role/OPERATINGLEASESTables">
        <link:definition>2350309 - Disclosure - OPERATING LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATINGLEASESDetails" roleURI="http://www.ashs.com/role/OPERATINGLEASESDetails">
        <link:definition>2451430 - Disclosure - OPERATING LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATINGLEASESNarrativeDetails" roleURI="http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails">
        <link:definition>2452431 - Disclosure - OPERATING LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2153112 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESTables" roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESTables">
        <link:definition>2354310 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESNarrativeDetails" roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails">
        <link:definition>2455432 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails" roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails">
        <link:definition>2456433 - Disclosure - COMMITMENTS AND CONTINGENCIES - Schedule of Long-term Purchase Commitment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONS" roleURI="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONS">
        <link:definition>2157113 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONSDetailsTextual" roleURI="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual">
        <link:definition>2458434 - Disclosure - RELATED PARTY TRANSACTIONS (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ams_OffsettingTaxBenefit" abstract="false" name="OffsettingTaxBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_Or21LlcMember" abstract="true" name="Or21LlcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock" abstract="false" name="ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ams_NumberOfCustomersWithIntentToTerminateContract" abstract="false" name="NumberOfCustomersWithIntentToTerminateContract" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ams_CarryingValuesMember" abstract="true" name="CarryingValuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ams_DomesticMember" abstract="true" name="DomesticMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_OtherFixedAssetsMember" abstract="true" name="OtherFixedAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_AssetRetirementObligationNumberOfSites" abstract="false" name="AssetRetirementObligationNumberOfSites" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ams_NumberOfImpairedAssetUnits" abstract="false" name="NumberOfImpairedAssetUnits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ams_AssetAcquisitionAxis" abstract="true" name="AssetAcquisitionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ams_IncentiveCompensationPlanMember" abstract="true" name="IncentiveCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_AssetAcquisitionPercentageOfOutstandingShares" abstract="false" name="AssetAcquisitionPercentageOfOutstandingShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ams_NumberOfEmployees" abstract="false" name="NumberOfEmployees" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" abstract="false" name="ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ams_PaymentsForWorkingCapital" abstract="false" name="PaymentsForWorkingCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_AssetAcquisitionEmployeeCompensationAndBenefits" abstract="false" name="AssetAcquisitionEmployeeCompensationAndBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue" abstract="false" name="IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember" abstract="true" name="UnitsThatWillBeRemovedFromServiceInFutureYearsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_GammaKnifeCenterEcuadorSAGKCEMember" abstract="true" name="GammaKnifeCenterEcuadorSAGKCEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_NumberOfDebtInstruments" abstract="false" name="NumberOfDebtInstruments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ams_GkfSubsidiaryMember" abstract="true" name="GkfSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_AssetAcquisitionConsiderationTransferred" abstract="false" name="AssetAcquisitionConsiderationTransferred" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_AssetAcquisitionLiabilitiesAssumed" abstract="false" name="AssetAcquisitionLiabilitiesAssumed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_GammaKnifePerfexionSystemMember" abstract="true" name="GammaKnifePerfexionSystemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_BalanceSheetParentheticalAbstract" abstract="true" name="BalanceSheetParentheticalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ams_PurchaseAgreementAnnualPrepayment" abstract="false" name="PurchaseAgreementAnnualPrepayment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember" abstract="true" name="DepositsTowardsPurchaseOfProtonBeamSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_LongTermPurchaseCommitmentRenewalTerm" abstract="false" name="LongTermPurchaseCommitmentRenewalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ams_FinanceLeaseObligations" abstract="false" name="FinanceLeaseObligations" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_EquipmentServiceContractsMember" abstract="true" name="EquipmentServiceContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_AssetAcquisitionAccountsPayable" abstract="false" name="AssetAcquisitionAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_PerformanceShareAwardAgreementMember" abstract="true" name="PerformanceShareAwardAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_GammaKnifeUnitMember" abstract="true" name="GammaKnifeUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_LongTermDebtMonthlyInstallments" abstract="false" name="LongTermDebtMonthlyInstallments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ams_RepaymentsOfLongTermFinanceLeaseObligations" abstract="false" name="RepaymentsOfLongTermFinanceLeaseObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_AssetRetirementObligationsPolicyPolicyTextBlock" abstract="false" name="AssetRetirementObligationsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ams_LeaseExpirationPeriod" abstract="false" name="LeaseExpirationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ams_PeruDeferredTaxAssetsMember" abstract="true" name="PeruDeferredTaxAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_NumberOfLeksellGammaKnifeIconSystemInstalls" abstract="false" name="NumberOfLeksellGammaKnifeIconSystemInstalls" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ams_ExecutiveCompensationMember" abstract="true" name="ExecutiveCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_GammaKnifeAndRadiationTherapyMember" abstract="true" name="GammaKnifeAndRadiationTherapyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_NonEmployeeDirectorsAndCorporateSecretaryMember" abstract="true" name="NonEmployeeDirectorsAndCorporateSecretaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_OperatingLeasesMember" abstract="true" name="OperatingLeasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_FinanceLeaseObligationInterestRate" abstract="false" name="FinanceLeaseObligationInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ams_LongTermServiceCommitmentPeriod" abstract="false" name="LongTermServiceCommitmentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ams_NumberOfPerfexionUpgrades" abstract="false" name="NumberOfPerfexionUpgrades" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ams_PaymentsToAcquireAsset" abstract="false" name="PaymentsToAcquireAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_CustomerOneMember" abstract="true" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_LongTermPurchaseCommitmentDepositsForAssets" abstract="false" name="LongTermPurchaseCommitmentDepositsForAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements" abstract="false" name="IncreaseDecreaseInOtherReceivableInsuranceSettlements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_NetIncomeLossMember" abstract="true" name="NetIncomeLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_EmployeeMember" abstract="true" name="EmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_ArchitecturalDesignCompanyMember" abstract="true" name="ArchitecturalDesignCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_AssetRetirementObligationNumberOfRemovedAssetUnits" abstract="false" name="AssetRetirementObligationNumberOfRemovedAssetUnits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ams_FinanceLeasesMember" abstract="true" name="FinanceLeasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_DocumentAndEntityInformationAbstract" abstract="true" name="DocumentAndEntityInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ams_NumberOfPurchaseCommitments" abstract="false" name="NumberOfPurchaseCommitments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ams_NoncontrollingInterestsPolicyTextBlock" abstract="false" name="NoncontrollingInterestsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ams_IncreaseDecreaseInLeaseLiabilities" abstract="false" name="IncreaseDecreaseInLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_InterestCapitalizedToPropertyAndEquipment" abstract="false" name="InterestCapitalizedToPropertyAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_MedicalEquipmentMember" abstract="true" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_FinanceLeaseAccountsReceivable" abstract="false" name="FinanceLeaseAccountsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_SeniorVicePresidentMember" abstract="true" name="SeniorVicePresidentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_ProtonBeamRadiationTherapyPBRTMember" abstract="true" name="ProtonBeamRadiationTherapyPBRTMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember" abstract="true" name="TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_GKCEAcquisitionMember" abstract="true" name="GKCEAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ams_AssetAcquisitionPrepaidExpenseAndOther" abstract="false" name="AssetAcquisitionPrepaidExpenseAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_AssetAcquisitionDeferredIncomeTaxes" abstract="false" name="AssetAcquisitionDeferredIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ams_MevionMedicalSystemsIncMember" abstract="true" name="MevionMedicalSystemsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_CustomerFourMember" abstract="true" name="CustomerFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_WorkingCapitalPaymentLiabilityCurrent" abstract="false" name="WorkingCapitalPaymentLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_AssetAcquisitionIncomeTaxesPayable" abstract="false" name="AssetAcquisitionIncomeTaxesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_RetainerFeesMember" abstract="true" name="RetainerFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_MedicalEquipmentAndFacilitiesMember" abstract="true" name="MedicalEquipmentAndFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_AssetAcquisitionPercentageOfSharesAcquired" abstract="false" name="AssetAcquisitionPercentageOfSharesAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ams_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ams_AcquisitionOfInsuranceWithShortTermFinancing" abstract="false" name="AcquisitionOfInsuranceWithShortTermFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_PercentageOfTaxBenefitRealizedUponSettlement" abstract="false" name="PercentageOfTaxBenefitRealizedUponSettlement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ams_ExecutiveEquityAwardsMember" abstract="true" name="ExecutiveEquityAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_ProceedsFromFinancingFromAcquisition" abstract="false" name="ProceedsFromFinancingFromAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_CustomerTwoMember" abstract="true" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_ForeignMember" abstract="true" name="ForeignMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_OperatingLeaseMonthlyLeaseExpense" abstract="false" name="OperatingLeaseMonthlyLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition" abstract="false" name="SubsequentWorkingCapitalPaymentAccruedForAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_UsSubsidiaryOfElektaMember" abstract="true" name="UsSubsidiaryOfElektaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities" abstract="false" name="LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_NumberOfFinancingLeases" abstract="false" name="NumberOfFinancingLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ams_BusinessAndCreditRiskPolicyTextBlock" abstract="false" name="BusinessAndCreditRiskPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" abstract="false" name="AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_AcquisitionWorkingCapitalPaymentsMember" abstract="true" name="AcquisitionWorkingCapitalPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_AssetAcquisitionAdditionalConsiderationTransferred" abstract="false" name="AssetAcquisitionAdditionalConsiderationTransferred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_AssetAcquisitionTransactionCosts" abstract="false" name="AssetAcquisitionTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_PaymentsForAssetAcquisitions" abstract="false" name="PaymentsForAssetAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_RSUsIssuedInLieuOfRetainerFeesMember" abstract="true" name="RSUsIssuedInLieuOfRetainerFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_UnitsRemovedFromServiceInCurrentYearMember" abstract="true" name="UnitsRemovedFromServiceInCurrentYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_InterestExpenseLeaseFinancing" abstract="false" name="InterestExpenseLeaseFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_IncomeTaxDisclosureTable" abstract="true" name="IncomeTaxDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ams_AssetAcquisitionAccountsReceivable" abstract="false" name="AssetAcquisitionAccountsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_AssetAcquisitionAssetsAcquired" abstract="false" name="AssetAcquisitionAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_LongTermServiceCommitmentAmount" abstract="false" name="LongTermServiceCommitmentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_NonCashLeaseExpense" abstract="false" name="NonCashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_NumberOfDeposits" abstract="false" name="NumberOfDeposits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ams_AccountingPoliciesTable" abstract="true" name="AccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ams_AccountingPoliciesLineItems" abstract="true" name="AccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ams_AcquisitionOfEquipmentWithLongTermDebtFinancing" abstract="false" name="AcquisitionOfEquipmentWithLongTermDebtFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ams_AssetAcquisitionCashAndCashEquivalents" abstract="false" name="AssetAcquisitionCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_FinanceLeaseObligationsMonthlyInstallments" abstract="false" name="FinanceLeaseObligationsMonthlyInstallments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ams_StockOptionExercisePrice" abstract="false" name="StockOptionExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="ams_AssetAcquisitionPercentageOfSharesRemaining" abstract="false" name="AssetAcquisitionPercentageOfSharesRemaining" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ams_IncomeTaxDisclosureLineItems" abstract="true" name="IncomeTaxDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ams_NonEmployeeDirectorsMember" abstract="true" name="NonEmployeeDirectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" abstract="false" name="ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_UnitsRemovedFromServiceInPriorYearsMember" abstract="true" name="UnitsRemovedFromServiceInPriorYearsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_NonCashRightOfUseAssetsAndLeaseLiabilities" abstract="false" name="NonCashRightOfUseAssetsAndLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_AssetAcquisitionTotalConsiderationTransferred" abstract="false" name="AssetAcquisitionTotalConsiderationTransferred" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ams_MedicalEquipmentAndOtherFixedAssetsMember" abstract="true" name="MedicalEquipmentAndOtherFixedAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_NumberOfCobalt60Reloads" abstract="false" name="NumberOfCobalt60Reloads" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ams_AnnualRSUAwardsMember" abstract="true" name="AnnualRSUAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_CustomerThreeMember" abstract="true" name="CustomerThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember" abstract="true" name="MaintenanceAndSupportAgreementTheMevionServiceAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_AssetAcquisitionDomain" abstract="true" name="AssetAcquisitionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ams_LINACSystemMember" abstract="true" name="LINACSystemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>ams-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4e6f91f2-1bf1-41c4-8e53-76168a3ee138,g:df8d0904-ed6f-4833-8eea-c587ca49bdb5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ashs.com/role/CoverPage" xlink:type="simple" xlink:href="ams-20201231.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ams-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_972c3928-12b2-42c4-8fe9-9649ddf4ac72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_750fd266-349f-4702-a61c-d690a1694fe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_972c3928-12b2-42c4-8fe9-9649ddf4ac72" xlink:to="loc_us-gaap_AccountsPayableCurrent_750fd266-349f-4702-a61c-d690a1694fe7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_36681f7b-937b-4544-9e33-40b004ceabe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_972c3928-12b2-42c4-8fe9-9649ddf4ac72" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_36681f7b-937b-4544-9e33-40b004ceabe1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5ac933f4-e182-4bb9-9a6a-c0fe660803d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_972c3928-12b2-42c4-8fe9-9649ddf4ac72" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5ac933f4-e182-4bb9-9a6a-c0fe660803d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_0f1dbfbc-9a03-4aa9-8572-638af6e7ed86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_972c3928-12b2-42c4-8fe9-9649ddf4ac72" xlink:to="loc_us-gaap_LongTermDebtCurrent_0f1dbfbc-9a03-4aa9-8572-638af6e7ed86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_ae899cdc-4d11-4bc7-9714-6cd76353ac19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_972c3928-12b2-42c4-8fe9-9649ddf4ac72" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_ae899cdc-4d11-4bc7-9714-6cd76353ac19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_WorkingCapitalPaymentLiabilityCurrent_87c4f0e6-6029-49d7-b2c9-b2770e5b7656" xlink:href="ams-20201231.xsd#ams_WorkingCapitalPaymentLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_972c3928-12b2-42c4-8fe9-9649ddf4ac72" xlink:to="loc_ams_WorkingCapitalPaymentLiabilityCurrent_87c4f0e6-6029-49d7-b2c9-b2770e5b7656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0e57310f-be41-4ce5-ada3-96a2b8c976c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_972c3928-12b2-42c4-8fe9-9649ddf4ac72" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0e57310f-be41-4ce5-ada3-96a2b8c976c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationCurrent_e8cb6538-aea4-4096-b079-843c5fbe7b71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_972c3928-12b2-42c4-8fe9-9649ddf4ac72" xlink:to="loc_us-gaap_AssetRetirementObligationCurrent_e8cb6538-aea4-4096-b079-843c5fbe7b71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1fe58e9b-1063-469c-8b4b-6fc356f235a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_972c3928-12b2-42c4-8fe9-9649ddf4ac72" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_1fe58e9b-1063-469c-8b4b-6fc356f235a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_14158eae-16c6-4bd9-ae12-93a82802d9c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_74ed2cf2-d2fc-4a36-81f1-dfdc50eae219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_14158eae-16c6-4bd9-ae12-93a82802d9c7" xlink:to="loc_us-gaap_StockholdersEquity_74ed2cf2-d2fc-4a36-81f1-dfdc50eae219" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e8ee72b7-372c-4505-8c2e-f13958933c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_14158eae-16c6-4bd9-ae12-93a82802d9c7" xlink:to="loc_us-gaap_MinorityInterest_e8ee72b7-372c-4505-8c2e-f13958933c6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_24f39045-9a5c-4cbd-8c4e-e9f9d180d7a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0e83cef6-7581-49bf-b906-ab001d75b1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_24f39045-9a5c-4cbd-8c4e-e9f9d180d7a6" xlink:to="loc_us-gaap_CommonStockValue_0e83cef6-7581-49bf-b906-ab001d75b1fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_dd1027d4-9959-4a0d-89ad-ff12208d7901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_24f39045-9a5c-4cbd-8c4e-e9f9d180d7a6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_dd1027d4-9959-4a0d-89ad-ff12208d7901" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5698630e-2554-4c78-b8aa-1e8d42ed61d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_24f39045-9a5c-4cbd-8c4e-e9f9d180d7a6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5698630e-2554-4c78-b8aa-1e8d42ed61d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e6fde21b-7078-471f-9474-4d6e3393b799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_5a8f7afe-6d1b-4c81-aeee-df7a3cfae834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e6fde21b-7078-471f-9474-4d6e3393b799" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_5a8f7afe-6d1b-4c81-aeee-df7a3cfae834" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_46cb34f5-4f15-4574-8c27-32c6b49c84f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e6fde21b-7078-471f-9474-4d6e3393b799" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_46cb34f5-4f15-4574-8c27-32c6b49c84f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3fad7607-3a42-4d53-bc15-0966fda4c20d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e6fde21b-7078-471f-9474-4d6e3393b799" xlink:to="loc_us-gaap_AssetsCurrent_3fad7607-3a42-4d53-bc15-0966fda4c20d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_59a7bf2f-db5b-4e63-9f01-a3380221848c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e6fde21b-7078-471f-9474-4d6e3393b799" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_59a7bf2f-db5b-4e63-9f01-a3380221848c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_1b7dc20d-4e38-4b58-a5d6-786f30a8138f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e6fde21b-7078-471f-9474-4d6e3393b799" xlink:to="loc_us-gaap_Land_1b7dc20d-4e38-4b58-a5d6-786f30a8138f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7964dff9-6d99-43a4-ba38-d7d2a951bd11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e6fde21b-7078-471f-9474-4d6e3393b799" xlink:to="loc_us-gaap_Goodwill_7964dff9-6d99-43a4-ba38-d7d2a951bd11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_97b6a36e-bed4-419f-83fd-8f386dbd78ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e6fde21b-7078-471f-9474-4d6e3393b799" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_97b6a36e-bed4-419f-83fd-8f386dbd78ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bf824ace-3ce6-4016-956e-2e8f5e31abf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_75f7270e-9e54-4c1f-89e4-f8c2ad8b3a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bf824ace-3ce6-4016-956e-2e8f5e31abf4" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_75f7270e-9e54-4c1f-89e4-f8c2ad8b3a86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3f51017a-a0e2-4ff0-ae54-8903fb2d2d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bf824ace-3ce6-4016-956e-2e8f5e31abf4" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3f51017a-a0e2-4ff0-ae54-8903fb2d2d96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8fe3a975-d3d3-41e1-9640-10e2845e742b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bf824ace-3ce6-4016-956e-2e8f5e31abf4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8fe3a975-d3d3-41e1-9640-10e2845e742b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_15652de8-650e-4591-a753-b41457882431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bf824ace-3ce6-4016-956e-2e8f5e31abf4" xlink:to="loc_us-gaap_LiabilitiesCurrent_15652de8-650e-4591-a753-b41457882431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a0eb6ada-a5fa-4f46-bf99-4313e89f2cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bf824ace-3ce6-4016-956e-2e8f5e31abf4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a0eb6ada-a5fa-4f46-bf99-4313e89f2cab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8e11f1d9-43a1-4839-954e-c9825980ca28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bf824ace-3ce6-4016-956e-2e8f5e31abf4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8e11f1d9-43a1-4839-954e-c9825980ca28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bde98925-3c03-48d4-a7aa-9f4ea4d523d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bf824ace-3ce6-4016-956e-2e8f5e31abf4" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bde98925-3c03-48d4-a7aa-9f4ea4d523d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5e8889c3-d769-4db4-8e8a-b204adcfb4bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bf824ace-3ce6-4016-956e-2e8f5e31abf4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5e8889c3-d769-4db4-8e8a-b204adcfb4bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_16e93075-efbb-486e-aa53-3cb12dc74645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_557a82de-a574-471b-86bc-f4d1a77c27b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_16e93075-efbb-486e-aa53-3cb12dc74645" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_557a82de-a574-471b-86bc-f4d1a77c27b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_c4fb218c-0689-4419-ae67-50aeb600786d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_16e93075-efbb-486e-aa53-3cb12dc74645" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_c4fb218c-0689-4419-ae67-50aeb600786d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4c092b6e-20ea-4856-bc0b-51feb68c1684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_16e93075-efbb-486e-aa53-3cb12dc74645" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4c092b6e-20ea-4856-bc0b-51feb68c1684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_83584364-52ae-48f5-8df6-4640dab0ff22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_16e93075-efbb-486e-aa53-3cb12dc74645" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_83584364-52ae-48f5-8df6-4640dab0ff22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_97bcfe48-42d4-4d9b-91c0-c2d25a54b9a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_16e93075-efbb-486e-aa53-3cb12dc74645" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_97bcfe48-42d4-4d9b-91c0-c2d25a54b9a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ams-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ams-20201231.xsd#STATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/STATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c33e71c8-4cf8-489c-a693-46ea215192b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_71a38bd3-2370-4b3b-a378-63a94bd7f585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c33e71c8-4cf8-489c-a693-46ea215192b6" xlink:to="loc_us-gaap_OperatingIncomeLoss_71a38bd3-2370-4b3b-a378-63a94bd7f585" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_77fc9f37-a10d-492c-8563-fd627b30666f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c33e71c8-4cf8-489c-a693-46ea215192b6" xlink:to="loc_us-gaap_InterestAndOtherIncome_77fc9f37-a10d-492c-8563-fd627b30666f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4431cbff-d936-43d8-a905-a9597c00081a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7cb4d7b1-8a5b-4b1a-acd0-6f941a39c7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4431cbff-d936-43d8-a905-a9597c00081a" xlink:to="loc_us-gaap_CostsAndExpenses_7cb4d7b1-8a5b-4b1a-acd0-6f941a39c7fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b5868bde-f894-48a2-a487-d2c07f6d0048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4431cbff-d936-43d8-a905-a9597c00081a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b5868bde-f894-48a2-a487-d2c07f6d0048" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0b90b479-f332-48cc-b238-27498ea41119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f7364762-09b3-420e-9b8d-5f956d53bf0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0b90b479-f332-48cc-b238-27498ea41119" xlink:to="loc_us-gaap_GrossProfit_f7364762-09b3-420e-9b8d-5f956d53bf0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_bb01e99b-fb97-432b-ab55-57bcad8c177e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0b90b479-f332-48cc-b238-27498ea41119" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_bb01e99b-fb97-432b-ab55-57bcad8c177e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3fdba6ca-aeec-408b-a05f-9a1314ee4834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0b90b479-f332-48cc-b238-27498ea41119" xlink:to="loc_us-gaap_InterestExpense_3fdba6ca-aeec-408b-a05f-9a1314ee4834" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_bc428fb6-a4ca-4d83-a84e-912988d1a658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0b90b479-f332-48cc-b238-27498ea41119" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_bc428fb6-a4ca-4d83-a84e-912988d1a658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_14b33d3f-7073-4118-8771-5d9043f68d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d584b957-d88c-4a28-8404-8d2f7b278188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_14b33d3f-7073-4118-8771-5d9043f68d02" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d584b957-d88c-4a28-8404-8d2f7b278188" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_678e0a0c-fbc7-485f-8c29-f5cbc39a4a10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_14b33d3f-7073-4118-8771-5d9043f68d02" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_678e0a0c-fbc7-485f-8c29-f5cbc39a4a10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8e15e50a-6563-4653-bc59-aac39d432bd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_00039c42-a5dd-4749-9938-9de0a4f56721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8e15e50a-6563-4653-bc59-aac39d432bd0" xlink:to="loc_us-gaap_ProfitLoss_00039c42-a5dd-4749-9938-9de0a4f56721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b37b8e05-5a77-41c8-8619-f0cf4da213de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8e15e50a-6563-4653-bc59-aac39d432bd0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b37b8e05-5a77-41c8-8619-f0cf4da213de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_049e937f-fcdc-4afe-af1a-35f04acc2569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectOperatingMaintenanceSuppliesCosts_37bea50d-5bc5-45ef-9a8a-d9c995d12f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DirectOperatingMaintenanceSuppliesCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_049e937f-fcdc-4afe-af1a-35f04acc2569" xlink:to="loc_us-gaap_DirectOperatingMaintenanceSuppliesCosts_37bea50d-5bc5-45ef-9a8a-d9c995d12f0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_6444cee7-ec29-4a43-94e8-9e0a922c9107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_049e937f-fcdc-4afe-af1a-35f04acc2569" xlink:to="loc_us-gaap_DepreciationAndAmortization_6444cee7-ec29-4a43-94e8-9e0a922c9107" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostOfOperatingRevenue_3b4baa41-8b84-4772-b368-ce2a44165f02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_049e937f-fcdc-4afe-af1a-35f04acc2569" xlink:to="loc_us-gaap_OtherCostOfOperatingRevenue_3b4baa41-8b84-4772-b368-ce2a44165f02" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="ams-20201231.xsd#CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ams-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4ef6d2a5-392a-4d0e-a165-116f63dfeeb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0f3194ed-a212-46c1-80bd-c11a2f612ee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4ef6d2a5-392a-4d0e-a165-116f63dfeeb5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0f3194ed-a212-46c1-80bd-c11a2f612ee4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19a0ca03-47f0-47e8-8fd9-dcf12b61cc7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4ef6d2a5-392a-4d0e-a165-116f63dfeeb5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19a0ca03-47f0-47e8-8fd9-dcf12b61cc7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a4d68095-17ec-4d34-9711-341e04dddd64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4ef6d2a5-392a-4d0e-a165-116f63dfeeb5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a4d68095-17ec-4d34-9711-341e04dddd64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_65279cec-1144-48eb-8f23-e5b80623ba51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f410a5be-c5d9-48fc-81c3-59e00c65d0e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_65279cec-1144-48eb-8f23-e5b80623ba51" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f410a5be-c5d9-48fc-81c3-59e00c65d0e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_89897345-affc-4dcc-b812-223b22a505ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_65279cec-1144-48eb-8f23-e5b80623ba51" xlink:to="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_89897345-affc-4dcc-b812-223b22a505ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1d33cb81-f556-47b4-bd03-c3072137fc1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_65279cec-1144-48eb-8f23-e5b80623ba51" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1d33cb81-f556-47b4-bd03-c3072137fc1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_db3e6c8e-02a0-40b2-9365-8fa580f7e382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_480dc6c4-321a-41c7-a1c5-d2b5095c0b07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_db3e6c8e-02a0-40b2-9365-8fa580f7e382" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_480dc6c4-321a-41c7-a1c5-d2b5095c0b07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_0474e220-a923-4e0a-a96e-b9f7cee4d3e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_db3e6c8e-02a0-40b2-9365-8fa580f7e382" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_0474e220-a923-4e0a-a96e-b9f7cee4d3e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_35484031-7d8f-4cd8-bbc6-089a5f7caa5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_db3e6c8e-02a0-40b2-9365-8fa580f7e382" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_35484031-7d8f-4cd8-bbc6-089a5f7caa5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermCapitalLeaseObligations_65530803-1a17-40aa-beb1-b25c89ef833b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermCapitalLeaseObligations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_db3e6c8e-02a0-40b2-9365-8fa580f7e382" xlink:to="loc_us-gaap_ProceedsFromLongTermCapitalLeaseObligations_65530803-1a17-40aa-beb1-b25c89ef833b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_RepaymentsOfLongTermFinanceLeaseObligations_e8bbfa8c-c7af-423e-aa77-fe3cc8d233d0" xlink:href="ams-20201231.xsd#ams_RepaymentsOfLongTermFinanceLeaseObligations"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_db3e6c8e-02a0-40b2-9365-8fa580f7e382" xlink:to="loc_ams_RepaymentsOfLongTermFinanceLeaseObligations_e8bbfa8c-c7af-423e-aa77-fe3cc8d233d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ProceedsFromFinancingFromAcquisition_de1005f0-7dfc-438d-b4cd-1cbc517209b9" xlink:href="ams-20201231.xsd#ams_ProceedsFromFinancingFromAcquisition"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_db3e6c8e-02a0-40b2-9365-8fa580f7e382" xlink:to="loc_ams_ProceedsFromFinancingFromAcquisition_de1005f0-7dfc-438d-b4cd-1cbc517209b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2c677095-4e4f-422f-822a-a7411a77a56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_db3e6c8e-02a0-40b2-9365-8fa580f7e382" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2c677095-4e4f-422f-822a-a7411a77a56e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_35c5a84d-7da2-46f9-8dfd-f64b1f7a8c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_us-gaap_ProfitLoss_35c5a84d-7da2-46f9-8dfd-f64b1f7a8c91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_70320bb6-3810-4860-92a0-5ba238445753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_70320bb6-3810-4860-92a0-5ba238445753" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5b82d01b-4757-4738-b4bb-b6c4dd7e86ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5b82d01b-4757-4738-b4bb-b6c4dd7e86ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4e80f48f-fb76-437c-a9a3-6f210c701cfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_us-gaap_ShareBasedCompensation_4e80f48f-fb76-437c-a9a3-6f210c701cfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3ad7be98-3dbd-4ce1-9756-44d081adfc6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3ad7be98-3dbd-4ce1-9756-44d081adfc6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fac60588-81f8-439d-9ecf-d5903d0898e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fac60588-81f8-439d-9ecf-d5903d0898e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue_5afe496a-dcc2-4abb-a35f-e960b739dfe8" xlink:href="ams-20201231.xsd#ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue_5afe496a-dcc2-4abb-a35f-e960b739dfe8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements_87252fff-5691-4e36-b1cf-402b0f18d036" xlink:href="ams-20201231.xsd#ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements_87252fff-5691-4e36-b1cf-402b0f18d036" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncreaseDecreaseInLeaseLiabilities_32e8683b-5027-45e5-9ffc-d1541693683e" xlink:href="ams-20201231.xsd#ams_IncreaseDecreaseInLeaseLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_ams_IncreaseDecreaseInLeaseLiabilities_32e8683b-5027-45e5-9ffc-d1541693683e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_0b43b260-9b7a-4993-b326-6a894c6d0469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_0b43b260-9b7a-4993-b326-6a894c6d0469" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonCashLeaseExpense_4479c399-59df-41d7-aa0b-86515d8e8a34" xlink:href="ams-20201231.xsd#ams_NonCashLeaseExpense"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_ams_NonCashLeaseExpense_4479c399-59df-41d7-aa0b-86515d8e8a34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_c0f48b27-4e67-4c29-bf11-a0b090c50349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_c0f48b27-4e67-4c29-bf11-a0b090c50349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_3f6772e4-2f16-46bc-8279-ebb9a9fe7257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_us-gaap_AssetImpairmentCharges_3f6772e4-2f16-46bc-8279-ebb9a9fe7257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_InterestExpenseLeaseFinancing_2b95c1d7-ec74-4bdc-b266-b75e4683052e" xlink:href="ams-20201231.xsd#ams_InterestExpenseLeaseFinancing"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_304bdb1c-b965-4fa0-a7ba-46eeaea434bf" xlink:to="loc_ams_InterestExpenseLeaseFinancing_2b95c1d7-ec74-4bdc-b266-b75e4683052e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="ams-20201231.xsd#BUSINESSANDBASISOFPRESENTATION"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#BUSINESSANDBASISOFPRESENTATIONNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESTables"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESScheduleofFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_82c70aef-5de9-4862-aba2-6080efc3d715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_290eb8ec-cda2-4c2b-8e76-28f30141b565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_82c70aef-5de9-4862-aba2-6080efc3d715" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_290eb8ec-cda2-4c2b-8e76-28f30141b565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_233bfd2d-b711-497b-bc16-d29209d8220a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_5fcb3eed-558c-4af7-a5db-83e99108ccdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_233bfd2d-b711-497b-bc16-d29209d8220a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_5fcb3eed-558c-4af7-a5db-83e99108ccdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0567e06f-1cf7-4244-a927-21e08cc5a0bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_10de99f9-a182-4baa-8502-29172dab80bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0567e06f-1cf7-4244-a927-21e08cc5a0bd" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_10de99f9-a182-4baa-8502-29172dab80bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_72cd68cb-060d-430d-af85-d945a01d88d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0d9bffa8-c7df-4f8a-890f-e788fbd3bd5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_72cd68cb-060d-430d-af85-d945a01d88d8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0d9bffa8-c7df-4f8a-890f-e788fbd3bd5c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESScheduleofEPSDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c9a37921-8bf5-455b-adde-53d49ade1748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_cc6885fb-c373-4636-b95d-0f59e89ca2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c9a37921-8bf5-455b-adde-53d49ade1748" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_cc6885fb-c373-4636-b95d-0f59e89ca2cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_355b118e-1545-447d-8abb-82d45fa03069" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c9a37921-8bf5-455b-adde-53d49ade1748" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_355b118e-1545-447d-8abb-82d45fa03069" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="ams-20201231.xsd#PROPERTYANDEQUIPMENT"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/PROPERTYANDEQUIPMENT" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="ams-20201231.xsd#PROPERTYANDEQUIPMENTTables"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_ba840486-b571-4584-9269-01e74bc19878" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_08c1cf50-dead-45fe-aef3-360977559626" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_ba840486-b571-4584-9269-01e74bc19878" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_08c1cf50-dead-45fe-aef3-360977559626" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_97de1023-b890-4798-bb79-2188d524eea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_ba840486-b571-4584-9269-01e74bc19878" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_97de1023-b890-4798-bb79-2188d524eea0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#PROPERTYANDEQUIPMENTNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITION" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITION"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/GKCEACQUISITION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITIONTables" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITIONTables"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/GKCEACQUISITIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITIONNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionConsiderationTransferred_5bbb1714-a5e4-44bb-9423-3ceaec88f037" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionConsiderationTransferred"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAdditionalConsiderationTransferred_ab080f17-fecc-4a01-a0c3-33a15f2962cd" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAdditionalConsiderationTransferred"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionConsiderationTransferred_5bbb1714-a5e4-44bb-9423-3ceaec88f037" xlink:to="loc_ams_AssetAcquisitionAdditionalConsiderationTransferred_ab080f17-fecc-4a01-a0c3-33a15f2962cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsForWorkingCapital_8a9765c2-41a7-4773-bb96-ec1f952fae6c" xlink:href="ams-20201231.xsd#ams_PaymentsForWorkingCapital"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionConsiderationTransferred_5bbb1714-a5e4-44bb-9423-3ceaec88f037" xlink:to="loc_ams_PaymentsForWorkingCapital_8a9765c2-41a7-4773-bb96-ec1f952fae6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionTotalConsiderationTransferred_2a49dd38-44a4-4055-8159-dd2053f9bcde" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionTotalConsiderationTransferred"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionConsiderationTransferred_5bbb1714-a5e4-44bb-9423-3ceaec88f037" xlink:to="loc_ams_AssetAcquisitionTotalConsiderationTransferred_2a49dd38-44a4-4055-8159-dd2053f9bcde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionLiabilitiesAssumed_cf2a7cac-633f-4547-bcdc-0884478b8b2a" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionLiabilitiesAssumed"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionIncomeTaxesPayable_05aa0b53-9295-414e-a175-00b998e4820d" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionIncomeTaxesPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionLiabilitiesAssumed_cf2a7cac-633f-4547-bcdc-0884478b8b2a" xlink:to="loc_ams_AssetAcquisitionIncomeTaxesPayable_05aa0b53-9295-414e-a175-00b998e4820d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAccountsPayable_0a060996-1451-4791-b4dc-d71c581471a7" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAccountsPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionLiabilitiesAssumed_cf2a7cac-633f-4547-bcdc-0884478b8b2a" xlink:to="loc_ams_AssetAcquisitionAccountsPayable_0a060996-1451-4791-b4dc-d71c581471a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDeferredIncomeTaxes_a196d86b-6c88-4262-82ac-28419d079080" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDeferredIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionLiabilitiesAssumed_cf2a7cac-633f-4547-bcdc-0884478b8b2a" xlink:to="loc_ams_AssetAcquisitionDeferredIncomeTaxes_a196d86b-6c88-4262-82ac-28419d079080" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionEmployeeCompensationAndBenefits_4e7c73ab-8ee7-46b9-8d35-65a816bedb9c" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionEmployeeCompensationAndBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionLiabilitiesAssumed_cf2a7cac-633f-4547-bcdc-0884478b8b2a" xlink:to="loc_ams_AssetAcquisitionEmployeeCompensationAndBenefits_4e7c73ab-8ee7-46b9-8d35-65a816bedb9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionTotalConsiderationTransferred_08525323-f060-4664-9049-cf8f62feac06" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionTotalConsiderationTransferred"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAssetsAcquired_52a9ad12-212a-47f2-8a7e-058eca96fa5c" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionTotalConsiderationTransferred_08525323-f060-4664-9049-cf8f62feac06" xlink:to="loc_ams_AssetAcquisitionAssetsAcquired_52a9ad12-212a-47f2-8a7e-058eca96fa5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionLiabilitiesAssumed_c19ff85d-5e59-4a7b-bd1d-a64380c96ff8" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionLiabilitiesAssumed"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionTotalConsiderationTransferred_08525323-f060-4664-9049-cf8f62feac06" xlink:to="loc_ams_AssetAcquisitionLiabilitiesAssumed_c19ff85d-5e59-4a7b-bd1d-a64380c96ff8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAssetsAcquired_70db4759-05b0-4ee7-8d06-ffb6513edd0d" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_0d3d532f-5f3e-477c-b20a-c6450020a98e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionAssetsAcquired_70db4759-05b0-4ee7-8d06-ffb6513edd0d" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_0d3d532f-5f3e-477c-b20a-c6450020a98e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_d443ce1c-8aff-47ab-b352-a08603022e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionAssetsAcquired_70db4759-05b0-4ee7-8d06-ffb6513edd0d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_d443ce1c-8aff-47ab-b352-a08603022e4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_8d100d5c-3f56-4e37-a88c-406da457022d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionAssetsAcquired_70db4759-05b0-4ee7-8d06-ffb6513edd0d" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_8d100d5c-3f56-4e37-a88c-406da457022d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAccountsReceivable_054544d7-433d-4412-b7be-675fc21f5de1" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAccountsReceivable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionAssetsAcquired_70db4759-05b0-4ee7-8d06-ffb6513edd0d" xlink:to="loc_ams_AssetAcquisitionAccountsReceivable_054544d7-433d-4412-b7be-675fc21f5de1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPrepaidExpenseAndOther_211259fb-9955-42b2-b305-015c268f95bc" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPrepaidExpenseAndOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionAssetsAcquired_70db4759-05b0-4ee7-8d06-ffb6513edd0d" xlink:to="loc_ams_AssetAcquisitionPrepaidExpenseAndOther_211259fb-9955-42b2-b305-015c268f95bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionCashAndCashEquivalents_0e80a72f-185e-4b3c-90ff-c356fc8af7ee" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionCashAndCashEquivalents"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_AssetAcquisitionAssetsAcquired_70db4759-05b0-4ee7-8d06-ffb6513edd0d" xlink:to="loc_ams_AssetAcquisitionCashAndCashEquivalents_0e80a72f-185e-4b3c-90ff-c356fc8af7ee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LONGTERMDEBT" xlink:type="simple" xlink:href="ams-20201231.xsd#LONGTERMDEBT"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/LONGTERMDEBT" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LONGTERMDEBTTables" xlink:type="simple" xlink:href="ams-20201231.xsd#LONGTERMDEBTTables"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/LONGTERMDEBTTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#LONGTERMDEBTNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LONGTERMDEBTDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#LONGTERMDEBTDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/LONGTERMDEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f39c8efc-aedd-4348-a58b-c35a0d3d2f7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f97020dd-9a3f-4ca3-b0b3-76b44b8f7fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f39c8efc-aedd-4348-a58b-c35a0d3d2f7d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f97020dd-9a3f-4ca3-b0b3-76b44b8f7fdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_e465b949-8132-44a7-807d-c3b3963cecf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f39c8efc-aedd-4348-a58b-c35a0d3d2f7d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_e465b949-8132-44a7-807d-c3b3963cecf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2428685d-889b-4262-9cc8-78e036ff6a19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f39c8efc-aedd-4348-a58b-c35a0d3d2f7d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2428685d-889b-4262-9cc8-78e036ff6a19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_3f5b212b-9d03-44e4-8ed6-d7bb6f9f5287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f39c8efc-aedd-4348-a58b-c35a0d3d2f7d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_3f5b212b-9d03-44e4-8ed6-d7bb6f9f5287" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_836e76db-500b-4b23-9eb5-06c1b918afcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f39c8efc-aedd-4348-a58b-c35a0d3d2f7d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_836e76db-500b-4b23-9eb5-06c1b918afcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_480447ea-f34b-461d-af32-ccded03de3fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f39c8efc-aedd-4348-a58b-c35a0d3d2f7d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_480447ea-f34b-461d-af32-ccded03de3fb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASES" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASES"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/FINANCELEASES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASESTables"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/FINANCELEASESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/FINANCELEASESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASESDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASESDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/FINANCELEASESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_0b1a441b-907d-424e-95f0-98bd82876f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f26af53e-4b74-440c-96ed-af734a0cf33d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_0b1a441b-907d-424e-95f0-98bd82876f6f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f26af53e-4b74-440c-96ed-af734a0cf33d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_75f28896-b110-4362-b5c7-d5c19180a20f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_0b1a441b-907d-424e-95f0-98bd82876f6f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_75f28896-b110-4362-b5c7-d5c19180a20f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_59365ecb-8763-4376-8e6b-c54d3dac5988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_43f5421f-3fc3-4daf-af84-fbb1b308b24d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_59365ecb-8763-4376-8e6b-c54d3dac5988" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_43f5421f-3fc3-4daf-af84-fbb1b308b24d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_9f5d4e35-1848-466b-baab-04ec8e6a688a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_59365ecb-8763-4376-8e6b-c54d3dac5988" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_9f5d4e35-1848-466b-baab-04ec8e6a688a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_74b0759a-bbed-4874-9dd7-de9be48bfc1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_59365ecb-8763-4376-8e6b-c54d3dac5988" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_74b0759a-bbed-4874-9dd7-de9be48bfc1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_bd19f90b-584b-44e4-9e0b-d0d85d9515df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_59365ecb-8763-4376-8e6b-c54d3dac5988" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_bd19f90b-584b-44e4-9e0b-d0d85d9515df" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASESDetails_1" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASESDetails_1"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/FINANCELEASESDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_7d94d187-ea76-4ebf-b2cf-09b26b07e1ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_8e006965-d58c-44f9-91c7-db913737431a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_7d94d187-ea76-4ebf-b2cf-09b26b07e1ab" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_8e006965-d58c-44f9-91c7-db913737431a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b9bf3696-ed5b-449e-a223-7cfcd0490b4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_7d94d187-ea76-4ebf-b2cf-09b26b07e1ab" xlink:to="loc_us-gaap_FinanceLeaseLiability_b9bf3696-ed5b-449e-a223-7cfcd0490b4f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASES" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASES"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/LEASES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASESTables"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/LEASESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/LEASESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b1bd0466-fb13-41fd-8dd4-f1efbee0a849" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b211ce5e-d302-4477-beec-80989bf6d96e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b1bd0466-fb13-41fd-8dd4-f1efbee0a849" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b211ce5e-d302-4477-beec-80989bf6d96e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0cc76dda-0a29-412f-8e96-d1475db08a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b1bd0466-fb13-41fd-8dd4-f1efbee0a849" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0cc76dda-0a29-412f-8e96-d1475db08a58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ff11c049-b570-4974-a02a-57291db79c38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b1bd0466-fb13-41fd-8dd4-f1efbee0a849" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ff11c049-b570-4974-a02a-57291db79c38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bc3323fa-6c5e-494a-8293-ab1e5b095119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b1bd0466-fb13-41fd-8dd4-f1efbee0a849" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bc3323fa-6c5e-494a-8293-ab1e5b095119" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails_1" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails_1"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b7bf0064-039c-4ebb-9439-1c1fb88d4333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_aeac36a2-bae1-4d50-8eb8-9e9b1dd0b637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b7bf0064-039c-4ebb-9439-1c1fb88d4333" xlink:to="loc_us-gaap_OperatingLeaseLiability_aeac36a2-bae1-4d50-8eb8-9e9b1dd0b637" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_aa62444d-3829-4f92-ab79-5f4564390c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b7bf0064-039c-4ebb-9439-1c1fb88d4333" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_aa62444d-3829-4f92-ab79-5f4564390c64" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXES" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXES"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/INCOMETAXES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESTables"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/INCOMETAXESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_111ac177-a13c-43fd-8a55-0f3dc720f118" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_7344fcfe-1a17-4d42-ad62-1d5c006a8a77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_111ac177-a13c-43fd-8a55-0f3dc720f118" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_7344fcfe-1a17-4d42-ad62-1d5c006a8a77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_61db59d0-8c65-48a0-bb37-b3e031ee7a54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_111ac177-a13c-43fd-8a55-0f3dc720f118" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_61db59d0-8c65-48a0-bb37-b3e031ee7a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_f4c5f469-3267-4c56-9842-dd05de521d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_111ac177-a13c-43fd-8a55-0f3dc720f118" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_f4c5f469-3267-4c56-9842-dd05de521d3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6262ad31-8611-4560-a548-ef04100567ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bc7f9b7e-b4da-4230-9d1c-d39902b3d2e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6262ad31-8611-4560-a548-ef04100567ad" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bc7f9b7e-b4da-4230-9d1c-d39902b3d2e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_4f92c536-04a7-45d4-98f9-2923776b9c80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6262ad31-8611-4560-a548-ef04100567ad" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_4f92c536-04a7-45d4-98f9-2923776b9c80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_c48a2e66-d933-4443-859d-f01dc4c2adf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_944d5b24-7c07-4a6c-9b75-1a6765ce810d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_c48a2e66-d933-4443-859d-f01dc4c2adf5" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_944d5b24-7c07-4a6c-9b75-1a6765ce810d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1882089b-144b-4718-9fa3-894fc2936e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_c48a2e66-d933-4443-859d-f01dc4c2adf5" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1882089b-144b-4718-9fa3-894fc2936e1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1bca2562-a8bf-4bec-8a65-8c30612eee1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_c48a2e66-d933-4443-859d-f01dc4c2adf5" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1bca2562-a8bf-4bec-8a65-8c30612eee1d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_798ecadb-e7e8-4617-993c-ed00b1ee03c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_30e1b049-0fd1-4c15-a9c5-64deae00d9c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_798ecadb-e7e8-4617-993c-ed00b1ee03c5" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_30e1b049-0fd1-4c15-a9c5-64deae00d9c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_046ff808-2c90-4a81-ba60-85211cf2f770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_798ecadb-e7e8-4617-993c-ed00b1ee03c5" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_046ff808-2c90-4a81-ba60-85211cf2f770" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_29ad45b9-3849-4fc2-b29f-e024b4cc5334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_ece0931f-3995-4647-8c94-a5fe40b0c521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_29ad45b9-3849-4fc2-b29f-e024b4cc5334" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_ece0931f-3995-4647-8c94-a5fe40b0c521" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d97bbe61-1c0d-4a1f-bc3c-60d31289402d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_29ad45b9-3849-4fc2-b29f-e024b4cc5334" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_d97bbe61-1c0d-4a1f-bc3c-60d31289402d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4260c566-d4c4-4c00-be42-fea51479ab90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_29ad45b9-3849-4fc2-b29f-e024b4cc5334" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4260c566-d4c4-4c00-be42-fea51479ab90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_2954a077-1e67-414a-bacc-54df3139c711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2a729607-8faf-4585-9673-1cd32bd37eb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2954a077-1e67-414a-bacc-54df3139c711" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2a729607-8faf-4585-9673-1cd32bd37eb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_05eece06-ae80-4845-99f6-880897c06870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2954a077-1e67-414a-bacc-54df3139c711" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_05eece06-ae80-4845-99f6-880897c06870" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_81f0805d-a0ae-4fda-b283-502e3fdc8ee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2954a077-1e67-414a-bacc-54df3139c711" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_81f0805d-a0ae-4fda-b283-502e3fdc8ee2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_78811d33-d402-4e2c-99ee-8dddee4a3c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2954a077-1e67-414a-bacc-54df3139c711" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_78811d33-d402-4e2c-99ee-8dddee4a3c20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_96953a4c-47f9-433b-89d2-e3b0a2cf1bda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2954a077-1e67-414a-bacc-54df3139c711" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_96953a4c-47f9-433b-89d2-e3b0a2cf1bda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_4f84b6eb-6b13-4d6f-9a12-51c086bc4c83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_df96272d-a9f5-4bd1-995e-b60ff56a88ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_4f84b6eb-6b13-4d6f-9a12-51c086bc4c83" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_df96272d-a9f5-4bd1-995e-b60ff56a88ae" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_f4b5ee5f-1205-4dfa-b399-a4393ef9cc62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b69cfa1d-647d-4e2d-9bce-92e77509f4ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f4b5ee5f-1205-4dfa-b399-a4393ef9cc62" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b69cfa1d-647d-4e2d-9bce-92e77509f4ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b264af18-3c08-4be2-a57f-e094cac61662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_d2752721-2329-4dc1-8721-1785815e4677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_b264af18-3c08-4be2-a57f-e094cac61662" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_d2752721-2329-4dc1-8721-1785815e4677" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_5a9221f2-d342-4d74-a313-977b051aed9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_b264af18-3c08-4be2-a57f-e094cac61662" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_5a9221f2-d342-4d74-a313-977b051aed9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_f7d75089-2c44-43dc-8b3c-21e81e573efb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_b264af18-3c08-4be2-a57f-e094cac61662" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_f7d75089-2c44-43dc-8b3c-21e81e573efb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_dbb0f9f1-91f4-4477-a26f-b5f9bc09ba84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_b264af18-3c08-4be2-a57f-e094cac61662" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_dbb0f9f1-91f4-4477-a26f-b5f9bc09ba84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_ae3cc6ac-a072-4001-ad14-e0837f64e86f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_b264af18-3c08-4be2-a57f-e094cac61662" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_ae3cc6ac-a072-4001-ad14-e0837f64e86f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount_fda36c51-04f5-4cdc-8353-decf0bd48d3b" xlink:href="ams-20201231.xsd#ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_b264af18-3c08-4be2-a57f-e094cac61662" xlink:to="loc_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount_fda36c51-04f5-4cdc-8353-decf0bd48d3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_c26a6046-5f19-46a3-9be4-9a43b729cad2" xlink:href="ams-20201231.xsd#ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_b264af18-3c08-4be2-a57f-e094cac61662" xlink:to="loc_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_c26a6046-5f19-46a3-9be4-9a43b729cad2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount_47c96783-76eb-4916-bedf-027e812c01cb" xlink:href="ams-20201231.xsd#ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_b264af18-3c08-4be2-a57f-e094cac61662" xlink:to="loc_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount_47c96783-76eb-4916-bedf-027e812c01cb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSE" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSE"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSETables"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/RETIREMENTPLAN" xlink:type="simple" xlink:href="ams-20201231.xsd#RETIREMENTPLAN"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/RETIREMENTPLAN" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/RETIREMENTPLANDetailsTextual" xlink:type="simple" xlink:href="ams-20201231.xsd#RETIREMENTPLANDetailsTextual"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/RETIREMENTPLANDetailsTextual" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/OPERATINGLEASES" xlink:type="simple" xlink:href="ams-20201231.xsd#OPERATINGLEASES"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/OPERATINGLEASES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/OPERATINGLEASESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#OPERATINGLEASESTables"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/OPERATINGLEASESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/OPERATINGLEASESDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#OPERATINGLEASESDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/OPERATINGLEASESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue_288286aa-4056-44ac-81cb-1474b9f63ac9" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths_afdc7602-e95b-4fcf-9c7b-5d8611bbb1a4" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue_288286aa-4056-44ac-81cb-1474b9f63ac9" xlink:to="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths_afdc7602-e95b-4fcf-9c7b-5d8611bbb1a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo_7adf80b6-dc1b-40a1-a08d-2fcce678e9b4" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue_288286aa-4056-44ac-81cb-1474b9f63ac9" xlink:to="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo_7adf80b6-dc1b-40a1-a08d-2fcce678e9b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree_8f30543f-d547-447b-9b97-cb0c072ffcd5" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue_288286aa-4056-44ac-81cb-1474b9f63ac9" xlink:to="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree_8f30543f-d547-447b-9b97-cb0c072ffcd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour_137b7c8a-03e7-46d2-bac1-bad9300546a7" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue_288286aa-4056-44ac-81cb-1474b9f63ac9" xlink:to="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour_137b7c8a-03e7-46d2-bac1-bad9300546a7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#OPERATINGLEASESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="ams-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#COMMITMENTSANDCONTINGENCIESTables"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#COMMITMENTSANDCONTINGENCIESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_ef8e7029-ce93-404c-b5d9-ee316ed66648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInFourthAndFifthYear_70f1814e-7145-4f35-bca2-081a5e5ff250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInFourthAndFifthYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_ef8e7029-ce93-404c-b5d9-ee316ed66648" xlink:to="loc_us-gaap_ContractualObligationDueInFourthAndFifthYear_70f1814e-7145-4f35-bca2-081a5e5ff250" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInSecondAndThirdYear_ebfe23ec-fdd6-473a-a2b1-9c1850371761" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInSecondAndThirdYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_ef8e7029-ce93-404c-b5d9-ee316ed66648" xlink:to="loc_us-gaap_ContractualObligationDueInSecondAndThirdYear_ebfe23ec-fdd6-473a-a2b1-9c1850371761" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueAfterFifthYear_c0be3d57-f818-4f33-9839-f93e1c2a5f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueAfterFifthYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_ef8e7029-ce93-404c-b5d9-ee316ed66648" xlink:to="loc_us-gaap_ContractualObligationDueAfterFifthYear_c0be3d57-f818-4f33-9839-f93e1c2a5f7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_8b4e000a-5cd5-4bd9-93b7-5f49e55da399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_ef8e7029-ce93-404c-b5d9-ee316ed66648" xlink:to="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_8b4e000a-5cd5-4bd9-93b7-5f49e55da399" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="ams-20201231.xsd#RELATEDPARTYTRANSACTIONS"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual" xlink:type="simple" xlink:href="ams-20201231.xsd#RELATEDPARTYTRANSACTIONSDetailsTextual"/>
  <link:calculationLink xlink:role="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>ams-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4e6f91f2-1bf1-41c4-8e53-76168a3ee138,g:df8d0904-ed6f-4833-8eea-c587ca49bdb5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ashs.com/role/CoverPage" xlink:type="simple" xlink:href="ams-20201231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/CoverPage" xlink:type="extended" id="ic2877a46c5504177a2da0d07ee7e59cc_CoverPage"/>
  <link:roleRef roleURI="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ams-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="ie17e19706d1549ceab423cf4d66044c8_CONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ams-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="iceee0e178ae946f28338c084c9ab2361_CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ams-20201231.xsd#STATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/STATEMENTSOFOPERATIONS" xlink:type="extended" id="i2258b03ade4d4994a2fe2813170f46e3_STATEMENTSOFOPERATIONS"/>
  <link:roleRef roleURI="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="ams-20201231.xsd#CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" xlink:type="extended" id="i179c07716b5e4083982950e644aa5a31_CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8cabca8f-7d9a-465b-8f23-bd3f5b9541be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8cabca8f-7d9a-465b-8f23-bd3f5b9541be" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e0235d8b-fc26-43a1-97b0-c42355127e91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e0235d8b-fc26-43a1-97b0-c42355127e91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_0546966d-8de6-45ba-a66c-5e7d70be2a5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_SharesOutstanding_0546966d-8de6-45ba-a66c-5e7d70be2a5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f5bfdc5f-13ac-47b3-a101-cd57f82b8c09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f5bfdc5f-13ac-47b3-a101-cd57f82b8c09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2eedd5f1-4c9e-455c-bc97-bed41c4dd831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2eedd5f1-4c9e-455c-bc97-bed41c4dd831" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3d9d33de-89b1-4ea0-abd0-627b18899fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3d9d33de-89b1-4ea0-abd0-627b18899fd6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_87ba31da-8270-4f5d-beb3-5c277e162a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_87ba31da-8270-4f5d-beb3-5c277e162a25" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_143b5fce-0724-4d39-b5ea-5d1c786c8034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_143b5fce-0724-4d39-b5ea-5d1c786c8034" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_104737b6-4eb6-48e9-a250-c0ea9f49cef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_104737b6-4eb6-48e9-a250-c0ea9f49cef7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f1182e96-1ba7-4654-b323-4a94e3979ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_ProfitLoss_f1182e96-1ba7-4654-b323-4a94e3979ba6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_2ca24194-6d12-4715-acdd-1e88ec09b950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_2ca24194-6d12-4715-acdd-1e88ec09b950" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_bdfd33bd-cb34-47fb-adf0-1d174424002c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_bdfd33bd-cb34-47fb-adf0-1d174424002c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8dddb6b8-0b57-4021-b2c6-6d46dd8f39a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e7e990e0-53ba-467b-9c5e-0999dfa73ef6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c793b712-0fd8-4573-94bb-a75d6f1315c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8cabca8f-7d9a-465b-8f23-bd3f5b9541be" xlink:to="loc_us-gaap_StatementTable_c793b712-0fd8-4573-94bb-a75d6f1315c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3f12bab3-9b2b-4215-94ad-39c1c8ab87ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c793b712-0fd8-4573-94bb-a75d6f1315c8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3f12bab3-9b2b-4215-94ad-39c1c8ab87ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3f12bab3-9b2b-4215-94ad-39c1c8ab87ce_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3f12bab3-9b2b-4215-94ad-39c1c8ab87ce" xlink:to="loc_us-gaap_EquityComponentDomain_3f12bab3-9b2b-4215-94ad-39c1c8ab87ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3f12bab3-9b2b-4215-94ad-39c1c8ab87ce" xlink:to="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6166caaf-cf36-4f49-88a2-45bd1e619c39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:to="loc_us-gaap_CommonStockMember_6166caaf-cf36-4f49-88a2-45bd1e619c39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_60212b02-9907-4209-872c-161cb11c0e16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_60212b02-9907-4209-872c-161cb11c0e16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5fe2ed78-661a-4e74-8cf1-2ee7a84743a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:to="loc_us-gaap_RetainedEarningsMember_5fe2ed78-661a-4e74-8cf1-2ee7a84743a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_dea869b5-f627-49c7-a11f-8aa8233c43cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:to="loc_us-gaap_ParentMember_dea869b5-f627-49c7-a11f-8aa8233c43cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_3bf0517e-991d-48b0-81d8-e93fb9e62bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:to="loc_us-gaap_NoncontrollingInterestMember_3bf0517e-991d-48b0-81d8-e93fb9e62bdb" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ams-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i73aa7bcf23c5434589bae711c75ca769_CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:roleRef roleURI="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="ams-20201231.xsd#BUSINESSANDBASISOFPRESENTATION"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATION" xlink:type="extended" id="idcb478dc283542a781d5e4d8d86c6b2a_BUSINESSANDBASISOFPRESENTATION"/>
  <link:roleRef roleURI="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#BUSINESSANDBASISOFPRESENTATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails" xlink:type="extended" id="id023c7bd1d084b2390aca5c05cb93964_BUSINESSANDBASISOFPRESENTATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfSharesAcquired_73a9d4a6-c864-4af2-a3ff-9594ac25ec8b" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_ams_AssetAcquisitionPercentageOfSharesAcquired_73a9d4a6-c864-4af2-a3ff-9594ac25ec8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfSharesRemaining_acc6d108-1797-41a2-9558-13acec95477e" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfSharesRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_ams_AssetAcquisitionPercentageOfSharesRemaining_acc6d108-1797-41a2-9558-13acec95477e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionConsiderationTransferred_e618b29a-efbb-436b-9038-988ff40fb7ef" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_ams_AssetAcquisitionConsiderationTransferred_e618b29a-efbb-436b-9038-988ff40fb7ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsForAssetAcquisitions_302721a5-0f8c-4642-a027-5acbe84d0a01" xlink:href="ams-20201231.xsd#ams_PaymentsForAssetAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_ams_PaymentsForAssetAcquisitions_302721a5-0f8c-4642-a027-5acbe84d0a01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionTransactionCosts_5f3eda4d-fffe-4370-9b4c-bf7493a07601" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_ams_AssetAcquisitionTransactionCosts_5f3eda4d-fffe-4370-9b4c-bf7493a07601" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f9696d79-2bb0-4cfc-a746-fa30b744c9ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f9696d79-2bb0-4cfc-a746-fa30b744c9ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ec50f0ce-91b1-4144-831a-5b6dbf3ee50b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ec50f0ce-91b1-4144-831a-5b6dbf3ee50b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05c2a951-2008-45b6-9796-5ba06340d1cf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ec50f0ce-91b1-4144-831a-5b6dbf3ee50b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05c2a951-2008-45b6-9796-5ba06340d1cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_05c2a951-2008-45b6-9796-5ba06340d1cf_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05c2a951-2008-45b6-9796-5ba06340d1cf" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_05c2a951-2008-45b6-9796-5ba06340d1cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2a7b4abf-2b18-4282-9c1c-c624d1243854" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05c2a951-2008-45b6-9796-5ba06340d1cf" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2a7b4abf-2b18-4282-9c1c-c624d1243854" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_Or21LlcMember_8a1a9134-ce6e-4a6f-91b6-67f0627f20e3" xlink:href="ams-20201231.xsd#ams_Or21LlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2a7b4abf-2b18-4282-9c1c-c624d1243854" xlink:to="loc_ams_Or21LlcMember_8a1a9134-ce6e-4a6f-91b6-67f0627f20e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ArchitecturalDesignCompanyMember_5b43d5a8-e82d-41dc-a9ee-a831ce93f038" xlink:href="ams-20201231.xsd#ams_ArchitecturalDesignCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2a7b4abf-2b18-4282-9c1c-c624d1243854" xlink:to="loc_ams_ArchitecturalDesignCompanyMember_5b43d5a8-e82d-41dc-a9ee-a831ce93f038" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAxis_a621b995-b524-4545-a7e1-01170d732631" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ec50f0ce-91b1-4144-831a-5b6dbf3ee50b" xlink:to="loc_ams_AssetAcquisitionAxis_a621b995-b524-4545-a7e1-01170d732631" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_a621b995-b524-4545-a7e1-01170d732631_default" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ams_AssetAcquisitionAxis_a621b995-b524-4545-a7e1-01170d732631" xlink:to="loc_ams_AssetAcquisitionDomain_a621b995-b524-4545-a7e1-01170d732631_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_a1bf8ab5-583f-486e-ab50-b5a7688b57aa" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ams_AssetAcquisitionAxis_a621b995-b524-4545-a7e1-01170d732631" xlink:to="loc_ams_AssetAcquisitionDomain_a1bf8ab5-583f-486e-ab50-b5a7688b57aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GKCEAcquisitionMember_5094a75d-eb77-487e-b705-0b73e6f2e26c" xlink:href="ams-20201231.xsd#ams_GKCEAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AssetAcquisitionDomain_a1bf8ab5-583f-486e-ab50-b5a7688b57aa" xlink:to="loc_ams_GKCEAcquisitionMember_5094a75d-eb77-487e-b705-0b73e6f2e26c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIES"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIES" xlink:type="extended" id="i674229ff22064ae38630df3cfd683f01_ACCOUNTINGPOLICIES"/>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESPolicies"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies" xlink:type="extended" id="ib0d32f5717654ddaa38da992a8cd3196_ACCOUNTINGPOLICIESPolicies"/>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESTables"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESTables" xlink:type="extended" id="i9177edfc1ce94d0994aaf396a8f8a206_ACCOUNTINGPOLICIESTables"/>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended" id="if8cd518e0da74b849d7529ddaa1967bf_ACCOUNTINGPOLICIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:href="ams-20201231.xsd#ams_AccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_5dbea4a4-c05e-498a-a56c-7f406b2e7371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_AdvertisingExpense_5dbea4a4-c05e-498a-a56c-7f406b2e7371" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_9cece9a5-6320-452e-acd0-8686d7c819a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_9cece9a5-6320-452e-acd0-8686d7c819a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d019f4ff-7fef-476a-9def-8acbd2d033ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d019f4ff-7fef-476a-9def-8acbd2d033ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_cd1738ea-025a-41dd-8f0d-7816840f40db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_InterestCostsCapitalized_cd1738ea-025a-41dd-8f0d-7816840f40db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d67a28c0-3094-4df6-9a9c-2275c877e99a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d67a28c0-3094-4df6-9a9c-2275c877e99a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_7a31e1a2-a6d7-4f10-a8dc-3bfdb8e837f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_7a31e1a2-a6d7-4f10-a8dc-3bfdb8e837f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_33f51870-0578-4709-b390-d4780040dd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_33f51870-0578-4709-b390-d4780040dd2f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfImpairedAssetUnits_a9eef59b-735e-48bd-b2c4-11ca3421cd9e" xlink:href="ams-20201231.xsd#ams_NumberOfImpairedAssetUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_ams_NumberOfImpairedAssetUnits_a9eef59b-735e-48bd-b2c4-11ca3421cd9e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_05b33eed-cdc0-44f5-8184-05aa55b9c9d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_05b33eed-cdc0-44f5-8184-05aa55b9c9d8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_366096ee-7076-4c15-b1b6-a33504215c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_366096ee-7076-4c15-b1b6-a33504215c2d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_ecef7273-8f31-4d69-ba09-e949c7928ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_ecef7273-8f31-4d69-ba09-e949c7928ad3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dc4f7bcb-964c-49dd-be42-5fcf347fffda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dc4f7bcb-964c-49dd-be42-5fcf347fffda" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PercentageOfTaxBenefitRealizedUponSettlement_39088797-2f90-420f-910b-f8c6d3962d01" xlink:href="ams-20201231.xsd#ams_PercentageOfTaxBenefitRealizedUponSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_ams_PercentageOfTaxBenefitRealizedUponSettlement_39088797-2f90-420f-910b-f8c6d3962d01" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfCustomersWithIntentToTerminateContract_da3c2faa-0c1b-46af-9d6c-10fdeac5e373" xlink:href="ams-20201231.xsd#ams_NumberOfCustomersWithIntentToTerminateContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_ams_NumberOfCustomersWithIntentToTerminateContract_da3c2faa-0c1b-46af-9d6c-10fdeac5e373" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetRetirementObligationNumberOfSites_61707daf-9936-46e5-a66e-46758b3803a0" xlink:href="ams-20201231.xsd#ams_AssetRetirementObligationNumberOfSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_ams_AssetRetirementObligationNumberOfSites_61707daf-9936-46e5-a66e-46758b3803a0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_deba02c6-2d92-49e3-aebc-d3339d9614ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_deba02c6-2d92-49e3-aebc-d3339d9614ee" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_StockOptionExercisePrice_9570fd2b-f1de-4c08-b9d5-430c2ae59f47" xlink:href="ams-20201231.xsd#ams_StockOptionExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_ams_StockOptionExercisePrice_9570fd2b-f1de-4c08-b9d5-430c2ae59f47" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_18ab7b4e-29c1-4ead-aeba-91ba348564df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_NumberOfReportableSegments_18ab7b4e-29c1-4ead-aeba-91ba348564df" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_28fb13ad-d7be-409d-aa36-720c55d0d7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_28fb13ad-d7be-409d-aa36-720c55d0d7c8" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_c4c6e54a-3476-43d6-aa39-01337c2f5d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_c4c6e54a-3476-43d6-aa39-01337c2f5d92" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:href="ams-20201231.xsd#ams_AccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_74dc2d55-6fa8-4d19-a39c-b0995105eeb8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_srt_RangeAxis_74dc2d55-6fa8-4d19-a39c-b0995105eeb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_74dc2d55-6fa8-4d19-a39c-b0995105eeb8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_74dc2d55-6fa8-4d19-a39c-b0995105eeb8" xlink:to="loc_srt_RangeMember_74dc2d55-6fa8-4d19-a39c-b0995105eeb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5ce5658b-2f0e-409d-81a0-e660264a19d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_74dc2d55-6fa8-4d19-a39c-b0995105eeb8" xlink:to="loc_srt_RangeMember_5ce5658b-2f0e-409d-81a0-e660264a19d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_876bdc4c-d152-4569-a114-55aafb155a9f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5ce5658b-2f0e-409d-81a0-e660264a19d4" xlink:to="loc_srt_MaximumMember_876bdc4c-d152-4569-a114-55aafb155a9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_86f0aada-c6a1-4a2c-8912-20790af7ce0a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5ce5658b-2f0e-409d-81a0-e660264a19d4" xlink:to="loc_srt_MinimumMember_86f0aada-c6a1-4a2c-8912-20790af7ce0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1bbc12b9-a9b0-4595-a75f-7a5cf8d299e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1bbc12b9-a9b0-4595-a75f-7a5cf8d299e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_1bbc12b9-a9b0-4595-a75f-7a5cf8d299e9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1bbc12b9-a9b0-4595-a75f-7a5cf8d299e9" xlink:to="loc_us-gaap_RelatedPartyDomain_1bbc12b9-a9b0-4595-a75f-7a5cf8d299e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_819aff86-8131-4156-bf15-7e3a72b8062c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1bbc12b9-a9b0-4595-a75f-7a5cf8d299e9" xlink:to="loc_us-gaap_RelatedPartyDomain_819aff86-8131-4156-bf15-7e3a72b8062c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeCenterEcuadorSAGKCEMember_4a542582-b070-4fc1-bae8-0dc21d9f6e9f" xlink:href="ams-20201231.xsd#ams_GammaKnifeCenterEcuadorSAGKCEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_819aff86-8131-4156-bf15-7e3a72b8062c" xlink:to="loc_ams_GammaKnifeCenterEcuadorSAGKCEMember_4a542582-b070-4fc1-bae8-0dc21d9f6e9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeUnitMember_baa4eade-8525-43eb-8d17-67f679ec07e3" xlink:href="ams-20201231.xsd#ams_GammaKnifeUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_819aff86-8131-4156-bf15-7e3a72b8062c" xlink:to="loc_ams_GammaKnifeUnitMember_baa4eade-8525-43eb-8d17-67f679ec07e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f37cd13-3377-494f-9a26-a20eef5453c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f37cd13-3377-494f-9a26-a20eef5453c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f37cd13-3377-494f-9a26-a20eef5453c4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f37cd13-3377-494f-9a26-a20eef5453c4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f37cd13-3377-494f-9a26-a20eef5453c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3611e782-420e-4092-bde8-3db4521b77a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f37cd13-3377-494f-9a26-a20eef5453c4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3611e782-420e-4092-bde8-3db4521b77a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_53619dab-ab8f-466f-b987-5d3053577733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3611e782-420e-4092-bde8-3db4521b77a5" xlink:to="loc_us-gaap_OfficeEquipmentMember_53619dab-ab8f-466f-b987-5d3053577733" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ProtonBeamRadiationTherapyPBRTMember_4362ef54-eff5-4c10-bf25-24c14bb0328a" xlink:href="ams-20201231.xsd#ams_ProtonBeamRadiationTherapyPBRTMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3611e782-420e-4092-bde8-3db4521b77a5" xlink:to="loc_ams_ProtonBeamRadiationTherapyPBRTMember_4362ef54-eff5-4c10-bf25-24c14bb0328a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeAndRadiationTherapyMember_1c9d085b-6e2a-462b-9946-d8705c359a91" xlink:href="ams-20201231.xsd#ams_GammaKnifeAndRadiationTherapyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3611e782-420e-4092-bde8-3db4521b77a5" xlink:to="loc_ams_GammaKnifeAndRadiationTherapyMember_1c9d085b-6e2a-462b-9946-d8705c359a91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c0691cdb-f1b2-4e6b-b03a-846f93870922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c0691cdb-f1b2-4e6b-b03a-846f93870922" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_c0691cdb-f1b2-4e6b-b03a-846f93870922_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c0691cdb-f1b2-4e6b-b03a-846f93870922" xlink:to="loc_us-gaap_TypeOfAdoptionMember_c0691cdb-f1b2-4e6b-b03a-846f93870922_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_02394484-6fe5-42e4-89a1-1cbd9c02aaac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c0691cdb-f1b2-4e6b-b03a-846f93870922" xlink:to="loc_us-gaap_TypeOfAdoptionMember_02394484-6fe5-42e4-89a1-1cbd9c02aaac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_26657c14-3acf-4dfc-a865-01a9de4a3e1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_02394484-6fe5-42e4-89a1-1cbd9c02aaac" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_26657c14-3acf-4dfc-a865-01a9de4a3e1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_b54aef66-4df0-4f77-9b25-9ade6fe5baf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_02394484-6fe5-42e4-89a1-1cbd9c02aaac" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_b54aef66-4df0-4f77-9b25-9ade6fe5baf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0580e887-7197-4434-a48e-004ccc40afee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_us-gaap_AwardTypeAxis_0580e887-7197-4434-a48e-004ccc40afee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0580e887-7197-4434-a48e-004ccc40afee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0580e887-7197-4434-a48e-004ccc40afee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0580e887-7197-4434-a48e-004ccc40afee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43a4a02f-d6a9-4374-b949-154282b14342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0580e887-7197-4434-a48e-004ccc40afee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43a4a02f-d6a9-4374-b949-154282b14342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a26ebe54-a700-4aa8-8a01-49c01f1d906c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43a4a02f-d6a9-4374-b949-154282b14342" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a26ebe54-a700-4aa8-8a01-49c01f1d906c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_66fbd26b-c482-46d0-b4ec-ce101e9de5f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_srt_MajorCustomersAxis_66fbd26b-c482-46d0-b4ec-ce101e9de5f0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_66fbd26b-c482-46d0-b4ec-ce101e9de5f0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_66fbd26b-c482-46d0-b4ec-ce101e9de5f0" xlink:to="loc_srt_NameOfMajorCustomerDomain_66fbd26b-c482-46d0-b4ec-ce101e9de5f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e2deddf5-0e03-42d4-a4a1-1cf84e2c00bf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_66fbd26b-c482-46d0-b4ec-ce101e9de5f0" xlink:to="loc_srt_NameOfMajorCustomerDomain_e2deddf5-0e03-42d4-a4a1-1cf84e2c00bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CustomerOneMember_dd5b1214-9e21-449f-b86c-aee881a63cab" xlink:href="ams-20201231.xsd#ams_CustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e2deddf5-0e03-42d4-a4a1-1cf84e2c00bf" xlink:to="loc_ams_CustomerOneMember_dd5b1214-9e21-449f-b86c-aee881a63cab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CustomerTwoMember_610ddb0c-2f8d-43c7-b7ef-2098859bc29d" xlink:href="ams-20201231.xsd#ams_CustomerTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e2deddf5-0e03-42d4-a4a1-1cf84e2c00bf" xlink:to="loc_ams_CustomerTwoMember_610ddb0c-2f8d-43c7-b7ef-2098859bc29d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CustomerThreeMember_7eb5a71a-7874-4e81-9bc8-313b87bb570e" xlink:href="ams-20201231.xsd#ams_CustomerThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e2deddf5-0e03-42d4-a4a1-1cf84e2c00bf" xlink:to="loc_ams_CustomerThreeMember_7eb5a71a-7874-4e81-9bc8-313b87bb570e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CustomerFourMember_0ba5f436-6116-4deb-9c83-16b02d6202f6" xlink:href="ams-20201231.xsd#ams_CustomerFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e2deddf5-0e03-42d4-a4a1-1cf84e2c00bf" xlink:to="loc_ams_CustomerFourMember_0ba5f436-6116-4deb-9c83-16b02d6202f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e0bb7c4-03c4-4ad5-9f83-a7df32f79e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e0bb7c4-03c4-4ad5-9f83-a7df32f79e6c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8e0bb7c4-03c4-4ad5-9f83-a7df32f79e6c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e0bb7c4-03c4-4ad5-9f83-a7df32f79e6c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8e0bb7c4-03c4-4ad5-9f83-a7df32f79e6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43bd614a-1c58-4585-a0e8-df9449cf1583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e0bb7c4-03c4-4ad5-9f83-a7df32f79e6c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43bd614a-1c58-4585-a0e8-df9449cf1583" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_8910ab23-ea5c-44e9-bcd4-48284053c619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43bd614a-1c58-4585-a0e8-df9449cf1583" xlink:to="loc_us-gaap_SalesRevenueNetMember_8910ab23-ea5c-44e9-bcd4-48284053c619" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_740a543c-6042-4a81-9b5c-b56e72d130b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43bd614a-1c58-4585-a0e8-df9449cf1583" xlink:to="loc_us-gaap_AccountsReceivableMember_740a543c-6042-4a81-9b5c-b56e72d130b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAxis_ae9ca81c-c878-4584-ab5a-e96b220509f2" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_ams_AssetAcquisitionAxis_ae9ca81c-c878-4584-ab5a-e96b220509f2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_ae9ca81c-c878-4584-ab5a-e96b220509f2_default" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ams_AssetAcquisitionAxis_ae9ca81c-c878-4584-ab5a-e96b220509f2" xlink:to="loc_ams_AssetAcquisitionDomain_ae9ca81c-c878-4584-ab5a-e96b220509f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_713d0655-daed-414c-ba39-783f173ccaaf" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ams_AssetAcquisitionAxis_ae9ca81c-c878-4584-ab5a-e96b220509f2" xlink:to="loc_ams_AssetAcquisitionDomain_713d0655-daed-414c-ba39-783f173ccaaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GKCEAcquisitionMember_dc55c47f-bbfc-4f7a-abb5-8330aa38954e" xlink:href="ams-20201231.xsd#ams_GKCEAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AssetAcquisitionDomain_713d0655-daed-414c-ba39-783f173ccaaf" xlink:to="loc_ams_GKCEAcquisitionMember_dc55c47f-bbfc-4f7a-abb5-8330aa38954e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_30338871-1b84-4762-9419-08e48479d438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_30338871-1b84-4762-9419-08e48479d438" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_30338871-1b84-4762-9419-08e48479d438_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_30338871-1b84-4762-9419-08e48479d438" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_30338871-1b84-4762-9419-08e48479d438_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_afd81e64-1618-4696-b0ca-1501af264615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_30338871-1b84-4762-9419-08e48479d438" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_afd81e64-1618-4696-b0ca-1501af264615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a7de1fc7-6b90-4f09-8015-f168815d7abd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_afd81e64-1618-4696-b0ca-1501af264615" xlink:to="loc_us-gaap_TradeNamesMember_a7de1fc7-6b90-4f09-8015-f168815d7abd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESScheduleofFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails" xlink:type="extended" id="i656579f8332c4aa5a5d0dc60d09a9b70_ACCOUNTINGPOLICIESScheduleofFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_64574e25-6a2a-42d7-94ed-d8d9fd7f7f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_438c9cb3-f29b-476d-bc48-40caf014ed6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_64574e25-6a2a-42d7-94ed-d8d9fd7f7f59" xlink:to="loc_us-gaap_AssetsAbstract_438c9cb3-f29b-476d-bc48-40caf014ed6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7ced0139-ad74-4628-b799-bf410e1190a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_438c9cb3-f29b-476d-bc48-40caf014ed6c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7ced0139-ad74-4628-b799-bf410e1190a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_dea1a639-c03a-47e0-aab4-9af1dc72b844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_438c9cb3-f29b-476d-bc48-40caf014ed6c" xlink:to="loc_us-gaap_Assets_dea1a639-c03a-47e0-aab4-9af1dc72b844" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_0093ee62-919f-440c-a171-82e20c2d67fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_64574e25-6a2a-42d7-94ed-d8d9fd7f7f59" xlink:to="loc_us-gaap_LiabilitiesAbstract_0093ee62-919f-440c-a171-82e20c2d67fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_a3661a95-666f-4b9a-bd6e-2604512af359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0093ee62-919f-440c-a171-82e20c2d67fa" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_a3661a95-666f-4b9a-bd6e-2604512af359" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_779e9a2f-cb84-4af0-b409-d0d32484bc08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0093ee62-919f-440c-a171-82e20c2d67fa" xlink:to="loc_us-gaap_Liabilities_779e9a2f-cb84-4af0-b409-d0d32484bc08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_3855bc9b-b666-44aa-bee9-22bd61918fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_64574e25-6a2a-42d7-94ed-d8d9fd7f7f59" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_3855bc9b-b666-44aa-bee9-22bd61918fce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20ed1966-d006-4f2c-97c9-346524c97349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_3855bc9b-b666-44aa-bee9-22bd61918fce" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20ed1966-d006-4f2c-97c9-346524c97349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7b4934ef-7d54-424a-827c-fddba109d711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_3855bc9b-b666-44aa-bee9-22bd61918fce" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_7b4934ef-7d54-424a-827c-fddba109d711" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_feb62d8b-d81e-4145-ac83-820ef096ef22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_64574e25-6a2a-42d7-94ed-d8d9fd7f7f59" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_feb62d8b-d81e-4145-ac83-820ef096ef22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_a83a0323-b3dc-454e-9765-2e2dbf0502dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_feb62d8b-d81e-4145-ac83-820ef096ef22" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_a83a0323-b3dc-454e-9765-2e2dbf0502dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_8dfd7db8-f45a-4d3b-b1eb-f5006c7294a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_feb62d8b-d81e-4145-ac83-820ef096ef22" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_8dfd7db8-f45a-4d3b-b1eb-f5006c7294a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_211cef6c-917b-4c32-8305-5069adcdf056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_64574e25-6a2a-42d7-94ed-d8d9fd7f7f59" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_211cef6c-917b-4c32-8305-5069adcdf056" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ac1c0adc-daba-412d-8951-9b10c5588d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_211cef6c-917b-4c32-8305-5069adcdf056" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ac1c0adc-daba-412d-8951-9b10c5588d2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ac1c0adc-daba-412d-8951-9b10c5588d2e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ac1c0adc-daba-412d-8951-9b10c5588d2e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ac1c0adc-daba-412d-8951-9b10c5588d2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51795597-1ec2-4059-99d6-03efcc269205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ac1c0adc-daba-412d-8951-9b10c5588d2e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51795597-1ec2-4059-99d6-03efcc269205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6f7173d1-acfc-4987-8286-797efab47344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51795597-1ec2-4059-99d6-03efcc269205" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6f7173d1-acfc-4987-8286-797efab47344" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8dcc3d9b-663c-4642-8efd-1a9e9668a499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51795597-1ec2-4059-99d6-03efcc269205" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8dcc3d9b-663c-4642-8efd-1a9e9668a499" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ca965ee9-b935-495a-ba31-8c43434e4ad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51795597-1ec2-4059-99d6-03efcc269205" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ca965ee9-b935-495a-ba31-8c43434e4ad5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_84a39118-99e3-4be1-b208-227b1e3a11e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_211cef6c-917b-4c32-8305-5069adcdf056" xlink:to="loc_us-gaap_FinancialInstrumentAxis_84a39118-99e3-4be1-b208-227b1e3a11e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_84a39118-99e3-4be1-b208-227b1e3a11e7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_84a39118-99e3-4be1-b208-227b1e3a11e7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_84a39118-99e3-4be1-b208-227b1e3a11e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c11b1b33-6ebe-4c6a-8fb3-0a1065445165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_84a39118-99e3-4be1-b208-227b1e3a11e7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c11b1b33-6ebe-4c6a-8fb3-0a1065445165" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CarryingValuesMember_aae423d5-fd9c-409c-9dfd-2fab9d3e79e7" xlink:href="ams-20201231.xsd#ams_CarryingValuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c11b1b33-6ebe-4c6a-8fb3-0a1065445165" xlink:to="loc_ams_CarryingValuesMember_aae423d5-fd9c-409c-9dfd-2fab9d3e79e7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESScheduleofEPSDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails" xlink:type="extended" id="ib88b81625fd34bc58a4595abc547a8e8_ACCOUNTINGPOLICIESScheduleofEPSDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails" xlink:type="extended" id="i7f5f8d7dbc5c45ba8713663ed3b6061d_ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ams_AccountingPoliciesLineItems_73ad6c20-63b2-4aaf-bb00-8b2e6af4f801" xlink:href="ams-20201231.xsd#ams_AccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3d3c5069-272e-4b86-b8c3-e2bd18608398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_73ad6c20-63b2-4aaf-bb00-8b2e6af4f801" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3d3c5069-272e-4b86-b8c3-e2bd18608398" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_02f2594d-b677-4657-a290-b158c46b787f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_73ad6c20-63b2-4aaf-bb00-8b2e6af4f801" xlink:to="loc_us-gaap_NetIncomeLoss_02f2594d-b677-4657-a290-b158c46b787f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f2c7c22e-25f1-4ca9-965d-a491bfaf0ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AccountingPoliciesLineItems_73ad6c20-63b2-4aaf-bb00-8b2e6af4f801" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f2c7c22e-25f1-4ca9-965d-a491bfaf0ba8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AccountingPoliciesTable_bc76c83f-7e19-4fd4-a224-913a09acef67" xlink:href="ams-20201231.xsd#ams_AccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ams_AccountingPoliciesLineItems_73ad6c20-63b2-4aaf-bb00-8b2e6af4f801" xlink:to="loc_ams_AccountingPoliciesTable_bc76c83f-7e19-4fd4-a224-913a09acef67" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8a6cf640-18f7-4f5c-ba34-576cbbeb4287" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_AccountingPoliciesTable_bc76c83f-7e19-4fd4-a224-913a09acef67" xlink:to="loc_srt_StatementGeographicalAxis_8a6cf640-18f7-4f5c-ba34-576cbbeb4287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8a6cf640-18f7-4f5c-ba34-576cbbeb4287_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_8a6cf640-18f7-4f5c-ba34-576cbbeb4287" xlink:to="loc_srt_SegmentGeographicalDomain_8a6cf640-18f7-4f5c-ba34-576cbbeb4287_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c778ee4a-3ee6-47a9-8582-9180b451aeeb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_8a6cf640-18f7-4f5c-ba34-576cbbeb4287" xlink:to="loc_srt_SegmentGeographicalDomain_c778ee4a-3ee6-47a9-8582-9180b451aeeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_DomesticMember_66e41db1-27f0-4f1d-b148-022b05b1da8a" xlink:href="ams-20201231.xsd#ams_DomesticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c778ee4a-3ee6-47a9-8582-9180b451aeeb" xlink:to="loc_ams_DomesticMember_66e41db1-27f0-4f1d-b148-022b05b1da8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ForeignMember_bfbf2f47-c433-418a-baaf-251e8849d3cd" xlink:href="ams-20201231.xsd#ams_ForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c778ee4a-3ee6-47a9-8582-9180b451aeeb" xlink:to="loc_ams_ForeignMember_bfbf2f47-c433-418a-baaf-251e8849d3cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_772f1683-246f-4313-8b4e-7e192add6d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_AccountingPoliciesTable_bc76c83f-7e19-4fd4-a224-913a09acef67" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_772f1683-246f-4313-8b4e-7e192add6d6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_772f1683-246f-4313-8b4e-7e192add6d6e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_772f1683-246f-4313-8b4e-7e192add6d6e" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_772f1683-246f-4313-8b4e-7e192add6d6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_40e11a2c-44fe-490b-94a4-63d5bedb06b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_772f1683-246f-4313-8b4e-7e192add6d6e" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_40e11a2c-44fe-490b-94a4-63d5bedb06b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_09e2f366-2de9-479c-b107-b03f15a10ffb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_40e11a2c-44fe-490b-94a4-63d5bedb06b0" xlink:to="loc_us-gaap_SalesRevenueNetMember_09e2f366-2de9-479c-b107-b03f15a10ffb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NetIncomeLossMember_45c95c26-7e1c-42b4-954e-6f882400e10c" xlink:href="ams-20201231.xsd#ams_NetIncomeLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_40e11a2c-44fe-490b-94a4-63d5bedb06b0" xlink:to="loc_ams_NetIncomeLossMember_45c95c26-7e1c-42b4-954e-6f882400e10c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_54fa1982-310f-42c9-9285-6e4dbf3c35e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_40e11a2c-44fe-490b-94a4-63d5bedb06b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_54fa1982-310f-42c9-9285-6e4dbf3c35e4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="ams-20201231.xsd#PROPERTYANDEQUIPMENT"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/PROPERTYANDEQUIPMENT" xlink:type="extended" id="i0344c3d5bebe4d0997502aa872c43c67_PROPERTYANDEQUIPMENT"/>
  <link:roleRef roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="ams-20201231.xsd#PROPERTYANDEQUIPMENTTables"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="extended" id="i389b30b9158c46c7b17e504f999a7709_PROPERTYANDEQUIPMENTTables"/>
  <link:roleRef roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended" id="ice40bc7976cc4a92b458ffcc300fb8c0_PROPERTYANDEQUIPMENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2f4e503c-d8f6-484e-aab4-e9a32ffe631f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0fa0837e-6617-4d27-a71d-1e0c8a4f5a17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2f4e503c-d8f6-484e-aab4-e9a32ffe631f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0fa0837e-6617-4d27-a71d-1e0c8a4f5a17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_8f9ddb62-c5ba-4de4-84a3-02ff721a47e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2f4e503c-d8f6-484e-aab4-e9a32ffe631f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_8f9ddb62-c5ba-4de4-84a3-02ff721a47e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d7da7fae-fc89-46f4-b9a0-715ff12334d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2f4e503c-d8f6-484e-aab4-e9a32ffe631f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d7da7fae-fc89-46f4-b9a0-715ff12334d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_78f16370-8921-4a59-9bf4-311fc174761a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2f4e503c-d8f6-484e-aab4-e9a32ffe631f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_78f16370-8921-4a59-9bf4-311fc174761a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e24ed15f-1f81-4780-be1b-8c5f1ea64b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_78f16370-8921-4a59-9bf4-311fc174761a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e24ed15f-1f81-4780-be1b-8c5f1ea64b58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e24ed15f-1f81-4780-be1b-8c5f1ea64b58_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e24ed15f-1f81-4780-be1b-8c5f1ea64b58" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e24ed15f-1f81-4780-be1b-8c5f1ea64b58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1944d7ec-d27b-4841-8358-1d565d82bfa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e24ed15f-1f81-4780-be1b-8c5f1ea64b58" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1944d7ec-d27b-4841-8358-1d565d82bfa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MedicalEquipmentAndFacilitiesMember_f7b770e1-01b4-4f1f-808a-78347c08ed95" xlink:href="ams-20201231.xsd#ams_MedicalEquipmentAndFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1944d7ec-d27b-4841-8358-1d565d82bfa1" xlink:to="loc_ams_MedicalEquipmentAndFacilitiesMember_f7b770e1-01b4-4f1f-808a-78347c08ed95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_cce64d63-6978-4927-960d-8a17e09ec412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1944d7ec-d27b-4841-8358-1d565d82bfa1" xlink:to="loc_us-gaap_OfficeEquipmentMember_cce64d63-6978-4927-960d-8a17e09ec412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_679a113e-acbd-4177-9e70-afb3219a14c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1944d7ec-d27b-4841-8358-1d565d82bfa1" xlink:to="loc_us-gaap_ConstructionInProgressMember_679a113e-acbd-4177-9e70-afb3219a14c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember_2d647bbb-058c-4d25-819c-c5b275045d5f" xlink:href="ams-20201231.xsd#ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1944d7ec-d27b-4841-8358-1d565d82bfa1" xlink:to="loc_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember_2d647bbb-058c-4d25-819c-c5b275045d5f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#PROPERTYANDEQUIPMENTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails" xlink:type="extended" id="i0ec8521d8fe24600b0e3c21cf9a19e2f_PROPERTYANDEQUIPMENTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7d394f1e-cc62-4a59-aafe-0d7221e0142c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7d394f1e-cc62-4a59-aafe-0d7221e0142c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_4d46ad78-d93c-417e-b24d-209112411624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_4d46ad78-d93c-417e-b24d-209112411624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfImpairedAssetUnits_f329dd6d-3a18-47b8-aefb-937d9c0143cc" xlink:href="ams-20201231.xsd#ams_NumberOfImpairedAssetUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_ams_NumberOfImpairedAssetUnits_f329dd6d-3a18-47b8-aefb-937d9c0143cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfDeposits_9cc584c2-50f8-4533-9bb1-ea754e41c162" xlink:href="ams-20201231.xsd#ams_NumberOfDeposits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_ams_NumberOfDeposits_9cc584c2-50f8-4533-9bb1-ea754e41c162" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3f53dd77-0f45-45bc-b1e9-10a694072ed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3f53dd77-0f45-45bc-b1e9-10a694072ed7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetRetirementObligationNumberOfRemovedAssetUnits_386bfaf9-f46e-495e-be20-9e9ee4576c08" xlink:href="ams-20201231.xsd#ams_AssetRetirementObligationNumberOfRemovedAssetUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_ams_AssetRetirementObligationNumberOfRemovedAssetUnits_386bfaf9-f46e-495e-be20-9e9ee4576c08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_63f37a95-21e5-4209-bfff-896597dd79be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_AssetRetirementObligation_63f37a95-21e5-4209-bfff-896597dd79be" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_c90e8a7d-f854-4ed2-b51a-1c07082b308f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_c90e8a7d-f854-4ed2-b51a-1c07082b308f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_8bb8fe61-e9eb-418b-86aa-eb035ce55870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_8bb8fe61-e9eb-418b-86aa-eb035ce55870" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedCapitalizedInterestCosts_a0e225a3-0b9a-44f5-8fc8-9a7c7d631bae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedCapitalizedInterestCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_AccumulatedCapitalizedInterestCosts_a0e225a3-0b9a-44f5-8fc8-9a7c7d631bae" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermPurchaseCommitmentDepositsForAssets_10deeb35-a287-45b9-b370-bb006ee298ac" xlink:href="ams-20201231.xsd#ams_LongTermPurchaseCommitmentDepositsForAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_ams_LongTermPurchaseCommitmentDepositsForAssets_10deeb35-a287-45b9-b370-bb006ee298ac" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2614bc5b-12ac-4ccb-a0a0-75bbdec5d39c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2614bc5b-12ac-4ccb-a0a0-75bbdec5d39c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_be54de74-4b95-4705-9cb4-34fd577c9bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2614bc5b-12ac-4ccb-a0a0-75bbdec5d39c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_be54de74-4b95-4705-9cb4-34fd577c9bb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be54de74-4b95-4705-9cb4-34fd577c9bb5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_be54de74-4b95-4705-9cb4-34fd577c9bb5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be54de74-4b95-4705-9cb4-34fd577c9bb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_be54de74-4b95-4705-9cb4-34fd577c9bb5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember_452df044-c538-471e-9851-de734cbab8a8" xlink:href="ams-20201231.xsd#ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:to="loc_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember_452df044-c538-471e-9851-de734cbab8a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember_256f633b-07c9-45a0-8437-9a24ca195f54" xlink:href="ams-20201231.xsd#ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:to="loc_ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember_256f633b-07c9-45a0-8437-9a24ca195f54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_UnitsRemovedFromServiceInPriorYearsMember_d8f2c506-b562-4a47-8003-bf94f7535c60" xlink:href="ams-20201231.xsd#ams_UnitsRemovedFromServiceInPriorYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:to="loc_ams_UnitsRemovedFromServiceInPriorYearsMember_d8f2c506-b562-4a47-8003-bf94f7535c60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_UnitsRemovedFromServiceInCurrentYearMember_665e1c0b-63e2-4bce-84c5-d078e1a74c2a" xlink:href="ams-20201231.xsd#ams_UnitsRemovedFromServiceInCurrentYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:to="loc_ams_UnitsRemovedFromServiceInCurrentYearMember_665e1c0b-63e2-4bce-84c5-d078e1a74c2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember_9cc63e5c-f8e9-448a-a6f7-1f0a97144069" xlink:href="ams-20201231.xsd#ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:to="loc_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember_9cc63e5c-f8e9-448a-a6f7-1f0a97144069" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8ec99028-2ed0-495c-8ba7-0bd6d5a918b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2614bc5b-12ac-4ccb-a0a0-75bbdec5d39c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8ec99028-2ed0-495c-8ba7-0bd6d5a918b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8ec99028-2ed0-495c-8ba7-0bd6d5a918b7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8ec99028-2ed0-495c-8ba7-0bd6d5a918b7" xlink:to="loc_us-gaap_RelatedPartyDomain_8ec99028-2ed0-495c-8ba7-0bd6d5a918b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_de108c80-67e3-4efb-8be6-4d7fa1b3eb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8ec99028-2ed0-495c-8ba7-0bd6d5a918b7" xlink:to="loc_us-gaap_RelatedPartyDomain_de108c80-67e3-4efb-8be6-4d7fa1b3eb4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeUnitMember_349d7a86-7be9-4865-9d8a-36731da613ff" xlink:href="ams-20201231.xsd#ams_GammaKnifeUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_de108c80-67e3-4efb-8be6-4d7fa1b3eb4d" xlink:to="loc_ams_GammaKnifeUnitMember_349d7a86-7be9-4865-9d8a-36731da613ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ProtonBeamRadiationTherapyPBRTMember_3df8fcd6-2002-461c-9361-b3e9822e3748" xlink:href="ams-20201231.xsd#ams_ProtonBeamRadiationTherapyPBRTMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_de108c80-67e3-4efb-8be6-4d7fa1b3eb4d" xlink:to="loc_ams_ProtonBeamRadiationTherapyPBRTMember_3df8fcd6-2002-461c-9361-b3e9822e3748" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_67dc8488-8209-4f5a-a93b-1efb3cb4e1e5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2614bc5b-12ac-4ccb-a0a0-75bbdec5d39c" xlink:to="loc_srt_StatementGeographicalAxis_67dc8488-8209-4f5a-a93b-1efb3cb4e1e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_67dc8488-8209-4f5a-a93b-1efb3cb4e1e5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_67dc8488-8209-4f5a-a93b-1efb3cb4e1e5" xlink:to="loc_srt_SegmentGeographicalDomain_67dc8488-8209-4f5a-a93b-1efb3cb4e1e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5e7e4819-8401-4678-9bcc-bf1a28f3aa84" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_67dc8488-8209-4f5a-a93b-1efb3cb4e1e5" xlink:to="loc_srt_SegmentGeographicalDomain_5e7e4819-8401-4678-9bcc-bf1a28f3aa84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_da532dd5-f31f-41ce-93d9-58260bccf9aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5e7e4819-8401-4678-9bcc-bf1a28f3aa84" xlink:to="loc_us-gaap_NonUsMember_da532dd5-f31f-41ce-93d9-58260bccf9aa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITION" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITION"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/GKCEACQUISITION" xlink:type="extended" id="iea1ff3c408a7427a968ca39eba78fb4b_GKCEACQUISITION"/>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITIONTables" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITIONTables"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/GKCEACQUISITIONTables" xlink:type="extended" id="i81ba332e79ba49c2a36206c2bbe4d78a_GKCEACQUISITIONTables"/>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails" xlink:type="extended" id="i097f4670d62b477482c22000f518182d_GKCEACQUISITIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfSharesAcquired_7f4b1ed4-b401-49bb-b318-388e98001700" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionPercentageOfSharesAcquired_7f4b1ed4-b401-49bb-b318-388e98001700" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfSharesRemaining_882ed945-3b9f-47f5-81c6-ac139968cd22" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfSharesRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionPercentageOfSharesRemaining_882ed945-3b9f-47f5-81c6-ac139968cd22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_c5903d87-16db-4200-b697-25a662ae5559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_c5903d87-16db-4200-b697-25a662ae5559" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfOutstandingShares_c44d2541-2630-4566-be09-ad0efacc7a83" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfOutstandingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionPercentageOfOutstandingShares_c44d2541-2630-4566-be09-ad0efacc7a83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionTotalConsiderationTransferred_5eaaadd0-7b86-4752-b495-04ae727b904a" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionTotalConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionTotalConsiderationTransferred_5eaaadd0-7b86-4752-b495-04ae727b904a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionConsiderationTransferred_ea4116cb-0d1a-4e79-8b51-5cca9b624c42" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionConsiderationTransferred_ea4116cb-0d1a-4e79-8b51-5cca9b624c42" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsForAssetAcquisitions_54be5eb5-4b12-44b3-a45f-91937190d981" xlink:href="ams-20201231.xsd#ams_PaymentsForAssetAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_PaymentsForAssetAcquisitions_54be5eb5-4b12-44b3-a45f-91937190d981" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionTransactionCosts_ec1a39e0-90f8-4e61-bcbc-172af9ce0e6b" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionTransactionCosts_ec1a39e0-90f8-4e61-bcbc-172af9ce0e6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsForWorkingCapital_b874dbda-fda6-40d2-8da9-8f0d055e459f" xlink:href="ams-20201231.xsd#ams_PaymentsForWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_PaymentsForWorkingCapital_b874dbda-fda6-40d2-8da9-8f0d055e459f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAdditionalConsiderationTransferred_e2225b9d-72ec-4f9e-aec2-70c777697278" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAdditionalConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionAdditionalConsiderationTransferred_e2225b9d-72ec-4f9e-aec2-70c777697278" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsToAcquireAsset_ce70f186-16e9-4287-bf4b-fc5ca26aa54d" xlink:href="ams-20201231.xsd#ams_PaymentsToAcquireAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_PaymentsToAcquireAsset_ce70f186-16e9-4287-bf4b-fc5ca26aa54d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition_baf2a220-deca-407a-8d3e-2975692f21cc" xlink:href="ams-20201231.xsd#ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition_baf2a220-deca-407a-8d3e-2975692f21cc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAccountsReceivable_39be6227-dd02-4cc4-8510-bdd3b13d6cff" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionAccountsReceivable_39be6227-dd02-4cc4-8510-bdd3b13d6cff" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionLiabilitiesAssumed_b7cfc423-a0fe-406c-aea4-3edf20ffd29d" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionLiabilitiesAssumed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionLiabilitiesAssumed_b7cfc423-a0fe-406c-aea4-3edf20ffd29d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration_ac2f05b0-c481-457c-847b-e0e2832245ee" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration_ac2f05b0-c481-457c-847b-e0e2832245ee" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_d835c312-112a-4491-bc37-6a83104b4a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_d835c312-112a-4491-bc37-6a83104b4a1d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6845070c-2fe4-4755-a57c-74e208d40930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6845070c-2fe4-4755-a57c-74e208d40930" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36872d8d-084c-4f27-a2a2-4b369d50440d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36872d8d-084c-4f27-a2a2-4b369d50440d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAxis_0ed3ea08-180f-44a7-b6a2-8d17db355d89" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36872d8d-084c-4f27-a2a2-4b369d50440d" xlink:to="loc_ams_AssetAcquisitionAxis_0ed3ea08-180f-44a7-b6a2-8d17db355d89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_0ed3ea08-180f-44a7-b6a2-8d17db355d89_default" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ams_AssetAcquisitionAxis_0ed3ea08-180f-44a7-b6a2-8d17db355d89" xlink:to="loc_ams_AssetAcquisitionDomain_0ed3ea08-180f-44a7-b6a2-8d17db355d89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_1a796513-2cd2-49ea-a130-2f7bfa434172" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ams_AssetAcquisitionAxis_0ed3ea08-180f-44a7-b6a2-8d17db355d89" xlink:to="loc_ams_AssetAcquisitionDomain_1a796513-2cd2-49ea-a130-2f7bfa434172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GKCEAcquisitionMember_3c57c83f-a6bf-43a8-9d2b-2bf081216783" xlink:href="ams-20201231.xsd#ams_GKCEAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AssetAcquisitionDomain_1a796513-2cd2-49ea-a130-2f7bfa434172" xlink:to="loc_ams_GKCEAcquisitionMember_3c57c83f-a6bf-43a8-9d2b-2bf081216783" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_20b50a00-87f2-4a71-8e06-a141b6ba74fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36872d8d-084c-4f27-a2a2-4b369d50440d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_20b50a00-87f2-4a71-8e06-a141b6ba74fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_20b50a00-87f2-4a71-8e06-a141b6ba74fd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_20b50a00-87f2-4a71-8e06-a141b6ba74fd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_20b50a00-87f2-4a71-8e06-a141b6ba74fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_67b9ee77-10f8-4fd6-9c9a-31ea7d223a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_20b50a00-87f2-4a71-8e06-a141b6ba74fd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_67b9ee77-10f8-4fd6-9c9a-31ea7d223a9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_948d8c8f-5687-44f6-8607-e608d0963a7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_67b9ee77-10f8-4fd6-9c9a-31ea7d223a9a" xlink:to="loc_us-gaap_TradeNamesMember_948d8c8f-5687-44f6-8607-e608d0963a7d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails" xlink:type="extended" id="i30a695094b764c75b7cba3fd575d630e_GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionCashAndCashEquivalents_2a605fb2-8010-4e8f-ae38-baf403d5410a" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionCashAndCashEquivalents_2a605fb2-8010-4e8f-ae38-baf403d5410a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAccountsReceivable_be51955e-a0ea-4a74-989e-6a8e7cbcfd3a" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionAccountsReceivable_be51955e-a0ea-4a74-989e-6a8e7cbcfd3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPrepaidExpenseAndOther_67a49cff-19e7-46da-80d5-4d1c7ae8a716" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPrepaidExpenseAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionPrepaidExpenseAndOther_67a49cff-19e7-46da-80d5-4d1c7ae8a716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_552ad9b7-b8ef-466a-b512-5e7a8b7c11cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_552ad9b7-b8ef-466a-b512-5e7a8b7c11cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_2c4fc3f5-524e-4ec9-b147-fa8010b08630" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_2c4fc3f5-524e-4ec9-b147-fa8010b08630" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_f4feb5cd-e88e-41a1-994a-97fdd65dafaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_f4feb5cd-e88e-41a1-994a-97fdd65dafaa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAssetsAcquired_22c1b082-7cc9-4c7f-8d39-5aa6af674bb0" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionAssetsAcquired_22c1b082-7cc9-4c7f-8d39-5aa6af674bb0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAccountsPayable_8c1681b5-8bab-48d1-a5ee-6ce5da93c040" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionAccountsPayable_8c1681b5-8bab-48d1-a5ee-6ce5da93c040" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionIncomeTaxesPayable_2d1ad9cd-a894-426e-90fb-1598e2975f9a" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionIncomeTaxesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionIncomeTaxesPayable_2d1ad9cd-a894-426e-90fb-1598e2975f9a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDeferredIncomeTaxes_0d559c57-70bd-4ecd-9aef-f87d88deeeb7" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDeferredIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionDeferredIncomeTaxes_0d559c57-70bd-4ecd-9aef-f87d88deeeb7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionEmployeeCompensationAndBenefits_05d2a7c9-4c6f-4d23-9f45-e35651fadc59" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionEmployeeCompensationAndBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionEmployeeCompensationAndBenefits_05d2a7c9-4c6f-4d23-9f45-e35651fadc59" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionLiabilitiesAssumed_f29865d1-afbf-4a96-9866-60524b8184ea" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionLiabilitiesAssumed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionLiabilitiesAssumed_f29865d1-afbf-4a96-9866-60524b8184ea" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionTotalConsiderationTransferred_fd8b7bb4-3015-4a40-a098-28bf51c2996a" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionTotalConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionTotalConsiderationTransferred_fd8b7bb4-3015-4a40-a098-28bf51c2996a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsForWorkingCapital_ede0adc8-2d4a-44bc-989c-d8057e8f8084" xlink:href="ams-20201231.xsd#ams_PaymentsForWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_PaymentsForWorkingCapital_ede0adc8-2d4a-44bc-989c-d8057e8f8084" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAdditionalConsiderationTransferred_a04a084b-51c5-4498-9ba6-1dc854d498b3" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAdditionalConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionAdditionalConsiderationTransferred_a04a084b-51c5-4498-9ba6-1dc854d498b3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionConsiderationTransferred_34bf9ed5-540b-48e2-92aa-a5a95df0860b" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionConsiderationTransferred_34bf9ed5-540b-48e2-92aa-a5a95df0860b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_759b04fd-403a-438c-9d0e-b997d224ba78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_759b04fd-403a-438c-9d0e-b997d224ba78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAxis_67702436-7015-4656-a61a-ebe2153ca332" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_759b04fd-403a-438c-9d0e-b997d224ba78" xlink:to="loc_ams_AssetAcquisitionAxis_67702436-7015-4656-a61a-ebe2153ca332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_67702436-7015-4656-a61a-ebe2153ca332_default" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ams_AssetAcquisitionAxis_67702436-7015-4656-a61a-ebe2153ca332" xlink:to="loc_ams_AssetAcquisitionDomain_67702436-7015-4656-a61a-ebe2153ca332_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_4124a53a-1967-490d-be04-20f2853385ab" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ams_AssetAcquisitionAxis_67702436-7015-4656-a61a-ebe2153ca332" xlink:to="loc_ams_AssetAcquisitionDomain_4124a53a-1967-490d-be04-20f2853385ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GKCEAcquisitionMember_b6a449fd-a32d-439c-88e5-33ceca2e4ab1" xlink:href="ams-20201231.xsd#ams_GKCEAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AssetAcquisitionDomain_4124a53a-1967-490d-be04-20f2853385ab" xlink:to="loc_ams_GKCEAcquisitionMember_b6a449fd-a32d-439c-88e5-33ceca2e4ab1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_63bd672a-7005-4104-a547-2fecdd9f658b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_759b04fd-403a-438c-9d0e-b997d224ba78" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_63bd672a-7005-4104-a547-2fecdd9f658b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_63bd672a-7005-4104-a547-2fecdd9f658b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_63bd672a-7005-4104-a547-2fecdd9f658b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_63bd672a-7005-4104-a547-2fecdd9f658b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b92b9507-9464-412e-9b2b-f1fdd871e71f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_63bd672a-7005-4104-a547-2fecdd9f658b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b92b9507-9464-412e-9b2b-f1fdd871e71f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_372b30e0-ad8e-44e3-b06f-22fe99b3a1c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b92b9507-9464-412e-9b2b-f1fdd871e71f" xlink:to="loc_us-gaap_TradeNamesMember_372b30e0-ad8e-44e3-b06f-22fe99b3a1c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a5955af6-b222-4bc2-bacb-8af3f7d31b80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_759b04fd-403a-438c-9d0e-b997d224ba78" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a5955af6-b222-4bc2-bacb-8af3f7d31b80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a5955af6-b222-4bc2-bacb-8af3f7d31b80_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a5955af6-b222-4bc2-bacb-8af3f7d31b80" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a5955af6-b222-4bc2-bacb-8af3f7d31b80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bc7a1e2-502c-4888-8fd6-968677c2815e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a5955af6-b222-4bc2-bacb-8af3f7d31b80" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bc7a1e2-502c-4888-8fd6-968677c2815e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_151632cf-86da-4958-8514-a813d2a6ec24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bc7a1e2-502c-4888-8fd6-968677c2815e" xlink:to="loc_us-gaap_BuildingMember_151632cf-86da-4958-8514-a813d2a6ec24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_75956205-7d88-46c7-ab2f-0305db22ac42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bc7a1e2-502c-4888-8fd6-968677c2815e" xlink:to="loc_us-gaap_LandMember_75956205-7d88-46c7-ab2f-0305db22ac42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MedicalEquipmentAndOtherFixedAssetsMember_cd5a37bf-648e-4f13-b34e-a8e00d33a7d6" xlink:href="ams-20201231.xsd#ams_MedicalEquipmentAndOtherFixedAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bc7a1e2-502c-4888-8fd6-968677c2815e" xlink:to="loc_ams_MedicalEquipmentAndOtherFixedAssetsMember_cd5a37bf-648e-4f13-b34e-a8e00d33a7d6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails" xlink:type="extended" id="ic83b41369c66416f97efeee7f9fe0b41_GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_380bd533-25a7-41aa-a04b-a6c866800a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_1e955514-2c5d-4625-a3ff-91063005ddff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_380bd533-25a7-41aa-a04b-a6c866800a67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_1e955514-2c5d-4625-a3ff-91063005ddff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_4e3abf8c-9a20-43a2-b6c3-6511556b20f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_380bd533-25a7-41aa-a04b-a6c866800a67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_4e3abf8c-9a20-43a2-b6c3-6511556b20f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67cad83b-b67d-4e31-869c-aeecdbac13aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_380bd533-25a7-41aa-a04b-a6c866800a67" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67cad83b-b67d-4e31-869c-aeecdbac13aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAxis_a175605d-c550-4fb7-825a-2076f216a250" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67cad83b-b67d-4e31-869c-aeecdbac13aa" xlink:to="loc_ams_AssetAcquisitionAxis_a175605d-c550-4fb7-825a-2076f216a250" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_a175605d-c550-4fb7-825a-2076f216a250_default" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ams_AssetAcquisitionAxis_a175605d-c550-4fb7-825a-2076f216a250" xlink:to="loc_ams_AssetAcquisitionDomain_a175605d-c550-4fb7-825a-2076f216a250_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_c9ed72fb-2aba-49af-b4db-b6e08c1ae539" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ams_AssetAcquisitionAxis_a175605d-c550-4fb7-825a-2076f216a250" xlink:to="loc_ams_AssetAcquisitionDomain_c9ed72fb-2aba-49af-b4db-b6e08c1ae539" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GKCEAcquisitionMember_15af0998-44e0-42cf-bcc1-cf78c7a87e99" xlink:href="ams-20201231.xsd#ams_GKCEAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_AssetAcquisitionDomain_c9ed72fb-2aba-49af-b4db-b6e08c1ae539" xlink:to="loc_ams_GKCEAcquisitionMember_15af0998-44e0-42cf-bcc1-cf78c7a87e99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_788f0955-7274-4fd8-a58c-d7bf9e1ae07e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67cad83b-b67d-4e31-869c-aeecdbac13aa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_788f0955-7274-4fd8-a58c-d7bf9e1ae07e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_788f0955-7274-4fd8-a58c-d7bf9e1ae07e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_788f0955-7274-4fd8-a58c-d7bf9e1ae07e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_788f0955-7274-4fd8-a58c-d7bf9e1ae07e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8bbb77-ecca-49f5-b660-5af7cfd68c4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_788f0955-7274-4fd8-a58c-d7bf9e1ae07e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8bbb77-ecca-49f5-b660-5af7cfd68c4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_45ec9ad0-bac8-496e-b692-405ee5158035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8bbb77-ecca-49f5-b660-5af7cfd68c4e" xlink:to="loc_us-gaap_BuildingMember_45ec9ad0-bac8-496e-b692-405ee5158035" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_7f884c29-ba2e-4cd2-b48f-b9a823d6fc05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8bbb77-ecca-49f5-b660-5af7cfd68c4e" xlink:to="loc_us-gaap_LandMember_7f884c29-ba2e-4cd2-b48f-b9a823d6fc05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MedicalEquipmentMember_7022e401-a613-4c42-96eb-ed262578aac9" xlink:href="ams-20201231.xsd#ams_MedicalEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8bbb77-ecca-49f5-b660-5af7cfd68c4e" xlink:to="loc_ams_MedicalEquipmentMember_7022e401-a613-4c42-96eb-ed262578aac9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_OtherFixedAssetsMember_f2ea8fe8-5020-4be9-90c7-2860518b63db" xlink:href="ams-20201231.xsd#ams_OtherFixedAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8bbb77-ecca-49f5-b660-5af7cfd68c4e" xlink:to="loc_ams_OtherFixedAssetsMember_f2ea8fe8-5020-4be9-90c7-2860518b63db" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LONGTERMDEBT" xlink:type="simple" xlink:href="ams-20201231.xsd#LONGTERMDEBT"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/LONGTERMDEBT" xlink:type="extended" id="ibfa635b678094eb8a603d950921359ce_LONGTERMDEBT"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LONGTERMDEBTTables" xlink:type="simple" xlink:href="ams-20201231.xsd#LONGTERMDEBTTables"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/LONGTERMDEBTTables" xlink:type="extended" id="i98fbe47894c241369e7a8aca8057797a_LONGTERMDEBTTables"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#LONGTERMDEBTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails" xlink:type="extended" id="i5375fa24a0c04a36b899efffb6c62a0f_LONGTERMDEBTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfDebtInstruments_2ec04c42-68a2-4d8e-8b7c-77891740faa2" xlink:href="ams-20201231.xsd#ams_NumberOfDebtInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_ams_NumberOfDebtInstruments_2ec04c42-68a2-4d8e-8b7c-77891740faa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCollateralAmount_5a188577-fa83-4f35-bc9c-1cacdb79839d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCollateralAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_us-gaap_DebtInstrumentCollateralAmount_5a188577-fa83-4f35-bc9c-1cacdb79839d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_1a7d709f-2e0f-48c4-8477-b5777f0b1dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_1a7d709f-2e0f-48c4-8477-b5777f0b1dc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermDebtMonthlyInstallments_c4d7816e-a2a4-4823-af8e-40b078835862" xlink:href="ams-20201231.xsd#ams_LongTermDebtMonthlyInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_ams_LongTermDebtMonthlyInstallments_c4d7816e-a2a4-4823-af8e-40b078835862" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingVariableInterestRate_b6c9d684-8732-4ed5-9e58-325394a62fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtPercentageBearingVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingVariableInterestRate_b6c9d684-8732-4ed5-9e58-325394a62fb5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_5f878072-e6f9-4f0f-af0e-cfe084e1337d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_5f878072-e6f9-4f0f-af0e-cfe084e1337d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_40b87a79-2229-456a-a961-f09080fe7c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_us-gaap_DebtInstrumentTable_40b87a79-2229-456a-a961-f09080fe7c3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0a87a4b9-70b6-4ef6-af67-98e3da262390" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_40b87a79-2229-456a-a961-f09080fe7c3c" xlink:to="loc_srt_RangeAxis_0a87a4b9-70b6-4ef6-af67-98e3da262390" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0a87a4b9-70b6-4ef6-af67-98e3da262390_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0a87a4b9-70b6-4ef6-af67-98e3da262390" xlink:to="loc_srt_RangeMember_0a87a4b9-70b6-4ef6-af67-98e3da262390_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b61cdb43-d72b-4dbf-b2e4-8d72a270c531" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0a87a4b9-70b6-4ef6-af67-98e3da262390" xlink:to="loc_srt_RangeMember_b61cdb43-d72b-4dbf-b2e4-8d72a270c531" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5c446948-f5de-4686-b305-9b0b26e4ae2c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b61cdb43-d72b-4dbf-b2e4-8d72a270c531" xlink:to="loc_srt_MinimumMember_5c446948-f5de-4686-b305-9b0b26e4ae2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5d12addf-828d-4a22-b430-f443e56639c9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b61cdb43-d72b-4dbf-b2e4-8d72a270c531" xlink:to="loc_srt_MaximumMember_5d12addf-828d-4a22-b430-f443e56639c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f35b46bc-81e1-4273-b5b4-93a186c91960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_40b87a79-2229-456a-a961-f09080fe7c3c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f35b46bc-81e1-4273-b5b4-93a186c91960" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f35b46bc-81e1-4273-b5b4-93a186c91960_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f35b46bc-81e1-4273-b5b4-93a186c91960" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f35b46bc-81e1-4273-b5b4-93a186c91960_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b7e8b021-9990-4676-a5af-9983c73500d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f35b46bc-81e1-4273-b5b4-93a186c91960" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b7e8b021-9990-4676-a5af-9983c73500d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeUnitMember_a6ab247e-9740-4676-aab8-7cde0c729ff5" xlink:href="ams-20201231.xsd#ams_GammaKnifeUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b7e8b021-9990-4676-a5af-9983c73500d9" xlink:to="loc_ams_GammaKnifeUnitMember_a6ab247e-9740-4676-aab8-7cde0c729ff5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LONGTERMDEBTDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#LONGTERMDEBTDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/LONGTERMDEBTDetails" xlink:type="extended" id="i16ff799747f943fcafb27ea7a91d5e3c_LONGTERMDEBTDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASES" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASES"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/FINANCELEASES" xlink:type="extended" id="ia48ad2819d5442f8bc63a37204ffe708_FINANCELEASES"/>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASESTables"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/FINANCELEASESTables" xlink:type="extended" id="i229562ee176641539de193760483718d_FINANCELEASESTables"/>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/FINANCELEASESNarrativeDetails" xlink:type="extended" id="idcab888ac3274a459e6ea3a3f857a4d8_FINANCELEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfFinancingLeases_57a5b582-52e2-4a10-affd-8571cf7548f3" xlink:href="ams-20201231.xsd#ams_NumberOfFinancingLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:to="loc_ams_NumberOfFinancingLeases_57a5b582-52e2-4a10-affd-8571cf7548f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeaseObligations_da247cdc-cf61-4bb1-8d7b-6d7b1093e353" xlink:href="ams-20201231.xsd#ams_FinanceLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:to="loc_ams_FinanceLeaseObligations_da247cdc-cf61-4bb1-8d7b-6d7b1093e353" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeaseAccountsReceivable_879cc247-8478-4975-ad64-7edc0ebeb571" xlink:href="ams-20201231.xsd#ams_FinanceLeaseAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:to="loc_ams_FinanceLeaseAccountsReceivable_879cc247-8478-4975-ad64-7edc0ebeb571" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeaseObligationInterestRate_9c85a613-a701-4a9c-adda-5666882fcfb3" xlink:href="ams-20201231.xsd#ams_FinanceLeaseObligationInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:to="loc_ams_FinanceLeaseObligationInterestRate_9c85a613-a701-4a9c-adda-5666882fcfb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeaseObligationsMonthlyInstallments_df43e3b6-0764-4dcc-ba99-a9a2a3aadfd8" xlink:href="ams-20201231.xsd#ams_FinanceLeaseObligationsMonthlyInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:to="loc_ams_FinanceLeaseObligationsMonthlyInstallments_df43e3b6-0764-4dcc-ba99-a9a2a3aadfd8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_80c639f9-221d-44e7-ae67-de542e70a64e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_80c639f9-221d-44e7-ae67-de542e70a64e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e00d418c-a97b-4e5d-ad20-c504dfe1b93a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_80c639f9-221d-44e7-ae67-de542e70a64e" xlink:to="loc_srt_RangeAxis_e00d418c-a97b-4e5d-ad20-c504dfe1b93a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e00d418c-a97b-4e5d-ad20-c504dfe1b93a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e00d418c-a97b-4e5d-ad20-c504dfe1b93a" xlink:to="loc_srt_RangeMember_e00d418c-a97b-4e5d-ad20-c504dfe1b93a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1638d5ae-0a3d-4e7e-ba1a-d866b95f20a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e00d418c-a97b-4e5d-ad20-c504dfe1b93a" xlink:to="loc_srt_RangeMember_1638d5ae-0a3d-4e7e-ba1a-d866b95f20a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5ae39fb0-4d2e-4885-9335-cd6a3ff6454f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1638d5ae-0a3d-4e7e-ba1a-d866b95f20a6" xlink:to="loc_srt_MinimumMember_5ae39fb0-4d2e-4885-9335-cd6a3ff6454f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bbba5dfa-e7c1-4210-9de1-c1fa26702b43" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1638d5ae-0a3d-4e7e-ba1a-d866b95f20a6" xlink:to="loc_srt_MaximumMember_bbba5dfa-e7c1-4210-9de1-c1fa26702b43" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASESDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASESDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/FINANCELEASESDetails" xlink:type="extended" id="i60545c9dc3164d49ac11049001473850_FINANCELEASESDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASES" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASES"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/LEASES" xlink:type="extended" id="iec09783fdf8143fe9db793a5a63ff73d_LEASES"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASESTables"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/LEASESTables" xlink:type="extended" id="i8389b167d46c41148719d59e05ebec8b_LEASESTables"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/LEASESNarrativeDetails" xlink:type="extended" id="i1e38476699474874bb8cd3260045d654_LEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_c9089eb8-ab6f-4457-bdd3-2e171c9e3bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_c9089eb8-ab6f-4457-bdd3-2e171c9e3bb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_7a0540cf-2dfc-4d76-b45b-ac2886f58cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_7a0540cf-2dfc-4d76-b45b-ac2886f58cba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_75f00bf0-ee4e-4a45-856c-57e0db777fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_75f00bf0-ee4e-4a45-856c-57e0db777fc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_15dc7a3a-2d1b-4562-9cfb-f95c989c3c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_us-gaap_OperatingLeaseLiability_15dc7a3a-2d1b-4562-9cfb-f95c989c3c76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities_267bf6fd-f3b9-4739-9c5d-c81a2b677ea6" xlink:href="ams-20201231.xsd#ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities_267bf6fd-f3b9-4739-9c5d-c81a2b677ea6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonCashRightOfUseAssetsAndLeaseLiabilities_9dde9c49-e00c-4f34-9848-aa7cb456acfe" xlink:href="ams-20201231.xsd#ams_NonCashRightOfUseAssetsAndLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_ams_NonCashRightOfUseAssetsAndLeaseLiabilities_9dde9c49-e00c-4f34-9848-aa7cb456acfe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_97ebe3d1-3586-4853-9c72-72a0e97445fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_97ebe3d1-3586-4853-9c72-72a0e97445fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e5c00dd7-a01e-44cc-8187-691ced417861" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_97ebe3d1-3586-4853-9c72-72a0e97445fd" xlink:to="loc_srt_RangeAxis_e5c00dd7-a01e-44cc-8187-691ced417861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e5c00dd7-a01e-44cc-8187-691ced417861_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e5c00dd7-a01e-44cc-8187-691ced417861" xlink:to="loc_srt_RangeMember_e5c00dd7-a01e-44cc-8187-691ced417861_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_981856cc-975b-41af-8203-98cc9ab4e21e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e5c00dd7-a01e-44cc-8187-691ced417861" xlink:to="loc_srt_RangeMember_981856cc-975b-41af-8203-98cc9ab4e21e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b898473f-0a5d-4588-8fd0-d63c74101a37" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_981856cc-975b-41af-8203-98cc9ab4e21e" xlink:to="loc_srt_MinimumMember_b898473f-0a5d-4588-8fd0-d63c74101a37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_311932a5-99f7-4be7-94f8-ef0dc84fe2af" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_981856cc-975b-41af-8203-98cc9ab4e21e" xlink:to="loc_srt_MaximumMember_311932a5-99f7-4be7-94f8-ef0dc84fe2af" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails" xlink:type="extended" id="i94db37425ad840a3b2a38d1185f6217f_LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXES" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXES"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/INCOMETAXES" xlink:type="extended" id="i15a487b97d914bb98336b58bff448db1_INCOMETAXES"/>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESTables"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/INCOMETAXESTables" xlink:type="extended" id="ie5744edcc8af4dc49a603c3fa9ae6661_INCOMETAXESTables"/>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended" id="ic54d53c0fe0243d6bc02933d2a53ec82_INCOMETAXESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:href="ams-20201231.xsd#ams_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8944f82b-e1c0-4d9b-b3ad-5df6134254c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8944f82b-e1c0-4d9b-b3ad-5df6134254c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_aba284d6-c129-4d98-b611-389f2c613223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_aba284d6-c129-4d98-b611-389f2c613223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_591d5350-600e-41eb-ba65-63e32c89c3e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_591d5350-600e-41eb-ba65-63e32c89c3e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_3bf9c72d-f10f-4a2b-b00e-07f8d6f49939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_OperatingLossCarryforwards_3bf9c72d-f10f-4a2b-b00e-07f8d6f49939" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_5db52322-b7e9-441d-9f51-37143b2ad60e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_5db52322-b7e9-441d-9f51-37143b2ad60e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8d436216-acc5-4a6b-9a19-487f1e67c7e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8d436216-acc5-4a6b-9a19-487f1e67c7e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ecb85919-a009-4551-8b08-84780e00b716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ecb85919-a009-4551-8b08-84780e00b716" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8316bcd7-40e4-4535-bee0-8d821e5e0fc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8316bcd7-40e4-4535-bee0-8d821e5e0fc0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncomeTaxDisclosureTable_24cd36a4-3369-4e27-b705-5380caddfb89" xlink:href="ams-20201231.xsd#ams_IncomeTaxDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_ams_IncomeTaxDisclosureTable_24cd36a4-3369-4e27-b705-5380caddfb89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_f5b46500-c508-471d-9c01-992f864d55e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_IncomeTaxDisclosureTable_24cd36a4-3369-4e27-b705-5380caddfb89" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_f5b46500-c508-471d-9c01-992f864d55e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f5b46500-c508-471d-9c01-992f864d55e9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f5b46500-c508-471d-9c01-992f864d55e9" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f5b46500-c508-471d-9c01-992f864d55e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d21c9a0e-5251-4610-a2aa-2f8eb30659c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f5b46500-c508-471d-9c01-992f864d55e9" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d21c9a0e-5251-4610-a2aa-2f8eb30659c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_5878f8a9-7fc7-45c7-96ab-6be6ac50b9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d21c9a0e-5251-4610-a2aa-2f8eb30659c0" xlink:to="loc_us-gaap_DomesticCountryMember_5878f8a9-7fc7-45c7-96ab-6be6ac50b9f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_2e664684-7b64-4330-b47d-aab9ac34fc56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d21c9a0e-5251-4610-a2aa-2f8eb30659c0" xlink:to="loc_us-gaap_ForeignCountryMember_2e664684-7b64-4330-b47d-aab9ac34fc56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_1da40c29-659f-4ef2-be86-b2467648f9fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d21c9a0e-5251-4610-a2aa-2f8eb30659c0" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_1da40c29-659f-4ef2-be86-b2467648f9fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9abcad9b-4f06-4052-846b-43100b0e9505" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_IncomeTaxDisclosureTable_24cd36a4-3369-4e27-b705-5380caddfb89" xlink:to="loc_srt_StatementGeographicalAxis_9abcad9b-4f06-4052-846b-43100b0e9505" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9abcad9b-4f06-4052-846b-43100b0e9505_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9abcad9b-4f06-4052-846b-43100b0e9505" xlink:to="loc_srt_SegmentGeographicalDomain_9abcad9b-4f06-4052-846b-43100b0e9505_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_95372195-45bb-4e11-8ebd-2a811117ed8f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9abcad9b-4f06-4052-846b-43100b0e9505" xlink:to="loc_srt_SegmentGeographicalDomain_95372195-45bb-4e11-8ebd-2a811117ed8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PeruDeferredTaxAssetsMember_c6c46f1a-6513-4735-a2b3-010c5c49c3e4" xlink:href="ams-20201231.xsd#ams_PeruDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_95372195-45bb-4e11-8ebd-2a811117ed8f" xlink:to="loc_ams_PeruDeferredTaxAssetsMember_c6c46f1a-6513-4735-a2b3-010c5c49c3e4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="extended" id="if80714a83c5d4e5dbd91221d17badc4a_INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="i31f0d5eb31aa4c32a47e8fc810ff3332_INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails" xlink:type="extended" id="ic74223fa8d5b494bb1eff9f4566707a7_INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended" id="ieb2fbbc99ebc46c1b0d1f6f2c1ecd82e_INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended" id="i527c12d6afa84a3d9c88d7ff615c9b35_INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSE" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSE"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSE" xlink:type="extended" id="ib964714f132f4cda8111f8d1f08462f5_STOCKBASEDCOMPENSATIONEXPENSE"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSETables"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables" xlink:type="extended" id="ic150dbc54e3f46a0b5555c4bfcf1b99c_STOCKBASEDCOMPENSATIONEXPENSETables"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails" xlink:type="extended" id="id98775d6ac0048a99412a874b1393857_STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1d72df0a-7ba1-45d1-9e82-11f4b00abf1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1d72df0a-7ba1-45d1-9e82-11f4b00abf1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant_2476a300-fae1-458c-9519-76133b79fcae" xlink:href="ams-20201231.xsd#ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant_2476a300-fae1-458c-9519-76133b79fcae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_58c36d89-da0c-4a6d-bb9d-729319f59ed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_58c36d89-da0c-4a6d-bb9d-729319f59ed2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_eb38c1aa-bd64-4c24-9642-9c2dbd57bf10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_eb38c1aa-bd64-4c24-9642-9c2dbd57bf10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d45edb3f-aa1f-4bd5-8d4d-324468997bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d45edb3f-aa1f-4bd5-8d4d-324468997bc1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_02ccb848-e8ef-48f5-bdd3-1a7868a155de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_02ccb848-e8ef-48f5-bdd3-1a7868a155de" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfEmployees_dcf83fb1-ba1b-4124-9e0c-f187a3cd196b" xlink:href="ams-20201231.xsd#ams_NumberOfEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_ams_NumberOfEmployees_dcf83fb1-ba1b-4124-9e0c-f187a3cd196b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8b5ed5a4-a6a1-4339-b268-b472222ef04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8b5ed5a4-a6a1-4339-b268-b472222ef04f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_75007d09-d1a2-4843-b343-6bba37236fbf" xlink:href="ams-20201231.xsd#ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_75007d09-d1a2-4843-b343-6bba37236fbf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_9d8919bf-580b-4b05-87da-1fa43f2975a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_9d8919bf-580b-4b05-87da-1fa43f2975a9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_6a28a34f-867b-405e-a502-d66a6d1ebf16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_6a28a34f-867b-405e-a502-d66a6d1ebf16" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_OffsettingTaxBenefit_31619ac6-d4fd-4b6f-90fa-5442c1e97443" xlink:href="ams-20201231.xsd#ams_OffsettingTaxBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_ams_OffsettingTaxBenefit_31619ac6-d4fd-4b6f-90fa-5442c1e97443" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_68df0dc4-af73-489d-b608-e80b5552d591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_68df0dc4-af73-489d-b608-e80b5552d591" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9ebabc7f-c2a8-4c5c-853f-f450bec29ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9ebabc7f-c2a8-4c5c-853f-f450bec29ac0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_34a91801-99a3-49a0-b917-d5326684dada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_34a91801-99a3-49a0-b917-d5326684dada" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9ef46b8e-c244-480b-824b-26003fa68fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9ef46b8e-c244-480b-824b-26003fa68fef" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_02441046-f404-4b38-9ce8-d0ccfdb8f323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_02441046-f404-4b38-9ce8-d0ccfdb8f323" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3cc50d7a-0f6c-4400-b0ab-8c8a498210f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3cc50d7a-0f6c-4400-b0ab-8c8a498210f4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_36df5028-4e29-4ecc-b50f-179f91032006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_36df5028-4e29-4ecc-b50f-179f91032006" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_18466512-e96d-40a9-a2c0-0d394e704ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_18466512-e96d-40a9-a2c0-0d394e704ad6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5079621b-c8c6-4ec2-bc7b-659d2d3b92b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5079621b-c8c6-4ec2-bc7b-659d2d3b92b0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_403529fc-cc15-4a8c-b182-97d5954fa0c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_403529fc-cc15-4a8c-b182-97d5954fa0c6" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_bbccfe63-5eff-4187-a3b3-d143ade80b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_bbccfe63-5eff-4187-a3b3-d143ade80b03" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_087ab8ed-9de1-4b2f-b159-1fe158d02c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_087ab8ed-9de1-4b2f-b159-1fe158d02c71" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_aaef88cc-a3d7-4a53-b67c-1b344f113203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_aaef88cc-a3d7-4a53-b67c-1b344f113203" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fada9122-d1bc-4a78-a0a4-8da45dbcb78d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fada9122-d1bc-4a78-a0a4-8da45dbcb78d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fada9122-d1bc-4a78-a0a4-8da45dbcb78d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fada9122-d1bc-4a78-a0a4-8da45dbcb78d" xlink:to="loc_us-gaap_ClassOfStockDomain_fada9122-d1bc-4a78-a0a4-8da45dbcb78d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a50f010b-b84f-469f-9b70-1f23fca1f295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fada9122-d1bc-4a78-a0a4-8da45dbcb78d" xlink:to="loc_us-gaap_ClassOfStockDomain_a50f010b-b84f-469f-9b70-1f23fca1f295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_RetainerFeesMember_3658342e-3799-4842-9f28-9bf27f1ac2ae" xlink:href="ams-20201231.xsd#ams_RetainerFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a50f010b-b84f-469f-9b70-1f23fca1f295" xlink:to="loc_ams_RetainerFeesMember_3658342e-3799-4842-9f28-9bf27f1ac2ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f3234699-e5bf-48ea-a6ec-c42c34969336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:to="loc_us-gaap_PlanNameAxis_f3234699-e5bf-48ea-a6ec-c42c34969336" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f3234699-e5bf-48ea-a6ec-c42c34969336_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_f3234699-e5bf-48ea-a6ec-c42c34969336" xlink:to="loc_us-gaap_PlanNameDomain_f3234699-e5bf-48ea-a6ec-c42c34969336_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3d0aa30e-cd69-423e-ab3a-393ffaee992e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_f3234699-e5bf-48ea-a6ec-c42c34969336" xlink:to="loc_us-gaap_PlanNameDomain_3d0aa30e-cd69-423e-ab3a-393ffaee992e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncentiveCompensationPlanMember_80e2ac41-11f5-46e7-bff0-d842807b59be" xlink:href="ams-20201231.xsd#ams_IncentiveCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3d0aa30e-cd69-423e-ab3a-393ffaee992e" xlink:to="loc_ams_IncentiveCompensationPlanMember_80e2ac41-11f5-46e7-bff0-d842807b59be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ExecutiveEquityAwardsMember_650c9e7e-5aaa-4c83-bd9f-dd84e9e5d716" xlink:href="ams-20201231.xsd#ams_ExecutiveEquityAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3d0aa30e-cd69-423e-ab3a-393ffaee992e" xlink:to="loc_ams_ExecutiveEquityAwardsMember_650c9e7e-5aaa-4c83-bd9f-dd84e9e5d716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PerformanceShareAwardAgreementMember_bfd14294-97b5-4d48-96ca-015953ecaac0" xlink:href="ams-20201231.xsd#ams_PerformanceShareAwardAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3d0aa30e-cd69-423e-ab3a-393ffaee992e" xlink:to="loc_ams_PerformanceShareAwardAgreementMember_bfd14294-97b5-4d48-96ca-015953ecaac0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_efef92c2-55a7-4606-b3ae-183e9b0c4c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_efef92c2-55a7-4606-b3ae-183e9b0c4c53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_efef92c2-55a7-4606-b3ae-183e9b0c4c53_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_efef92c2-55a7-4606-b3ae-183e9b0c4c53" xlink:to="loc_us-gaap_RelatedPartyDomain_efef92c2-55a7-4606-b3ae-183e9b0c4c53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c0068d11-cf51-47a2-b859-74a369768981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_efef92c2-55a7-4606-b3ae-183e9b0c4c53" xlink:to="loc_us-gaap_RelatedPartyDomain_c0068d11-cf51-47a2-b859-74a369768981" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonEmployeeDirectorsMember_29153db3-3270-474f-bae0-a1859c943625" xlink:href="ams-20201231.xsd#ams_NonEmployeeDirectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c0068d11-cf51-47a2-b859-74a369768981" xlink:to="loc_ams_NonEmployeeDirectorsMember_29153db3-3270-474f-bae0-a1859c943625" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonEmployeeDirectorsAndCorporateSecretaryMember_2ed9e02e-529f-4171-baf2-22e1588c1393" xlink:href="ams-20201231.xsd#ams_NonEmployeeDirectorsAndCorporateSecretaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c0068d11-cf51-47a2-b859-74a369768981" xlink:to="loc_ams_NonEmployeeDirectorsAndCorporateSecretaryMember_2ed9e02e-529f-4171-baf2-22e1588c1393" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_060bfc36-ea2f-4659-947b-948096c716aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:to="loc_srt_TitleOfIndividualAxis_060bfc36-ea2f-4659-947b-948096c716aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_060bfc36-ea2f-4659-947b-948096c716aa_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_060bfc36-ea2f-4659-947b-948096c716aa" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_060bfc36-ea2f-4659-947b-948096c716aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aec73033-ce2e-4e21-a2fd-c82e367663f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_060bfc36-ea2f-4659-947b-948096c716aa" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aec73033-ce2e-4e21-a2fd-c82e367663f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EmployeeMember_4d2facd3-0fbf-4496-ad92-f32135db703f" xlink:href="ams-20201231.xsd#ams_EmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aec73033-ce2e-4e21-a2fd-c82e367663f0" xlink:to="loc_ams_EmployeeMember_4d2facd3-0fbf-4496-ad92-f32135db703f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_a67c50db-196f-4a13-8ac1-c016a9f5fbf3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aec73033-ce2e-4e21-a2fd-c82e367663f0" xlink:to="loc_srt_ChiefExecutiveOfficerMember_a67c50db-196f-4a13-8ac1-c016a9f5fbf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_SeniorVicePresidentMember_0b710bf0-a793-4712-b426-82bcaaa74de8" xlink:href="ams-20201231.xsd#ams_SeniorVicePresidentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aec73033-ce2e-4e21-a2fd-c82e367663f0" xlink:to="loc_ams_SeniorVicePresidentMember_0b710bf0-a793-4712-b426-82bcaaa74de8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_aae66ebc-dfe2-4cdf-a6a4-118c669f34a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:to="loc_us-gaap_AwardTypeAxis_aae66ebc-dfe2-4cdf-a6a4-118c669f34a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aae66ebc-dfe2-4cdf-a6a4-118c669f34a4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_aae66ebc-dfe2-4cdf-a6a4-118c669f34a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aae66ebc-dfe2-4cdf-a6a4-118c669f34a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0aa14135-123a-4228-8e60-c581032040c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_aae66ebc-dfe2-4cdf-a6a4-118c669f34a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0aa14135-123a-4228-8e60-c581032040c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_37b0a635-0762-44f7-bac1-a803fabcba36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0aa14135-123a-4228-8e60-c581032040c4" xlink:to="loc_us-gaap_RestrictedStockMember_37b0a635-0762-44f7-bac1-a803fabcba36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6b065365-7697-4b96-b10b-b3faeb255e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0aa14135-123a-4228-8e60-c581032040c4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6b065365-7697-4b96-b10b-b3faeb255e9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_67a67826-9b9d-4e83-92c5-4ab655bea673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0aa14135-123a-4228-8e60-c581032040c4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_67a67826-9b9d-4e83-92c5-4ab655bea673" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails" xlink:type="extended" id="i82af8bb86a53418da15b5b1115baa72f_STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44e4644d-1fb4-41af-b079-d4956bf6e26a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20184a91-0a90-4f8c-8b7c-1649940371a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44e4644d-1fb4-41af-b079-d4956bf6e26a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20184a91-0a90-4f8c-8b7c-1649940371a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_bf9d0f07-c2a2-4b68-a426-2049dc8adc56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20184a91-0a90-4f8c-8b7c-1649940371a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_bf9d0f07-c2a2-4b68-a426-2049dc8adc56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_274bcce9-a5ad-481c-a3bd-461b89b814ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20184a91-0a90-4f8c-8b7c-1649940371a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_274bcce9-a5ad-481c-a3bd-461b89b814ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2baa4d27-2844-40bc-9944-d83e41362231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20184a91-0a90-4f8c-8b7c-1649940371a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2baa4d27-2844-40bc-9944-d83e41362231" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_5765e7b9-572e-472b-95e5-28a190f79ece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_634a5f02-ce9a-49a1-98cb-ede6215886a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44e4644d-1fb4-41af-b079-d4956bf6e26a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_634a5f02-ce9a-49a1-98cb-ede6215886a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8e8c1196-279c-4964-8c42-1b27c6a19c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_634a5f02-ce9a-49a1-98cb-ede6215886a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8e8c1196-279c-4964-8c42-1b27c6a19c06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6f0f2d33-b18a-4477-944b-6ac79ecb6ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_634a5f02-ce9a-49a1-98cb-ede6215886a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6f0f2d33-b18a-4477-944b-6ac79ecb6ffd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_240a842c-c84f-4fd9-9afe-f131fac6472e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_634a5f02-ce9a-49a1-98cb-ede6215886a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_240a842c-c84f-4fd9-9afe-f131fac6472e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_97174ec8-3645-4301-9cb9-f40bd87b39a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_7c81dd40-7a3e-40ef-8e85-5999f9c3710b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44e4644d-1fb4-41af-b079-d4956bf6e26a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_7c81dd40-7a3e-40ef-8e85-5999f9c3710b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_74bcae1b-5e5f-45e3-ad8c-223da39a51a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_7c81dd40-7a3e-40ef-8e85-5999f9c3710b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_74bcae1b-5e5f-45e3-ad8c-223da39a51a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_bcde8366-6789-4833-88d3-2f6712e00b43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_7c81dd40-7a3e-40ef-8e85-5999f9c3710b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_bcde8366-6789-4833-88d3-2f6712e00b43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_b0308584-e6a7-4284-a4dd-69a79f6265a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_7c81dd40-7a3e-40ef-8e85-5999f9c3710b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_b0308584-e6a7-4284-a4dd-69a79f6265a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_5d92d06a-82ae-4c7d-9a9f-d738f0d4f72e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e4712c41-4980-4202-a04b-b37b6c5f85be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44e4644d-1fb4-41af-b079-d4956bf6e26a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e4712c41-4980-4202-a04b-b37b6c5f85be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e9a8ae53-1fcd-4703-a8df-5f0c14f26a42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e4712c41-4980-4202-a04b-b37b6c5f85be" xlink:to="loc_us-gaap_AwardTypeAxis_e9a8ae53-1fcd-4703-a8df-5f0c14f26a42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9a8ae53-1fcd-4703-a8df-5f0c14f26a42_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e9a8ae53-1fcd-4703-a8df-5f0c14f26a42" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9a8ae53-1fcd-4703-a8df-5f0c14f26a42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c3383c2-7dd5-4764-8b64-fcd03a071a89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e9a8ae53-1fcd-4703-a8df-5f0c14f26a42" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c3383c2-7dd5-4764-8b64-fcd03a071a89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d4008dbc-5839-42c8-a89d-8d7cc8c093b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c3383c2-7dd5-4764-8b64-fcd03a071a89" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d4008dbc-5839-42c8-a89d-8d7cc8c093b5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails" xlink:type="extended" id="ib07a86695e534aec8717400c4f1fbb7c_STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f867ccdd-e1ab-4a88-8a93-f6804093cecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a955f9d2-21e0-4c58-9294-1bb537501230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f867ccdd-e1ab-4a88-8a93-f6804093cecd" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a955f9d2-21e0-4c58-9294-1bb537501230" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1db035c0-9558-4931-9d1f-d6e209882264" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f867ccdd-e1ab-4a88-8a93-f6804093cecd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1db035c0-9558-4931-9d1f-d6e209882264" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e45743be-c481-480b-b4fa-7a7691542e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f867ccdd-e1ab-4a88-8a93-f6804093cecd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e45743be-c481-480b-b4fa-7a7691542e88" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c99883a0-8f13-4820-b75d-b72560ada743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e45743be-c481-480b-b4fa-7a7691542e88" xlink:to="loc_us-gaap_AwardTypeAxis_c99883a0-8f13-4820-b75d-b72560ada743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c99883a0-8f13-4820-b75d-b72560ada743_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c99883a0-8f13-4820-b75d-b72560ada743" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c99883a0-8f13-4820-b75d-b72560ada743_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd79f855-2705-4ac9-99ee-719b66f0095c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c99883a0-8f13-4820-b75d-b72560ada743" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd79f855-2705-4ac9-99ee-719b66f0095c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_606727df-66f5-4b41-954e-090e34fc2bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd79f855-2705-4ac9-99ee-719b66f0095c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_606727df-66f5-4b41-954e-090e34fc2bca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_RSUsIssuedInLieuOfRetainerFeesMember_40610584-7f07-4a2c-8a8a-b3590e245c53" xlink:href="ams-20201231.xsd#ams_RSUsIssuedInLieuOfRetainerFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd79f855-2705-4ac9-99ee-719b66f0095c" xlink:to="loc_ams_RSUsIssuedInLieuOfRetainerFeesMember_40610584-7f07-4a2c-8a8a-b3590e245c53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AnnualRSUAwardsMember_eb255a51-0337-4096-8584-a1aa16e35501" xlink:href="ams-20201231.xsd#ams_AnnualRSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd79f855-2705-4ac9-99ee-719b66f0095c" xlink:to="loc_ams_AnnualRSUAwardsMember_eb255a51-0337-4096-8584-a1aa16e35501" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ExecutiveCompensationMember_d796946b-a78f-493c-96d9-99cf7dc30094" xlink:href="ams-20201231.xsd#ams_ExecutiveCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd79f855-2705-4ac9-99ee-719b66f0095c" xlink:to="loc_ams_ExecutiveCompensationMember_d796946b-a78f-493c-96d9-99cf7dc30094" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails" xlink:type="extended" id="i9b16619fa72f44c48a9525a8c8ef3f52_STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails" xlink:type="extended" id="i98a2df8354434fdf9a79417ee87cdeb6_STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:type="extended" id="i684d15200b2a4081bbc85f5481f44b77_STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/RETIREMENTPLAN" xlink:type="simple" xlink:href="ams-20201231.xsd#RETIREMENTPLAN"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/RETIREMENTPLAN" xlink:type="extended" id="i86dc9d37c8354e5b8cbd2eb7bb05b534_RETIREMENTPLAN"/>
  <link:roleRef roleURI="http://www.ashs.com/role/RETIREMENTPLANDetailsTextual" xlink:type="simple" xlink:href="ams-20201231.xsd#RETIREMENTPLANDetailsTextual"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/RETIREMENTPLANDetailsTextual" xlink:type="extended" id="i4de023641b26420a990b9965979c89c1_RETIREMENTPLANDetailsTextual"/>
  <link:roleRef roleURI="http://www.ashs.com/role/OPERATINGLEASES" xlink:type="simple" xlink:href="ams-20201231.xsd#OPERATINGLEASES"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/OPERATINGLEASES" xlink:type="extended" id="i14fb546887c44ed6af68f39bd8bab071_OPERATINGLEASES"/>
  <link:roleRef roleURI="http://www.ashs.com/role/OPERATINGLEASESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#OPERATINGLEASESTables"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/OPERATINGLEASESTables" xlink:type="extended" id="ib9b8b132c08c4bce8413c3a8f143ae9e_OPERATINGLEASESTables"/>
  <link:roleRef roleURI="http://www.ashs.com/role/OPERATINGLEASESDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#OPERATINGLEASESDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/OPERATINGLEASESDetails" xlink:type="extended" id="i27522efe3cc444fdb0d3a89af4056df0_OPERATINGLEASESDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#OPERATINGLEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails" xlink:type="extended" id="ie018ac5db21e45d3ab523a5c60d137c5_OPERATINGLEASESNarrativeDetails"/>
  <link:roleRef roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="ams-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended" id="i565094b2638d461badd8d7e8cea38772_COMMITMENTSANDCONTINGENCIES"/>
  <link:roleRef roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#COMMITMENTSANDCONTINGENCIESTables"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="extended" id="ib8e41b7eb25f4d0685a43329cc137690_COMMITMENTSANDCONTINGENCIESTables"/>
  <link:roleRef roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#COMMITMENTSANDCONTINGENCIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="extended" id="ia58f612ec8da41c7b8a595c8e5cebf80_COMMITMENTSANDCONTINGENCIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:href="ams-20201231.xsd#ams_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfCobalt60Reloads_7f65c3bd-2da9-48ac-9092-f9a256858a7e" xlink:href="ams-20201231.xsd#ams_NumberOfCobalt60Reloads"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_NumberOfCobalt60Reloads_7f65c3bd-2da9-48ac-9092-f9a256858a7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfLeksellGammaKnifeIconSystemInstalls_b9b92cf6-b7c3-49c7-bf47-a278fcdb719c" xlink:href="ams-20201231.xsd#ams_NumberOfLeksellGammaKnifeIconSystemInstalls"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_NumberOfLeksellGammaKnifeIconSystemInstalls_b9b92cf6-b7c3-49c7-bf47-a278fcdb719c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfPurchaseCommitments_d9b7ce19-6398-4922-9050-56990cdd8668" xlink:href="ams-20201231.xsd#ams_NumberOfPurchaseCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_NumberOfPurchaseCommitments_d9b7ce19-6398-4922-9050-56990cdd8668" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_511ae672-d096-4ac5-959a-69d9ee68a40c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_511ae672-d096-4ac5-959a-69d9ee68a40c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermPurchaseCommitmentRenewalTerm_1868a79f-c08e-429d-bf00-8c24c808c66f" xlink:href="ams-20201231.xsd#ams_LongTermPurchaseCommitmentRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_LongTermPurchaseCommitmentRenewalTerm_1868a79f-c08e-429d-bf00-8c24c808c66f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PurchaseAgreementAnnualPrepayment_d8a367c7-db2a-4f1e-a540-3de66fe343cc" xlink:href="ams-20201231.xsd#ams_PurchaseAgreementAnnualPrepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_PurchaseAgreementAnnualPrepayment_d8a367c7-db2a-4f1e-a540-3de66fe343cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_1e693ee2-16e8-45d5-b006-b77004e50841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_us-gaap_LongtermPurchaseCommitmentPeriod_1e693ee2-16e8-45d5-b006-b77004e50841" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermServiceCommitmentPeriod_b3d8fe35-230e-4d17-a0c2-22d886e6318b" xlink:href="ams-20201231.xsd#ams_LongTermServiceCommitmentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_LongTermServiceCommitmentPeriod_b3d8fe35-230e-4d17-a0c2-22d886e6318b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermServiceCommitmentAmount_376d6ef8-1f6d-4187-9a90-2485085ab160" xlink:href="ams-20201231.xsd#ams_LongTermServiceCommitmentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_LongTermServiceCommitmentAmount_376d6ef8-1f6d-4187-9a90-2485085ab160" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CommitmentsAndContingenciesTable_bbe43238-9104-478f-9ed5-a065db8c421d" xlink:href="ams-20201231.xsd#ams_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_CommitmentsAndContingenciesTable_bbe43238-9104-478f-9ed5-a065db8c421d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e05646cb-f70c-486a-974d-bac4b7fa304f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_CommitmentsAndContingenciesTable_bbe43238-9104-478f-9ed5-a065db8c421d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e05646cb-f70c-486a-974d-bac4b7fa304f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e05646cb-f70c-486a-974d-bac4b7fa304f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e05646cb-f70c-486a-974d-bac4b7fa304f" xlink:to="loc_us-gaap_RelatedPartyDomain_e05646cb-f70c-486a-974d-bac4b7fa304f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_69e98d27-c788-4540-ad81-64ec242eee41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e05646cb-f70c-486a-974d-bac4b7fa304f" xlink:to="loc_us-gaap_RelatedPartyDomain_69e98d27-c788-4540-ad81-64ec242eee41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MevionMedicalSystemsIncMember_bb284147-1b80-40e4-99b9-fc719ce0098b" xlink:href="ams-20201231.xsd#ams_MevionMedicalSystemsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_69e98d27-c788-4540-ad81-64ec242eee41" xlink:to="loc_ams_MevionMedicalSystemsIncMember_bb284147-1b80-40e4-99b9-fc719ce0098b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_98445979-5d40-437e-87c9-78b4b63c8644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_CommitmentsAndContingenciesTable_bbe43238-9104-478f-9ed5-a065db8c421d" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_98445979-5d40-437e-87c9-78b4b63c8644" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_98445979-5d40-437e-87c9-78b4b63c8644_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_98445979-5d40-437e-87c9-78b4b63c8644" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_98445979-5d40-437e-87c9-78b4b63c8644_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_84990e0e-9789-4eb8-84d3-8b8776892db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_98445979-5d40-437e-87c9-78b4b63c8644" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_84990e0e-9789-4eb8-84d3-8b8776892db4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifePerfexionSystemMember_46aefee6-27bf-4781-abc3-3b5447341dbe" xlink:href="ams-20201231.xsd#ams_GammaKnifePerfexionSystemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_84990e0e-9789-4eb8-84d3-8b8776892db4" xlink:to="loc_ams_GammaKnifePerfexionSystemMember_46aefee6-27bf-4781-abc3-3b5447341dbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LINACSystemMember_89c5bbff-7d87-41b1-b21a-32d17f28912a" xlink:href="ams-20201231.xsd#ams_LINACSystemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_84990e0e-9789-4eb8-84d3-8b8776892db4" xlink:to="loc_ams_LINACSystemMember_89c5bbff-7d87-41b1-b21a-32d17f28912a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember_5a7f95f1-0022-41a5-b6df-de5567587de7" xlink:href="ams-20201231.xsd#ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_84990e0e-9789-4eb8-84d3-8b8776892db4" xlink:to="loc_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember_5a7f95f1-0022-41a5-b6df-de5567587de7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d08ca747-3b99-4d41-936a-a2955b7fa2c3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ams_CommitmentsAndContingenciesTable_bbe43238-9104-478f-9ed5-a065db8c421d" xlink:to="loc_srt_RangeAxis_d08ca747-3b99-4d41-936a-a2955b7fa2c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d08ca747-3b99-4d41-936a-a2955b7fa2c3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d08ca747-3b99-4d41-936a-a2955b7fa2c3" xlink:to="loc_srt_RangeMember_d08ca747-3b99-4d41-936a-a2955b7fa2c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_05154926-d63c-4670-b017-d1bbe7a4bd82" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d08ca747-3b99-4d41-936a-a2955b7fa2c3" xlink:to="loc_srt_RangeMember_05154926-d63c-4670-b017-d1bbe7a4bd82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_150d1f20-a5cc-42c1-8ad1-58d7dd98f115" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_05154926-d63c-4670-b017-d1bbe7a4bd82" xlink:to="loc_srt_MaximumMember_150d1f20-a5cc-42c1-8ad1-58d7dd98f115" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9f39112e-c22f-4b1f-bef8-4a4b86aa7228" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_05154926-d63c-4670-b017-d1bbe7a4bd82" xlink:to="loc_srt_MinimumMember_9f39112e-c22f-4b1f-bef8-4a4b86aa7228" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails" xlink:type="extended" id="i54ba678b85d24b00a4a2205b7eeec24a_COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_552189c6-a78f-4209-9263-6a4eb45fb88a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:to="loc_us-gaap_ContractualObligation_552189c6-a78f-4209-9263-6a4eb45fb88a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_40980952-163a-4d09-ab71-e9971e5a0612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:to="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_40980952-163a-4d09-ab71-e9971e5a0612" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInSecondAndThirdYear_1ce6766d-b1e1-48cb-9346-41e70e447640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInSecondAndThirdYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:to="loc_us-gaap_ContractualObligationDueInSecondAndThirdYear_1ce6766d-b1e1-48cb-9346-41e70e447640" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInFourthAndFifthYear_9afe0546-7bbd-420e-a44a-26e1b702b97d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInFourthAndFifthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:to="loc_us-gaap_ContractualObligationDueInFourthAndFifthYear_9afe0546-7bbd-420e-a44a-26e1b702b97d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueAfterFifthYear_44e25b9f-8271-4d40-bad4-21b0e1def1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueAfterFifthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:to="loc_us-gaap_ContractualObligationDueAfterFifthYear_44e25b9f-8271-4d40-bad4-21b0e1def1c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_b02f33ce-a755-4543-be23-d914505a6dd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_b02f33ce-a755-4543-be23-d914505a6dd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_169938c3-ce58-4ab8-8dd5-6649126e89fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_b02f33ce-a755-4543-be23-d914505a6dd4" xlink:to="loc_us-gaap_OtherCommitmentsAxis_169938c3-ce58-4ab8-8dd5-6649126e89fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_169938c3-ce58-4ab8-8dd5-6649126e89fb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_169938c3-ce58-4ab8-8dd5-6649126e89fb" xlink:to="loc_us-gaap_OtherCommitmentsDomain_169938c3-ce58-4ab8-8dd5-6649126e89fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_169938c3-ce58-4ab8-8dd5-6649126e89fb" xlink:to="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_9e206e7c-57c0-4408-b9a6-f07f1e27d418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:to="loc_us-gaap_LongTermDebtMember_9e206e7c-57c0-4408-b9a6-f07f1e27d418" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeasesMember_17aec406-1185-48c6-91c7-b94c38c8ab2b" xlink:href="ams-20201231.xsd#ams_FinanceLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:to="loc_ams_FinanceLeasesMember_17aec406-1185-48c6-91c7-b94c38c8ab2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_f466e62b-9680-4a75-b16f-78f7b38c1f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:to="loc_us-gaap_EquipmentMember_f466e62b-9680-4a75-b16f-78f7b38c1f60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EquipmentServiceContractsMember_194ec222-45e0-4e1f-b3aa-ed6967e9f429" xlink:href="ams-20201231.xsd#ams_EquipmentServiceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:to="loc_ams_EquipmentServiceContractsMember_194ec222-45e0-4e1f-b3aa-ed6967e9f429" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AcquisitionWorkingCapitalPaymentsMember_4bd9c0f7-f4f3-41fb-a599-b5fb335918cb" xlink:href="ams-20201231.xsd#ams_AcquisitionWorkingCapitalPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:to="loc_ams_AcquisitionWorkingCapitalPaymentsMember_4bd9c0f7-f4f3-41fb-a599-b5fb335918cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_OperatingLeasesMember_92cc434a-8cc4-40ed-b810-3360e2529e73" xlink:href="ams-20201231.xsd#ams_OperatingLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:to="loc_ams_OperatingLeasesMember_92cc434a-8cc4-40ed-b810-3360e2529e73" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="ams-20201231.xsd#RELATEDPARTYTRANSACTIONS"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="extended" id="iace6641a6e0d44c3ae4d122210c0278c_RELATEDPARTYTRANSACTIONS"/>
  <link:roleRef roleURI="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual" xlink:type="simple" xlink:href="ams-20201231.xsd#RELATEDPARTYTRANSACTIONSDetailsTextual"/>
  <link:definitionLink xlink:role="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual" xlink:type="extended" id="ifb21071911164baeb6e6af139a312597_RELATEDPARTYTRANSACTIONSDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_8496a681-6ac8-4fd9-a4f5-5513ead9af03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_a65d525a-23aa-4979-ae53-ec3896ca95f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8496a681-6ac8-4fd9-a4f5-5513ead9af03" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_a65d525a-23aa-4979-ae53-ec3896ca95f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfCobalt60Reloads_8ddf9b5c-e422-4780-8a0d-eddd83f74543" xlink:href="ams-20201231.xsd#ams_NumberOfCobalt60Reloads"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8496a681-6ac8-4fd9-a4f5-5513ead9af03" xlink:to="loc_ams_NumberOfCobalt60Reloads_8ddf9b5c-e422-4780-8a0d-eddd83f74543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfPerfexionUpgrades_d257a3a9-62d9-4fb3-ab0e-8eb62d05f6a5" xlink:href="ams-20201231.xsd#ams_NumberOfPerfexionUpgrades"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8496a681-6ac8-4fd9-a4f5-5513ead9af03" xlink:to="loc_ams_NumberOfPerfexionUpgrades_d257a3a9-62d9-4fb3-ab0e-8eb62d05f6a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfLeksellGammaKnifeIconSystemInstalls_09d971ba-4a2b-4ba8-b786-c041263afde1" xlink:href="ams-20201231.xsd#ams_NumberOfLeksellGammaKnifeIconSystemInstalls"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8496a681-6ac8-4fd9-a4f5-5513ead9af03" xlink:to="loc_ams_NumberOfLeksellGammaKnifeIconSystemInstalls_09d971ba-4a2b-4ba8-b786-c041263afde1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1d5fb7bd-7cf0-4e66-a70b-c94618d58577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8496a681-6ac8-4fd9-a4f5-5513ead9af03" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1d5fb7bd-7cf0-4e66-a70b-c94618d58577" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_e91646ff-53f2-47b6-b40a-84b34ca91422" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1d5fb7bd-7cf0-4e66-a70b-c94618d58577" xlink:to="loc_srt_OwnershipAxis_e91646ff-53f2-47b6-b40a-84b34ca91422" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e91646ff-53f2-47b6-b40a-84b34ca91422_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_e91646ff-53f2-47b6-b40a-84b34ca91422" xlink:to="loc_srt_OwnershipDomain_e91646ff-53f2-47b6-b40a-84b34ca91422_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b2dbeddd-998a-468c-9bd6-45e74b9e272e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_e91646ff-53f2-47b6-b40a-84b34ca91422" xlink:to="loc_srt_OwnershipDomain_b2dbeddd-998a-468c-9bd6-45e74b9e272e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GkfSubsidiaryMember_a3acb346-42bc-403c-b38a-8904541f9960" xlink:href="ams-20201231.xsd#ams_GkfSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_b2dbeddd-998a-468c-9bd6-45e74b9e272e" xlink:to="loc_ams_GkfSubsidiaryMember_a3acb346-42bc-403c-b38a-8904541f9960" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_UsSubsidiaryOfElektaMember_3de13fe0-8913-4195-905f-590cdc3f4cd0" xlink:href="ams-20201231.xsd#ams_UsSubsidiaryOfElektaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_b2dbeddd-998a-468c-9bd6-45e74b9e272e" xlink:to="loc_ams_UsSubsidiaryOfElektaMember_3de13fe0-8913-4195-905f-590cdc3f4cd0" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>ams-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4e6f91f2-1bf1-41c4-8e53-76168a3ee138,g:df8d0904-ed6f-4833-8eea-c587ca49bdb5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_b98c8ad7-ad48-446a-8fa7-b018cef60a74_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTextBlock_e9f993a5-6ea5-4637-9f2b-60ee1e03cd88_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Purchase Commitment</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6dd8e13e-bd12-465c-8647-e33659ea57a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0498b12c-3e72-4432-a101-7c044144b3b3_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_537eea7b-ff5b-469c-92b9-80ecd93d809f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_5b078a12-2759-48db-9536-b11891303bdc_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_1f5da40d-ae82-42ce-8a56-f2fbfea2011e_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2cb10045-d889-4212-80b5-30429ca1397b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c950c393-247a-4d1e-8af1-aff73149dd77_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8d6929aa-9baf-4086-9468-5e1f59edda3d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2844e1c6-a5c0-46f1-bc8a-db826cd314ff_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_c2ac1326-e4d1-4cd9-affa-62e7361971b7_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RETIREMENT PLAN</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9fd12d4f-1170-45ca-bbf3-9c05849bb2a2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Date Weighted-Average Fair Value, Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_eec6479e-1f8b-4098-8745-e654b949d391_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionAccountsPayable_915746d7-4dee-4856-943c-ed3e90549650_negatedTerseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_ams_AssetAcquisitionAccountsPayable_label_en-US" xlink:label="lab_ams_AssetAcquisitionAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Accounts Payable</link:label>
    <link:label id="lab_ams_AssetAcquisitionAccountsPayable_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAccountsPayable" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionAccountsPayable" xlink:to="lab_ams_AssetAcquisitionAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligation_5d249590-1ecb-49c7-b188-a8e2fd3c5391_totalLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amounts committed</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_label_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation" xlink:to="lab_us-gaap_ContractualObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_2233cb30-7095-481b-b88d-82231aeaaaf4_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computed expected federal income tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_PeruDeferredTaxAssetsMember_65c937ed-8109-4653-8f40-627897de71fb_terseLabel_en-US" xlink:label="lab_ams_PeruDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peru</link:label>
    <link:label id="lab_ams_PeruDeferredTaxAssetsMember_label_en-US" xlink:label="lab_ams_PeruDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peru Deferred Tax Assets [Member]</link:label>
    <link:label id="lab_ams_PeruDeferredTaxAssetsMember_documentation_en-US" xlink:label="lab_ams_PeruDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peru Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PeruDeferredTaxAssetsMember" xlink:href="ams-20201231.xsd#ams_PeruDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_PeruDeferredTaxAssetsMember" xlink:to="lab_ams_PeruDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_2a3ca4f9-8e50-4fc9-b3bc-53d3122cced7_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from warrants and options exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_0612d07d-8843-4645-a398-9e5803ca546c_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_06b03912-04a7-483b-aafe-4f1594396e7c_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_bb338166-6cc5-4278-b8be-762db88a400d_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75fff461-552e-4124-a95c-763851a380e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LongTermServiceCommitmentAmount_b41949ac-b5aa-43b0-acb1-3d6f3d0eb470_terseLabel_en-US" xlink:label="lab_ams_LongTermServiceCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service commitment, amount</link:label>
    <link:label id="lab_ams_LongTermServiceCommitmentAmount_label_en-US" xlink:label="lab_ams_LongTermServiceCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Service Commitment, Amount</link:label>
    <link:label id="lab_ams_LongTermServiceCommitmentAmount_documentation_en-US" xlink:label="lab_ams_LongTermServiceCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Service Commitment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermServiceCommitmentAmount" xlink:href="ams-20201231.xsd#ams_LongTermServiceCommitmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LongTermServiceCommitmentAmount" xlink:to="lab_ams_LongTermServiceCommitmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c5e7f72a-9421-4535-9522-ab3d7ae795fb_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash distributions to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5e68c9e1-5132-4408-94f8-1c0284b8ab46_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_49909751-3753-48ed-9097-f927e24e7681_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes (non-current)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2660ff04-b7fb-46ac-be6f-47c60b87b175_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8537d076-7e9b-466e-a901-7c9b62dffdcb_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AcquisitionOfInsuranceWithShortTermFinancing_a95d031d-bad6-498c-b4e6-93cb12530108_terseLabel_en-US" xlink:label="lab_ams_AcquisitionOfInsuranceWithShortTermFinancing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of insurance with short-term financing</link:label>
    <link:label id="lab_ams_AcquisitionOfInsuranceWithShortTermFinancing_label_en-US" xlink:label="lab_ams_AcquisitionOfInsuranceWithShortTermFinancing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Of Insurance With Short-Term Financing</link:label>
    <link:label id="lab_ams_AcquisitionOfInsuranceWithShortTermFinancing_documentation_en-US" xlink:label="lab_ams_AcquisitionOfInsuranceWithShortTermFinancing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Of Insurance With Short-Term Financing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AcquisitionOfInsuranceWithShortTermFinancing" xlink:href="ams-20201231.xsd#ams_AcquisitionOfInsuranceWithShortTermFinancing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AcquisitionOfInsuranceWithShortTermFinancing" xlink:to="lab_ams_AcquisitionOfInsuranceWithShortTermFinancing" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2a8995a5-9c02-4bc0-be83-694ee7749190_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating (loss) income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_66864868-85f2-434a-b83a-56bcc35901db_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_167b5ba3-13d4-4ffc-8318-0f75e91f18dc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_f1cb5886-42fe-429b-8bba-a6df03cb8081_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable and doubtful accounts</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_592030bf-2596-4098-83bb-fa0c5586e9df_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_31eb9f61-a469-493e-8e08-2dca58e5f581_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Date Weighted-Average Fair Value, Outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e65bb8c3-aba9-4bcc-877b-4306ce1a9e90_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Date Weighted-Average Fair Value, Outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing_ebf98396-66aa-4650-8e12-68aabf24fdae_verboseLabel_en-US" xlink:label="lab_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of equipment with long-term debt financing</link:label>
    <link:label id="lab_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing_label_en-US" xlink:label="lab_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Of Equipment With Long term Debt Financing</link:label>
    <link:label id="lab_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing_documentation_en-US" xlink:label="lab_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing" xlink:href="ams-20201231.xsd#ams_AcquisitionOfEquipmentWithLongTermDebtFinancing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing" xlink:to="lab_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8078d5c6-3b23-471c-a039-aee0cd50e7ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_bc750ca8-2eda-4b87-94e2-c015ebbedc14_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES (See Note 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_48a159ba-dc7b-430f-9860-ef38ba6cd77e_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_ed5f1672-66da-4b87-86af-6b69be9e4235_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NCI investment in acquisition</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_6495daba-7fe2-46aa-9795-a8ec7b9b6270_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_380878e6-5d54-4371-b199-a666db5a6780_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_41e27c5a-1126-4d4e-9fa1-1ae704fe1c02_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86b05410-3092-457b-9145-b737b85facb3_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8044ea39-d267-429b-a203-2038a01b527c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_f6c5f90e-9417-45d4-a626-0ec3b3177117_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_IncreaseDecreaseInLeaseLiabilities_723522b9-4ee4-4422-8aca-d8140444e7a1_terseLabel_en-US" xlink:label="lab_ams_IncreaseDecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_ams_IncreaseDecreaseInLeaseLiabilities_label_en-US" xlink:label="lab_ams_IncreaseDecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Lease Liabilities</link:label>
    <link:label id="lab_ams_IncreaseDecreaseInLeaseLiabilities_documentation_en-US" xlink:label="lab_ams_IncreaseDecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncreaseDecreaseInLeaseLiabilities" xlink:href="ams-20201231.xsd#ams_IncreaseDecreaseInLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_IncreaseDecreaseInLeaseLiabilities" xlink:to="lab_ams_IncreaseDecreaseInLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_eab69f80-962b-4ba5-9e81-d12f2ce183df_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3e2b97cd-35a7-4366-9d4e-d2924f7a03ca_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_CustomerTwoMember_e500f0ef-de47-4695-a658-4bd6b3aeb2aa_terseLabel_en-US" xlink:label="lab_ams_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two</link:label>
    <link:label id="lab_ams_CustomerTwoMember_label_en-US" xlink:label="lab_ams_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two [Member]</link:label>
    <link:label id="lab_ams_CustomerTwoMember_documentation_en-US" xlink:label="lab_ams_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CustomerTwoMember" xlink:href="ams-20201231.xsd#ams_CustomerTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_CustomerTwoMember" xlink:to="lab_ams_CustomerTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_1c92cab7-3aa2-4952-8853-36d633912bd0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1d9a66b1-2140-4617-b7ee-166e72befcd4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d61614df-54e1-496f-8997-c8e7057b90ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_MedicalEquipmentAndOtherFixedAssetsMember_42a29fd6-b9f1-4bd9-9638-8da0ba1f410d_terseLabel_en-US" xlink:label="lab_ams_MedicalEquipmentAndOtherFixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment</link:label>
    <link:label id="lab_ams_MedicalEquipmentAndOtherFixedAssetsMember_label_en-US" xlink:label="lab_ams_MedicalEquipmentAndOtherFixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment And Other Fixed Assets [Member]</link:label>
    <link:label id="lab_ams_MedicalEquipmentAndOtherFixedAssetsMember_documentation_en-US" xlink:label="lab_ams_MedicalEquipmentAndOtherFixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment And Other Fixed Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MedicalEquipmentAndOtherFixedAssetsMember" xlink:href="ams-20201231.xsd#ams_MedicalEquipmentAndOtherFixedAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_MedicalEquipmentAndOtherFixedAssetsMember" xlink:to="lab_ams_MedicalEquipmentAndOtherFixedAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_2bb49884-6c2e-457d-a961-1238331a7c69_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_db204d19-2f88-42f8-a0d6-7917bc6559f1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NonCashLeaseExpense_344440a4-8c36-4c42-828e-439003ebac69_terseLabel_en-US" xlink:label="lab_ams_NonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non cash lease expense</link:label>
    <link:label id="lab_ams_NonCashLeaseExpense_label_en-US" xlink:label="lab_ams_NonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Lease Expense</link:label>
    <link:label id="lab_ams_NonCashLeaseExpense_documentation_en-US" xlink:label="lab_ams_NonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonCashLeaseExpense" xlink:href="ams-20201231.xsd#ams_NonCashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NonCashLeaseExpense" xlink:to="lab_ams_NonCashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_00338260-bb50-461a-8a11-e88357a31e8f_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5a7b5c44-426e-4403-aaa6-d9d9afc0306a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RIGHT OF USE ASSETS</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6084102d-1a83-4bfd-853e-11c5e715a01e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NonEmployeeDirectorsAndCorporateSecretaryMember_072df953-82eb-4d20-bc2f-d2a3936cbc5e_verboseLabel_en-US" xlink:label="lab_ams_NonEmployeeDirectorsAndCorporateSecretaryMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Employee Directors and Corporate Secretary</link:label>
    <link:label id="lab_ams_NonEmployeeDirectorsAndCorporateSecretaryMember_label_en-US" xlink:label="lab_ams_NonEmployeeDirectorsAndCorporateSecretaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Employee Directors And Corporate Secretary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonEmployeeDirectorsAndCorporateSecretaryMember" xlink:href="ams-20201231.xsd#ams_NonEmployeeDirectorsAndCorporateSecretaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NonEmployeeDirectorsAndCorporateSecretaryMember" xlink:to="lab_ams_NonEmployeeDirectorsAndCorporateSecretaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_e27d0b3e-6c30-41e8-b176-fb7bbe58c59f_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_e4ee06b0-581b-4994-b17d-0abfa8f5a875_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of equipment with finance leases</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_InterestCapitalizedToPropertyAndEquipment_19f9ce4b-c003-434c-80ca-f8ac309891dc_terseLabel_en-US" xlink:label="lab_ams_InterestCapitalizedToPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest capitalized to property and equipment</link:label>
    <link:label id="lab_ams_InterestCapitalizedToPropertyAndEquipment_label_en-US" xlink:label="lab_ams_InterestCapitalizedToPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Capitalized To Property And Equipment</link:label>
    <link:label id="lab_ams_InterestCapitalizedToPropertyAndEquipment_documentation_en-US" xlink:label="lab_ams_InterestCapitalizedToPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of interest capitalized to property and equipment in noncash transaction.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_InterestCapitalizedToPropertyAndEquipment" xlink:href="ams-20201231.xsd#ams_InterestCapitalizedToPropertyAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_InterestCapitalizedToPropertyAndEquipment" xlink:to="lab_ams_InterestCapitalizedToPropertyAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a1540ed4-37ec-4598-9159-1f3865d43e9e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_be4e1f97-b8ed-47cc-8f56-046067ebadd0_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_548a0d8f-56ae-4db0-b22e-162512204043_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c0a1d2db-ad3c-4670-92a1-4a79d8ad188c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0c105c00-fb67-487d-8e5a-90858283002c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_25cc6d11-22c3-4b8f-9360-0ec5bce2e287_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_ArchitecturalDesignCompanyMember_d8128a16-b33f-4d48-8ce4-afcdf63d0954_terseLabel_en-US" xlink:label="lab_ams_ArchitecturalDesignCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Architectural Design Company</link:label>
    <link:label id="lab_ams_ArchitecturalDesignCompanyMember_label_en-US" xlink:label="lab_ams_ArchitecturalDesignCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Architectural Design Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ArchitecturalDesignCompanyMember" xlink:href="ams-20201231.xsd#ams_ArchitecturalDesignCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_ArchitecturalDesignCompanyMember" xlink:to="lab_ams_ArchitecturalDesignCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_125a6cef-bcde-4e1d-9b6b-72e1413ea4c9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d6c51010-c001-4362-96e6-863c7b742059_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6a79d92e-3edc-4c83-b9d2-3e711ce63bb7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_RSUsIssuedInLieuOfRetainerFeesMember_872d98da-f186-4922-9d26-d4cdda0a21ef_terseLabel_en-US" xlink:label="lab_ams_RSUsIssuedInLieuOfRetainerFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs Issued in Lieu of Retainer Fees</link:label>
    <link:label id="lab_ams_RSUsIssuedInLieuOfRetainerFeesMember_label_en-US" xlink:label="lab_ams_RSUsIssuedInLieuOfRetainerFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs Issued In Lieu Of Retainer Fees [Member]</link:label>
    <link:label id="lab_ams_RSUsIssuedInLieuOfRetainerFeesMember_documentation_en-US" xlink:label="lab_ams_RSUsIssuedInLieuOfRetainerFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs Issued In Lieu Of Retainer Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_RSUsIssuedInLieuOfRetainerFeesMember" xlink:href="ams-20201231.xsd#ams_RSUsIssuedInLieuOfRetainerFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_RSUsIssuedInLieuOfRetainerFeesMember" xlink:to="lab_ams_RSUsIssuedInLieuOfRetainerFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_d3e9ca80-6f3a-404c-b446-e34c623ed439_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a4cb4186-25d7-42b6-bf77-d3970312ec18_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LongTermDebtMonthlyInstallments_c6a5641f-c697-4099-a13e-a45e2c0e7704_terseLabel_en-US" xlink:label="lab_ams_LongTermDebtMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly installments</link:label>
    <link:label id="lab_ams_LongTermDebtMonthlyInstallments_label_en-US" xlink:label="lab_ams_LongTermDebtMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt, Monthly Installments</link:label>
    <link:label id="lab_ams_LongTermDebtMonthlyInstallments_documentation_en-US" xlink:label="lab_ams_LongTermDebtMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt, Monthly Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermDebtMonthlyInstallments" xlink:href="ams-20201231.xsd#ams_LongTermDebtMonthlyInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LongTermDebtMonthlyInstallments" xlink:to="lab_ams_LongTermDebtMonthlyInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_GammaKnifeUnitMember_d28cd373-161f-4df7-ac08-bb33f367e10f_terseLabel_en-US" xlink:label="lab_ams_GammaKnifeUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gamma Knife Unit</link:label>
    <link:label id="lab_ams_GammaKnifeUnitMember_label_en-US" xlink:label="lab_ams_GammaKnifeUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gamma Knife Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeUnitMember" xlink:href="ams-20201231.xsd#ams_GammaKnifeUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_GammaKnifeUnitMember" xlink:to="lab_ams_GammaKnifeUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_2dc97767-2bc1-41cb-a40b-2e18817f808f_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_a55cf3fd-ec0b-492a-9e48-46e21c128292_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_c9175b95-ae55-4697-ab30-c8b6b28ea14d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_6415739c-e195-4216-a32f-656efb419351_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_87ca0e5f-cb91-4e76-b197-a40208f7dea5_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_152a1925-9ab0-4fcd-940e-c6a028ad244d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options, Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_86fe6930-f3bb-449c-93e6-600bc6d9c279_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_3bebdd90-b54c-49d6-8185-cdc23a8181c8_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs of revenue:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_CustomerThreeMember_254ca397-5e07-46f5-9de3-823d2e1a07ea_terseLabel_en-US" xlink:label="lab_ams_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three</link:label>
    <link:label id="lab_ams_CustomerThreeMember_label_en-US" xlink:label="lab_ams_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CustomerThreeMember" xlink:href="ams-20201231.xsd#ams_CustomerThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_CustomerThreeMember" xlink:to="lab_ams_CustomerThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_6f762ca4-96d1-423d-9e93-6e8efb4bbead_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of options vested in period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligation_5b77de9e-8eda-4c1e-981d-276efb5a5a49_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset retirement obligation liability</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligation_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligation" xlink:to="lab_us-gaap_AssetRetirementObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_cf3b89c5-89dd-4dfe-acc4-49e5e2edad29_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4d88014-6dea-45ff-a85c-064533d0a292_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LeaseExpirationPeriod_e3e3afbe-07af-479b-9bee-3a9023e95380_terseLabel_en-US" xlink:label="lab_ams_LeaseExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease expiration period</link:label>
    <link:label id="lab_ams_LeaseExpirationPeriod_label_en-US" xlink:label="lab_ams_LeaseExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Expiration Period</link:label>
    <link:label id="lab_ams_LeaseExpirationPeriod_documentation_en-US" xlink:label="lab_ams_LeaseExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period on which lease or group of leases is set to expire.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LeaseExpirationPeriod" xlink:href="ams-20201231.xsd#ams_LeaseExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LeaseExpirationPeriod" xlink:to="lab_ams_LeaseExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_4fddd0c2-e93c-4433-ada2-7ffe0eb6c33b_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_MedicalEquipmentMember_02e6a0b9-de23-46de-86f0-ff5049267ec3_terseLabel_en-US" xlink:label="lab_ams_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment</link:label>
    <link:label id="lab_ams_MedicalEquipmentMember_label_en-US" xlink:label="lab_ams_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Member]</link:label>
    <link:label id="lab_ams_MedicalEquipmentMember_documentation_en-US" xlink:label="lab_ams_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MedicalEquipmentMember" xlink:href="ams-20201231.xsd#ams_MedicalEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_MedicalEquipmentMember" xlink:to="lab_ams_MedicalEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_928f7168-a569-4c52-94f5-5fa981740d3b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_ddf0fa28-b759-42b2-b6f5-bd1b5f5065b4_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_OtherFixedAssetsMember_7f7f0713-335b-46de-896c-0147a20abc12_terseLabel_en-US" xlink:label="lab_ams_OtherFixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other fixed assets</link:label>
    <link:label id="lab_ams_OtherFixedAssetsMember_label_en-US" xlink:label="lab_ams_OtherFixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Fixed Assets [Member]</link:label>
    <link:label id="lab_ams_OtherFixedAssetsMember_documentation_en-US" xlink:label="lab_ams_OtherFixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Fixed Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_OtherFixedAssetsMember" xlink:href="ams-20201231.xsd#ams_OtherFixedAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_OtherFixedAssetsMember" xlink:to="lab_ams_OtherFixedAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_5ed58a43-9a73-49ae-b2e9-5288804539aa_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_5621238d-ecdb-47d3-9cfb-0d239da0de89_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_b6e6b373-2690-4568-8748-ed82bfee6b58_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term purchase commitment amount</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_cac21dc4-5d05-46cd-9858-d62bf4ec9b05_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_b35b68d8-6631-43e1-a978-7f3397bc56a4_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e6d02f88-5d12-4f3f-b7b1-46e1e91645d0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_53d8f565-c79d-4a41-a8b3-6db6fe7aebef_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Machinery and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_25268a8b-4b55-487f-a7b6-07c57aee1c15_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_7c090e19-f957-46e6-b68e-2c1fe50667fd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_7b8b07ba-d0cf-4c90-ad61-5d4b5dbc9862_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AnnualRSUAwardsMember_87b56b5e-da8f-47e5-ab3f-435696ab7f7e_terseLabel_en-US" xlink:label="lab_ams_AnnualRSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual RSU Awards</link:label>
    <link:label id="lab_ams_AnnualRSUAwardsMember_label_en-US" xlink:label="lab_ams_AnnualRSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual RSU Awards [Member]</link:label>
    <link:label id="lab_ams_AnnualRSUAwardsMember_documentation_en-US" xlink:label="lab_ams_AnnualRSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual RSU Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AnnualRSUAwardsMember" xlink:href="ams-20201231.xsd#ams_AnnualRSUAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AnnualRSUAwardsMember" xlink:to="lab_ams_AnnualRSUAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_cfb9909f-80d6-460c-a8ae-ee4a42970783_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_PaymentsToAcquireAsset_6998e1e6-2938-4ecb-b450-4de294e9e237_terseLabel_en-US" xlink:label="lab_ams_PaymentsToAcquireAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire asset</link:label>
    <link:label id="lab_ams_PaymentsToAcquireAsset_label_en-US" xlink:label="lab_ams_PaymentsToAcquireAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Asset</link:label>
    <link:label id="lab_ams_PaymentsToAcquireAsset_documentation_en-US" xlink:label="lab_ams_PaymentsToAcquireAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsToAcquireAsset" xlink:href="ams-20201231.xsd#ams_PaymentsToAcquireAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_PaymentsToAcquireAsset" xlink:to="lab_ams_PaymentsToAcquireAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ec3a0b22-85da-43d3-b43a-6684842b9091_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LongTermPurchaseCommitmentDepositsForAssets_8ab2f3ee-e9d2-4a4c-9ccc-f91e731dd237_terseLabel_en-US" xlink:label="lab_ams_LongTermPurchaseCommitmentDepositsForAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term purchase commitment deposits for assets</link:label>
    <link:label id="lab_ams_LongTermPurchaseCommitmentDepositsForAssets_label_en-US" xlink:label="lab_ams_LongTermPurchaseCommitmentDepositsForAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Purchase Commitment Deposits For Assets</link:label>
    <link:label id="lab_ams_LongTermPurchaseCommitmentDepositsForAssets_documentation_en-US" xlink:label="lab_ams_LongTermPurchaseCommitmentDepositsForAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term Purchase commitment deposits for the assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermPurchaseCommitmentDepositsForAssets" xlink:href="ams-20201231.xsd#ams_LongTermPurchaseCommitmentDepositsForAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LongTermPurchaseCommitmentDepositsForAssets" xlink:to="lab_ams_LongTermPurchaseCommitmentDepositsForAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_cf4ef076-1cbb-415d-832b-a56f903dc23e_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember_1cb12f47-d8f5-4f73-919e-907e779c11b1_verboseLabel_en-US" xlink:label="lab_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits towards purchase of proton beam systems</link:label>
    <link:label id="lab_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember_label_en-US" xlink:label="lab_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Towards Purchase of Proton Beam Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember" xlink:href="ams-20201231.xsd#ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember" xlink:to="lab_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_fd7e8213-48f0-4b00-a3d8-3ba7141e31be_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LAND</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_45f48b67-f32b-42fd-b0b3-3a3c3f07cc99_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_cf985e72-b034-4069-a105-91c81a0e1f7a_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5b412d3-6542-4e35-9991-8b09151d4dfd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_IncomeTaxDisclosureLineItems_ff360f3f-2cfa-4bbc-af84-59600f567d36_terseLabel_en-US" xlink:label="lab_ams_IncomeTaxDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Line Items]</link:label>
    <link:label id="lab_ams_IncomeTaxDisclosureLineItems_label_en-US" xlink:label="lab_ams_IncomeTaxDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncomeTaxDisclosureLineItems" xlink:href="ams-20201231.xsd#ams_IncomeTaxDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_IncomeTaxDisclosureLineItems" xlink:to="lab_ams_IncomeTaxDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_PurchaseAgreementAnnualPrepayment_f4a72b92-dac8-43cb-bb92-99eda3f9f801_terseLabel_en-US" xlink:label="lab_ams_PurchaseAgreementAnnualPrepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase agreement annual prepayment</link:label>
    <link:label id="lab_ams_PurchaseAgreementAnnualPrepayment_label_en-US" xlink:label="lab_ams_PurchaseAgreementAnnualPrepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Agreement Annual Prepayment</link:label>
    <link:label id="lab_ams_PurchaseAgreementAnnualPrepayment_documentation_en-US" xlink:label="lab_ams_PurchaseAgreementAnnualPrepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">It represents the amount of purchase agreement annual prepayment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PurchaseAgreementAnnualPrepayment" xlink:href="ams-20201231.xsd#ams_PurchaseAgreementAnnualPrepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_PurchaseAgreementAnnualPrepayment" xlink:to="lab_ams_PurchaseAgreementAnnualPrepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0be6ade0-11d6-4253-a1fc-9ec0b6496f73_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NumberOfCobalt60Reloads_4fedd1a5-862e-45c7-9e84-24b801b2958d_terseLabel_en-US" xlink:label="lab_ams_NumberOfCobalt60Reloads" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Cobalt-60 reloads</link:label>
    <link:label id="lab_ams_NumberOfCobalt60Reloads_label_en-US" xlink:label="lab_ams_NumberOfCobalt60Reloads" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Cobalt-60 Reloads</link:label>
    <link:label id="lab_ams_NumberOfCobalt60Reloads_documentation_en-US" xlink:label="lab_ams_NumberOfCobalt60Reloads" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Cobalt-60 Reloads</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfCobalt60Reloads" xlink:href="ams-20201231.xsd#ams_NumberOfCobalt60Reloads"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NumberOfCobalt60Reloads" xlink:to="lab_ams_NumberOfCobalt60Reloads" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_fa812e09-befe-45b2-9429-d3438c5fef94_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term (Years), Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_FinanceLeaseObligationInterestRate_2cc876c0-0b63-4bf6-9e6c-199c9c5577d2_terseLabel_en-US" xlink:label="lab_ams_FinanceLeaseObligationInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligation interest rate</link:label>
    <link:label id="lab_ams_FinanceLeaseObligationInterestRate_label_en-US" xlink:label="lab_ams_FinanceLeaseObligationInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Obligation Interest Rate</link:label>
    <link:label id="lab_ams_FinanceLeaseObligationInterestRate_documentation_en-US" xlink:label="lab_ams_FinanceLeaseObligationInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate of capital lease obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeaseObligationInterestRate" xlink:href="ams-20201231.xsd#ams_FinanceLeaseObligationInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_FinanceLeaseObligationInterestRate" xlink:to="lab_ams_FinanceLeaseObligationInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionAssetsAcquired_3ef78824-9e68-446b-9b8e-d2bb9639843a_totalLabel_en-US" xlink:label="lab_ams_AssetAcquisitionAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_ams_AssetAcquisitionAssetsAcquired_label_en-US" xlink:label="lab_ams_AssetAcquisitionAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Assets Acquired</link:label>
    <link:label id="lab_ams_AssetAcquisitionAssetsAcquired_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAssetsAcquired" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionAssetsAcquired" xlink:to="lab_ams_AssetAcquisitionAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligationCurrent_e3efcdae-2315-4626-829b-60891e16ac96_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset retirement obligations</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligationCurrent" xlink:to="lab_us-gaap_AssetRetirementObligationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_98aee867-3c26-48e3-90ba-4dad99342b4f_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d3380cb2-159e-497b-ab0c-ad59ec0bb067_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_4a266fd0-fa77-4583-a747-b18f0b529fe6_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_d42501a7-f9b3-4150-8186-bd436624430d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount accrued for income tax penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_413787fb-1494-4e68-8884-e8fefd6245cd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCE LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5a14705c-3ef3-4577-8d27-7189aaf7fb63_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_169e83ce-5035-4770-ab47-3c20c330ebaf_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionPercentageOfSharesAcquired_6fdacd0a-f992-44de-86e0-6bd072caa605_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionPercentageOfSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisition, percentage of shares acquired</link:label>
    <link:label id="lab_ams_AssetAcquisitionPercentageOfSharesAcquired_label_en-US" xlink:label="lab_ams_AssetAcquisitionPercentageOfSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Percentage Of Shares Acquired</link:label>
    <link:label id="lab_ams_AssetAcquisitionPercentageOfSharesAcquired_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionPercentageOfSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Percentage Of Shares Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfSharesAcquired" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionPercentageOfSharesAcquired" xlink:to="lab_ams_AssetAcquisitionPercentageOfSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2852383-92f0-4643-b512-ac2ffd32dd8a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_65d2fe44-982f-40e4-ae55-f86f6f1dc975_terseLabel_en-US" xlink:label="lab_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain Tax Positions</link:label>
    <link:label id="lab_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_label_en-US" xlink:label="lab_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount</link:label>
    <link:label id="lab_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_documentation_en-US" xlink:label="lab_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" xlink:href="ams-20201231.xsd#ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" xlink:to="lab_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_dcde2634-a88e-4786-a9dc-1e70f331e421_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_d7fda5e7-9b1f-4624-a764-84f70ecf77be_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_OperatingLeaseMonthlyLeaseExpense_54ee63f3-306e-4683-a170-bb136ea8d734_terseLabel_en-US" xlink:label="lab_ams_OperatingLeaseMonthlyLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly lease expense</link:label>
    <link:label id="lab_ams_OperatingLeaseMonthlyLeaseExpense_label_en-US" xlink:label="lab_ams_OperatingLeaseMonthlyLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Monthly Lease Expense</link:label>
    <link:label id="lab_ams_OperatingLeaseMonthlyLeaseExpense_documentation_en-US" xlink:label="lab_ams_OperatingLeaseMonthlyLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Monthly Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_OperatingLeaseMonthlyLeaseExpense" xlink:href="ams-20201231.xsd#ams_OperatingLeaseMonthlyLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_OperatingLeaseMonthlyLeaseExpense" xlink:to="lab_ams_OperatingLeaseMonthlyLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_OffsettingTaxBenefit_37be4582-48bd-4cfa-bf22-fa896cc76a45_terseLabel_en-US" xlink:label="lab_ams_OffsettingTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting tax benefit</link:label>
    <link:label id="lab_ams_OffsettingTaxBenefit_label_en-US" xlink:label="lab_ams_OffsettingTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Tax Benefit</link:label>
    <link:label id="lab_ams_OffsettingTaxBenefit_documentation_en-US" xlink:label="lab_ams_OffsettingTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of offsetting tax benefit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_OffsettingTaxBenefit" xlink:href="ams-20201231.xsd#ams_OffsettingTaxBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_OffsettingTaxBenefit" xlink:to="lab_ams_OffsettingTaxBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_c7608044-2775-4b30-afc5-ecb2480f0829_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_9ffdffb9-c631-457f-a29e-1291671b0335_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_GkfSubsidiaryMember_e4dd66f0-d2b5-43bd-a5b8-4633b15ce504_terseLabel_en-US" xlink:label="lab_ams_GkfSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GKF Subsidiary</link:label>
    <link:label id="lab_ams_GkfSubsidiaryMember_label_en-US" xlink:label="lab_ams_GkfSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GKF Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GkfSubsidiaryMember" xlink:href="ams-20201231.xsd#ams_GkfSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_GkfSubsidiaryMember" xlink:to="lab_ams_GkfSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LongTermServiceCommitmentPeriod_f2f40ef0-1796-4ca7-9780-dd5b70d742e7_terseLabel_en-US" xlink:label="lab_ams_LongTermServiceCommitmentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service commitment, period</link:label>
    <link:label id="lab_ams_LongTermServiceCommitmentPeriod_label_en-US" xlink:label="lab_ams_LongTermServiceCommitmentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Service Commitment, Period</link:label>
    <link:label id="lab_ams_LongTermServiceCommitmentPeriod_documentation_en-US" xlink:label="lab_ams_LongTermServiceCommitmentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Service Commitment, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermServiceCommitmentPeriod" xlink:href="ams-20201231.xsd#ams_LongTermServiceCommitmentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LongTermServiceCommitmentPeriod" xlink:to="lab_ams_LongTermServiceCommitmentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b59c9d5-a669-47b1-9d9e-1adc8a16b069_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_0f7e022e-bff0-4c0c-bb42-c033a899ca44_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c4c83f08-8781-4972-b4d9-4e83799faacd_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NumberOfImpairedAssetUnits_325f0157-4c09-4b4e-b0a8-004efa7886c6_terseLabel_en-US" xlink:label="lab_ams_NumberOfImpairedAssetUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of impaired asset units</link:label>
    <link:label id="lab_ams_NumberOfImpairedAssetUnits_label_en-US" xlink:label="lab_ams_NumberOfImpairedAssetUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Impaired Asset Units</link:label>
    <link:label id="lab_ams_NumberOfImpairedAssetUnits_documentation_en-US" xlink:label="lab_ams_NumberOfImpairedAssetUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Impaired Asset Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfImpairedAssetUnits" xlink:href="ams-20201231.xsd#ams_NumberOfImpairedAssetUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NumberOfImpairedAssetUnits" xlink:to="lab_ams_NumberOfImpairedAssetUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingVariableInterestRate_d533c3c1-8833-4ec5-97f1-da07502fff14_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt percentage rate</link:label>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingVariableInterestRate_label_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtPercentageBearingVariableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:to="lab_us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_300728c5-85e0-4a1c-a2fc-ffb138502a04_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to non-vested shares</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetRetirementObligationsPolicyPolicyTextBlock_0046d16a-785f-444f-ac2d-d413ea172719_terseLabel_en-US" xlink:label="lab_ams_AssetRetirementObligationsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligations</link:label>
    <link:label id="lab_ams_AssetRetirementObligationsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_ams_AssetRetirementObligationsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligations Policy [Policy Text Block]</link:label>
    <link:label id="lab_ams_AssetRetirementObligationsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_ams_AssetRetirementObligationsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for asset retirement obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetRetirementObligationsPolicyPolicyTextBlock" xlink:href="ams-20201231.xsd#ams_AssetRetirementObligationsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetRetirementObligationsPolicyPolicyTextBlock" xlink:to="lab_ams_AssetRetirementObligationsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionEmployeeCompensationAndBenefits_d0b4ce9d-b4ef-452d-9ddf-96843a4836c0_negatedLabel_en-US" xlink:label="lab_ams_AssetAcquisitionEmployeeCompensationAndBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_ams_AssetAcquisitionEmployeeCompensationAndBenefits_label_en-US" xlink:label="lab_ams_AssetAcquisitionEmployeeCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Employee Compensation And Benefits</link:label>
    <link:label id="lab_ams_AssetAcquisitionEmployeeCompensationAndBenefits_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionEmployeeCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Employee Compensation And Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionEmployeeCompensationAndBenefits" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionEmployeeCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionEmployeeCompensationAndBenefits" xlink:to="lab_ams_AssetAcquisitionEmployeeCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_c7f9ba0d-0675-41a4-b819-2e2db04a48c4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_e4d6e48c-0f4f-4d18-b036-2e4eeb674e86_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic Value, Outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_ba24e074-c085-4cbd-842f-85e677d3ee54_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic Value, Outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_304274dc-7e70-4963-b4d1-43cd15a6b830_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant-Date Fair Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_35dee3c6-846e-4ba4-ad8a-a442b3fc56c4_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_51ecdc46-6d0e-4b26-b721-e5fe275a63a8_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities Employee stock options and restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3aaca966-1b18-4807-8b04-985bf03c5eb4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_c0facd3f-f9e6-4d50-8764-2394fdd629ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionCashAndCashEquivalents_0fd29e6a-34d2-4483-9ded-04d9540c1263_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ams_AssetAcquisitionCashAndCashEquivalents_label_en-US" xlink:label="lab_ams_AssetAcquisitionCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Cash And Cash Equivalents</link:label>
    <link:label id="lab_ams_AssetAcquisitionCashAndCashEquivalents_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Cash And Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionCashAndCashEquivalents" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionCashAndCashEquivalents" xlink:to="lab_ams_AssetAcquisitionCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_18e38691-2142-40ca-9445-8140b5a02f75_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest costs capitalized</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationDueInFourthAndFifthYear_514abd22-3a88-4518-844f-d15ab4f499f8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInFourthAndFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024-2025</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInFourthAndFifthYear_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInFourthAndFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Year Four and Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInFourthAndFifthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInFourthAndFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInFourthAndFifthYear" xlink:to="lab_us-gaap_ContractualObligationDueInFourthAndFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f1643b2d-31da-4014-96e7-5c8f1bb14c07_verboseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0fa650c7-6dfc-4eb0-b848-b75b4143215d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_50f4ae14-712f-4345-b051-efba10032e3a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_675d1093-cb40-4553-8f81-5b083dd1e91b_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8597a041-b690-408f-9e11-ac73031b3305_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_0f2037c5-2301-4347-bd1a-f4204afcc66d_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_e9e4613a-9d58-44ac-9b3c-83b399dee675_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_ff4136a6-0a5e-43b6-8f8a-b0e7a66eecc5_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_503b693d-d4b4-48b5-aa34-ca34a5bf38f6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndOtherIncome_87c75856-9adc-4efb-9168-6efe39dbdad7_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestAndOtherIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income</link:label>
    <link:label id="lab_us-gaap_InterestAndOtherIncome_label_en-US" xlink:label="lab_us-gaap_InterestAndOtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndOtherIncome" xlink:to="lab_us-gaap_InterestAndOtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_250ffb47-6dc1-4eb9-9a30-38c1609d240c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for services (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_457065c8-990f-40cb-96f6-2e3e6928a90b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ASSETS</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_7bd81204-db1b-4c0e-bea7-1d11be00dc9d_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3a65e5ae-bf04-43cb-81a0-be72fcd0b029_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock awards (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_3f585665-fec9-4623-89d5-7295c2b7ecfa_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_02fac13a-fe7f-4af5-b0f5-3c7de09be63a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_ProceedsFromFinancingFromAcquisition_5bee483c-c014-4d9b-bfb2-c374d7c750f2_terseLabel_en-US" xlink:label="lab_ams_ProceedsFromFinancingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from financing from acquisition</link:label>
    <link:label id="lab_ams_ProceedsFromFinancingFromAcquisition_label_en-US" xlink:label="lab_ams_ProceedsFromFinancingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Financing From Acquisition</link:label>
    <link:label id="lab_ams_ProceedsFromFinancingFromAcquisition_documentation_en-US" xlink:label="lab_ams_ProceedsFromFinancingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Financing From Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ProceedsFromFinancingFromAcquisition" xlink:href="ams-20201231.xsd#ams_ProceedsFromFinancingFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_ProceedsFromFinancingFromAcquisition" xlink:to="lab_ams_ProceedsFromFinancingFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_06b02fa3-1dce-401f-a99d-6e026803a338_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of nonvested options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b37c5e92-04f3-4b7b-b5c4-a63d0d495623_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NumberOfDebtInstruments_b18e3ca4-ab04-4848-8a85-e1f6796fcc94_terseLabel_en-US" xlink:label="lab_ams_NumberOfDebtInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of notes</link:label>
    <link:label id="lab_ams_NumberOfDebtInstruments_label_en-US" xlink:label="lab_ams_NumberOfDebtInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Debt Instruments</link:label>
    <link:label id="lab_ams_NumberOfDebtInstruments_documentation_en-US" xlink:label="lab_ams_NumberOfDebtInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Debt Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfDebtInstruments" xlink:href="ams-20201231.xsd#ams_NumberOfDebtInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NumberOfDebtInstruments" xlink:to="lab_ams_NumberOfDebtInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9c60f80c-e4ac-4ba8-a805-3fdaf77fc8b7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Date Weighted-Average Fair Value, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_09f1fefe-79a0-4bc6-ad7f-0fe00665b7dd_verboseLabel_en-US" xlink:label="lab_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Presented in Financial Statements</link:label>
    <link:label id="lab_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Components Of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label id="lab_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="ams-20201231.xsd#ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_73f4e057-5da8-47d9-b18c-cdfa1658f630_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_CarryingValuesMember_35be6463-1370-49a4-9db2-e305b1a60c9c_terseLabel_en-US" xlink:label="lab_ams_CarryingValuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_ams_CarryingValuesMember_label_en-US" xlink:label="lab_ams_CarryingValuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Values [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CarryingValuesMember" xlink:href="ams-20201231.xsd#ams_CarryingValuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_CarryingValuesMember" xlink:to="lab_ams_CarryingValuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_1f73f8a3-2ab0-4d4a-8060-ce636e7f63a8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING LEASES</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:to="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_45ad49c3-78b7-4e49-aab3-e39a0af28063_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_78982bec-7b83-40fd-983f-6090d8902e1c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Lease Payments for Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationDueInNextTwelveMonths_93fef5f1-5ff9-4dc3-addf-91ade1a4eb28_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_d9a032ee-ceba-4ebf-8a0f-f7452cd0fe15_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_8922b35a-f7af-4fe4-b0a1-b3a43786e816_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_538a3d7c-c96f-4e50-9650-dd0934f96862_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized to be repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_8b2a05aa-691d-40f0-ba20-e66aab565d5b_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8d4a622a-41ad-48d6-b3eb-2130db8f2e24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_FinanceLeaseObligations_d13b5040-aac6-4203-881a-0a2a47f3960e_terseLabel_en-US" xlink:label="lab_ams_FinanceLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net book value of finance lease obligations</link:label>
    <link:label id="lab_ams_FinanceLeaseObligations_label_en-US" xlink:label="lab_ams_FinanceLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations</link:label>
    <link:label id="lab_ams_FinanceLeaseObligations_documentation_en-US" xlink:label="lab_ams_FinanceLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeaseObligations" xlink:href="ams-20201231.xsd#ams_FinanceLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_FinanceLeaseObligations" xlink:to="lab_ams_FinanceLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_3386f9ff-3fb8-4d6e-b236-053af5b69e5f_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation_14eac6e0-1ab3-4b30-a369-6e01bb127856_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefits and share-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits and Share-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:to="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_a0c46ae7-ab77-4dc5-af19-cd6d9cf06ea2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_e95a6169-30d9-4017-a906-744cefd91c35_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ef1d9a55-ec76-4d76-be61-475e60aa1169_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_b272339f-905c-47d3-a375-b77b12d4ef26_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_9ffe7527-acdd-432c-9ac9-716f782ef0e3_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dcb3ee85-e4f9-4291-8a06-343d684a27ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ba6e4909-3a8d-4eb4-8cc2-3cae50a00d34_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_71b72728-e852-4796-b1fd-04c90694be66_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_d94e6006-a6be-4041-8dec-82d725bc1896_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements_960052eb-d195-4861-b316-171943aded29_negatedLabel_en-US" xlink:label="lab_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net insurance proceeds receivable</link:label>
    <link:label id="lab_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements_label_en-US" xlink:label="lab_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease in Other Receivable Insurance Settlements</link:label>
    <link:label id="lab_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements_documentation_en-US" xlink:label="lab_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in the amount due from insurance settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements" xlink:href="ams-20201231.xsd#ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements" xlink:to="lab_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount_c2190bd6-af57-465b-828d-98d7222552c1_terseLabel_en-US" xlink:label="lab_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return to Provision True-up</link:label>
    <link:label id="lab_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount_label_en-US" xlink:label="lab_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return To Provision True-Up, Amount</link:label>
    <link:label id="lab_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount_documentation_en-US" xlink:label="lab_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return To Provision True-Up, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount" xlink:href="ams-20201231.xsd#ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount" xlink:to="lab_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1692b49-3ff4-4a4a-80c5-15f3f6a25622_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionConsiderationTransferred_8396227b-8864-440f-9e71-218ed3a8c9ba_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base purchase consideration</link:label>
    <link:label id="lab_ams_AssetAcquisitionConsiderationTransferred_665aee6d-5bba-41e0-bdcc-ee6298ea2966_totalLabel_en-US" xlink:label="lab_ams_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base purchase consideration</link:label>
    <link:label id="lab_ams_AssetAcquisitionConsiderationTransferred_label_en-US" xlink:label="lab_ams_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:label id="lab_ams_AssetAcquisitionConsiderationTransferred_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionConsiderationTransferred" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionConsiderationTransferred" xlink:to="lab_ams_AssetAcquisitionConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_d541e1d8-0448-4587-a65a-c00c70f4c8fd_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in net valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock_866da3d8-5f51-43d1-9f70-07b5c11d9f87_terseLabel_en-US" xlink:label="lab_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Domestic and Foreign Break out Percentages</link:label>
    <link:label id="lab_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock_label_en-US" xlink:label="lab_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Domestic and Foreign Break out Percentages [Table Text Block]</link:label>
    <link:label id="lab_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock_documentation_en-US" xlink:label="lab_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the presentation of foreign and domestic break out on the statement of financial position.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock" xlink:href="ams-20201231.xsd#ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock" xlink:to="lab_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_068bcd56-6533-4b21-aafb-a888e8246b0e_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Nonvested, Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_b1ff2b7c-9779-49ac-b7a7-3c04ad699a09_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_ef413104-7abc-417b-8ba9-a74e370b7150_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of purchase price consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NoncontrollingInterestsPolicyTextBlock_c91a7d40-841b-4490-9ff3-df6e8faf6ad8_verboseLabel_en-US" xlink:label="lab_ams_NoncontrollingInterestsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_ams_NoncontrollingInterestsPolicyTextBlock_label_en-US" xlink:label="lab_ams_NoncontrollingInterestsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests [Policy Text Block]</link:label>
    <link:label id="lab_ams_NoncontrollingInterestsPolicyTextBlock_documentation_en-US" xlink:label="lab_ams_NoncontrollingInterestsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NoncontrollingInterestsPolicyTextBlock" xlink:href="ams-20201231.xsd#ams_NoncontrollingInterestsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NoncontrollingInterestsPolicyTextBlock" xlink:to="lab_ams_NoncontrollingInterestsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_f13736bc-9fcc-41c6-ae8e-f4bc6949eece_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f22c09f2-3947-4daa-b473-3e30cb8e4120_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash from operating activities (excluding assets acquired and liabilities assumed):</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_c95fa9b4-305c-4ca3-92fa-da3e2b4a0ec8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense associated with lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_ef595cfc-7c52-4131-82bc-453c002aeea3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_8aa2ac51-6c91-4ba3-a1ae-24d772b48318_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_5e1ad991-d86e-44d4-9e06-5611a12a5c3d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_30b2909d-75b1-41c0-9a07-7920aa211363_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_InterestExpenseLeaseFinancing_e0d6296a-adbc-419f-bf69-93ae87f30fdc_terseLabel_en-US" xlink:label="lab_ams_InterestExpenseLeaseFinancing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest on lease financing</link:label>
    <link:label id="lab_ams_InterestExpenseLeaseFinancing_label_en-US" xlink:label="lab_ams_InterestExpenseLeaseFinancing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Lease Financing</link:label>
    <link:label id="lab_ams_InterestExpenseLeaseFinancing_documentation_en-US" xlink:label="lab_ams_InterestExpenseLeaseFinancing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Lease Financing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_InterestExpenseLeaseFinancing" xlink:href="ams-20201231.xsd#ams_InterestExpenseLeaseFinancing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_InterestExpenseLeaseFinancing" xlink:to="lab_ams_InterestExpenseLeaseFinancing" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_a9b1c4a1-746f-400b-9032-7d62d7acfd31_terseLabel_en-US" xlink:label="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested and outstanding (in shares)</link:label>
    <link:label id="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number</link:label>
    <link:label id="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_documentation_en-US" xlink:label="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:href="ams-20201231.xsd#ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_5df2048b-2f38-42e1-8ae6-b798be6255b3_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital loss carryover</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_PercentageOfTaxBenefitRealizedUponSettlement_6a52a2c3-27da-4d1b-bc22-44cd6ae7b782_terseLabel_en-US" xlink:label="lab_ams_PercentageOfTaxBenefitRealizedUponSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of tax benefit realized upon settlement</link:label>
    <link:label id="lab_ams_PercentageOfTaxBenefitRealizedUponSettlement_label_en-US" xlink:label="lab_ams_PercentageOfTaxBenefitRealizedUponSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Tax Benefit Realized Upon Settlement</link:label>
    <link:label id="lab_ams_PercentageOfTaxBenefitRealizedUponSettlement_documentation_en-US" xlink:label="lab_ams_PercentageOfTaxBenefitRealizedUponSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">It represents the percentage of tax benefit realized upon ultimate settlement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PercentageOfTaxBenefitRealizedUponSettlement" xlink:href="ams-20201231.xsd#ams_PercentageOfTaxBenefitRealizedUponSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_PercentageOfTaxBenefitRealizedUponSettlement" xlink:to="lab_ams_PercentageOfTaxBenefitRealizedUponSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_ef3bbcaf-59e2-4caa-b5df-019aef680635_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5e95eb53-206f-4656-bde7-da3d838123b0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6f3ece3b-9bce-4b1d-b3db-462ae31e3e27_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_147c174b-830f-4fe7-9170-a83f0c3193a9_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_dc062929-b8b5-4c6a-be2a-3ed11bc6f9eb_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for acquisition, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_3ca4a962-ead4-41ee-99df-80ab1c15b970_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_3aedabcb-f9fe-4fc4-9dc8-224abdef97b6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock options exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_cc9c57e6-f94f-462e-98f2-934880327b90_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_e0739b6e-f7a3-4cf5-9b86-69a13ee7a2d3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_GammaKnifeAndRadiationTherapyMember_d9a654a4-3e22-48f4-8cac-1e32d2bd40e3_terseLabel_en-US" xlink:label="lab_ams_GammaKnifeAndRadiationTherapyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gamma Knife And Radiation Therapy</link:label>
    <link:label id="lab_ams_GammaKnifeAndRadiationTherapyMember_label_en-US" xlink:label="lab_ams_GammaKnifeAndRadiationTherapyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gamma Knife And Radiation Therapy [Member]</link:label>
    <link:label id="lab_ams_GammaKnifeAndRadiationTherapyMember_documentation_en-US" xlink:label="lab_ams_GammaKnifeAndRadiationTherapyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gamma Knife And Radiation Therapy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeAndRadiationTherapyMember" xlink:href="ams-20201231.xsd#ams_GammaKnifeAndRadiationTherapyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_GammaKnifeAndRadiationTherapyMember" xlink:to="lab_ams_GammaKnifeAndRadiationTherapyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_OperatingLeasesMember_21bc8119-2cd9-4927-834f-f595a7f75be8_terseLabel_en-US" xlink:label="lab_ams_OperatingLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_ams_OperatingLeasesMember_label_en-US" xlink:label="lab_ams_OperatingLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases [Member]</link:label>
    <link:label id="lab_ams_OperatingLeasesMember_documentation_en-US" xlink:label="lab_ams_OperatingLeasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_OperatingLeasesMember" xlink:href="ams-20201231.xsd#ams_OperatingLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_OperatingLeasesMember" xlink:to="lab_ams_OperatingLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationDueInSecondAndThirdYear_c7722a8e-e07a-4001-aa42-904bf22194c9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInSecondAndThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022-2023</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInSecondAndThirdYear_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInSecondAndThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Year Two and Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInSecondAndThirdYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInSecondAndThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInSecondAndThirdYear" xlink:to="lab_us-gaap_ContractualObligationDueInSecondAndThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_dd3ba233-8df2-4651-b155-0615a586737e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_8b7b67ae-17a0-4dd2-b234-3b540e8a00f1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM LEASE LIABILITIES, less current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cfc0b712-39b4-45b8-be91-1c40d5a7f899_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_a84cd56a-430f-47fb-9028-eb7fe6496c43_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_44d9b3ef-d57f-4030-a202-09d2f396d380_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of estimates in the preparation of financial statements</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_2886bd34-5cfb-4a28-be59-f384eaf7bdb1_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_f6103077-98f7-47bb-8e1e-2724237e25f6_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt obligations, Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_0008ec29-97a3-47b2-bab8-8624b58df703_terseLabel_en-US" xlink:label="lab_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of tangible assets acquired as part of business combination</link:label>
    <link:label id="lab_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_label_en-US" xlink:label="lab_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Tangible Assets Acquired As Part Of Business Combination [Table Text Block]</link:label>
    <link:label id="lab_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_documentation_en-US" xlink:label="lab_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Tangible Assets Acquired As Part Of Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:href="ams-20201231.xsd#ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="lab_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_724b9732-7553-4e7f-aa8a-f8445f607c06_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember_04e82b2d-09f7-4852-a616-da5bbc8b3dec_terseLabel_en-US" xlink:label="lab_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units that will be removed from service in future years</link:label>
    <link:label id="lab_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember_label_en-US" xlink:label="lab_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units That Will Be Removed From Service In Future Years [Member]</link:label>
    <link:label id="lab_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember_documentation_en-US" xlink:label="lab_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units That Will Be Removed From Service In Future Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember" xlink:href="ams-20201231.xsd#ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember" xlink:to="lab_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LINACSystemMember_b8f2905c-4dd5-4d8b-8ea1-416f38104637_terseLabel_en-US" xlink:label="lab_ams_LINACSystemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LINAC system</link:label>
    <link:label id="lab_ams_LINACSystemMember_label_en-US" xlink:label="lab_ams_LINACSystemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LINAC system [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LINACSystemMember" xlink:href="ams-20201231.xsd#ams_LINACSystemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LINACSystemMember" xlink:to="lab_ams_LINACSystemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_StockOptionExercisePrice_863e76ef-e065-490e-9a4c-07e1c88066ea_terseLabel_en-US" xlink:label="lab_ams_StockOptionExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options exercise price (in dollars per share)</link:label>
    <link:label id="lab_ams_StockOptionExercisePrice_label_en-US" xlink:label="lab_ams_StockOptionExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option, Exercise Price</link:label>
    <link:label id="lab_ams_StockOptionExercisePrice_documentation_en-US" xlink:label="lab_ams_StockOptionExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The range of exercise prices of common stock that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_StockOptionExercisePrice" xlink:href="ams-20201231.xsd#ams_StockOptionExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_StockOptionExercisePrice" xlink:to="lab_ams_StockOptionExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f6bad4f7-a9cb-469c-ace9-4e349bea6f7b_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_062c486d-d7ae-47a2-a35d-3a0c9791957a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_4e405f67-092f-47e4-bfa9-ccac7e378ac9_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_311036d4-9e83-4c70-8fbe-c139c2834008_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c7ca9c60-b131-4812-9a01-263e4a7cf252_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_FinanceLeasesMember_c63df64b-d803-45d3-b861-18065ddcbbb1_terseLabel_en-US" xlink:label="lab_ams_FinanceLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases (includes interest)</link:label>
    <link:label id="lab_ams_FinanceLeasesMember_label_en-US" xlink:label="lab_ams_FinanceLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases [Member]</link:label>
    <link:label id="lab_ams_FinanceLeasesMember_documentation_en-US" xlink:label="lab_ams_FinanceLeasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeasesMember" xlink:href="ams-20201231.xsd#ams_FinanceLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_FinanceLeasesMember" xlink:to="lab_ams_FinanceLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_IncentiveCompensationPlanMember_22801ebe-fb93-4699-8a94-58d117673fca_terseLabel_en-US" xlink:label="lab_ams_IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Compensation Plan</link:label>
    <link:label id="lab_ams_IncentiveCompensationPlanMember_label_en-US" xlink:label="lab_ams_IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Compensation Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncentiveCompensationPlanMember" xlink:href="ams-20201231.xsd#ams_IncentiveCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_IncentiveCompensationPlanMember" xlink:to="lab_ams_IncentiveCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0658bff0-a591-444f-bcc1-d56e909aa00f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_f02a4d4d-c6fd-42ff-9b3d-ff265e581985_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_2159e892-d947-470f-bb4f-f7ef39535569_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_96f42e77-933e-44d0-8d1b-317291752122_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_689217f8-afde-446f-ba3d-e3aaa1d3962a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG TERM DEBT</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_BusinessAndCreditRiskPolicyTextBlock_20bce699-a9b8-4d85-953d-38132797c749_terseLabel_en-US" xlink:label="lab_ams_BusinessAndCreditRiskPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business and credit risk</link:label>
    <link:label id="lab_ams_BusinessAndCreditRiskPolicyTextBlock_label_en-US" xlink:label="lab_ams_BusinessAndCreditRiskPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business And Credit Risk [Policy Text Block]</link:label>
    <link:label id="lab_ams_BusinessAndCreditRiskPolicyTextBlock_documentation_en-US" xlink:label="lab_ams_BusinessAndCreditRiskPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for business and credit risk.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_BusinessAndCreditRiskPolicyTextBlock" xlink:href="ams-20201231.xsd#ams_BusinessAndCreditRiskPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_BusinessAndCreditRiskPolicyTextBlock" xlink:to="lab_ams_BusinessAndCreditRiskPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_WorkingCapitalPaymentLiabilityCurrent_854d0bb3-7489-40d7-accd-3f0d7a232811_terseLabel_en-US" xlink:label="lab_ams_WorkingCapitalPaymentLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital payment due</link:label>
    <link:label id="lab_ams_WorkingCapitalPaymentLiabilityCurrent_label_en-US" xlink:label="lab_ams_WorkingCapitalPaymentLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working Capital Payment Liability, Current</link:label>
    <link:label id="lab_ams_WorkingCapitalPaymentLiabilityCurrent_documentation_en-US" xlink:label="lab_ams_WorkingCapitalPaymentLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working Capital Payment Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_WorkingCapitalPaymentLiabilityCurrent" xlink:href="ams-20201231.xsd#ams_WorkingCapitalPaymentLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_WorkingCapitalPaymentLiabilityCurrent" xlink:to="lab_ams_WorkingCapitalPaymentLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_0d0ac182-025b-4e92-a865-7c6daafd4573_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2e0aea7a-ddbb-465d-a4ef-f9cca4518751_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c6e7ad16-4a3e-4489-9455-44aeeb32d593_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Date Weighted-Average Fair Value, Outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_e73272eb-72b3-4cea-afcf-797f7496ad15_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Date Weighted-Average Fair Value, Outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_33aae340-44ef-49fb-bbce-73c2f5265cbf_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_871d686e-d8ba-4df7-8070-b08b8610be68_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_ec81f322-6688-40bb-b567-f6e900d74683_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_181f8d64-a801-408b-a737-9eface7f9197_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_ae81ad46-3eaf-4718-830c-ee3fbc5f3584_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long lived asset impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_8abb7aac-3523-4abd-b27c-f762500ac254_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour_6dfa6a97-d4d9-4b83-b730-33573f5c9ff7_terseLabel_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour_label_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Four</link:label>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour_documentation_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour" xlink:to="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_0e5bc2fa-ca0c-4a5f-9c60-1f506460efc9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue_85b5de16-7241-4609-9553-bc746a52803f_negatedLabel_en-US" xlink:label="lab_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities and deferred revenue</link:label>
    <link:label id="lab_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue_label_en-US" xlink:label="lab_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Accounts Payable, Accrued Liabilities And Deferred Revenue</link:label>
    <link:label id="lab_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue_documentation_en-US" xlink:label="lab_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid and deferred revenue.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue" xlink:href="ams-20201231.xsd#ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue" xlink:to="lab_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ef9556c2-33ae-4704-a461-36afa87c965f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_651fccca-f44d-42c6-a74d-27e996f3e7a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted common shares returned to plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermPurchaseCommitmentPeriod_bfca9112-0456-4ef2-bed8-244d36a971c7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment period</link:label>
    <link:label id="lab_us-gaap_LongtermPurchaseCommitmentPeriod_label_en-US" xlink:label="lab_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:to="lab_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetRetirementObligationNumberOfSites_753d54dd-9250-464e-bd75-6fcbe142187b_terseLabel_en-US" xlink:label="lab_ams_AssetRetirementObligationNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites</link:label>
    <link:label id="lab_ams_AssetRetirementObligationNumberOfSites_label_en-US" xlink:label="lab_ams_AssetRetirementObligationNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation, Number Of Sites</link:label>
    <link:label id="lab_ams_AssetRetirementObligationNumberOfSites_documentation_en-US" xlink:label="lab_ams_AssetRetirementObligationNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation, Number Of Sites</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetRetirementObligationNumberOfSites" xlink:href="ams-20201231.xsd#ams_AssetRetirementObligationNumberOfSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetRetirementObligationNumberOfSites" xlink:to="lab_ams_AssetRetirementObligationNumberOfSites" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_a6d63fae-70bf-4ce8-82e0-0b4878f2539d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_GKCEAcquisitionMember_06ff2a81-2096-4515-942b-bc1b4850d7d8_terseLabel_en-US" xlink:label="lab_ams_GKCEAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GKCE acquisition</link:label>
    <link:label id="lab_ams_GKCEAcquisitionMember_label_en-US" xlink:label="lab_ams_GKCEAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GKCE Acquisition [Member]</link:label>
    <link:label id="lab_ams_GKCEAcquisitionMember_documentation_en-US" xlink:label="lab_ams_GKCEAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GKCE Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GKCEAcquisitionMember" xlink:href="ams-20201231.xsd#ams_GKCEAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_GKCEAcquisitionMember" xlink:to="lab_ams_GKCEAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_fe31f054-9709-4a75-ae03-57f61eb5b398_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution, percent of employee gross pay</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_87bc9d4f-fabd-4c99-90e4-a81007f9c2c1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals and allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Returns and Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_aa857c1e-c3d2-415c-a880-f7945bebfa5d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_PaymentsForWorkingCapital_a9e02887-a47e-4877-be2d-dae047112279_verboseLabel_en-US" xlink:label="lab_ams_PaymentsForWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First working capital payment related to acquisition, withholding taxes</link:label>
    <link:label id="lab_ams_PaymentsForWorkingCapital_864f1603-2d58-417a-890e-0b871ae5a5b6_terseLabel_en-US" xlink:label="lab_ams_PaymentsForWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First working capital payment</link:label>
    <link:label id="lab_ams_PaymentsForWorkingCapital_49df69da-8e3b-459a-a6f1-dd14a34495cb_negatedTerseLabel_en-US" xlink:label="lab_ams_PaymentsForWorkingCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First working capital payment</link:label>
    <link:label id="lab_ams_PaymentsForWorkingCapital_label_en-US" xlink:label="lab_ams_PaymentsForWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Working Capital</link:label>
    <link:label id="lab_ams_PaymentsForWorkingCapital_documentation_en-US" xlink:label="lab_ams_PaymentsForWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsForWorkingCapital" xlink:href="ams-20201231.xsd#ams_PaymentsForWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_PaymentsForWorkingCapital" xlink:to="lab_ams_PaymentsForWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_69cb311d-a7b5-4e29-8dd2-35d3a19976c9_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining number of shares authorized to be repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_5070d108-ce4c-4630-b4ed-bd8f47ad9bf5_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic Value, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_3021579a-69f4-4546-af87-cb7fdf0f4ff9_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_6a93f398-cd3b-4250-92b9-0d41c2573c0a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_b0fe186c-efb0-4837-879e-378d74813eca_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities_20f51100-bb12-459a-bf0b-0788f08195ee_terseLabel_en-US" xlink:label="lab_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease reassessment right of use assets and lease liabilities</link:label>
    <link:label id="lab_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities_label_en-US" xlink:label="lab_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Reassessment, Right-Of-Use Assets And Lease Liabilities</link:label>
    <link:label id="lab_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities_documentation_en-US" xlink:label="lab_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Reassessment, Right-Of-Use Assets And Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities" xlink:href="ams-20201231.xsd#ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities" xlink:to="lab_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionDeferredIncomeTaxes_4d97f854-d8f1-4be0-b2ca-b8ea8f6d1a04_negatedLabel_en-US" xlink:label="lab_ams_AssetAcquisitionDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_ams_AssetAcquisitionDeferredIncomeTaxes_label_en-US" xlink:label="lab_ams_AssetAcquisitionDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Deferred Income Taxes</link:label>
    <link:label id="lab_ams_AssetAcquisitionDeferredIncomeTaxes_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDeferredIncomeTaxes" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionDeferredIncomeTaxes" xlink:to="lab_ams_AssetAcquisitionDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_5e6f5751-4892-456c-bdde-f5538328355d_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt obligations, Carrying Value</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_GammaKnifeCenterEcuadorSAGKCEMember_15a5c17d-4617-43d3-8832-354b4840789c_terseLabel_en-US" xlink:label="lab_ams_GammaKnifeCenterEcuadorSAGKCEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gamma Knife Center Ecuador S.A. (&#8220;GKCE&#8221;)</link:label>
    <link:label id="lab_ams_GammaKnifeCenterEcuadorSAGKCEMember_label_en-US" xlink:label="lab_ams_GammaKnifeCenterEcuadorSAGKCEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gamma Knife Center Ecuador S.A. (&#8220;GKCE&#8221;) [Member]</link:label>
    <link:label id="lab_ams_GammaKnifeCenterEcuadorSAGKCEMember_documentation_en-US" xlink:label="lab_ams_GammaKnifeCenterEcuadorSAGKCEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gamma Knife Center Ecuador S.A. (&#8220;GKCE&#8221;)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeCenterEcuadorSAGKCEMember" xlink:href="ams-20201231.xsd#ams_GammaKnifeCenterEcuadorSAGKCEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_GammaKnifeCenterEcuadorSAGKCEMember" xlink:to="lab_ams_GammaKnifeCenterEcuadorSAGKCEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_c8248ce9-bc5e-4b7a-8d0d-555e9dedd274_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_dad1ae3b-1ecb-4fa2-84de-debac9128121_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_13e6986d-2757-4c14-97e5-3eafb7a653d7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NumberOfPurchaseCommitments_a72aa374-b4a6-4145-8ecb-ee58822816e6_terseLabel_en-US" xlink:label="lab_ams_NumberOfPurchaseCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of purchase commitments</link:label>
    <link:label id="lab_ams_NumberOfPurchaseCommitments_label_en-US" xlink:label="lab_ams_NumberOfPurchaseCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Purchase Commitments</link:label>
    <link:label id="lab_ams_NumberOfPurchaseCommitments_documentation_en-US" xlink:label="lab_ams_NumberOfPurchaseCommitments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Purchase Commitments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfPurchaseCommitments" xlink:href="ams-20201231.xsd#ams_NumberOfPurchaseCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NumberOfPurchaseCommitments" xlink:to="lab_ams_NumberOfPurchaseCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_5d203fd3-4258-41cc-b4cd-ed5ce91a5eba_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo_be53ae64-3f4a-49d9-8b68-e4c78c96cf10_terseLabel_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo_label_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Two</link:label>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo_documentation_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo" xlink:to="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_eb7ba3b6-571a-415d-9c34-c5fea87efd1c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_1271adfc-67d4-4035-bd80-3615acd31315_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_6a43d4bd-416d-4011-94ac-08d824448dd6_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetRetirementObligationNumberOfRemovedAssetUnits_cf7dbb0f-4383-4230-9b4e-cb5582e9da9b_terseLabel_en-US" xlink:label="lab_ams_AssetRetirementObligationNumberOfRemovedAssetUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of removed asset units</link:label>
    <link:label id="lab_ams_AssetRetirementObligationNumberOfRemovedAssetUnits_label_en-US" xlink:label="lab_ams_AssetRetirementObligationNumberOfRemovedAssetUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation, Number Of Removed Asset Units</link:label>
    <link:label id="lab_ams_AssetRetirementObligationNumberOfRemovedAssetUnits_documentation_en-US" xlink:label="lab_ams_AssetRetirementObligationNumberOfRemovedAssetUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation, Number Of Removed Asset Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetRetirementObligationNumberOfRemovedAssetUnits" xlink:href="ams-20201231.xsd#ams_AssetRetirementObligationNumberOfRemovedAssetUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetRetirementObligationNumberOfRemovedAssetUnits" xlink:to="lab_ams_AssetRetirementObligationNumberOfRemovedAssetUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_cdac89e4-fb09-4b87-b9c1-f78e0cfb781f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_e6d97dfd-8787-4dd2-8746-08c8bb29eab6_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original cost of operating lease contracts</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d91e6ced-6222-4931-9e70-734285e9a889_netLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_580e9236-8a95-4edc-97c8-6a3e679ff7d9_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_4e066ab4-45cf-4d8e-bbd9-e3512f63b787_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NumberOfDeposits_1d13d836-5cc3-4205-9f73-1db159aea416_terseLabel_en-US" xlink:label="lab_ams_NumberOfDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of deposits</link:label>
    <link:label id="lab_ams_NumberOfDeposits_label_en-US" xlink:label="lab_ams_NumberOfDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Deposits</link:label>
    <link:label id="lab_ams_NumberOfDeposits_documentation_en-US" xlink:label="lab_ams_NumberOfDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfDeposits" xlink:href="ams-20201231.xsd#ams_NumberOfDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NumberOfDeposits" xlink:to="lab_ams_NumberOfDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NumberOfCustomersWithIntentToTerminateContract_d75596b8-be72-475a-9ec8-6d1b42f3da79_terseLabel_en-US" xlink:label="lab_ams_NumberOfCustomersWithIntentToTerminateContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of customers with intent to terminate contract</link:label>
    <link:label id="lab_ams_NumberOfCustomersWithIntentToTerminateContract_label_en-US" xlink:label="lab_ams_NumberOfCustomersWithIntentToTerminateContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Customers With Intent To Terminate Contract</link:label>
    <link:label id="lab_ams_NumberOfCustomersWithIntentToTerminateContract_documentation_en-US" xlink:label="lab_ams_NumberOfCustomersWithIntentToTerminateContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Customers With Intent To Terminate Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfCustomersWithIntentToTerminateContract" xlink:href="ams-20201231.xsd#ams_NumberOfCustomersWithIntentToTerminateContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NumberOfCustomersWithIntentToTerminateContract" xlink:to="lab_ams_NumberOfCustomersWithIntentToTerminateContract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_CustomerOneMember_5d41e661-2060-41e7-8d94-09d1deea877c_terseLabel_en-US" xlink:label="lab_ams_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One</link:label>
    <link:label id="lab_ams_CustomerOneMember_label_en-US" xlink:label="lab_ams_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CustomerOneMember" xlink:href="ams-20201231.xsd#ams_CustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_CustomerOneMember" xlink:to="lab_ams_CustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2ddd8dfa-5754-4922-9e6a-d762d0b58c98_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_49f80280-83a3-4cbe-a7c7-1f887a369257_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_bf2b9151-c32b-4964-a67b-d139a1a63054_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_228e6be1-fd8f-429a-acf9-3c1c03a35ffb_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: net loss (income) attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_UsSubsidiaryOfElektaMember_90c72baa-35a9-4427-a648-dbee3b219d6e_terseLabel_en-US" xlink:label="lab_ams_UsSubsidiaryOfElektaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Subsidiary Of Elekta</link:label>
    <link:label id="lab_ams_UsSubsidiaryOfElektaMember_label_en-US" xlink:label="lab_ams_UsSubsidiaryOfElektaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Subsidiary Of Elekta [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_UsSubsidiaryOfElektaMember" xlink:href="ams-20201231.xsd#ams_UsSubsidiaryOfElektaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_UsSubsidiaryOfElektaMember" xlink:to="lab_ams_UsSubsidiaryOfElektaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostOfOperatingRevenue_7468fc6d-6458-4a55-a433-b0ab15b6d4d9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherCostOfOperatingRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other direct operating costs</link:label>
    <link:label id="lab_us-gaap_OtherCostOfOperatingRevenue_label_en-US" xlink:label="lab_us-gaap_OtherCostOfOperatingRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost of Operating Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostOfOperatingRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostOfOperatingRevenue" xlink:to="lab_us-gaap_OtherCostOfOperatingRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a708be79-33fb-47bc-a6ae-2426636439da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount_b6f125f9-f2b3-46ad-8369-eea94192897b_terseLabel_en-US" xlink:label="lab_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital loss carryforward expiration</link:label>
    <link:label id="lab_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount_label_en-US" xlink:label="lab_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Capital Loss Carryforward Expiration, Amount</link:label>
    <link:label id="lab_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount_documentation_en-US" xlink:label="lab_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Capital Loss Carryforward Expiration, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount" xlink:href="ams-20201231.xsd#ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount" xlink:to="lab_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_0f1c80cc-ec97-48b1-ab19-aad913c32a60_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c702f5f0-a731-4dc7-9dba-7aaabb989783_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_b88e3d07-4d8d-4ef9-aca4-b4eb38bf2dbc_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0d832115-44af-4b40-bdce-4202ec97d368_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_25b0cce3-8903-4ed1-9b10-797bdd6a5982_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION EXPENSE</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d5ab769e-e325-40d8-b060-e604171d0acd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Stock Options, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_fddf9c50-b159-40c6-b800-89803ad84720_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_f5ea946b-6d0f-46b0-a8f7-54207cec9bde_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d4a45682-70a3-4305-a9f3-f3480a967e80_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_ba4b284d-517c-4695-b58d-e544e62b7dd0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_9bbd0453-ca47-467f-b954-1ddb549f0562_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_d75a12d5-21b4-4051-9565-25554edb8e5a_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration_3842320a-ecc1-4760-b086-7a3586b340e5_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in amount of contingent consideration</link:label>
    <link:label id="lab_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration_label_en-US" xlink:label="lab_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration</link:label>
    <link:label id="lab_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" xlink:to="lab_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_3d7170df-78a6-4061-913d-6711df8d9f54_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_fc0ee926-2e18-4edb-8e57-d45a6e7c8a7c_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_5388895b-0549-4754-acdc-377024ee61f7_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_44fbf445-b6aa-48fe-832f-cb38bde1e583_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_f133a5e6-bcbf-432c-8397-0b30252cab72_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_6f631fae-ba24-4a92-8d3f-844904f3fe6b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AccountingPoliciesTable_a8df9123-aa98-4e7e-8097-f5596d8f75da_terseLabel_en-US" xlink:label="lab_ams_AccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Table]</link:label>
    <link:label id="lab_ams_AccountingPoliciesTable_label_en-US" xlink:label="lab_ams_AccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AccountingPoliciesTable" xlink:href="ams-20201231.xsd#ams_AccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AccountingPoliciesTable" xlink:to="lab_ams_AccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_6b0a9e43-eb04-48df-b1ed-4185808f79f4_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_edccfa3d-df74-4fed-a324-f54dfe373fc1_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on write down impaired assets</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_990b3559-1a9b-4f29-8c93-b97fcc1d26c7_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_GammaKnifePerfexionSystemMember_bb7581ff-8a5d-4ed4-adae-03648861f9a3_terseLabel_en-US" xlink:label="lab_ams_GammaKnifePerfexionSystemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gamma Knife Perfexion System</link:label>
    <link:label id="lab_ams_GammaKnifePerfexionSystemMember_label_en-US" xlink:label="lab_ams_GammaKnifePerfexionSystemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gamma Knife Perfexion System [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifePerfexionSystemMember" xlink:href="ams-20201231.xsd#ams_GammaKnifePerfexionSystemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_GammaKnifePerfexionSystemMember" xlink:to="lab_ams_GammaKnifePerfexionSystemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_fb07437a-af57-4122-9764-40f521faec71_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c2b12dff-a0a0-488f-b102-a478cd088e98_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Date Weighted- Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_53ba17b5-6dcd-4ef6-861a-c4f63ddb7f92_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_f8f22a21-fd27-4cb0-8ea6-4e1a595eb705_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_ff0d0ca1-df85-4f9d-bac8-b88e304e1bee_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_99ad3e7d-a241-4be8-ba7f-9ac954d74eee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree_6e124017-52d0-4b3b-a2fb-644a3dbf3fc1_terseLabel_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree_label_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Three</link:label>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree_documentation_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree" xlink:to="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_a4454847-62e6-41ca-b69e-10081e77a54c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1d23ec9e-c5ea-4064-84c6-e47dff952c8c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_d2c4be22-c7e7-4761-87d4-e5b17d2faf76_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts of $100,000 at December 31, 2020 and December 31, 2019</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_80681873-0714-4f5c-a16d-39ca892c2499_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bafbdc21-49f5-429d-b748-941d70d48bab_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue_56a0172a-3b9d-4711-af48-bba683c30a0e_totalLabel_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Future Minimum Payments Due</link:label>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue_label_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due</link:label>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue_documentation_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue" xlink:to="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_208154db-67e7-46da-b4cc-69005671b7ec_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other &#8211; net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionTransactionCosts_62236913-5d1d-4b41-ab4e-3b2234351888_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisition, transaction costs</link:label>
    <link:label id="lab_ams_AssetAcquisitionTransactionCosts_label_en-US" xlink:label="lab_ams_AssetAcquisitionTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Transaction Costs</link:label>
    <link:label id="lab_ams_AssetAcquisitionTransactionCosts_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionTransactionCosts" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionTransactionCosts" xlink:to="lab_ams_AssetAcquisitionTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_2d667356-4ace-432d-a06c-cc5e3cd11872_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_50ef74cb-bd3b-425e-88c9-e76d2054f698_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_57b1e0ad-ff3f-4392-9e21-2d393eb1693e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ecef82da-bd23-43bc-9762-66855b200e1d_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_ProtonBeamRadiationTherapyPBRTMember_8756e42c-b6f8-4210-b590-77a216f42150_terseLabel_en-US" xlink:label="lab_ams_ProtonBeamRadiationTherapyPBRTMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proton Beam Radiation Therapy (&#8220;PBRT&#8221;)</link:label>
    <link:label id="lab_ams_ProtonBeamRadiationTherapyPBRTMember_label_en-US" xlink:label="lab_ams_ProtonBeamRadiationTherapyPBRTMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proton Beam Radiation Therapy (&#8220;PBRT&#8221;) [Member]</link:label>
    <link:label id="lab_ams_ProtonBeamRadiationTherapyPBRTMember_documentation_en-US" xlink:label="lab_ams_ProtonBeamRadiationTherapyPBRTMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proton Beam Radiation Therapy (&#8220;PBRT&#8221;)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ProtonBeamRadiationTherapyPBRTMember" xlink:href="ams-20201231.xsd#ams_ProtonBeamRadiationTherapyPBRTMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_ProtonBeamRadiationTherapyPBRTMember" xlink:to="lab_ams_ProtonBeamRadiationTherapyPBRTMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_854ada2c-deb0-42cd-8288-5c88e79fcf46_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating&#8203; lease &#8203;remaining &#8203;lease &#8203;term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_910d150f-bdbb-4bd7-a711-eab8fcf2c625_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Functional currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_8faac105-9949-4fde-a6e7-4eddcfd5235f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7d12d221-6c4f-49fe-bed7-ad59d3433d13_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_b0312f27-5a83-493b-a735-6260c6c43bb6_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for basic and diluted (loss) earnings per share &#8211; weighted-average shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_ad6929cc-4048-44e9-aa13-1c8c11d59ed8_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets net of valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_CommitmentsAndContingenciesLineItems_331dcfe5-35a0-404c-9737-71a1aac529d1_terseLabel_en-US" xlink:label="lab_ams_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_ams_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_ams_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CommitmentsAndContingenciesLineItems" xlink:href="ams-20201231.xsd#ams_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems" xlink:to="lab_ams_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_CustomerFourMember_f63dc733-5502-44e2-ab4a-f8961889a78b_terseLabel_en-US" xlink:label="lab_ams_CustomerFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Four</link:label>
    <link:label id="lab_ams_CustomerFourMember_label_en-US" xlink:label="lab_ams_CustomerFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Four [Member]</link:label>
    <link:label id="lab_ams_CustomerFourMember_documentation_en-US" xlink:label="lab_ams_CustomerFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CustomerFourMember" xlink:href="ams-20201231.xsd#ams_CustomerFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_CustomerFourMember" xlink:to="lab_ams_CustomerFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_f90320ad-03b9-4bb9-9714-0c05e98aaa66_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred tax adjustments</link:label>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit" xlink:to="lab_us-gaap_OtherTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_1307932c-d560-402c-9f24-c045ca61fa02_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f7b1beed-ef7c-4aa9-b402-814d23599322_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_ec63fbd0-c17a-49a2-ad44-5aeda55f2f85_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_876f9864-402e-42a3-bbf6-cf2fbb902d1a_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths_940e07f0-56b6-459e-846c-81dc790ec8a9_terseLabel_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths_label_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Next Twelve Months</link:label>
    <link:label id="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths_documentation_en-US" xlink:label="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths" xlink:to="lab_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6f6dc025-db0e-4de2-9662-754e89f1fcf1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_cb89d351-1845-4035-b978-bae188e0fc79_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_3d1ae928-6665-45e2-9a60-da204a7980c6_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_956774e1-4946-4962-b1c7-c1a7fba7b9d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_17691f3b-26a2-400b-bfa7-42cfce105be8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NumberOfEmployees_df9331ea-e8c8-4c66-aae5-477c4bff5ad3_terseLabel_en-US" xlink:label="lab_ams_NumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of employees</link:label>
    <link:label id="lab_ams_NumberOfEmployees_label_en-US" xlink:label="lab_ams_NumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Employees</link:label>
    <link:label id="lab_ams_NumberOfEmployees_documentation_en-US" xlink:label="lab_ams_NumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfEmployees" xlink:href="ams-20201231.xsd#ams_NumberOfEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NumberOfEmployees" xlink:to="lab_ams_NumberOfEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e360ab8b-b8b1-4238-bd5c-b18753151404_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_fbb8f1d8-ea81-4e4e-8cbd-0e63c767a9fa_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_2096adc1-9e66-4624-896c-96c3b9be7724_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Fair Value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableRelatedParties_d181bf51-37fe-43e0-a795-1387821b8ebb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableRelatedParties_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableRelatedParties" xlink:to="lab_us-gaap_AccountsReceivableRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_MevionMedicalSystemsIncMember_1c361ef9-b209-4263-84f4-ed165d1b2dc3_terseLabel_en-US" xlink:label="lab_ams_MevionMedicalSystemsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mevion Medical Systems Inc</link:label>
    <link:label id="lab_ams_MevionMedicalSystemsIncMember_label_en-US" xlink:label="lab_ams_MevionMedicalSystemsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mevion Medical Systems Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MevionMedicalSystemsIncMember" xlink:href="ams-20201231.xsd#ams_MevionMedicalSystemsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_MevionMedicalSystemsIncMember" xlink:to="lab_ams_MevionMedicalSystemsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionPercentageOfOutstandingShares_596a25b1-a99c-4a39-bd54-9c14199cd35e_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionPercentageOfOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding shares</link:label>
    <link:label id="lab_ams_AssetAcquisitionPercentageOfOutstandingShares_label_en-US" xlink:label="lab_ams_AssetAcquisitionPercentageOfOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Percentage Of Outstanding Shares</link:label>
    <link:label id="lab_ams_AssetAcquisitionPercentageOfOutstandingShares_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionPercentageOfOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Percentage Of Outstanding Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfOutstandingShares" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfOutstandingShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionPercentageOfOutstandingShares" xlink:to="lab_ams_AssetAcquisitionPercentageOfOutstandingShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_89e2b022-341c-445d-b581-ee0d9bbd3ccf_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_35c0df0a-4205-4740-811d-2d42b5813554_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_DocumentAndEntityInformationAbstract_db60d3cf-a8d4-4afc-bbfe-e175b6a16c4d_terseLabel_en-US" xlink:label="lab_ams_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_ams_DocumentAndEntityInformationAbstract_label_en-US" xlink:label="lab_ams_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_ams_DocumentAndEntityInformationAbstract_documentation_en-US" xlink:label="lab_ams_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_DocumentAndEntityInformationAbstract" xlink:href="ams-20201231.xsd#ams_DocumentAndEntityInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_DocumentAndEntityInformationAbstract" xlink:to="lab_ams_DocumentAndEntityInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant_54e442d8-176e-418e-a63b-3c5121a35ae1_terseLabel_en-US" xlink:label="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining shares available for grant (in shares)</link:label>
    <link:label id="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Remaining Number Of Shares Available For Grant</link:label>
    <link:label id="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant_documentation_en-US" xlink:label="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The remaining number of shares available for grant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant" xlink:href="ams-20201231.xsd#ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant" xlink:to="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0bf1b600-05b0-420d-a874-a71900c8c69b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bdd90886-a60a-4162-85d4-d75c45b4e91e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for diluted (loss) earnings per share &#8211; adjusted weighted-average shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_89039962-5538-4d71-968b-f09fc39de91f_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_DomesticMember_90b99598-18c3-45ba-96d7-bd92993f6a97_terseLabel_en-US" xlink:label="lab_ams_DomesticMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_ams_DomesticMember_label_en-US" xlink:label="lab_ams_DomesticMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_DomesticMember" xlink:href="ams-20201231.xsd#ams_DomesticMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_DomesticMember" xlink:to="lab_ams_DomesticMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_6f14cf3d-1c12-4dbb-8491-3f1161edb5ce_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income per common share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_83fe3ef3-65a2-45a3-8a42-7780878653f0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) earnings per common share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AccountingPoliciesLineItems_c8a99724-addc-42b5-93b6-87fa2ee62fe0_terseLabel_en-US" xlink:label="lab_ams_AccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Line Items]</link:label>
    <link:label id="lab_ams_AccountingPoliciesLineItems_label_en-US" xlink:label="lab_ams_AccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AccountingPoliciesLineItems" xlink:href="ams-20201231.xsd#ams_AccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AccountingPoliciesLineItems" xlink:to="lab_ams_AccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3367ada2-7ea0-4de1-a94b-371021323e4e_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_RetainerFeesMember_0eda2eab-93e2-4747-9370-e4673432e83c_terseLabel_en-US" xlink:label="lab_ams_RetainerFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retainer Fees</link:label>
    <link:label id="lab_ams_RetainerFeesMember_label_en-US" xlink:label="lab_ams_RetainerFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retainer Fees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_RetainerFeesMember" xlink:href="ams-20201231.xsd#ams_RetainerFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_RetainerFeesMember" xlink:to="lab_ams_RetainerFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d3d3c126-f4aa-415c-864d-f982b60f7c78_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_10e034ee-b796-45fa-a6c0-9de3d6d43d7b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionIncomeTaxesPayable_9ab64797-5338-445a-9d90-a8b29fb43f05_negatedTerseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_ams_AssetAcquisitionIncomeTaxesPayable_label_en-US" xlink:label="lab_ams_AssetAcquisitionIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Income Taxes Payable</link:label>
    <link:label id="lab_ams_AssetAcquisitionIncomeTaxesPayable_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionIncomeTaxesPayable" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionIncomeTaxesPayable" xlink:to="lab_ams_AssetAcquisitionIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_0626ef17-6cad-4e87-9dce-2cfeb0d2066e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_UnitsRemovedFromServiceInPriorYearsMember_12073fda-d015-4b4a-a0e8-fde13bb1847b_terseLabel_en-US" xlink:label="lab_ams_UnitsRemovedFromServiceInPriorYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units removed from service in prior years</link:label>
    <link:label id="lab_ams_UnitsRemovedFromServiceInPriorYearsMember_label_en-US" xlink:label="lab_ams_UnitsRemovedFromServiceInPriorYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units Removed From Service In Prior Years [Member]</link:label>
    <link:label id="lab_ams_UnitsRemovedFromServiceInPriorYearsMember_documentation_en-US" xlink:label="lab_ams_UnitsRemovedFromServiceInPriorYearsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units Removed From Service In Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_UnitsRemovedFromServiceInPriorYearsMember" xlink:href="ams-20201231.xsd#ams_UnitsRemovedFromServiceInPriorYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_UnitsRemovedFromServiceInPriorYearsMember" xlink:to="lab_ams_UnitsRemovedFromServiceInPriorYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_34527ce0-7ec1-423c-8c61-0966985e5fcd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_26d8c74f-6f6d-405b-8cfa-92246fd50036_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationDueAfterFifthYear_cd35a6e5-ea13-4bcb-aff6-c272230c8f1a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 5&#160;years</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueAfterFifthYear_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueAfterFifthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueAfterFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueAfterFifthYear" xlink:to="lab_us-gaap_ContractualObligationDueAfterFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_UnitsRemovedFromServiceInCurrentYearMember_00cd110d-612a-459e-b3e2-35316b00bb65_terseLabel_en-US" xlink:label="lab_ams_UnitsRemovedFromServiceInCurrentYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units removed from service in current year</link:label>
    <link:label id="lab_ams_UnitsRemovedFromServiceInCurrentYearMember_label_en-US" xlink:label="lab_ams_UnitsRemovedFromServiceInCurrentYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units Removed From Service In Current Year [Member]</link:label>
    <link:label id="lab_ams_UnitsRemovedFromServiceInCurrentYearMember_documentation_en-US" xlink:label="lab_ams_UnitsRemovedFromServiceInCurrentYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units Removed From Service In Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_UnitsRemovedFromServiceInCurrentYearMember" xlink:href="ams-20201231.xsd#ams_UnitsRemovedFromServiceInCurrentYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_UnitsRemovedFromServiceInCurrentYearMember" xlink:to="lab_ams_UnitsRemovedFromServiceInCurrentYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_cd30ffda-2399-4be4-851f-7e091df5e084_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_7117ea5c-ece5-4b53-910a-846186dc38ab_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCollateralAmount_e2069e60-10a9-4181-813f-74785ddbae72_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCollateralAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate net book value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCollateralAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCollateralAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Collateral Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCollateralAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCollateralAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCollateralAmount" xlink:to="lab_us-gaap_DebtInstrumentCollateralAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_dd386d44-a22c-4074-8f3c-e20986c224d7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_cf74b89b-9cca-4f0d-854f-082282e0c34e_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_8ddbd8ff-26a9-4bdf-960b-c2c16cb4c6c3_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_ffd559b7-7919-412f-b3fc-9d029bcd30e0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized, including assessed tax</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f3bd597f-5655-4b67-bae7-48df3c850ee1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, no par value (10,000,000 authorized; Issued and outstanding shares &#8211; 5,714,000 at December 31, 2018 and 5,710,000 at December 31, 2017</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_10a9c344-ac90-4cb6-8b33-79da17eb6581_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt (includes interest)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionAccountsReceivable_a807eaeb-f292-45af-b561-fa3acb0da31a_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_ams_AssetAcquisitionAccountsReceivable_label_en-US" xlink:label="lab_ams_AssetAcquisitionAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Accounts Receivable</link:label>
    <link:label id="lab_ams_AssetAcquisitionAccountsReceivable_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAccountsReceivable" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionAccountsReceivable" xlink:to="lab_ams_AssetAcquisitionAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_dbafa58f-2107-4ccd-9e7d-d6c68db521ba_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_27f0a830-36d6-4dcd-9583-9edd3b4748e0_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_ForeignMember_f55e80bb-460b-4616-86a9-6e3172a0554e_terseLabel_en-US" xlink:label="lab_ams_ForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_ams_ForeignMember_label_en-US" xlink:label="lab_ams_ForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ForeignMember" xlink:href="ams-20201231.xsd#ams_ForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_ForeignMember" xlink:to="lab_ams_ForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionAxis_2e1b117b-7f6b-4a3c-aae4-0ac0aac26960_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_ams_AssetAcquisitionAxis_label_en-US" xlink:label="lab_ams_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_ams_AssetAcquisitionAxis_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAxis" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionAxis" xlink:to="lab_ams_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_ExecutiveCompensationMember_e67a3b09-0e80-435b-b14c-6a72d8fdfbd3_terseLabel_en-US" xlink:label="lab_ams_ExecutiveCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Compensation</link:label>
    <link:label id="lab_ams_ExecutiveCompensationMember_label_en-US" xlink:label="lab_ams_ExecutiveCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Compensation [Member]</link:label>
    <link:label id="lab_ams_ExecutiveCompensationMember_documentation_en-US" xlink:label="lab_ams_ExecutiveCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ExecutiveCompensationMember" xlink:href="ams-20201231.xsd#ams_ExecutiveCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_ExecutiveCompensationMember" xlink:to="lab_ams_ExecutiveCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2100dbaf-d770-4dd5-97eb-ce40ceadb649_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionPrepaidExpenseAndOther_7b069bcf-e456-4dd5-a2d2-adf7d5ffaf22_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionPrepaidExpenseAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expense and other</link:label>
    <link:label id="lab_ams_AssetAcquisitionPrepaidExpenseAndOther_label_en-US" xlink:label="lab_ams_AssetAcquisitionPrepaidExpenseAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Prepaid Expense And Other</link:label>
    <link:label id="lab_ams_AssetAcquisitionPrepaidExpenseAndOther_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionPrepaidExpenseAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Prepaid Expense And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPrepaidExpenseAndOther" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPrepaidExpenseAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionPrepaidExpenseAndOther" xlink:to="lab_ams_AssetAcquisitionPrepaidExpenseAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_76955d72-d565-4bb7-a656-6d6cb287add5_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_89ddbafb-bb18-442e-956f-3e0d2dc63ef1_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_74102a49-49b9-4fa2-99a4-88b2fd796c90_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectOperatingMaintenanceSuppliesCosts_0ddeddea-144d-49cd-936c-540d8e9b8cba_verboseLabel_en-US" xlink:label="lab_us-gaap_DirectOperatingMaintenanceSuppliesCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maintenance and supplies</link:label>
    <link:label id="lab_us-gaap_DirectOperatingMaintenanceSuppliesCosts_label_en-US" xlink:label="lab_us-gaap_DirectOperatingMaintenanceSuppliesCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Operating Maintenance Supplies Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectOperatingMaintenanceSuppliesCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DirectOperatingMaintenanceSuppliesCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectOperatingMaintenanceSuppliesCosts" xlink:to="lab_us-gaap_DirectOperatingMaintenanceSuppliesCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_645111ba-b738-4ac5-824d-fcb08968644d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, additions</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_67bd4978-a95b-4af6-a1b2-9b3a31afe913_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_8e5df194-9a50-4288-9ddf-9d9613cb16c6_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NetIncomeLossMember_d04a31fc-3bb1-4653-b000-4c470a3edb29_terseLabel_en-US" xlink:label="lab_ams_NetIncomeLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:label id="lab_ams_NetIncomeLossMember_label_en-US" xlink:label="lab_ams_NetIncomeLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) [Member]</link:label>
    <link:label id="lab_ams_NetIncomeLossMember_documentation_en-US" xlink:label="lab_ams_NetIncomeLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NetIncomeLossMember" xlink:href="ams-20201231.xsd#ams_NetIncomeLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NetIncomeLossMember" xlink:to="lab_ams_NetIncomeLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_090138cb-9046-4f64-9a92-43a4d2c4dc66_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_bcdfffbc-6c35-43be-9d50-1ec8e6296473_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_15870e81-0563-41b7-98a6-d05ea2bfb837_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_0e403b15-d7f3-4d35-a314-d413b3425e69_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests in subsidiaries</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90644e91-aab5-45c9-927e-806f6a3b7845_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date weighted-average fair value, granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bc5c1f1b-8b36-437a-a071-cc2e8300acfe_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Date Weighted-Average Fair Value, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ccaba0c4-bce5-4df1-a7eb-acf88ac15d86_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5b1cd8ab-3212-415f-8130-edf631b0e6aa_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_00ec9724-714d-46f9-87fa-b345ffabd1b0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_cdd363b6-4849-418b-a26f-ee76d99256d5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_50514d95-6d9d-4527-902c-b403c6d1960f_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash, Carrying Value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_MedicalEquipmentAndFacilitiesMember_aed8c659-ee72-433a-9479-8429331d9767_verboseLabel_en-US" xlink:label="lab_ams_MedicalEquipmentAndFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment and facilities</link:label>
    <link:label id="lab_ams_MedicalEquipmentAndFacilitiesMember_label_en-US" xlink:label="lab_ams_MedicalEquipmentAndFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment and Facilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MedicalEquipmentAndFacilitiesMember" xlink:href="ams-20201231.xsd#ams_MedicalEquipmentAndFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_MedicalEquipmentAndFacilitiesMember" xlink:to="lab_ams_MedicalEquipmentAndFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_54869d7d-634e-47cb-8cf3-cf03ff2aca7d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_84231bae-3ae2-49ab-bca4-a68d85f3f5f5_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_86963738-48e0-42fe-827f-e90624096641_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_93303d2c-b425-481b-a369-d1628b843139_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM DEBT, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_FinanceLeaseObligationsMonthlyInstallments_d9d13a50-04e7-4f06-89df-308ab1e71710_terseLabel_en-US" xlink:label="lab_ams_FinanceLeaseObligationsMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly installments</link:label>
    <link:label id="lab_ams_FinanceLeaseObligationsMonthlyInstallments_label_en-US" xlink:label="lab_ams_FinanceLeaseObligationsMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations, Monthly Installments</link:label>
    <link:label id="lab_ams_FinanceLeaseObligationsMonthlyInstallments_documentation_en-US" xlink:label="lab_ams_FinanceLeaseObligationsMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations, Monthly Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeaseObligationsMonthlyInstallments" xlink:href="ams-20201231.xsd#ams_FinanceLeaseObligationsMonthlyInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_FinanceLeaseObligationsMonthlyInstallments" xlink:to="lab_ams_FinanceLeaseObligationsMonthlyInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_3b919daa-ad0c-4790-88d9-d711b44bf6bc_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_20a6add9-dea1-47b5-951f-326eb95ec166_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_182dda84-445f-46cd-85ca-afa51a84f086_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity- American Shared Hospital Services</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NonCashRightOfUseAssetsAndLeaseLiabilities_f23c1f78-df0d-4f04-9f8b-e6dd45afe98c_terseLabel_en-US" xlink:label="lab_ams_NonCashRightOfUseAssetsAndLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets and lease liabilities</link:label>
    <link:label id="lab_ams_NonCashRightOfUseAssetsAndLeaseLiabilities_label_en-US" xlink:label="lab_ams_NonCashRightOfUseAssetsAndLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Right Of Use Assets And Lease Liabilities</link:label>
    <link:label id="lab_ams_NonCashRightOfUseAssetsAndLeaseLiabilities_documentation_en-US" xlink:label="lab_ams_NonCashRightOfUseAssetsAndLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of Right of use assets and lease liabilities that were incurred during a noncash or partial noncash transaction.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonCashRightOfUseAssetsAndLeaseLiabilities" xlink:href="ams-20201231.xsd#ams_NonCashRightOfUseAssetsAndLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NonCashRightOfUseAssetsAndLeaseLiabilities" xlink:to="lab_ams_NonCashRightOfUseAssetsAndLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AreaOfLand_ef46b4e1-a438-4541-ab8e-3a4cea381bd1_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfLand" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of facility</link:label>
    <link:label id="lab_us-gaap_AreaOfLand_label_en-US" xlink:label="lab_us-gaap_AreaOfLand" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfLand" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfLand"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfLand" xlink:to="lab_us-gaap_AreaOfLand" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_b9e96ddc-2f7e-4e24-8ac2-2d4e197d3742_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_b4ee6a04-2d1e-4839-ad65-b8407ff48be5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_4919c49a-4e4e-4f32-81a7-6fe06ddf12a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8297cf40-0188-4a56-aa37-3a02f2acb217_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_d3a48f82-e9c9-4017-b8dd-b09827d13174_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d543241-b232-490b-a612-6a791ff9ee4a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_bb310b40-f382-4728-8a52-5e54c78a6bcc_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_8ad369ac-96d7-4ae3-a18e-25d4a52a1acb_verboseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub-Total ASHS</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_f4b24264-ed71-4db6-be92-f636a70eba87_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_6a70cbdd-5e0b-4dd0-be31-f0b2abcb01a4_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a4d22efc-2b46-4d74-8bf8-f987e6ad192c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_da15ad1a-681a-4439-bf03-c54a3729ed91_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c85efb14-210a-4276-9692-13a2ebc6f466_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_15cf2e1e-d71e-4b09-9f64-33935d81ac9b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_1c831b0d-0784-445d-8e21-a8aca9317628_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_6426e1ec-26ba-4daf-b1fe-d3fb73323e58_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_91b2ca0a-7878-4d17-8808-593f0b3343ab_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionPercentageOfSharesRemaining_cd2df6db-b4a3-429d-b0c7-b0042771047e_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionPercentageOfSharesRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisition, percentage of shares remaining</link:label>
    <link:label id="lab_ams_AssetAcquisitionPercentageOfSharesRemaining_label_en-US" xlink:label="lab_ams_AssetAcquisitionPercentageOfSharesRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Percentage Of Shares Remaining</link:label>
    <link:label id="lab_ams_AssetAcquisitionPercentageOfSharesRemaining_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionPercentageOfSharesRemaining" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Percentage Of Shares Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfSharesRemaining" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfSharesRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionPercentageOfSharesRemaining" xlink:to="lab_ams_AssetAcquisitionPercentageOfSharesRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_a4750d17-9043-4587-9630-ec26778f9310_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_6d23c415-58cd-430a-a21a-f45d8ed976b8_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_6ce99766-8df2-470b-959f-eb36c0dacedc_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_a65d6ae0-8f94-4d59-a569-11ab26eb2a04_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_6f20452f-4895-420d-b181-d484bc2c7701_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income attributable to American Shared Hospital Services</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_c6f3c983-0c7b-431c-829b-e6b4597d2f91_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator for basic and diluted (loss) earnings per share</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_4129f94f-b5eb-4f11-93c7-f4fd1e4bc315_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_806c23e8-9e33-4b14-a8c7-c0a504e60b41_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM FINANCE LEASES, less current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_f6a90296-6019-421d-beda-8b005f91dbdf_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent portion finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_SeniorVicePresidentMember_022872d6-c6b6-46c4-8f67-7b222ec8b960_terseLabel_en-US" xlink:label="lab_ams_SeniorVicePresidentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Vice President</link:label>
    <link:label id="lab_ams_SeniorVicePresidentMember_label_en-US" xlink:label="lab_ams_SeniorVicePresidentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Vice President [Member]</link:label>
    <link:label id="lab_ams_SeniorVicePresidentMember_documentation_en-US" xlink:label="lab_ams_SeniorVicePresidentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Vice President</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_SeniorVicePresidentMember" xlink:href="ams-20201231.xsd#ams_SeniorVicePresidentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_SeniorVicePresidentMember" xlink:to="lab_ams_SeniorVicePresidentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_45deab68-b93e-4409-9336-11417764e084_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_RepaymentsOfLongTermFinanceLeaseObligations_16d951ce-b745-4d1b-b157-1e2431bba7bf_negatedTerseLabel_en-US" xlink:label="lab_ams_RepaymentsOfLongTermFinanceLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on finance leases</link:label>
    <link:label id="lab_ams_RepaymentsOfLongTermFinanceLeaseObligations_label_en-US" xlink:label="lab_ams_RepaymentsOfLongTermFinanceLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Long-term Finance Lease Obligations</link:label>
    <link:label id="lab_ams_RepaymentsOfLongTermFinanceLeaseObligations_documentation_en-US" xlink:label="lab_ams_RepaymentsOfLongTermFinanceLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Long-term Finance Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_RepaymentsOfLongTermFinanceLeaseObligations" xlink:href="ams-20201231.xsd#ams_RepaymentsOfLongTermFinanceLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_RepaymentsOfLongTermFinanceLeaseObligations" xlink:to="lab_ams_RepaymentsOfLongTermFinanceLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_1bd8421a-0530-41fa-a445-ac25a8c6b6f8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_06af8ac9-70d9-4d2c-977b-75a25785d6d9_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_066d0c10-5d86-4617-a088-c7f4cfba35bc_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased intangible assets</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0a381d1f-a433-414a-8aba-1be955d937fc_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_05845ab1-c970-4f6a-82aa-110a12316fed_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_f2ca9dfd-5b34-4aed-a894-7174abc80ae8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e3de1928-4835-48bf-8aef-78e78a290005_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income per share attributable to American Shared Hospital Services:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_749c67fc-1aac-4c88-b1e8-6128d8c7f19d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate_6b594f25-5833-4d2d-9259-5f0178a434f2_verboseLabel_en-US" xlink:label="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected forfeiture rate</link:label>
    <link:label id="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate_label_en-US" xlink:label="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Foreiture Rate</link:label>
    <link:label id="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate_documentation_en-US" xlink:label="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The estimated measure of the percentage by which a share price is expected to forfeiture during a period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate" xlink:href="ams-20201231.xsd#ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate" xlink:to="lab_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6feb469e-1e17-4f83-a014-cda8139b6acf_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_35cbc02c-6a8c-4dc8-be81-fb85969ced05_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_9978674a-f980-4a9b-802b-8bcac6701a11_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_1bef66ce-bcda-4b31-bc2f-973c45ff8150_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_90296b0a-24ab-4a76-864b-1ac4035a126d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_FinanceLeaseAccountsReceivable_28cf0a2e-4923-4006-b695-e0638810548b_terseLabel_en-US" xlink:label="lab_ams_FinanceLeaseAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_ams_FinanceLeaseAccountsReceivable_label_en-US" xlink:label="lab_ams_FinanceLeaseAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Accounts Receivable</link:label>
    <link:label id="lab_ams_FinanceLeaseAccountsReceivable_documentation_en-US" xlink:label="lab_ams_FinanceLeaseAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeaseAccountsReceivable" xlink:href="ams-20201231.xsd#ams_FinanceLeaseAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_FinanceLeaseAccountsReceivable" xlink:to="lab_ams_FinanceLeaseAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cfe4aeb5-b9cc-40b8-8244-28ae69e0bd48_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6a9eeade-e6fc-4582-b655-92c2f41f8946_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_df849343-433c-40d8-a216-936e839073a2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_58cbf752-8c40-46a8-99f5-fb5e9cd00e66_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AcquisitionWorkingCapitalPaymentsMember_5fa559b4-022a-41aa-b975-c074e98ac32d_terseLabel_en-US" xlink:label="lab_ams_AcquisitionWorkingCapitalPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition working capital payments</link:label>
    <link:label id="lab_ams_AcquisitionWorkingCapitalPaymentsMember_label_en-US" xlink:label="lab_ams_AcquisitionWorkingCapitalPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Working Capital Payments [Member]</link:label>
    <link:label id="lab_ams_AcquisitionWorkingCapitalPaymentsMember_documentation_en-US" xlink:label="lab_ams_AcquisitionWorkingCapitalPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Working Capital Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AcquisitionWorkingCapitalPaymentsMember" xlink:href="ams-20201231.xsd#ams_AcquisitionWorkingCapitalPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AcquisitionWorkingCapitalPaymentsMember" xlink:to="lab_ams_AcquisitionWorkingCapitalPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_e9ac9dd2-fb20-43a4-b651-feee641e0b39_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_dad6289b-9fd7-4a9b-893f-b68f4130bfb4_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_8c171f52-59d5-44b6-8229-4e0883948841_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED REVENUE, less current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_IncomeTaxDisclosureTable_d7188f1a-4c5a-4120-991b-2c73ff0b4950_terseLabel_en-US" xlink:label="lab_ams_IncomeTaxDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Table]</link:label>
    <link:label id="lab_ams_IncomeTaxDisclosureTable_label_en-US" xlink:label="lab_ams_IncomeTaxDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncomeTaxDisclosureTable" xlink:href="ams-20201231.xsd#ams_IncomeTaxDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_IncomeTaxDisclosureTable" xlink:to="lab_ams_IncomeTaxDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_807408fa-3b1f-4d3b-8539-65f15a219666_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_84ccbb76-18aa-49e6-8dca-a8381192b9a1_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW DISCLOSURE</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e4eadfb8-4422-4beb-be19-4cc5884f6b20_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_a08750d5-c762-4c53-af3b-0259d8133114_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_adf3d275-7d8b-4db2-95cd-1ee8cb0ac3de_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5b93f451-1855-4d04-9ad0-b14d05a50226_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_e29b24b9-3ae0-4ca4-8170-5cb71a8eb697_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, discount rate</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_c92fb06e-4f73-40fd-99c8-59061e7d12dd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_ExecutiveEquityAwardsMember_c95fbcb0-72a3-4db7-befe-c6a919bf6612_terseLabel_en-US" xlink:label="lab_ams_ExecutiveEquityAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Equity Awards</link:label>
    <link:label id="lab_ams_ExecutiveEquityAwardsMember_label_en-US" xlink:label="lab_ams_ExecutiveEquityAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Equity Awards [Member]</link:label>
    <link:label id="lab_ams_ExecutiveEquityAwardsMember_documentation_en-US" xlink:label="lab_ams_ExecutiveEquityAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Equity Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ExecutiveEquityAwardsMember" xlink:href="ams-20201231.xsd#ams_ExecutiveEquityAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_ExecutiveEquityAwardsMember" xlink:to="lab_ams_ExecutiveEquityAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_fa655a24-7b67-4dc5-b04f-e5cd045f9ee6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of contribution</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition_f0028fca-bbfa-4039-9487-84d946e21671_terseLabel_en-US" xlink:label="lab_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated subsequent working capital payment for acquisition</link:label>
    <link:label id="lab_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition_label_en-US" xlink:label="lab_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Working Capital Payment Accrued For Acquisition</link:label>
    <link:label id="lab_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition_documentation_en-US" xlink:label="lab_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Working Capital Payment Accrued For Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition" xlink:href="ams-20201231.xsd#ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition" xlink:to="lab_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_ee610607-1bba-46d1-8a8e-0da706f662f5_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic Value, Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_099617d3-e3d3-4b31-aaf5-27244ec6689b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_009e93d1-7846-49e9-9941-7e0ba8a53893_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_c16ddf76-91c8-4e04-8612-8a098007082a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember_81888523-3c6b-4578-b882-05474467b0e2_terseLabel_en-US" xlink:label="lab_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maintenance and Support Agreement (the &#8220;Mevion Service Agreement&#8221;)</link:label>
    <link:label id="lab_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember_label_en-US" xlink:label="lab_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maintenance And Support Agreement (The &#8220;Mevion Service Agreement&#8221;) [Member]</link:label>
    <link:label id="lab_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember_documentation_en-US" xlink:label="lab_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maintenance And Support Agreement (The &#8220;Mevion Service Agreement&#8221;)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember" xlink:href="ams-20201231.xsd#ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember" xlink:to="lab_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_f7b3555f-d0ad-4d1d-9f03-353bf7d0b5ba_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_a165473a-dac5-4b88-aa98-312f79e91aba_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionTotalConsiderationTransferred_e82cd4f5-c507-491e-ae05-30a036a3f8af_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionTotalConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration allocated to assets acquired and liabilities assumed</link:label>
    <link:label id="lab_ams_AssetAcquisitionTotalConsiderationTransferred_195da272-a2ee-4732-b693-c38be02075fd_totalLabel_en-US" xlink:label="lab_ams_AssetAcquisitionTotalConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration allocated to assets acquired and liabilities assumed</link:label>
    <link:label id="lab_ams_AssetAcquisitionTotalConsiderationTransferred_label_en-US" xlink:label="lab_ams_AssetAcquisitionTotalConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Total Consideration Transferred</link:label>
    <link:label id="lab_ams_AssetAcquisitionTotalConsiderationTransferred_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionTotalConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Total Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionTotalConsiderationTransferred" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionTotalConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionTotalConsiderationTransferred" xlink:to="lab_ams_AssetAcquisitionTotalConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NumberOfLeksellGammaKnifeIconSystemInstalls_9fbad4ae-ee08-4a73-9c06-c88cc57b3e22_terseLabel_en-US" xlink:label="lab_ams_NumberOfLeksellGammaKnifeIconSystemInstalls" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Leksell Gamma Knife Icon System installs</link:label>
    <link:label id="lab_ams_NumberOfLeksellGammaKnifeIconSystemInstalls_label_en-US" xlink:label="lab_ams_NumberOfLeksellGammaKnifeIconSystemInstalls" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Leksell Gamma Knife Icon System Installs</link:label>
    <link:label id="lab_ams_NumberOfLeksellGammaKnifeIconSystemInstalls_documentation_en-US" xlink:label="lab_ams_NumberOfLeksellGammaKnifeIconSystemInstalls" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Leksell Gamma Knife Icon System Installs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfLeksellGammaKnifeIconSystemInstalls" xlink:href="ams-20201231.xsd#ams_NumberOfLeksellGammaKnifeIconSystemInstalls"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NumberOfLeksellGammaKnifeIconSystemInstalls" xlink:to="lab_ams_NumberOfLeksellGammaKnifeIconSystemInstalls" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_BalanceSheetParentheticalAbstract_84c5951e-3bb2-4f05-93de-1693a2c61ef5_terseLabel_en-US" xlink:label="lab_ams_BalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Parenthetical [Abstract]</link:label>
    <link:label id="lab_ams_BalanceSheetParentheticalAbstract_label_en-US" xlink:label="lab_ams_BalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Parenthetical [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_BalanceSheetParentheticalAbstract" xlink:href="ams-20201231.xsd#ams_BalanceSheetParentheticalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_BalanceSheetParentheticalAbstract" xlink:to="lab_ams_BalanceSheetParentheticalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_279d8f3a-2b2c-4351-b3c1-e2a81473101b_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8b641590-b252-4464-807f-45903099ba33_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised in period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_40879f32-2e0a-46a9-8074-2e8ae565d00a_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_d326ebc5-ca5a-4642-840f-630a1fb4aa8b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f5954f28-4c81-491a-917b-e02d59e123ff_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_59607077-d6e5-4e4c-89a6-e2cf10fdfdab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GKCE ACQUISITION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_9593a434-0312-4617-bba9-cdaaaa1404b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6583a2eb-a620-49c4-a4b4-1904af85a500_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Maturities of Lessee Operating Lease</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2949983d-58dc-4ab7-a0a7-e8f8d082f1a4_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionLiabilitiesAssumed_b02e6d76-047a-4e88-98e2-2fcae76d6835_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_ams_AssetAcquisitionLiabilitiesAssumed_cc851cfb-27e2-4c4f-8554-ffc26dbb260e_negatedTotalLabel_en-US" xlink:label="lab_ams_AssetAcquisitionLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_ams_AssetAcquisitionLiabilitiesAssumed_label_en-US" xlink:label="lab_ams_AssetAcquisitionLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Liabilities Assumed</link:label>
    <link:label id="lab_ams_AssetAcquisitionLiabilitiesAssumed_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionLiabilitiesAssumed" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionLiabilitiesAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionLiabilitiesAssumed" xlink:to="lab_ams_AssetAcquisitionLiabilitiesAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_51247f2d-9d55-429b-b9a2-7be98ee02d09_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NonEmployeeDirectorsMember_0f627cd9-d9e2-44cb-9b0e-04617e9f9337_terseLabel_en-US" xlink:label="lab_ams_NonEmployeeDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Employee Directors</link:label>
    <link:label id="lab_ams_NonEmployeeDirectorsMember_label_en-US" xlink:label="lab_ams_NonEmployeeDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Employee Directors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonEmployeeDirectorsMember" xlink:href="ams-20201231.xsd#ams_NonEmployeeDirectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NonEmployeeDirectorsMember" xlink:to="lab_ams_NonEmployeeDirectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_EmployeeMember_e17774e9-0713-41de-93b7-17798ce1e039_terseLabel_en-US" xlink:label="lab_ams_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee</link:label>
    <link:label id="lab_ams_EmployeeMember_label_en-US" xlink:label="lab_ams_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EmployeeMember" xlink:href="ams-20201231.xsd#ams_EmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_EmployeeMember" xlink:to="lab_ams_EmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_CommitmentsAndContingenciesTable_ad79c201-505f-4c90-b61f-ed2462f90475_terseLabel_en-US" xlink:label="lab_ams_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_ams_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_ams_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CommitmentsAndContingenciesTable" xlink:href="ams-20201231.xsd#ams_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_CommitmentsAndContingenciesTable" xlink:to="lab_ams_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a1804cf6-cb85-4e6b-a038-f0ab9601f440_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_fad82df5-aeca-4a4e-8593-58d62026985b_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7894d76a-bb79-4e97-8cf1-c7554b7d8760_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_58140377-7dd4-4bd7-ad67-035f637c67a7_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_e820e278-c5a7-4ced-91f0-0edab175e710_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_PerformanceShareAwardAgreementMember_f2739ff5-8b7f-46e5-95e9-29b8286e2ace_terseLabel_en-US" xlink:label="lab_ams_PerformanceShareAwardAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Award Agreement</link:label>
    <link:label id="lab_ams_PerformanceShareAwardAgreementMember_label_en-US" xlink:label="lab_ams_PerformanceShareAwardAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Award Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PerformanceShareAwardAgreementMember" xlink:href="ams-20201231.xsd#ams_PerformanceShareAwardAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_PerformanceShareAwardAgreementMember" xlink:to="lab_ams_PerformanceShareAwardAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a6343385-9a0c-423a-9e4f-780380d10de2_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_Or21LlcMember_0a5eeca6-030d-42b1-ae78-b4732db3fb4f_terseLabel_en-US" xlink:label="lab_ams_Or21LlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OR21 LLC</link:label>
    <link:label id="lab_ams_Or21LlcMember_label_en-US" xlink:label="lab_ams_Or21LlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OR21 LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_Or21LlcMember" xlink:href="ams-20201231.xsd#ams_Or21LlcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_Or21LlcMember" xlink:to="lab_ams_Or21LlcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_2c0d6aa9-979c-49d6-a262-b756d3f9e66d_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_2adb4994-214e-4265-ac37-2dbba3721577_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_6756ffd3-fb77-4285-b397-91d1f1d97cd7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_0ce81af1-25fa-4a04-9eb6-7814f597fed9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_8bc9b03a-a3f1-4f92-b5b4-58bc826ae281_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionDomain_57822b01-885e-4cc4-952f-36cded83be7b_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_ams_AssetAcquisitionDomain_label_en-US" xlink:label="lab_ams_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_ams_AssetAcquisitionDomain_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionDomain" xlink:to="lab_ams_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_97c997b8-807f-4f02-9732-8e8b4b094e76_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ea07fd3c-4e9c-40a6-9818-d99be3aa2755_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_122972f6-99d4-4df1-b121-f002c0491af9_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3b4a1772-be69-4ec9-bec7-f7998b959453_verboseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS AND BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NumberOfPerfexionUpgrades_91dda9e0-b630-408d-9175-4d63acddf60e_terseLabel_en-US" xlink:label="lab_ams_NumberOfPerfexionUpgrades" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Perfexion upgrades</link:label>
    <link:label id="lab_ams_NumberOfPerfexionUpgrades_label_en-US" xlink:label="lab_ams_NumberOfPerfexionUpgrades" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Perfexion Upgrades</link:label>
    <link:label id="lab_ams_NumberOfPerfexionUpgrades_documentation_en-US" xlink:label="lab_ams_NumberOfPerfexionUpgrades" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Perfexion Upgrades</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfPerfexionUpgrades" xlink:href="ams-20201231.xsd#ams_NumberOfPerfexionUpgrades"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NumberOfPerfexionUpgrades" xlink:to="lab_ams_NumberOfPerfexionUpgrades" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4bd6e7b6-14a1-49db-b68f-e0032a2801f6_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_e60d9a64-35d5-40da-ba68-3a3c4e414e66_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a32dc54b-3ec1-4ce1-ba5c-9fa0e45f0be1_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_c42879ae-206b-4b76-bf08-88ba676d1761_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_00d11925-dda2-4626-8d31-f42a25be0ae5_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9f375190-0f94-4f1d-98e7-90da97125d59_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_49459f67-a25b-4abb-ae32-bd6eb053ad91_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_ad8abe9e-72c0-4e4f-a11a-ea0d3d45a6f3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_74912754-353b-4ae1-8c34-e6f690f69d88_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on write down of impaired assets and associated removal costs</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_4c808216-276a-4821-8c23-96d145648b25_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on write down of impaired assets and associated removal costs</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_61701e3e-1a94-4c91-a358-bc85de999d24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_6c3fef51-207e-43c8-81cb-ccda8bf8b913_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Relationship to Entity [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_c316758d-38f5-4135-9548-33dc1cab2978_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Fair Value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8a44f7f7-6a2c-41f2-8b0d-2a8b7c1a3218_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_d87ed845-ae86-4ba4-a86e-87db922fb139_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income per common share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_46deab1c-705c-4c19-9682-3ef24bbb3834_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) earnings per common share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_39c7adcf-49a1-4d35-af8d-d05051651003_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_57105970-a4ca-464f-bb76-74f44ae3ff3f_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_bce58ac2-7470-40e3-a94e-aa21c2c6d82a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_35bdf339-fdbe-401a-bd11-ddc4394e4c76_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_196c974d-ce9c-4627-a077-daaa9a4ff8c2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_dccaea3f-b866-4b0a-ad11-aae19aa578c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_de229bf4-8ec5-493b-ae1d-b98fc264545f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_PaymentsForAssetAcquisitions_efb1fc06-72f9-4e5a-8cd4-22a46dac0a08_terseLabel_en-US" xlink:label="lab_ams_PaymentsForAssetAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for asset acquisitions</link:label>
    <link:label id="lab_ams_PaymentsForAssetAcquisitions_label_en-US" xlink:label="lab_ams_PaymentsForAssetAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Asset Acquisitions</link:label>
    <link:label id="lab_ams_PaymentsForAssetAcquisitions_documentation_en-US" xlink:label="lab_ams_PaymentsForAssetAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Asset Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsForAssetAcquisitions" xlink:href="ams-20201231.xsd#ams_PaymentsForAssetAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_PaymentsForAssetAcquisitions" xlink:to="lab_ams_PaymentsForAssetAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_c73e43d5-a182-4be0-8557-15eb01c8df1f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermCapitalLeaseObligations_4adf77e2-1017-460e-bc0f-9389be3db36e_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on short-term financing</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Capital Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermCapitalLeaseObligations" xlink:to="lab_us-gaap_ProceedsFromLongTermCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1eaa969c-7704-47f1-8531-dce9c77f057a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_fdb31094-4a49-4591-8177-bd36aa9b2e63_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_c28e8e05-3486-4982-bdca-950abd6ec968_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_51c31ac6-61c5-493f-99be-b63cc8eb3abc_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5ef7a3bb-5d1c-4ce4-a4a3-4ec0341ece51_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0fd40b29-4c5c-47a5-bb32-324a9d79f494_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_fa1fbabf-ffc2-43b4-868e-fada8b54c051_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Marketing</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_7a8e4df3-5f11-4fdc-beed-cf2b9acfe99d_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets to be disposed of</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_af97e3f8-0831-4a8d-ad82-a1e1847de515_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_LongTermPurchaseCommitmentRenewalTerm_a24c7e6f-425c-45c8-8a57-84dacd73c7ef_terseLabel_en-US" xlink:label="lab_ams_LongTermPurchaseCommitmentRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_ams_LongTermPurchaseCommitmentRenewalTerm_label_en-US" xlink:label="lab_ams_LongTermPurchaseCommitmentRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Renewal Term</link:label>
    <link:label id="lab_ams_LongTermPurchaseCommitmentRenewalTerm_documentation_en-US" xlink:label="lab_ams_LongTermPurchaseCommitmentRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermPurchaseCommitmentRenewalTerm" xlink:href="ams-20201231.xsd#ams_LongTermPurchaseCommitmentRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_LongTermPurchaseCommitmentRenewalTerm" xlink:to="lab_ams_LongTermPurchaseCommitmentRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_fe3d6745-eb62-444f-8da3-b19ece59d305_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_24d79467-0453-4281-89e4-654d1fb00089_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests in Subsidiaries</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_fa8d2f8e-d8cf-4fe7-a939-fbf99ce4bc12_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_EquipmentServiceContractsMember_bc61831b-233a-4fee-aa47-6d9c69faaa81_terseLabel_en-US" xlink:label="lab_ams_EquipmentServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment service contracts</link:label>
    <link:label id="lab_ams_EquipmentServiceContractsMember_label_en-US" xlink:label="lab_ams_EquipmentServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Service Contracts [Member]</link:label>
    <link:label id="lab_ams_EquipmentServiceContractsMember_documentation_en-US" xlink:label="lab_ams_EquipmentServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Service Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EquipmentServiceContractsMember" xlink:href="ams-20201231.xsd#ams_EquipmentServiceContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_EquipmentServiceContractsMember" xlink:to="lab_ams_EquipmentServiceContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0e4be1f7-45b4-4965-b130-e1866a800f9f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_13d36b1f-b034-4ce3-ba7f-0138bb7a286e_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_7081ff93-f4f1-4862-8ea6-79f35c0473bc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_df51e086-baca-4f97-bc25-5b6b4c811e60_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15a0e366-bb18-4dd1-b65c-3e1ae2b7d31a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ea9e74e5-2b5b-4af3-8e48-a77ffe4bdaab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_310b0056-a784-46d3-9142-c21792f588f8_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_AssetAcquisitionAdditionalConsiderationTransferred_3ab54ee5-ed58-4b93-9cd7-f15e2bd86e01_terseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionAdditionalConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional consideration transferred</link:label>
    <link:label id="lab_ams_AssetAcquisitionAdditionalConsiderationTransferred_e4471011-af27-482c-88ab-ed9a8568aba0_negatedTerseLabel_en-US" xlink:label="lab_ams_AssetAcquisitionAdditionalConsiderationTransferred" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated subsequent working capital payment</link:label>
    <link:label id="lab_ams_AssetAcquisitionAdditionalConsiderationTransferred_label_en-US" xlink:label="lab_ams_AssetAcquisitionAdditionalConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Additional Consideration Transferred</link:label>
    <link:label id="lab_ams_AssetAcquisitionAdditionalConsiderationTransferred_documentation_en-US" xlink:label="lab_ams_AssetAcquisitionAdditionalConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Additional Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAdditionalConsiderationTransferred" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAdditionalConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_AssetAcquisitionAdditionalConsiderationTransferred" xlink:to="lab_ams_AssetAcquisitionAdditionalConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2e53a1d1-4dd6-49fe-bc5f-6703a456ef81_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_87012014-4383-4dc1-94c3-bd7ba1ad3a15_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_6559bffd-e938-4299-8a02-1cd846c9552a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_NumberOfFinancingLeases_fc1cb8c2-4eb7-4b00-8828-8cfc50e41d69_terseLabel_en-US" xlink:label="lab_ams_NumberOfFinancingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of financing leases</link:label>
    <link:label id="lab_ams_NumberOfFinancingLeases_label_en-US" xlink:label="lab_ams_NumberOfFinancingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Financing Leases</link:label>
    <link:label id="lab_ams_NumberOfFinancingLeases_documentation_en-US" xlink:label="lab_ams_NumberOfFinancingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Financing Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfFinancingLeases" xlink:href="ams-20201231.xsd#ams_NumberOfFinancingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_NumberOfFinancingLeases" xlink:to="lab_ams_NumberOfFinancingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_4f4b3cfe-4e09-47d0-91ec-622bd2a4f2be_verboseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical and Office equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_3a5a47ab-776b-4c3b-84c9-c30251d32d8a_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedCapitalizedInterestCosts_09b695b0-f4c2-47be-a4d3-02b65b449250_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedCapitalizedInterestCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated capitalized interest costs</link:label>
    <link:label id="lab_us-gaap_AccumulatedCapitalizedInterestCosts_label_en-US" xlink:label="lab_us-gaap_AccumulatedCapitalizedInterestCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Capitalized Interest Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedCapitalizedInterestCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedCapitalizedInterestCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedCapitalizedInterestCosts" xlink:to="lab_us-gaap_AccumulatedCapitalizedInterestCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3988198c-8c97-45de-8bf7-36975173aa59_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_2087f249-2290-4f07-8e5e-5f6b5c3bf3ce_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future equipment purchases</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember_9b10a1df-a8f1-44bb-84f4-20784d1340bc_terseLabel_en-US" xlink:label="lab_ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two MEVION S250i Proton Beam Radiation Therapy Systems</link:label>
    <link:label id="lab_ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember_label_en-US" xlink:label="lab_ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two MEVION S250i Proton Beam Radiation Therapy Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember" xlink:href="ams-20201231.xsd#ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember" xlink:to="lab_ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_12c17d3a-9af6-4bc1-a34e-17ddbf0f5036_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_e6dd4ddb-c81a-4105-a0da-67a235373322_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal statutory income tax rate, percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_6b762488-9e5e-4410-983e-4073765e4440_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_f03223d8-c746-4326-aed5-5d500d7581cf_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_d7cba418-dad8-4441-8c4f-037b7531782e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business segment information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3194f369-f474-4658-affa-500facefbebd_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting pronouncement issued and adopted and issued and not yet adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_06654110-2c4e-48d0-ab75-c685f930595b_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_20616c81-3659-40b5-8606-599b0fc794b3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_a5d7aad9-e308-49fa-88eb-4b5a00ef2606_terseLabel_en-US" xlink:label="lab_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term (Years) Granted</link:label>
    <link:label id="lab_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Granted, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:href="ams-20201231.xsd#ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:to="lab_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>ams-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4e6f91f2-1bf1-41c4-8e53-76168a3ee138,g:df8d0904-ed6f-4833-8eea-c587ca49bdb5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ashs.com/role/CoverPage" xlink:type="simple" xlink:href="ams-20201231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:href="ams-20201231.xsd#ams_DocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8f085353-f30b-4ea0-b598-731d2859c747" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_DocumentType_8f085353-f30b-4ea0-b598-731d2859c747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_9a28d47e-acf2-4282-886b-795a045f3a2a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_DocumentAnnualReport_9a28d47e-acf2-4282-886b-795a045f3a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9a6333cf-04c2-4a30-bd81-22a7d49da3d2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_DocumentPeriodEndDate_9a6333cf-04c2-4a30-bd81-22a7d49da3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_8612b1f0-4040-425b-b8c7-281a45f48f21" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_CurrentFiscalYearEndDate_8612b1f0-4040-425b-b8c7-281a45f48f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_ba161f82-7286-49bc-b017-c212b329c8a7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_DocumentTransitionReport_ba161f82-7286-49bc-b017-c212b329c8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_69a3a3ba-a089-4e2c-adcf-d6d07d9668a5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityFileNumber_69a3a3ba-a089-4e2c-adcf-d6d07d9668a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_578aaf1d-da74-4e6d-b8d3-573867c5c7fe" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityRegistrantName_578aaf1d-da74-4e6d-b8d3-573867c5c7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_5218c386-58f2-4034-be6a-c773815c75f2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_5218c386-58f2-4034-be6a-c773815c75f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8a52ff55-cb1a-4e27-8319-0dc64295537b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityTaxIdentificationNumber_8a52ff55-cb1a-4e27-8319-0dc64295537b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_39f1a692-4a84-48a7-986e-7f4d69365ad0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityAddressAddressLine1_39f1a692-4a84-48a7-986e-7f4d69365ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_3f3baafc-e6d9-4fad-b74a-ac8249a8d730" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityAddressAddressLine2_3f3baafc-e6d9-4fad-b74a-ac8249a8d730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_08e9d5a1-a3fb-48cb-9c4f-524383c53c02" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityAddressCityOrTown_08e9d5a1-a3fb-48cb-9c4f-524383c53c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_89cf780f-ba9a-438e-87cd-6346873f728c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityAddressStateOrProvince_89cf780f-ba9a-438e-87cd-6346873f728c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f8d0ba0e-6680-46b0-9523-a3783d766662" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityAddressPostalZipCode_f8d0ba0e-6680-46b0-9523-a3783d766662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3df17dc0-3496-446c-bb68-20e0f6130b0c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_CityAreaCode_3df17dc0-3496-446c-bb68-20e0f6130b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6a9d5684-51f3-492a-af57-74db3d674555" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_LocalPhoneNumber_6a9d5684-51f3-492a-af57-74db3d674555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e2eef629-5cdf-45f1-bc39-eb250bfc3338" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_Security12bTitle_e2eef629-5cdf-45f1-bc39-eb250bfc3338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2349310b-bc43-4355-9c43-963fc28e4a49" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_TradingSymbol_2349310b-bc43-4355-9c43-963fc28e4a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4e8cdb42-295a-4afe-910d-f666d31ff8aa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_SecurityExchangeName_4e8cdb42-295a-4afe-910d-f666d31ff8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_0f31506f-bb9d-45b8-a041-71fea04c3107" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_0f31506f-bb9d-45b8-a041-71fea04c3107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_c9fd5089-9bc1-440f-aca1-40584aa1479d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityVoluntaryFilers_c9fd5089-9bc1-440f-aca1-40584aa1479d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_1d79cf3b-78b8-4153-9fb8-ab28a9ea89d5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityCurrentReportingStatus_1d79cf3b-78b8-4153-9fb8-ab28a9ea89d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_8004152d-8025-4c1e-8276-1f4164653629" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityInteractiveDataCurrent_8004152d-8025-4c1e-8276-1f4164653629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a845570d-eba1-4367-86c2-29979541387c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityFilerCategory_a845570d-eba1-4367-86c2-29979541387c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_518d1829-cc01-4d27-b32d-3617cf0a945b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntitySmallBusiness_518d1829-cc01-4d27-b32d-3617cf0a945b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_0b6cc719-814f-4900-8880-c1d3fdeb7d3b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityEmergingGrowthCompany_0b6cc719-814f-4900-8880-c1d3fdeb7d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_9101c424-60f8-49b5-8dca-4e8602d33d81" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_IcfrAuditorAttestationFlag_9101c424-60f8-49b5-8dca-4e8602d33d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_34758636-f536-4cc5-94e0-8d6fbf5f735e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityShellCompany_34758636-f536-4cc5-94e0-8d6fbf5f735e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_6640b533-c8c6-4d44-8f1b-bfd771cea245" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityPublicFloat_6640b533-c8c6-4d44-8f1b-bfd771cea245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_bd765a1f-994f-48b2-b749-566429e38fbd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_bd765a1f-994f-48b2-b749-566429e38fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_0d54bdc1-fcb1-419f-9f28-7431ca797df5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_0d54bdc1-fcb1-419f-9f28-7431ca797df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_bcfb25b3-9ad2-4318-a867-481963830190" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_AmendmentFlag_bcfb25b3-9ad2-4318-a867-481963830190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d4686461-5ad7-4e73-b9ca-f893c88dd6e8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_DocumentFiscalYearFocus_d4686461-5ad7-4e73-b9ca-f893c88dd6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_25524436-1738-42e2-a36e-f7125d5ea96e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_DocumentFiscalPeriodFocus_25524436-1738-42e2-a36e-f7125d5ea96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b56b336c-34ca-4014-aa49-c557a975f8cc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_DocumentAndEntityInformationAbstract_3f4316fe-e6ff-40e6-83cd-1c54f12aeb2d" xlink:to="loc_dei_EntityCentralIndexKey_b56b336c-34ca-4014-aa49-c557a975f8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ams-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f1b6fa58-d178-4a75-9b6c-17d0b504e1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0b48d145-ec3a-43f3-8fdb-32fb06a37f8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f1b6fa58-d178-4a75-9b6c-17d0b504e1b6" xlink:to="loc_us-gaap_AssetsAbstract_0b48d145-ec3a-43f3-8fdb-32fb06a37f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f66fff08-0a62-4506-925b-630bc0982759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0b48d145-ec3a-43f3-8fdb-32fb06a37f8c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f66fff08-0a62-4506-925b-630bc0982759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81ad9536-5dc3-4996-8778-9080084def78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f66fff08-0a62-4506-925b-630bc0982759" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81ad9536-5dc3-4996-8778-9080084def78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_5349cf33-9eb3-4951-a799-0768ca09f45c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f66fff08-0a62-4506-925b-630bc0982759" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_5349cf33-9eb3-4951-a799-0768ca09f45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1c637e83-77d1-4636-9286-bb58110b5443" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f66fff08-0a62-4506-925b-630bc0982759" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1c637e83-77d1-4636-9286-bb58110b5443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_759b94fc-64d1-46f2-b560-f2dc4e92748f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f66fff08-0a62-4506-925b-630bc0982759" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_759b94fc-64d1-46f2-b560-f2dc4e92748f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_581f51fe-7ed5-4400-8135-04ae59f1ccb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f66fff08-0a62-4506-925b-630bc0982759" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_581f51fe-7ed5-4400-8135-04ae59f1ccb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2930b3f7-e914-4eec-9cfe-d64dd5d2074e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f66fff08-0a62-4506-925b-630bc0982759" xlink:to="loc_us-gaap_AssetsCurrent_2930b3f7-e914-4eec-9cfe-d64dd5d2074e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_ac44967e-6171-45be-8230-6d57813f157f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0b48d145-ec3a-43f3-8fdb-32fb06a37f8c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_ac44967e-6171-45be-8230-6d57813f157f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_1bee94a1-f98c-4691-b400-5d285d6b39d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0b48d145-ec3a-43f3-8fdb-32fb06a37f8c" xlink:to="loc_us-gaap_Land_1bee94a1-f98c-4691-b400-5d285d6b39d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_708b792c-7e74-46dd-9e98-a98fc523fda1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0b48d145-ec3a-43f3-8fdb-32fb06a37f8c" xlink:to="loc_us-gaap_Goodwill_708b792c-7e74-46dd-9e98-a98fc523fda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_60be2a5e-36fd-4c8d-8218-f1640fd0bad8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0b48d145-ec3a-43f3-8fdb-32fb06a37f8c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_60be2a5e-36fd-4c8d-8218-f1640fd0bad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0312fbea-47ce-4715-bc77-8ae0d94eb87b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0b48d145-ec3a-43f3-8fdb-32fb06a37f8c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0312fbea-47ce-4715-bc77-8ae0d94eb87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e8f57c62-b8af-4cb1-b49e-7cb71c143d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0b48d145-ec3a-43f3-8fdb-32fb06a37f8c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e8f57c62-b8af-4cb1-b49e-7cb71c143d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9479d7f9-03e4-49e0-9fc2-61e66fb24a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0b48d145-ec3a-43f3-8fdb-32fb06a37f8c" xlink:to="loc_us-gaap_Assets_9479d7f9-03e4-49e0-9fc2-61e66fb24a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b8e94d09-0056-4cd3-a6ff-602043c5c375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f1b6fa58-d178-4a75-9b6c-17d0b504e1b6" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b8e94d09-0056-4cd3-a6ff-602043c5c375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_0b5cffd2-3f01-462d-acdb-bc4405171fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b8e94d09-0056-4cd3-a6ff-602043c5c375" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_0b5cffd2-3f01-462d-acdb-bc4405171fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c3669bba-77a5-4853-aa8c-acdccc4408b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0b5cffd2-3f01-462d-acdb-bc4405171fa2" xlink:to="loc_us-gaap_AccountsPayableCurrent_c3669bba-77a5-4853-aa8c-acdccc4408b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d9c13958-0a15-4cc9-a15e-caff77dfdc54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0b5cffd2-3f01-462d-acdb-bc4405171fa2" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d9c13958-0a15-4cc9-a15e-caff77dfdc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_02aae0f3-e6da-4a5e-92d5-e69f8395c37b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0b5cffd2-3f01-462d-acdb-bc4405171fa2" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_02aae0f3-e6da-4a5e-92d5-e69f8395c37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationCurrent_421c8530-1b19-440f-bb0a-566e6fec6da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0b5cffd2-3f01-462d-acdb-bc4405171fa2" xlink:to="loc_us-gaap_AssetRetirementObligationCurrent_421c8530-1b19-440f-bb0a-566e6fec6da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_7f021d9e-f01d-490c-a7c9-1c5e1a463e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0b5cffd2-3f01-462d-acdb-bc4405171fa2" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_7f021d9e-f01d-490c-a7c9-1c5e1a463e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_WorkingCapitalPaymentLiabilityCurrent_193c90ab-c384-48e9-a340-02f0acd1c203" xlink:href="ams-20201231.xsd#ams_WorkingCapitalPaymentLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0b5cffd2-3f01-462d-acdb-bc4405171fa2" xlink:to="loc_ams_WorkingCapitalPaymentLiabilityCurrent_193c90ab-c384-48e9-a340-02f0acd1c203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e565b090-4809-4018-97b3-bd36e2b8b162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0b5cffd2-3f01-462d-acdb-bc4405171fa2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e565b090-4809-4018-97b3-bd36e2b8b162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_4e04c07e-9ab0-4eb3-8b98-432f3d8abd14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0b5cffd2-3f01-462d-acdb-bc4405171fa2" xlink:to="loc_us-gaap_LongTermDebtCurrent_4e04c07e-9ab0-4eb3-8b98-432f3d8abd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_0a1e0c11-61eb-44cc-aa1d-94d3c1d5df60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0b5cffd2-3f01-462d-acdb-bc4405171fa2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_0a1e0c11-61eb-44cc-aa1d-94d3c1d5df60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9840fff8-fc64-4419-9ebe-e801d5f0c52f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0b5cffd2-3f01-462d-acdb-bc4405171fa2" xlink:to="loc_us-gaap_LiabilitiesCurrent_9840fff8-fc64-4419-9ebe-e801d5f0c52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_30f65c6d-cc62-4b78-a87b-4ad2181d2377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b8e94d09-0056-4cd3-a6ff-602043c5c375" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_30f65c6d-cc62-4b78-a87b-4ad2181d2377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7fdf5d91-a754-4cc5-9911-34bee960b0f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b8e94d09-0056-4cd3-a6ff-602043c5c375" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7fdf5d91-a754-4cc5-9911-34bee960b0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_40be9b71-db2f-4fb4-b127-87118d977db3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b8e94d09-0056-4cd3-a6ff-602043c5c375" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_40be9b71-db2f-4fb4-b127-87118d977db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_273efe6b-e428-43f2-b17e-a782b938b5b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b8e94d09-0056-4cd3-a6ff-602043c5c375" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_273efe6b-e428-43f2-b17e-a782b938b5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2ff93b00-3c2f-4a59-b601-f088ea42e558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b8e94d09-0056-4cd3-a6ff-602043c5c375" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2ff93b00-3c2f-4a59-b601-f088ea42e558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_85c94e04-371f-4854-9b30-f6d5f1aaa850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b8e94d09-0056-4cd3-a6ff-602043c5c375" xlink:to="loc_us-gaap_CommitmentsAndContingencies_85c94e04-371f-4854-9b30-f6d5f1aaa850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_25fb3c29-6c81-4328-922a-1319f97abf1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b8e94d09-0056-4cd3-a6ff-602043c5c375" xlink:to="loc_us-gaap_StockholdersEquityAbstract_25fb3c29-6c81-4328-922a-1319f97abf1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6793844f-9b47-48e0-919f-4f11e88b49ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25fb3c29-6c81-4328-922a-1319f97abf1d" xlink:to="loc_us-gaap_CommonStockValue_6793844f-9b47-48e0-919f-4f11e88b49ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_01bbad4e-cb23-4888-811c-a3415b822dc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25fb3c29-6c81-4328-922a-1319f97abf1d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_01bbad4e-cb23-4888-811c-a3415b822dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4b239f76-1708-4adf-8691-688cb15a7876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25fb3c29-6c81-4328-922a-1319f97abf1d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4b239f76-1708-4adf-8691-688cb15a7876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f41d5d32-4500-46a2-8929-39445b514229" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25fb3c29-6c81-4328-922a-1319f97abf1d" xlink:to="loc_us-gaap_StockholdersEquity_f41d5d32-4500-46a2-8929-39445b514229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_14fbbb76-c218-4db9-ba55-abfc7e68de7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25fb3c29-6c81-4328-922a-1319f97abf1d" xlink:to="loc_us-gaap_MinorityInterest_14fbbb76-c218-4db9-ba55-abfc7e68de7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ba8c82e9-ccb6-4251-a65c-a29139890def" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25fb3c29-6c81-4328-922a-1319f97abf1d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ba8c82e9-ccb6-4251-a65c-a29139890def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e72f241d-2145-4575-a027-ba9bebba6e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b8e94d09-0056-4cd3-a6ff-602043c5c375" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e72f241d-2145-4575-a027-ba9bebba6e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ams-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ams_BalanceSheetParentheticalAbstract_b69d8e46-8f3f-4a75-b282-1e4af4b02c56" xlink:href="ams-20201231.xsd#ams_BalanceSheetParentheticalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c69d2ebe-46de-49fd-b8cb-d70fa77a1025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_BalanceSheetParentheticalAbstract_b69d8e46-8f3f-4a75-b282-1e4af4b02c56" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c69d2ebe-46de-49fd-b8cb-d70fa77a1025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_97d3fd29-ed83-47af-ac5d-0d2d6263c2b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_BalanceSheetParentheticalAbstract_b69d8e46-8f3f-4a75-b282-1e4af4b02c56" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_97d3fd29-ed83-47af-ac5d-0d2d6263c2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_c0fa9c74-7eb8-47da-89f7-f482de052f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_BalanceSheetParentheticalAbstract_b69d8e46-8f3f-4a75-b282-1e4af4b02c56" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_c0fa9c74-7eb8-47da-89f7-f482de052f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_450065a7-21fc-497e-a11f-21c0f45f6442" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_BalanceSheetParentheticalAbstract_b69d8e46-8f3f-4a75-b282-1e4af4b02c56" xlink:to="loc_us-gaap_CommonStockSharesIssued_450065a7-21fc-497e-a11f-21c0f45f6442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6b20d5a1-5b89-494b-86f8-a8e181b0fe71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_BalanceSheetParentheticalAbstract_b69d8e46-8f3f-4a75-b282-1e4af4b02c56" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6b20d5a1-5b89-494b-86f8-a8e181b0fe71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/STATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ams-20201231.xsd#STATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/STATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_4d980a6f-d6c2-4c5d-9ba6-055c189113be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_RevenuesAbstract_4d980a6f-d6c2-4c5d-9ba6-055c189113be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_43505b78-dbd7-4b1d-b63c-6b182d42fa26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_4d980a6f-d6c2-4c5d-9ba6-055c189113be" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_43505b78-dbd7-4b1d-b63c-6b182d42fa26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_3a426c87-d042-4b06-a3d6-1e816b4bb433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_CostOfRevenueAbstract_3a426c87-d042-4b06-a3d6-1e816b4bb433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectOperatingMaintenanceSuppliesCosts_dab50eb9-01d9-494b-aab2-82b58be44cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DirectOperatingMaintenanceSuppliesCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_3a426c87-d042-4b06-a3d6-1e816b4bb433" xlink:to="loc_us-gaap_DirectOperatingMaintenanceSuppliesCosts_dab50eb9-01d9-494b-aab2-82b58be44cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c6e11659-c062-4ce1-825c-a315585e3127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_3a426c87-d042-4b06-a3d6-1e816b4bb433" xlink:to="loc_us-gaap_DepreciationAndAmortization_c6e11659-c062-4ce1-825c-a315585e3127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostOfOperatingRevenue_00235435-550f-4cad-a8f3-ac4c67571314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_3a426c87-d042-4b06-a3d6-1e816b4bb433" xlink:to="loc_us-gaap_OtherCostOfOperatingRevenue_00235435-550f-4cad-a8f3-ac4c67571314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_45539d71-341d-46f3-aab3-7c23be24a98c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_3a426c87-d042-4b06-a3d6-1e816b4bb433" xlink:to="loc_us-gaap_CostsAndExpenses_45539d71-341d-46f3-aab3-7c23be24a98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c3d6c575-339d-4680-9e03-1fa37378a517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_GrossProfit_c3d6c575-339d-4680-9e03-1fa37378a517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e862b1cd-b667-4f97-9345-8ff972810167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e862b1cd-b667-4f97-9345-8ff972810167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_96300dd2-f4de-4f64-bdbc-8f6cade8934b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_InterestExpense_96300dd2-f4de-4f64-bdbc-8f6cade8934b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_cece9445-1ead-4144-b834-3dd58a88547d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_cece9445-1ead-4144-b834-3dd58a88547d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7459e654-c64f-4bab-9c1a-7247c5a94c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_OperatingIncomeLoss_7459e654-c64f-4bab-9c1a-7247c5a94c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_ff3d3c15-511d-495b-8ddd-53f057ea6571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_InterestAndOtherIncome_ff3d3c15-511d-495b-8ddd-53f057ea6571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6a3baa4a-4222-4dd5-89c7-74fe3464dd86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6a3baa4a-4222-4dd5-89c7-74fe3464dd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5dce4883-e8ec-4d79-8308-76fb3004e7af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5dce4883-e8ec-4d79-8308-76fb3004e7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_523b7df5-f2da-48f8-b694-e643fd740142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_ProfitLoss_523b7df5-f2da-48f8-b694-e643fd740142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0bb391e8-7bbc-459f-aa0f-aa076f8d399a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0bb391e8-7bbc-459f-aa0f-aa076f8d399a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b26fcfe2-73b7-4a88-845b-1bf9d2bb2d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_NetIncomeLoss_b26fcfe2-73b7-4a88-845b-1bf9d2bb2d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7121903c-c190-4802-b214-f3e90f264dd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba7e5894-7189-4d5e-a254-6b96409e6fe0" xlink:to="loc_us-gaap_EarningsPerShareAbstract_7121903c-c190-4802-b214-f3e90f264dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ef488872-1694-4020-a946-c960732c5e16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7121903c-c190-4802-b214-f3e90f264dd7" xlink:to="loc_us-gaap_EarningsPerShareBasic_ef488872-1694-4020-a946-c960732c5e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4fccdc7a-e4cb-453e-ae76-23fdc28f1afa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7121903c-c190-4802-b214-f3e90f264dd7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4fccdc7a-e4cb-453e-ae76-23fdc28f1afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="ams-20201231.xsd#CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_250fb63e-83d2-4332-bd25-bd09522af0a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c793b712-0fd8-4573-94bb-a75d6f1315c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_250fb63e-83d2-4332-bd25-bd09522af0a3" xlink:to="loc_us-gaap_StatementTable_c793b712-0fd8-4573-94bb-a75d6f1315c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3f12bab3-9b2b-4215-94ad-39c1c8ab87ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c793b712-0fd8-4573-94bb-a75d6f1315c8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3f12bab3-9b2b-4215-94ad-39c1c8ab87ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3f12bab3-9b2b-4215-94ad-39c1c8ab87ce" xlink:to="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6166caaf-cf36-4f49-88a2-45bd1e619c39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:to="loc_us-gaap_CommonStockMember_6166caaf-cf36-4f49-88a2-45bd1e619c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_60212b02-9907-4209-872c-161cb11c0e16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_60212b02-9907-4209-872c-161cb11c0e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5fe2ed78-661a-4e74-8cf1-2ee7a84743a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:to="loc_us-gaap_RetainedEarningsMember_5fe2ed78-661a-4e74-8cf1-2ee7a84743a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_dea869b5-f627-49c7-a11f-8aa8233c43cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:to="loc_us-gaap_ParentMember_dea869b5-f627-49c7-a11f-8aa8233c43cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_3bf0517e-991d-48b0-81d8-e93fb9e62bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1c4d298-2f83-4edb-9f6a-630f2eedfb7f" xlink:to="loc_us-gaap_NoncontrollingInterestMember_3bf0517e-991d-48b0-81d8-e93fb9e62bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8cabca8f-7d9a-465b-8f23-bd3f5b9541be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c793b712-0fd8-4573-94bb-a75d6f1315c8" xlink:to="loc_us-gaap_StatementLineItems_8cabca8f-7d9a-465b-8f23-bd3f5b9541be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8cabca8f-7d9a-465b-8f23-bd3f5b9541be" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e0235d8b-fc26-43a1-97b0-c42355127e91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e0235d8b-fc26-43a1-97b0-c42355127e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_0546966d-8de6-45ba-a66c-5e7d70be2a5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_SharesOutstanding_0546966d-8de6-45ba-a66c-5e7d70be2a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f5bfdc5f-13ac-47b3-a101-cd57f82b8c09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f5bfdc5f-13ac-47b3-a101-cd57f82b8c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2eedd5f1-4c9e-455c-bc97-bed41c4dd831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2eedd5f1-4c9e-455c-bc97-bed41c4dd831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3d9d33de-89b1-4ea0-abd0-627b18899fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3d9d33de-89b1-4ea0-abd0-627b18899fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_87ba31da-8270-4f5d-beb3-5c277e162a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_87ba31da-8270-4f5d-beb3-5c277e162a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_143b5fce-0724-4d39-b5ea-5d1c786c8034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_143b5fce-0724-4d39-b5ea-5d1c786c8034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_104737b6-4eb6-48e9-a250-c0ea9f49cef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_104737b6-4eb6-48e9-a250-c0ea9f49cef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f1182e96-1ba7-4654-b323-4a94e3979ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_ProfitLoss_f1182e96-1ba7-4654-b323-4a94e3979ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_2ca24194-6d12-4715-acdd-1e88ec09b950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_2ca24194-6d12-4715-acdd-1e88ec09b950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_bdfd33bd-cb34-47fb-adf0-1d174424002c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_bdfd33bd-cb34-47fb-adf0-1d174424002c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8dddb6b8-0b57-4021-b2c6-6d46dd8f39a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8dddb6b8-0b57-4021-b2c6-6d46dd8f39a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e7e990e0-53ba-467b-9c5e-0999dfa73ef6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5078d10-049e-420c-b7e6-830077985c76" xlink:to="loc_us-gaap_SharesOutstanding_e7e990e0-53ba-467b-9c5e-0999dfa73ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ams-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_33567b08-d8ae-47e8-b74f-751932aa26c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1a011cfd-c315-4fd4-b709-5a52da4083d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_33567b08-d8ae-47e8-b74f-751932aa26c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1a011cfd-c315-4fd4-b709-5a52da4083d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4cbedf11-3833-4096-8099-ad22c56690df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1a011cfd-c315-4fd4-b709-5a52da4083d0" xlink:to="loc_us-gaap_ProfitLoss_4cbedf11-3833-4096-8099-ad22c56690df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_22f2e10f-5cbc-40c2-bd8a-0a5aa1d9f038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1a011cfd-c315-4fd4-b709-5a52da4083d0" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_22f2e10f-5cbc-40c2-bd8a-0a5aa1d9f038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_17fe8c78-bb4c-4ab8-b848-5ba2a1f88c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_22f2e10f-5cbc-40c2-bd8a-0a5aa1d9f038" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_17fe8c78-bb4c-4ab8-b848-5ba2a1f88c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonCashLeaseExpense_c6267e0d-faf9-459d-8ff7-156c78b4331d" xlink:href="ams-20201231.xsd#ams_NonCashLeaseExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_22f2e10f-5cbc-40c2-bd8a-0a5aa1d9f038" xlink:to="loc_ams_NonCashLeaseExpense_c6267e0d-faf9-459d-8ff7-156c78b4331d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_c73edd56-739d-4d43-9615-221aae63e230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_22f2e10f-5cbc-40c2-bd8a-0a5aa1d9f038" xlink:to="loc_us-gaap_AssetImpairmentCharges_c73edd56-739d-4d43-9615-221aae63e230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7aa842e5-3348-49b9-b7c4-c2bbdb91bb58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_22f2e10f-5cbc-40c2-bd8a-0a5aa1d9f038" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7aa842e5-3348-49b9-b7c4-c2bbdb91bb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_InterestExpenseLeaseFinancing_655b8768-28b0-46e1-bffb-c2274ef59ad3" xlink:href="ams-20201231.xsd#ams_InterestExpenseLeaseFinancing"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_22f2e10f-5cbc-40c2-bd8a-0a5aa1d9f038" xlink:to="loc_ams_InterestExpenseLeaseFinancing_655b8768-28b0-46e1-bffb-c2274ef59ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3efa09a7-58fb-49bc-a70f-5a3311e7a835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_22f2e10f-5cbc-40c2-bd8a-0a5aa1d9f038" xlink:to="loc_us-gaap_ShareBasedCompensation_3efa09a7-58fb-49bc-a70f-5a3311e7a835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_fc27e810-8dc5-4d59-8450-4210783298e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_22f2e10f-5cbc-40c2-bd8a-0a5aa1d9f038" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_fc27e810-8dc5-4d59-8450-4210783298e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_abbb7075-2bf3-42f6-a6fb-ea664d7d965b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_22f2e10f-5cbc-40c2-bd8a-0a5aa1d9f038" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_abbb7075-2bf3-42f6-a6fb-ea664d7d965b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c1885b37-3749-4043-a644-df2689f15d6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_abbb7075-2bf3-42f6-a6fb-ea664d7d965b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c1885b37-3749-4043-a644-df2689f15d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e3f784f2-a4dd-4238-a03c-b796ce48fcad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_abbb7075-2bf3-42f6-a6fb-ea664d7d965b" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e3f784f2-a4dd-4238-a03c-b796ce48fcad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue_b5a22869-87c2-419c-9a3f-c746b3b902b9" xlink:href="ams-20201231.xsd#ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_abbb7075-2bf3-42f6-a6fb-ea664d7d965b" xlink:to="loc_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue_b5a22869-87c2-419c-9a3f-c746b3b902b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncreaseDecreaseInLeaseLiabilities_b0f3996d-ec40-4175-af9a-aae7473212ef" xlink:href="ams-20201231.xsd#ams_IncreaseDecreaseInLeaseLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_abbb7075-2bf3-42f6-a6fb-ea664d7d965b" xlink:to="loc_ams_IncreaseDecreaseInLeaseLiabilities_b0f3996d-ec40-4175-af9a-aae7473212ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_923a52d3-b139-4215-b360-eed1eb1b5cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_abbb7075-2bf3-42f6-a6fb-ea664d7d965b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_923a52d3-b139-4215-b360-eed1eb1b5cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements_229db698-4a51-432b-a1f0-46aced2af23a" xlink:href="ams-20201231.xsd#ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_abbb7075-2bf3-42f6-a6fb-ea664d7d965b" xlink:to="loc_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements_229db698-4a51-432b-a1f0-46aced2af23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ac7d3ccc-0bfd-4352-892f-ed3719dd7819" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1a011cfd-c315-4fd4-b709-5a52da4083d0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ac7d3ccc-0bfd-4352-892f-ed3719dd7819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e25c33a-68e2-4b00-8130-a4cb788a244a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_33567b08-d8ae-47e8-b74f-751932aa26c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e25c33a-68e2-4b00-8130-a4cb788a244a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1bb01650-f1d4-493c-8e03-86bf41358ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e25c33a-68e2-4b00-8130-a4cb788a244a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1bb01650-f1d4-493c-8e03-86bf41358ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_733c365e-7b17-4a67-a6f5-9e4417435ad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e25c33a-68e2-4b00-8130-a4cb788a244a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_733c365e-7b17-4a67-a6f5-9e4417435ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_702bffb1-3cd0-4ad3-b963-ebe1e1b1e0bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e25c33a-68e2-4b00-8130-a4cb788a244a" xlink:to="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_702bffb1-3cd0-4ad3-b963-ebe1e1b1e0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3b88e0a2-d338-48c8-93a1-682d7dc8331b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e25c33a-68e2-4b00-8130-a4cb788a244a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3b88e0a2-d338-48c8-93a1-682d7dc8331b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a7bcee1-2513-40e0-84d8-fe366d135f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_33567b08-d8ae-47e8-b74f-751932aa26c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a7bcee1-2513-40e0-84d8-fe366d135f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a567eb5c-53c5-4f28-83fb-c8cca607be2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a7bcee1-2513-40e0-84d8-fe366d135f63" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a567eb5c-53c5-4f28-83fb-c8cca607be2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_RepaymentsOfLongTermFinanceLeaseObligations_1591acb9-a505-4268-b6e6-909d13d06f74" xlink:href="ams-20201231.xsd#ams_RepaymentsOfLongTermFinanceLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a7bcee1-2513-40e0-84d8-fe366d135f63" xlink:to="loc_ams_RepaymentsOfLongTermFinanceLeaseObligations_1591acb9-a505-4268-b6e6-909d13d06f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ProceedsFromFinancingFromAcquisition_db74f1ed-a431-4804-8037-ddfefa8afc8f" xlink:href="ams-20201231.xsd#ams_ProceedsFromFinancingFromAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a7bcee1-2513-40e0-84d8-fe366d135f63" xlink:to="loc_ams_ProceedsFromFinancingFromAcquisition_db74f1ed-a431-4804-8037-ddfefa8afc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_165539a2-5b53-46f5-8dfa-3a396eb2ef3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a7bcee1-2513-40e0-84d8-fe366d135f63" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_165539a2-5b53-46f5-8dfa-3a396eb2ef3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4a7c02fe-e81b-4c5c-b2ad-407d3d338f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a7bcee1-2513-40e0-84d8-fe366d135f63" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4a7c02fe-e81b-4c5c-b2ad-407d3d338f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_ece2d608-6b81-4f39-8501-9349cd6de0e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a7bcee1-2513-40e0-84d8-fe366d135f63" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_ece2d608-6b81-4f39-8501-9349cd6de0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermCapitalLeaseObligations_4382eb27-8021-4c6a-acc6-f19d0029ac99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermCapitalLeaseObligations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a7bcee1-2513-40e0-84d8-fe366d135f63" xlink:to="loc_us-gaap_ProceedsFromLongTermCapitalLeaseObligations_4382eb27-8021-4c6a-acc6-f19d0029ac99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_18b836b1-16b3-491a-a3ce-65287928649b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a7bcee1-2513-40e0-84d8-fe366d135f63" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_18b836b1-16b3-491a-a3ce-65287928649b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7898007f-2b5d-435e-8425-b7d8a73ee1cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_33567b08-d8ae-47e8-b74f-751932aa26c4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7898007f-2b5d-435e-8425-b7d8a73ee1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_64732a8f-8664-428c-9bc0-946491694dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_33567b08-d8ae-47e8-b74f-751932aa26c4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_64732a8f-8664-428c-9bc0-946491694dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ac31f5ec-561c-4dc0-8b85-1bb2f811a3e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_33567b08-d8ae-47e8-b74f-751932aa26c4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ac31f5ec-561c-4dc0-8b85-1bb2f811a3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_fb0927d5-c390-4ef8-bd33-ddee554bb85d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_33567b08-d8ae-47e8-b74f-751932aa26c4" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_fb0927d5-c390-4ef8-bd33-ddee554bb85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_832cdaaf-1163-445d-bf2a-e0d83730ca12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_fb0927d5-c390-4ef8-bd33-ddee554bb85d" xlink:to="loc_us-gaap_InterestPaidNet_832cdaaf-1163-445d-bf2a-e0d83730ca12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_667530e4-50c1-4c11-9184-5f07724909e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_fb0927d5-c390-4ef8-bd33-ddee554bb85d" xlink:to="loc_us-gaap_IncomeTaxesPaid_667530e4-50c1-4c11-9184-5f07724909e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e8462244-b919-4169-a7a2-1982ea82c0b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_33567b08-d8ae-47e8-b74f-751932aa26c4" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e8462244-b919-4169-a7a2-1982ea82c0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities_e145a873-60b0-4681-b7fc-936384090f4f" xlink:href="ams-20201231.xsd#ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e8462244-b919-4169-a7a2-1982ea82c0b5" xlink:to="loc_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities_e145a873-60b0-4681-b7fc-936384090f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonCashRightOfUseAssetsAndLeaseLiabilities_fb7b95de-77f9-4a81-9e39-2fccd1c98352" xlink:href="ams-20201231.xsd#ams_NonCashRightOfUseAssetsAndLeaseLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e8462244-b919-4169-a7a2-1982ea82c0b5" xlink:to="loc_ams_NonCashRightOfUseAssetsAndLeaseLiabilities_fb7b95de-77f9-4a81-9e39-2fccd1c98352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_InterestCapitalizedToPropertyAndEquipment_7659f4e4-e065-4a16-8b86-aed11b42ab57" xlink:href="ams-20201231.xsd#ams_InterestCapitalizedToPropertyAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e8462244-b919-4169-a7a2-1982ea82c0b5" xlink:to="loc_ams_InterestCapitalizedToPropertyAndEquipment_7659f4e4-e065-4a16-8b86-aed11b42ab57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_fdec726d-d802-473f-a9c7-4adc92a8ca51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e8462244-b919-4169-a7a2-1982ea82c0b5" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_fdec726d-d802-473f-a9c7-4adc92a8ca51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing_4094ef34-f717-4427-ba60-d56729d9c1c7" xlink:href="ams-20201231.xsd#ams_AcquisitionOfEquipmentWithLongTermDebtFinancing"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e8462244-b919-4169-a7a2-1982ea82c0b5" xlink:to="loc_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing_4094ef34-f717-4427-ba60-d56729d9c1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AcquisitionOfInsuranceWithShortTermFinancing_a535c376-1708-44d4-8743-6e180484cd04" xlink:href="ams-20201231.xsd#ams_AcquisitionOfInsuranceWithShortTermFinancing"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e8462244-b919-4169-a7a2-1982ea82c0b5" xlink:to="loc_ams_AcquisitionOfInsuranceWithShortTermFinancing_a535c376-1708-44d4-8743-6e180484cd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsForWorkingCapital_441f8a26-cb7b-4169-810a-5fec9a93632f" xlink:href="ams-20201231.xsd#ams_PaymentsForWorkingCapital"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e8462244-b919-4169-a7a2-1982ea82c0b5" xlink:to="loc_ams_PaymentsForWorkingCapital_441f8a26-cb7b-4169-810a-5fec9a93632f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition_9e46768f-ca74-4a42-bf18-905a1f6a2f7f" xlink:href="ams-20201231.xsd#ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e8462244-b919-4169-a7a2-1982ea82c0b5" xlink:to="loc_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition_9e46768f-ca74-4a42-bf18-905a1f6a2f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="ams-20201231.xsd#BUSINESSANDBASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2c18dc55-81f2-4c88-8525-0b0960f6337e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_f80c3053-6dd3-47f5-abf8-4925cc92e3ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2c18dc55-81f2-4c88-8525-0b0960f6337e" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_f80c3053-6dd3-47f5-abf8-4925cc92e3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#BUSINESSANDBASISOFPRESENTATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_62de502f-8cb7-4871-b835-c6cee04ddb44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ec50f0ce-91b1-4144-831a-5b6dbf3ee50b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_62de502f-8cb7-4871-b835-c6cee04ddb44" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ec50f0ce-91b1-4144-831a-5b6dbf3ee50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05c2a951-2008-45b6-9796-5ba06340d1cf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ec50f0ce-91b1-4144-831a-5b6dbf3ee50b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05c2a951-2008-45b6-9796-5ba06340d1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2a7b4abf-2b18-4282-9c1c-c624d1243854" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_05c2a951-2008-45b6-9796-5ba06340d1cf" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2a7b4abf-2b18-4282-9c1c-c624d1243854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_Or21LlcMember_8a1a9134-ce6e-4a6f-91b6-67f0627f20e3" xlink:href="ams-20201231.xsd#ams_Or21LlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2a7b4abf-2b18-4282-9c1c-c624d1243854" xlink:to="loc_ams_Or21LlcMember_8a1a9134-ce6e-4a6f-91b6-67f0627f20e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ArchitecturalDesignCompanyMember_5b43d5a8-e82d-41dc-a9ee-a831ce93f038" xlink:href="ams-20201231.xsd#ams_ArchitecturalDesignCompanyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2a7b4abf-2b18-4282-9c1c-c624d1243854" xlink:to="loc_ams_ArchitecturalDesignCompanyMember_5b43d5a8-e82d-41dc-a9ee-a831ce93f038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAxis_a621b995-b524-4545-a7e1-01170d732631" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ec50f0ce-91b1-4144-831a-5b6dbf3ee50b" xlink:to="loc_ams_AssetAcquisitionAxis_a621b995-b524-4545-a7e1-01170d732631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_a1bf8ab5-583f-486e-ab50-b5a7688b57aa" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AssetAcquisitionAxis_a621b995-b524-4545-a7e1-01170d732631" xlink:to="loc_ams_AssetAcquisitionDomain_a1bf8ab5-583f-486e-ab50-b5a7688b57aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GKCEAcquisitionMember_5094a75d-eb77-487e-b705-0b73e6f2e26c" xlink:href="ams-20201231.xsd#ams_GKCEAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AssetAcquisitionDomain_a1bf8ab5-583f-486e-ab50-b5a7688b57aa" xlink:to="loc_ams_GKCEAcquisitionMember_5094a75d-eb77-487e-b705-0b73e6f2e26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ec50f0ce-91b1-4144-831a-5b6dbf3ee50b" xlink:to="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfSharesAcquired_73a9d4a6-c864-4af2-a3ff-9594ac25ec8b" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_ams_AssetAcquisitionPercentageOfSharesAcquired_73a9d4a6-c864-4af2-a3ff-9594ac25ec8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfSharesRemaining_acc6d108-1797-41a2-9558-13acec95477e" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfSharesRemaining"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_ams_AssetAcquisitionPercentageOfSharesRemaining_acc6d108-1797-41a2-9558-13acec95477e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionConsiderationTransferred_e618b29a-efbb-436b-9038-988ff40fb7ef" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_ams_AssetAcquisitionConsiderationTransferred_e618b29a-efbb-436b-9038-988ff40fb7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsForAssetAcquisitions_302721a5-0f8c-4642-a027-5acbe84d0a01" xlink:href="ams-20201231.xsd#ams_PaymentsForAssetAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_ams_PaymentsForAssetAcquisitions_302721a5-0f8c-4642-a027-5acbe84d0a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionTransactionCosts_5f3eda4d-fffe-4370-9b4c-bf7493a07601" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionTransactionCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_ams_AssetAcquisitionTransactionCosts_5f3eda4d-fffe-4370-9b4c-bf7493a07601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f9696d79-2bb0-4cfc-a746-fa30b744c9ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_73de002f-31f9-41d2-8535-eb9bd0666040" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f9696d79-2bb0-4cfc-a746-fa30b744c9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3fca0b75-b9ff-469f-b827-ed666af1f8c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_8770eb8c-cc78-4fe6-84d7-78d62e64eaff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3fca0b75-b9ff-469f-b827-ed666af1f8c8" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_8770eb8c-cc78-4fe6-84d7-78d62e64eaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_9778a3d4-a5ad-4744-a6fa-d67ae01bc252" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_UseOfEstimates_9778a3d4-a5ad-4744-a6fa-d67ae01bc252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_cbc8e8d1-89a2-4252-baf8-7c4097633223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_cbc8e8d1-89a2-4252-baf8-7c4097633223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_81baea39-c4bc-427f-8a07-559b65e27660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_81baea39-c4bc-427f-8a07-559b65e27660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b449d1c0-ca29-4006-995d-8f0298cd5f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b449d1c0-ca29-4006-995d-8f0298cd5f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_BusinessAndCreditRiskPolicyTextBlock_bcb4096b-bfa6-4b90-8ad2-97ce423b40f9" xlink:href="ams-20201231.xsd#ams_BusinessAndCreditRiskPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_ams_BusinessAndCreditRiskPolicyTextBlock_bcb4096b-bfa6-4b90-8ad2-97ce423b40f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_e31c8a30-0f7c-4745-a1f3-9196fff6ed6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_e31c8a30-0f7c-4745-a1f3-9196fff6ed6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NoncontrollingInterestsPolicyTextBlock_8ab9aec5-757d-44bf-87cf-e8e1bf3d882d" xlink:href="ams-20201231.xsd#ams_NoncontrollingInterestsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_ams_NoncontrollingInterestsPolicyTextBlock_8ab9aec5-757d-44bf-87cf-e8e1bf3d882d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1b258599-7dd6-4988-a0b3-86643479e41a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1b258599-7dd6-4988-a0b3-86643479e41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_305d6049-f20a-4c83-b667-b9cab5d8e7d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_305d6049-f20a-4c83-b667-b9cab5d8e7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_f1e230a8-0ce3-4c84-b7fa-7df5d1ba1261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_f1e230a8-0ce3-4c84-b7fa-7df5d1ba1261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_74f0b19c-7e64-4744-9c8d-58a5a475c335" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_74f0b19c-7e64-4744-9c8d-58a5a475c335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_6feca83e-0cce-4b21-8ee1-f6e0e98fde9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_6feca83e-0cce-4b21-8ee1-f6e0e98fde9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_eaeb624d-3bf4-4040-92fc-d54125feca81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_eaeb624d-3bf4-4040-92fc-d54125feca81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_adb1c6b6-e7ab-4979-a3f1-8d63a250b962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_adb1c6b6-e7ab-4979-a3f1-8d63a250b962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_733ba92d-f383-4d9d-9139-2e352ae43602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_733ba92d-f383-4d9d-9139-2e352ae43602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetRetirementObligationsPolicyPolicyTextBlock_c4956c65-845d-47ec-b995-f212350e5873" xlink:href="ams-20201231.xsd#ams_AssetRetirementObligationsPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_ams_AssetRetirementObligationsPolicyPolicyTextBlock_c4956c65-845d-47ec-b995-f212350e5873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_1a9c8176-efc7-4956-b6e2-b80e44d80d76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_1a9c8176-efc7-4956-b6e2-b80e44d80d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_052d2906-d510-44c3-aadb-75ff58ea5787" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_052d2906-d510-44c3-aadb-75ff58ea5787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_aa056716-ca88-4198-8fa6-4ba6d85cdb7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_aa056716-ca88-4198-8fa6-4ba6d85cdb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_f282d83b-7f91-400d-aec4-8577c3c3b6dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_f282d83b-7f91-400d-aec4-8577c3c3b6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_5c0ed8fb-3414-4d11-a359-482730ab7d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_5c0ed8fb-3414-4d11-a359-482730ab7d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2e660295-4cc9-43b7-86c1-98d85863cdaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff3d0b93-2312-44dc-8f25-ac7790acaae1" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2e660295-4cc9-43b7-86c1-98d85863cdaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c1a5c54f-6aaf-479c-a219-0d76289ca3fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c9891efd-bb45-4554-a63d-717fc90005d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c1a5c54f-6aaf-479c-a219-0d76289ca3fa" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c9891efd-bb45-4554-a63d-717fc90005d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a4ca780a-56e8-4d3e-bb23-20cc3dedbe3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c1a5c54f-6aaf-479c-a219-0d76289ca3fa" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a4ca780a-56e8-4d3e-bb23-20cc3dedbe3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock_85fcc79c-0fc5-45d0-93fd-4fa1d71d8e86" xlink:href="ams-20201231.xsd#ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c1a5c54f-6aaf-479c-a219-0d76289ca3fa" xlink:to="loc_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock_85fcc79c-0fc5-45d0-93fd-4fa1d71d8e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_259da689-082b-415e-ad33-893f71582725" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:href="ams-20201231.xsd#ams_AccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_259da689-082b-415e-ad33-893f71582725" xlink:to="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_74dc2d55-6fa8-4d19-a39c-b0995105eeb8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_srt_RangeAxis_74dc2d55-6fa8-4d19-a39c-b0995105eeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5ce5658b-2f0e-409d-81a0-e660264a19d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_74dc2d55-6fa8-4d19-a39c-b0995105eeb8" xlink:to="loc_srt_RangeMember_5ce5658b-2f0e-409d-81a0-e660264a19d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_876bdc4c-d152-4569-a114-55aafb155a9f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5ce5658b-2f0e-409d-81a0-e660264a19d4" xlink:to="loc_srt_MaximumMember_876bdc4c-d152-4569-a114-55aafb155a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_86f0aada-c6a1-4a2c-8912-20790af7ce0a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5ce5658b-2f0e-409d-81a0-e660264a19d4" xlink:to="loc_srt_MinimumMember_86f0aada-c6a1-4a2c-8912-20790af7ce0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1bbc12b9-a9b0-4595-a75f-7a5cf8d299e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1bbc12b9-a9b0-4595-a75f-7a5cf8d299e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_819aff86-8131-4156-bf15-7e3a72b8062c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1bbc12b9-a9b0-4595-a75f-7a5cf8d299e9" xlink:to="loc_us-gaap_RelatedPartyDomain_819aff86-8131-4156-bf15-7e3a72b8062c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeCenterEcuadorSAGKCEMember_4a542582-b070-4fc1-bae8-0dc21d9f6e9f" xlink:href="ams-20201231.xsd#ams_GammaKnifeCenterEcuadorSAGKCEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_819aff86-8131-4156-bf15-7e3a72b8062c" xlink:to="loc_ams_GammaKnifeCenterEcuadorSAGKCEMember_4a542582-b070-4fc1-bae8-0dc21d9f6e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeUnitMember_baa4eade-8525-43eb-8d17-67f679ec07e3" xlink:href="ams-20201231.xsd#ams_GammaKnifeUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_819aff86-8131-4156-bf15-7e3a72b8062c" xlink:to="loc_ams_GammaKnifeUnitMember_baa4eade-8525-43eb-8d17-67f679ec07e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f37cd13-3377-494f-9a26-a20eef5453c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f37cd13-3377-494f-9a26-a20eef5453c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3611e782-420e-4092-bde8-3db4521b77a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f37cd13-3377-494f-9a26-a20eef5453c4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3611e782-420e-4092-bde8-3db4521b77a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_53619dab-ab8f-466f-b987-5d3053577733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3611e782-420e-4092-bde8-3db4521b77a5" xlink:to="loc_us-gaap_OfficeEquipmentMember_53619dab-ab8f-466f-b987-5d3053577733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ProtonBeamRadiationTherapyPBRTMember_4362ef54-eff5-4c10-bf25-24c14bb0328a" xlink:href="ams-20201231.xsd#ams_ProtonBeamRadiationTherapyPBRTMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3611e782-420e-4092-bde8-3db4521b77a5" xlink:to="loc_ams_ProtonBeamRadiationTherapyPBRTMember_4362ef54-eff5-4c10-bf25-24c14bb0328a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeAndRadiationTherapyMember_1c9d085b-6e2a-462b-9946-d8705c359a91" xlink:href="ams-20201231.xsd#ams_GammaKnifeAndRadiationTherapyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3611e782-420e-4092-bde8-3db4521b77a5" xlink:to="loc_ams_GammaKnifeAndRadiationTherapyMember_1c9d085b-6e2a-462b-9946-d8705c359a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c0691cdb-f1b2-4e6b-b03a-846f93870922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c0691cdb-f1b2-4e6b-b03a-846f93870922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_02394484-6fe5-42e4-89a1-1cbd9c02aaac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c0691cdb-f1b2-4e6b-b03a-846f93870922" xlink:to="loc_us-gaap_TypeOfAdoptionMember_02394484-6fe5-42e4-89a1-1cbd9c02aaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_26657c14-3acf-4dfc-a865-01a9de4a3e1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_02394484-6fe5-42e4-89a1-1cbd9c02aaac" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_26657c14-3acf-4dfc-a865-01a9de4a3e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_b54aef66-4df0-4f77-9b25-9ade6fe5baf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_02394484-6fe5-42e4-89a1-1cbd9c02aaac" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_b54aef66-4df0-4f77-9b25-9ade6fe5baf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0580e887-7197-4434-a48e-004ccc40afee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_us-gaap_AwardTypeAxis_0580e887-7197-4434-a48e-004ccc40afee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43a4a02f-d6a9-4374-b949-154282b14342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0580e887-7197-4434-a48e-004ccc40afee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43a4a02f-d6a9-4374-b949-154282b14342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a26ebe54-a700-4aa8-8a01-49c01f1d906c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43a4a02f-d6a9-4374-b949-154282b14342" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a26ebe54-a700-4aa8-8a01-49c01f1d906c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_66fbd26b-c482-46d0-b4ec-ce101e9de5f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_srt_MajorCustomersAxis_66fbd26b-c482-46d0-b4ec-ce101e9de5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e2deddf5-0e03-42d4-a4a1-1cf84e2c00bf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_66fbd26b-c482-46d0-b4ec-ce101e9de5f0" xlink:to="loc_srt_NameOfMajorCustomerDomain_e2deddf5-0e03-42d4-a4a1-1cf84e2c00bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CustomerOneMember_dd5b1214-9e21-449f-b86c-aee881a63cab" xlink:href="ams-20201231.xsd#ams_CustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e2deddf5-0e03-42d4-a4a1-1cf84e2c00bf" xlink:to="loc_ams_CustomerOneMember_dd5b1214-9e21-449f-b86c-aee881a63cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CustomerTwoMember_610ddb0c-2f8d-43c7-b7ef-2098859bc29d" xlink:href="ams-20201231.xsd#ams_CustomerTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e2deddf5-0e03-42d4-a4a1-1cf84e2c00bf" xlink:to="loc_ams_CustomerTwoMember_610ddb0c-2f8d-43c7-b7ef-2098859bc29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CustomerThreeMember_7eb5a71a-7874-4e81-9bc8-313b87bb570e" xlink:href="ams-20201231.xsd#ams_CustomerThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e2deddf5-0e03-42d4-a4a1-1cf84e2c00bf" xlink:to="loc_ams_CustomerThreeMember_7eb5a71a-7874-4e81-9bc8-313b87bb570e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CustomerFourMember_0ba5f436-6116-4deb-9c83-16b02d6202f6" xlink:href="ams-20201231.xsd#ams_CustomerFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e2deddf5-0e03-42d4-a4a1-1cf84e2c00bf" xlink:to="loc_ams_CustomerFourMember_0ba5f436-6116-4deb-9c83-16b02d6202f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e0bb7c4-03c4-4ad5-9f83-a7df32f79e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e0bb7c4-03c4-4ad5-9f83-a7df32f79e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43bd614a-1c58-4585-a0e8-df9449cf1583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e0bb7c4-03c4-4ad5-9f83-a7df32f79e6c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43bd614a-1c58-4585-a0e8-df9449cf1583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_8910ab23-ea5c-44e9-bcd4-48284053c619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43bd614a-1c58-4585-a0e8-df9449cf1583" xlink:to="loc_us-gaap_SalesRevenueNetMember_8910ab23-ea5c-44e9-bcd4-48284053c619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_740a543c-6042-4a81-9b5c-b56e72d130b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43bd614a-1c58-4585-a0e8-df9449cf1583" xlink:to="loc_us-gaap_AccountsReceivableMember_740a543c-6042-4a81-9b5c-b56e72d130b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAxis_ae9ca81c-c878-4584-ab5a-e96b220509f2" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_ams_AssetAcquisitionAxis_ae9ca81c-c878-4584-ab5a-e96b220509f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_713d0655-daed-414c-ba39-783f173ccaaf" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AssetAcquisitionAxis_ae9ca81c-c878-4584-ab5a-e96b220509f2" xlink:to="loc_ams_AssetAcquisitionDomain_713d0655-daed-414c-ba39-783f173ccaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GKCEAcquisitionMember_dc55c47f-bbfc-4f7a-abb5-8330aa38954e" xlink:href="ams-20201231.xsd#ams_GKCEAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AssetAcquisitionDomain_713d0655-daed-414c-ba39-783f173ccaaf" xlink:to="loc_ams_GKCEAcquisitionMember_dc55c47f-bbfc-4f7a-abb5-8330aa38954e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_30338871-1b84-4762-9419-08e48479d438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_30338871-1b84-4762-9419-08e48479d438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_afd81e64-1618-4696-b0ca-1501af264615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_30338871-1b84-4762-9419-08e48479d438" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_afd81e64-1618-4696-b0ca-1501af264615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a7de1fc7-6b90-4f09-8015-f168815d7abd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_afd81e64-1618-4696-b0ca-1501af264615" xlink:to="loc_us-gaap_TradeNamesMember_a7de1fc7-6b90-4f09-8015-f168815d7abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:href="ams-20201231.xsd#ams_AccountingPoliciesLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_5d3d534c-aaa5-41b5-a527-dc1998e9a7f8" xlink:to="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_5dbea4a4-c05e-498a-a56c-7f406b2e7371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_AdvertisingExpense_5dbea4a4-c05e-498a-a56c-7f406b2e7371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_9cece9a5-6320-452e-acd0-8686d7c819a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_9cece9a5-6320-452e-acd0-8686d7c819a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d019f4ff-7fef-476a-9def-8acbd2d033ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d019f4ff-7fef-476a-9def-8acbd2d033ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_cd1738ea-025a-41dd-8f0d-7816840f40db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_InterestCostsCapitalized_cd1738ea-025a-41dd-8f0d-7816840f40db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d67a28c0-3094-4df6-9a9c-2275c877e99a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d67a28c0-3094-4df6-9a9c-2275c877e99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_7a31e1a2-a6d7-4f10-a8dc-3bfdb8e837f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_7a31e1a2-a6d7-4f10-a8dc-3bfdb8e837f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_33f51870-0578-4709-b390-d4780040dd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_33f51870-0578-4709-b390-d4780040dd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfImpairedAssetUnits_a9eef59b-735e-48bd-b2c4-11ca3421cd9e" xlink:href="ams-20201231.xsd#ams_NumberOfImpairedAssetUnits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_ams_NumberOfImpairedAssetUnits_a9eef59b-735e-48bd-b2c4-11ca3421cd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_05b33eed-cdc0-44f5-8184-05aa55b9c9d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_05b33eed-cdc0-44f5-8184-05aa55b9c9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_366096ee-7076-4c15-b1b6-a33504215c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_366096ee-7076-4c15-b1b6-a33504215c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_ecef7273-8f31-4d69-ba09-e949c7928ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_ecef7273-8f31-4d69-ba09-e949c7928ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dc4f7bcb-964c-49dd-be42-5fcf347fffda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dc4f7bcb-964c-49dd-be42-5fcf347fffda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PercentageOfTaxBenefitRealizedUponSettlement_39088797-2f90-420f-910b-f8c6d3962d01" xlink:href="ams-20201231.xsd#ams_PercentageOfTaxBenefitRealizedUponSettlement"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_ams_PercentageOfTaxBenefitRealizedUponSettlement_39088797-2f90-420f-910b-f8c6d3962d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfCustomersWithIntentToTerminateContract_da3c2faa-0c1b-46af-9d6c-10fdeac5e373" xlink:href="ams-20201231.xsd#ams_NumberOfCustomersWithIntentToTerminateContract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_ams_NumberOfCustomersWithIntentToTerminateContract_da3c2faa-0c1b-46af-9d6c-10fdeac5e373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetRetirementObligationNumberOfSites_61707daf-9936-46e5-a66e-46758b3803a0" xlink:href="ams-20201231.xsd#ams_AssetRetirementObligationNumberOfSites"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_ams_AssetRetirementObligationNumberOfSites_61707daf-9936-46e5-a66e-46758b3803a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_deba02c6-2d92-49e3-aebc-d3339d9614ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_deba02c6-2d92-49e3-aebc-d3339d9614ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_StockOptionExercisePrice_9570fd2b-f1de-4c08-b9d5-430c2ae59f47" xlink:href="ams-20201231.xsd#ams_StockOptionExercisePrice"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_ams_StockOptionExercisePrice_9570fd2b-f1de-4c08-b9d5-430c2ae59f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_18ab7b4e-29c1-4ead-aeba-91ba348564df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_NumberOfReportableSegments_18ab7b4e-29c1-4ead-aeba-91ba348564df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_28fb13ad-d7be-409d-aa36-720c55d0d7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_28fb13ad-d7be-409d-aa36-720c55d0d7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_c4c6e54a-3476-43d6-aa39-01337c2f5d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_8c40fa64-2a37-4d24-ae52-ad2d616408d0" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_c4c6e54a-3476-43d6-aa39-01337c2f5d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESScheduleofFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_07870a4e-c5bc-4a95-bc53-09a59646d0e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_211cef6c-917b-4c32-8305-5069adcdf056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07870a4e-c5bc-4a95-bc53-09a59646d0e1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_211cef6c-917b-4c32-8305-5069adcdf056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ac1c0adc-daba-412d-8951-9b10c5588d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_211cef6c-917b-4c32-8305-5069adcdf056" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ac1c0adc-daba-412d-8951-9b10c5588d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51795597-1ec2-4059-99d6-03efcc269205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ac1c0adc-daba-412d-8951-9b10c5588d2e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51795597-1ec2-4059-99d6-03efcc269205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6f7173d1-acfc-4987-8286-797efab47344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51795597-1ec2-4059-99d6-03efcc269205" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6f7173d1-acfc-4987-8286-797efab47344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8dcc3d9b-663c-4642-8efd-1a9e9668a499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51795597-1ec2-4059-99d6-03efcc269205" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8dcc3d9b-663c-4642-8efd-1a9e9668a499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ca965ee9-b935-495a-ba31-8c43434e4ad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51795597-1ec2-4059-99d6-03efcc269205" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ca965ee9-b935-495a-ba31-8c43434e4ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_84a39118-99e3-4be1-b208-227b1e3a11e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_211cef6c-917b-4c32-8305-5069adcdf056" xlink:to="loc_us-gaap_FinancialInstrumentAxis_84a39118-99e3-4be1-b208-227b1e3a11e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c11b1b33-6ebe-4c6a-8fb3-0a1065445165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_84a39118-99e3-4be1-b208-227b1e3a11e7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c11b1b33-6ebe-4c6a-8fb3-0a1065445165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CarryingValuesMember_aae423d5-fd9c-409c-9dfd-2fab9d3e79e7" xlink:href="ams-20201231.xsd#ams_CarryingValuesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c11b1b33-6ebe-4c6a-8fb3-0a1065445165" xlink:to="loc_ams_CarryingValuesMember_aae423d5-fd9c-409c-9dfd-2fab9d3e79e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_64574e25-6a2a-42d7-94ed-d8d9fd7f7f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_211cef6c-917b-4c32-8305-5069adcdf056" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_64574e25-6a2a-42d7-94ed-d8d9fd7f7f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_438c9cb3-f29b-476d-bc48-40caf014ed6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_64574e25-6a2a-42d7-94ed-d8d9fd7f7f59" xlink:to="loc_us-gaap_AssetsAbstract_438c9cb3-f29b-476d-bc48-40caf014ed6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7ced0139-ad74-4628-b799-bf410e1190a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_438c9cb3-f29b-476d-bc48-40caf014ed6c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7ced0139-ad74-4628-b799-bf410e1190a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_dea1a639-c03a-47e0-aab4-9af1dc72b844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_438c9cb3-f29b-476d-bc48-40caf014ed6c" xlink:to="loc_us-gaap_Assets_dea1a639-c03a-47e0-aab4-9af1dc72b844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_0093ee62-919f-440c-a171-82e20c2d67fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_64574e25-6a2a-42d7-94ed-d8d9fd7f7f59" xlink:to="loc_us-gaap_LiabilitiesAbstract_0093ee62-919f-440c-a171-82e20c2d67fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_a3661a95-666f-4b9a-bd6e-2604512af359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0093ee62-919f-440c-a171-82e20c2d67fa" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_a3661a95-666f-4b9a-bd6e-2604512af359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_779e9a2f-cb84-4af0-b409-d0d32484bc08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0093ee62-919f-440c-a171-82e20c2d67fa" xlink:to="loc_us-gaap_Liabilities_779e9a2f-cb84-4af0-b409-d0d32484bc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_3855bc9b-b666-44aa-bee9-22bd61918fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_64574e25-6a2a-42d7-94ed-d8d9fd7f7f59" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_3855bc9b-b666-44aa-bee9-22bd61918fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20ed1966-d006-4f2c-97c9-346524c97349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_3855bc9b-b666-44aa-bee9-22bd61918fce" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20ed1966-d006-4f2c-97c9-346524c97349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7b4934ef-7d54-424a-827c-fddba109d711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_3855bc9b-b666-44aa-bee9-22bd61918fce" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_7b4934ef-7d54-424a-827c-fddba109d711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_feb62d8b-d81e-4145-ac83-820ef096ef22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_64574e25-6a2a-42d7-94ed-d8d9fd7f7f59" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_feb62d8b-d81e-4145-ac83-820ef096ef22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_a83a0323-b3dc-454e-9765-2e2dbf0502dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_feb62d8b-d81e-4145-ac83-820ef096ef22" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_a83a0323-b3dc-454e-9765-2e2dbf0502dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_8dfd7db8-f45a-4d3b-b1eb-f5006c7294a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_feb62d8b-d81e-4145-ac83-820ef096ef22" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_8dfd7db8-f45a-4d3b-b1eb-f5006c7294a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESScheduleofEPSDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7b695989-523c-4325-b31a-b7d927dc3ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5c3841df-b9ad-467d-b82a-fe59716350a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7b695989-523c-4325-b31a-b7d927dc3ea3" xlink:to="loc_us-gaap_NetIncomeLoss_5c3841df-b9ad-467d-b82a-fe59716350a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bebbb04b-a749-4b3c-9cd7-ba3e99b5c48e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7b695989-523c-4325-b31a-b7d927dc3ea3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bebbb04b-a749-4b3c-9cd7-ba3e99b5c48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_197e168e-6efd-4b11-82a6-f7021c519b97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bebbb04b-a749-4b3c-9cd7-ba3e99b5c48e" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_197e168e-6efd-4b11-82a6-f7021c519b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_2f9e6d68-02c6-44b9-bf59-7e17fe066c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bebbb04b-a749-4b3c-9cd7-ba3e99b5c48e" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_2f9e6d68-02c6-44b9-bf59-7e17fe066c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_96a25cda-6667-43af-9afd-f99cb77709cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_2f9e6d68-02c6-44b9-bf59-7e17fe066c3c" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_96a25cda-6667-43af-9afd-f99cb77709cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e7cd0158-7e0d-421a-872a-4013569c5857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_2f9e6d68-02c6-44b9-bf59-7e17fe066c3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e7cd0158-7e0d-421a-872a-4013569c5857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9b58bcfe-02f2-49ae-b916-385a1b9475cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bebbb04b-a749-4b3c-9cd7-ba3e99b5c48e" xlink:to="loc_us-gaap_EarningsPerShareBasic_9b58bcfe-02f2-49ae-b916-385a1b9475cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b2f2aeee-c1d7-4e05-bc7a-08157082e3d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bebbb04b-a749-4b3c-9cd7-ba3e99b5c48e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b2f2aeee-c1d7-4e05-bc7a-08157082e3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_43c31381-34ff-44e3-b1a3-9d4ec4bcc410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AccountingPoliciesTable_bc76c83f-7e19-4fd4-a224-913a09acef67" xlink:href="ams-20201231.xsd#ams_AccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_43c31381-34ff-44e3-b1a3-9d4ec4bcc410" xlink:to="loc_ams_AccountingPoliciesTable_bc76c83f-7e19-4fd4-a224-913a09acef67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8a6cf640-18f7-4f5c-ba34-576cbbeb4287" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_bc76c83f-7e19-4fd4-a224-913a09acef67" xlink:to="loc_srt_StatementGeographicalAxis_8a6cf640-18f7-4f5c-ba34-576cbbeb4287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c778ee4a-3ee6-47a9-8582-9180b451aeeb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_8a6cf640-18f7-4f5c-ba34-576cbbeb4287" xlink:to="loc_srt_SegmentGeographicalDomain_c778ee4a-3ee6-47a9-8582-9180b451aeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_DomesticMember_66e41db1-27f0-4f1d-b148-022b05b1da8a" xlink:href="ams-20201231.xsd#ams_DomesticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c778ee4a-3ee6-47a9-8582-9180b451aeeb" xlink:to="loc_ams_DomesticMember_66e41db1-27f0-4f1d-b148-022b05b1da8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ForeignMember_bfbf2f47-c433-418a-baaf-251e8849d3cd" xlink:href="ams-20201231.xsd#ams_ForeignMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c778ee4a-3ee6-47a9-8582-9180b451aeeb" xlink:to="loc_ams_ForeignMember_bfbf2f47-c433-418a-baaf-251e8849d3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_772f1683-246f-4313-8b4e-7e192add6d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_bc76c83f-7e19-4fd4-a224-913a09acef67" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_772f1683-246f-4313-8b4e-7e192add6d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_40e11a2c-44fe-490b-94a4-63d5bedb06b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_772f1683-246f-4313-8b4e-7e192add6d6e" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_40e11a2c-44fe-490b-94a4-63d5bedb06b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_09e2f366-2de9-479c-b107-b03f15a10ffb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_40e11a2c-44fe-490b-94a4-63d5bedb06b0" xlink:to="loc_us-gaap_SalesRevenueNetMember_09e2f366-2de9-479c-b107-b03f15a10ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NetIncomeLossMember_45c95c26-7e1c-42b4-954e-6f882400e10c" xlink:href="ams-20201231.xsd#ams_NetIncomeLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_40e11a2c-44fe-490b-94a4-63d5bedb06b0" xlink:to="loc_ams_NetIncomeLossMember_45c95c26-7e1c-42b4-954e-6f882400e10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_54fa1982-310f-42c9-9285-6e4dbf3c35e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_40e11a2c-44fe-490b-94a4-63d5bedb06b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_54fa1982-310f-42c9-9285-6e4dbf3c35e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AccountingPoliciesLineItems_73ad6c20-63b2-4aaf-bb00-8b2e6af4f801" xlink:href="ams-20201231.xsd#ams_AccountingPoliciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesTable_bc76c83f-7e19-4fd4-a224-913a09acef67" xlink:to="loc_ams_AccountingPoliciesLineItems_73ad6c20-63b2-4aaf-bb00-8b2e6af4f801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3d3c5069-272e-4b86-b8c3-e2bd18608398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_73ad6c20-63b2-4aaf-bb00-8b2e6af4f801" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3d3c5069-272e-4b86-b8c3-e2bd18608398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_02f2594d-b677-4657-a290-b158c46b787f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_73ad6c20-63b2-4aaf-bb00-8b2e6af4f801" xlink:to="loc_us-gaap_NetIncomeLoss_02f2594d-b677-4657-a290-b158c46b787f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f2c7c22e-25f1-4ca9-965d-a491bfaf0ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AccountingPoliciesLineItems_73ad6c20-63b2-4aaf-bb00-8b2e6af4f801" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f2c7c22e-25f1-4ca9-965d-a491bfaf0ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="ams-20201231.xsd#PROPERTYANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/PROPERTYANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_11fddd0a-f172-4d8c-bb93-845e1e044164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0d71a350-2041-40a1-83cc-36302c702ce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_11fddd0a-f172-4d8c-bb93-845e1e044164" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0d71a350-2041-40a1-83cc-36302c702ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="ams-20201231.xsd#PROPERTYANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_895b6049-b1ea-4474-8139-deeced667ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_a8564c2a-7d1a-4d9c-9fbb-690bd86caa21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_895b6049-b1ea-4474-8139-deeced667ba9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_a8564c2a-7d1a-4d9c-9fbb-690bd86caa21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6c3a5d0d-c0cc-4857-adda-9b487cc6dfac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_78f16370-8921-4a59-9bf4-311fc174761a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6c3a5d0d-c0cc-4857-adda-9b487cc6dfac" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_78f16370-8921-4a59-9bf4-311fc174761a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e24ed15f-1f81-4780-be1b-8c5f1ea64b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_78f16370-8921-4a59-9bf4-311fc174761a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e24ed15f-1f81-4780-be1b-8c5f1ea64b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1944d7ec-d27b-4841-8358-1d565d82bfa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e24ed15f-1f81-4780-be1b-8c5f1ea64b58" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1944d7ec-d27b-4841-8358-1d565d82bfa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MedicalEquipmentAndFacilitiesMember_f7b770e1-01b4-4f1f-808a-78347c08ed95" xlink:href="ams-20201231.xsd#ams_MedicalEquipmentAndFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1944d7ec-d27b-4841-8358-1d565d82bfa1" xlink:to="loc_ams_MedicalEquipmentAndFacilitiesMember_f7b770e1-01b4-4f1f-808a-78347c08ed95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_cce64d63-6978-4927-960d-8a17e09ec412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1944d7ec-d27b-4841-8358-1d565d82bfa1" xlink:to="loc_us-gaap_OfficeEquipmentMember_cce64d63-6978-4927-960d-8a17e09ec412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_679a113e-acbd-4177-9e70-afb3219a14c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1944d7ec-d27b-4841-8358-1d565d82bfa1" xlink:to="loc_us-gaap_ConstructionInProgressMember_679a113e-acbd-4177-9e70-afb3219a14c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember_2d647bbb-058c-4d25-819c-c5b275045d5f" xlink:href="ams-20201231.xsd#ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1944d7ec-d27b-4841-8358-1d565d82bfa1" xlink:to="loc_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember_2d647bbb-058c-4d25-819c-c5b275045d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2f4e503c-d8f6-484e-aab4-e9a32ffe631f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_78f16370-8921-4a59-9bf4-311fc174761a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2f4e503c-d8f6-484e-aab4-e9a32ffe631f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0fa0837e-6617-4d27-a71d-1e0c8a4f5a17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2f4e503c-d8f6-484e-aab4-e9a32ffe631f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0fa0837e-6617-4d27-a71d-1e0c8a4f5a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_8f9ddb62-c5ba-4de4-84a3-02ff721a47e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2f4e503c-d8f6-484e-aab4-e9a32ffe631f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_8f9ddb62-c5ba-4de4-84a3-02ff721a47e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d7da7fae-fc89-46f4-b9a0-715ff12334d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2f4e503c-d8f6-484e-aab4-e9a32ffe631f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d7da7fae-fc89-46f4-b9a0-715ff12334d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#PROPERTYANDEQUIPMENTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5724c382-9c13-4474-a583-b54dc26a1510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2614bc5b-12ac-4ccb-a0a0-75bbdec5d39c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5724c382-9c13-4474-a583-b54dc26a1510" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2614bc5b-12ac-4ccb-a0a0-75bbdec5d39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_be54de74-4b95-4705-9cb4-34fd577c9bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2614bc5b-12ac-4ccb-a0a0-75bbdec5d39c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_be54de74-4b95-4705-9cb4-34fd577c9bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_be54de74-4b95-4705-9cb4-34fd577c9bb5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember_452df044-c538-471e-9851-de734cbab8a8" xlink:href="ams-20201231.xsd#ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:to="loc_ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember_452df044-c538-471e-9851-de734cbab8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember_256f633b-07c9-45a0-8437-9a24ca195f54" xlink:href="ams-20201231.xsd#ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:to="loc_ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember_256f633b-07c9-45a0-8437-9a24ca195f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_UnitsRemovedFromServiceInPriorYearsMember_d8f2c506-b562-4a47-8003-bf94f7535c60" xlink:href="ams-20201231.xsd#ams_UnitsRemovedFromServiceInPriorYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:to="loc_ams_UnitsRemovedFromServiceInPriorYearsMember_d8f2c506-b562-4a47-8003-bf94f7535c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_UnitsRemovedFromServiceInCurrentYearMember_665e1c0b-63e2-4bce-84c5-d078e1a74c2a" xlink:href="ams-20201231.xsd#ams_UnitsRemovedFromServiceInCurrentYearMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:to="loc_ams_UnitsRemovedFromServiceInCurrentYearMember_665e1c0b-63e2-4bce-84c5-d078e1a74c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember_9cc63e5c-f8e9-448a-a6f7-1f0a97144069" xlink:href="ams-20201231.xsd#ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaba96a8-ef3f-48b4-bb23-14a4311bef20" xlink:to="loc_ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember_9cc63e5c-f8e9-448a-a6f7-1f0a97144069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8ec99028-2ed0-495c-8ba7-0bd6d5a918b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2614bc5b-12ac-4ccb-a0a0-75bbdec5d39c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8ec99028-2ed0-495c-8ba7-0bd6d5a918b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_de108c80-67e3-4efb-8be6-4d7fa1b3eb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8ec99028-2ed0-495c-8ba7-0bd6d5a918b7" xlink:to="loc_us-gaap_RelatedPartyDomain_de108c80-67e3-4efb-8be6-4d7fa1b3eb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeUnitMember_349d7a86-7be9-4865-9d8a-36731da613ff" xlink:href="ams-20201231.xsd#ams_GammaKnifeUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_de108c80-67e3-4efb-8be6-4d7fa1b3eb4d" xlink:to="loc_ams_GammaKnifeUnitMember_349d7a86-7be9-4865-9d8a-36731da613ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ProtonBeamRadiationTherapyPBRTMember_3df8fcd6-2002-461c-9361-b3e9822e3748" xlink:href="ams-20201231.xsd#ams_ProtonBeamRadiationTherapyPBRTMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_de108c80-67e3-4efb-8be6-4d7fa1b3eb4d" xlink:to="loc_ams_ProtonBeamRadiationTherapyPBRTMember_3df8fcd6-2002-461c-9361-b3e9822e3748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_67dc8488-8209-4f5a-a93b-1efb3cb4e1e5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2614bc5b-12ac-4ccb-a0a0-75bbdec5d39c" xlink:to="loc_srt_StatementGeographicalAxis_67dc8488-8209-4f5a-a93b-1efb3cb4e1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5e7e4819-8401-4678-9bcc-bf1a28f3aa84" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_67dc8488-8209-4f5a-a93b-1efb3cb4e1e5" xlink:to="loc_srt_SegmentGeographicalDomain_5e7e4819-8401-4678-9bcc-bf1a28f3aa84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_da532dd5-f31f-41ce-93d9-58260bccf9aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5e7e4819-8401-4678-9bcc-bf1a28f3aa84" xlink:to="loc_us-gaap_NonUsMember_da532dd5-f31f-41ce-93d9-58260bccf9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2614bc5b-12ac-4ccb-a0a0-75bbdec5d39c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7d394f1e-cc62-4a59-aafe-0d7221e0142c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7d394f1e-cc62-4a59-aafe-0d7221e0142c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_4d46ad78-d93c-417e-b24d-209112411624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_4d46ad78-d93c-417e-b24d-209112411624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfImpairedAssetUnits_f329dd6d-3a18-47b8-aefb-937d9c0143cc" xlink:href="ams-20201231.xsd#ams_NumberOfImpairedAssetUnits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_ams_NumberOfImpairedAssetUnits_f329dd6d-3a18-47b8-aefb-937d9c0143cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfDeposits_9cc584c2-50f8-4533-9bb1-ea754e41c162" xlink:href="ams-20201231.xsd#ams_NumberOfDeposits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_ams_NumberOfDeposits_9cc584c2-50f8-4533-9bb1-ea754e41c162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3f53dd77-0f45-45bc-b1e9-10a694072ed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3f53dd77-0f45-45bc-b1e9-10a694072ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetRetirementObligationNumberOfRemovedAssetUnits_386bfaf9-f46e-495e-be20-9e9ee4576c08" xlink:href="ams-20201231.xsd#ams_AssetRetirementObligationNumberOfRemovedAssetUnits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_ams_AssetRetirementObligationNumberOfRemovedAssetUnits_386bfaf9-f46e-495e-be20-9e9ee4576c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_63f37a95-21e5-4209-bfff-896597dd79be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_AssetRetirementObligation_63f37a95-21e5-4209-bfff-896597dd79be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_c90e8a7d-f854-4ed2-b51a-1c07082b308f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_c90e8a7d-f854-4ed2-b51a-1c07082b308f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_8bb8fe61-e9eb-418b-86aa-eb035ce55870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_8bb8fe61-e9eb-418b-86aa-eb035ce55870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedCapitalizedInterestCosts_a0e225a3-0b9a-44f5-8fc8-9a7c7d631bae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedCapitalizedInterestCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_us-gaap_AccumulatedCapitalizedInterestCosts_a0e225a3-0b9a-44f5-8fc8-9a7c7d631bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermPurchaseCommitmentDepositsForAssets_10deeb35-a287-45b9-b370-bb006ee298ac" xlink:href="ams-20201231.xsd#ams_LongTermPurchaseCommitmentDepositsForAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7cbdc345-e237-4a4c-9893-9dc2bee580df" xlink:to="loc_ams_LongTermPurchaseCommitmentDepositsForAssets_10deeb35-a287-45b9-b370-bb006ee298ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITION" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITION"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/GKCEACQUISITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_17fc1d0e-314b-48b4-bf89-8b37e9eedd9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_c5b60136-49d1-4f6e-a587-ba50419ac807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_17fc1d0e-314b-48b4-bf89-8b37e9eedd9f" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_c5b60136-49d1-4f6e-a587-ba50419ac807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITIONTables" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITIONTables"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/GKCEACQUISITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_f465b856-d80b-4d5a-b8eb-2dd6756bcb73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_bfd0589d-cec5-47e1-aee9-deec08ae93d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_f465b856-d80b-4d5a-b8eb-2dd6756bcb73" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_bfd0589d-cec5-47e1-aee9-deec08ae93d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_435a420e-216b-448b-bce0-2e3c2cf44d9d" xlink:href="ams-20201231.xsd#ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_f465b856-d80b-4d5a-b8eb-2dd6756bcb73" xlink:to="loc_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_435a420e-216b-448b-bce0-2e3c2cf44d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_67cc470c-a372-4bfa-838c-0b6f68e348a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36872d8d-084c-4f27-a2a2-4b369d50440d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_67cc470c-a372-4bfa-838c-0b6f68e348a2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36872d8d-084c-4f27-a2a2-4b369d50440d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAxis_0ed3ea08-180f-44a7-b6a2-8d17db355d89" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36872d8d-084c-4f27-a2a2-4b369d50440d" xlink:to="loc_ams_AssetAcquisitionAxis_0ed3ea08-180f-44a7-b6a2-8d17db355d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_1a796513-2cd2-49ea-a130-2f7bfa434172" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AssetAcquisitionAxis_0ed3ea08-180f-44a7-b6a2-8d17db355d89" xlink:to="loc_ams_AssetAcquisitionDomain_1a796513-2cd2-49ea-a130-2f7bfa434172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GKCEAcquisitionMember_3c57c83f-a6bf-43a8-9d2b-2bf081216783" xlink:href="ams-20201231.xsd#ams_GKCEAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AssetAcquisitionDomain_1a796513-2cd2-49ea-a130-2f7bfa434172" xlink:to="loc_ams_GKCEAcquisitionMember_3c57c83f-a6bf-43a8-9d2b-2bf081216783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_20b50a00-87f2-4a71-8e06-a141b6ba74fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36872d8d-084c-4f27-a2a2-4b369d50440d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_20b50a00-87f2-4a71-8e06-a141b6ba74fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_67b9ee77-10f8-4fd6-9c9a-31ea7d223a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_20b50a00-87f2-4a71-8e06-a141b6ba74fd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_67b9ee77-10f8-4fd6-9c9a-31ea7d223a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_948d8c8f-5687-44f6-8607-e608d0963a7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_67b9ee77-10f8-4fd6-9c9a-31ea7d223a9a" xlink:to="loc_us-gaap_TradeNamesMember_948d8c8f-5687-44f6-8607-e608d0963a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_36872d8d-084c-4f27-a2a2-4b369d50440d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfSharesAcquired_7f4b1ed4-b401-49bb-b318-388e98001700" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionPercentageOfSharesAcquired_7f4b1ed4-b401-49bb-b318-388e98001700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfSharesRemaining_882ed945-3b9f-47f5-81c6-ac139968cd22" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfSharesRemaining"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionPercentageOfSharesRemaining_882ed945-3b9f-47f5-81c6-ac139968cd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_c5903d87-16db-4200-b697-25a662ae5559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_c5903d87-16db-4200-b697-25a662ae5559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPercentageOfOutstandingShares_c44d2541-2630-4566-be09-ad0efacc7a83" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPercentageOfOutstandingShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionPercentageOfOutstandingShares_c44d2541-2630-4566-be09-ad0efacc7a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionTotalConsiderationTransferred_5eaaadd0-7b86-4752-b495-04ae727b904a" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionTotalConsiderationTransferred"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionTotalConsiderationTransferred_5eaaadd0-7b86-4752-b495-04ae727b904a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionConsiderationTransferred_ea4116cb-0d1a-4e79-8b51-5cca9b624c42" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionConsiderationTransferred_ea4116cb-0d1a-4e79-8b51-5cca9b624c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsForAssetAcquisitions_54be5eb5-4b12-44b3-a45f-91937190d981" xlink:href="ams-20201231.xsd#ams_PaymentsForAssetAcquisitions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_PaymentsForAssetAcquisitions_54be5eb5-4b12-44b3-a45f-91937190d981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionTransactionCosts_ec1a39e0-90f8-4e61-bcbc-172af9ce0e6b" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionTransactionCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionTransactionCosts_ec1a39e0-90f8-4e61-bcbc-172af9ce0e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsForWorkingCapital_b874dbda-fda6-40d2-8da9-8f0d055e459f" xlink:href="ams-20201231.xsd#ams_PaymentsForWorkingCapital"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_PaymentsForWorkingCapital_b874dbda-fda6-40d2-8da9-8f0d055e459f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAdditionalConsiderationTransferred_e2225b9d-72ec-4f9e-aec2-70c777697278" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAdditionalConsiderationTransferred"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionAdditionalConsiderationTransferred_e2225b9d-72ec-4f9e-aec2-70c777697278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsToAcquireAsset_ce70f186-16e9-4287-bf4b-fc5ca26aa54d" xlink:href="ams-20201231.xsd#ams_PaymentsToAcquireAsset"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_PaymentsToAcquireAsset_ce70f186-16e9-4287-bf4b-fc5ca26aa54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition_baf2a220-deca-407a-8d3e-2975692f21cc" xlink:href="ams-20201231.xsd#ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition_baf2a220-deca-407a-8d3e-2975692f21cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAccountsReceivable_39be6227-dd02-4cc4-8510-bdd3b13d6cff" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAccountsReceivable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionAccountsReceivable_39be6227-dd02-4cc4-8510-bdd3b13d6cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionLiabilitiesAssumed_b7cfc423-a0fe-406c-aea4-3edf20ffd29d" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionLiabilitiesAssumed"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionLiabilitiesAssumed_b7cfc423-a0fe-406c-aea4-3edf20ffd29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration_ac2f05b0-c481-457c-847b-e0e2832245ee" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration_ac2f05b0-c481-457c-847b-e0e2832245ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_d835c312-112a-4491-bc37-6a83104b4a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_d835c312-112a-4491-bc37-6a83104b4a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6845070c-2fe4-4755-a57c-74e208d40930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_11a6edea-1576-4453-9df2-80e980e4a7e7" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6845070c-2fe4-4755-a57c-74e208d40930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d2726874-4630-4a50-a083-25360899e3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_759b04fd-403a-438c-9d0e-b997d224ba78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d2726874-4630-4a50-a083-25360899e3a8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_759b04fd-403a-438c-9d0e-b997d224ba78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAxis_67702436-7015-4656-a61a-ebe2153ca332" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_759b04fd-403a-438c-9d0e-b997d224ba78" xlink:to="loc_ams_AssetAcquisitionAxis_67702436-7015-4656-a61a-ebe2153ca332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_4124a53a-1967-490d-be04-20f2853385ab" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AssetAcquisitionAxis_67702436-7015-4656-a61a-ebe2153ca332" xlink:to="loc_ams_AssetAcquisitionDomain_4124a53a-1967-490d-be04-20f2853385ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GKCEAcquisitionMember_b6a449fd-a32d-439c-88e5-33ceca2e4ab1" xlink:href="ams-20201231.xsd#ams_GKCEAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AssetAcquisitionDomain_4124a53a-1967-490d-be04-20f2853385ab" xlink:to="loc_ams_GKCEAcquisitionMember_b6a449fd-a32d-439c-88e5-33ceca2e4ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_63bd672a-7005-4104-a547-2fecdd9f658b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_759b04fd-403a-438c-9d0e-b997d224ba78" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_63bd672a-7005-4104-a547-2fecdd9f658b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b92b9507-9464-412e-9b2b-f1fdd871e71f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_63bd672a-7005-4104-a547-2fecdd9f658b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b92b9507-9464-412e-9b2b-f1fdd871e71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_372b30e0-ad8e-44e3-b06f-22fe99b3a1c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b92b9507-9464-412e-9b2b-f1fdd871e71f" xlink:to="loc_us-gaap_TradeNamesMember_372b30e0-ad8e-44e3-b06f-22fe99b3a1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a5955af6-b222-4bc2-bacb-8af3f7d31b80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_759b04fd-403a-438c-9d0e-b997d224ba78" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a5955af6-b222-4bc2-bacb-8af3f7d31b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bc7a1e2-502c-4888-8fd6-968677c2815e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a5955af6-b222-4bc2-bacb-8af3f7d31b80" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bc7a1e2-502c-4888-8fd6-968677c2815e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_151632cf-86da-4958-8514-a813d2a6ec24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bc7a1e2-502c-4888-8fd6-968677c2815e" xlink:to="loc_us-gaap_BuildingMember_151632cf-86da-4958-8514-a813d2a6ec24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_75956205-7d88-46c7-ab2f-0305db22ac42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bc7a1e2-502c-4888-8fd6-968677c2815e" xlink:to="loc_us-gaap_LandMember_75956205-7d88-46c7-ab2f-0305db22ac42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MedicalEquipmentAndOtherFixedAssetsMember_cd5a37bf-648e-4f13-b34e-a8e00d33a7d6" xlink:href="ams-20201231.xsd#ams_MedicalEquipmentAndOtherFixedAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bc7a1e2-502c-4888-8fd6-968677c2815e" xlink:to="loc_ams_MedicalEquipmentAndOtherFixedAssetsMember_cd5a37bf-648e-4f13-b34e-a8e00d33a7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_759b04fd-403a-438c-9d0e-b997d224ba78" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionCashAndCashEquivalents_2a605fb2-8010-4e8f-ae38-baf403d5410a" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionCashAndCashEquivalents_2a605fb2-8010-4e8f-ae38-baf403d5410a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAccountsReceivable_be51955e-a0ea-4a74-989e-6a8e7cbcfd3a" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionAccountsReceivable_be51955e-a0ea-4a74-989e-6a8e7cbcfd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionPrepaidExpenseAndOther_67a49cff-19e7-46da-80d5-4d1c7ae8a716" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionPrepaidExpenseAndOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionPrepaidExpenseAndOther_67a49cff-19e7-46da-80d5-4d1c7ae8a716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_552ad9b7-b8ef-466a-b512-5e7a8b7c11cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_552ad9b7-b8ef-466a-b512-5e7a8b7c11cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_2c4fc3f5-524e-4ec9-b147-fa8010b08630" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_2c4fc3f5-524e-4ec9-b147-fa8010b08630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_f4feb5cd-e88e-41a1-994a-97fdd65dafaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_f4feb5cd-e88e-41a1-994a-97fdd65dafaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAssetsAcquired_22c1b082-7cc9-4c7f-8d39-5aa6af674bb0" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAssetsAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionAssetsAcquired_22c1b082-7cc9-4c7f-8d39-5aa6af674bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAccountsPayable_8c1681b5-8bab-48d1-a5ee-6ce5da93c040" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAccountsPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionAccountsPayable_8c1681b5-8bab-48d1-a5ee-6ce5da93c040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionIncomeTaxesPayable_2d1ad9cd-a894-426e-90fb-1598e2975f9a" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionIncomeTaxesPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionIncomeTaxesPayable_2d1ad9cd-a894-426e-90fb-1598e2975f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDeferredIncomeTaxes_0d559c57-70bd-4ecd-9aef-f87d88deeeb7" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDeferredIncomeTaxes"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionDeferredIncomeTaxes_0d559c57-70bd-4ecd-9aef-f87d88deeeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionEmployeeCompensationAndBenefits_05d2a7c9-4c6f-4d23-9f45-e35651fadc59" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionEmployeeCompensationAndBenefits"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionEmployeeCompensationAndBenefits_05d2a7c9-4c6f-4d23-9f45-e35651fadc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionLiabilitiesAssumed_f29865d1-afbf-4a96-9866-60524b8184ea" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionLiabilitiesAssumed"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionLiabilitiesAssumed_f29865d1-afbf-4a96-9866-60524b8184ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionTotalConsiderationTransferred_fd8b7bb4-3015-4a40-a098-28bf51c2996a" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionTotalConsiderationTransferred"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionTotalConsiderationTransferred_fd8b7bb4-3015-4a40-a098-28bf51c2996a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PaymentsForWorkingCapital_ede0adc8-2d4a-44bc-989c-d8057e8f8084" xlink:href="ams-20201231.xsd#ams_PaymentsForWorkingCapital"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_PaymentsForWorkingCapital_ede0adc8-2d4a-44bc-989c-d8057e8f8084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAdditionalConsiderationTransferred_a04a084b-51c5-4498-9ba6-1dc854d498b3" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAdditionalConsiderationTransferred"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionAdditionalConsiderationTransferred_a04a084b-51c5-4498-9ba6-1dc854d498b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionConsiderationTransferred_34bf9ed5-540b-48e2-92aa-a5a95df0860b" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0113843a-148d-4837-8005-8678de65b61e" xlink:to="loc_ams_AssetAcquisitionConsiderationTransferred_34bf9ed5-540b-48e2-92aa-a5a95df0860b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6d5971a7-2644-47a5-a862-8c3ce97a3ac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67cad83b-b67d-4e31-869c-aeecdbac13aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6d5971a7-2644-47a5-a862-8c3ce97a3ac8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67cad83b-b67d-4e31-869c-aeecdbac13aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionAxis_a175605d-c550-4fb7-825a-2076f216a250" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67cad83b-b67d-4e31-869c-aeecdbac13aa" xlink:to="loc_ams_AssetAcquisitionAxis_a175605d-c550-4fb7-825a-2076f216a250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AssetAcquisitionDomain_c9ed72fb-2aba-49af-b4db-b6e08c1ae539" xlink:href="ams-20201231.xsd#ams_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AssetAcquisitionAxis_a175605d-c550-4fb7-825a-2076f216a250" xlink:to="loc_ams_AssetAcquisitionDomain_c9ed72fb-2aba-49af-b4db-b6e08c1ae539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GKCEAcquisitionMember_15af0998-44e0-42cf-bcc1-cf78c7a87e99" xlink:href="ams-20201231.xsd#ams_GKCEAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_AssetAcquisitionDomain_c9ed72fb-2aba-49af-b4db-b6e08c1ae539" xlink:to="loc_ams_GKCEAcquisitionMember_15af0998-44e0-42cf-bcc1-cf78c7a87e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_788f0955-7274-4fd8-a58c-d7bf9e1ae07e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67cad83b-b67d-4e31-869c-aeecdbac13aa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_788f0955-7274-4fd8-a58c-d7bf9e1ae07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8bbb77-ecca-49f5-b660-5af7cfd68c4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_788f0955-7274-4fd8-a58c-d7bf9e1ae07e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8bbb77-ecca-49f5-b660-5af7cfd68c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_45ec9ad0-bac8-496e-b692-405ee5158035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8bbb77-ecca-49f5-b660-5af7cfd68c4e" xlink:to="loc_us-gaap_BuildingMember_45ec9ad0-bac8-496e-b692-405ee5158035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_7f884c29-ba2e-4cd2-b48f-b9a823d6fc05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8bbb77-ecca-49f5-b660-5af7cfd68c4e" xlink:to="loc_us-gaap_LandMember_7f884c29-ba2e-4cd2-b48f-b9a823d6fc05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MedicalEquipmentMember_7022e401-a613-4c42-96eb-ed262578aac9" xlink:href="ams-20201231.xsd#ams_MedicalEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8bbb77-ecca-49f5-b660-5af7cfd68c4e" xlink:to="loc_ams_MedicalEquipmentMember_7022e401-a613-4c42-96eb-ed262578aac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_OtherFixedAssetsMember_f2ea8fe8-5020-4be9-90c7-2860518b63db" xlink:href="ams-20201231.xsd#ams_OtherFixedAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8bbb77-ecca-49f5-b660-5af7cfd68c4e" xlink:to="loc_ams_OtherFixedAssetsMember_f2ea8fe8-5020-4be9-90c7-2860518b63db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_380bd533-25a7-41aa-a04b-a6c866800a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67cad83b-b67d-4e31-869c-aeecdbac13aa" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_380bd533-25a7-41aa-a04b-a6c866800a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_1e955514-2c5d-4625-a3ff-91063005ddff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_380bd533-25a7-41aa-a04b-a6c866800a67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_1e955514-2c5d-4625-a3ff-91063005ddff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_4e3abf8c-9a20-43a2-b6c3-6511556b20f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_380bd533-25a7-41aa-a04b-a6c866800a67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_4e3abf8c-9a20-43a2-b6c3-6511556b20f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LONGTERMDEBT" xlink:type="simple" xlink:href="ams-20201231.xsd#LONGTERMDEBT"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/LONGTERMDEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9d7811d4-31b1-4805-8ca1-7dc1aa5490c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_45dacee7-0e05-4c1c-8170-43aaa7324137" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9d7811d4-31b1-4805-8ca1-7dc1aa5490c8" xlink:to="loc_us-gaap_LongTermDebtTextBlock_45dacee7-0e05-4c1c-8170-43aaa7324137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LONGTERMDEBTTables" xlink:type="simple" xlink:href="ams-20201231.xsd#LONGTERMDEBTTables"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/LONGTERMDEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ef92a8cb-3831-4616-90c9-7e08863b8754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_bca8bf39-f83b-459d-808f-9c0a059839cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ef92a8cb-3831-4616-90c9-7e08863b8754" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_bca8bf39-f83b-459d-808f-9c0a059839cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#LONGTERMDEBTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b1f11d98-57fd-4fcd-bb31-eb995f382f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_40b87a79-2229-456a-a961-f09080fe7c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b1f11d98-57fd-4fcd-bb31-eb995f382f84" xlink:to="loc_us-gaap_DebtInstrumentTable_40b87a79-2229-456a-a961-f09080fe7c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0a87a4b9-70b6-4ef6-af67-98e3da262390" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_40b87a79-2229-456a-a961-f09080fe7c3c" xlink:to="loc_srt_RangeAxis_0a87a4b9-70b6-4ef6-af67-98e3da262390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b61cdb43-d72b-4dbf-b2e4-8d72a270c531" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0a87a4b9-70b6-4ef6-af67-98e3da262390" xlink:to="loc_srt_RangeMember_b61cdb43-d72b-4dbf-b2e4-8d72a270c531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5c446948-f5de-4686-b305-9b0b26e4ae2c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b61cdb43-d72b-4dbf-b2e4-8d72a270c531" xlink:to="loc_srt_MinimumMember_5c446948-f5de-4686-b305-9b0b26e4ae2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5d12addf-828d-4a22-b430-f443e56639c9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b61cdb43-d72b-4dbf-b2e4-8d72a270c531" xlink:to="loc_srt_MaximumMember_5d12addf-828d-4a22-b430-f443e56639c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f35b46bc-81e1-4273-b5b4-93a186c91960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_40b87a79-2229-456a-a961-f09080fe7c3c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f35b46bc-81e1-4273-b5b4-93a186c91960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b7e8b021-9990-4676-a5af-9983c73500d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f35b46bc-81e1-4273-b5b4-93a186c91960" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b7e8b021-9990-4676-a5af-9983c73500d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifeUnitMember_a6ab247e-9740-4676-aab8-7cde0c729ff5" xlink:href="ams-20201231.xsd#ams_GammaKnifeUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b7e8b021-9990-4676-a5af-9983c73500d9" xlink:to="loc_ams_GammaKnifeUnitMember_a6ab247e-9740-4676-aab8-7cde0c729ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_40b87a79-2229-456a-a961-f09080fe7c3c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfDebtInstruments_2ec04c42-68a2-4d8e-8b7c-77891740faa2" xlink:href="ams-20201231.xsd#ams_NumberOfDebtInstruments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_ams_NumberOfDebtInstruments_2ec04c42-68a2-4d8e-8b7c-77891740faa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCollateralAmount_5a188577-fa83-4f35-bc9c-1cacdb79839d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCollateralAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_us-gaap_DebtInstrumentCollateralAmount_5a188577-fa83-4f35-bc9c-1cacdb79839d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_1a7d709f-2e0f-48c4-8477-b5777f0b1dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_1a7d709f-2e0f-48c4-8477-b5777f0b1dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermDebtMonthlyInstallments_c4d7816e-a2a4-4823-af8e-40b078835862" xlink:href="ams-20201231.xsd#ams_LongTermDebtMonthlyInstallments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_ams_LongTermDebtMonthlyInstallments_c4d7816e-a2a4-4823-af8e-40b078835862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingVariableInterestRate_b6c9d684-8732-4ed5-9e58-325394a62fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtPercentageBearingVariableInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingVariableInterestRate_b6c9d684-8732-4ed5-9e58-325394a62fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_5f878072-e6f9-4f0f-af0e-cfe084e1337d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_302c0cd5-cf6e-40fb-bba8-76a94217c008" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_5f878072-e6f9-4f0f-af0e-cfe084e1337d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LONGTERMDEBTDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#LONGTERMDEBTDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/LONGTERMDEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b1656e03-f780-4b00-8778-1dc6fbd5c239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_0a3342c1-ac9c-45ca-8676-e835618636ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b1656e03-f780-4b00-8778-1dc6fbd5c239" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_0a3342c1-ac9c-45ca-8676-e835618636ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_21ada6d8-7bc0-4fc3-8d7f-d2624ded199f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0a3342c1-ac9c-45ca-8676-e835618636ca" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_21ada6d8-7bc0-4fc3-8d7f-d2624ded199f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4ce77a36-e850-455e-90e4-a6596caf162e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0a3342c1-ac9c-45ca-8676-e835618636ca" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4ce77a36-e850-455e-90e4-a6596caf162e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c22d1825-e48c-4cc3-8950-e237695c2459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0a3342c1-ac9c-45ca-8676-e835618636ca" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c22d1825-e48c-4cc3-8950-e237695c2459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2fbfdcf3-fae8-48bd-a452-3bb46d081ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0a3342c1-ac9c-45ca-8676-e835618636ca" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2fbfdcf3-fae8-48bd-a452-3bb46d081ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_118abb95-2bdf-4db1-86a7-79e0dd487329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0a3342c1-ac9c-45ca-8676-e835618636ca" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_118abb95-2bdf-4db1-86a7-79e0dd487329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_24509ac3-f994-4839-90d7-0afb02bdc988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0a3342c1-ac9c-45ca-8676-e835618636ca" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_24509ac3-f994-4839-90d7-0afb02bdc988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b187d0d7-9c6a-4754-b5ed-9551d56fe8e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0a3342c1-ac9c-45ca-8676-e835618636ca" xlink:to="loc_us-gaap_LongTermDebt_b187d0d7-9c6a-4754-b5ed-9551d56fe8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASES" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASES"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/FINANCELEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ee92fd45-289f-466c-8557-8fd63dc7150b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_a87c264e-e625-462e-8158-081aee3cd2cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ee92fd45-289f-466c-8557-8fd63dc7150b" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_a87c264e-e625-462e-8158-081aee3cd2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASESTables"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/FINANCELEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_26493017-9736-4907-9186-69a7498dcfaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_4a8b9e4f-fc8f-4afd-a907-0bda81127f4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_26493017-9736-4907-9186-69a7498dcfaf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_4a8b9e4f-fc8f-4afd-a907-0bda81127f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/FINANCELEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_20d93456-ce10-4b4b-aaff-7429cc44bbb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_80c639f9-221d-44e7-ae67-de542e70a64e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_20d93456-ce10-4b4b-aaff-7429cc44bbb1" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_80c639f9-221d-44e7-ae67-de542e70a64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e00d418c-a97b-4e5d-ad20-c504dfe1b93a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_80c639f9-221d-44e7-ae67-de542e70a64e" xlink:to="loc_srt_RangeAxis_e00d418c-a97b-4e5d-ad20-c504dfe1b93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1638d5ae-0a3d-4e7e-ba1a-d866b95f20a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e00d418c-a97b-4e5d-ad20-c504dfe1b93a" xlink:to="loc_srt_RangeMember_1638d5ae-0a3d-4e7e-ba1a-d866b95f20a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5ae39fb0-4d2e-4885-9335-cd6a3ff6454f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1638d5ae-0a3d-4e7e-ba1a-d866b95f20a6" xlink:to="loc_srt_MinimumMember_5ae39fb0-4d2e-4885-9335-cd6a3ff6454f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bbba5dfa-e7c1-4210-9de1-c1fa26702b43" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1638d5ae-0a3d-4e7e-ba1a-d866b95f20a6" xlink:to="loc_srt_MaximumMember_bbba5dfa-e7c1-4210-9de1-c1fa26702b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_80c639f9-221d-44e7-ae67-de542e70a64e" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfFinancingLeases_57a5b582-52e2-4a10-affd-8571cf7548f3" xlink:href="ams-20201231.xsd#ams_NumberOfFinancingLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:to="loc_ams_NumberOfFinancingLeases_57a5b582-52e2-4a10-affd-8571cf7548f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeaseObligations_da247cdc-cf61-4bb1-8d7b-6d7b1093e353" xlink:href="ams-20201231.xsd#ams_FinanceLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:to="loc_ams_FinanceLeaseObligations_da247cdc-cf61-4bb1-8d7b-6d7b1093e353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeaseAccountsReceivable_879cc247-8478-4975-ad64-7edc0ebeb571" xlink:href="ams-20201231.xsd#ams_FinanceLeaseAccountsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:to="loc_ams_FinanceLeaseAccountsReceivable_879cc247-8478-4975-ad64-7edc0ebeb571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeaseObligationInterestRate_9c85a613-a701-4a9c-adda-5666882fcfb3" xlink:href="ams-20201231.xsd#ams_FinanceLeaseObligationInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:to="loc_ams_FinanceLeaseObligationInterestRate_9c85a613-a701-4a9c-adda-5666882fcfb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeaseObligationsMonthlyInstallments_df43e3b6-0764-4dcc-ba99-a9a2a3aadfd8" xlink:href="ams-20201231.xsd#ams_FinanceLeaseObligationsMonthlyInstallments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_38e79204-83a2-4ba4-b3f9-62c5c10872e2" xlink:to="loc_ams_FinanceLeaseObligationsMonthlyInstallments_df43e3b6-0764-4dcc-ba99-a9a2a3aadfd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASESDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASESDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/FINANCELEASESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_61a21c96-bcb8-4c2b-8f7b-d8ff5c070cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_316936ea-7dea-4aec-897f-a8bcfc4f7bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_61a21c96-bcb8-4c2b-8f7b-d8ff5c070cb9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_316936ea-7dea-4aec-897f-a8bcfc4f7bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_7de17e77-50d7-4949-820d-cce3be0ac475" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_61a21c96-bcb8-4c2b-8f7b-d8ff5c070cb9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_7de17e77-50d7-4949-820d-cce3be0ac475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_95bb59d1-c2f9-410c-98a4-99332d9c7090" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_61a21c96-bcb8-4c2b-8f7b-d8ff5c070cb9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_95bb59d1-c2f9-410c-98a4-99332d9c7090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_b9ef9bcf-9941-4804-aa9b-cbfade69443d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_61a21c96-bcb8-4c2b-8f7b-d8ff5c070cb9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_b9ef9bcf-9941-4804-aa9b-cbfade69443d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_22532bdc-8fb0-4608-afbe-a480a82a4546" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_61a21c96-bcb8-4c2b-8f7b-d8ff5c070cb9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_22532bdc-8fb0-4608-afbe-a480a82a4546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_b9e44c62-9f18-4352-9f70-9e2e75d1f7c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_61a21c96-bcb8-4c2b-8f7b-d8ff5c070cb9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_b9e44c62-9f18-4352-9f70-9e2e75d1f7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_516d6c25-2163-46cf-a2a5-45ebeb2eb422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_61a21c96-bcb8-4c2b-8f7b-d8ff5c070cb9" xlink:to="loc_us-gaap_FinanceLeaseLiability_516d6c25-2163-46cf-a2a5-45ebeb2eb422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_796d4109-3d22-4cb4-8abd-40e0d1a52446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_61a21c96-bcb8-4c2b-8f7b-d8ff5c070cb9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_796d4109-3d22-4cb4-8abd-40e0d1a52446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c99109a8-d95b-4d91-918e-86c7684bd165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_61a21c96-bcb8-4c2b-8f7b-d8ff5c070cb9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c99109a8-d95b-4d91-918e-86c7684bd165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/FINANCELEASESDetails_1" xlink:type="simple" xlink:href="ams-20201231.xsd#FINANCELEASESDetails_1"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/FINANCELEASESDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASES" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_60618e9e-8518-4b68-ad7f-8369a56fc3ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_37101997-4e5c-48c9-a9dc-a800f698f8ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_60618e9e-8518-4b68-ad7f-8369a56fc3ca" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_37101997-4e5c-48c9-a9dc-a800f698f8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_16c15ffb-c0a1-4b6e-9c65-764a20337655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1b565668-cc20-437f-aed5-723b0490c4bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_16c15ffb-c0a1-4b6e-9c65-764a20337655" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1b565668-cc20-437f-aed5-723b0490c4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/LEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_382dced1-d826-4af3-b6af-f115fe6e1e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_97ebe3d1-3586-4853-9c72-72a0e97445fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_382dced1-d826-4af3-b6af-f115fe6e1e9d" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_97ebe3d1-3586-4853-9c72-72a0e97445fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e5c00dd7-a01e-44cc-8187-691ced417861" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_97ebe3d1-3586-4853-9c72-72a0e97445fd" xlink:to="loc_srt_RangeAxis_e5c00dd7-a01e-44cc-8187-691ced417861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_981856cc-975b-41af-8203-98cc9ab4e21e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e5c00dd7-a01e-44cc-8187-691ced417861" xlink:to="loc_srt_RangeMember_981856cc-975b-41af-8203-98cc9ab4e21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b898473f-0a5d-4588-8fd0-d63c74101a37" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_981856cc-975b-41af-8203-98cc9ab4e21e" xlink:to="loc_srt_MinimumMember_b898473f-0a5d-4588-8fd0-d63c74101a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_311932a5-99f7-4be7-94f8-ef0dc84fe2af" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_981856cc-975b-41af-8203-98cc9ab4e21e" xlink:to="loc_srt_MaximumMember_311932a5-99f7-4be7-94f8-ef0dc84fe2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_97ebe3d1-3586-4853-9c72-72a0e97445fd" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_c9089eb8-ab6f-4457-bdd3-2e171c9e3bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_c9089eb8-ab6f-4457-bdd3-2e171c9e3bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_7a0540cf-2dfc-4d76-b45b-ac2886f58cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_7a0540cf-2dfc-4d76-b45b-ac2886f58cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_75f00bf0-ee4e-4a45-856c-57e0db777fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_75f00bf0-ee4e-4a45-856c-57e0db777fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_15dc7a3a-2d1b-4562-9cfb-f95c989c3c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_us-gaap_OperatingLeaseLiability_15dc7a3a-2d1b-4562-9cfb-f95c989c3c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities_267bf6fd-f3b9-4739-9c5d-c81a2b677ea6" xlink:href="ams-20201231.xsd#ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities_267bf6fd-f3b9-4739-9c5d-c81a2b677ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonCashRightOfUseAssetsAndLeaseLiabilities_9dde9c49-e00c-4f34-9848-aa7cb456acfe" xlink:href="ams-20201231.xsd#ams_NonCashRightOfUseAssetsAndLeaseLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_232be067-f291-410d-82aa-9040dfc85781" xlink:to="loc_ams_NonCashRightOfUseAssetsAndLeaseLiabilities_9dde9c49-e00c-4f34-9848-aa7cb456acfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_67c33eba-d991-4415-94d4-cecca124b6f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7279670c-b9c0-4e29-b6f6-9f794520b7b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67c33eba-d991-4415-94d4-cecca124b6f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7279670c-b9c0-4e29-b6f6-9f794520b7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_faf0e642-f3ae-4066-85d0-0ced52765e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67c33eba-d991-4415-94d4-cecca124b6f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_faf0e642-f3ae-4066-85d0-0ced52765e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6ede6226-111d-477d-be66-7a0dd6589247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67c33eba-d991-4415-94d4-cecca124b6f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6ede6226-111d-477d-be66-7a0dd6589247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e5469e4a-0e43-47f7-a537-5bb5f8427e17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67c33eba-d991-4415-94d4-cecca124b6f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e5469e4a-0e43-47f7-a537-5bb5f8427e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_35a25e28-0fb9-4062-929f-283e06d12eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67c33eba-d991-4415-94d4-cecca124b6f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_35a25e28-0fb9-4062-929f-283e06d12eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e951a1a3-0009-48bb-9d68-7a2ded8478e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67c33eba-d991-4415-94d4-cecca124b6f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e951a1a3-0009-48bb-9d68-7a2ded8478e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_3678a370-3c93-4ae3-9f7a-8bc0b87e260c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67c33eba-d991-4415-94d4-cecca124b6f2" xlink:to="loc_us-gaap_OperatingLeaseLiability_3678a370-3c93-4ae3-9f7a-8bc0b87e260c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails_1" xlink:type="simple" xlink:href="ams-20201231.xsd#LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails_1"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXES" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_cc7babb1-1791-4d53-b138-f854e922ea9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_a296e374-ef22-4a2a-909a-6a52100cd1c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cc7babb1-1791-4d53-b138-f854e922ea9d" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_a296e374-ef22-4a2a-909a-6a52100cd1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9116980b-704d-4499-9ce2-0940f7febd24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_91f778f3-7b9b-4fe8-81c5-0b07aa7f3f9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9116980b-704d-4499-9ce2-0940f7febd24" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_91f778f3-7b9b-4fe8-81c5-0b07aa7f3f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_877a5e90-34f0-45eb-9360-414e978517df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9116980b-704d-4499-9ce2-0940f7febd24" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_877a5e90-34f0-45eb-9360-414e978517df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_bc2a38c9-b6e1-4ddb-b22a-89e19e9a5c27" xlink:href="ams-20201231.xsd#ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9116980b-704d-4499-9ce2-0940f7febd24" xlink:to="loc_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_bc2a38c9-b6e1-4ddb-b22a-89e19e9a5c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b3cda057-8ac1-48a2-a454-e8100137c97e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9116980b-704d-4499-9ce2-0940f7febd24" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b3cda057-8ac1-48a2-a454-e8100137c97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_9ac98df3-e039-4193-bbbb-c2e1841721a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9116980b-704d-4499-9ce2-0940f7febd24" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_9ac98df3-e039-4193-bbbb-c2e1841721a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_218d8998-4cb1-47a9-a090-acdfd234b837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncomeTaxDisclosureTable_24cd36a4-3369-4e27-b705-5380caddfb89" xlink:href="ams-20201231.xsd#ams_IncomeTaxDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_218d8998-4cb1-47a9-a090-acdfd234b837" xlink:to="loc_ams_IncomeTaxDisclosureTable_24cd36a4-3369-4e27-b705-5380caddfb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_f5b46500-c508-471d-9c01-992f864d55e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_IncomeTaxDisclosureTable_24cd36a4-3369-4e27-b705-5380caddfb89" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_f5b46500-c508-471d-9c01-992f864d55e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d21c9a0e-5251-4610-a2aa-2f8eb30659c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f5b46500-c508-471d-9c01-992f864d55e9" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d21c9a0e-5251-4610-a2aa-2f8eb30659c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_5878f8a9-7fc7-45c7-96ab-6be6ac50b9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d21c9a0e-5251-4610-a2aa-2f8eb30659c0" xlink:to="loc_us-gaap_DomesticCountryMember_5878f8a9-7fc7-45c7-96ab-6be6ac50b9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_2e664684-7b64-4330-b47d-aab9ac34fc56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d21c9a0e-5251-4610-a2aa-2f8eb30659c0" xlink:to="loc_us-gaap_ForeignCountryMember_2e664684-7b64-4330-b47d-aab9ac34fc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_1da40c29-659f-4ef2-be86-b2467648f9fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d21c9a0e-5251-4610-a2aa-2f8eb30659c0" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_1da40c29-659f-4ef2-be86-b2467648f9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9abcad9b-4f06-4052-846b-43100b0e9505" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_IncomeTaxDisclosureTable_24cd36a4-3369-4e27-b705-5380caddfb89" xlink:to="loc_srt_StatementGeographicalAxis_9abcad9b-4f06-4052-846b-43100b0e9505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_95372195-45bb-4e11-8ebd-2a811117ed8f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9abcad9b-4f06-4052-846b-43100b0e9505" xlink:to="loc_srt_SegmentGeographicalDomain_95372195-45bb-4e11-8ebd-2a811117ed8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PeruDeferredTaxAssetsMember_c6c46f1a-6513-4735-a2b3-010c5c49c3e4" xlink:href="ams-20201231.xsd#ams_PeruDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_95372195-45bb-4e11-8ebd-2a811117ed8f" xlink:to="loc_ams_PeruDeferredTaxAssetsMember_c6c46f1a-6513-4735-a2b3-010c5c49c3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:href="ams-20201231.xsd#ams_IncomeTaxDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_IncomeTaxDisclosureTable_24cd36a4-3369-4e27-b705-5380caddfb89" xlink:to="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8944f82b-e1c0-4d9b-b3ad-5df6134254c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8944f82b-e1c0-4d9b-b3ad-5df6134254c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_aba284d6-c129-4d98-b611-389f2c613223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_aba284d6-c129-4d98-b611-389f2c613223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_591d5350-600e-41eb-ba65-63e32c89c3e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_591d5350-600e-41eb-ba65-63e32c89c3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_3bf9c72d-f10f-4a2b-b00e-07f8d6f49939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_OperatingLossCarryforwards_3bf9c72d-f10f-4a2b-b00e-07f8d6f49939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_5db52322-b7e9-441d-9f51-37143b2ad60e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_5db52322-b7e9-441d-9f51-37143b2ad60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8d436216-acc5-4a6b-9a19-487f1e67c7e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8d436216-acc5-4a6b-9a19-487f1e67c7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ecb85919-a009-4551-8b08-84780e00b716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ecb85919-a009-4551-8b08-84780e00b716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8316bcd7-40e4-4535-bee0-8d821e5e0fc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_IncomeTaxDisclosureLineItems_4d52bd56-7497-46af-a448-84dc396da43b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8316bcd7-40e4-4535-bee0-8d821e5e0fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1afe7802-2b6e-4bbf-b0c9-7c1e94ae39e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_55e32364-22f9-4dad-a06e-9ca58a051100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1afe7802-2b6e-4bbf-b0c9-7c1e94ae39e4" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_55e32364-22f9-4dad-a06e-9ca58a051100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_c8311310-0fd4-48ee-89e8-2bda11f93244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_55e32364-22f9-4dad-a06e-9ca58a051100" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_c8311310-0fd4-48ee-89e8-2bda11f93244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b4ec6c95-2d82-4c99-8317-236a5d8a38e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_55e32364-22f9-4dad-a06e-9ca58a051100" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b4ec6c95-2d82-4c99-8317-236a5d8a38e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bdd56dcd-ccee-4eab-8701-3a712ec76949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_55e32364-22f9-4dad-a06e-9ca58a051100" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bdd56dcd-ccee-4eab-8701-3a712ec76949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_66dde541-bc65-474e-a248-4b53c5b4b33c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_55e32364-22f9-4dad-a06e-9ca58a051100" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_66dde541-bc65-474e-a248-4b53c5b4b33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_e1bc610a-9913-443e-8683-970e3825833f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1afe7802-2b6e-4bbf-b0c9-7c1e94ae39e4" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_e1bc610a-9913-443e-8683-970e3825833f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_dd4eb537-84a5-4311-a265-60f82c39e3d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_e1bc610a-9913-443e-8683-970e3825833f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_dd4eb537-84a5-4311-a265-60f82c39e3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_4b76345c-c669-4c99-8ea3-67e4d75a443f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_e1bc610a-9913-443e-8683-970e3825833f" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_4b76345c-c669-4c99-8ea3-67e4d75a443f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_cde81739-735b-4671-8141-9e2aa4332270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_e1bc610a-9913-443e-8683-970e3825833f" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_cde81739-735b-4671-8141-9e2aa4332270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_9723b916-5335-4644-b57f-93bf1b3f5a56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_e1bc610a-9913-443e-8683-970e3825833f" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_9723b916-5335-4644-b57f-93bf1b3f5a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9271696d-15ca-42da-a790-20dd9e1caf34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1afe7802-2b6e-4bbf-b0c9-7c1e94ae39e4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9271696d-15ca-42da-a790-20dd9e1caf34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6a301bc4-904a-4837-8af3-7249ac9218de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_6d2c2436-08a5-484c-a584-9a881c631abd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6a301bc4-904a-4837-8af3-7249ac9218de" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_6d2c2436-08a5-484c-a584-9a881c631abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_8210151e-65cd-43e5-815c-149f39d8d460" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_6d2c2436-08a5-484c-a584-9a881c631abd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_8210151e-65cd-43e5-815c-149f39d8d460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_f15e46e7-2053-4dfb-965a-5c63e458a0c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_6d2c2436-08a5-484c-a584-9a881c631abd" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_f15e46e7-2053-4dfb-965a-5c63e458a0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_84374c03-2001-468c-ab6c-899993e13ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6a301bc4-904a-4837-8af3-7249ac9218de" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_84374c03-2001-468c-ab6c-899993e13ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2ad4857f-65a5-44ec-9afc-bb59d9ec8042" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_84374c03-2001-468c-ab6c-899993e13ca7" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2ad4857f-65a5-44ec-9afc-bb59d9ec8042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_f3fdd526-caf4-4377-ac88-ab3be0a2b4a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_84374c03-2001-468c-ab6c-899993e13ca7" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_f3fdd526-caf4-4377-ac88-ab3be0a2b4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_45cc1d78-3312-48b7-89c9-23cff0e7ec33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_84374c03-2001-468c-ab6c-899993e13ca7" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_45cc1d78-3312-48b7-89c9-23cff0e7ec33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_b36c59ae-9a84-497a-90bf-dd7d32832a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_84374c03-2001-468c-ab6c-899993e13ca7" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_b36c59ae-9a84-497a-90bf-dd7d32832a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_f15922db-fe10-4c83-92e8-2fec4643572e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_84374c03-2001-468c-ab6c-899993e13ca7" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_f15922db-fe10-4c83-92e8-2fec4643572e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_364c706e-1349-4fc7-82c3-ac6dfd362b4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_84374c03-2001-468c-ab6c-899993e13ca7" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_364c706e-1349-4fc7-82c3-ac6dfd362b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_478a82e6-229f-45b5-9c43-3ea3956112e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_84374c03-2001-468c-ab6c-899993e13ca7" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_478a82e6-229f-45b5-9c43-3ea3956112e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_ff8c5608-63ca-43eb-aeae-313a0c5dd0c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_84374c03-2001-468c-ab6c-899993e13ca7" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_ff8c5608-63ca-43eb-aeae-313a0c5dd0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_ce0a43cf-90fa-4694-9f43-0e607f0cb059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_84374c03-2001-468c-ab6c-899993e13ca7" xlink:to="loc_us-gaap_DeferredTaxLiabilities_ce0a43cf-90fa-4694-9f43-0e607f0cb059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_976dca58-abce-4048-9946-5a2ff8d03e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_510bee50-81c3-494c-9740-6ef1fe86a0fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_976dca58-abce-4048-9946-5a2ff8d03e29" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_510bee50-81c3-494c-9740-6ef1fe86a0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_3eb72b7b-e561-409f-8d1e-e57e6abba435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_976dca58-abce-4048-9946-5a2ff8d03e29" xlink:to="loc_us-gaap_DeferredTaxLiabilities_3eb72b7b-e561-409f-8d1e-e57e6abba435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b779a6d6-6af1-4f78-ae76-7a7784a1ae92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_6faf1293-4d95-4181-b946-415d7df28aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b779a6d6-6af1-4f78-ae76-7a7784a1ae92" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_6faf1293-4d95-4181-b946-415d7df28aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_a59586f3-4b69-4ea2-ae7d-758f87d5b750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b779a6d6-6af1-4f78-ae76-7a7784a1ae92" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_a59586f3-4b69-4ea2-ae7d-758f87d5b750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_cb0ebaaa-7f82-4fec-9c20-fa01b3256e31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b779a6d6-6af1-4f78-ae76-7a7784a1ae92" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_cb0ebaaa-7f82-4fec-9c20-fa01b3256e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount_4b3b75bb-11d0-4dea-ae88-89d07a1530a8" xlink:href="ams-20201231.xsd#ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b779a6d6-6af1-4f78-ae76-7a7784a1ae92" xlink:to="loc_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount_4b3b75bb-11d0-4dea-ae88-89d07a1530a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_4dbfd923-7f57-47dd-9230-16dec8acf1f8" xlink:href="ams-20201231.xsd#ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b779a6d6-6af1-4f78-ae76-7a7784a1ae92" xlink:to="loc_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_4dbfd923-7f57-47dd-9230-16dec8acf1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount_fb8b5519-c605-418e-8a3e-30a8a8038f8b" xlink:href="ams-20201231.xsd#ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b779a6d6-6af1-4f78-ae76-7a7784a1ae92" xlink:to="loc_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount_fb8b5519-c605-418e-8a3e-30a8a8038f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_188b6b60-7299-4a71-bf0e-dedd58d5c131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b779a6d6-6af1-4f78-ae76-7a7784a1ae92" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_188b6b60-7299-4a71-bf0e-dedd58d5c131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_3c30f361-44c8-4f80-ab55-08367ad13c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b779a6d6-6af1-4f78-ae76-7a7784a1ae92" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_3c30f361-44c8-4f80-ab55-08367ad13c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_47d545a8-cba3-4c32-9e31-4d6fb4e8df6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b779a6d6-6af1-4f78-ae76-7a7784a1ae92" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_47d545a8-cba3-4c32-9e31-4d6fb4e8df6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_33e8a1e9-8c17-4669-8e57-1131cd446d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6c2fd435-7a3a-4dd3-b9a7-030f8e3cfe7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33e8a1e9-8c17-4669-8e57-1131cd446d2c" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6c2fd435-7a3a-4dd3-b9a7-030f8e3cfe7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ccd11a54-f21e-4ec4-b4e0-31cb34e7b34f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6c2fd435-7a3a-4dd3-b9a7-030f8e3cfe7d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ccd11a54-f21e-4ec4-b4e0-31cb34e7b34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c9586963-3ed1-40b3-837e-6e3e876e6f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6c2fd435-7a3a-4dd3-b9a7-030f8e3cfe7d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c9586963-3ed1-40b3-837e-6e3e876e6f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_92205b78-c133-421f-9fa0-bd1f7ad181cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6c2fd435-7a3a-4dd3-b9a7-030f8e3cfe7d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_92205b78-c133-421f-9fa0-bd1f7ad181cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSE" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSE"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_4a08ee8c-8305-4e37-b022-88a866db26d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_dd1b08c4-1108-4f09-8eb9-1acb48306040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4a08ee8c-8305-4e37-b022-88a866db26d1" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_dd1b08c4-1108-4f09-8eb9-1acb48306040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSETables"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_330c83af-2f2e-4cb8-90fe-addbf3bf5ccf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_41c19df6-20af-4548-a50d-c0ba0ba3ae07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_330c83af-2f2e-4cb8-90fe-addbf3bf5ccf" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_41c19df6-20af-4548-a50d-c0ba0ba3ae07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_2670e93a-034e-4687-b87e-dbea635fa579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_330c83af-2f2e-4cb8-90fe-addbf3bf5ccf" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_2670e93a-034e-4687-b87e-dbea635fa579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_c5e5d962-fd2e-416e-95d0-1b153281a913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_330c83af-2f2e-4cb8-90fe-addbf3bf5ccf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_c5e5d962-fd2e-416e-95d0-1b153281a913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_a50d0069-e4a2-4dd3-a327-4958c6842d51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_330c83af-2f2e-4cb8-90fe-addbf3bf5ccf" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_a50d0069-e4a2-4dd3-a327-4958c6842d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c4ca8f39-60e9-4df6-acaf-f5b524851355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_330c83af-2f2e-4cb8-90fe-addbf3bf5ccf" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c4ca8f39-60e9-4df6-acaf-f5b524851355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_2ed1373a-b318-4329-bf7d-bd55a1c933ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_2ed1373a-b318-4329-bf7d-bd55a1c933ca" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fada9122-d1bc-4a78-a0a4-8da45dbcb78d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fada9122-d1bc-4a78-a0a4-8da45dbcb78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a50f010b-b84f-469f-9b70-1f23fca1f295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fada9122-d1bc-4a78-a0a4-8da45dbcb78d" xlink:to="loc_us-gaap_ClassOfStockDomain_a50f010b-b84f-469f-9b70-1f23fca1f295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_RetainerFeesMember_3658342e-3799-4842-9f28-9bf27f1ac2ae" xlink:href="ams-20201231.xsd#ams_RetainerFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a50f010b-b84f-469f-9b70-1f23fca1f295" xlink:to="loc_ams_RetainerFeesMember_3658342e-3799-4842-9f28-9bf27f1ac2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f3234699-e5bf-48ea-a6ec-c42c34969336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:to="loc_us-gaap_PlanNameAxis_f3234699-e5bf-48ea-a6ec-c42c34969336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3d0aa30e-cd69-423e-ab3a-393ffaee992e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_f3234699-e5bf-48ea-a6ec-c42c34969336" xlink:to="loc_us-gaap_PlanNameDomain_3d0aa30e-cd69-423e-ab3a-393ffaee992e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_IncentiveCompensationPlanMember_80e2ac41-11f5-46e7-bff0-d842807b59be" xlink:href="ams-20201231.xsd#ams_IncentiveCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3d0aa30e-cd69-423e-ab3a-393ffaee992e" xlink:to="loc_ams_IncentiveCompensationPlanMember_80e2ac41-11f5-46e7-bff0-d842807b59be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ExecutiveEquityAwardsMember_650c9e7e-5aaa-4c83-bd9f-dd84e9e5d716" xlink:href="ams-20201231.xsd#ams_ExecutiveEquityAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3d0aa30e-cd69-423e-ab3a-393ffaee992e" xlink:to="loc_ams_ExecutiveEquityAwardsMember_650c9e7e-5aaa-4c83-bd9f-dd84e9e5d716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PerformanceShareAwardAgreementMember_bfd14294-97b5-4d48-96ca-015953ecaac0" xlink:href="ams-20201231.xsd#ams_PerformanceShareAwardAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3d0aa30e-cd69-423e-ab3a-393ffaee992e" xlink:to="loc_ams_PerformanceShareAwardAgreementMember_bfd14294-97b5-4d48-96ca-015953ecaac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_efef92c2-55a7-4606-b3ae-183e9b0c4c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_efef92c2-55a7-4606-b3ae-183e9b0c4c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c0068d11-cf51-47a2-b859-74a369768981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_efef92c2-55a7-4606-b3ae-183e9b0c4c53" xlink:to="loc_us-gaap_RelatedPartyDomain_c0068d11-cf51-47a2-b859-74a369768981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonEmployeeDirectorsMember_29153db3-3270-474f-bae0-a1859c943625" xlink:href="ams-20201231.xsd#ams_NonEmployeeDirectorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c0068d11-cf51-47a2-b859-74a369768981" xlink:to="loc_ams_NonEmployeeDirectorsMember_29153db3-3270-474f-bae0-a1859c943625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NonEmployeeDirectorsAndCorporateSecretaryMember_2ed9e02e-529f-4171-baf2-22e1588c1393" xlink:href="ams-20201231.xsd#ams_NonEmployeeDirectorsAndCorporateSecretaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c0068d11-cf51-47a2-b859-74a369768981" xlink:to="loc_ams_NonEmployeeDirectorsAndCorporateSecretaryMember_2ed9e02e-529f-4171-baf2-22e1588c1393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_060bfc36-ea2f-4659-947b-948096c716aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:to="loc_srt_TitleOfIndividualAxis_060bfc36-ea2f-4659-947b-948096c716aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aec73033-ce2e-4e21-a2fd-c82e367663f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_060bfc36-ea2f-4659-947b-948096c716aa" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aec73033-ce2e-4e21-a2fd-c82e367663f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EmployeeMember_4d2facd3-0fbf-4496-ad92-f32135db703f" xlink:href="ams-20201231.xsd#ams_EmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aec73033-ce2e-4e21-a2fd-c82e367663f0" xlink:to="loc_ams_EmployeeMember_4d2facd3-0fbf-4496-ad92-f32135db703f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_a67c50db-196f-4a13-8ac1-c016a9f5fbf3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aec73033-ce2e-4e21-a2fd-c82e367663f0" xlink:to="loc_srt_ChiefExecutiveOfficerMember_a67c50db-196f-4a13-8ac1-c016a9f5fbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_SeniorVicePresidentMember_0b710bf0-a793-4712-b426-82bcaaa74de8" xlink:href="ams-20201231.xsd#ams_SeniorVicePresidentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aec73033-ce2e-4e21-a2fd-c82e367663f0" xlink:to="loc_ams_SeniorVicePresidentMember_0b710bf0-a793-4712-b426-82bcaaa74de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_aae66ebc-dfe2-4cdf-a6a4-118c669f34a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:to="loc_us-gaap_AwardTypeAxis_aae66ebc-dfe2-4cdf-a6a4-118c669f34a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0aa14135-123a-4228-8e60-c581032040c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_aae66ebc-dfe2-4cdf-a6a4-118c669f34a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0aa14135-123a-4228-8e60-c581032040c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_37b0a635-0762-44f7-bac1-a803fabcba36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0aa14135-123a-4228-8e60-c581032040c4" xlink:to="loc_us-gaap_RestrictedStockMember_37b0a635-0762-44f7-bac1-a803fabcba36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6b065365-7697-4b96-b10b-b3faeb255e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0aa14135-123a-4228-8e60-c581032040c4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6b065365-7697-4b96-b10b-b3faeb255e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_67a67826-9b9d-4e83-92c5-4ab655bea673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0aa14135-123a-4228-8e60-c581032040c4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_67a67826-9b9d-4e83-92c5-4ab655bea673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7191e5eb-901b-4d71-b153-5fc8c419e525" xlink:to="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1d72df0a-7ba1-45d1-9e82-11f4b00abf1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1d72df0a-7ba1-45d1-9e82-11f4b00abf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant_2476a300-fae1-458c-9519-76133b79fcae" xlink:href="ams-20201231.xsd#ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant_2476a300-fae1-458c-9519-76133b79fcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_58c36d89-da0c-4a6d-bb9d-729319f59ed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_58c36d89-da0c-4a6d-bb9d-729319f59ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_eb38c1aa-bd64-4c24-9642-9c2dbd57bf10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_eb38c1aa-bd64-4c24-9642-9c2dbd57bf10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d45edb3f-aa1f-4bd5-8d4d-324468997bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d45edb3f-aa1f-4bd5-8d4d-324468997bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_02ccb848-e8ef-48f5-bdd3-1a7868a155de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_02ccb848-e8ef-48f5-bdd3-1a7868a155de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfEmployees_dcf83fb1-ba1b-4124-9e0c-f187a3cd196b" xlink:href="ams-20201231.xsd#ams_NumberOfEmployees"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_ams_NumberOfEmployees_dcf83fb1-ba1b-4124-9e0c-f187a3cd196b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8b5ed5a4-a6a1-4339-b268-b472222ef04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8b5ed5a4-a6a1-4339-b268-b472222ef04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_75007d09-d1a2-4843-b343-6bba37236fbf" xlink:href="ams-20201231.xsd#ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_75007d09-d1a2-4843-b343-6bba37236fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_9d8919bf-580b-4b05-87da-1fa43f2975a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_9d8919bf-580b-4b05-87da-1fa43f2975a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_6a28a34f-867b-405e-a502-d66a6d1ebf16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_6a28a34f-867b-405e-a502-d66a6d1ebf16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_OffsettingTaxBenefit_31619ac6-d4fd-4b6f-90fa-5442c1e97443" xlink:href="ams-20201231.xsd#ams_OffsettingTaxBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_ams_OffsettingTaxBenefit_31619ac6-d4fd-4b6f-90fa-5442c1e97443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_68df0dc4-af73-489d-b608-e80b5552d591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_68df0dc4-af73-489d-b608-e80b5552d591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9ebabc7f-c2a8-4c5c-853f-f450bec29ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9ebabc7f-c2a8-4c5c-853f-f450bec29ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_34a91801-99a3-49a0-b917-d5326684dada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_34a91801-99a3-49a0-b917-d5326684dada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9ef46b8e-c244-480b-824b-26003fa68fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9ef46b8e-c244-480b-824b-26003fa68fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_02441046-f404-4b38-9ce8-d0ccfdb8f323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_02441046-f404-4b38-9ce8-d0ccfdb8f323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3cc50d7a-0f6c-4400-b0ab-8c8a498210f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3cc50d7a-0f6c-4400-b0ab-8c8a498210f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_36df5028-4e29-4ecc-b50f-179f91032006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_36df5028-4e29-4ecc-b50f-179f91032006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_18466512-e96d-40a9-a2c0-0d394e704ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_18466512-e96d-40a9-a2c0-0d394e704ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5079621b-c8c6-4ec2-bc7b-659d2d3b92b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5079621b-c8c6-4ec2-bc7b-659d2d3b92b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_403529fc-cc15-4a8c-b182-97d5954fa0c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_403529fc-cc15-4a8c-b182-97d5954fa0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_bbccfe63-5eff-4187-a3b3-d143ade80b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_bbccfe63-5eff-4187-a3b3-d143ade80b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_087ab8ed-9de1-4b2f-b159-1fe158d02c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_087ab8ed-9de1-4b2f-b159-1fe158d02c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_aaef88cc-a3d7-4a53-b67c-1b344f113203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acddb317-27f6-4212-ae43-7dadbde9ec4c" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_aaef88cc-a3d7-4a53-b67c-1b344f113203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1d1b3395-717f-4c3f-8b87-0590e30de92e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e4712c41-4980-4202-a04b-b37b6c5f85be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1d1b3395-717f-4c3f-8b87-0590e30de92e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e4712c41-4980-4202-a04b-b37b6c5f85be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e9a8ae53-1fcd-4703-a8df-5f0c14f26a42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e4712c41-4980-4202-a04b-b37b6c5f85be" xlink:to="loc_us-gaap_AwardTypeAxis_e9a8ae53-1fcd-4703-a8df-5f0c14f26a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c3383c2-7dd5-4764-8b64-fcd03a071a89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e9a8ae53-1fcd-4703-a8df-5f0c14f26a42" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c3383c2-7dd5-4764-8b64-fcd03a071a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d4008dbc-5839-42c8-a89d-8d7cc8c093b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c3383c2-7dd5-4764-8b64-fcd03a071a89" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d4008dbc-5839-42c8-a89d-8d7cc8c093b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44e4644d-1fb4-41af-b079-d4956bf6e26a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e4712c41-4980-4202-a04b-b37b6c5f85be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44e4644d-1fb4-41af-b079-d4956bf6e26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20184a91-0a90-4f8c-8b7c-1649940371a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44e4644d-1fb4-41af-b079-d4956bf6e26a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20184a91-0a90-4f8c-8b7c-1649940371a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_bf9d0f07-c2a2-4b68-a426-2049dc8adc56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20184a91-0a90-4f8c-8b7c-1649940371a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_bf9d0f07-c2a2-4b68-a426-2049dc8adc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_274bcce9-a5ad-481c-a3bd-461b89b814ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20184a91-0a90-4f8c-8b7c-1649940371a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_274bcce9-a5ad-481c-a3bd-461b89b814ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2baa4d27-2844-40bc-9944-d83e41362231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20184a91-0a90-4f8c-8b7c-1649940371a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2baa4d27-2844-40bc-9944-d83e41362231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_5765e7b9-572e-472b-95e5-28a190f79ece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20184a91-0a90-4f8c-8b7c-1649940371a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_5765e7b9-572e-472b-95e5-28a190f79ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_634a5f02-ce9a-49a1-98cb-ede6215886a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44e4644d-1fb4-41af-b079-d4956bf6e26a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_634a5f02-ce9a-49a1-98cb-ede6215886a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8e8c1196-279c-4964-8c42-1b27c6a19c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_634a5f02-ce9a-49a1-98cb-ede6215886a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8e8c1196-279c-4964-8c42-1b27c6a19c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6f0f2d33-b18a-4477-944b-6ac79ecb6ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_634a5f02-ce9a-49a1-98cb-ede6215886a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6f0f2d33-b18a-4477-944b-6ac79ecb6ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_240a842c-c84f-4fd9-9afe-f131fac6472e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_634a5f02-ce9a-49a1-98cb-ede6215886a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_240a842c-c84f-4fd9-9afe-f131fac6472e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_97174ec8-3645-4301-9cb9-f40bd87b39a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_634a5f02-ce9a-49a1-98cb-ede6215886a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_97174ec8-3645-4301-9cb9-f40bd87b39a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_7c81dd40-7a3e-40ef-8e85-5999f9c3710b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44e4644d-1fb4-41af-b079-d4956bf6e26a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_7c81dd40-7a3e-40ef-8e85-5999f9c3710b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_74bcae1b-5e5f-45e3-ad8c-223da39a51a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_7c81dd40-7a3e-40ef-8e85-5999f9c3710b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_74bcae1b-5e5f-45e3-ad8c-223da39a51a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_bcde8366-6789-4833-88d3-2f6712e00b43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_7c81dd40-7a3e-40ef-8e85-5999f9c3710b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_bcde8366-6789-4833-88d3-2f6712e00b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_b0308584-e6a7-4284-a4dd-69a79f6265a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_7c81dd40-7a3e-40ef-8e85-5999f9c3710b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_b0308584-e6a7-4284-a4dd-69a79f6265a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_5d92d06a-82ae-4c7d-9a9f-d738f0d4f72e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_7c81dd40-7a3e-40ef-8e85-5999f9c3710b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_5d92d06a-82ae-4c7d-9a9f-d738f0d4f72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e197171c-4252-44de-b8c0-808f81f43617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e45743be-c481-480b-b4fa-7a7691542e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e197171c-4252-44de-b8c0-808f81f43617" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e45743be-c481-480b-b4fa-7a7691542e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c99883a0-8f13-4820-b75d-b72560ada743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e45743be-c481-480b-b4fa-7a7691542e88" xlink:to="loc_us-gaap_AwardTypeAxis_c99883a0-8f13-4820-b75d-b72560ada743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd79f855-2705-4ac9-99ee-719b66f0095c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c99883a0-8f13-4820-b75d-b72560ada743" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd79f855-2705-4ac9-99ee-719b66f0095c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_606727df-66f5-4b41-954e-090e34fc2bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd79f855-2705-4ac9-99ee-719b66f0095c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_606727df-66f5-4b41-954e-090e34fc2bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_RSUsIssuedInLieuOfRetainerFeesMember_40610584-7f07-4a2c-8a8a-b3590e245c53" xlink:href="ams-20201231.xsd#ams_RSUsIssuedInLieuOfRetainerFeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd79f855-2705-4ac9-99ee-719b66f0095c" xlink:to="loc_ams_RSUsIssuedInLieuOfRetainerFeesMember_40610584-7f07-4a2c-8a8a-b3590e245c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AnnualRSUAwardsMember_eb255a51-0337-4096-8584-a1aa16e35501" xlink:href="ams-20201231.xsd#ams_AnnualRSUAwardsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd79f855-2705-4ac9-99ee-719b66f0095c" xlink:to="loc_ams_AnnualRSUAwardsMember_eb255a51-0337-4096-8584-a1aa16e35501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ExecutiveCompensationMember_d796946b-a78f-493c-96d9-99cf7dc30094" xlink:href="ams-20201231.xsd#ams_ExecutiveCompensationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd79f855-2705-4ac9-99ee-719b66f0095c" xlink:to="loc_ams_ExecutiveCompensationMember_d796946b-a78f-493c-96d9-99cf7dc30094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f867ccdd-e1ab-4a88-8a93-f6804093cecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e45743be-c481-480b-b4fa-7a7691542e88" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f867ccdd-e1ab-4a88-8a93-f6804093cecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a955f9d2-21e0-4c58-9294-1bb537501230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f867ccdd-e1ab-4a88-8a93-f6804093cecd" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a955f9d2-21e0-4c58-9294-1bb537501230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1db035c0-9558-4931-9d1f-d6e209882264" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f867ccdd-e1ab-4a88-8a93-f6804093cecd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1db035c0-9558-4931-9d1f-d6e209882264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_c434cabb-a34b-4114-aa6b-825a3ec752a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e5922cc-96b4-44ff-b7f7-ce68f74b5bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c434cabb-a34b-4114-aa6b-825a3ec752a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e5922cc-96b4-44ff-b7f7-ce68f74b5bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ce64acdd-4dc6-43a8-8555-943b8ee0a5dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e5922cc-96b4-44ff-b7f7-ce68f74b5bb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ce64acdd-4dc6-43a8-8555-943b8ee0a5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1d856e0c-8a6e-41a6-bdba-335f40968a3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e5922cc-96b4-44ff-b7f7-ce68f74b5bb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1d856e0c-8a6e-41a6-bdba-335f40968a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e71b881a-1efe-4eb2-adc9-a3b40442e1eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e5922cc-96b4-44ff-b7f7-ce68f74b5bb7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e71b881a-1efe-4eb2-adc9-a3b40442e1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1d5de241-c566-481a-b1ae-b41fd0d9e988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e5922cc-96b4-44ff-b7f7-ce68f74b5bb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1d5de241-c566-481a-b1ae-b41fd0d9e988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9684b4b7-094c-472f-a1af-676c7d47414d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e5922cc-96b4-44ff-b7f7-ce68f74b5bb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9684b4b7-094c-472f-a1af-676c7d47414d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1081620a-6258-4c50-9274-25e7e1390a91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c434cabb-a34b-4114-aa6b-825a3ec752a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1081620a-6258-4c50-9274-25e7e1390a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6aad7ef6-bd38-47a6-a2c2-7bb75716cea8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c434cabb-a34b-4114-aa6b-825a3ec752a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6aad7ef6-bd38-47a6-a2c2-7bb75716cea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3fe43f17-6bcf-41fb-8dec-5efbb1cf78db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6aad7ef6-bd38-47a6-a2c2-7bb75716cea8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3fe43f17-6bcf-41fb-8dec-5efbb1cf78db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ef2282f4-8fcf-4a95-9aa8-6170bf998970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6aad7ef6-bd38-47a6-a2c2-7bb75716cea8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ef2282f4-8fcf-4a95-9aa8-6170bf998970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3ad78904-e336-4bdf-9ca4-6aa237089ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6aad7ef6-bd38-47a6-a2c2-7bb75716cea8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3ad78904-e336-4bdf-9ca4-6aa237089ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_cf9d61a4-2ae3-4dcc-aec7-8f021cf8d3f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6aad7ef6-bd38-47a6-a2c2-7bb75716cea8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_cf9d61a4-2ae3-4dcc-aec7-8f021cf8d3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_535aee80-4cdb-4eda-8c71-abd76c0bc74b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6aad7ef6-bd38-47a6-a2c2-7bb75716cea8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_535aee80-4cdb-4eda-8c71-abd76c0bc74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f99b988a-4d36-4c06-b056-dfa6ce2899bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c434cabb-a34b-4114-aa6b-825a3ec752a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f99b988a-4d36-4c06-b056-dfa6ce2899bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b7d07060-23ef-40fb-bbba-fe1c7fe5efab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c434cabb-a34b-4114-aa6b-825a3ec752a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b7d07060-23ef-40fb-bbba-fe1c7fe5efab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_4ca0b086-879c-474b-b997-744f86f539a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b7d07060-23ef-40fb-bbba-fe1c7fe5efab" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_4ca0b086-879c-474b-b997-744f86f539a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_27b261ba-9ca0-4475-9c4f-8a61825f0949" xlink:href="ams-20201231.xsd#ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b7d07060-23ef-40fb-bbba-fe1c7fe5efab" xlink:to="loc_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_27b261ba-9ca0-4475-9c4f-8a61825f0949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3c667960-4b9c-4ca9-ad01-a421bb691e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c434cabb-a34b-4114-aa6b-825a3ec752a2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3c667960-4b9c-4ca9-ad01-a421bb691e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_3227d420-59bb-4a39-91d6-91caed3b1d91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c434cabb-a34b-4114-aa6b-825a3ec752a2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_3227d420-59bb-4a39-91d6-91caed3b1d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a391bfe1-d252-4631-924e-ce9deb5803ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_3227d420-59bb-4a39-91d6-91caed3b1d91" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a391bfe1-d252-4631-924e-ce9deb5803ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2855d02a-3e6c-403f-a38d-7ea519cede7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c434cabb-a34b-4114-aa6b-825a3ec752a2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2855d02a-3e6c-403f-a38d-7ea519cede7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_f95f753b-4d2d-48b4-a5d5-a588325191b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_26e41ff3-7993-4e71-8a95-53d16d553fde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f95f753b-4d2d-48b4-a5d5-a588325191b3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_26e41ff3-7993-4e71-8a95-53d16d553fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_39a5880c-ec78-4836-a189-bbec2d90b92a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_26e41ff3-7993-4e71-8a95-53d16d553fde" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_39a5880c-ec78-4836-a189-bbec2d90b92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c1732b82-cee6-4db4-b29a-05c5f88a8069" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_26e41ff3-7993-4e71-8a95-53d16d553fde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c1732b82-cee6-4db4-b29a-05c5f88a8069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_7a09971a-70b3-4d2b-a847-df8cce8d05d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_26e41ff3-7993-4e71-8a95-53d16d553fde" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_7a09971a-70b3-4d2b-a847-df8cce8d05d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_63f7f0cb-b142-473c-a16b-2eb9e0ad107d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_26e41ff3-7993-4e71-8a95-53d16d553fde" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_63f7f0cb-b142-473c-a16b-2eb9e0ad107d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_681c73e1-626b-4471-9e95-16cf8986ab41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f95f753b-4d2d-48b4-a5d5-a588325191b3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_681c73e1-626b-4471-9e95-16cf8986ab41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_f4dba2fe-43c3-4841-84c6-0bdd89817e74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_681c73e1-626b-4471-9e95-16cf8986ab41" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_f4dba2fe-43c3-4841-84c6-0bdd89817e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b551e732-242f-4309-a960-3c66abeb2877" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_681c73e1-626b-4471-9e95-16cf8986ab41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b551e732-242f-4309-a960-3c66abeb2877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_bb3cc101-6e69-46f3-b0d2-ec45899a2c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_681c73e1-626b-4471-9e95-16cf8986ab41" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_bb3cc101-6e69-46f3-b0d2-ec45899a2c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_11470ba1-95d7-4ff1-9be5-38a828d5dffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_681c73e1-626b-4471-9e95-16cf8986ab41" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_11470ba1-95d7-4ff1-9be5-38a828d5dffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_8f526463-a333-4259-b0f2-85e94ce3341d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f1def466-6a22-4789-8824-55940811b220" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8f526463-a333-4259-b0f2-85e94ce3341d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f1def466-6a22-4789-8824-55940811b220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate_e715f2d2-7019-4752-a182-abc880e86e7a" xlink:href="ams-20201231.xsd#ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8f526463-a333-4259-b0f2-85e94ce3341d" xlink:to="loc_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate_e715f2d2-7019-4752-a182-abc880e86e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b80e4a36-d09a-4395-86e6-fad9771e9974" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8f526463-a333-4259-b0f2-85e94ce3341d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b80e4a36-d09a-4395-86e6-fad9771e9974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b588dbdd-8999-4609-9c26-1fedfbf52528" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8f526463-a333-4259-b0f2-85e94ce3341d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b588dbdd-8999-4609-9c26-1fedfbf52528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ac62892c-aff6-4898-b331-4b894d0aa85b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8f526463-a333-4259-b0f2-85e94ce3341d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ac62892c-aff6-4898-b331-4b894d0aa85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/RETIREMENTPLAN" xlink:type="simple" xlink:href="ams-20201231.xsd#RETIREMENTPLAN"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/RETIREMENTPLAN" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4c49b99a-e80a-4253-8962-11dc31e0ea9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_94183286-a9c9-495a-91d1-d6489bf886dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4c49b99a-e80a-4253-8962-11dc31e0ea9c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_94183286-a9c9-495a-91d1-d6489bf886dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/RETIREMENTPLANDetailsTextual" xlink:type="simple" xlink:href="ams-20201231.xsd#RETIREMENTPLANDetailsTextual"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/RETIREMENTPLANDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_64d843c7-16c6-4754-a3cf-2eece7da4a64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_f9dfa490-b3da-4851-b25e-b88082518226" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_64d843c7-16c6-4754-a3cf-2eece7da4a64" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_f9dfa490-b3da-4851-b25e-b88082518226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_28ae5631-3f24-4d49-8779-d80b85b23b4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_64d843c7-16c6-4754-a3cf-2eece7da4a64" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_28ae5631-3f24-4d49-8779-d80b85b23b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/OPERATINGLEASES" xlink:type="simple" xlink:href="ams-20201231.xsd#OPERATINGLEASES"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/OPERATINGLEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_c04c6e4b-2549-4f78-873d-240225f57f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_38d81f41-8d16-4ae6-bb2e-6978d890edeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_c04c6e4b-2549-4f78-873d-240225f57f39" xlink:to="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_38d81f41-8d16-4ae6-bb2e-6978d890edeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/OPERATINGLEASESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#OPERATINGLEASESTables"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/OPERATINGLEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_d157dd56-1ff7-403e-8587-5c131139cbe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f5f08484-1b22-4369-a6db-95e54975e2cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_d157dd56-1ff7-403e-8587-5c131139cbe9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f5f08484-1b22-4369-a6db-95e54975e2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/OPERATINGLEASESDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#OPERATINGLEASESDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/OPERATINGLEASESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_8b43996b-9bb3-4a22-9ac2-d6757db41894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths_c6c432e3-aab2-47a0-b51d-c0fbcfc46c81" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_8b43996b-9bb3-4a22-9ac2-d6757db41894" xlink:to="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths_c6c432e3-aab2-47a0-b51d-c0fbcfc46c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo_3b6ff055-7f27-47b3-a640-b71f7e9d018f" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_8b43996b-9bb3-4a22-9ac2-d6757db41894" xlink:to="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo_3b6ff055-7f27-47b3-a640-b71f7e9d018f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree_b834cf0c-7fb2-4da7-bbb1-4e7084eab229" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_8b43996b-9bb3-4a22-9ac2-d6757db41894" xlink:to="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree_b834cf0c-7fb2-4da7-bbb1-4e7084eab229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour_d691b19c-f490-454d-960f-96ce8075c69e" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_8b43996b-9bb3-4a22-9ac2-d6757db41894" xlink:to="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour_d691b19c-f490-454d-960f-96ce8075c69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue_1f76fbae-1d24-4420-9e22-690c4e126371" xlink:href="ams-20201231.xsd#ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_8b43996b-9bb3-4a22-9ac2-d6757db41894" xlink:to="loc_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue_1f76fbae-1d24-4420-9e22-690c4e126371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#OPERATINGLEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_b68155b6-0f24-4964-ae4c-53f47c269e64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LeaseExpirationPeriod_4729dd9f-1b4e-4471-815b-2aa13ce4aea3" xlink:href="ams-20201231.xsd#ams_LeaseExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_b68155b6-0f24-4964-ae4c-53f47c269e64" xlink:to="loc_ams_LeaseExpirationPeriod_4729dd9f-1b4e-4471-815b-2aa13ce4aea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfLand_fc5ce546-0f5d-4e2c-9d41-5bb9905a821d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfLand"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_b68155b6-0f24-4964-ae4c-53f47c269e64" xlink:to="loc_us-gaap_AreaOfLand_fc5ce546-0f5d-4e2c-9d41-5bb9905a821d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_OperatingLeaseMonthlyLeaseExpense_f47e034f-aaf5-44a9-9f30-69eccc32f37a" xlink:href="ams-20201231.xsd#ams_OperatingLeaseMonthlyLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_b68155b6-0f24-4964-ae4c-53f47c269e64" xlink:to="loc_ams_OperatingLeaseMonthlyLeaseExpense_f47e034f-aaf5-44a9-9f30-69eccc32f37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_01cef58b-f820-4fa5-85ae-ac7255c0544b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_b68155b6-0f24-4964-ae4c-53f47c269e64" xlink:to="loc_us-gaap_OperatingLeaseExpense_01cef58b-f820-4fa5-85ae-ac7255c0544b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="ams-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4dc8a778-c61a-4aea-b345-088576524e52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7ee51d7b-ab22-4233-a12d-baa293e608fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4dc8a778-c61a-4aea-b345-088576524e52" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7ee51d7b-ab22-4233-a12d-baa293e608fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="simple" xlink:href="ams-20201231.xsd#COMMITMENTSANDCONTINGENCIESTables"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a2c46705-3128-4471-aeaa-ac5a219aafda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTextBlock_e28ec836-3a2a-4040-b6c8-24f72e29bfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a2c46705-3128-4471-aeaa-ac5a219aafda" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTextBlock_e28ec836-3a2a-4040-b6c8-24f72e29bfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#COMMITMENTSANDCONTINGENCIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_74154d96-e26a-45a0-956e-d4512b6ddaaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CommitmentsAndContingenciesTable_bbe43238-9104-478f-9ed5-a065db8c421d" xlink:href="ams-20201231.xsd#ams_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_74154d96-e26a-45a0-956e-d4512b6ddaaf" xlink:to="loc_ams_CommitmentsAndContingenciesTable_bbe43238-9104-478f-9ed5-a065db8c421d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e05646cb-f70c-486a-974d-bac4b7fa304f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesTable_bbe43238-9104-478f-9ed5-a065db8c421d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e05646cb-f70c-486a-974d-bac4b7fa304f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_69e98d27-c788-4540-ad81-64ec242eee41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e05646cb-f70c-486a-974d-bac4b7fa304f" xlink:to="loc_us-gaap_RelatedPartyDomain_69e98d27-c788-4540-ad81-64ec242eee41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MevionMedicalSystemsIncMember_bb284147-1b80-40e4-99b9-fc719ce0098b" xlink:href="ams-20201231.xsd#ams_MevionMedicalSystemsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_69e98d27-c788-4540-ad81-64ec242eee41" xlink:to="loc_ams_MevionMedicalSystemsIncMember_bb284147-1b80-40e4-99b9-fc719ce0098b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_98445979-5d40-437e-87c9-78b4b63c8644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesTable_bbe43238-9104-478f-9ed5-a065db8c421d" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_98445979-5d40-437e-87c9-78b4b63c8644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_84990e0e-9789-4eb8-84d3-8b8776892db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_98445979-5d40-437e-87c9-78b4b63c8644" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_84990e0e-9789-4eb8-84d3-8b8776892db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GammaKnifePerfexionSystemMember_46aefee6-27bf-4781-abc3-3b5447341dbe" xlink:href="ams-20201231.xsd#ams_GammaKnifePerfexionSystemMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_84990e0e-9789-4eb8-84d3-8b8776892db4" xlink:to="loc_ams_GammaKnifePerfexionSystemMember_46aefee6-27bf-4781-abc3-3b5447341dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LINACSystemMember_89c5bbff-7d87-41b1-b21a-32d17f28912a" xlink:href="ams-20201231.xsd#ams_LINACSystemMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_84990e0e-9789-4eb8-84d3-8b8776892db4" xlink:to="loc_ams_LINACSystemMember_89c5bbff-7d87-41b1-b21a-32d17f28912a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember_5a7f95f1-0022-41a5-b6df-de5567587de7" xlink:href="ams-20201231.xsd#ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_84990e0e-9789-4eb8-84d3-8b8776892db4" xlink:to="loc_ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember_5a7f95f1-0022-41a5-b6df-de5567587de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d08ca747-3b99-4d41-936a-a2955b7fa2c3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesTable_bbe43238-9104-478f-9ed5-a065db8c421d" xlink:to="loc_srt_RangeAxis_d08ca747-3b99-4d41-936a-a2955b7fa2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_05154926-d63c-4670-b017-d1bbe7a4bd82" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d08ca747-3b99-4d41-936a-a2955b7fa2c3" xlink:to="loc_srt_RangeMember_05154926-d63c-4670-b017-d1bbe7a4bd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_150d1f20-a5cc-42c1-8ad1-58d7dd98f115" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_05154926-d63c-4670-b017-d1bbe7a4bd82" xlink:to="loc_srt_MaximumMember_150d1f20-a5cc-42c1-8ad1-58d7dd98f115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9f39112e-c22f-4b1f-bef8-4a4b86aa7228" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_05154926-d63c-4670-b017-d1bbe7a4bd82" xlink:to="loc_srt_MinimumMember_9f39112e-c22f-4b1f-bef8-4a4b86aa7228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:href="ams-20201231.xsd#ams_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesTable_bbe43238-9104-478f-9ed5-a065db8c421d" xlink:to="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfCobalt60Reloads_7f65c3bd-2da9-48ac-9092-f9a256858a7e" xlink:href="ams-20201231.xsd#ams_NumberOfCobalt60Reloads"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_NumberOfCobalt60Reloads_7f65c3bd-2da9-48ac-9092-f9a256858a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfLeksellGammaKnifeIconSystemInstalls_b9b92cf6-b7c3-49c7-bf47-a278fcdb719c" xlink:href="ams-20201231.xsd#ams_NumberOfLeksellGammaKnifeIconSystemInstalls"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_NumberOfLeksellGammaKnifeIconSystemInstalls_b9b92cf6-b7c3-49c7-bf47-a278fcdb719c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfPurchaseCommitments_d9b7ce19-6398-4922-9050-56990cdd8668" xlink:href="ams-20201231.xsd#ams_NumberOfPurchaseCommitments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_NumberOfPurchaseCommitments_d9b7ce19-6398-4922-9050-56990cdd8668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_511ae672-d096-4ac5-959a-69d9ee68a40c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_511ae672-d096-4ac5-959a-69d9ee68a40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermPurchaseCommitmentRenewalTerm_1868a79f-c08e-429d-bf00-8c24c808c66f" xlink:href="ams-20201231.xsd#ams_LongTermPurchaseCommitmentRenewalTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_LongTermPurchaseCommitmentRenewalTerm_1868a79f-c08e-429d-bf00-8c24c808c66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_PurchaseAgreementAnnualPrepayment_d8a367c7-db2a-4f1e-a540-3de66fe343cc" xlink:href="ams-20201231.xsd#ams_PurchaseAgreementAnnualPrepayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_PurchaseAgreementAnnualPrepayment_d8a367c7-db2a-4f1e-a540-3de66fe343cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_1e693ee2-16e8-45d5-b006-b77004e50841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_us-gaap_LongtermPurchaseCommitmentPeriod_1e693ee2-16e8-45d5-b006-b77004e50841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermServiceCommitmentPeriod_b3d8fe35-230e-4d17-a0c2-22d886e6318b" xlink:href="ams-20201231.xsd#ams_LongTermServiceCommitmentPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_LongTermServiceCommitmentPeriod_b3d8fe35-230e-4d17-a0c2-22d886e6318b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_LongTermServiceCommitmentAmount_376d6ef8-1f6d-4187-9a90-2485085ab160" xlink:href="ams-20201231.xsd#ams_LongTermServiceCommitmentAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ams_CommitmentsAndContingenciesLineItems_253f2bfd-ce92-40ba-8908-8d885b5363dc" xlink:to="loc_ams_LongTermServiceCommitmentAmount_376d6ef8-1f6d-4187-9a90-2485085ab160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails" xlink:type="simple" xlink:href="ams-20201231.xsd#COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_200c2c73-2979-4db4-b505-64162fdac52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_b02f33ce-a755-4543-be23-d914505a6dd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_200c2c73-2979-4db4-b505-64162fdac52d" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_b02f33ce-a755-4543-be23-d914505a6dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_169938c3-ce58-4ab8-8dd5-6649126e89fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_b02f33ce-a755-4543-be23-d914505a6dd4" xlink:to="loc_us-gaap_OtherCommitmentsAxis_169938c3-ce58-4ab8-8dd5-6649126e89fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_169938c3-ce58-4ab8-8dd5-6649126e89fb" xlink:to="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_9e206e7c-57c0-4408-b9a6-f07f1e27d418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:to="loc_us-gaap_LongTermDebtMember_9e206e7c-57c0-4408-b9a6-f07f1e27d418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_FinanceLeasesMember_17aec406-1185-48c6-91c7-b94c38c8ab2b" xlink:href="ams-20201231.xsd#ams_FinanceLeasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:to="loc_ams_FinanceLeasesMember_17aec406-1185-48c6-91c7-b94c38c8ab2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_f466e62b-9680-4a75-b16f-78f7b38c1f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:to="loc_us-gaap_EquipmentMember_f466e62b-9680-4a75-b16f-78f7b38c1f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_EquipmentServiceContractsMember_194ec222-45e0-4e1f-b3aa-ed6967e9f429" xlink:href="ams-20201231.xsd#ams_EquipmentServiceContractsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:to="loc_ams_EquipmentServiceContractsMember_194ec222-45e0-4e1f-b3aa-ed6967e9f429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_AcquisitionWorkingCapitalPaymentsMember_4bd9c0f7-f4f3-41fb-a599-b5fb335918cb" xlink:href="ams-20201231.xsd#ams_AcquisitionWorkingCapitalPaymentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:to="loc_ams_AcquisitionWorkingCapitalPaymentsMember_4bd9c0f7-f4f3-41fb-a599-b5fb335918cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_OperatingLeasesMember_92cc434a-8cc4-40ed-b810-3360e2529e73" xlink:href="ams-20201231.xsd#ams_OperatingLeasesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2deac982-0fbb-4d04-b471-2b6752767e2f" xlink:to="loc_ams_OperatingLeasesMember_92cc434a-8cc4-40ed-b810-3360e2529e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_b02f33ce-a755-4543-be23-d914505a6dd4" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_552189c6-a78f-4209-9263-6a4eb45fb88a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:to="loc_us-gaap_ContractualObligation_552189c6-a78f-4209-9263-6a4eb45fb88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_40980952-163a-4d09-ab71-e9971e5a0612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:to="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_40980952-163a-4d09-ab71-e9971e5a0612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInSecondAndThirdYear_1ce6766d-b1e1-48cb-9346-41e70e447640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInSecondAndThirdYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:to="loc_us-gaap_ContractualObligationDueInSecondAndThirdYear_1ce6766d-b1e1-48cb-9346-41e70e447640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInFourthAndFifthYear_9afe0546-7bbd-420e-a44a-26e1b702b97d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInFourthAndFifthYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:to="loc_us-gaap_ContractualObligationDueInFourthAndFifthYear_9afe0546-7bbd-420e-a44a-26e1b702b97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueAfterFifthYear_44e25b9f-8271-4d40-bad4-21b0e1def1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueAfterFifthYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_623467a3-6489-4653-b599-8e6fe6d908ce" xlink:to="loc_us-gaap_ContractualObligationDueAfterFifthYear_44e25b9f-8271-4d40-bad4-21b0e1def1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="ams-20201231.xsd#RELATEDPARTYTRANSACTIONS"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_72a0ccb5-88c7-4183-aa83-3780e4cfe91e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_3175003c-1b19-449c-8329-8e2c8230ab2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_72a0ccb5-88c7-4183-aa83-3780e4cfe91e" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_3175003c-1b19-449c-8329-8e2c8230ab2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual" xlink:type="simple" xlink:href="ams-20201231.xsd#RELATEDPARTYTRANSACTIONSDetailsTextual"/>
  <link:presentationLink xlink:role="http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_ff799e62-16bb-4902-a7c7-69fe03711509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1d5fb7bd-7cf0-4e66-a70b-c94618d58577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_ff799e62-16bb-4902-a7c7-69fe03711509" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1d5fb7bd-7cf0-4e66-a70b-c94618d58577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_e91646ff-53f2-47b6-b40a-84b34ca91422" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1d5fb7bd-7cf0-4e66-a70b-c94618d58577" xlink:to="loc_srt_OwnershipAxis_e91646ff-53f2-47b6-b40a-84b34ca91422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b2dbeddd-998a-468c-9bd6-45e74b9e272e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_e91646ff-53f2-47b6-b40a-84b34ca91422" xlink:to="loc_srt_OwnershipDomain_b2dbeddd-998a-468c-9bd6-45e74b9e272e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_GkfSubsidiaryMember_a3acb346-42bc-403c-b38a-8904541f9960" xlink:href="ams-20201231.xsd#ams_GkfSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_b2dbeddd-998a-468c-9bd6-45e74b9e272e" xlink:to="loc_ams_GkfSubsidiaryMember_a3acb346-42bc-403c-b38a-8904541f9960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_UsSubsidiaryOfElektaMember_3de13fe0-8913-4195-905f-590cdc3f4cd0" xlink:href="ams-20201231.xsd#ams_UsSubsidiaryOfElektaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_b2dbeddd-998a-468c-9bd6-45e74b9e272e" xlink:to="loc_ams_UsSubsidiaryOfElektaMember_3de13fe0-8913-4195-905f-590cdc3f4cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_8496a681-6ac8-4fd9-a4f5-5513ead9af03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1d5fb7bd-7cf0-4e66-a70b-c94618d58577" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_8496a681-6ac8-4fd9-a4f5-5513ead9af03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_a65d525a-23aa-4979-ae53-ec3896ca95f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8496a681-6ac8-4fd9-a4f5-5513ead9af03" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_a65d525a-23aa-4979-ae53-ec3896ca95f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfCobalt60Reloads_8ddf9b5c-e422-4780-8a0d-eddd83f74543" xlink:href="ams-20201231.xsd#ams_NumberOfCobalt60Reloads"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8496a681-6ac8-4fd9-a4f5-5513ead9af03" xlink:to="loc_ams_NumberOfCobalt60Reloads_8ddf9b5c-e422-4780-8a0d-eddd83f74543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfPerfexionUpgrades_d257a3a9-62d9-4fb3-ab0e-8eb62d05f6a5" xlink:href="ams-20201231.xsd#ams_NumberOfPerfexionUpgrades"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8496a681-6ac8-4fd9-a4f5-5513ead9af03" xlink:to="loc_ams_NumberOfPerfexionUpgrades_d257a3a9-62d9-4fb3-ab0e-8eb62d05f6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ams_NumberOfLeksellGammaKnifeIconSystemInstalls_09d971ba-4a2b-4ba8-b786-c041263afde1" xlink:href="ams-20201231.xsd#ams_NumberOfLeksellGammaKnifeIconSystemInstalls"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_8496a681-6ac8-4fd9-a4f5-5513ead9af03" xlink:to="loc_ams_NumberOfLeksellGammaKnifeIconSystemInstalls_09d971ba-4a2b-4ba8-b786-c041263afde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ashsex1011dfullyexecuted001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ashsex1011dfullyexecuted001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!X# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !2#K2T@.: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "D%+1B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ****  G%%%% !1110 4444 %%%% !1110 4444 %
M)T-+1Q0 4444 %%%% !1110 4444 %%%% !1110 44@S2T %%%% !1110 44
M44 %%%% !1110 4F:6B@ HHHH **** "BBDYS0 M%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !11FB@ HHHH **** "BBB@ HHHH ****
M "D(YI:3N* %'2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3
M- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !BBBB@ HHHH **** "BBB@ HHHH ***
M* "D)I:0]10 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4F*6B
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HI",TM !1110 4444 %%%% !11
M10 4A[4M(>HH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBD% "T444 %%%% !112=Z %HH
MHH *0]J6D/:@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?$EMXYO?$UM<Z5ON@P\IQ)A?D50<C_=%:V@> XM/MM6FU"Y6YU35E<7-RL8
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MBLO2O$>CZW))'INHP73Q@%UC;) /0UJ4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4449H **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FD\@4ZFMV^M
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M7UX]W<:? \[@;G*\G'K3KSPUIE_;Q6UQ:1FVB&U(1Q'CTVC@T#N>6W,MS?\
MB'PII_B&2.#34B6:SF@7&YV7"JS$X!&.E>R331V]N\TKA(T4LS'H .]<_=>
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MXP"-H R>,4Z/PC:CP>GAJXGENK9(?)$LN X ^Z>!C(XQ]*0S@?'K"*W\&&/
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M **** "BBB@ HHHH **** "BBB@ Q1110 4444 %%%% !1110 4A'?O2T4
MHHHH *,"BB@ HQ110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 448HH **** "FMT'UIU(>E "T444 %%%%
M!1110 4444 %%%!&: .;N/&^B6]N\\DUSY:736F1:R'=*#@J/EYYX%1/X[TD
M7]G8HMT;JYN%@$4D#QE,C.X[@./I67\2O+AT_1HD98_,U>VPH.-Q\U2>/UIG
MC]&?Q)X1B2[DMO.O\,8T!+$#CD],9-,+G8ZOJ7]EZ<]V+>:YVLBF.%<L=S!<
MX]LY_"KJL"HSQGUKRJ*_UW_A']35-;N]VG:VEM#/(%,DB>8%(?C!'S=@*LZA
MJ5_I_BV[?4-5O[2Q-] EO-"%>WVE5S$XQE23GGG[PI >G52U+5;+2+=)[Z<0
MQO*D2D@G+,P51Q[D5;#9 Q7F'C!6\4ZO?V8T^\O+73K9TA\F/*_:V'!)R/N@
M@_6@#T34]3M=(TVXU"]D,=M;H7D<*6P![#FL>+QWH,C0[[BX@CF($<MQ:RQ1
ML3T^9E _6N8E\0GQ!\%=2NYD*7,-L]O<H5QMD3 /%7]3&G-\((_[89##_9J?
M,_\ ?V#;CWSB@#H-5\6:5HVH0V-X]U]HF0O$D-I++N ZX**1^%2:;XHTK57N
M([:>3S[<;I()87CD4=<[& ./PKB]#6[CN/A\+T;9Q9W D$ARWW%Q^E7O% MX
M_B3X3:V)74))91)MX#0!&SN(]]N,T :R_$#09(99DEO'AB<I)(MC,54@X.3M
MQQ5ZU\5:1=ZLNEQW+K=NADC22)D$BCJ5)&&Z]J\_\&QZ]<:+K TVZL?LW]L7
M(D2="7";^<-G'YBKWB;34\4>)-._LJYC2?\ LB2XL;I<[582QD8QV/3Z&F'4
M[*7Q1ID&JW.F.]R;NV@^T2(MM(P$?J"%P>_ YXJ@OQ#\.&S2\-Q=K:N-PG>Q
MF6,#.,EBN /K6!X0UF;Q!XFU.ZGA\BZ@TR.UNHLY"S+))G'J"""/K6GX06UG
M^%EG'>\VWV-A+N ^[SDC-(#;U/Q5I&D-9"[N7'VU@EN8XGD$A/3!4$5-J6OV
M&DSV<-Y),KWCB.'9 [AF]"5! _&O);*Y231O <@EE^S#69HX'E&2\>2$_3%>
MA>+'_P")MX80GKJJGKS_ *M^WXT :VF>)=*U>_N[&RN2]S:,5FC:-D(YQQD#
M(R.HIUWXATRQUBSTJXN=M[>9\F(*6)QZX''XUYFUR^BZS%XM?S5BCU*:QU$Y
MVKY)8A';U )7I5RRDN;OX@Z)JUW;;&U(W'D@G++ @7R\_BS'\10!ZIGBN;B\
M<Z',DSQ373QPL5D=;24JA!P03MQ71UYA;3^)YI_%:Z/9VDD4EUM4R2%61_+4
M'"XP>,&F%SMKCQ7HUM965TUWOCO5W6RQ1L[RC&<JH!)X]J=;>*-)N[6YGBN'
M M1NFC>)DD0>I0C=^E<GI$$"?%V]AEA2,V^FQK:QCHJ\9*CH.W2G^(T1?B-
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M;:XCVZQ)*I, !W1;QG/]X>V14OQ!BN5\?6>HV14W.GZ8UV(W) D5'8D9 ZT
M>KLZHI9F"J.22>E()HF;:LBEL9P#SBO+/'GB&+Q!X<%O8NRPK8?VG<G!QL!
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MU8:O)>164WF-9S&";Y2 KCJ.>OX5'-K^G1>($T-Y6%\\!N @C)&P=3NZ=NE
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MZC-)8WHBL;1)K1YS%<1@9.^+D9SDY'L*]?N%@,+?:1&8L?,) -N/QJ%K/3Y
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MKS;H/-VO&6!(.X=UZ8KH;_P/;7%ZT]A>W&FK+$L%Q%;'"2QCH,= <<9'-">
M[&UUW3-3L+B2T73[=K>.WC4;&4DDY[Y.>M [G,Z=XN\2W-EI6I&XM94FU/\
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MNDZ3X8L9],BCTR[@8"[609#*A?)7T(!K=T[Q;K-_?6DD>AA]*N_-\JXCD^=
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M+Z2TLKF>0K$WECYRYZK\P91T&0#TK%\06VAVNC0> +6._N=5A$4L!AC;,1+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=/C=+6$1AW:1^Y9B<DDGDUP<7B_Q%;:/J6IW]O8&&S>2U58)"S23B54!P5'
M!;ZU%:^-/$%M%=VMW:K+</<PV]A<7"?9Q,TC!2-@W<+G.<\T >AW=Y:V%I)=
MWEQ%;V\0W/+*P55'N3TIT%Q!=01SV\J2PRJ&CD0Y#@C(((ZBO/O$&IZ_I_@S
MQ-%KEM8W36EN);>XV?N[E2>5,?8K@9Z]15.WO=6G\9^$[2WO4M;*;2UNTMHX
M $0;0&3KR,=/3B@#U#:%Y_G5>TU"ROGF2TNH)V@?9*(W#&-O0XZ&N#TKQQJ,
MGBBTLKPVSK?S2Q?8XQ\]F$. 6<<.6].,5@V?B&]\/S^+7M8U5)/$!@-PT99+
M52"6D8#J!CU'7K0![&5 H( KEK75/$%YIEE)#'I\S->1I+/!+O1[?(S(!CY2
M1V[>]=5UH 3 Z4FP4_:.M&*0!BD*DTZB@!N,=:Q_$/AV+Q%90VTUU<6WE3I.
MKVY ;*G@<@\5M8HH :%P .M&,4ZB@! .*,#T%+10 TH#U%* !VI:* $(!&",
MBD" # &!Z4ZB@! ,4UD#=5!YSR*?10 W;Z@4ZBB@!,4F*=10 W:-V['/K2XX
MI:* &E:38N<[1G&,T^C% $4=O%"7,<2(7.YBJ@;CZGUI7A20@NBL0<C<,XJ2
MB@!C(K*5905/!!&0:3R5P0$4+Z8XJ2B@!I0$8(!'I04!&"!CT(IU% ##&N0Q
M5<CH<4UH(WR6C0[A@DJ#D5+10!$8D#JX1=PZ''-/QD<XIV** *D&F6-K*)+>
MRMHG&0&CB53SUY IW]GVGV@7 M8?.!R)/+&[/UJS10!3.EV)BEB-G;F.5M\B
MF,8=NN2.YJ06-IYS3?98?-9=C/Y8R5],^GM5BB@"G_9=B+=H%LK=8F(+((P%
M)'J*LQ1)#$L<:A44850, "GT4 8,WA]U\41:Y97"PR/'Y-W&RY$R=B.>&! Y
M],UML@="K#@C!%/HH IV^F65K;);06L20HVY4"\ YSG\ZD^Q6WGF?R(O-8%2
M^T9(/K^0JQBC% %"WT;3K-IVM[*",SC$FU -P]#[4RST+3;#'V:RBBPA0%1R
M%)R1GTK2HH%8R7\-Z1)I"Z4^GPFP4Y$)'R@YS3Y- TJ86HDL(&%HVZ ;>$/M
M6G10%C*3PWI$:1HMA"%CN#=(H'"RG^(>]:>WBG447"QE#PWHZWANUTZW$Y)8
MOM[GK3[_ $'3-4,1OK&&?R3^[WK]WZ5I44!8R7\-Z3)JO]J/81&]\C[/YW.?
M+_N]<8YJ!O".@-8VED=,A^S6<GFV\?.(VYY'/N:W:3% 6,8^%-#.LMJYTR Z
M@W6?!W'^E6=-T33](-P;"TCMS<2>9+LS\[>IS6C10%C.UNTO+S1KJVT^:."Y
MF3RUDD7<%SP3COQFN?\ ^$ LP=%4-&(], (/E?O'<-N+;L\9;DC'<UV-% 6&
M/&)$*,,J1@CVJG!H]A:PVD4%I$D=F2;=5'$?!''X$U?HH"QG/HNG2ZNFJO:1
MM?I$8%G(^8(>J_2LV+P+X9M]ABT2S4QN)$(CZ,.A%=%B@]*!E+3](L-+\\V-
MK';^?(99=@QO8]2?>D&C:>FJ-J:V<0OF3RS.%^8KZ9]*O#I2T 8]OX8T6TU%
MM1MM,M8KQB29UC&XYZ\^].MO#6C6=O=6]OIEK'#='=.BH,2'U/K6MBC% &&G
MA#P_'9W%HFCV:V]QCSHQ&,/@Y&?H0*MW^A:9JD$<%_8V]S%']Q)4#!?I6CBC
M% &1%X9T>&ZM;F+3X(Y;5#';E5QY2DDD+Z=34/\ PA^@_P!EMIATR!K-I?.,
M3#(+_P![Z\UNT4"L8TGA70Y=+&F/I=L;-<E8M@P">I'O[U/HVAZ=H%BMEI=I
M';6XYV(.I]3ZFM*C% 6,6;PKH\^OG6Y;-7OVB,+2%CRA&,$=.G%1Z+X/T70)
M3)I]IL;)*EY&?9GJ%R3M'TK>HHN%C(U_PWIGB:Q6SU6W,\".)% D9"&'?((/
M>J9\$:$SZBQM7SJ,"V]S^_?YT P!UXX]*Z/%&*!G*W/P[\,WBZ<MQ8&3^SXQ
M% 3,^=@Z*QS\PXZ'-=/#%'!"D42*D:*%55&  .@%/Q10 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %(>E+10 @Z4M%% !1110 4
M4G.:6@ HHHH  ,4444 %(W2EI#TH 6B@=** *]];R7=E-!%</;O(I59D +(?
M4 \?G7*#X?QCPW9Z0VLWIDLI_/M;P!%EB/8# QCD]1SFNSHH XR;P']JLM22
M[UN^N+W4$$,EXRH'6+O&J@;0#SG J<^"EFO+*>]U.XNDM;)[,PRQILD5Q@L1
MCK@#\JZO I<4"L<AI7@AM/FTLW.M7=[!I@/V6&5$4(2I4'*@$X4D<TEUX!L+
MAO$DAFE$NNILE? )B&S;\OX 5V%(1D4[A8Y;4?!<%[X%7PK#=206RQ1PB4*&
M8A2#D^_%59O @E?5C_:LW_$PT^.P9&B4A%0$!AZGD\>]=F!@4N!1<+'D'B&V
M@T36M)LK_4+FTM+'3/L=O>MIJW/G2$JH &Q@#MR/4UW/@Q]4?0I(]2<OY<K1
MVTYM_L[21 #!,>!L(.1C Z ]ZZ*2"*4#S(T?!R-RYP?6G@<4AG()X&0^'M2T
MB[U.XG2]N&N?.V*CQN6W9&/<5#<?#Y-2L)(=4UB\O+D1HMO=-A7MRIR&7'\6
M>IZFNVHQ0!Q%SX&O;_2-7M=0UZ>[N;Z%+=)Y(E40QJ<_*HXR>Y[X%27?@22:
M\TR[MM9GM9K'3S8!TB1BRG W9(.#QVKLZ,4 >?6WPUN+0:>EMXENXH[&1I(E
M6WCY9CDECC+$GUJ63P/J<<VH/9ZSY"W6IM?%3'N5U9&!B=3P5R1^5=Y@44 <
M9H_@RYT6W1;+4S;F6^%W<QQ0*(V&U5,:C'RKA>WK78@4OX4M !1110 4444
M%!HHH !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 F.:6BB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D;I2TC=*  =!2
MT@Z"EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M G%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 449HH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M($$#$DDI@;3SSTJ_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 !Z4@Z4M% !1110 444F>: %I&Z&EI"* $':G4@Z4M
M !1110 4444 %%%% !1110 4444 %%%% !12 YI: "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *@O(
M9)[.:&*3RI'0JK[<[21C.#UJ>@\T >;KX"\51,&M_&S1,.C+IT((XYY"]ZLK
MX-\6B,[O'$Q<GYG^QIDCTXKON]&T4 >=OX!\32HH/CFZ7!'W+50,>F,XQ5N'
MP'JHC(G\9:H\A8D%%55&?0<UW.*,4 <0W@?6%<-%XTU1,# W(C?S%56\$>*]
M[>5X\N@O\(:TC.#7H!%*!B@5CSE/ ?BI3)O\5VUPLBXD673(R'.<@G'7FK+>
M$O%?E&W36M(6T(Y@&F+L+=SC.*[ZB@9GZ):WMGI$%OJ$\,UQ'D%X8_+3&3M
M7M@8'X5H444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC#3X/# \00K-=61 /[A,L!G'(]CUJM;^-X9=3L[*?2M3M3=RF**2> JI;:6
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MA:O<W<\<$"8W22-A1DX'/U-2HP= RD$$9!'>@!U%5;C4+2T=$N+F*)G("JS
M$FK*L",@@CVH 6BBC- !1110 4444 %%%% !1110 449I"P4$D@ =2: %HIL
M<B2H'C=70]&4Y!IU !12,ZHI9V"J.I)P!2(ZR*&1@RGH0<@T .HHHH ****
M"BBFI(KYVL&P<'!Z&@!U%%% !1110 4444 %%%% !112;AZB@!:*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH 3K2BD[TM !1110 4444 %(:6B@ '2BBB@ HHZ4F1ZT +10#FB@
M HHHH *0TM% 'E'B^Y7PQX^>[83/!KMC]BVJORQR%E4'W."3^%5?!5C<2W=G
MX.O&<?\ "-71GF ^594.&A.>YR22*]1U'1['59+1KV$2&TG%Q!DD;7 (!]^"
M:2UT>PLM1O-0@@"W5Z5:>3)); P/IP.U '(7$6NS>.=>_L.ZM8)!%9^8;B,N
M",29Q[UDZ6\S>&OB(+DPO<+),DDD/"N1;CH.WO7?6GAW3;'6[K5[>*1;V[ $
MSF9V#8Z?*3@?@*HKX&\/K#J42VDBQZDY>Z1;B0"1B<D\-Q^':@# \-R:QI&@
M:/J6H:WIXT)+-?-C^R^6RY VX()S6%XEGUFT\8^,;K1;>*>;^S;96&-T@4_>
M*KT/&>XKNT\"Z L<<1MIY8(\;89KJ5XQCI\K,1^E6[/PII-CKL^M002+?SY\
MR0SNVX>F"<8]!VIB.'U'^SK'X,9T2026TJ99W.69S][..^>WM74P/K>EWT-Q
MK.K:?+I1B"G]P8Y!*2 N.3G.32/\._#4EM+;?9;@02RF9XENY50OG.=H;'6I
M_P#A!M$::*66.[G,3^8BSWLLBJV,9 9B,\TAG"^.X[CQ5K-_:QZ/JUY!IT!6
MSEM2HC^U$9R23R "!]<UNBXLO&_PQA_M&]CMIG58Y)PO^IN <=/7/\ZZW2=#
ML=#M)+:QCD2%W,A5Y6?YCU.6)Q_]>LZV\#:!;Z7=Z;%:RBTNVW2QFX<_-G.1
MD\'/<4P,+0=3U2R\70Z)XHBBFN8H9)-/U&(;5DC  ;<">N.:]!#AE!!R#T(K
MEKSP9I2VMU(MI->7+VK6R^=<NS;#U4,3Q]>M:GAK2Y=%T&VL)YS-)$N-Q)./
M8$\D#WH$<%+JNK3^&M2\3IK,T=Q:7\\:6V[$ CCD*[63N2%Z^]0ZGK.M#_A+
M+U=9GC73(HY[>!   3DX/7*\5VLO@70I;B64VLH$LXN)(EN'$;R=<E =ISCG
MCFI)O!FAS#5E>S8KJRJMX/-8;P.F.?E_#%(9HZ1<S7>BV5S.4,TL".^P?+D@
M$XK@?#USXBO#KDVC1V"QR:R?,^T,3\@5 ^,>PXKT6UM(;2SBM805AB0(@+$D
M #'4\UGZ+X:TWP\+A=,BDB6XD,LBM,S@L>I )./PH X+5O$>NW^JZU'HL<T
MT@JL1,@CB!4?.9%Y+*>U5[2/5[WQ=XJFTS4HK&80VL\C^7N5G,(.-V>%SU'?
M-=W?>"]%U+5)=2N()OM4RA)72X= ZCH" 0"/:H[GP1I$]Y<W*)+";N(0W*1R
ML$EC P%QG X[CF@#E%O?$WB.[T.&UU[^SQJ.D-<R-';@[75D!*\\9W5:FO\
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M+6NE7:SI((V\THO1>F.A(H L-X@ATS6O$TW]E6XOX9[6V62-_FN6E"B/=GH
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M0\0:7<P0:9<H8;E+K#1!%5T0+T.\_P#H6*]'\.G5#HT(U>VAM[E!LV0R%AM
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MHH **** "BBB@ HHHH ***#0 44"B@!,\TM)CFEH **09I: "BBB@ I#2T4
M(#2TT=*,4 8_BOQ#!X6\.W.K7",ZQ8547^)V.%'YD5A)IOB%M/CU6\\1BVU)
MTR+<8^R+D$A2IP6/OFKWQ!\/W'B;P?<Z=:,%N2R2QD_WD8-C]*Y;Q'K?]M>!
M[K1[_1+M=;,8C6V^S/(BRC !$@&T=^<TP.GN_&^GZ%8V UN>+[=/%O>.TS(H
MQ]Y@?[H]:FU/QWH&DR0QW5ZOF30?:$5!N)3C!P/7->>ZA:ZI9Q1Z)-I<MG;C
M17$9L;8.9YBN71G R@W<XSS4/A2&Y36M"NKFQO$2W\/R1S;K=^#N("].OM2
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MR5TDCD(7+,J\X..WI79>!K*UL='G%A87-I9R7#O$MT[-))GJY#<C)R<4 5]
MUW6;_P :ZWI5W-9FTTXJ%$<+*[[U!!)+$<9]*GT_Q+*->\00:C=VT=CIQBVO
ML*%=^?O$DYZ5B6FHIX;^(WB*;5DEAM[_ ,EK6586<2;4 (RH/IWK&\0&:^\)
M^.]<6UECM;Q(4M@Z%3((S@MM/(R3WI >FVFO:7J,\MM9ZA!-/&@=D1LD*>A^
ME<KI'C"UT?2X/[9U^TU"6[OI(8+F#[NT'OZ8Z&L6QC2U^(OA-88#%&VA,6"Q
MD#=C/)_QK$\.R6]AX0T"_N/,%O!X@D9V$9;Y6W]ADXSCI3 ]NBD2:))8V#(P
MRK#H15*]UW3-.O(;2\O[>"XG_P!7&[8+54TOQ1IVKZK>:9;-(+BU56*R1E-R
MD=1D=.U>=^/KM'UG6[=(WCE^RVY95MVE>Y4/D@$ [ /;K0!Z;=^(=)L+Z&RN
MK^"*YF*B.-FY8DX _$U<N;N"T@:>XE2*)1EG=@ *\EOM6MSXB:XTTO>1RW5J
M9=.N+)E#$*H1XWVY&W@X..E=7\1[J.U\-1//8"ZC-U&I5@2(^?OD '.*0'1Q
M>(-)FTQM2CU"W:R4D&?>-H(]341\4Z$L,LS:M9B*)E1W,HPI;H#]:\EUJY2Y
MT#QHAN7NQ(;1E/V1HE?!4,0N/PK3O+71AKNKEUMXHX=!B+A[?<OF MDD8Y(!
M'YT[ >GWVLZ?IMLMQ>7L,$+\J[MP?I3Y-5L881-)>0+&4WAC( "OK]*\CM]1
M73'\/7.L3E-+ET9;>*>.+<MO+\I;S![XP*GLHM!E\3^&[*-3);3VUU(D=XGS
M-DD@\_PD[B!VH ]5&L:>=-74?MD'V-@&6?>-I!Z<U@Z%XBNM4\3:Y:O+;-IU
MEY?DRQ \[E!.6SCC/I7F&@7HM] \/7FH".708]5N6O-@RL4A.(]P_NC)]N15
MV\9[J[\8G1;=WT\S6C,+:-E9HQM\X#CD%<G Z_C0!Z[9:SI^H6K7-G>0SPH2
MKR(V0I'7-9.FZ_-J'BR[L8Y;2:P6U$T,D));.[:0QSCKFO.+^6RGTF^O]!EN
M;\E(X]3N$MS%%Y(;)&SN_J1FNH\*W%C-\1=6_LUX6LS8PB 0QX55X.,]_6@5
MSI+O79;'Q3%87,EM'8R6DDXD<X;*L@Y.<8^:M9-4LI+B*W2ZA:6:/S8T#9+)
M_>'J*XOQ%_8]SX\MH-9CA-I'ITP)N!\NXLO"D]\9KGELIM"\/:;XHC61H])O
M)51#%\_V%G(V_@#NR: N>NK,C.R*ZLR_> /(^M8>I:[.OB&ST73H5FN7Q-=.
MWW88,X)_WB> /QJ'P?I,MG8W&H7FTZAJ<QN9RJXVY^ZOT Q5+P\^/&_BB.=D
M^T[H6P!_!L '/^>: +ESJFM66FW]\]O:WBVUPQ2*V<[FA 'U^?.>*W+"]AU'
M3[>^MFWP7$:R1MZJ1D5QW@>2RCT;Q EJT9A2^G8%&SP5')_'-6/AH;F/X:Z.
MUVAW"WW( <DID[?TQ0,ZN.^MIIGACGC>1.&16!(J5Y$C4L[JJ^K' KQW1=0T
MM/$>BWEM]FM5EO+J-HXR6D+=_,;J6)Z+V&*['Q]=V]DFC3ZEC^QQ?#[82A92
M/+<+N _AW;?QQ2 ZYKRV6 S-<1"(=7WC:/QH^TP"(2>=%Y9. V\8_.O'=6?2
M(;*"/1WF3PR^I>??7)@\R",[5PH#?P@C)[<FL_5H-+7P^T5IJKWFGS:_:AY#
M%Y-N"P?<L>.W3..^*8'LHU_33K"Z6+E#=/#YR@'@KG'7USVJY]KBE1_(EBD=
M0> XZCU]*\R_LGP_X;\=?84M85BCTQKBW1SN=YO-)RI/5AV]JSO#-S96NNV+
M1R:= M[I-PB+%)N<E2IS(>I? )([8- 'J.FWEP+"-M4DM8KDEMPCD!7 8XP3
M[8K1CD29 \;JZGHRG(->,6<>E78\$PWLEJZF>^WKO!##YBJGVSZUVWPSDMV\
M/7:6SQ^4E],$2-]P1<\ >@]J -KQ1XA3PUHDU^T)GD7Y8H0<&1CT%7K#4(=2
MTRWOX74PS1B0-GL17%ZG/<>)_&20Z4^GS1:*"9A<Y8-)(,8P#V7G/K7.6>L7
M%AX-\5>%X[HMJNDE_*$#99HCM)*+UP 3],T@.VG\6E_&^DZ/8M:W%I=0RR2S
M12AF4J.!@=O>IM=\3C3]5TJSM)[&5I[Q;>YB,W[U0PXPHS^.<=J\\DU#1/\
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M<YH&7+JTAO+.:TN$$D$T9CD0_P 2D8(_*L8>"M ^PP6?V$"&!BT061@4R "
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M]L%MM-M8[_4%M;&X>Y6+SS\[-CJ>N!SCZFMM[Y]*\/B\U>2+S(+<-<-$,*S
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M6S^TQ:U_:$AW';Y9)) XZ\T ;VH^.[S3;^7SM%*6$5XEH9GGQ(Q;&&5,<C+
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M(&&&"C(STI /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3 Q@#&ZD![+8:E9ZE"TUE<Q7$:L4+1L" 1U%97B=O$?V:,>'FLHG 9Y9;K)
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M=2+)EI5RX&6X]!S5UDUB+1-8O6\07\ATG4#%;IOP6 *9\P_Q Y_#\:0'K&T
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M=1M"&4,[' 3DTAGHQQ2!1NS7GB>+/$K7ES#'I@$2Z>;A;BXMI(XTF5<LA/\
M$#@XQW]JET_Q1XEGU'2H+B'2UCU6Q:: HLF8Y NX!AGD4P.^PCCL1WK,U7Q'
MI&B2Q1ZC?16S2XV!\]SCD@<#/<US/PLN[_4O#EQJ%]>BY:XNY&''*D,01_\
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MH&<OX@\+7FJZU9ZI9:C';S6T;Q[)X/.0ANX7(P?>K/A'0KOPWX=@TJZOA>F
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MP8, 0081VKO8(3!;QQ;V<HH7>W5L#J:YS0?"=SHWB+4]7EUA[MM18-+$;=4
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MO--U:T@MYHH(KJ,P2[QLD+  G Y!0UA_$G1;.W\'>)-3BB O+R.$2S'T5U
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MY\NK2QQR21G:BD@(&8#" XXSCH:[&]\;:%IUU/#<74@^SLB32I [QQEC@!G
M*C\37EA\/:V_@#5;%] N_M+ZZEPD109DA,F<@Y^N?3-7I-"U'3M8U^SN_!KZ
MS%J5U]IAG$V(@#T#?3@_G0!Z1XJU"^L_#\EWI<,UQ+\O%NH=]AZLH/4@<USR
M:SKU_J>IQ&/4=-A&FK-:O);HR;AR23C[W;::[:RB,-C!$T:(R1JI1/NJ0.@]
MJ@UN1X=#O7CMY9W\E@L<*[F8D8X%(#G_ (;:GJ6M^#;35M3O#<3W>7QY:J$
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M 4444 %%%% !1110 A&:6BB@!".:6BB@!,4HXHHH 0"@KDYI:* $Q2]!110
MG6C%+BB@!.U(!FG44 %(!2T4 4=1T>PU9(5U"TAN1!()HA*NX(XZ,/?DU=4!
M5  P!Z4M% !1110 A&: N.E+10 @7!ZTM%% !1110 F*6BB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH 0=32T@ZFEH 3%'0TM% !28I:* $Q2 <TZB@!,4A QBG44
M)@ 4F:<>E(* #%&T4M% "8HQ2T4 )BE(S110 F*-H-+10 F*"H)SBEHH 3;2
M.@="I) (QD'FG44 8T7AG3(-%_LD1,UJS;I-[9:5LY)8]R3U]:U8XDAB6.-0
ML: *J@8  [5)10 S:/0>E*$ Z ?E3J* $VBEHHH *3/-+10 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %% .:* "BBB@ HHHH ****
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M#*&>4 +(&SAEYSC@UK[J %HJAJNH2Z=9B>"PGOGWJOE08W8/?D@8%70V1G%
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MD!Z$BK] !1103B@ HJG%JMA/J4^G17D#WL"AI;=9 9$!Z$KU .15R@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** <T4 %%%%
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M4M2L=8EM9[RQCM5Q&K;"F</S]>GO0*YUN:*JZ?#/;Z?;0W,YGGCB5))2,;V
MP3CW-6J0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M!.]+110 4444 %%%% !12"EH **** &C[QIU)_%2T %%%% !1110 4444 %(
M*6B@ HHHH 04M%% !1110 4444 %%%% !28YI:* "BBB@ I*6B@ HZ444 )W
MI:** $ Q2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 F.:6
MBB@ IIIU&,T (*6BB@ HHHH **** "DI:* $I:** $(I:** "BBB@ HHHH *
M*** "DI:* "D(I:* $ I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0[S2M*B:"]N98)DDN,%60-P#CT4G\,59_P"$_E/AF]U@:.[&RO#;3PI.#M4
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M9((O,A^9'))V  9P,'!- ':T5F:-KECKD4SV3N?)D\N5'4JR-@'!!Z<$5IT
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M#N(_&HK_ .'UQJ<9FN=6Q?R7\%[+(L(*XC!Q&!GIR>:[E9%X7@$] 3S3MP!
M/7TH P=)T&?3?$VM:HUPKQ:B8V$87&PJNW^0J'7?#5S>ZW8ZUIEZMI?6H96#
M)E9T./E<]<<5T%Q=06UO)<32I'#$I9W8X"@=<FLN[UR6+4-)AL].FO;6_+;[
MN$YC@4#(9O8T <[J/@6]NM%OK2/4\W6H7!N;F>3/WAS&%'8*0H^@KM;5)$M8
M4F</*J*KL.A(')_.I-Z[MN[YL9Q[4%U7 ) R<#GO2 \\U'X=:C<0>(;2UUE(
M[/59?.$+P!L.?O;CUQZ8J[+X$DN_$4-Y=W4;V7]C?V9/ @(9C_>![5W/:C-
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MB:7]CM[[SHM6=(FF:+?O(V]F/W0>W6K=EH_B"RLM%A_L;)MM6FNYL7*\1EF
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M7S6Z$@,6#="QP5]O>I$TC4=2EM]=TGPU8WT%W;);M;WN"+9HQM#(?XE(Y]Z
M.VO/%UE>6D":;9W.J"ZM_/9;=?\ 5Q'(R23P<@C'L:H_"%BW@2/=*\A6YF4L
M[;NC=CZ53BTCQ;X?U=+JV@MM36\LO(N$C(B6&122F!VC^;''/%-\*OKGA&U\
M.Z%<:?;;+R:;S@)?WD0ZJ<=#WR?I0!TOC'Q!=>'K*UFMK-[CSYUA8HNXIN(
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MH *0C-+10 F*",TM% !1110 A&:4=*** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_FP>7% P!*!&/WP0#GKVJ/3?$'B#^Q_"263Z9 =76;<K6[!4(W.-H4C P,4
M>GYI))$B1G=@JJ,DGH!7,^!]=NM=T.62]"_:;:YDMI&7HY7'S#\_TK'T[Q;J
M6H>*VTB=[&(QW<\4UI.C)*\(+>7)&2<-D 9^M ':Z9J=IK%A'?6,HEMI<['
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M$7#_ &F(@J4"Y&&R1Q76>#H-0@M=2.H6#6;SZA-/'&SJQVNV1RI(KI2 1TH
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MW_Q+F36KJ&PL4GM[.YCMI8R6\V5F/)0!2./<CI7I$;;HU;!&1G![4 .HHHH
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M^U:1-#)/%OE7%V3%N V]L>I[U<\37-QX)\%V]OH=N[(KI"K2RY:$$YSSU]*
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MSD<DGITKD]<\-Z_?30G3]&%E?0V]M%;:G#=A3$ !O61<_, <CW%>I[12D>U
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MK7;#1?AKHE[<NYA%O%%F-"QW'"XQ]:[0'(S2;%V[=HQZ8XIU !1110 4444
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MSKNJ^(/#<USJLZ272S&,.D84 ;5/0=>M</#IFMV%[IMX^F7,L,NC/8N@B+M
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MYK[QO%XAG2WOQ 4LX6G9=T7E?*5&<')Q^)H ]2TC44U;2+34$4HMS$LH1CR
M1G%7<CUKQ'0M6BMM?T4WVI%+&3PV!NDF*JTF3GI@9&/K3-,N%U!/!44MW/<)
M+I=VTRI=.-\B!<;B#R1TH ]QR*PO$_B)_#=A'=_V=->(TBQD1.JE2>!]XCO7
MF5A)-%_P@EW#-<I-=7\\<Y>Y8AD5R I!.#QQ7;?$^XCB\(E'<HTMS"BE>N2X
MZ>_>@#7TW7=0N]4:SOM N[!=A9)GD21&QVRA.#]:V4FCE!,<BN 2"5.<$=17
M$>([?5O#/A#7+NUU6XO)7/FB2X*AX%P =N  <8X&*PY[:VL/%6G#PT\ITZZT
MNYENQ%,[*5VY5SDGYMV/?F@#U;(]:,\]:\1\/:T/[)^&\,VH,US)/,)D,Q+,
M&9E7=Z\^M;7PR:QM?":^)]2OI8GB>X@FEFN&,97S0 2#T(P!^)H ]5JO>W)M
M+&:X6,RF-"VQ3RV.U8GBW6[.Q\&7>I232_99(@J2VYPQ\S"J5/;[PY[5R.@2
MRZ=KNJ::<I!+H\5T8S=&3RG/F#DG[Q( R1@<=* .G3QGYD.@31Z;(\.L8"NL
MJGR6*EL-ZXQVKJL@=Z\LL8XK70?AQ@HB&<%LMNY:!_ZXK=\;ZF\&L^'=+E,B
MZ=J-T8KHH=N1CY5+=@30(ZZ]O(;&QGNYWVQ0HSL>O &36+HWB6YU.^:"XT:Z
MLH?(%Q'<2,&1U).!D< XP<'D9K@=9B%G;^+]#+SR:-:6\4UN99-WDR,,^6IZ
MD'KR>,5U\-G9:;\.)3!;;HI+ .\8<MO/E@'G/\J!EV]\7VMMK6B:?#']JCU8
MN([F*12B[5W9]\X[5T0<;=Q(QZYKQ+2M.LY=,^'D4*^0+ER9I()?F)\M\CVS
MC!^N*JV/B&ZA(T>>^,.C#7;BV>28&18HHPI1"<C"EB>] 'O!88R"*KVU]:WD
M32V]S%-&K%2R," 1P17)>"]EQ#K%D=:;5+<38C98RB0HR_ZM#DY ^M>?::L&
MDZ'9P07WV:*_U>XM[R60EPD4<C;4P", X - 'NP((R""/6C<"< BO&]>OKK2
M],&G6'B6[G UV"!C%^[:)&#9B5\G(&/3BM<:-]G^("Z.OB'68[4:89VS>G<6
M$IYSV !_6@#TZC(]:\=T.^U..+P7J3Z]J,_V^ZDM[F.6X#H_+8!'J M:NDWN
MHKXWM+>^N[Y89+NZ-K+'/O@O(_G.UU/*E. /]V@#TSCUI<CUKR7QWKTK:AKH
MTC5[Q9]/L5$B1W!BBMY,L<XS\[$=L8XZU&+_ %'5M9NTFU?48MGAV*^6.VN6
MB"R[ 2<#U)H ]<9@JEO3FLGPYXAM_$NE_;[:*:*/S7CV3+M8%3CI7F6A:O?Z
M]J/AS2=0U>ZABFT4WA,5P8Y99=[*,OGG@=*Z;X42?:_ KYDDR]W."Q?+\MUS
MZT =_D>M&1ZUXU+J&L:9H<.N0:SJ-Q=1:V]@+:60NDL?G%<;3U;'>D^W:U"/
M%OB"/6M1D;2=0F6*S=V:$Q[6 7;G& 2&_P" XH ]FI":\JGGU"PU/PM';:SJ
M5Q;^(HRMVK7#.8SL#;XC_P L^6[>@JGX?OM6O+]O!UQJVI/J%AJ[233F9EEE
MLP"0VX_P[MHP/6@#U&PU4W]U<P?8;RW$!QYD\859/]TYYHU;5DTE;4M;7-Q]
MHG6 "!-Q4G/)]!QUKSS5+O6WU?Q3::;=W4LD-Q:".W:YV?(P4N$8D;203TJ(
MZK<C0-+;3K_6 TGB%;:6.[E)FC4CYHR23D#KS0!ZQD8ZTN1ZUY*]WJ-_H/B/
MQ$OB*:&^T^\F6")9F6*)8NB-'G:Q8#N.]0W=]J]S;:[?R:KJ-KY>FVVH10K+
MM\F1MV0,'[OR_=/!SS0!Z_GWI:\@O-;U"6/3M5U34[ZVLI[6V<7-BW%I*0&8
M31CJ'Z D=Z]<A<20HZMN#*"#C&10 ^BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN>*YZ/XC6Q@G<V+NUK<117(AGC=84D^ZY8-@CL<4 =&/#VD*+8+IMJ!:NTD
M$8_=LW4CT)JU=Z=9Z@D:WEK%.L;!T$B!MK#N,UA:SXUL=%&H--%(\=G#&YD0
M@JSN2%3.>#P#SV(K+;XEVD.E:E>263RFP\OS$MYXY P?@$$' Y['GIZT =RR
MJR%64$$8(-4[+1].TTRM964%N93F3RD"[C[URFI>/[BUM-7C_L::"_L;5;I8
MIY$VO&<C?D'D#'(ZUN^#[Z]U/PEIEYJ,;)=2VZ-(6(RY(!W8'3/7% %F'P_I
M%LZ/!IEI&\;,Z%8E!5F^\1QQFJEWX;TY_#MQHEK;6UI:3@@H(04&XY)V\#/O
MZU4U/QBUG+J*VFDW5^FFC_2WB95V';NP WWC@CIZUSWB/6WUK6/#UM9VUW<Z
M?>(UU#]GN4B^T$#!!R00!NY'?\* .\ATNT32(]+>)9K1(5@V2C<&4# !SUX%
M4D\(^'HPP70[ !HO);$"\Q]=O3I[5)I-G%X>T$0^9<-'$&D/GOYCKDEMN>^,
MX'TK*T[QNE]?1V\FE7=LD\$D]M))@B94^]P.G4=?6@#37PIX?C2V1=%L%2U;
M? ! N(FSG*\<<U=O],L=6MOL]_:0W4&0WES(&&1T.#7(:;\2H-0&E3R:3=6U
MCJ4S00W4K#;O ) QUP<<&KT/CF%M#UK4)[&6";29&26T9U,C8 (/MG/&: -=
M?#>C+ISZ>-+LQ9R-N>#R5V,?4CO5RVT^UL[-;.VMHHK91@1(@"@>F/QJ6.1V
M@61T\MBN2I.=OXUR:_$*R_M+3X)+29+74;B2VM+HD8DD0[2-O4#(/- &I%X/
M\/V\]M-;:19P/;2>9$8853#>O J1O"VAFRN+,Z7:>1<2^=,AB&'?.=Q]3[U@
M#XE6)GMY5L;EM,N;G[+%?@?(TF<=.N,\9IT_Q)TVWO+N">PU&.*UNQ:S7#6Y
M"(QQ@Y]\_ES0*QU-G86FG6XM[&UAMXLYVQ(%&?7BLJ3P9X>DM[Z!]*MFCOI/
M,G!C'+=>/3GGZD^M<1KEROB#QO>6-];:E##8V,QA:&5D4D$,)"5/?&!GUIVB
M3VK?#OPQ%J$VJL+B^ 2>)LL'\UBOF-SP>E,9WO\ PB^AFW@M_P"S+7RH)/-C
M7RAP_P#>^OO3W\.Z5)J,U^]G&]S,I5Y&&200 1^0K(NOB#I-E<RQS6]^(HKL
M6;7 MR8O-)QC=[=_K1X7\5W&O:OJ]K-I\L4=G=F&*41G:5"J>6SUR3^&*!%^
M'P?H-N]J\&FP(;21Y8-J@>6S8W$>G04^P\*:/IE^U[;V@$Y=G4L2P1F)+%0?
MNYR<X]:FUG7+?1((&ECEEEN9A!!%$NYG<@D#]*Q3\0M,72GO)+6^WQ3_ &:>
MWC@+212=@RYZ'L>] S1U'P;X?U:\EN[W3()9I8_+=BOWAU'X\GFG+X4T9)9)
M4M LDMK]D9@Q!,73;^E6-%UN'7+%[J*VN[=5D*%+J(QOD>WI7+2ZOH^D^)/$
M&MN=9:XM(8HKJWV;H]I.%9%[GN3GI2 VYO WA^:SL+5M/4)8 "V=6(>, YP&
M'./:K^D:%I_AZQ>UTNV$,3.TGE@]6/7K6;9^.-,NKFYAECNK,P68OF>ZBV*T
M)_C!R<CBH-/\?Z9J%X]N;74+5EMFNE:YM]BO&N,E3GW% %/PMX,B@\R^U>P9
M+];VXEB!N3(JJ[L58+G:IP>PS70Z;X9TK2UOEM;;"W[F2Y5V+B1CUR":S=*\
M=Z9JM[':"WO;66:V^U0"ZAV">/KE.3FJVD_$K1]8?3/(MK](M2D:*VGE@VHS
MKG*DYX/!_*@#7TGPGHVAW!GLK39)C"%G+^6/1,D[1[#%7(M'L8M8GU6.W07T
M\:Q23=RJYP/UK$C\=Z9/JD5AY%ZB3RO!#=^3^Y>1>JA@>N>.1UK,\-^*-+@\
M/OJ%K=:UJ8N+QH(HKHJ\S2+G*H.!C )Z]J ->3P'X>FDO'DLF+WDBRS-YS[B
MRMN4@YXP?2GGP/H+6<5J;1C'%<?:ES*Y/F_WR<Y)K)D^(0FOM)2ST?498KL2
MF53"!(A0E=H!;J"I)'IS5^#Q_H\^I):*)U64/Y,[*/+E9>JJ0<EOPH L77@?
MP_>:A)>SZ<K2R2"610Y".PQ@LH.">.XJ67PAHD]QJ4\EGN?4HQ%='S&PZCH,
M9X_"LC3_ (GZ!J=[96L(ND-V2(WDAP@;.-I.>I]LU?D\<Z1#J_\ 9[M* 93
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M ?[->E#I7,:9IGASP':I$LZVQNY5C,US,6>>3L,D]?85TXZ4@%HHHH ****
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M10 U(TC1410JJ  HZ "EP*6B@!,"D -.HH 3:*3'/2G44 -QUXZTN!2T8YH
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M$9IIAC*A?+4J.@QQ4E% $8B3*_(OR]..E#0QL&!12&^\,=?K4E% #1&@((4
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M6XM,TY[+3KF2&1!,XD*H>3R,=*Z#6/%\UKX1L]?L+5)8KA4?;*Q!56''3J:
M.LHKFK;5/$ U2RCO+&T:PN8V9IK<N3$0H(W9]<XJI:>*-6UC[3>:1IT,FE6[
ME5DF9A)<[<[M@'3D8&>M '845Q5YXXF>RT*?3+.-VU2<VY2Y<H89!P01U.&R
M#6YHM]J\]U=V^JVD$30E=DD!8H^1D]?2@#9HJ.>>.VA>:9UCB12S.QP% ZDF
MN8NO%LK7>@RZ9';W&EZE*8Y+AW*LAP2N%]PK=?2@#JZ*:)$,>_<NW&<YXI59
M7&58$>H- "T4TN%R20 *1I%7&YU&>F30 ^BD) ')%9LFKQS17RZ=MNKJT^5H
M0<?/C(&3Q0!IT52TRYN;G3+>>^MQ;7+H#)"'#!&/;(ZU<W#('K0 M%8WBC7?
M^$;T"XU0P&<0E%\L'&=SA1^K5J02F:".0C&]0V/3(H EHHR/6DR/4<T +131
M(K,5#*2.P-#NJ#+, />@!U%,$T9Q^\3GISUI=Z_-\P^7KSTH =130ZE=P8$>
MN: P/0C'K0 ZBFR2+'&\C'"J"2?0"H[6ZBO;:.X@=9(95#HXZ$'I0!-13)',
M<3N%+%5)"CJ?:L[0-:37M,^VI!) !-+"8Y,;@R.4/ZJ: -2BN=\1>,++P]IK
M7A5KL)<K;.D!!*.>Q].H_.MNXG,%M+,(WDV*6V(,LV.P% $]%9VAZH^L:1!?
MR6<]FTH;,$Z[73#$<C\,_C6C0 45G7&MV%MJUMI<MRBWER&:.+N0/Y?UK0)P
M* %HK+T;7;/7H;B6R+E;>XDMI-Z%<.AP>OO2Z3K=MJ\VH10;@]C<M;2AACYA
M@\?G0!IT444 %%9<.N6\WB&?1=LBW,5NMP2R$*RDXX/?FM2@ HHHH **PM8\
M6:=HFI6^GW*W3W5Q&TD<<%NTI('!^Z*FTCQ'I^MS7,%J\BW%L0)H9HS&Z9 (
M)4\XYH UZ*!10 444A- "T5S^M>,=*T*=XKLW#>4JO.\,+.L"L<*9"/N@]L^
MAJ#2?'FC:SK,6F6GVDRRK(T4C0,L<@0D-ANAY!_*@#IZ**1F51EB!DX&?6@!
M:*SH-9M+G6;G2XF8W-M&LDGR_* Q('/KQ6C0 4444 %%%% !11FL5?%FAOJB
MZ:NHPF[:9H%CYYD')4'&,B@#:HJM>7UO86D]U=2K%!!&997/\*CDD_D:33[^
MVU.QAO;.99K:= \<B]&4]Z +5%%(3B@!:*IV&IVFIK*]G.DR0RM#(5_A=>H_
M"KE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !2#I2T@Z4 +156[U"SL
MK7EU#;JY(4RN%!.,]_8&H[+5].U-G6POK>Y* %A#(&QGZ4 7J*0&C(]: %HH
MS29% !WKD/B>Q'@#40JEG;RPH )/WU[5UK,J@L2  ,DGM4<-Q!>0)-!*DT3C
M*NC!@: /.;W4+*>\\#VT4DLL4I /RG:P"%2&&/7C\*KV&AZEX<\>Z5I; 2:#
M]HFN+%P/]2S1G,?L.I KU+:N1P*4@9S0!!?VD5_83VDR*\<J%&5NAR*\*GTO
M6$\(WFKW2%KWPW=):Z<(E(WQHP5AZX/'/M7OAYHVJ 1@8/:@#SKQ#:0Z+\)K
MJ$AQ+<H7QMSF:4EMI'IEL5H:#J5E#\*;:=YU\J+3_*=RI&&"[2,8SUXKL6,?
MF",NI?J%)Y_*G&-<!=HQZ4Q(X+X7:A;1?#"U>5U06J2>> I&S!)Z?0BN?TWP
MY-J7@71?$>A3F#7-.C<H2I G4.Q,;CCC!XKUX1Q[2NT 'J*%557   ]J!GCE
MSJEK-\)EN-0F>"2^U5G($91U)N-SX'.,*&/X5M1ZEX2MO$]CJ=CJEQ>WSJMC
M';K*S(%89W$$?K7H[01.%W1J0IR,CI35MX4Y6)%/J%%(#Q+4KW16MCXK\-W1
ML?$!V23Z;&6Q([-M*D8 SUYQ70:^VCZUJ][(]\^@>(M-50EQ"V6E'EJY!&/F
M4%L?A7IX@0'/EI^0H,$;-N9%)]2*8C.\/7%Y=>'--GU!=MW);(TPZ?,5&:\Z
MUO2;E_B+<:%&^^RUDPWTB9V*BQ<.N!UW #T_&O6<8[4;%)W8&[IFD,\U^&]E
M?IO_ +41431$?3K=U/##<#)GUP54 _6J/@VPBU:;7KP:[=V:QZG*^VUD"*4S
M@,00?>O54A5%90HP221CKGK4,>F6<(D$=M&GF##X7&X4P/%=+GAB^"_B**>X
M)ENK^6)2S;BS,5QT'< FNMTJ\T2RU;3KJWUZ\U.ZGC2WBM#+N5%8C+  <8![
M^E=L^A:5) ;=[" Q%@Y0H,;AT-+#HFFVQ;R+&"/<NUMJ8R/2C01X?IECJ%]X
M7U6ZLIQ=1V.JS27.E<>7<1D\,<<D]>_.*[+Q9K>E:S\-;>72;OR89I8XH%5A
M&5(894@CC !_*N^L-#TO2S*;#3[>V,V/,\J,+NQGK^9_.JX\)Z!N=CH]F6<Y
M8F(')H Y9[.STZZ9CXAO+ZYU&!;"")I!(58#)8!<=B"34O@SQ%IVF>#([:_E
MCL[C2\V]S%(<,&7OCWZUT]IX:T6PO%N[32K2&X4$"5(P& /7FI)M TJXU#[?
M-I]O)=@ ><R MQTYH \C^QW<3^&Y9KAX8M1\0W%Q =N&BC8Y4C/3/WOQKTK3
MTM?".E2'4]7:1);EY#<7;\Y8\#TK4O\ 1--U3R3?6,%P8&W1>8N=A]15;Q#H
M?]NZ;]B,B1(6!8F,/QW ST/O0!7\9%9O NMX^=7L)L8YSE#C%<!96^F7?A3P
M3IS-'(9KR.2XC5B"?W<@)//':O68;9(;5+?&Z-4"8;G( QS6:GA/P_&\3IH]
MD'B),;>4,KGKBD,\A2^G@TEK1;XV^E0^))())&1I$C12"BL00=I;@\UV_P /
M8+:WU?7Q!K4>HF1XI&C@B988,[L*A)/XUUL/A_2+>UGM(M-MDMYW,DL8C&UV
M/4D>M6K.PM=/MEM[2!((EX"1K@"@#RK5[.TOO%OCE;]Y0MO8I+ VYOW;>5R5
M /)K%U6>8^%R]Z)%U*'0X3)//<E2"6?:J1CG>0#\Q/&!7H<7@E9O'NJZWJ5M
M:75I<1Q?9U<;FC=!R<$8KH[C0=*O;K[5=Z?;37'E^5YCQ@G9Z?2@#S*.RMM8
M\3>$[:]FN&6[TCSKB..Y*K*R@ ;N<G'I^-/AL-/M8/&<2E()X0\4:K,P9$*J
M6[_[0YKT>#PUHEM=V]W!I=K'<6Z[89%C 9!C& >W%++X<T:::\FDTRU:6]3R
M[ES&,RKZ-ZBF(\=8S7=U86FH:K!96?\ 8J&UDO8W9&+!=[*0Z_,#ZU?O Z:'
M;7CWTFKVD.F[+DK,UO<1HLAVSH"3GI]3@5ZE-X=T>XM[>WFTRUDAM@! C1@B
M/'3'I3;_ ,+Z%JMREQ?Z5:W$R*%5Y$R0!VH&<U\0YHKKX574L)=HI4MF4L<,
M5,L?7WQ6-?QV6DOK\1NKFWM7T&WF<13,TJMND!9<GK@ ?@*])OM*L-3LC97M
MI%/;'&8I%RO!R./P%5G\,Z)(\SOI5HS31^5*3&#O3IM/M0!YGH.EF?Q)J?AJ
M61([6YTE7^SI=F;;)N7#,>I;J<C&>>*G\/WVJ:_9"1HS)<>'+:>$,(\+-=@,
MJC&[H%V'\:]'L/#FBZ7.)[#2K2VF"E=\405L'J,CZ"K<%C:VAE-M;11&9]\I
M10-[8 R?4X H \<\+?V:-1\-W<6M;M3D8QRVMI:8>0'.?.8MT'KBNJ^(=]]B
MOM$6\NXK33Y;@[I9(O.3>!E=Z<#&<8.>#7:6VCZ;9W#7%MI]K#.PP9(XE5B/
M3(%2W5C:7T7E7=K#<1_W)D#C\C0!X_<Z;H]SX;DCL+]KK4SJ9.F/'$(5:7*L
MR(N3E,+D\XJ&?4H;?PN)(;P*LNJE?$<TWSF&3<!C;GF//&/[M>OKH^FQ/ \>
MG6BM;DF$K"H,>>NWCC/M33H.DLLZMI=F1<',P\A<2'.?FXYYYYH#4\NN8-,T
MRW>S;Q )M-EU*V6\CM8O)BB5E<XR">&(4'Z"I?$4%OH?A#7K72]<E98KRWEC
MVG:MGYCJ=H;ICG/MFO23X>TC[!-8+IEHEI,<R0I"JJY]2 *@G\)Z'-HMQI T
MRVCLK@ 211QA0V.AX[C Y]J!'G_BHRI+XHMX[R>6$:.MXD8E^7S6)!/&.P%,
MEBO?[0TKP[$\UQ:Q:.DX@-X+4N^X@L>O3CC/%=Y'X*T&.6>1=-B#3VPM9, ?
M-'_B>,GOBLZ3X9>&)+"TM#:2@6@81RB4B0J>H+=2.3Q0%SG-,N=3UW5]*\.Z
MMJ3;K6QDN+F6UF 6XD+($4D==N3TZFNG\ K)'X:GCED,C)?72LY^\W[ULL?4
MDDG\:M:CX(T+48M/C>U,(T_(MS =A0'J,CMQ6AHNA66@V7V2P0I&7+DN<EF/
M4DT!<\;U*U&F^$?$*0W,S9\1A0TC;FP0@Y'KR:ZVSNM3TSQAXDTX:E>W%M#I
MC7,?VA@=LAQRIQ]:WKWX>:#J$EX\J7*F\G%Q,(YBH9QT/Z5</@[3'U6XU-OM
M1NKBW^S2L9VPT>,8Q^OUH"YYY'J6MW7@KPQJ=]=ZA+:K!+/?7%FZB6-@3MD(
M_B &>!7J>A2F7P_8RM>B]W0*3=;=OF\?>QVS6(/AWH<=I96]O]LMA9PF".2"
MY9':,G)5B.HR>AKH/[,MAI7]FQH8K81>4%C.TJN,<&D,\D\0W$US=7GB^UL+
MZ:6ROHS;S%,1BUA(,@/?[WF"NWU"_DU_5]'L=.U2:UL[JTDO3<6I 9]I4*H)
M!X._/_ :UXO#%A#X8?P\#<-8O$\3;Y27*MG/S=<\FL]? &D+;V$227R'3PXM
M94NF$D:MU4-UQQTH X31;JZ@MK;1+*]EL_[0U^[AGO"0)OW9W$@XP6?![?Q4
MRVN-0TY]?L-+FD%U/K26;7,L@1Y/E9BWF8(#'&,[?PYKM_\ A6N@?98X,7I,
M=TUVDOVI_,65@,L&ZCI3G^''AZ73;JPGAN9XKJX%S*TMPS.9 , [LYH YC4K
MCQ1I^GW%@^K);W,E[;?93YWVB6.-W"L7;"@J2#@8JWJ&J:OX<L_$UJFIRW4D
M)MOLT]P-S1&8[2.W ZBM]OA_HK:1/IV+LQS2I,TIN&,NY,;<.3G QTJSJ'@S
M2]5FU"6[^T/]OA2"9!,0I52"IQZ\=:8KG&WEI=:%K>NK_:EW>WD?AQ[BWNIG
M&^,@D8!'^T-P^OM52TU_64B\ W!U*=VU&SG-X)#\LC*@*D^ASWKLK3X?:3;3
M32M/J,[S6C6;^==NP\IL_* 3QUXJ*S^&VC63V#B6_F-BK+;B:Z=ECW#!P"<#
M@]* .-MM:\0?V9X;U)M=E:34-1>U9&3]V$9R.G\1'\)XP/6NO\%W]^_B3Q/I
M-W>27<-A<QF"27E@'4DKGT&.*MKX#TA;#2;)3<>3I=R+J >:<E\YY/<9[5IZ
M9X=LM*UG4]4M_,^T:DZO/N<D94$# [=:0SE?%KW4?Q)\//8PQS7?V:?RHY7V
M(Q[@L 2.,GI1J%_K]CI4'VU+2RU6_P!2CM&N(%W*L)88()QD\G%;^M^$XM9U
MW3]7^W7-O<6(Q&(2 #DY.?J./H:N>(= M/$>F?8;T/L$BRJT;;65U.0130F<
M+XC\3:]H5UXCT])T=+>P6^LK@KEU.]59&&>1\XYXI=9\3ZW::PEO#. K^&I;
M[[O'GA3@_3(%=%'X!L'M-234+BXOKK48O(GNI6PY08P!C@8P.GI52#X:6$4<
MAEU#49[A[![ 3RS9*HX() Z XQ^5 7-#P9/JVI:';:KJ.I1W*7ENCI$EN(_*
M..?FS\WY"N8N?%'B&[U76+C1;62ZBL;J*&.)F6.((HS+O)/WB>AQ7>Z'I*:)
MHUKIL<TDR6Z!%>3&XC\*YW4/AOH]YK;ZAYMW!'.0UU:0S%8;EAT+KW]_6@+F
M/!INI_\ "1^*G_MDLRVD;2K);AE965RJCGC;@C/?-9N@:CJMM\/?#5M;W$\T
M^JAMCP0H)H5"ERJ[B Q.#R2.#7=0^%FBU+5;P:K<D:C&(WBV)M11D#'&> 2.
M:RT^&FGCPQ8Z(VHZ@R6$IEM+@2!98<CH" ..O6@+F)'KWB=AI'A^ZN!97E[>
M2QBYF13*;>-<C*JQ&\_6JWB^7Q%;KX=M-0U6!Y'UA;?_ $9.O\2.X]0-N5Z=
MZZAOAOI3Z)#I_P!IO?.AG:X6^,F9_,;J=WOZ4/\ #72CI5O:K<WPN8+I;Q;Y
MIM\QF5=H8EL@\<8QBD,BNM0\0PW_ (DL+6Z@GN[>QBGM&: +M9MX(;GD?+69
M+XWU$Z+'JT%PDD%MI8DNQ'$#FZD $:]>!DYKK+/PPMGXCNM:>_NIY;BW6W,,
MFWRPHYZ =<YZ^II+3PAIEII.IZ;'%^XU%Y'FPJC&_/ P,8&>* ,;PWJ?BLZ]
M!;ZM;E["YM]XFD$49C<#)"A&)<<CD],4>-/$%_I>I1PVVK16$0M)).+4W#O(
M"-HVCH,9R?<5H>'_  -9:%=QW)N;J[F@#);M<2%O*0C! _ #\JDUGP<FK:L=
M074[RSD>V:V<6^SYD;&1\RG'2@#DM8\9ZQ!%IDCWPTVWO-*CG6[-GYL1N3U1
MC@[1TKM/$NNR:-X,OM:M5BN'@M_-3YL*YX[^G-8K?#G]Q]E37M3^S/:"TE1V
M1MR D@@%< XXSC-=$_AW3I/#)\/&%O[/,'D;-W.WZ^M CE8=1\3VUQ86U_>Q
M2QZO9L4GCB4-:S["V% X88[FE^&=E)<:"MW=O'/&MU+)")$!=9,D%RW7=U'X
MUIZ/X(_LZ:![O5KW4!:Q&&T28H%A4C&1M49;'&36CX9\-0>%M,>PMKFXF@,A
MD7SV!*D]<8 H&<=JKZB/$_B=A?-)'!IRN+<QC#+\Q"=/7//O5;PUJ^NZ-:^%
M8I)+>;2[ZV*^4(]K184L#^F*ZK5/!KZCK-Y?Q:O=V@N[;R)(XMN#UP>0>F:;
M!X'2%/#RM?32?V/N #=)05(YQWYH$<_X<\8>)=4U:TNI-.GDTN[)7(\I8X@6
M(4ACAF. ,CW.*ZSQ!J5ZNIZ=HNG2+#<WHDD-PPR(T3&<#NQR,?C69I7P]BTR
M[\O^T[N71XI?.MM-8CRXWSNR3C<<'D<UJ^(/#3:Q>6.H6UY):7]D6\F1>1AA
MR".XZ?E0,XG0]8U'3/#UQ$MS:)<'7+B"\NIL XY.Z)?XVS@ <_2F6?B'7M:T
M[1;EKX)';ZZEI/A"CW"$C86'&#SR.E;R_#ITMK91K-PUQ%J1U!I9$!^<@@A1
MVZTT?#N>TL9[?3M8DC+:E'J$;3QB3:RG)!Z9S3%<H7GCG7#K%PFFZ<T\-M>+
M9O%]FD;.& >3>!M[\#/3.:],'2N$E^'<W]MO=VVN75O8W4XN+ZSC48GD'.0?
MX1GM7=J,*!Z4ABT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%%  3BCJ***  #%%%% !1110 'I31R*<>E(
MHXH \W\2:;=ZC\5-(B+VCPBPG81S1%EV'"MD9Y.2,'TS5:TN[OPOHGB9]+TO
M2H)-+G";88V42#8K%C\V?XAQ76W_ (8N[OQ7:Z[%JK0M;QF%8?)!!C)!8$^Y
M K*F\ WL]EK-M)XBN"-48-(3 O&#_5=J_P# :8BGJOBOQ-HK6,.IV]C:+=2,
M/MX#20K@9", <J3_ 'LXXI;36?$5]XXTNW;4+)+6>R^U-!;J9$8!MK?/GG.,
M@]JW=;\-:CJRVXAUR6UV6[P3*L(9)@P&25/':J=EX CTRZTF33]1F@BT^W6W
M\L*,R*'+D$]@23Q2 L>)/$5]HFO:/ $A33[T2Q27$HX24+NC!.> <-6#H?C[
M4M7M]*LXULY=4EU!K>[V!A&L2G<77GG,?(]R*[#Q'X<MO$FD'3[H +YBR*Q&
M2K ]1^&1^-06?A.VT[6=1U6TD,5S>11Q#Y<K$$4*N!]!3 Y;P_XI\5>(K6YO
M38::VEQ27,,@W$2,4X4=?KFJEEK&M)!X.T_14L=/M[R L8_+9DR$8[<9SMXS
MUS[UU.B^#I="\,WVD6VILTMU+)+]H:$?(S]?ESBJ*?#ZYM]/T2.TUN6*]T@D
M0W#PA@R$$;2N?0XS0!B:;X]U>#3=0U:\:"^@;4&L+>VMH&$GG# P.?N\$XZ^
M]:,_CG6].L;YKO1G9[=XA%<O&T$4P=@H&&)(()YYJ=OAK&=,U+3?[1)M+J<7
M4(:(%K>?@F16SZ@\=LU'<_#O4K[3KN.]\33W%].4"W;PC,2*P<*JY_O#-(#<
MT+Q!J%YKMYI.JV$5I<0PI<)Y4WF!D8D=?7(JAXC\=2>'M5NK>;3\6T%L)UF>
M4+YQ[J@]16CIWAR\M/%-UK-SJ2W(GMDMQ'Y 5E"\YW9YR23T[UEZ[X$O=5UC
M4KZUUQK--0MDMI8OLX?"J"/E)/&<TP,>?5FD^*.GW5MIKW-Q=:&)H4^T; F2
MQ(.>"2"!FM;3/B"VK2Z=:1Z//;W]Y//$897&(EBQO8GOU''O3&\"ZM!?:?J%
MGK\<=[:V(L6D>R#AD!."!N&#S2M\.OLUOIDVF:DT&JV,DDGVJ6/S!(TF/,RA
M(ZD#OQB@8EU\1FM;;6&?1+@W6E3!9K82#<8FQB7/9><^U7[_ ,;P:=/?>;:$
MVMG9QW+SK*,,SD[4 [G@\U/I/A-;8:I-JLT5_>:G\MS,(?+#(%"A<9/&*J6/
MP]T^S\$R>&_,8HY9C<*,,')R&'TX% BQI_C![S4]/L7TBXC%VC-YZL'CC9?X
M6([UU&*X[3_".M0+%]M\2S73VT;K;,(0FUBI4,V#\V,UTVEV]W:Z;!!?78N[
ME%P\X39O/KCM2&7**** "D[TM% !1110 8H(S110 4444 %%%% !1110 444
M4 %(3BEHH .HHZ444 %%%%  1FBBB@ HHHH **** "BBB@ HHHH **** "DQ
M2YHH 3%&*6B@!,<4M%% !1110 48HHH ,4444 % &*** $QBEHHH 3%+110
M4444 %)BEHH 3%!&:6B@!HHQS3J* "BBB@ (S2  4M% !1110 4F*6B@ I,4
MM% "8I<444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% .:* "BBD Q
M0 IZ4@Z4M YH *3%+10 @H[TM% !1110 A'/M2T44 %(:6B@ HHHH **** #
M%%%% !2&EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M64UJ;!+=FBE+.\A;>S'CU)'7I5W2O EAI.O:M=VZJECJ$ C:U7H#D[C[#I3
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MBJF%)(SM7&#(S@'*@#(Z]<"H+OQ/J=QXOG\.V-W8V4]O;K(7O(2?/)Z[ &'
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M-\P'J: -&B@44 %%%% !28%+10 F*,"EHH 3 HI:* &XI< TM% "8%&!2T4
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M?TS6Z#FD,7-%)TI10 44A.*RF\2:2NJQ:;]MB:[D8J(UY((&<''2@#6HH%%
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MQ?'GAQ^/[1"G'\4;KCZY'% &QJ.G6FK6AM+V!9H"P8HW3(.1^HJOK&KVVAV
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MA5Z95!U-6;?P3=V<OG6FK6T,O]]-*A!HUCP=JNN:<]A>^*)FM9,!XUL8ANH
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MC^'[W:I9O EHR 6^JZQ"P.=WV^5_YM7">&=4U:V\*Z>D-[<-=ZMJ4JR.Q!*
M;BQ4XP"2.^:UKC6/%FGZ0D-\\C^7?/%/<60$TT< 4,K.,8W<\X%(9O'P-+M
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MXXQ]:TM+\3:9JU[?6UI.C_9"@:0,-K;AG@^U &E8P26MG!!+,\\D:!6E?JY
MZGZU9JK9ZE9:A$TMG<Q3QHQ5FC;(!'446U_:WPD:UGCF$;F-RC9VL.H/O2 M
M45S%]XMBTWQC8Z#<PD"]C,D<^[@<X /N3Q3/%?C%/#=S86L=L;BXNI -N<!4
MR 23Z\CB@#JJ*JSWUM:RPQ7$\<4D[;(E9L%SZ"II9HXHR\CJBCJ6.* )**B\
M^/<T88&15W%<\XKFO!'BB?Q'H[7.H1V]O<&YEBCCB;(94(YY/7GF@#JJ*B:X
MB6982ZB1AD*3R13]XSB@!U%%% !1110 4444 %%%% !1110!C-H\C^*H]9-T
M2D5LUND&T8&X@DYZ]5%9-WX'LWU#6[RTD^ROJUB;64*. Q)^<>_-=?2>U 'F
M^D^!=>TO4M/OSJMA-)!:M:21BT$:B/L%*C/7DYI++P1KMAI?A:S@N[+.CW)D
ME)#?O%PR\=\X:O2<48IB/-KOP5X@O;76R;JTM[NXU&+4;.1&9@'C  5P1T.T
M9K3M;'QM!IE[.TVE_P!IN$2WB5"(5 ^\Q/4D_I7;TAI#&Q;_ "$\S;OVC=MZ
M9[XJ"74K*"0QS7EO&XZJ\J@C\":M=JR+OPOHM_=RW5UIEM-/* '>2,$D#I_*
M@"S_ &QIA_YB-I_W_7_&O+];M++5_B+>A-6@MF-FDD%R)$P)59>"<\@C.17?
M+X)\-*R,-%L@4Z?NA4\'A+P_:LS0Z+8(6;<2+=>OY5<)\CNB)1YD<T^L^()+
M46R:IX=A?[IO!=!C^"=,_C7(^,93I0B:37DU/3[N1?MN+CGY>@V@GY2 <]N*
M]7/AO0RNW^Q[#'I]F3_"AO#FC,&!TFQ(;KFW7G]*JG5Y7>Q,J=U8X'PW,EYJ
MMSJ<ILM,L'C2&WCBN%C\U5'&5S_,=,5@>#/$]AI^DBX22+4M>E<VUO$9,)"B
MDX&YN%'K@]A7K,?A70XX_+_LJS==Q<;X@V"3GC/2FCPCX? C"Z/9+Y9RNV%1
M@_@*'5NQ>ST.;M=,8Z3>./$*1:K>2_:;AH)U." ,1KST"@#/XUG>&-0GTOPX
M+./2OLSR>8\]S<W405F/4\-NR>,<5V%SX+T"Z<O)IL08C&8R4XX]/I3#X&\/
M%0K:>K 9ZR,>N,]_:FJBM9@Z9A?"R&*'PFQVHMV;F4R;N6^\=N3UZ8%4-9&H
M6GC'2Y=9U(PQ7,4D1DME*+$N0=I<>N!R:ZU? WA]$=$L=BORVV5QGG/8^M0R
M?#[PW,A2:Q:5-V[$L\CC/XM2C4M)L;IW5C8TVS@LK7;!--,CG=OEF,A/'J2:
MYV^@\7:5JUY>Z8\&J6=P0RV<[^6T/^Z>F*O+X%T!%55M90JC"J+F0 #Z;J3_
M (03P]C;]CE_\"I?_BJB^MV7;2R,G^W_ !Z<+_PB%L&)Y)OEP/UJS!H6K:Q<
MI>>(;D1I&=T%I:D@1MV8MW(J\/ N@ 8%I(!C'_'S)_\ %4O_  @N@%2#:2D'
ML;F3_P"*IJ=MB>5O=G*7$$GAKXB/?MIFH7=K-;,L<ZAYV#D@D=#@<'K4GBZZ
MU?7_  CJ3_V7)86D$)N%:X(,DI52<!0>/3FNF;P)X?;&;.3@8XN9!_[-39?
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M?X4 5E\6^'&&1K^F?^!:?XTO_"5>'1_S'M,_\"X_\:L_V+I7_0,L_P#OPO\
MA1_8VEC_ )AMG_WX7_"@"M_PE?AW_H/:7_X%Q_XT#Q3X>/37=,/TNX_\:M?V
M-I?_ $#;/_OPO^% TC35.1I]H"/2%?\ "@"K_P )7X=_Z#VF?^!<?^--;Q=X
M:7[WB'2A];R/_&KHTO3_ /GQMO\ ORO^%']F6&<_8;;/_7%?\* */_"8^&,9
M_P"$BTG'_7['_C2_\)=X;/37]+/_ &]Q_P"-7QIUB!@6=N!Z>4O^%+_9]G_S
MZ0>O^K'^% &>?%WAL'!\0:7GT^UQ_P"-7['4K'4X#/87D%U"&VEX) ZY],BG
M"QM <BUA!_ZYBI8X8XAB-%09SA1B@!]%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%!H'2@ HI!FEH **** "BBB@ --[YIU-[T .HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH 0G%+110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %)CFEHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH 3/-+110 4444 %%%% !1110 4W.33J;W- #J*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH #29I:* "BBB@ HHHH **,T4
M%%%% !1110 449HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "DQ@TM(>M "T444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 8HHHH *
M*** "BBB@ Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% ""EHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "D[TM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %(>M+2'K0 M->1(\;W5<
M\#)Q2MTKA=,AM?$/B37GU=Q,]I*L,-C*05A15#"0+_>))^;VH [K<HZD4C2(
M@RS!1ZDXKR"U.KWV@6-]#?\ ]I#3TN@(Y+@I)/#D!9@<X+*,X)J_<)+KT5G9
MVB3:G;S:';RK'<7!C9B)?ODC^/'>F!ZCD49%<QXPU:31_#Z1P"<75Y(MK$8D
M,C(6'+8')P >E<YIGC2>T\-6EA%ON=52^730UXCQG[V$=P1G)CPU(#TD.ISA
M@<'!QVI0P(R#D>HKS#0]6U+3]2U#2G6VDO+_ %2[9W:1MBK''$2%[DX;^=0^
M'_%&JZ?H>DZ1IEBE]=QV"W<_VFXV?NRP'RLW7@Y]L8H ]6I,BO/G^(&IVEVG
MV[2[5+1KEK9F2X.]2$5PP!'S###I6$_C+6=-OM0\0W$'F0RZ5#<V]FEPS18:
M55S@C ;![4 >O#K2YKA)O&^J-J0L;+289)6N7@!>4@*%A23<<#U<C\*M>'O%
M]]K.IVD%WIB6L%Y8?;('$N\G! 8'CC[PQ0!V&12UYCJ#7NH>*M6LXYM;"^?'
M;K-97>([3>H^=H\].]:5CX\FNKFWDM[*.;1Y9I;..[$V9#-&I.2N.A"M[T =
MY17GVD_$I]3TU;W^RRL?]DRZ@P$G(9'*E>G0XK?@UW59?#%WJKZ,8[E%:2WL
MS,-TB!01D] 3S^5 '19HKC+'Q-_PE^D70LY9=.6.VBFDO4(81.P#%!ZD#(-6
M/!FH:B_AJ2ZU:<RHDC^3/(FQI(@>&(]\?EB@#J\T5YC_ ,)O?IK8U5K.9=-F
MTMKF"#S@?-/F(JG'\)^;GZUMR^-;Y83!'HKG5(YFB>W:08)6/S3M(SU7I[]:
M .SHKEX?%SW'B/\ L1--D2ZC<-,'<<0E21(,=MV!CKS74 Y&: "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **0G%+0 4444 %%% .: "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **3O2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110  8HHHH **** "D/44M(>HH 6BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHS10 4444 %%%&: "
MBBC(- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 A.*6BB@ HHHH *0]:6D- "T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4A '4TM(1D4 &*4#%'04AY
MH 6BBB@!IYI0*6D.: %QFC%(.11F@!:*3OFEH **,T4 %%%% !1110 44F><
M4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !11FB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBC- !1110 F>:6BB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0T
MM(>HH 6BCI0* "BBB@ HHHH *** <T %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %)@4$XHZT  SWI:** $-+03BD!SVH 7I3< ]:5NE!
M&!0 M%(!WHV\YH 7%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !BBBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "C%%% !1110 4444 (,TM%% !1110 4444 %%%% !1110 4444 %%&,T4
M%%%% !1110 4444 %%%% !12$T=: %HI.E)G!H =2'J*6FDX(H =UHIM.% !
M12&EH ***,4 %(*6B@ HI,\TM !111TH **** "BB@T %%)GBE!S0 4444 %
M%%% !110>* "BC.12%L T (0#UIU-!I10  _,1FEIA7G(I06]* '4A(%&32%
M<]2: %!S2T44 %&1128H 6BDS2B@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B@T"@ HHHH ****
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MB@!W7CI322#110 I/%,SEO2BB@!^..*:6QBBB@!2>:#R:** &EB* 3D^U%%
M#@QQ32>:** '9XSBD!R:** #/.*<#QTHHH !S3=W)HHH  Y.:&.!BBB@ !XS
M1G]:** #/7VI0:** $W9-.(Q110 %L#I3=V>U%% !DD&E4Y%%% !G&:"?EHH
MH :#^E+G ^M%% #L[2!ZTF23110 A^]BEZ-110 N<D4'@FBB@!H8TPL2***
M%#&FECFBB@ #$\TJL>M%% $BG/:@N20*** %)P*53D444@#<<XI:** $!R:0
ML1GVHHH 4'BD!YQ113 4FF@Y/2BB@!<_+Q2!B5S110 TDD4=!110 X'(S0&)
MXHHH 8>M.QTYZBBB@!I;)IH8DXHHH <3THZ444 )DT[)Q110 N>U 8\444 /
MZ4W/M110 W.3TIP?/:BB@ S@T$T44 (#3\\T44 .)[4F<$"BBD 4%L+110 S
M>2*4$DXHHI@ )W8I,DL:** &[\$BG ]*** #O0&-%% #Z7-%%(!0<T&BB@!,
0TM%% !0#FBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>ams-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ams="http://www.ashs.com/20201231"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ams-20201231.xsd" xlink:type="simple"/>
    <context id="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ied252e58dda6439bb22835292add17c7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1e22177dad944968a24a1d8af4b54161_I20210322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
        </entity>
        <period>
            <instant>2021-03-22</instant>
        </period>
    </context>
    <context id="i6687a8b13ec24af5990e629224319cec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i882bf9794e8244f388b36b7749f33ee3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i80d152c66b98490fac1712dd5160d5b6_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6f2c5098442b4ca0990024d0a044f71d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4eb01d36262d48dab3093fa93a55a639_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ieffba5f94e464f3c9847c0ba5b17a15d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1eaabaa2b68f452d814855cd3337f66d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i88d4659da27e48458ba86016aae09e94_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="idce4f3d545f2476ebdc0f7f36157ebb5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id5dfe6ce5ed7480b9e09f5b3476be864_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0811458740d6449891c3119d222599c5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0146f023f5af475e8c42899ccb2714bd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i49250096dac54dbc9d6f411a7223e401_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1933947a2065450e947da821bf4a32d6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i95945ee330d74bbe84786fe63dbd0fe7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i031366823611429984ba59da571f0cf4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i63c0e34c40b84e128c70ede3ca6deb9b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibaf32a31b8e945bca3c5332f1bd4ea42_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icdb999bd1cf140c987a60e65653baa9d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0c7ecb5b71704129a21136aa3a829d59_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i90f32e02b365478c95091f9014bef961_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib9a7f6cfe5f24a45b55dad44c8b94d99_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id6742d6b210b4bc7b247bbd2b1bbcdcd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if300614914f840d5afcad30cf88400e1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1d457b7646a4469d9fe2d92f4b9ba9dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iedffb7791f4c42a8a3e5d969848aaeb4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02bbd8133d3c48bebba8d7203bfb8f52_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i890ba0391e8b420f8705f2e7726453b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6422158328d64dee80e1ac0f4c7ef41f_I20200612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-12</instant>
        </period>
    </context>
    <context id="i795a789ed9064252be4a8f64e1390165_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-12</startDate>
            <endDate>2020-06-12</endDate>
        </period>
    </context>
    <context id="i410be01cd1af4746a125e7746f1d7df8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ams:Or21LlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40610f194f284cf08a0a82249bb51162_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ams:ArchitecturalDesignCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id972ed669aba469da1b189f82f5af5dc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8e8116d241f44505a3ffdf0d7e29c59b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i56e19fee70bc48ac882fd81a5a98bbfc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5fd315d5d86b412e8a98e82bbe77f732_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i400c6be02aad4a9fafc38382c1213485_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie3e0fe294ba6407abae7a2107d1721a7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i28c7add148a045bb833ce1179113d93f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i40f23635f374477d8f08757fc9c0b712_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie606429758a940aeb109be90c15f3903_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ams:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i05ae369147604a31ac9acde67baf1fe0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6ad83fb416a54f079b45eac2cfce2818_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i57e5d37f53fe4fc2b7edcc04f231b5d7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:ProtonBeamRadiationTherapyPBRTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i298febcd82414e288d184f34830a1679_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:GammaKnifeAndRadiationTherapyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a373e6624244f4798fe5b5d28dbef2a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:GammaKnifeAndRadiationTherapyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i284508e025b34d6d9f64d3b93def6455_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7279522e293b495db1b4d192e00ff1e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ea0bf1639814d3381a9b42a27326780_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2cea93e95519466ca67288ae891587b5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40f6d3eb893e49dba2c9816815bdc0a1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ams:CarryingValuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifd382747b25b4861a422a0f266d39f5d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i519145167b974aab9b393f963cdb8d7a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i93ecdfacebdb44469bdc41efe4acc1dc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4d629e14069b4f1ca36dd799f3eb6039_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ams:CarryingValuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic5fff1c8944b46cb882c1df18912daf8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i17d0a114a3a64f229fe1ddcdd3b7eb1c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i71d12ecde1e645d39bc55a9ecf494e71_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:GammaKnifeCenterEcuadorSAGKCEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6f48202c104045e5af8b285017387f01_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifce03623ecd94f9a9f86454660e7a747_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i279a2dc09a1e4d058baa0f82d26d3fec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i201f554e454a461689418aeaf993818a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i430692827c684c1ca5be2f83d2a702f5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iacead3b29e7846bcac84408721d0ef98_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieeeee52fa85b4659bb8c93af9403c135_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:DomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7d5ec3bfbd86448fa8f03c6346be0f99_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:DomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i673d3ab8cf484509b5a1f6277fa696b3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:ForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id8922c16f8684389b3b97dd8f6e8ab60_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:ForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i51994c25a7e04ee08bec394c54e6c3c0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifc4a678d396245e9bf4323d16c22d03a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7bf5e95df79b44f7a18e189b2382eb21_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:DomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ams:NetIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7934b69f46a945fba713a315452b7c67_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:DomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ams:NetIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i10727c3b4215451ba7e2258b5cc61bdd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:ForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ams:NetIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6958c1fb3942499d88011d908e7f5162_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:ForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ams:NetIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i714b56581adc46f6942c585891e61544_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ams:NetIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8d9c32da78d040efa62915a5cb124fe4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ams:NetIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id7895e51adef4d9988611e06cb9a3c5c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:DomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i426af3a3d5514c93814df64d63f704ff_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:DomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i309db3889f874fdb939e6cc89fd12897_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:ForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ida6822c327084e89b634c2f2b2084d15_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:ForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idfd154d740fb4aa0a7b0a97723469ebb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia83787ee66d2452c9afe259fa7fe0fea_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0e4c0e6386194ed79a0a74908a8481c4_D20200612-20200612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-12</startDate>
            <endDate>2020-06-12</endDate>
        </period>
    </context>
    <context id="i75857421209a4a9a88a2265cd4aa4e0c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:MedicalEquipmentAndFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i510367b0210f42978fd2121a0200735d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:MedicalEquipmentAndFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i37f3a64c6fb840d18f0efb0eaa318c44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ice7b40f1c9e14f0b8d6cb5971b5d802c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d358d5eef3047409dc23e990ed19c02_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76faded4f4504bc18d38d7c6fa9479aa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7084175c89f34387ac3446f385b5e3e1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:DepositsTowardsPurchaseOfProtonBeamSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1cb27f70c0184108b4804f5d0b9480eb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:DepositsTowardsPurchaseOfProtonBeamSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3035febde0194678b2773c7062226a54_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f932b9ba0be489d8eb94b2f6d54477c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:UnitsRemovedFromServiceInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf316d9d1b244b2bade2edc301cde456_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:UnitsRemovedFromServiceInCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i22e35e1d597d4b4399ba9a87a43dd7da_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:UnitsThatWillBeRemovedFromServiceInFutureYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id856a65ad9834e49b099b1d1d0c6aaa4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8f30f61a17e747c2ad1bc8c1d865eb97_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c2842d69fdd4db49a077b810d27392c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:ProtonBeamRadiationTherapyPBRTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7f7bc9edba63482baa71fc49aef7db07_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i205b91ae82344e9d8e528defe6019354_D20200612-20200612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-12</startDate>
            <endDate>2020-06-12</endDate>
        </period>
    </context>
    <context id="i24fa28513d1d4cedb8ff3631c13643d4_D20200612-20200612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-12</startDate>
            <endDate>2020-06-12</endDate>
        </period>
    </context>
    <context id="i381af277ce4b42e2a421005e64fa2c53_D20200612-20200612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:MedicalEquipmentAndOtherFixedAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-12</startDate>
            <endDate>2020-06-12</endDate>
        </period>
    </context>
    <context id="ief5ace117998418a93ba873e84fcee06_D20200612-20200612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:MedicalEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-12</startDate>
            <endDate>2020-06-12</endDate>
        </period>
    </context>
    <context id="ie7107c47918d4072a7fa9c7ea3337757_D20200612-20200612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:OtherFixedAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-12</startDate>
            <endDate>2020-06-12</endDate>
        </period>
    </context>
    <context id="ie13445cb0ba94819a5bcc00de48c6ac3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9aed20455da74365bfd0779fe7c8fe53_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ams:AssetAcquisitionAxis">ams:GKCEAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iea6020aa13c8441883aae4fa8107203a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icfa5f63042e644d5b31c703f3ac54c9a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf0485b3300f4c709015ee46dc45d199_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a19b56e39284cc2bd0fe2b1a910fdc9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ams:GammaKnifeUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3dfd28bb44084d2ab54958e2d4bfab65_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibeda16fd19d5413fa54b8ddbc438d749_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i087b2dc2b4b54227989cfb9e793c3951_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie9aab6c477354d8aabfd59fedcdc7f0c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ams:PeruDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic40a5c6d28184e559db2655dfa2504c5_I20100630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-06-30</instant>
        </period>
    </context>
    <context id="i4b2e49a8ba0e4110902423280570dd60_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7da1cbcaab824c258a3e435ef167afeb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75ab1b400ca446ebafefb5497cfcbe7f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:NonEmployeeDirectorsAndCorporateSecretaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i439999ffc655418594f79bcae4f8e02b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:NonEmployeeDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ams:RetainerFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i865f409e789f412d9649eea7a779efbf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ams:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8948e770c9f64598b68bf6a898112dab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ams:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5065887f6a4b4118b70267038309da91_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:ExecutiveEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8cf66345370f4da19371bd488b60d7d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if1ed81d1b3e0406887e3f7c0a942518d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1182cb262dd5404e857585d6453d5008_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i75a3e8aadc8a42998ea1f668ddc598aa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1abe365945b24f1187e85f47a39fb40b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ams:RetainerFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4a54847db3184f809b995f6ca5865dd9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icdcf8f1e671343ef84efbcc784e706a6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:ExecutiveEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8a5840910bb84c9ab051118c87f6190d_D20200803-20200803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:ExecutiveEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-03</startDate>
            <endDate>2020-08-03</endDate>
        </period>
    </context>
    <context id="idcb7ef47ef694053b29237a21986aa43_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ams:SeniorVicePresidentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:ExecutiveEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6bdba3f703e740a8b387f2723b455d9a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:ExecutiveEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i54f1ddba4c6143a2b7471da1ecaeeeaa_D20170104-20170104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:PerformanceShareAwardAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-04</startDate>
            <endDate>2017-01-04</endDate>
        </period>
    </context>
    <context id="i32da477d172646529ddc5afd23e6ed4d_D20170104-20170104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:PerformanceShareAwardAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-04</startDate>
            <endDate>2017-01-04</endDate>
        </period>
    </context>
    <context id="ibe8c67bc767f4ff48911673917d29035_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:PerformanceShareAwardAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9f9e8e77770741a39de67b6d254f0f78_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ams:PerformanceShareAwardAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8b626e312a7d4b85bdb7b11f21a56788_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifa091c4ef68c4bb68bd7b854b530cc2c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ams:RSUsIssuedInLieuOfRetainerFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0e761c88d6f049ee8b2df4c059245e51_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ams:AnnualRSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie00f50be40664dab98b855706c8871d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ams:ExecutiveCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id87939e5af644ee294503aa4bedb6bbc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i613b14d7d6ca4d3f82337708f6ffc78f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia2672c01483e420db7e4c638ebae606e_I20011231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
        </entity>
        <period>
            <instant>2001-12-31</instant>
        </period>
    </context>
    <context id="ib40f3f2ed22f45ceb3ad41a1918f4939_D20160813-20160813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
        </entity>
        <period>
            <startDate>2016-08-13</startDate>
            <endDate>2016-08-13</endDate>
        </period>
    </context>
    <context id="i5e5ea45669af4723953be698788c51f5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ams:LINACSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i588196b8c9c6489fab6078ddb17065d6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ams:GammaKnifePerfexionSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie52549c616fe4dc18135044ebe97c162_D20170905-20170905">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ams:MaintenanceAndSupportAgreementTheMevionServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:MevionMedicalSystemsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-05</startDate>
            <endDate>2017-09-05</endDate>
        </period>
    </context>
    <context id="i160dbde260894a5d8df523d1c2359928_I20170905">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ams:MaintenanceAndSupportAgreementTheMevionServiceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ams:MevionMedicalSystemsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-05</instant>
        </period>
    </context>
    <context id="i303d240dda61403d9ec1de771f26041e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ams:LINACSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i922a42f468f946e8b4a7d5f99e207fbf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ams:LINACSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8e9d39e86c2548f0bf5e350d4df09116_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i18863b680ebc4002ab41bd4bd5d80267_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">ams:FinanceLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0c1a379a87884628a8b8200736f37e34_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if7d6fa8d4f2d4414a11cd4e62eebfcc7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">ams:EquipmentServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i735df263f1544be9ab7b0ae62cd61c55_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">ams:AcquisitionWorkingCapitalPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf60e6023f1042189106a9ed43c03bcb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">ams:OperatingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5032e2b4fc36495cbac498a4109a1461_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ams:GkfSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i24a2c7db33474c15b8617c78beae2b0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ams:UsSubsidiaryOfElektaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="unit">
        <measure>ams:unit</measure>
    </unit>
    <unit id="customer">
        <measure>ams:customer</measure>
    </unit>
    <unit id="site">
        <measure>ams:site</measure>
    </unit>
    <unit id="segment">
        <measure>ams:segment</measure>
    </unit>
    <unit id="deposit">
        <measure>ams:deposit</measure>
    </unit>
    <unit id="note">
        <measure>ams:note</measure>
    </unit>
    <unit id="lease">
        <measure>ams:lease</measure>
    </unit>
    <unit id="employee">
        <measure>ams:employee</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="reload">
        <measure>ams:reload</measure>
    </unit>
    <unit id="install">
        <measure>ams:install</measure>
    </unit>
    <unit id="purchase">
        <measure>ams:purchase</measure>
    </unit>
    <unit id="upgrade">
        <measure>ams:upgrade</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF80L2ZyYWc6MmNjYTQ1NDE2ZjFkNDU0YmIwYzAxYmY0OTZkZmI3NDQvdGFibGU6YWMxYTAzZmRmMzBmNDNlZmIwMjVlZmE3MmQxOGY0OTkvdGFibGVyYW5nZTphYzFhMDNmZGYzMGY0M2VmYjAyNWVmYTcyZDE4ZjQ5OV8yLTEtMS0xLTA_b82fd032-1241-40ee-bf0a-d036b9693c52">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF80L2ZyYWc6MmNjYTQ1NDE2ZjFkNDU0YmIwYzAxYmY0OTZkZmI3NDQvdGFibGU6YWMxYTAzZmRmMzBmNDNlZmIwMjVlZmE3MmQxOGY0OTkvdGFibGVyYW5nZTphYzFhMDNmZGYzMGY0M2VmYjAyNWVmYTcyZDE4ZjQ5OV80LTEtMS0xLTA_ef4b0960-b7ff-44ca-9612-85f62b5008b7">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF80L2ZyYWc6MmNjYTQ1NDE2ZjFkNDU0YmIwYzAxYmY0OTZkZmI3NDQvdGFibGU6YWMxYTAzZmRmMzBmNDNlZmIwMjVlZmE3MmQxOGY0OTkvdGFibGVyYW5nZTphYzFhMDNmZGYzMGY0M2VmYjAyNWVmYTcyZDE4ZjQ5OV81LTEtMS0xLTA_db48d250-0fc2-4917-818b-f0ded592cc33">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF80L2ZyYWc6MmNjYTQ1NDE2ZjFkNDU0YmIwYzAxYmY0OTZkZmI3NDQvdGFibGU6YWMxYTAzZmRmMzBmNDNlZmIwMjVlZmE3MmQxOGY0OTkvdGFibGVyYW5nZTphYzFhMDNmZGYzMGY0M2VmYjAyNWVmYTcyZDE4ZjQ5OV83LTEtMS0xLTA_4be47c8a-f877-4a07-bdc1-d56b146665e9">0000744825</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF80L2ZyYWc6MmNjYTQ1NDE2ZjFkNDU0YmIwYzAxYmY0OTZkZmI3NDQvdGFibGU6YWMxYTAzZmRmMzBmNDNlZmIwMjVlZmE3MmQxOGY0OTkvdGFibGVyYW5nZTphYzFhMDNmZGYzMGY0M2VmYjAyNWVmYTcyZDE4ZjQ5OV84LTEtMS0xLTA_2e0a608b-18fc-4aed-8242-8ab6dda96308">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:LongtermPurchaseCommitmentPeriod
      contextRef="ie52549c616fe4dc18135044ebe97c162_D20170905-20170905"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU4MTM_78bf16e5-2777-43c0-8b8e-f765c5397ed5">P1Y</us-gaap:LongtermPurchaseCommitmentPeriod>
    <dei:DocumentType
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8xMTY_c5ad0a00-7540-4b27-9afd-15ed9e075dbd">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6Zjg3NjQ4NjA3YzkzNDNhOGJiYTAxOTc2NTdhYjZkNmMvdGFibGVyYW5nZTpmODc2NDg2MDdjOTM0M2E4YmJhMDE5NzY1N2FiNmQ2Y18wLTAtMS0xLTE0MTk_8a942da5-4a1e-4e0d-8b73-8b56230cac44">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyNzA2_18f63be1-5687-4556-97da-a546c5f0bc03">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyNzA2_dee5a09e-9251-42c5-bde9-8124aa80224a">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6OGUyNzU2ZGQwNGM2NDYyN2JiYzEyM2E2NmY3NzRmZWUvdGFibGVyYW5nZTo4ZTI3NTZkZDA0YzY0NjI3YmJjMTIzYTY2Zjc3NGZlZV8wLTAtMS0xLTE0MjE_df9e9f81-a3d2-4e82-b07f-1fa31027a101">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8zMjk4NTM0ODg1ODQ1_3ffa0ed8-4aed-450a-8af1-82e4ab782966">1-08789</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yMDE_34193e0a-6190-4abc-ab66-a980183f47f4">American Shared Hospital Services</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6Y2VhNTIwMmI0MDk0NDBmODkzNjVmNTljN2QyYzcyMTAvdGFibGVyYW5nZTpjZWE1MjAyYjQwOTQ0MGY4OTM2NWY1OWM3ZDJjNzIxMF8wLTAtMS0xLTE4NjE_75ec161e-df4b-41ab-846f-7334f5bd7080">CA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6Y2VhNTIwMmI0MDk0NDBmODkzNjVmNTljN2QyYzcyMTAvdGFibGVyYW5nZTpjZWE1MjAyYjQwOTQ0MGY4OTM2NWY1OWM3ZDJjNzIxMF8wLTItMS0xLTE4NjY_faa7fc78-725e-45c0-aa2e-6960f3b931de">94-2918118</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6NjMwYWFiMzQ0OWIwNDMzOGI2NGExZDE2ZjVjOWMxZDQvdGFibGVyYW5nZTo2MzBhYWIzNDQ5YjA0MzM4YjY0YTFkMTZmNWM5YzFkNF8wLTAtMS0xLTQxMzE_307b5e23-fd23-425d-8169-7b1dd885a464">Two Embarcadero Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6NjMwYWFiMzQ0OWIwNDMzOGI2NGExZDE2ZjVjOWMxZDQvdGFibGVyYW5nZTo2MzBhYWIzNDQ5YjA0MzM4YjY0YTFkMTZmNWM5YzFkNF8wLTEtMS0xLTQxMzE_2010238d-723a-4cd4-b0e4-52907a45ba5e">Suite 410,</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6NjMwYWFiMzQ0OWIwNDMzOGI2NGExZDE2ZjVjOWMxZDQvdGFibGVyYW5nZTo2MzBhYWIzNDQ5YjA0MzM4YjY0YTFkMTZmNWM5YzFkNF8wLTItMS0xLTQxMzE_31ad1c8e-7230-4f19-bfde-16a1cb8d5249">San Francisco,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6NjMwYWFiMzQ0OWIwNDMzOGI2NGExZDE2ZjVjOWMxZDQvdGFibGVyYW5nZTo2MzBhYWIzNDQ5YjA0MzM4YjY0YTFkMTZmNWM5YzFkNF8wLTMtMS0xLTQxMzE_56be4c4d-8228-4283-b958-5cdd41972e8e">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6NjMwYWFiMzQ0OWIwNDMzOGI2NGExZDE2ZjVjOWMxZDQvdGFibGVyYW5nZTo2MzBhYWIzNDQ5YjA0MzM4YjY0YTFkMTZmNWM5YzFkNF8wLTQtMS0xLTQxMzE_7c09316b-e2a6-4dd6-b81c-ad5efe62b7c1">94111-4107</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8zMjk4NTM0ODg1ODQ3_12cb4db5-f2d9-4223-b822-e334a579f9ef">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8zMjk4NTM0ODg1ODU2_deaaac84-ed01-461e-a2f0-5b544c3ff1a7">788-5300</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6MWFmMTQyMWNiZWQ2NDMyZWE3NTdkM2U2ZmJkOWNlYjIvdGFibGVyYW5nZToxYWYxNDIxY2JlZDY0MzJlYTc1N2QzZTZmYmQ5Y2ViMl8xLTAtMS0xLTE5MjM_3f8970da-8096-4fc3-955d-14de6136c848">Common Stock No Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6MWFmMTQyMWNiZWQ2NDMyZWE3NTdkM2U2ZmJkOWNlYjIvdGFibGVyYW5nZToxYWYxNDIxY2JlZDY0MzJlYTc1N2QzZTZmYmQ5Y2ViMl8xLTItMS0xLTE5MjU_8740f470-6469-4314-ab14-bab356765bfb">AMS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGFibGU6MWFmMTQyMWNiZWQ2NDMyZWE3NTdkM2U2ZmJkOWNlYjIvdGFibGVyYW5nZToxYWYxNDIxY2JlZDY0MzJlYTc1N2QzZTZmYmQ5Y2ViMl8xLTQtMS0xLTE5Mjc_330adf03-6069-4f9a-873c-b9e98e2e4857">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyNzA5_4b4722af-3f0b-4be2-8159-0de1737a689b">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl83MTE_438851b9-a051-43a4-8c11-3192c03d76e2">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8xMDYz_de1177ee-4d35-4797-b5a3-16d55a8257cc">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8zMjk4NTM0ODg1ODU3_6800f245-6238-4c12-87e6-1bf2ec303dfa">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyNjg1_07820e8f-0925-4ced-aaea-1dc6e7642986">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyNjg2_89bf56af-2686-447f-b55d-a475d04d1986">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyNjg3_bcee887f-ccaa-4f98-a05f-5e709b1e4690">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcyMzgx_922e575f-d0de-49e3-84a0-38dd3fa8477a">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8zMjk4NTM0ODg1ODYy_0202318a-02c0-4f0e-9169-77716e3fa8ce">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ied252e58dda6439bb22835292add17c7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yMjM1_33d64205-8209-45e3-9dd4-20ab1fc48a39"
      unitRef="usd">8188000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i1e22177dad944968a24a1d8af4b54161_I20210322"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yMzEy_fe853f52-e918-4ca2-862f-2b445fb15d0e"
      unitRef="shares">5801000</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xL2ZyYWc6NjU2NzE5YmJhNGQxNDE4Y2I2ODcwMmE5NmU3MWNkNmIvdGV4dHJlZ2lvbjo2NTY3MTliYmE0ZDE0MThjYjY4NzAyYTk2ZTcxY2Q2Yl8yNzQ4Nzc5MDcxOTkz_0bade264-92bf-474f-95ef-830c8304fdec">Portions of the registrant&#x2019;s definitive Proxy Statement for the 2021 Annual Meeting of Shareholders are incorporated by reference into Part III of this report.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzYtMS0xLTEtMA_092806ca-702d-4ea1-a4db-e74b94172956"
      unitRef="usd">3961000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzYtMy0xLTEtMA_7f7973a3-3cb0-4e44-81a6-b8ccb6006150"
      unitRef="usd">1429000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzctMS0xLTEtMA_c934fc15-98c9-4069-900f-5fe5880d0d9c"
      unitRef="usd">364000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzctMy0xLTEtMA_0f1166b4-e86d-460f-a9dd-f2dfb0753677"
      unitRef="usd">350000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzgtMC0xLTEtMjY2My90ZXh0cmVnaW9uOmQ5Yjk2MTJmNWQzNzQzMjM4YzdkZWQ5ZTdiYzMxNzNiXzI3NDg3NzkwNjk1NzE_0429ca44-01ad-44ba-868c-ee23a45c00ab"
      unitRef="usd">100000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzgtMC0xLTEtMjY2My90ZXh0cmVnaW9uOmQ5Yjk2MTJmNWQzNzQzMjM4YzdkZWQ5ZTdiYzMxNzNiXzI3NDg3NzkwNjk1NzE_88febbbe-bc4b-47b6-847a-7433679dddeb"
      unitRef="usd">100000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzgtMS0xLTEtMA_3c00ee99-e2ef-4cd8-8f5f-350ccdafa0f0"
      unitRef="usd">4303000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzgtMy0xLTEtMA_3f928428-1fcb-4767-a180-778d154431a2"
      unitRef="usd">6894000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzEwLTEtMS0xLTA_841e744f-0b2c-4536-bbfb-50d6bd866746"
      unitRef="usd">272000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzEwLTMtMS0xLTA_00dca547-464c-4ec3-afef-de60a8b3ee03"
      unitRef="usd">169000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzExLTEtMS0xLTA_30a5e906-4f81-48a8-92aa-41b9affab3e5"
      unitRef="usd">1950000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzExLTMtMS0xLTA_f2763ff9-3742-4797-81ad-2aab14670a5d"
      unitRef="usd">1900000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzEyLTEtMS0xLTA_1b383320-8562-4fec-82a2-11c0fb7feebb"
      unitRef="usd">10850000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzEyLTMtMS0xLTA_8d050e4b-9574-4b85-99c8-84950a148bdf"
      unitRef="usd">10742000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzEzLTEtMS0xLTA_6bd063b7-b4a9-4d93-ad31-ea2d2b1547c5"
      unitRef="usd">30418000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzEzLTMtMS0xLTA_d164508d-832d-4f75-a56b-c3c1b0a09c62"
      unitRef="usd">41480000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:Land
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE0LTEtMS0xLTE4_a25d47c3-c6ea-49d8-a03e-2a6e7cb0e552"
      unitRef="usd">19000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE0LTMtMS0xLTE4_de480bef-dc6c-4816-aa26-deebd3739d75"
      unitRef="usd">0</us-gaap:Land>
    <us-gaap:Goodwill
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE1LTEtMS0xLTE4_9d8a24c1-4fa7-4c12-a664-9d1f036bfb94"
      unitRef="usd">1265000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE1LTMtMS0xLTE4_815fb9d0-f592-46b6-b159-0ef1181ece91"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE2LTEtMS0xLTE4_558836c3-8b79-4b00-9183-a5c304f51855"
      unitRef="usd">78000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE2LTMtMS0xLTE4_8c055011-0688-428c-86cc-476a3ecb92ba"
      unitRef="usd">0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE0LTEtMS0xLTA_f9cdfa60-a91d-43ef-a26a-09785e37c59a"
      unitRef="usd">886000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE0LTMtMS0xLTA_28b33269-42f4-4d50-84d0-a3c313ba52ae"
      unitRef="usd">1106000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE1LTEtMS0xLTA_71cbca6f-ffc2-41c9-ba2b-161719f0b622"
      unitRef="usd">137000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE1LTMtMS0xLTA_2b780a75-71bb-462e-a532-9c2b3a64bed1"
      unitRef="usd">455000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE2LTEtMS0xLTA_27d471d0-4965-4426-9fa4-87e500e262b9"
      unitRef="usd">43653000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzE2LTMtMS0xLTA_d53aa3f0-e0e0-4fcb-a91b-c8154d70c5ad"
      unitRef="usd">53783000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIwLTEtMS0xLTA_fb031434-2032-461d-b64f-04215eb32c38"
      unitRef="usd">683000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIwLTMtMS0xLTA_bd4ed85a-ecdf-4b6a-9732-12b041d153a1"
      unitRef="usd">557000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIxLTEtMS0xLTA_bdc2e922-1ddd-4d9c-a1e8-56d6514a3a10"
      unitRef="usd">405000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIxLTMtMS0xLTA_2899758b-6e88-4cdb-aac1-54392617b20e"
      unitRef="usd">234000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIyLTEtMS0xLTA_95bfae69-edc8-439e-b63c-7425463ef52c"
      unitRef="usd">2045000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIyLTMtMS0xLTA_fcada92e-30f3-4798-be2a-daef4cc17c4d"
      unitRef="usd">1779000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AssetRetirementObligationCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIzLTEtMS0xLTA_48283e14-2c63-4191-a141-ceb0c4d85c4a"
      unitRef="usd">1270000</us-gaap:AssetRetirementObligationCurrent>
    <us-gaap:AssetRetirementObligationCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzIzLTMtMS0xLTA_860adf6e-19aa-4757-8d6a-608d99cd4b93"
      unitRef="usd">0</us-gaap:AssetRetirementObligationCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI0LTEtMS0xLTA_6ab89680-a0c1-41ce-9004-b95662e68101"
      unitRef="usd">373000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI0LTMtMS0xLTA_73d50b92-4c7d-4ff8-89a8-7ba22387b03e"
      unitRef="usd">130000</us-gaap:AccruedIncomeTaxesCurrent>
    <ams:WorkingCapitalPaymentLiabilityCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI1LTEtMS0xLTA_f43466cf-82d4-473f-9b26-d235af98a15f"
      unitRef="usd">197000</ams:WorkingCapitalPaymentLiabilityCurrent>
    <ams:WorkingCapitalPaymentLiabilityCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI1LTMtMS0xLTA_2146c603-6763-4db4-8907-fcd3cd59abc5"
      unitRef="usd">0</ams:WorkingCapitalPaymentLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI2LTEtMS0xLTA_bd8b43aa-4967-4cc2-87fe-2d22f752ef45"
      unitRef="usd">305000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI2LTMtMS0xLTA_ded74b30-0810-49b0-b40f-9acc228d8bc5"
      unitRef="usd">279000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI3LTEtMS0xLTA_9baddc88-947c-4010-9596-31ee6f297dbe"
      unitRef="usd">1157000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI3LTMtMS0xLTA_c095c964-8b98-49f1-94e4-adf388d7b8d7"
      unitRef="usd">1526000</us-gaap:LongTermDebtCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI4LTEtMS0xLTA_8233fbf7-fb05-4f91-8d3c-895df5ba19ea"
      unitRef="usd">5945000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI4LTMtMS0xLTA_f6f440fc-0d8b-4048-8db4-6753caeddecf"
      unitRef="usd">3709000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI5LTEtMS0xLTA_3c726980-921b-47c8-894f-8f110b8f3338"
      unitRef="usd">12380000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzI5LTMtMS0xLTA_833f2b43-c710-4d8f-b871-b905097f7236"
      unitRef="usd">8214000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMwLTEtMS0xLTA_f5d5dc47-02bd-4599-ad33-00bdfc189c3d"
      unitRef="usd">581000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMwLTMtMS0xLTA_910cec93-2af1-4f48-bd64-6fea2560d203"
      unitRef="usd">827000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMxLTEtMS0xLTA_331f8bac-a278-4087-a056-3a7c1b00968b"
      unitRef="usd">3440000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMxLTMtMS0xLTA_c3414f0c-0c3a-4f6a-8c5d-077d17ebb64a"
      unitRef="usd">1954000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMyLTEtMS0xLTA_7db5dcf1-3efd-4fec-861d-465460954ce1"
      unitRef="usd">2974000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMyLTMtMS0xLTA_4b66b329-345b-4d55-a29c-5048ca1bd751"
      unitRef="usd">8177000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMzLTEtMS0xLTA_ae870812-1f0b-4286-af29-df897d71909f"
      unitRef="usd">210000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzMzLTMtMS0xLTA_5bff2c0d-edf5-4d39-ab35-a204784d1f52"
      unitRef="usd">286000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM0LTEtMS0xLTA_02b08c63-3ab3-4a80-ac31-4498c19089d5"
      unitRef="usd">418000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM0LTMtMS0xLTA_f5bc53df-8a94-457a-8869-6182cb5235b2"
      unitRef="usd">2514000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM1LTEtMS0xLTA_a6090ca0-38b8-427d-a8d4-d3c1e81b3f2e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM1LTMtMS0xLTA_7844d93e-2c99-46ec-a8d8-40e3fc58fdbb"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NTk5_ebf75eca-a045-44de-a943-46fa1e2bd7cf"
      unitRef="usdPerShare">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NTk5_f914defb-57e7-445a-8443-be53460b5b53"
      unitRef="usdPerShare">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NjE1_73fb4fd6-06f0-4443-aa34-a7ab3929bc29"
      unitRef="shares">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NjE1_f694fbe4-db78-4c61-ac60-4af15e7ec4b5"
      unitRef="shares">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NjI3_1a52923a-a261-4b93-ab48-52cbe1f1d2a0"
      unitRef="shares">5791000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NjI3_f40bb426-d6e9-42b9-8bd7-b995c95bd563"
      unitRef="shares">5791000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NjM5_1c0b362e-17d9-41da-acbf-70ec3e3de298"
      unitRef="shares">5817000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjowY2Q2ZTkwN2ZmZmY0ZWRhYWFiY2YyMTE4ZGZlZDM4YV8yNzQ4Nzc5MDY5NjM5_4380a950-0f33-4a81-ba15-8852ab00c6b1"
      unitRef="shares">5817000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTEtMS0xLTA_78fce6e7-e4f4-4d9f-89cc-abc0e13a04ae"
      unitRef="usd">10753000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM4LTMtMS0xLTA_4da90bd5-2de0-4296-a009-4c5c0870de91"
      unitRef="usd">10753000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM5LTEtMS0xLTA_bc4fb771-26c8-42ca-931b-e128f7aa6c47"
      unitRef="usd">7024000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzM5LTMtMS0xLTA_94120501-4720-4ac1-95dc-e76f8afd3d2d"
      unitRef="usd">6725000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQwLTEtMS0xLTA_71abb2df-813e-4bbb-b31f-6bf0451ea96f"
      unitRef="usd">1497000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQwLTMtMS0xLTA_0e1507f6-d070-42b5-b6be-cfeef9d53e32"
      unitRef="usd">8555000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQxLTEtMS0xLTA_c2650b12-e148-4c45-b284-83a2259b6a10"
      unitRef="usd">19274000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQxLTMtMS0xLTA_f4180a09-5adc-43d5-96f5-fc3971c414f3"
      unitRef="usd">26033000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQyLTEtMS0xLTA_d08bfa14-a64f-4fc5-bb90-51008f86f144"
      unitRef="usd">4376000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQyLTMtMS0xLTA_957f1c73-a5f0-4118-9ffd-01fb9fd1738d"
      unitRef="usd">5778000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQzLTEtMS0xLTA_ad7fd597-d2ab-4617-9f96-f1766114b3fa"
      unitRef="usd">23650000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQzLTMtMS0xLTA_b0822b7d-b939-453a-bb97-84c07e954339"
      unitRef="usd">31811000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQ0LTEtMS0xLTA_72359ec0-65d0-49a3-a02c-e570d2803514"
      unitRef="usd">43653000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzMvZnJhZzpiODRjODliY2QzYjE0ZDAzYWNkNjNjZTkwMDIzYjQyNy90YWJsZTozMGFiNDExZmY4YTY0OWNjODQ3MWIyY2I1YWIxZmQ2MS90YWJsZXJhbmdlOjMwYWI0MTFmZjhhNjQ5Y2M4NDcxYjJjYjVhYjFmZDYxXzQ0LTMtMS0xLTA_d56133d1-1896-4764-a1fb-5ce43ffab3c6"
      unitRef="usd">53783000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzUtMS0xLTEtMA_7443c910-8728-48f6-8de8-401e58e83516"
      unitRef="usd">17837000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzUtMy0xLTEtMA_dfa411c6-d907-4ab1-83ac-c5d905a21cae"
      unitRef="usd">20605000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzYtMS0xLTEtMA_227e61a8-1cdd-4ff9-8b9d-961855811d67"
      unitRef="usd">17837000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzYtMy0xLTEtMA_4326c5a9-76e7-421c-9a2f-8d2a2d14afb9"
      unitRef="usd">20605000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DirectOperatingMaintenanceSuppliesCosts
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzgtMS0xLTEtMA_bd89200a-dc55-4509-aeb7-c8ce08eab5ee"
      unitRef="usd">2385000</us-gaap:DirectOperatingMaintenanceSuppliesCosts>
    <us-gaap:DirectOperatingMaintenanceSuppliesCosts
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzgtMy0xLTEtMA_40eea2cb-20a2-45bc-963a-296d8341022b"
      unitRef="usd">2618000</us-gaap:DirectOperatingMaintenanceSuppliesCosts>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzktMS0xLTEtMA_1459d246-fe90-4b3e-8d8a-9db2573b3d0b"
      unitRef="usd">6789000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzktMy0xLTEtMA_fc5a9801-f26d-4077-9a57-af9d96e56a91"
      unitRef="usd">7341000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzEwLTEtMS0xLTA_5c4ffc29-5115-4dad-a5d0-c3656b15539a"
      unitRef="usd">4197000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzEwLTMtMS0xLTA_4c2dcfee-70a0-4d5d-8028-cea3ee5fcfe8"
      unitRef="usd">3726000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:CostsAndExpenses
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzExLTEtMS0xLTA_67a8e5a8-6eed-4765-a7b1-6c497d12166b"
      unitRef="usd">13371000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzExLTMtMS0xLTA_9692db23-8372-4015-b755-897349a4d871"
      unitRef="usd">13685000</us-gaap:CostsAndExpenses>
    <us-gaap:GrossProfit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzEyLTEtMS0xLTA_e0411bf3-f1f8-4db3-b3e7-4d6b91763093"
      unitRef="usd">4466000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzEyLTMtMS0xLTA_4e680b05-57a3-43c9-a28b-5dfab2874391"
      unitRef="usd">6920000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzEzLTEtMS0xLTA_1a4296db-02a9-4d12-93c9-70d729c62101"
      unitRef="usd">4608000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzEzLTMtMS0xLTA_d794d4d2-a286-4b0a-aeae-6dc9c5f114f7"
      unitRef="usd">4060000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:InterestExpense
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE0LTEtMS0xLTA_05820a0a-60d0-4f42-9c8f-8a3489c728c2"
      unitRef="usd">1057000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE0LTMtMS0xLTA_33d99d3a-9235-48e9-8fa0-cbce9763785d"
      unitRef="usd">1318000</us-gaap:InterestExpense>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE1LTEtMS0xLTUxNzk_9719ba06-9230-4b0f-8649-54256864f377"
      unitRef="usd">-8264000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE1LTMtMS0xLTUxNzk_0bbadc99-61e3-40f0-af4e-1c735895af77"
      unitRef="usd">0</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE1LTEtMS0xLTA_15172400-7b98-4cbc-8e1d-4c2ab4e06726"
      unitRef="usd">-9463000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE1LTMtMS0xLTA_93fab3ff-cf21-4e4c-a56d-fac686a3d2c4"
      unitRef="usd">1542000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndOtherIncome
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE5LTEtMS0xLTA_5546307f-6986-4462-bf26-e273970be272"
      unitRef="usd">10000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzE5LTMtMS0xLTA_0e7875a5-4c1d-465d-abc1-ec5912f044ae"
      unitRef="usd">16000</us-gaap:InterestAndOtherIncome>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIwLTEtMS0xLTA_3a559130-b177-4b4a-937d-cbd5d550870a"
      unitRef="usd">-9453000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIwLTMtMS0xLTA_6db2da13-d314-4dcd-9828-ad514bf6aba9"
      unitRef="usd">1558000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIxLTEtMS0xLTA_f32b30fb-3def-4eef-a1b9-34465e0ba455"
      unitRef="usd">-1737000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIxLTMtMS0xLTA_b01a6a80-ac64-41bd-b034-5ae631e4d351"
      unitRef="usd">128000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIyLTEtMS0xLTA_6be388ae-110a-40f5-8827-be36b6ee91bf"
      unitRef="usd">-7716000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIyLTMtMS0xLTA_487e5b5a-6ee6-4b93-8987-6ce9b5fb3536"
      unitRef="usd">1430000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIzLTEtMS0xLTA_d18263ff-5214-4313-b68a-fdbabf00edf7"
      unitRef="usd">-658000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzIzLTMtMS0xLTA_e66c55ea-d15e-4e23-95d6-6ed6154fded1"
      unitRef="usd">771000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzI0LTEtMS0xLTA_f28b55e7-79fb-4bdf-8b98-69de8d81a909"
      unitRef="usd">-7058000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzI0LTMtMS0xLTA_64cfafbe-5fa1-437b-94ab-5f61bc73b7da"
      unitRef="usd">659000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzI3LTEtMS0xLTA_722ed7ff-92ab-4527-b905-dde89dd59c6f"
      unitRef="usdPerShare">-1.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzI3LTMtMS0xLTA_bbc47080-7216-4160-a042-dfcbbd51deb8"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzI4LTEtMS0xLTA_a1d1abb4-b12f-475a-b30b-6b4af0871213"
      unitRef="usdPerShare">-1.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xMzkvZnJhZzo0MGY1NjRmY2YxNWU0YmE2OTNhZGJkYjYzMmIwOWZmOC90YWJsZTo2MjA1ZmU2ZTFlYTg0OGJiYTI0MmU2ZTE4NjQ3OGI5My90YWJsZXJhbmdlOjYyMDVmZTZlMWVhODQ4YmJhMjQyZTZlMTg2NDc4YjkzXzI4LTMtMS0xLTA_21e8872c-f590-4999-974c-c03022cad30a"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharesOutstanding
      contextRef="i80d152c66b98490fac1712dd5160d5b6_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTEtMS0xLTA_23885de8-45f0-49bc-9458-0aab3e8dcddb"
      unitRef="shares">5714000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80d152c66b98490fac1712dd5160d5b6_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTMtMS0xLTA_a4519d03-85e3-4430-90bf-d5efed42fd3f"
      unitRef="usd">10711000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f2c5098442b4ca0990024d0a044f71d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTUtMS0xLTA_498b21f6-a172-4dbc-bd31-c45d1a1eee35"
      unitRef="usd">6495000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4eb01d36262d48dab3093fa93a55a639_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTctMS0xLTA_4681e222-57dd-4efb-9074-c5ee6f00d25b"
      unitRef="usd">7896000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieffba5f94e464f3c9847c0ba5b17a15d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTktMS0xLTA_18df6782-5010-4fb9-8fb9-70b5dc46522c"
      unitRef="usd">25102000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1eaabaa2b68f452d814855cd3337f66d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTExLTEtMS0w_fafd6955-2e1a-4dc3-9ceb-405bdf1c135e"
      unitRef="usd">5946000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i88d4659da27e48458ba86016aae09e94_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE0LTEzLTEtMS0w_e2a9e8a7-d15e-4d7b-ae3b-afa89ea92666"
      unitRef="usd">31048000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="idce4f3d545f2476ebdc0f7f36157ebb5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE1LTEtMS0xLTA_d07b95e7-96cf-4e4f-9783-ca00b736ed37"
      unitRef="shares">4000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id5dfe6ce5ed7480b9e09f5b3476be864_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE1LTUtMS0xLTA_cd11d104-ad0c-48ab-9630-f47bbd8b2630"
      unitRef="usd">230000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0811458740d6449891c3119d222599c5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE1LTktMS0xLTA_c3a3c89b-0382-43fa-80f6-30362e67ac55"
      unitRef="usd">230000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE1LTEzLTEtMS0w_678580f5-2744-44a4-ab6f-8afd5fb0c787"
      unitRef="usd">230000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idce4f3d545f2476ebdc0f7f36157ebb5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE2LTEtMS0xLTA_11abaeee-b0e1-47b9-9f30-348310c190b7"
      unitRef="shares">16000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="idce4f3d545f2476ebdc0f7f36157ebb5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE2LTMtMS0xLTA_b443e44d-a62c-447a-b686-799eeaa32bc6"
      unitRef="usd">42000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0811458740d6449891c3119d222599c5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE2LTktMS0xLTA_7d68d442-0ded-4fce-ac33-582d811ea773"
      unitRef="usd">42000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE2LTEzLTEtMS0w_c6b9b129-5b0d-424b-b4a7-fa6fb01734d4"
      unitRef="usd">42000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="idce4f3d545f2476ebdc0f7f36157ebb5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE3LTEtMS0xLTA_74cdabe3-49ac-4ffb-b473-5ffb4ab9c338"
      unitRef="shares">83000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0146f023f5af475e8c42899ccb2714bd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE4LTExLTEtMS0w_f92669e1-1688-47fa-96b7-d87ffb494086"
      unitRef="usd">939000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE4LTEzLTEtMS0w_5d5f84eb-4e25-4d63-a1c1-961b5b813854"
      unitRef="usd">939000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:ProfitLoss
      contextRef="i49250096dac54dbc9d6f411a7223e401_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE5LTctMS0xLTA_d8578e43-f869-4149-a7cf-fdccb7931207"
      unitRef="usd">659000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0811458740d6449891c3119d222599c5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE5LTktMS0xLTA_a9c0bace-a411-4177-8124-e9a7904a7fb4"
      unitRef="usd">659000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0146f023f5af475e8c42899ccb2714bd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE5LTExLTEtMS0w_0a000fe8-5737-42a0-9beb-a00b9103a17b"
      unitRef="usd">771000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzE5LTEzLTEtMS0w_e21807ca-ed28-4540-b9cb-92248080ca75"
      unitRef="usd">1430000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="i1933947a2065450e947da821bf4a32d6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTEtMS0xLTA_1a9d0939-bbfb-4188-afd4-e5c9729c7825"
      unitRef="shares">5817000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1933947a2065450e947da821bf4a32d6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTMtMS0xLTA_88a0c18a-1dab-4849-b262-c213ced74d33"
      unitRef="usd">10753000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95945ee330d74bbe84786fe63dbd0fe7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTUtMS0xLTA_388c2e77-7c7e-4807-9a2e-1593e96dc858"
      unitRef="usd">6725000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i031366823611429984ba59da571f0cf4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTctMS0xLTA_a627a827-78be-4498-be7c-3c0d979c5f83"
      unitRef="usd">8555000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i63c0e34c40b84e128c70ede3ca6deb9b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTktMS0xLTA_bb97b688-bf75-454d-a898-e6e8d1126d74"
      unitRef="usd">26033000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibaf32a31b8e945bca3c5332f1bd4ea42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTExLTEtMS0w_cd42bebe-6831-4b41-8579-a93b8c09505e"
      unitRef="usd">5778000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIwLTEzLTEtMS0w_3a9ea9ef-1b38-4ec7-94d9-5f9db3a00a15"
      unitRef="usd">31811000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="icdb999bd1cf140c987a60e65653baa9d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIxLTEtMS0xLTEzOA_378e2961-e52f-4f1e-8de0-900764db95f5"
      unitRef="shares">103000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0c7ecb5b71704129a21136aa3a829d59_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIxLTUtMS0xLTEzOA_6a20acd6-71ab-4bc7-9f6b-1a68d8708df9"
      unitRef="usd">299000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i90f32e02b365478c95091f9014bef961_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIxLTktMS0xLTEzOA_2418feed-4a0e-4389-9af8-b5b826b01d5e"
      unitRef="usd">299000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIxLTEzLTEtMS0xMzg_9d865349-3a3a-422f-b4f9-fa474e67b182"
      unitRef="usd">299000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ib9a7f6cfe5f24a45b55dad44c8b94d99_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIyLTExLTEtMS0xMzg_5c2614e8-c647-450d-97a0-f062365a1760"
      unitRef="usd">761000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIyLTEzLTEtMS0xMzg_8dfbb1c7-73c5-4118-800c-b13c769f06e3"
      unitRef="usd">761000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ib9a7f6cfe5f24a45b55dad44c8b94d99_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIzLTExLTEtMS0xMzg_3aeb274f-248b-4c6f-a4ce-eb1c13a1bc5a"
      unitRef="usd">17000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzIzLTEzLTEtMS0xMzg_b3f1e105-a623-4a64-9b30-11a2dd11fe74"
      unitRef="usd">17000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI0LTEtMS0xLTEzOA_ba2f84f4-3da8-40a3-8022-f6805ed088d6"
      unitRef="shares">129000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ProfitLoss
      contextRef="id6742d6b210b4bc7b247bbd2b1bbcdcd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI1LTctMS0xLTEzOA_d3a8202f-bbd5-4927-9d8c-2d02b56cc27d"
      unitRef="usd">-7058000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i90f32e02b365478c95091f9014bef961_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI1LTktMS0xLTEzOA_313e4285-29eb-4e53-aa56-e41af355e486"
      unitRef="usd">-7058000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib9a7f6cfe5f24a45b55dad44c8b94d99_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI1LTExLTEtMS0xMzg_bdce3a63-d3bd-4c14-b886-08984e3b917d"
      unitRef="usd">-658000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI1LTEzLTEtMS0xMzg_9095e95c-f30e-4986-a7cc-dfb785a1b9f2"
      unitRef="usd">-7716000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="if300614914f840d5afcad30cf88400e1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTEtMS0xLTEzOA_94855859-21f6-4db2-b770-0e605fe2223e"
      unitRef="shares">5791000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if300614914f840d5afcad30cf88400e1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTMtMS0xLTEzOA_60458678-4b10-4b78-ab5e-986179c82d79"
      unitRef="usd">10753000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1d457b7646a4469d9fe2d92f4b9ba9dc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTUtMS0xLTEzOA_af86c758-04de-4081-8d7c-2b14fe8fe50b"
      unitRef="usd">7024000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iedffb7791f4c42a8a3e5d969848aaeb4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTctMS0xLTEzOA_ad6d4ef6-a244-4e11-9399-8b0ce12ddeb4"
      unitRef="usd">1497000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i02bbd8133d3c48bebba8d7203bfb8f52_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTktMS0xLTEzOA_72755649-eb38-4624-a2f7-4b9a67ae21b2"
      unitRef="usd">19274000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i890ba0391e8b420f8705f2e7726453b8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTExLTEtMS0xMzg_dcbf62d3-bb07-4e26-8e93-378556d99415"
      unitRef="usd">4376000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDIvZnJhZzo0MTRkNTE4YTA3ZGI0M2EyOWY5YTkwNDg4OTRiODZiNS90YWJsZTo2MGE0YmUyMjYwM2U0ZDUyYWJjNmJiN2U1YTZhOGFiNS90YWJsZXJhbmdlOjYwYTRiZTIyNjAzZTRkNTJhYmM2YmI3ZTVhNmE4YWI1XzI2LTEzLTEtMS0xMzg_f1e9a6e5-8d0a-42b7-a513-b8dcdc385a70"
      unitRef="usd">23650000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzUtMS0xLTEtMA_8faf4301-e0ef-44ee-9bf0-8a0f547f5590"
      unitRef="usd">-7716000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzUtMy0xLTEtMA_5046d674-cc5a-4658-9e08-47b635d9b4b6"
      unitRef="usd">1430000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzctMS0xLTEtMA_ab351ba6-5e6a-48f7-87dc-51507375a6a7"
      unitRef="usd">6970000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzctMy0xLTEtMA_10b18e8c-fa44-42e2-bedd-b7872aeb92f3"
      unitRef="usd">7411000</us-gaap:DepreciationDepletionAndAmortization>
    <ams:NonCashLeaseExpense
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzktMS0xLTEtMA_cdab8824-5236-4433-9017-aebc6c9b0d83"
      unitRef="usd">288000</ams:NonCashLeaseExpense>
    <ams:NonCashLeaseExpense
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzktMy0xLTEtMA_8c7462e9-de06-4237-9351-c01486f5d2a2"
      unitRef="usd">256000</ams:NonCashLeaseExpense>
    <us-gaap:AssetImpairmentCharges
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzExLTEtMS0xLTA_06614a17-2dca-4c52-90c5-f82702cf5f8c"
      unitRef="usd">8184000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzExLTMtMS0xLTA_4155545e-3246-4e0c-a7f4-623201434e16"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzEyLTEtMS0xLTA_4ea65335-61a9-4754-af2c-4a60da3a9a07"
      unitRef="usd">-2162000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzEyLTMtMS0xLTA_f9ad7509-3166-4171-957e-9d66a3270812"
      unitRef="usd">-444000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <ams:InterestExpenseLeaseFinancing
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzEzLTEtMS0xLTA_16149612-dd8d-422f-96d5-26883714d1cb"
      unitRef="usd">0</ams:InterestExpenseLeaseFinancing>
    <ams:InterestExpenseLeaseFinancing
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzEzLTMtMS0xLTA_4e2132ea-2c96-47f5-9a5d-4a498f557e25"
      unitRef="usd">29000</ams:InterestExpenseLeaseFinancing>
    <us-gaap:ShareBasedCompensation
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE0LTEtMS0xLTA_c88df995-bd79-43e7-9368-691cb7e7aa65"
      unitRef="usd">299000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE0LTMtMS0xLTA_008f6512-ae53-4bd6-a63f-cb911c7e4917"
      unitRef="usd">230000</us-gaap:ShareBasedCompensation>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE1LTEtMS0xLTA_c427173e-490c-4c36-a80b-cb70fc2c3c88"
      unitRef="usd">65000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE1LTMtMS0xLTA_b2d5279d-0b77-43c6-97c1-ac27d221ca84"
      unitRef="usd">76000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE3LTEtMS0xLTA_7941462c-ceae-455e-ab03-5f48b10f7023"
      unitRef="usd">-2966000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE3LTMtMS0xLTA_837e9145-0919-4a38-88ef-b0b25ba00b5d"
      unitRef="usd">1187000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE4LTEtMS0xLTA_e30bfd5a-1047-4fab-abac-af1c0aae5f1a"
      unitRef="usd">-762000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE4LTMtMS0xLTA_90282408-4cb7-45a9-b9ec-5cec845a1780"
      unitRef="usd">-260000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <ams:IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE5LTEtMS0xLTA_4760da30-a59b-42bd-bf64-51241301992a"
      unitRef="usd">-263000</ams:IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue>
    <ams:IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzE5LTMtMS0xLTA_8b226a2b-2957-4d01-81ad-83a21bfc474b"
      unitRef="usd">-28000</ams:IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue>
    <ams:IncreaseDecreaseInLeaseLiabilities
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIwLTEtMS0xLTA_fa0dafbe-41f9-46b7-80ba-874e8c885215"
      unitRef="usd">-353000</ams:IncreaseDecreaseInLeaseLiabilities>
    <ams:IncreaseDecreaseInLeaseLiabilities
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIwLTMtMS0xLTA_ac146585-e33e-4838-9049-45c53cb78e46"
      unitRef="usd">-332000</ams:IncreaseDecreaseInLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIxLTEtMS0xLTA_af8550a3-f40b-4f12-91dc-34c8c6f161b2"
      unitRef="usd">179000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIxLTMtMS0xLTA_cd14f6d1-c794-4cea-8d7c-6995f0c775ea"
      unitRef="usd">130000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <ams:IncreaseDecreaseInOtherReceivableInsuranceSettlements
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIyLTEtMS0xLTA_abf61b2c-5a23-4877-aef0-394eb2ce9c65"
      unitRef="usd">0</ams:IncreaseDecreaseInOtherReceivableInsuranceSettlements>
    <ams:IncreaseDecreaseInOtherReceivableInsuranceSettlements
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIyLTMtMS0xLTA_fcea387e-63f3-461c-bfa5-371368ec3c77"
      unitRef="usd">-160000</ams:IncreaseDecreaseInOtherReceivableInsuranceSettlements>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIzLTEtMS0xLTA_beecc687-bf3f-4fd6-966a-421b89f32670"
      unitRef="usd">9745000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzIzLTMtMS0xLTA_d200ea4b-c41e-4980-b283-f574529cf33d"
      unitRef="usd">8047000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI1LTEtMS0xLTA_c96057a7-2af4-43d4-89d8-b34bce355608"
      unitRef="usd">455000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI1LTMtMS0xLTA_bea55071-4cca-408b-a382-82a37a7ece6e"
      unitRef="usd">990000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI2LTEtMS0xLTIyMw_b6a1b83d-c3d7-43b3-9ffa-b70ce7fa1c1b"
      unitRef="usd">2084000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI2LTMtMS0xLTIyMw_a94c7358-3bcb-4bde-9c3a-e3a312bbf359"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromSaleOfMachineryAndEquipment
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI3LTEtMS0xLTA_388ea922-428b-4bfd-8eff-ff35376d057f"
      unitRef="usd">150000</us-gaap:ProceedsFromSaleOfMachineryAndEquipment>
    <us-gaap:ProceedsFromSaleOfMachineryAndEquipment
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI3LTMtMS0xLTA_2522d97b-a542-4f27-8487-db4ddec4fa42"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfMachineryAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI4LTEtMS0xLTA_1ad51bdc-231b-4af4-86a8-e9c42dd49b9c"
      unitRef="usd">-2389000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzI4LTMtMS0xLTA_f7900913-da91-44b1-a454-6ab6e34bd6c4"
      unitRef="usd">-990000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMwLTEtMS0xLTA_172c4586-51de-4757-a3bc-333d16f29927"
      unitRef="usd">1726000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMwLTMtMS0xLTA_05563121-c001-4ebb-9e0c-9e8eb6fec0f6"
      unitRef="usd">1980000</us-gaap:RepaymentsOfLongTermDebt>
    <ams:RepaymentsOfLongTermFinanceLeaseObligations
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMxLTEtMS0xLTA_99b34724-fe90-46b6-a9ea-f2bf3aeef827"
      unitRef="usd">3199000</ams:RepaymentsOfLongTermFinanceLeaseObligations>
    <ams:RepaymentsOfLongTermFinanceLeaseObligations
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMxLTMtMS0xLTA_08d12668-61ac-41bc-b5bf-d44e4f37abc8"
      unitRef="usd">4142000</ams:RepaymentsOfLongTermFinanceLeaseObligations>
    <ams:ProceedsFromFinancingFromAcquisition
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMzLTEtMS0xLTIzNw_6a763bdd-8105-4be2-994a-134d96ca0381"
      unitRef="usd">1425000</ams:ProceedsFromFinancingFromAcquisition>
    <ams:ProceedsFromFinancingFromAcquisition
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMzLTMtMS0xLTIzNw_820b4c00-38bc-4b6a-8e49-fba7e60be3a9"
      unitRef="usd">0</ams:ProceedsFromFinancingFromAcquisition>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMyLTEtMS0xLTA_e3e25877-b36f-40af-bbe6-0711d6f5379c"
      unitRef="usd">761000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMyLTMtMS0xLTA_7fd8e08b-6c16-4d6c-aeb3-6f51c579ab33"
      unitRef="usd">939000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM0LTEtMS0xLTIzMA_f0499933-9b2d-4c30-a45b-8bb96f1dbcc9"
      unitRef="usd">30000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM0LTMtMS0xLTIzMA_31839de7-6474-4165-b3c3-14a0700cf45d"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMzLTEtMS0xLTA_3300ff4e-32de-4890-b45f-bf18cf0b9ebb"
      unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzMzLTMtMS0xLTA_e89c5577-6bdc-45e8-8fd0-624707b669d6"
      unitRef="usd">42000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromLongTermCapitalLeaseObligations
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM0LTEtMS0xLTA_f654a360-d23d-4fb1-9e91-8ab173c9dfce"
      unitRef="usd">-519000</us-gaap:ProceedsFromLongTermCapitalLeaseObligations>
    <us-gaap:ProceedsFromLongTermCapitalLeaseObligations
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM0LTMtMS0xLTA_4edef950-f459-49af-b394-1e0562bb5237"
      unitRef="usd">-51000</us-gaap:ProceedsFromLongTermCapitalLeaseObligations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM1LTEtMS0xLTA_d4ab6625-fc0e-48fe-a773-5c1599441bc2"
      unitRef="usd">-4810000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM1LTMtMS0xLTA_ac7de1b0-e784-4e5a-8593-79e591a76b6d"
      unitRef="usd">-7070000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM2LTEtMS0xLTA_f8bf15a3-e437-4bd4-9332-d0f89bea89ea"
      unitRef="usd">2546000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM2LTMtMS0xLTA_0d31be1f-1e8e-43f5-8889-68f96cdd93e4"
      unitRef="usd">-13000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM3LTEtMS0xLTA_8212e90b-04f8-430c-aacd-fbb89a8a7851"
      unitRef="usd">1779000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i88d4659da27e48458ba86016aae09e94_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM3LTMtMS0xLTA_eae9f06a-b8b0-4a18-9e7a-2331528271d0"
      unitRef="usd">1792000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM4LTEtMS0xLTA_7ff09e56-fd5e-4d65-80ab-736f890c3726"
      unitRef="usd">4325000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzM4LTMtMS0xLTA_3817f54c-cc3f-41b9-93ba-e3f495a8a722"
      unitRef="usd">1779000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQxLTEtMS0xLTA_140135d4-3875-4779-b62e-8114e89b13b9"
      unitRef="usd">938000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQxLTMtMS0xLTA_e2d36e24-d2bd-41fe-8b30-a99e77653065"
      unitRef="usd">1318000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQyLTEtMS0xLTA_2c007dde-bfaf-4876-867f-f97a56b6e95b"
      unitRef="usd">339000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQyLTMtMS0xLTA_0af0a81f-c9fe-4895-ac28-1020d601cb7f"
      unitRef="usd">397000</us-gaap:IncomeTaxesPaid>
    <ams:LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ4LTEtMS0xLTI0NA_f5804c7c-b9ef-4e80-8e91-745fcd8e29b0"
      unitRef="usd">67000</ams:LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities>
    <ams:NonCashRightOfUseAssetsAndLeaseLiabilities
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ5LTEtMS0xLTI0OA_935cbe2a-459d-4b3a-955e-733d6a998c95"
      unitRef="usd">135000</ams:NonCashRightOfUseAssetsAndLeaseLiabilities>
    <ams:NonCashRightOfUseAssetsAndLeaseLiabilities
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ5LTMtMS0xLTI0OA_b9dcc3ee-12c3-4946-9815-e73c6ad840d1"
      unitRef="usd">1362000</ams:NonCashRightOfUseAssetsAndLeaseLiabilities>
    <ams:InterestCapitalizedToPropertyAndEquipment
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzUwLTEtMS0xLTI3MDA_33ecb4cb-7938-47df-852a-7f303091b190"
      unitRef="usd">119000</ams:InterestCapitalizedToPropertyAndEquipment>
    <ams:InterestCapitalizedToPropertyAndEquipment
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzUwLTMtMS0xLTI3MDU_38d7f488-ddf4-4a68-95b5-7e3d7adee3e1"
      unitRef="usd">110000</ams:InterestCapitalizedToPropertyAndEquipment>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ1LTEtMS0xLTA_b265f6a7-553c-4a31-839a-3c28b27014c1"
      unitRef="usd">496000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ1LTMtMS0xLTA_e65c16d5-6760-4a7f-aef6-581cbaa4e607"
      unitRef="usd">1293000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <ams:AcquisitionOfEquipmentWithLongTermDebtFinancing
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ2LTEtMS0xLTA_dced186a-ad66-4893-989e-25f2631d9e94"
      unitRef="usd">1184000</ams:AcquisitionOfEquipmentWithLongTermDebtFinancing>
    <ams:AcquisitionOfEquipmentWithLongTermDebtFinancing
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ2LTMtMS0xLTA_a0fc1536-2d56-446e-b1b9-4a130229f688"
      unitRef="usd">0</ams:AcquisitionOfEquipmentWithLongTermDebtFinancing>
    <ams:AcquisitionOfInsuranceWithShortTermFinancing
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ3LTEtMS0xLTA_a72c2dca-184a-48f2-bc3e-b74e6bfe44a9"
      unitRef="usd">634000</ams:AcquisitionOfInsuranceWithShortTermFinancing>
    <ams:AcquisitionOfInsuranceWithShortTermFinancing
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzQ3LTMtMS0xLTA_5e5a7713-327f-43c8-b5b5-d2df275307a9"
      unitRef="usd">526000</ams:AcquisitionOfInsuranceWithShortTermFinancing>
    <ams:PaymentsForWorkingCapital
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzU0LTEtMS0xLTI1Ng_1a29e144-e477-463c-b947-ddd3acebac9f"
      unitRef="usd">43000</ams:PaymentsForWorkingCapital>
    <ams:SubsequentWorkingCapitalPaymentAccruedForAcquisition
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNDUvZnJhZzpkZmEyNTlkNjZjZTA0Mzk4OGVkM2RlOWI4YWQ5NzhkOS90YWJsZToyYjZiM2UwZGY0ODM0OWVmYjlhZjc0YWY5YjEwODY2OS90YWJsZXJhbmdlOjJiNmIzZTBkZjQ4MzQ5ZWZiOWFmNzRhZjliMTA4NjY5XzU1LTEtMS0xLTI2Nw_882eaea4-0c7d-4fd5-9720-d3845f42f869"
      unitRef="usd">154000</ams:SubsequentWorkingCapitalPaymentAccruedForAcquisition>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzMwMDg_31dc4483-0996-4026-9197-d61d3a1cfb20">B&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;USINESS AND&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; B&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ASIS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;OF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; P&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;RESENTATION&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; These consolidated financial statements include the accounts of American Shared Hospital Services and its subsidiaries (the &#x201c;Company&#x201d;) as follows: the Company wholly-owns the subsidiaries American Shared Radiosurgery Services (&#x201c;ASRS&#x201d;), PBRT Orlando, LLC (&#x201c;Orlando&#x201d;), OR21, Inc., and MedLeader.com, Inc. (&#x201c;MedLeader&#x201d;); the Company is the majority owner of Long Beach Equipment, LLC (&#x201c;LBE&#x201d;); ASRS is the majority-owner of GK Financing, LLC (&#x201c;GKF&#x201d;) which wholly-owns the subsidiary Instituto de Gamma Knife del Pacifico S.A.C. (&#x201c;GKPeru&#x201d;). GKF is the majority owner of the subsidiaries Albuquerque GK Equipment, LLC (&#x201c;AGKE&#x201d;) and Jacksonville GK Equipment, LLC (&#x201c;JGKE&#x201d;).  GKF formed HoldCo GKC S.A. (&#x201c;HoldCo&#x201d;) to acquire Gamma Knife Center Ecuador S.A. (&#x201c;GKCE&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company (through ASRS) and Elekta AG (&#x201c;Elekta&#x201d;), the manufacturer of the Gamma Knife (through its wholly-owned United States subsidiary, GKV Investments, Inc.), entered into an operating agreement and formed GKF. During 2020 GKF provided Gamma Knife units to fifteen medical centers in the United States in the states of Arkansas, California, Florida, Illinois, Indiana, Massachusetts, Mississippi, Nebraska, New Mexico, New York, Ohio, Oregon, Tennessee, and Texas. GKF also owns and operates single-unit Gamma Knife facilities in Lima, Peru and Guayaquil, Ecuador. The Company through its wholly-owned subsidiary, Orlando, provided proton beam radiation therapy (&#x201c;PBRT&#x201d;) and related equipment to a customer in the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company formed the subsidiary GKPeru and acquired GKCE for the purposes of expanding its business internationally; Orlando and LBE to provide PBRT equipment and services in Orlando, Florida and Long Beach, California, respectively; and AGKE and JGKE to provide Gamma Knife equipment and services in Albuquerque, New Mexico and Jacksonville, Florida, respectively. AGKE began operations in the second quarter of 2011 and JGKE began operations in the fourth quarter of 2011. Orlando treated its first patient in April 2016. GKPeru treated its first patient in July 2017. LBE is not expected to generate revenue within the next two years.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 12, 2020, GKF, through HoldCo, purchased approximately 98% of the total outstanding shares of GKCE, from GKCE&#x2019;s majority shareholders (the &#x201c;Acquisition&#x201d;). As of December 31, 2020, the Company had acquired approximately 99.3% of the total outstanding shares of GKCE and intends to acquire the remaining 0.7% at a later date. The base purchase price for the Acquisition, including acquisition of the minority shares was approximately $2,000,000. This purchase price was paid with $575,000 in cash and a $1,425,000 loan from the United States International Development Finance Corporation (&#x201c;DFC&#x201d;).  The purchase price is subject to certain post-closing adjustments, including adjustment for GKCE's working capital and excess cash.  The DFC loan is denominated in U.S. dollars, which is also the currency of Ecuador.  See &#x201c;Note 4. GKCE Acquisition&#x201d; for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to develop its design and business model for The Operating Room for the 21st Century&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;SM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; through its 50% owned OR21, LLC (&#x201c;OR21&#x201d;). The remaining 50% of OR21 is owned by an architectural design company. OR21 is not expected to generate significant revenue within the next two years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MedLeader was formed to provide continuing medical education online and through videos for doctors, nurses, and other healthcare workers. This subsidiary is not operational at this time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All significant intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to risks and uncertainties as a result of the COVID-19 pandemic and the extent and duration of the future impact on the Company's business is highly uncertain and difficult to predict. The COVID-19 pandemic has adversely impacted, and is likely to further adversely impact, nearly all aspects of the Company&#x2019;s business and markets, including its employees, operations, contractors, customers, government and third party payors and others. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition will depend on future developments that are highly uncertain and difficult to predict.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <ams:AssetAcquisitionPercentageOfSharesAcquired
      contextRef="i6422158328d64dee80e1ac0f4c7ef41f_I20200612"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzEwOTk1MTE2MzQyMjM_ed5c7eea-9179-48d8-a91e-2ef37a6e782a"
      unitRef="number">0.98</ams:AssetAcquisitionPercentageOfSharesAcquired>
    <ams:AssetAcquisitionPercentageOfSharesAcquired
      contextRef="i795a789ed9064252be4a8f64e1390165_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzEwOTk1MTE2MzQzODQ_6aaec314-8670-477e-9520-c07294e43b18"
      unitRef="number">0.993</ams:AssetAcquisitionPercentageOfSharesAcquired>
    <ams:AssetAcquisitionPercentageOfSharesRemaining
      contextRef="i6422158328d64dee80e1ac0f4c7ef41f_I20200612"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzEwOTk1MTE2MzQ0NjU_1f7296a2-bc46-409a-a9f6-0a6e4b69855c"
      unitRef="number">0.007</ams:AssetAcquisitionPercentageOfSharesRemaining>
    <ams:AssetAcquisitionConsiderationTransferred
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzEwOTk1MTE2MzQ1OTQ_02ad57f5-05a6-4c3d-858e-8592e5b4352c"
      unitRef="usd">2000000</ams:AssetAcquisitionConsiderationTransferred>
    <ams:PaymentsForAssetAcquisitions
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzEwOTk1MTE2MzQ2MzM_3e10a72d-f775-4667-a6cf-dd3955856731"
      unitRef="usd">575000</ams:PaymentsForAssetAcquisitions>
    <ams:AssetAcquisitionTransactionCosts
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzEwOTk1MTE2MzQ2NTE_424bdd03-0fad-4364-9dce-071060dbdc60"
      unitRef="usd">1425000</ams:AssetAcquisitionTransactionCosts>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i410be01cd1af4746a125e7746f1d7df8_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzI1NDk_bdb76607-46e7-4622-bc9a-ade1161f1421"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i40610f194f284cf08a0a82249bb51162_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTEvZnJhZzpkNjM0NjU5YTExMzM0OTQxYjkyYzY5MDY5NTlkYzc0NC90ZXh0cmVnaW9uOmQ2MzQ2NTlhMTEzMzQ5NDFiOTJjNjkwNjk1OWRjNzQ0XzI1OTI_3f7dd106-1a52-4d15-b85f-910b4d02b077"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTgz_fec59777-864b-42e5-9886-7491a01a906d">A&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;CCOUNTING&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; P&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;OLICIES&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of estimates in the preparation of financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; In preparing the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates reflected in the Company&#x2019;s consolidated financial statements include the estimated useful lives of fixed assets and its salvage values, revenues and costs of sales for turn-key and revenue sharing arrangements.&#160; Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company expenses advertising costs as incurred. Advertising costs were $237,000 and $144,000 during the years ended December&#160;31, 2020 and 2019. Advertising costs are recorded in other direct operating costs and sales and administrative costs in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company considers all liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. Restricted cash is not considered a cash equivalent for purposes of the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Restricted cash represents the minimum cash that must be maintained in GKF to fund operations, per the subsidiary&#x2019;s operating agreement, the minimum cash that must be maintained by GKF per it&#x2019;s financing agreement with DFC, and the minimum cash that must be maintained in Orlando per the subsidiary&#x2019;s financing agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business and credit risk&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company maintains its cash balances, which exceed federally insured limits, in financial institutions. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents. The Company monitors the financial condition of the financial institutions it uses on a regular basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s revenue was provided by eighteen and seventeen customers in 2020 and 2019. One customer accounted for approximately 35% and 30% of the Company&#x2019;s total revenue in 2020 and 2019. At December&#160;31, 2020, four customers each individually accounted for 11%, 11%, 11% and 20% of total accounts receivable, respectively. At December&#160;31, 2019, three customers each individually accounted for 12%, 15% and 30% of total accounts receivable, respectively. The Company performs credit evaluations of its customers and generally does not require collateral. The Company has not experienced significant losses related to receivables from individual customers or groups of customers in any particular geographic area.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s radiosurgery devices have been purchased through Elekta, to date. However, there are other manufacturers that also make radiosurgery devices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts receivable and doubtful accounts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Accounts receivable are recorded at net realizable value. An allowance for doubtful accounts is estimated based on historical collections plus an allowance for probable losses. Receivables are considered past due based on contractual terms and are charged off in the period that they are deemed uncollectible. Recoveries of receivables previously charged off are offset against bad debt expense when received.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company reports its non-controlling interests as a separate component of shareholders&#x2019; equity. The Company also presents the consolidated net income and the portion of the consolidated net income allocable to the non-controlling interests and to the shareholders of the Company separately in its consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Property and equipment are stated at cost less accumulated depreciation. Depreciation for Gamma Knife, IGRT, and other equipment is determined using the straight-line method over the estimated useful lives of the assets, which for medical and office equipment is generally 3 &#x2013; 10 years, and after accounting for salvage value on the equipment where indicated. Salvage value is based on the estimated fair value of the equipment at the end of its useful life.  The Company acquired a building as part of the Acquisition in June 2020.  Depreciation for buildings is determined using the straight-line method over 20 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation for PBRT and related equipment is determined using the modified units of production method, which is a function of both time and usage of the equipment. This depreciation method allocates costs considering the projected volume of usage through the useful life of the PBRT unit, which has been estimated at 20 years. The estimated useful life of the PBRT unit is consistent with the estimated economic life of 20 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes interest incurred on property and equipment that is under construction, for which deposits or progress payments have been made. When a rate is not readily available, imputed interest is calculated using the Company&#x2019;s incremental borrowing rate. The interest capitalized for property and equipment is the portion of interest cost incurred during the acquisition periods that could have been avoided if expenditures for the equipment had not been made. The Company capitalized interest of $119,000 and $110,000 in 2020 and 2019, respectively, as costs of medical equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases Gamma Knife and radiation therapy equipment to its customers under arrangements accounted for as operating leases. At December&#160;31, 2020, the Company held equipment under operating lease contracts with customers with an original cost of $75,241,000 and accumulated depreciation of $45,416,000. At December&#160;31, 2019, the Company held equipment under operating lease contracts with customers with an original cost of $92,135,000 and accumulated depreciation of $55,148,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company recognized a loss on the write down of impaired assets of $8,264,000.  The impaired assets included six (6) Gamma Knife units and the Company's deposits towards purchase of proton beam systems and related capitalized interest.  See further discussion under Note 2 - Long-lived asset impairment and Note 3 - Property and Equipment for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company&#x2019;s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels. Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company&#x2019;s own assumptions about the assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s assets and liabilities as of December&#160;31, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company recognizes revenues under ASC 842 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 842&#x201d;) and ASC 606 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 606&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rental income from medical services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company recognizes revenues under ASC 842 when services have been rendered and collectability is reasonably assured, on either a fee per use or revenue sharing basis. The terms of the contracts do not contain any guaranteed minimum payments. The Company&#x2019;s contracts are typically for a 10-year term and are classified as either fee per use or retail. Retail arrangements are further classified as either turn-key or revenue sharing. Revenues from fee per use contracts is determined by each hospital&#x2019;s contracted rate. Revenues are recognized at the time the procedures are performed, based on each hospital&#x2019;s contracted rate and the number of procedures performed. Under revenue sharing arrangements, the Company receives a contracted percentage of the reimbursement received by the hospital. The amount the Company expects to receive is recorded as revenue and estimated based on historical experience. Revenue estimates are reviewed periodically and adjusted as necessary. Under turn-key arrangements, the Company receives payment from the hospital in the amount of the hospital&#x2019;s reimbursement from third party payors, and the Company is responsible for paying all the operating costs of the equipment. Operating costs are determined primarily based on historical treatment protocols and cost schedules with the hospital. The Company records an estimate of operating costs which are reviewed on a regular basis and adjusted as necessary to more accurately reflect the actual operating costs. For turn-key sites, the Company also shares a percentage of net operating profit. The Company records an estimate of net operating profit based on estimated revenues, less estimated operating costs. The operating costs and estimated net operating profit are recorded as other direct operating costs in the consolidated statement of operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As of December&#160;31, 2020 and 2019, the Company recognized revenues of approximately $16,204,000 and $19,396,000 under ASC 842, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patient income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company has stand-alone facilities in Lima, Peru and Guayaquil, Ecuador, where a contract exists between the Company&#x2019;s facilities and the individual patient treated at the facility. Under ASC 606, the Company acts as the principal in this transaction and provides, at a point in time, a single performance obligation, in the form of a Gamma Knife treatment. Revenue related to a Gamma Knife treatment is recognized on a gross basis at the time when the patient receives treatment. There is no variable consideration present in the Company&#x2019;s performance obligation and the transaction price is agreed upon per the stated contractual rate. GKPeru's payment terms are typically prepaid for self-pay patients and insurance provider payments are paid net 30 days. GKCE's patient population is primarily covered by a government payor and payments are paid approximately 30 to 60 days upon invoice. The Company did not capitalize any incremental costs related to the fulfillment of its customer contracts.  Accounts receivable earned by GKPeru were not significant for the year ended December&#160;31, 2020 and 2019. GKCE's accounts receivable were $467,000 for the year ended December&#160;31, 2020. As of December&#160;31, 2020 and 2019, the Company recognized revenues of approximately $1,633,000 and $1,209,000 under ASC 606, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company measures all stock-based compensation awards at fair value and records such expense in its consolidated financial statements over the requisite service period of the related award. See Note 9 for additional information on the Company&#x2019;s stock-based compensation programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Costs of revenue &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's costs of revenue consist primarily of maintenance and supplies, depreciation and amortization, and other operating expenses (such as insurance, property taxes, sales taxes, marketing costs and operating costs from the Company&#x2019;s retail sites). Costs of revenues are recognized as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Sales and Marketing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company markets its services through its preferred provider status with Elekta and a direct sales effort led by its Senior Vice President of Sales and Business Development, its President and Chief Financial and Operating Officer and its Chief Executive Officer (&#x201c;CEO&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company typically provides the equipment, as well as planning, installation, reimbursement and marketing support services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for uncertainty in income taxes as required by the provisions of ASC 740 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 740&#x201d;), which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to estimate and measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement. It is inherently difficult and subjective to estimate such amounts, as this requires the Company to determine the probability of various possible outcomes. The Company considers many factors when evaluating and estimating the Company&#x2019;s tax positions and tax benefits, which may require periodic adjustments and may not accurately anticipate actual outcomes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 8 for further discussion on income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Functional currency&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Based on guidance provided in accordance with ASC 830, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 830&#x201d;), the Company analyzes its operations outside the United States to determine the functional currency of each operation. Management has determined that these operations are initially accounted for in U.S. dollars since the primary transactions incurred are in U.S. dollars and the Company provides significant funding towards the startup of the operation. When Management determines that an operation has become predominantly self-sufficient, the Company will change its accounting for the operation to the local currency from the U.S. dollar. The Company analyzed it&#x2019;s Gamma Knife site in Peru under ASC 830 as of December&#160;31, 2020 and 2019 and concluded the functional currency was the U.S. dollar. As facts and circumstances change, the Company will revisit this conclusion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Asset Retirement Obligations &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Based on the guidance provided in ASC 410 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Asset Retirement Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 410&#x201d;), the Company analyzed its existing lease agreements and determined an asset retirement obligation (&#x201c;ARO&#x201d;) exists to remove the respective units at the end of the lease terms. As of December&#160;31, 2020, four (4) of the Company's Gamma Knife customers notified the Company of their intent to terminate their contracts at the contract lease term.  The Company recorded an ARO liability for these four (4) sites, using estimates from Elekta.  No liability has been recorded as of December&#160;31, 2020 for the remaining Gamma Knife sites, or as of December&#160;31, 2019, because it is uncertain these units will be removed and the Company historically has not removed the Gamma Knife equipment at the end of the lease term. The Company will re-evaluate the need to record additional ARO liabilities on a periodic basis when facts and circumstances change that could affect this conclusion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the year. The fully vested restricted stock units not issued and outstanding, are also included therein. Diluted earnings per share reflect the potential dilution that could occur if common shares were issued pursuant to the exercise of options or warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because the Company reported a loss for the year ended December&#160;31, 2020, the potentially dilutive effects of approximately 13,000, of the Company's unvested restricted stock awards were not considered for the reporting periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 31, 2020, the Company&#x2019;s Award Agreements (as defined below) expired and the unvested performance share awards were returned to the Company&#x2019;s stock incentive plan - see Note 9 for further discussion.  Based on the guidance provided in accordance with ASC 260, the weighted average common shares for basic earnings per share, for the year ended December 31, 2019 excluded the weighted average impact of the unvested performance share awards. These awards were legally outstanding but not deemed participating securities and therefore were excluded from the calculation of basic earnings per share. The unvested shares were also excluded from the denominator for diluted earnings per share because they were considered contingent shares not deemed probable as of December 31, 2019.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the computations of basic and diluted earnings per share for the years ended December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.440%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for basic and diluted (loss) earnings per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,058,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for basic and diluted (loss) earnings per share &#x2013; weighted-average shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,182,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,919,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities Employee stock options and restricted stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for diluted (loss) earnings per share &#x2013; adjusted weighted-average shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,182,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,930,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) earnings per common share- basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) earnings per common share- diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, options outstanding to purchase 406,000 shares of common stock at an exercise price range of $2.25 - $3.90 per share and 13,000 restricted stock units were not included in the calculation of diluted earnings per share because they would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, options outstanding to purchase 387,000 shares of common stock at an exercise price range of $2.68 - $3.90 per share and 3,000 restricted stock units were not included in the calculation of diluted earnings per share because they would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business segment information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Based on the guidance provided in accordance with ASC 280 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 280&#x201d;), the Company analyzed its subsidiaries which are all in the business of leasing radiosurgery and radiation therapy equipment to healthcare providers, and concluded there are two reportable segments, domestic and foreign. The Company provides Gamma Knife and PBRT equipment to fifteen hospitals in the United States and owns and operates two single-unit facilities in Lima, Peru and Guayaquil, Ecuador as of December&#160;31, 2020. The Company determined two reportable segments existed due to similarities in economics of business operations and geographic location. The operating results of the two reportable segments are reviewed by the Company&#x2019;s CEO and President, Chief Operating and Financial Officer, who are also deemed the Company&#x2019;s Chief Operating Decision Makers (&#x201c;CODMs&#x201d;).  As of December&#160;31, 2019, the Company had one reportable segment.  Following the Company's acquisition of GKCE in June 2020, the Company concluded it had two reportable segments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The revenues, profit or loss, and net property and equipment allocations for the Company's two reportable segments as of December&#160;31, 2020 consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,204,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,396,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,837,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,605,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Profit or (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,082,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,058,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,223,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,593,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,195,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,887,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,418,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,480,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Long lived asset impairment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company assesses the recoverability of its long-lived assets when events or changes in circumstances indicate their carrying value may not be recoverable. Such events or changes in circumstances may include: a significant adverse change in the extent or manner in which a long-lived asset is being used, significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset, an accumulation of costs significantly in excess of the amount originally expected for the acquisition or development of a long-lived asset, current or future operating or cash flow losses that demonstrate continuing losses associated with the use of a long-lived asset, or a current expectation that, more likely than not, a long-lived asset will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company performs impairment testing at the asset group level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. The Company assesses recoverability of a long-lived asset by determining whether the carrying value of the asset group can be recovered through projected undiscounted cash flows over their remaining lives. If the carrying value of the asset group exceeds the forecasted undiscounted cash flows, an impairment loss is recognized, measured as the amount by which the carrying amount exceeds estimated fair value. An impairment loss is charged to the consolidated statement of operations in the period in which management determines such impairment. As of December&#160;31, 2020, the Company determined circumstances existed indicating its assets could be impaired, concluded an impairment existed, and recognized a loss on the write down of impaired assets of $8,264,000.  No such impairment has been noted as of  December&#160;31, 2019.  See Note 3 - Property and Equipment for further discussion. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill and intangible assets - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded goodwill of $1,265,000 and an intangible asset with a fair value of $78,000 as part of the Acquisition in June 2020.  The intangible asset identified was GKCE's trade name and the Company assigned an indefinite useful life to the asset.  Based on the guidance provided in accordance with ASC 350 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles-Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 350&#x201d;), the Company does not amortize the intangible asset because it has an indefinite life.  The Company assesses goodwill at the reporting unit level, which has been determined to be GKCE. Each reporting period, the Company assesses whether events or circumstances continue to support an indefinite useful life for the intangible asset.  Per ASC 350, the Company tests goodwill and intangibles for impairment annually or as events or circumstances change that indicate the fair value may be below the carrying amount.  As of December&#160;31, 2020, there has been no change to the Company's assessment of the value of intangible assets or goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company records acquisitions according to ASC 805 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 805&#x201d;) using the acquisition method of accounting. Under the acquisition method of accounting, all assets acquired, including goodwill and other intangible assets, should be stated at fair value at the time of acquisition. The allocation of purchase price consideration is preliminary, pending the completion of the fair value of certain tangible, intangible assets, and residual goodwill.  During the measurement period, which can be no more than one year from the Closing Date, the Company expects to continue to obtain information to assist in determining the final fair value of assets acquired.  See Note 4 - GKCE Acquisition for further discussion on acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Accounting pronouncement issued and adopted &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In February 2018, the FASB issued ASU No. 2018-03 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Recognition and Measurement of Financial Assets and Financial Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (&#x201c;ASU 2018-03&#x201d;), which clarifies certain aspects of ASU 2016-1. These are: equity securities without a readily determinable fair value &#x2013; discontinuation, equity securities without a readily determinable fair value &#x2013; adjustments, forward contracts and purchased options, presentation requirements for certain fair value option liabilities, fair value option liabilities denominated in a foreign currency, and transition guidance for equity securities without a readily determinable fair value. In August 2018, the FASB issued ASU No. 2018-13 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework &#x2013; Changes to the Disclosure Requirements to Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (&#x201c;ASU 2018-13&#x201d;), which amended the effective date and other certain measurement aspects of ASU 2018-03. The new guidance is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The Company adopted ASU 2018-03 and ASU 2018-13 on January 1, 2020. There was no significant impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting pronouncement issued and not yet adopted &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In December 2019, the FASB issued ASU 2019-12 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2019-12&#x201d;) which removes specific exceptions to the general principles in Topic 740 and eliminates the need for an organization to analyze whether the following apply in a given period: exception to the incremental approach for intraperiod tax allocation; exceptions to accounting for basis differences when there are ownership changes in foreign investments; exception in interim period income tax accounting for year-to-date losses that exceed anticipated losses.  The new guidance is effective for fiscal years and interim periods beginning after December 15, 2020.  The Company is currently evaluating ASU 2019-12 to determine the impact it may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTg0_d36d8f61-a064-4f67-be17-258235e59709">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of estimates in the preparation of financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; In preparing the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates reflected in the Company&#x2019;s consolidated financial statements include the estimated useful lives of fixed assets and its salvage values, revenues and costs of sales for turn-key and revenue sharing arrangements.&#160; Actual results could differ from those estimates.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTk3_0319408e-908d-4e9f-86c7-7ec1dd2a9fc1">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company expenses advertising costs as incurred. Advertising costs were $237,000 and $144,000 during the years ended December&#160;31, 2020 and 2019. Advertising costs are recorded in other direct operating costs and sales and administrative costs in the consolidated statements of operations.&lt;/span&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzkyNQ_f7ced1f2-0435-4f6b-855e-915d34dea3b5"
      unitRef="usd">237000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzkyOQ_e9cad694-7f74-4cf0-8f7e-7da4c399589b"
      unitRef="usd">144000</us-gaap:AdvertisingExpense>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjAw_13fd9917-6f25-42b6-84e4-575ba5bbb30f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company considers all liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. Restricted cash is not considered a cash equivalent for purposes of the consolidated statements of cash flows.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjAx_eef58b10-a54b-4a7f-9a4f-23b66b506a89">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Restricted cash represents the minimum cash that must be maintained in GKF to fund operations, per the subsidiary&#x2019;s operating agreement, the minimum cash that must be maintained by GKF per it&#x2019;s financing agreement with DFC, and the minimum cash that must be maintained in Orlando per the subsidiary&#x2019;s financing agreement.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <ams:BusinessAndCreditRiskPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTkw_76ec18de-8d5c-444a-9e02-016885fbc661">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business and credit risk&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company maintains its cash balances, which exceed federally insured limits, in financial institutions. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents. The Company monitors the financial condition of the financial institutions it uses on a regular basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s revenue was provided by eighteen and seventeen customers in 2020 and 2019. One customer accounted for approximately 35% and 30% of the Company&#x2019;s total revenue in 2020 and 2019. At December&#160;31, 2020, four customers each individually accounted for 11%, 11%, 11% and 20% of total accounts receivable, respectively. At December&#160;31, 2019, three customers each individually accounted for 12%, 15% and 30% of total accounts receivable, respectively. The Company performs credit evaluations of its customers and generally does not require collateral. The Company has not experienced significant losses related to receivables from individual customers or groups of customers in any particular geographic area.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s radiosurgery devices have been purchased through Elekta, to date. However, there are other manufacturers that also make radiosurgery devices.&lt;/span&gt;&lt;/div&gt;</ams:BusinessAndCreditRiskPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id972ed669aba469da1b189f82f5af5dc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzIxNDk_5fbfe811-01b8-4ff7-bb88-fd2780238d83"
      unitRef="number">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8e8116d241f44505a3ffdf0d7e29c59b_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzIxNTM_925c886e-9945-4cba-8625-76cfbeb3e44d"
      unitRef="number">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i56e19fee70bc48ac882fd81a5a98bbfc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0MjY_55b8d5c8-9366-42ba-a839-792d0d79aaa0"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5fd315d5d86b412e8a98e82bbe77f732_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0MzE_9d52eb7c-e861-4c91-ac42-0ded5498881d"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i400c6be02aad4a9fafc38382c1213485_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0MzY_3c8a0bef-7df1-4ff6-af9c-b77848f75c7d"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie3e0fe294ba6407abae7a2107d1721a7_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0NDE_03f69871-f838-4057-9a6b-486d73802296"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i28c7add148a045bb833ce1179113d93f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0NDY_bbca7065-bb78-4c30-b232-29519c502458"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i40f23635f374477d8f08757fc9c0b712_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0NTE_bf0d4378-3060-4e35-998c-1acf2ba0d4d8"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie606429758a940aeb109be90c15f3903_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTQ0NTY_8303e417-b09b-4a4f-938b-e560fe3ff37c"
      unitRef="number">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTkx_afa1b7ff-91e3-48ea-b91d-6f2ca2c2f6a5">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts receivable and doubtful accounts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Accounts receivable are recorded at net realizable value. An allowance for doubtful accounts is estimated based on historical collections plus an allowance for probable losses. Receivables are considered past due based on contractual terms and are charged off in the period that they are deemed uncollectible. Recoveries of receivables previously charged off are offset against bad debt expense when received.&lt;/span&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <ams:NoncontrollingInterestsPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTc3_9c16c1a7-8c2b-48e0-9e6f-532248cb26ec">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company reports its non-controlling interests as a separate component of shareholders&#x2019; equity. The Company also presents the consolidated net income and the portion of the consolidated net income allocable to the non-controlling interests and to the shareholders of the Company separately in its consolidated statements of operations.&lt;/span&gt;</ams:NoncontrollingInterestsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTky_b857888e-087e-4bf4-99a4-aea2291a663a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Property and equipment are stated at cost less accumulated depreciation. Depreciation for Gamma Knife, IGRT, and other equipment is determined using the straight-line method over the estimated useful lives of the assets, which for medical and office equipment is generally 3 &#x2013; 10 years, and after accounting for salvage value on the equipment where indicated. Salvage value is based on the estimated fair value of the equipment at the end of its useful life.  The Company acquired a building as part of the Acquisition in June 2020.  Depreciation for buildings is determined using the straight-line method over 20 years.&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation for PBRT and related equipment is determined using the modified units of production method, which is a function of both time and usage of the equipment. This depreciation method allocates costs considering the projected volume of usage through the useful life of the PBRT unit, which has been estimated at 20 years. The estimated useful life of the PBRT unit is consistent with the estimated economic life of 20 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes interest incurred on property and equipment that is under construction, for which deposits or progress payments have been made. When a rate is not readily available, imputed interest is calculated using the Company&#x2019;s incremental borrowing rate. The interest capitalized for property and equipment is the portion of interest cost incurred during the acquisition periods that could have been avoided if expenditures for the equipment had not been made. The Company capitalized interest of $119,000 and $110,000 in 2020 and 2019, respectively, as costs of medical equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases Gamma Knife and radiation therapy equipment to its customers under arrangements accounted for as operating leases. At December&#160;31, 2020, the Company held equipment under operating lease contracts with customers with an original cost of $75,241,000 and accumulated depreciation of $45,416,000. At December&#160;31, 2019, the Company held equipment under operating lease contracts with customers with an original cost of $92,135,000 and accumulated depreciation of $55,148,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company recognized a loss on the write down of impaired assets of $8,264,000.  The impaired assets included six (6) Gamma Knife units and the Company's deposits towards purchase of proton beam systems and related capitalized interest.  See further discussion under Note 2 - Long-lived asset impairment and Note 3 - Property and Equipment for further discussion.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i05ae369147604a31ac9acde67baf1fe0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzM4ODU_489a8dc4-c32b-47da-8358-0e15385baa85">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6ad83fb416a54f079b45eac2cfce2818_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzM4OTA_be582d99-2281-4946-885b-9f6ce255ffb3">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i57e5d37f53fe4fc2b7edcc04f231b5d7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQzODU_48a2e7f0-f771-45e0-8db7-e8f52d7882a9">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i57e5d37f53fe4fc2b7edcc04f231b5d7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQ0ODI_26e84d24-9f9e-4736-8fe3-ea01e4cf60f5">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:InterestCostsCapitalized
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQ5OTc_8f66be8e-3de5-47af-9307-c11c5c46c0b6"
      unitRef="usd">119000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzUwMDE_327452a3-6307-4166-ba17-ec3df060beb3"
      unitRef="usd">110000</us-gaap:InterestCostsCapitalized>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i298febcd82414e288d184f34830a1679_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzUzMjc_b150eee3-5c6d-4c1e-b619-c70d6bac24fe"
      unitRef="usd">75241000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i298febcd82414e288d184f34830a1679_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzUzNjI_961a063e-abfc-4eb5-8726-6022e7e6362f"
      unitRef="usd">45416000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i8a373e6624244f4798fe5b5d28dbef2a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzU0NzI_ef2c7ab1-d722-42f3-98c7-c52d3f008466"
      unitRef="usd">92135000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i8a373e6624244f4798fe5b5d28dbef2a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzU1MDc_2ecaae17-e206-4239-aae9-56da63f4b7bb"
      unitRef="usd">55148000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQ5NDc4MDIzNjk3ODc_9719ba06-9230-4b0f-8649-54256864f377"
      unitRef="usd">-8264000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <ams:NumberOfImpairedAssetUnits
      contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMDkzMTk_a072cc61-7aa7-4ccd-88e9-2661b7467e40"
      unitRef="unit">6</ams:NumberOfImpairedAssetUnits>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTkz_714de1d7-338d-42b8-9268-d0cace3adc3f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company&#x2019;s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels. Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company&#x2019;s own assumptions about the assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjA0_6da0fe00-1ab8-4262-9d2f-7be5e7f360bb">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s assets and liabilities as of December&#160;31, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7279522e293b495db1b4d192e00ff1e6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzMtMS0xLTEtMA_c44c110d-194f-4aa0-a607-a48e1c6e170d"
      unitRef="usd">4325000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3ea0bf1639814d3381a9b42a27326780_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzMtMy0xLTEtMA_1f80178c-8ff1-4a21-aaa3-694cef4b3c94"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2cea93e95519466ca67288ae891587b5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzMtNS0xLTEtMA_9b66817c-18d4-416e-99a2-6ae597bb9820"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzMtNy0xLTEtMA_8909f28d-2aed-4c64-b4c6-2d43d6e380c7"
      unitRef="usd">4325000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i40f6d3eb893e49dba2c9816815bdc0a1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzMtOS0xLTEtMA_92933f52-759d-498a-acf7-2a08143ed425"
      unitRef="usd">4325000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7279522e293b495db1b4d192e00ff1e6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzQtMS0xLTEtMA_53e14eed-d8fb-499d-8179-c924aeb515bd"
      unitRef="usd">4325000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3ea0bf1639814d3381a9b42a27326780_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzQtMy0xLTEtMA_3a0aa28c-c79d-4883-a4ed-52c5af2907cc"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2cea93e95519466ca67288ae891587b5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzQtNS0xLTEtMA_626354f6-1d3d-43df-b12e-71bbc2a685d3"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzQtNy0xLTEtMA_8fb3d78c-5d77-4ff3-b309-0ac8e020c5e6"
      unitRef="usd">4325000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Assets
      contextRef="i40f6d3eb893e49dba2c9816815bdc0a1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzQtOS0xLTEtMA_0f4fb04d-3aa2-411a-a32b-6669d0577b4f"
      unitRef="usd">4325000</us-gaap:Assets>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i7279522e293b495db1b4d192e00ff1e6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzctMS0xLTEtMA_97edb270-1714-4af0-bd35-b8095b7467cc"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i3ea0bf1639814d3381a9b42a27326780_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzctMy0xLTEtMA_242bc82a-df30-407e-bba1-22d211b63d35"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i2cea93e95519466ca67288ae891587b5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzctNS0xLTEtMA_14983684-4c3c-4612-863a-adbc06288931"
      unitRef="usd">4662000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzctNy0xLTEtMA_acf650e2-f5d4-4ef7-8aa7-280bf557299a"
      unitRef="usd">4662000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i40f6d3eb893e49dba2c9816815bdc0a1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzctOS0xLTEtMA_e1ddf535-1fc6-48a4-819f-63cadcb49067"
      unitRef="usd">4624000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7279522e293b495db1b4d192e00ff1e6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzgtMS0xLTEtMA_d1a7a2a6-b5e1-49b1-aa12-adc288c28f3f"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3ea0bf1639814d3381a9b42a27326780_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzgtMy0xLTEtMA_767b6295-8a74-4891-a13a-857998a8171a"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2cea93e95519466ca67288ae891587b5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzgtNS0xLTEtMA_67a0f1f1-3a58-4373-9ac9-e255a64cae99"
      unitRef="usd">4662000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzgtNy0xLTEtMA_3c9b3892-cac6-44bd-9c05-4ac7e6b4167d"
      unitRef="usd">4662000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:Liabilities
      contextRef="i40f6d3eb893e49dba2c9816815bdc0a1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzgtOS0xLTEtMA_69cd4785-2716-4a53-8a02-33420519f4e7"
      unitRef="usd">4624000</us-gaap:Liabilities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifd382747b25b4861a422a0f266d39f5d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEyLTEtMS0xLTA_b35c2877-a6ae-4798-acc5-45449292f7b8"
      unitRef="usd">1779000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i519145167b974aab9b393f963cdb8d7a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEyLTMtMS0xLTA_ec3e2286-9de9-460a-990a-12902c9bbe3e"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i93ecdfacebdb44469bdc41efe4acc1dc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEyLTUtMS0xLTA_133a254a-a17b-46e3-a495-f9786d8a702c"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEyLTctMS0xLTA_91f57361-af13-4e01-9854-3a9b2b14b1a5"
      unitRef="usd">1779000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4d629e14069b4f1ca36dd799f3eb6039_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEyLTktMS0xLTA_39d683c9-3694-4869-9243-176d704cde5d"
      unitRef="usd">1779000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifd382747b25b4861a422a0f266d39f5d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEzLTEtMS0xLTA_00e2224c-faa1-4a4a-a65e-970c00c9eb1a"
      unitRef="usd">1779000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i519145167b974aab9b393f963cdb8d7a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEzLTMtMS0xLTA_1a634cdb-97f4-4f68-b525-3dee9747245b"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i93ecdfacebdb44469bdc41efe4acc1dc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEzLTUtMS0xLTA_bee8590e-af47-4687-8a84-cd6ca377e336"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEzLTctMS0xLTA_8fab7185-dc12-489e-ae6d-eac1724f2e56"
      unitRef="usd">1779000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Assets
      contextRef="i4d629e14069b4f1ca36dd799f3eb6039_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzEzLTktMS0xLTA_fec96ee5-0896-452b-b20f-2dca02dfce42"
      unitRef="usd">1779000</us-gaap:Assets>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ifd382747b25b4861a422a0f266d39f5d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE2LTEtMS0xLTA_562d1d11-1294-469b-82ad-89ffa5b6ffc9"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i519145167b974aab9b393f963cdb8d7a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE2LTMtMS0xLTA_eabfc1ee-d236-430c-b69b-aa588b99c63e"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i93ecdfacebdb44469bdc41efe4acc1dc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE2LTUtMS0xLTA_cc1060a6-e20b-406b-9906-5ad769b83412"
      unitRef="usd">3075000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE2LTctMS0xLTA_636dc3f9-74f7-487a-ac49-02d66ba1da4d"
      unitRef="usd">3075000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i4d629e14069b4f1ca36dd799f3eb6039_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE2LTktMS0xLTA_1d4fce45-162e-49f9-9f54-f57a2e71c102"
      unitRef="usd">3480000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifd382747b25b4861a422a0f266d39f5d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE3LTEtMS0xLTA_0a80f3dc-3a9b-4b4b-9867-d7cb29f59e48"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i519145167b974aab9b393f963cdb8d7a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE3LTMtMS0xLTA_7cf27020-1b72-4299-9565-df53ca8c25a3"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i93ecdfacebdb44469bdc41efe4acc1dc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE3LTUtMS0xLTA_51c54708-baf7-40cc-bb2c-6f802bb9bad6"
      unitRef="usd">3075000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE3LTctMS0xLTA_77ef98e3-2969-45e3-a29a-fd000190c2e3"
      unitRef="usd">3075000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:Liabilities
      contextRef="i4d629e14069b4f1ca36dd799f3eb6039_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmNTk5Y2Q0NWEzOTU0OTA5OGZjNTE2ZGE2NjdjMjVlMi90YWJsZXJhbmdlOmY1OTljZDQ1YTM5NTQ5MDk4ZmM1MTZkYTY2N2MyNWUyXzE3LTktMS0xLTA_7efb078d-d472-4d66-a1b4-63239295e779"
      unitRef="usd">3480000</us-gaap:Liabilities>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjA1_dc745c08-b5ff-4b56-8003-6164e1bfeeb7">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company recognizes revenues under ASC 842 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 842&#x201d;) and ASC 606 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 606&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rental income from medical services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company recognizes revenues under ASC 842 when services have been rendered and collectability is reasonably assured, on either a fee per use or revenue sharing basis. The terms of the contracts do not contain any guaranteed minimum payments. The Company&#x2019;s contracts are typically for a 10-year term and are classified as either fee per use or retail. Retail arrangements are further classified as either turn-key or revenue sharing. Revenues from fee per use contracts is determined by each hospital&#x2019;s contracted rate. Revenues are recognized at the time the procedures are performed, based on each hospital&#x2019;s contracted rate and the number of procedures performed. Under revenue sharing arrangements, the Company receives a contracted percentage of the reimbursement received by the hospital. The amount the Company expects to receive is recorded as revenue and estimated based on historical experience. Revenue estimates are reviewed periodically and adjusted as necessary. Under turn-key arrangements, the Company receives payment from the hospital in the amount of the hospital&#x2019;s reimbursement from third party payors, and the Company is responsible for paying all the operating costs of the equipment. Operating costs are determined primarily based on historical treatment protocols and cost schedules with the hospital. The Company records an estimate of operating costs which are reviewed on a regular basis and adjusted as necessary to more accurately reflect the actual operating costs. For turn-key sites, the Company also shares a percentage of net operating profit. The Company records an estimate of net operating profit based on estimated revenues, less estimated operating costs. The operating costs and estimated net operating profit are recorded as other direct operating costs in the consolidated statement of operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As of December&#160;31, 2020 and 2019, the Company recognized revenues of approximately $16,204,000 and $19,396,000 under ASC 842, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patient income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company has stand-alone facilities in Lima, Peru and Guayaquil, Ecuador, where a contract exists between the Company&#x2019;s facilities and the individual patient treated at the facility. Under ASC 606, the Company acts as the principal in this transaction and provides, at a point in time, a single performance obligation, in the form of a Gamma Knife treatment. Revenue related to a Gamma Knife treatment is recognized on a gross basis at the time when the patient receives treatment. There is no variable consideration present in the Company&#x2019;s performance obligation and the transaction price is agreed upon per the stated contractual rate. GKPeru's payment terms are typically prepaid for self-pay patients and insurance provider payments are paid net 30 days. GKCE's patient population is primarily covered by a government payor and payments are paid approximately 30 to 60 days upon invoice. The Company did not capitalize any incremental costs related to the fulfillment of its customer contracts.  Accounts receivable earned by GKPeru were not significant for the year ended December&#160;31, 2020 and 2019. GKCE's accounts receivable were $467,000 for the year ended December&#160;31, 2020. As of December&#160;31, 2020 and 2019, the Company recognized revenues of approximately $1,633,000 and $1,209,000 under ASC 606, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMDYyMzc_b0c673c8-2522-4a44-8922-3123bac5b65e">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic5fff1c8944b46cb882c1df18912daf8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQ5NDc4MDIzNzAxNzc_0cfb9f91-290d-4df5-8aa3-2a825a780334"
      unitRef="usd">16204000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i17d0a114a3a64f229fe1ddcdd3b7eb1c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTU0NDg_3d62b226-6bac-43f4-b791-a97d00e1ca89"
      unitRef="usd">19396000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="i71d12ecde1e645d39bc55a9ecf494e71_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NTUxNjI_0413149c-71b1-40a4-b563-1c79fea715e0"
      unitRef="usd">467000</us-gaap:AccountsReceivableRelatedParties>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f48202c104045e5af8b285017387f01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQ5NDc4MDIzNzAzODE_a758cd8b-ab21-4079-9b06-ed21a460866c"
      unitRef="usd">1633000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifce03623ecd94f9a9f86454660e7a747_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTU0NjE_a7df14b3-6f08-48da-af2f-79ffb0b8d89c"
      unitRef="usd">1209000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTc5_a0a73d5f-1f09-4973-834f-68dd02b71fd1">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company measures all stock-based compensation awards at fair value and records such expense in its consolidated financial statements over the requisite service period of the related award. See Note 9 for additional information on the Company&#x2019;s stock-based compensation programs.&lt;/span&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTg1_18a544fd-7014-4890-9613-a292bb06eee2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Costs of revenue &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's costs of revenue consist primarily of maintenance and supplies, depreciation and amortization, and other operating expenses (such as insurance, property taxes, sales taxes, marketing costs and operating costs from the Company&#x2019;s retail sites). Costs of revenues are recognized as incurred.&lt;/span&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTk0_c4fe7f42-3a82-4216-b348-c0380a91d715">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Sales and Marketing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company markets its services through its preferred provider status with Elekta and a direct sales effort led by its Senior Vice President of Sales and Business Development, its President and Chief Financial and Operating Officer and its Chief Executive Officer (&#x201c;CEO&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company typically provides the equipment, as well as planning, installation, reimbursement and marketing support services.&lt;/span&gt;&lt;/div&gt;</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTg3_36a009b8-c52e-42d4-9f51-bcb21d73ad1d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for uncertainty in income taxes as required by the provisions of ASC 740 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 740&#x201d;), which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to estimate and measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement. It is inherently difficult and subjective to estimate such amounts, as this requires the Company to determine the probability of various possible outcomes. The Company considers many factors when evaluating and estimating the Company&#x2019;s tax positions and tax benefits, which may require periodic adjustments and may not accurately anticipate actual outcomes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 8 for further discussion on income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <ams:PercentageOfTaxBenefitRealizedUponSettlement
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEyODk0_f9081b3b-e557-4cee-b0e5-1768c5ea1da1"
      unitRef="number">0.50</ams:PercentageOfTaxBenefitRealizedUponSettlement>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjAy_c664fe6a-8aca-484b-b40b-1f190dda25ab">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Functional currency&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Based on guidance provided in accordance with ASC 830, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 830&#x201d;), the Company analyzes its operations outside the United States to determine the functional currency of each operation. Management has determined that these operations are initially accounted for in U.S. dollars since the primary transactions incurred are in U.S. dollars and the Company provides significant funding towards the startup of the operation. When Management determines that an operation has become predominantly self-sufficient, the Company will change its accounting for the operation to the local currency from the U.S. dollar. The Company analyzed it&#x2019;s Gamma Knife site in Peru under ASC 830 as of December&#160;31, 2020 and 2019 and concluded the functional currency was the U.S. dollar. As facts and circumstances change, the Company will revisit this conclusion.&lt;/span&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <ams:AssetRetirementObligationsPolicyPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTgw_2ad1b9e4-2eb1-43b6-89f1-8ee9161647fb">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Asset Retirement Obligations &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Based on the guidance provided in ASC 410 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Asset Retirement Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 410&#x201d;), the Company analyzed its existing lease agreements and determined an asset retirement obligation (&#x201c;ARO&#x201d;) exists to remove the respective units at the end of the lease terms. As of December&#160;31, 2020, four (4) of the Company's Gamma Knife customers notified the Company of their intent to terminate their contracts at the contract lease term.  The Company recorded an ARO liability for these four (4) sites, using estimates from Elekta.  No liability has been recorded as of December&#160;31, 2020 for the remaining Gamma Knife sites, or as of December&#160;31, 2019, because it is uncertain these units will be removed and the Company historically has not removed the Gamma Knife equipment at the end of the lease term. The Company will re-evaluate the need to record additional ARO liabilities on a periodic basis when facts and circumstances change that could affect this conclusion.&lt;/span&gt;</ams:AssetRetirementObligationsPolicyPolicyTextBlock>
    <ams:NumberOfCustomersWithIntentToTerminateContract
      contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMDYyMTQ_fdba9b6f-5935-4214-857a-485fa9947f2f"
      unitRef="customer">4</ams:NumberOfCustomersWithIntentToTerminateContract>
    <ams:AssetRetirementObligationNumberOfSites
      contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMDYyMTc_acb794ea-c713-4746-b5fb-a78225ca2e55"
      unitRef="site">4</ams:AssetRetirementObligationNumberOfSites>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTk4_1b88dd75-408a-4db9-9dfa-9a70f8cc34f0">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the year. The fully vested restricted stock units not issued and outstanding, are also included therein. Diluted earnings per share reflect the potential dilution that could occur if common shares were issued pursuant to the exercise of options or warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because the Company reported a loss for the year ended December&#160;31, 2020, the potentially dilutive effects of approximately 13,000, of the Company's unvested restricted stock awards were not considered for the reporting periods. &lt;/span&gt;&lt;/div&gt;On March 31, 2020, the Company&#x2019;s Award Agreements (as defined below) expired and the unvested performance share awards were returned to the Company&#x2019;s stock incentive plan - see Note 9 for further discussion.  Based on the guidance provided in accordance with ASC 260, the weighted average common shares for basic earnings per share, for the year ended December 31, 2019 excluded the weighted average impact of the unvested performance share awards. These awards were legally outstanding but not deemed participating securities and therefore were excluded from the calculation of basic earnings per share. The unvested shares were also excluded from the denominator for diluted earnings per share because they were considered contingent shares not deemed probable as of December 31, 2019.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NjkzMDg_59901d93-0298-4745-be2d-fabf789f27ab"
      unitRef="shares">13000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjA2_c7575923-9153-479b-b03e-98999c7df187">The following table illustrates the computations of basic and diluted earnings per share for the years ended December&#160;31, 2020 and 2019.&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.440%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for basic and diluted (loss) earnings per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,058,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for basic and diluted (loss) earnings per share &#x2013; weighted-average shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,182,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,919,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities Employee stock options and restricted stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for diluted (loss) earnings per share &#x2013; adjusted weighted-average shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,182,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,930,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) earnings per common share- basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) earnings per common share- diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzEtMS0xLTEtMA_71e3f40c-7196-4616-a86c-49a50e9c776e"
      unitRef="usd">-7058000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzEtMy0xLTEtMA_86f1d953-b79a-4f5f-ae02-c760e0f5ef9b"
      unitRef="usd">659000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzMtMS0xLTEtMA_89e5531d-0ddb-448f-afe5-6a463519d29b"
      unitRef="shares">6182000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzMtMy0xLTEtMA_06849fb9-3fc0-4c6e-aea2-6c0dda1e34ac"
      unitRef="shares">5919000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzQtMS0xLTEtMA_ca5db7a3-7157-4c17-a6fe-d764a4a83cbf"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzQtMy0xLTEtMA_3ec8f0e6-7ef2-4fb2-be4e-b6f643ce3170"
      unitRef="shares">11000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzUtMS0xLTEtMA_7885bea2-7150-40b2-b830-013aae782815"
      unitRef="shares">6182000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzUtMy0xLTEtMA_8bb433b7-0589-4718-bfd0-df416375ae0d"
      unitRef="shares">5930000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzYtMS0xLTEtMA_f48d0ff5-96ff-4ca4-bde9-f88f0c8e1227"
      unitRef="usdPerShare">-1.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzYtMy0xLTEtMA_2b2d2e2a-d698-40ee-b248-c5c223533944"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzctMS0xLTEtMA_f68b9aeb-83a2-44bf-a90c-992a30285e7a"
      unitRef="usdPerShare">-1.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToxYWRjYjIxN2FkMDg0NWNlYTU1MjViOWFiNzg5YjhmYy90YWJsZXJhbmdlOjFhZGNiMjE3YWQwODQ1Y2VhNTUyNWI5YWI3ODliOGZjXzctMy0xLTEtMA_355d2ce0-5425-40c4-b02f-f963745ea216"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1NDYx_10fd4c8a-491e-42cb-b617-2fd7f04d1fc8"
      unitRef="shares">406000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <ams:StockOptionExercisePrice
      contextRef="i279a2dc09a1e4d058baa0f82d26d3fec_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1NTE3_5f1e852c-b376-47de-9912-d1eb4b851723"
      unitRef="usdPerShare">2.25</ams:StockOptionExercisePrice>
    <ams:StockOptionExercisePrice
      contextRef="i201f554e454a461689418aeaf993818a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1NTIy_7cae83e6-c8c1-4f60-8954-266c0c7d81a9"
      unitRef="usdPerShare">3.90</ams:StockOptionExercisePrice>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1NTM5_031969c6-a930-4383-bca8-81b5020414fb"
      unitRef="shares">13000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1NzA4_8bef095c-770b-4ca2-bed9-eb3735cb86ed"
      unitRef="shares">387000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <ams:StockOptionExercisePrice
      contextRef="i430692827c684c1ca5be2f83d2a702f5_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1NzY3_b02d3ad2-7be7-417b-b2d6-42b7ce8471c0"
      unitRef="usdPerShare">2.68</ams:StockOptionExercisePrice>
    <ams:StockOptionExercisePrice
      contextRef="iacead3b29e7846bcac84408721d0ef98_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1Nzcy_316c36fd-806a-4eef-b727-65918581b7d7"
      unitRef="usdPerShare">3.90</ams:StockOptionExercisePrice>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE1Nzg5_63bd8992-192c-49a0-9b83-b139c6b4c735"
      unitRef="shares">3000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTgy_44b81264-a964-4a78-afa6-6c9a97777081">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business segment information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Based on the guidance provided in accordance with ASC 280 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt; (&#x201c;ASC 280&#x201d;), the Company analyzed its subsidiaries which are all in the business of leasing radiosurgery and radiation therapy equipment to healthcare providers, and concluded there are two reportable segments, domestic and foreign. The Company provides Gamma Knife and PBRT equipment to fifteen hospitals in the United States and owns and operates two single-unit facilities in Lima, Peru and Guayaquil, Ecuador as of December&#160;31, 2020. The Company determined two reportable segments existed due to similarities in economics of business operations and geographic location. The operating results of the two reportable segments are reviewed by the Company&#x2019;s CEO and President, Chief Operating and Financial Officer, who are also deemed the Company&#x2019;s Chief Operating Decision Makers (&#x201c;CODMs&#x201d;).  As of December&#160;31, 2019, the Company had one reportable segment.  Following the Company's acquisition of GKCE in June 2020, the Company concluded it had two reportable segments.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMDYyMjY_91df8203-27f5-41bd-8ed8-317fce023dad"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NjkwMzE_91df8203-27f5-41bd-8ed8-317fce023dad"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NjkwMzQ_91df8203-27f5-41bd-8ed8-317fce023dad"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NzQ2MjE_91df8203-27f5-41bd-8ed8-317fce023dad"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <ams:ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MjAz_4abcd9d2-34ca-409f-81e9-6783d13d586b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The revenues, profit or loss, and net property and equipment allocations for the Company's two reportable segments as of December&#160;31, 2020 consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,204,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,396,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,837,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,605,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Profit or (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,082,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,058,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,223,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,593,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,195,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,887,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,418,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,480,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ams:ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieeeee52fa85b4659bb8c93af9403c135_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToyMWU4OTdhYmQ3ODQ0NWYzYmEzMjkyZWMyMzVmODVlOC90YWJsZXJhbmdlOjIxZTg5N2FiZDc4NDQ1ZjNiYTMyOTJlYzIzNWY4NWU4XzItMS0xLTEtMA_6b3ba4de-aad3-4a6a-a3fe-823e64c297e4"
      unitRef="usd">16204000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d5ec3bfbd86448fa8f03c6346be0f99_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToyMWU4OTdhYmQ3ODQ0NWYzYmEzMjkyZWMyMzVmODVlOC90YWJsZXJhbmdlOjIxZTg5N2FiZDc4NDQ1ZjNiYTMyOTJlYzIzNWY4NWU4XzItMy0xLTEtMA_2be7dd6a-fed9-48d2-bbd7-a218cfad23f0"
      unitRef="usd">19396000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i673d3ab8cf484509b5a1f6277fa696b3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToyMWU4OTdhYmQ3ODQ0NWYzYmEzMjkyZWMyMzVmODVlOC90YWJsZXJhbmdlOjIxZTg5N2FiZDc4NDQ1ZjNiYTMyOTJlYzIzNWY4NWU4XzMtMS0xLTEtMA_01c8bd9f-9074-4eb9-ac0b-ea7fa0974130"
      unitRef="usd">1633000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8922c16f8684389b3b97dd8f6e8ab60_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToyMWU4OTdhYmQ3ODQ0NWYzYmEzMjkyZWMyMzVmODVlOC90YWJsZXJhbmdlOjIxZTg5N2FiZDc4NDQ1ZjNiYTMyOTJlYzIzNWY4NWU4XzMtMy0xLTEtMA_ad8508df-b598-431d-887e-78602b2a498d"
      unitRef="usd">1209000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i51994c25a7e04ee08bec394c54e6c3c0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToyMWU4OTdhYmQ3ODQ0NWYzYmEzMjkyZWMyMzVmODVlOC90YWJsZXJhbmdlOjIxZTg5N2FiZDc4NDQ1ZjNiYTMyOTJlYzIzNWY4NWU4XzQtMS0xLTEtMA_e87870fa-19d7-49be-b7d1-ebb0d1ca1285"
      unitRef="usd">17837000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc4a678d396245e9bf4323d16c22d03a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZToyMWU4OTdhYmQ3ODQ0NWYzYmEzMjkyZWMyMzVmODVlOC90YWJsZXJhbmdlOjIxZTg5N2FiZDc4NDQ1ZjNiYTMyOTJlYzIzNWY4NWU4XzQtMy0xLTEtMA_5a0dff1c-8ed1-4286-82fa-66e7d9eb8aa7"
      unitRef="usd">20605000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetIncomeLoss
      contextRef="i7bf5e95df79b44f7a18e189b2382eb21_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTo2YzVmZTU4NDk2ZjY0NjJjOGM0ZTA0YjAxMzgzNDFlNy90YWJsZXJhbmdlOjZjNWZlNTg0OTZmNjQ2MmM4YzRlMDRiMDEzODM0MWU3XzItMS0xLTEtNjExOA_de3522ab-10e3-4f17-b2dd-4a8ccc6200e7"
      unitRef="usd">-7082000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7934b69f46a945fba713a315452b7c67_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTo2YzVmZTU4NDk2ZjY0NjJjOGM0ZTA0YjAxMzgzNDFlNy90YWJsZXJhbmdlOjZjNWZlNTg0OTZmNjQ2MmM4YzRlMDRiMDEzODM0MWU3XzItMy0xLTEtNjExOA_2c4fc1a7-b783-4505-99d4-f6afe1a4bd50"
      unitRef="usd">769000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i10727c3b4215451ba7e2258b5cc61bdd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTo2YzVmZTU4NDk2ZjY0NjJjOGM0ZTA0YjAxMzgzNDFlNy90YWJsZXJhbmdlOjZjNWZlNTg0OTZmNjQ2MmM4YzRlMDRiMDEzODM0MWU3XzMtMS0xLTEtNjExOA_6032ad35-289b-49e8-9306-d22c8dd73f74"
      unitRef="usd">24000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6958c1fb3942499d88011d908e7f5162_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTo2YzVmZTU4NDk2ZjY0NjJjOGM0ZTA0YjAxMzgzNDFlNy90YWJsZXJhbmdlOjZjNWZlNTg0OTZmNjQ2MmM4YzRlMDRiMDEzODM0MWU3XzMtMy0xLTEtNjExOA_aac8bf06-3d15-41b3-bdbc-a2c840e06393"
      unitRef="usd">-110000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i714b56581adc46f6942c585891e61544_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTo2YzVmZTU4NDk2ZjY0NjJjOGM0ZTA0YjAxMzgzNDFlNy90YWJsZXJhbmdlOjZjNWZlNTg0OTZmNjQ2MmM4YzRlMDRiMDEzODM0MWU3XzQtMS0xLTEtNjExOA_b54a77a4-ca6d-4920-a2e9-9de69be7f549"
      unitRef="usd">-7058000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8d9c32da78d040efa62915a5cb124fe4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTo2YzVmZTU4NDk2ZjY0NjJjOGM0ZTA0YjAxMzgzNDFlNy90YWJsZXJhbmdlOjZjNWZlNTg0OTZmNjQ2MmM4YzRlMDRiMDEzODM0MWU3XzQtMy0xLTEtNjExOA_1ef6b364-22a0-4d45-8b9c-ebcd3ea02c75"
      unitRef="usd">659000</us-gaap:NetIncomeLoss>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="id7895e51adef4d9988611e06cb9a3c5c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmMWY1OGE2N2Y2YTQ0MjNmOGJjMzNjZTdhZWM3ZjllYS90YWJsZXJhbmdlOmYxZjU4YTY3ZjZhNDQyM2Y4YmMzM2NlN2FlYzdmOWVhXzItMS0xLTEtMA_46957341-07fe-4ceb-960d-b5bbca686f3d"
      unitRef="usd">27223000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i426af3a3d5514c93814df64d63f704ff_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmMWY1OGE2N2Y2YTQ0MjNmOGJjMzNjZTdhZWM3ZjllYS90YWJsZXJhbmdlOmYxZjU4YTY3ZjZhNDQyM2Y4YmMzM2NlN2FlYzdmOWVhXzItMy0xLTEtMA_26cd7c13-c642-495c-befe-00bb7fcb9e93"
      unitRef="usd">38593000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i309db3889f874fdb939e6cc89fd12897_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmMWY1OGE2N2Y2YTQ0MjNmOGJjMzNjZTdhZWM3ZjllYS90YWJsZXJhbmdlOmYxZjU4YTY3ZjZhNDQyM2Y4YmMzM2NlN2FlYzdmOWVhXzMtMS0xLTEtMA_94e6b979-3c91-418e-af0f-b2a70d718bfc"
      unitRef="usd">3195000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ida6822c327084e89b634c2f2b2084d15_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmMWY1OGE2N2Y2YTQ0MjNmOGJjMzNjZTdhZWM3ZjllYS90YWJsZXJhbmdlOmYxZjU4YTY3ZjZhNDQyM2Y4YmMzM2NlN2FlYzdmOWVhXzMtMy0xLTEtMA_b21e0c6a-b327-4273-b3d4-37a14f43534e"
      unitRef="usd">2887000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="idfd154d740fb4aa0a7b0a97723469ebb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmMWY1OGE2N2Y2YTQ0MjNmOGJjMzNjZTdhZWM3ZjllYS90YWJsZXJhbmdlOmYxZjU4YTY3ZjZhNDQyM2Y4YmMzM2NlN2FlYzdmOWVhXzQtMS0xLTEtMA_d19e5100-3cef-4be2-9a3f-7625bedbe96d"
      unitRef="usd">30418000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ia83787ee66d2452c9afe259fa7fe0fea_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90YWJsZTpmMWY1OGE2N2Y2YTQ0MjNmOGJjMzNjZTdhZWM3ZjllYS90YWJsZXJhbmdlOmYxZjU4YTY3ZjZhNDQyM2Y4YmMzM2NlN2FlYzdmOWVhXzQtMy0xLTEtMA_a0f1ecbb-04ab-4fb9-adae-a363f956a6ec"
      unitRef="usd">41480000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTg4_e89bd3ad-d5ce-4b54-a879-46a300804852">Long lived asset impairment &#x2013; The Company assesses the recoverability of its long-lived assets when events or changes in circumstances indicate their carrying value may not be recoverable. Such events or changes in circumstances may include: a significant adverse change in the extent or manner in which a long-lived asset is being used, significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset, an accumulation of costs significantly in excess of the amount originally expected for the acquisition or development of a long-lived asset, current or future operating or cash flow losses that demonstrate continuing losses associated with the use of a long-lived asset, or a current expectation that, more likely than not, a long-lived asset will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company performs impairment testing at the asset group level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. The Company assesses recoverability of a long-lived asset by determining whether the carrying value of the asset group can be recovered through projected undiscounted cash flows over their remaining lives. If the carrying value of the asset group exceeds the forecasted undiscounted cash flows, an impairment loss is recognized, measured as the amount by which the carrying amount exceeds estimated fair value. An impairment loss is charged to the consolidated statement of operations in the period in which management determines such impairment. As of December&#160;31, 2020, the Company determined circumstances existed indicating its assets could be impaired, concluded an impairment existed, and recognized a loss on the write down of impaired assets of $8,264,000.  No such impairment has been noted as of  December&#160;31, 2019.  See Note 3 - Property and Equipment for further discussion.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzQ5NDc4MDIzNjk3OTM_9719ba06-9230-4b0f-8649-54256864f377"
      unitRef="usd">-8264000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzE4OTY2_8f49d677-63f0-466a-9431-682511e2523b"
      unitRef="usd">0</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMDgzMDE_bb079044-2218-4621-8800-12473b7fab1f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill and intangible assets - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded goodwill of $1,265,000 and an intangible asset with a fair value of $78,000 as part of the Acquisition in June 2020.  The intangible asset identified was GKCE's trade name and the Company assigned an indefinite useful life to the asset.  Based on the guidance provided in accordance with ASC 350 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles-Goodwill and Other&lt;/span&gt; (&#x201c;ASC 350&#x201d;), the Company does not amortize the intangible asset because it has an indefinite life.  The Company assesses goodwill at the reporting unit level, which has been determined to be GKCE. Each reporting period, the Company assesses whether events or circumstances continue to support an indefinite useful life for the intangible asset.  Per ASC 350, the Company tests goodwill and intangibles for impairment annually or as events or circumstances change that indicate the fair value may be below the carrying amount.  As of December&#160;31, 2020, there has been no change to the Company's assessment of the value of intangible assets or goodwill.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NjUxMjk_66ffde27-4bc2-4717-bb94-9ea22bc469b7"
      unitRef="usd">1265000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired
      contextRef="i0e4c0e6386194ed79a0a74908a8481c4_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzEwOTk1MTE2NjUyMTc_0076888b-9ed5-4f32-a0df-76d3837ebaac"
      unitRef="usd">78000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI3NDg3NzkxMTE5MDU_3c41fb74-cdf0-4936-a065-1c8f98b2a860">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company records acquisitions according to ASC 805 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 805&#x201d;) using the acquisition method of accounting. Under the acquisition method of accounting, all assets acquired, including goodwill and other intangible assets, should be stated at fair value at the time of acquisition. The allocation of purchase price consideration is preliminary, pending the completion of the fair value of certain tangible, intangible assets, and residual goodwill.  During the measurement period, which can be no more than one year from the Closing Date, the Company expects to continue to obtain information to assist in determining the final fair value of assets acquired.  See Note 4 - GKCE Acquisition for further discussion on acquisitions.&lt;/span&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTQvZnJhZzpjMzY0MmYzOTdhNjU0ZTE0OTMyYzI5YTZiMDBhZmVjOS90ZXh0cmVnaW9uOmMzNjQyZjM5N2E2NTRlMTQ5MzJjMjlhNmIwMGFmZWM5XzI0MTk1_51157c5d-de47-4089-943e-7a6f682c9e07">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Accounting pronouncement issued and adopted &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In February 2018, the FASB issued ASU No. 2018-03 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Recognition and Measurement of Financial Assets and Financial Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (&#x201c;ASU 2018-03&#x201d;), which clarifies certain aspects of ASU 2016-1. These are: equity securities without a readily determinable fair value &#x2013; discontinuation, equity securities without a readily determinable fair value &#x2013; adjustments, forward contracts and purchased options, presentation requirements for certain fair value option liabilities, fair value option liabilities denominated in a foreign currency, and transition guidance for equity securities without a readily determinable fair value. In August 2018, the FASB issued ASU No. 2018-13 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework &#x2013; Changes to the Disclosure Requirements to Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (&#x201c;ASU 2018-13&#x201d;), which amended the effective date and other certain measurement aspects of ASU 2018-03. The new guidance is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The Company adopted ASU 2018-03 and ASU 2018-13 on January 1, 2020. There was no significant impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting pronouncement issued and not yet adopted &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In December 2019, the FASB issued ASU 2019-12 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2019-12&#x201d;) which removes specific exceptions to the general principles in Topic 740 and eliminates the need for an organization to analyze whether the following apply in a given period: exception to the incremental approach for intraperiod tax allocation; exceptions to accounting for basis differences when there are ownership changes in foreign investments; exception in interim period income tax accounting for year-to-date losses that exceed anticipated losses.  The new guidance is effective for fiscal years and interim periods beginning after December 15, 2020.  The Company is currently evaluating ASU 2019-12 to determine the impact it may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzE3MTQ_088013a6-26cb-4016-9f74-094d06ed40f2">P&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ROPERTY&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;AND&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; E&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;QUIPMENT&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DECEMBER 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment and facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,657,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,132,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits towards purchase of proton beam systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,157,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,941,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,739,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,461,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,418,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,480,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, approximately $3,195,000 of the net property and equipment balance is outside of the United States. As December&#160;31, 2020, the Company recognized a loss on the write down of impaired assets of $8,264,000.  The impaired assets included six (6) Gamma Knife units and related removal costs, and two (2) deposits towards the purchase of proton beam systems and related capitalized interest.  The six (6) Gamma Knife units that were impaired consisted of two (2) units that had been taken out of service in prior years, one (1) unit that was taken out of service in 2020 and three (3) units that have already been, or the Company anticipates will be, taken out of service in 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;totaling $3,051,000.  In addition to this impairment write-off of $3,051,000 were estimated costs of de-install and removal (ARO) of four (4) of the Gamma Knife units of $1,350,000 (of which, the Company has paid $80,000) as of December&#160;31, 2020. Total impairment related to the Gamma Knife business was $4,401,000 for the year ended December&#160;31, 2020.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews the carrying value of its long-lived assets for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value may not be recoverable.  The Company has reviewed its Gamma Knife equipment, in light of available information as of December&#160;31, 2020 and based on current customer prospects, the probability of future contract extensions or renewals, and the high turnover rate in contract terminations compared to the Company's historical contract termination rate, the Company determined that these six (6) Gamma Knife units were more-than temporarily impaired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to December&#160;31, 2020, the Company had $2,250,000 in deposits toward the purchase of two MEVION S250i PBRT systems from Mevion. The Company reviews the carrying value of its deposits for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value may not be recoverable. The Company has reviewed the deposits, in light of available information, as of December&#160;31, 2020 and based on its current customer prospects, the impact that the COVID-19 pandemic has had on medical centers undertaking large capital expenditure projects for a limited patient base, and the length of time required to negotiate and implement a proton therapy project, the Company determined that its deposits of $2,250,000, related capitalized interest and other charges of $1,613,000 were other-than temporarily impaired.  Total impairment related to the proton therapy business was $3,863,000.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzE3MTU_912bdb2c-7310-4eff-8dce-948a199b458e">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DECEMBER 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment and facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,657,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,132,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits towards purchase of proton beam systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,157,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,941,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,739,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,461,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,418,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,480,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i75857421209a4a9a88a2265cd4aa4e0c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzItMS0xLTEtMA_25353d86-5a6d-4502-ab71-72a08e5764d0"
      unitRef="usd">75657000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i510367b0210f42978fd2121a0200735d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzItMy0xLTEtMA_3b7f1955-1902-4cc3-a8ef-72217145dbf5"
      unitRef="usd">92132000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i37f3a64c6fb840d18f0efb0eaa318c44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzMtMS0xLTEtMA_9edae9c1-f66b-4481-a37a-fa909817d16f"
      unitRef="usd">330000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ice7b40f1c9e14f0b8d6cb5971b5d802c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzMtMy0xLTEtMA_a9900305-5068-48dc-834f-3b2fc736f1a0"
      unitRef="usd">594000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i9d358d5eef3047409dc23e990ed19c02_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzQtMS0xLTEtMA_ce502bb1-65f2-4cf4-8bcd-4d8a74a24d96"
      unitRef="usd">170000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i76faded4f4504bc18d38d7c6fa9479aa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzQtMy0xLTEtMA_c9abe255-a16d-4361-8309-ddf3863e2d3c"
      unitRef="usd">1965000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i7084175c89f34387ac3446f385b5e3e1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzUtMS0xLTEtMA_9dbe29be-d5c1-455c-b50f-3638e80c9c42"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i1cb27f70c0184108b4804f5d0b9480eb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzUtMy0xLTEtMA_67cb0bb4-7172-4f14-89c0-039d9b863976"
      unitRef="usd">2250000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzYtMS0xLTEtMA_5183e26d-146b-4d05-aa28-7a4fdf9e4e7a"
      unitRef="usd">76157000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzYtMy0xLTEtMA_28980f86-52f9-4053-8ba0-542405343151"
      unitRef="usd">96941000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzctMS0xLTEtMA_6df8f86c-c9c7-4125-8a52-f04d3437108a"
      unitRef="usd">45739000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzctMy0xLTEtMA_1515eb1f-4c3a-4724-b72c-2a4aa1f8fdb0"
      unitRef="usd">55461000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzgtMS0xLTEtMA_a9662cdb-75ea-45a4-bb27-9c27ee6b5c02"
      unitRef="usd">30418000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90YWJsZTozZTIyMDdhZTMyZGY0NThhODE3OTUxNDBkZWE4NzIwNy90YWJsZXJhbmdlOjNlMjIwN2FlMzJkZjQ1OGE4MTc5NTE0MGRlYTg3MjA3XzgtMy0xLTEtMA_d25cffd6-8e08-4d7b-a1a6-b40020b308dd"
      unitRef="usd">41480000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i3035febde0194678b2773c7062226a54_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzQ5NDc4MDIzMzc5MDU_67362ddd-37d2-41ec-bb95-a2e4033d3f93"
      unitRef="usd">3195000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzQ5NDc4MDIzMzc3NzM_9719ba06-9230-4b0f-8649-54256864f377"
      unitRef="usd">-8264000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <ams:NumberOfImpairedAssetUnits
      contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwMjk_a072cc61-7aa7-4ccd-88e9-2661b7467e40"
      unitRef="unit">6</ams:NumberOfImpairedAssetUnits>
    <ams:NumberOfDeposits
      contextRef="i7084175c89f34387ac3446f385b5e3e1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwMzI_36fd4b86-524a-4fa0-b06d-4569b38838b2"
      unitRef="deposit">2</ams:NumberOfDeposits>
    <ams:NumberOfImpairedAssetUnits
      contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwMjU_a072cc61-7aa7-4ccd-88e9-2661b7467e40"
      unitRef="unit">6</ams:NumberOfImpairedAssetUnits>
    <ams:NumberOfImpairedAssetUnits
      contextRef="i8f932b9ba0be489d8eb94b2f6d54477c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwMzU_bc6eb77e-dd9a-45ab-835f-510697af9f9a"
      unitRef="unit">2</ams:NumberOfImpairedAssetUnits>
    <ams:NumberOfImpairedAssetUnits
      contextRef="icf316d9d1b244b2bade2edc301cde456_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwMzg_52288b9c-d646-4976-ad0f-b0f8d232cbb5"
      unitRef="unit">1</ams:NumberOfImpairedAssetUnits>
    <ams:NumberOfImpairedAssetUnits
      contextRef="i22e35e1d597d4b4399ba9a87a43dd7da_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwNDE_aa0fafe6-ee0e-48ea-87a0-1d9ef4af2f13"
      unitRef="unit">3</ams:NumberOfImpairedAssetUnits>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="id856a65ad9834e49b099b1d1d0c6aaa4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODc3Njc_95276bee-222a-4576-8136-061f880ca1ce"
      unitRef="usd">3051000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="id856a65ad9834e49b099b1d1d0c6aaa4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODc3ODk_95276bee-222a-4576-8136-061f880ca1ce"
      unitRef="usd">3051000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <ams:AssetRetirementObligationNumberOfRemovedAssetUnits
      contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwNDQ_c9d6872b-5100-48df-bdad-669c5004802f"
      unitRef="unit">4</ams:AssetRetirementObligationNumberOfRemovedAssetUnits>
    <us-gaap:AssetRetirementObligation
      contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwNDc_83e4c7aa-529c-4874-8e68-d07c70ed3b70"
      unitRef="usd">1350000</us-gaap:AssetRetirementObligation>
    <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties
      contextRef="id856a65ad9834e49b099b1d1d0c6aaa4_D20200101-20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIwNjk_fcd7b96a-5d07-4c4c-9ffc-d9a0ed65688c"
      unitRef="usd">-80000</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="id856a65ad9834e49b099b1d1d0c6aaa4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODc3OTI_7a703fee-58eb-4a79-a1dc-dcee136acb53"
      unitRef="usd">4401000</us-gaap:TangibleAssetImpairmentCharges>
    <ams:NumberOfImpairedAssetUnits
      contextRef="i284508e025b34d6d9f64d3b93def6455_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODIxODk_a072cc61-7aa7-4ccd-88e9-2661b7467e40"
      unitRef="unit">6</ams:NumberOfImpairedAssetUnits>
    <ams:LongTermPurchaseCommitmentDepositsForAssets
      contextRef="i8f30f61a17e747c2ad1bc8c1d865eb97_I20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzQ5NDc4MDIzMzg3MjY_f33b260e-5148-41f8-8a90-59d8709a37ae"
      unitRef="usd">2250000</ams:LongTermPurchaseCommitmentDepositsForAssets>
    <ams:LongTermPurchaseCommitmentDepositsForAssets
      contextRef="i8f30f61a17e747c2ad1bc8c1d865eb97_I20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzQ5NDc4MDIzMzkzOTE_f33b260e-5148-41f8-8a90-59d8709a37ae"
      unitRef="usd">2250000</ams:LongTermPurchaseCommitmentDepositsForAssets>
    <us-gaap:AccumulatedCapitalizedInterestCosts
      contextRef="i8f30f61a17e747c2ad1bc8c1d865eb97_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODc4MDQ_5beb0624-fd88-4d72-b862-9a14e54d405f"
      unitRef="usd">1613000</us-gaap:AccumulatedCapitalizedInterestCosts>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i8c2842d69fdd4db49a077b810d27392c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNTcvZnJhZzphOGQ5YzNmOTE5ZTQ0OWQ1OTNiYmVkNWQ2MzQwNTllZS90ZXh0cmVnaW9uOmE4ZDljM2Y5MTllNDQ5ZDU5M2JiZWQ1ZDYzNDA1OWVlXzI3NDg3NzkwODc4MTY_df8b7029-c619-415c-9fb9-9b355a42045d"
      unitRef="usd">3863000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzMyOTg1MzQ4OTQyMjY_b1a0c792-17f7-4bae-9fa9-cfb94239a2b7">GKCE ACQUISITION&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;On June 18, 2019, the Company entered into a Stock Purchase Agreement to acquire Gamma Knife Center Ecuador S.A. (&#x201c;GKCE&#x201d;) from GKCE&#x2019;s selling majority shareholders. GKCE is a well-established Gamma Knife operation founded in 2009 as a private clinic to introduce advanced stereotactic radiosurgery into Ecuador and continues to operate the only Gamma Knife unit in the country. The Company acquired GKCE for the continued expansion of its business internationally. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;On June 12, 2020 (the &#x201c;Closing Date&#x201d;), the Company acquired approximately 98% of the total outstanding shares of GKCE.  As of December&#160;31, 2020, the Company acquired approximately 99.3% of the total outstanding shares of GKCE and intends to acquire the remaining 0.7% at a later date. The fair value of the non-controlling interests (&#x201c;NCI&#x201d;) on the Closing Date was approximately $58,000, which was consistent with the purchase price in the executed NCI agreements. The total purchase consideration for 100% of the outstanding shares of GKCE was $2,883,000, including $2,000,000 of base purchase price, subject to certain price adjustments for current assets and liabilities and tax withholding. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;The base purchase price of $2,000,000 was paid with $575,000 of cash and a $1,425,000 loan from the United States International Development Finance Corporation (&#x201c;DFC&#x201d;). The DFC loan is denominated in U.S. dollars, which is also the currency of Ecuador. The price adjustments will be paid by the Company in the post-closing period with the adjustments related to the amount of working capital that GKCE had as of the Closing Date.  The first price adjustment for working capital as of the Closing Date was approximately $515,000, which was paid by the Company in August 2020.  As of December&#160;31, 2020, the Company owed the withholding taxes related to this payment totaling approximately $43,000. The Company estimates an additional contingent consideration of approximately $368,000 will be remitted to the seller based on the collection of Closing Date accounts receivable balances, net of related costs, during the three-month, six-month and twelve-month periods after the Closing Date. As of December&#160;31, 2020, $214,000 of the contingent considerations had been paid and $154,000 is estimated to be paid for the twelve-month period after the Closing Date. The Company reviewed historical patient treatments, invoice, and collection data from GKCE to determine an appropriate estimate of the contingent consideration at the Closing Date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;The acquisition has been accounted for according to ASC 805 using the acquisition method of accounting.  Under the acquisition method of accounting, all assets acquired, including goodwill and other intangible assets, should be stated at fair value at the time of acquisition.  The allocation of purchase price consideration is preliminary, pending the completion of the fair value of certain tangible, intangible assets, and residual goodwill.  During the measurement period, which can be no more than one year from the Closing Date, the Company expects to continue to obtain information to assist in determining the final fair value of assets acquired.  The assets acquired were recorded based on valuations derived from estimated fair value assessments and assumptions used by the Company.  Thus, the provisional measurements of fair value discussed below are subject to change.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;As of December&#160;31, 2020, accounting for the Closing Date accounts receivable balances, allowance on the uncollected accounts receivable balances, and related liabilities, was not complete.  The accounting for these amounts will be complete following the twelve-month period after the Closing Date, per the terms of the Stock Purchase Agreement. The Company expects to finalize the valuation as soon as practicable, but no later than one year from the Closing Date.  While the Company believes its estimates and assumptions underlying the valuations are reasonable, different estimates and assumptions could result in different valuations assigned to the individual assets acquired, and the resulting amount of goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;After the Acquisition date, the Company received additional information regarding the amounts recorded as accounts receivable as of June 12, 2020.  After reviewing the information obtained, the Company booked an additional $27,000 of accounts receivable as of December&#160;31, 2020.  As a result, related liabilities were increased by $13,000 and the contingent consideration increased by $14,000.  There was no impact to goodwill or net loss as of December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:105%"&gt;N&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:105%"&gt;OTE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:105%"&gt; 4 - GKCE ACQUISITION (CONTINUED)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;The fair value of assets acquired and liabilities assumed were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.873%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 12, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expense and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,374,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(141,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(491,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consideration allocated to assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,883,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First working capital payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(515,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated subsequent working capital payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(368,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Base purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;The Company has allocated the purchase price of GKCE to the tangible assets, liabilities, and intangible asset acquired, based on their estimated fair values.  Goodwill represents the excess of the purchase price consideration over the fair value of the identifiable tangible and intangible assets assumed.  The Company believes the amount of goodwill resulting from the acquisition is primarily attributable to expected synergies from an assembled and trained workforce and enhanced opportunities for growth and innovation.  The goodwill resulting from the acquisition is not tax deductible.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;The preliminary value of the acquired tangible assets acquired are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful Life (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total tangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;The Company also acquired intangible assets with a fair value of $78,000.  The intangible asset identified was GKCE's trade name and the Company assigned an indefinite useful life to the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;The Company incurred costs related to the acquisition of approximately $93,000 for the three-month period ended June 30, 2020 and $69,000 for the three-month period ended September&#160;30, 2020.  All acquisition related costs were expensed as incurred and have been recorded in selling and administrative expense in the Company's consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:105%"&gt;N&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:105%"&gt;OTE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:105%"&gt; 4 - GKCE ACQUISITION (CONTINUED)&lt;/span&gt;The revenue and earnings of GKCE have been included in the Company&#x2019;s consolidated results since the Closing Date and are not material to the Company&#x2019;s consolidated financial results.  Historical financial statements and pro forma results of the operations of GKCE as if the Acquisition occurred earlier than the Closing Date have not been presented, as the applicable significance thresholds are not exceeded by the Acquisition and the corresponding requirements to provide historical financial statements and corresponding pro forma financial information are not applicable to the Acquisition. In addition, the Company believes that the financial impact of the Acquisition to the Company&#x2019;s consolidated financial statements is not material and such historical financial information and pro forma financial information would not be meaningful for investors and financial statement users.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <ams:AssetAcquisitionPercentageOfSharesAcquired
      contextRef="i6422158328d64dee80e1ac0f4c7ef41f_I20200612"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDY4MDI_72b7007e-8fb8-4414-98fc-69623fc23221"
      unitRef="number">0.98</ams:AssetAcquisitionPercentageOfSharesAcquired>
    <ams:AssetAcquisitionPercentageOfSharesAcquired
      contextRef="i795a789ed9064252be4a8f64e1390165_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDY5MDk_6aaec314-8670-477e-9520-c07294e43b18"
      unitRef="number">0.993</ams:AssetAcquisitionPercentageOfSharesAcquired>
    <ams:AssetAcquisitionPercentageOfSharesRemaining
      contextRef="i6422158328d64dee80e1ac0f4c7ef41f_I20200612"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDY5OTA_92858028-cb7e-4370-af3a-9e904462e041"
      unitRef="number">0.007</ams:AssetAcquisitionPercentageOfSharesRemaining>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i6422158328d64dee80e1ac0f4c7ef41f_I20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDcxMDU_097300ee-da73-4ab0-92f8-2319cd9bb72a"
      unitRef="usd">58000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <ams:AssetAcquisitionPercentageOfOutstandingShares
      contextRef="i6422158328d64dee80e1ac0f4c7ef41f_I20200612"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDcyMjQ_21575d1a-01f7-4efc-af95-f6977c8cfe45"
      unitRef="number">1</ams:AssetAcquisitionPercentageOfOutstandingShares>
    <ams:AssetAcquisitionTotalConsiderationTransferred
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzQ5NDc4MDIzMzY5NjM_78527f09-99cd-4f14-94ed-68ed4c933b4b"
      unitRef="usd">2883000</ams:AssetAcquisitionTotalConsiderationTransferred>
    <ams:AssetAcquisitionConsiderationTransferred
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDcyODE_f7a91ac8-3055-4774-a076-1f6162c3fe39"
      unitRef="usd">2000000</ams:AssetAcquisitionConsiderationTransferred>
    <ams:AssetAcquisitionConsiderationTransferred
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDc0MzE_f7a91ac8-3055-4774-a076-1f6162c3fe39"
      unitRef="usd">2000000</ams:AssetAcquisitionConsiderationTransferred>
    <ams:PaymentsForAssetAcquisitions
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDc0NDk_72d92dc6-b536-4f70-81d8-cf6240d9922a"
      unitRef="usd">575000</ams:PaymentsForAssetAcquisitions>
    <ams:AssetAcquisitionTransactionCosts
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDc0Njc_5a42daa5-9b25-4e40-aa0e-0432bde5fe13"
      unitRef="usd">1425000</ams:AssetAcquisitionTransactionCosts>
    <ams:PaymentsForWorkingCapital
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDc5MDQ_e510f954-eafc-4d1c-ae2e-af61567022c0"
      unitRef="usd">515000</ams:PaymentsForWorkingCapital>
    <ams:PaymentsForWorkingCapital
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NDgwNjg_c3c45449-6b33-4711-b9e8-08866d4ef8f7"
      unitRef="usd">43000</ams:PaymentsForWorkingCapital>
    <ams:AssetAcquisitionAdditionalConsiderationTransferred
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzQ5NDc4MDIzMzY5NTA_c5ba8dca-30cf-4937-b9a2-51548fed0a6a"
      unitRef="usd">368000</ams:AssetAcquisitionAdditionalConsiderationTransferred>
    <ams:PaymentsToAcquireAsset
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzI3NDg3NzkwODEzODc_a343d88f-96f3-4e11-ac54-b984b4bd1f08"
      unitRef="usd">214000</ams:PaymentsToAcquireAsset>
    <ams:SubsequentWorkingCapitalPaymentAccruedForAcquisition
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzEwOTk1MTE2Mzg5Njk_882eaea4-0c7d-4fd5-9720-d3845f42f869"
      unitRef="usd">154000</ams:SubsequentWorkingCapitalPaymentAccruedForAcquisition>
    <ams:AssetAcquisitionAccountsReceivable
      contextRef="i7f7bc9edba63482baa71fc49aef7db07_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzEwOTk1MTE2Mzk2NDA_ded1c62e-ab67-4818-b340-d6f862c38909"
      unitRef="usd">27000</ams:AssetAcquisitionAccountsReceivable>
    <ams:AssetAcquisitionLiabilitiesAssumed
      contextRef="i7f7bc9edba63482baa71fc49aef7db07_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzEwOTk1MTE2Mzk2NTA_ab5e1b94-1571-4455-a743-fc22228d26ea"
      unitRef="usd">13000</ams:AssetAcquisitionLiabilitiesAssumed>
    <ams:AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration
      contextRef="i7f7bc9edba63482baa71fc49aef7db07_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzEwOTk1MTE2Mzk2NjA_eb356d34-1dca-4559-a75b-34b7605159ab"
      unitRef="usd">14000</ams:AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzMyOTg1MzQ4OTQzMDM_9510b790-3c6c-45d3-980d-be27516cb555">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;The fair value of assets acquired and liabilities assumed were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.873%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 12, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expense and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,374,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(141,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(491,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consideration allocated to assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,883,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First working capital payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(515,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated subsequent working capital payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(368,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Base purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <ams:AssetAcquisitionCashAndCashEquivalents
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzEtMy0xLTEtMTk3Mg_6b42217f-c7c6-420b-9efa-24bb3c23101b"
      unitRef="usd">432000</ams:AssetAcquisitionCashAndCashEquivalents>
    <ams:AssetAcquisitionAccountsReceivable
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzItMy0xLTEtMTk3Mg_a03f9f3e-c6d2-4272-ac54-80a13d028c36"
      unitRef="usd">854000</ams:AssetAcquisitionAccountsReceivable>
    <ams:AssetAcquisitionPrepaidExpenseAndOther
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzMtMy0xLTEtMTk3Mg_2b43bc84-1f04-401c-a8ca-27d0dad39944"
      unitRef="usd">22000</ams:AssetAcquisitionPrepaidExpenseAndOther>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i205b91ae82344e9d8e528defe6019354_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzQtMy0xLTEtMTk3Mg_a5b55453-aae6-4243-b34f-cadb5545f34f"
      unitRef="usd">385000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i24fa28513d1d4cedb8ff3631c13643d4_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzUtMy0xLTEtMjQxMA_16108eb0-e82e-4e45-aa03-af6c37407d5b"
      unitRef="usd">19000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i381af277ce4b42e2a421005e64fa2c53_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzUtMy0xLTEtMTk3Mg_fad19fea-5fe8-4608-894c-bb313ecea127"
      unitRef="usd">319000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired
      contextRef="i0e4c0e6386194ed79a0a74908a8481c4_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzYtMy0xLTEtMTk3Mg_772a2024-cf32-4ed4-8bba-43c26eb0742c"
      unitRef="usd">78000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzctMy0xLTEtMTk3Mg_515e08e7-60c7-4e01-877f-7cf4319988a0"
      unitRef="usd">1265000</us-gaap:GoodwillAcquiredDuringPeriod>
    <ams:AssetAcquisitionAssetsAcquired
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzgtMy0xLTEtMTk3Mg_fd848574-9b1b-4424-bbef-52e9effb4f8b"
      unitRef="usd">3374000</ams:AssetAcquisitionAssetsAcquired>
    <ams:AssetAcquisitionAccountsPayable
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzEwLTMtMS0xLTE5NzI_3a7efcbc-7859-4d35-ba51-6110b491189c"
      unitRef="usd">193000</ams:AssetAcquisitionAccountsPayable>
    <ams:AssetAcquisitionIncomeTaxesPayable
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzExLTMtMS0xLTE5NzI_27896274-2c39-4d42-99c1-1f42e4e2ceeb"
      unitRef="usd">141000</ams:AssetAcquisitionIncomeTaxesPayable>
    <ams:AssetAcquisitionDeferredIncomeTaxes
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzEyLTMtMS0xLTE5NzI_ee965866-3263-4b12-83f5-f0d7e8c006fe"
      unitRef="usd">66000</ams:AssetAcquisitionDeferredIncomeTaxes>
    <ams:AssetAcquisitionEmployeeCompensationAndBenefits
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzEzLTMtMS0xLTE5NzI_88fbd95e-d672-4da7-a0ba-dff8c7dbdc59"
      unitRef="usd">91000</ams:AssetAcquisitionEmployeeCompensationAndBenefits>
    <ams:AssetAcquisitionLiabilitiesAssumed
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzE0LTMtMS0xLTE5NzI_7226fefc-47af-4d90-b17d-412bdab22b46"
      unitRef="usd">491000</ams:AssetAcquisitionLiabilitiesAssumed>
    <ams:AssetAcquisitionTotalConsiderationTransferred
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzE1LTMtMS0xLTE5NzQ_78527f09-99cd-4f14-94ed-68ed4c933b4b"
      unitRef="usd">2883000</ams:AssetAcquisitionTotalConsiderationTransferred>
    <ams:PaymentsForWorkingCapital
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzE3LTMtMS0xLTE5NzI_c7d4b4db-aec9-4d80-8801-8a1169a8c620"
      unitRef="usd">515000</ams:PaymentsForWorkingCapital>
    <ams:AssetAcquisitionAdditionalConsiderationTransferred
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzE4LTMtMS0xLTE5NzI_c5ba8dca-30cf-4937-b9a2-51548fed0a6a"
      unitRef="usd">368000</ams:AssetAcquisitionAdditionalConsiderationTransferred>
    <ams:AssetAcquisitionConsiderationTransferred
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTpjY2U2NWY0NDc1OGM0NDQ2YTM2NWFjYzU2MWY3YWYwNy90YWJsZXJhbmdlOmNjZTY1ZjQ0NzU4YzQ0NDZhMzY1YWNjNTYxZjdhZjA3XzE5LTMtMS0xLTE5NzI_a8ba3c7e-4833-4535-ba7d-cb41cb9c6198"
      unitRef="usd">2000000</ams:AssetAcquisitionConsiderationTransferred>
    <ams:ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzMyOTg1MzQ4OTQzMDQ_3696a234-a0ac-451a-be28-4ef96af5e92f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;The preliminary value of the acquired tangible assets acquired are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful Life (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total tangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ams:ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i205b91ae82344e9d8e528defe6019354_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzItMS0xLTEtNDY0_c4d954ed-740b-4669-b887-86320abd27a5"
      unitRef="usd">385000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i205b91ae82344e9d8e528defe6019354_D20200612-20200612"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzItMy0xLTEtNDY0_2bd0b18c-c35b-4dd8-957e-c032b422d6e8">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i24fa28513d1d4cedb8ff3631c13643d4_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzMtMS0xLTEtMjQxOQ_fd9f59ed-f3a2-4a2b-9ba1-e133f5edcd6f"
      unitRef="usd">19000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ief5ace117998418a93ba873e84fcee06_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzMtMS0xLTEtNDY0_f3994350-a752-4bf9-bb85-c39ae3c7184d"
      unitRef="usd">302000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ief5ace117998418a93ba873e84fcee06_D20200612-20200612"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzMtMy0xLTEtNDY0_659f2e7b-13cb-4bd4-b779-27f36865c619">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ie7107c47918d4072a7fa9c7ea3337757_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzQtMS0xLTEtNDY0_ff55a5a7-b6d6-4f31-9e3d-6378698ee9f9"
      unitRef="usd">17000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie7107c47918d4072a7fa9c7ea3337757_D20200612-20200612"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzQtMy0xLTEtNDY0_9482f541-e152-4432-b636-4bc3173084cb">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90YWJsZTozMTVkODUzY2M1NTY0NzEyYmJhZTc3NmU2NGE1MDA0Ny90YWJsZXJhbmdlOjMxNWQ4NTNjYzU1NjQ3MTJiYmFlNzc2ZTY0YTUwMDQ3XzUtMS0xLTEtNDY0_19a57ec7-f0f5-4b32-bc8d-3621d9b7a4ff"
      unitRef="usd">723000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired
      contextRef="i0e4c0e6386194ed79a0a74908a8481c4_D20200612-20200612"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NTEwODY_0076888b-9ed5-4f32-a0df-76d3837ebaac"
      unitRef="usd">78000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie13445cb0ba94819a5bcc00de48c6ac3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NTEyODM_18880fd5-6bc6-43a2-afc6-3dd691b357b5"
      unitRef="usd">93000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i9aed20455da74365bfd0779fe7c8fe53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjAvZnJhZzpmYjMwMjdhYWEzOTM0MGE1ODU1ZTUxODFjZTI2ZjA5OC90ZXh0cmVnaW9uOmZiMzAyN2FhYTM5MzQwYTU4NTVlNTE4MWNlMjZmMDk4XzE2NDkyNjc0NTEzMzg_4133fa21-513c-44b3-bf79-6a3038dfd8b7"
      unitRef="usd">69000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzgxNQ_9b594c2f-3806-4454-bce4-b316f446c5eb">LONG TERM DEBT&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists primarily of seven notes with three financing companies collateralized by the Gamma Knife equipment having an aggregate net book value of $11,023,000, the individual customer contracts, and related accounts receivable of $1,718,000 at December&#160;31, 2020. These notes are predominantly payable in 36 to 84 fully amortizing monthly installments, mature between January 2021 and September 2027. The notes accrue interest at fixed annual rates between 3.67% and 6.90%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2019, the Company had six notes with two financing companies collateralized by the Gamma Knife equipment having an aggregate net book value of $13,130,000, the individual customer contracts, and related accounts receivable of $1,848,000. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are contractual maturities of long-term debt by year at December&#160;31, 2020, excluding debt issuance costs of $27,000:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,624,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <ams:NumberOfDebtInstruments
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzI3NDg3NzkwNzA2Nzg_d3c4fc1c-ad2d-42d2-9a0e-41b76297f759"
      unitRef="note">7</ams:NumberOfDebtInstruments>
    <us-gaap:DebtInstrumentCollateralAmount
      contextRef="iea6020aa13c8441883aae4fa8107203a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzE4Nw_e44aedf8-a0d8-4fdb-811a-18342fbdd8af"
      unitRef="usd">11023000</us-gaap:DebtInstrumentCollateralAmount>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="iea6020aa13c8441883aae4fa8107203a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzE2NDkyNjc0NDI2MDg_3f1d49f7-3a3b-4d99-a029-fc5222d65c34"
      unitRef="usd">1718000</us-gaap:AccountsReceivableRelatedParties>
    <ams:LongTermDebtMonthlyInstallments
      contextRef="i279a2dc09a1e4d058baa0f82d26d3fec_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzI5Nw_3c74e0b4-cf70-498a-9aa2-a302addfaa02">P36Y</ams:LongTermDebtMonthlyInstallments>
    <ams:LongTermDebtMonthlyInstallments
      contextRef="i201f554e454a461689418aeaf993818a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzMwMw_d65c13f1-7d3d-4122-8510-a024b01130a4">P84M</ams:LongTermDebtMonthlyInstallments>
    <us-gaap:LongTermDebtPercentageBearingVariableInterestRate
      contextRef="icfa5f63042e644d5b31c703f3ac54c9a_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzUwMw_2d6e8175-6df4-4e89-bb6a-375649fe2810"
      unitRef="number">0.0367</us-gaap:LongTermDebtPercentageBearingVariableInterestRate>
    <us-gaap:LongTermDebtPercentageBearingVariableInterestRate
      contextRef="ibf0485b3300f4c709015ee46dc45d199_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzUxMA_fe3d6585-68bd-4da0-bcbe-2058e40f0657"
      unitRef="number">0.0690</us-gaap:LongTermDebtPercentageBearingVariableInterestRate>
    <ams:NumberOfDebtInstruments
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzI3NDg3NzkwNzA2ODI_848c6152-ef84-4e3d-bf15-b8b0df2e5ab0"
      unitRef="note">6</ams:NumberOfDebtInstruments>
    <us-gaap:DebtInstrumentCollateralAmount
      contextRef="i2a19b56e39284cc2bd0fe2b1a910fdc9_I20191231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzE2NDkyNjc0NDI4NDg_28ad0ccf-d199-48ce-9b30-da58aebde747"
      unitRef="usd">13130000</us-gaap:DebtInstrumentCollateralAmount>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="i2a19b56e39284cc2bd0fe2b1a910fdc9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzE2NDkyNjc0NDI4NDQ_33635bf8-b844-4949-ae39-c3384f837939"
      unitRef="usd">1848000</us-gaap:AccountsReceivableRelatedParties>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzgxNA_c87fcac5-16e3-4a83-9385-0196c2912760">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are contractual maturities of long-term debt by year at December&#160;31, 2020, excluding debt issuance costs of $27,000:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,624,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90ZXh0cmVnaW9uOjU4NGIxOTQxMzE2NzQ2YzdhMzJlODUyZDFlMmU1ODFiXzE2NDkyNjc0NDI2MDI_5df757f7-8fe5-4eb5-ad35-1e1494996c83"
      unitRef="usd">27000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzEtMi0xLTEtMA_6d932243-939b-47f6-8ad2-d11e947feff5"
      unitRef="usd">1157000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzItMi0xLTEtMA_10637805-f123-466b-9d95-3dd7198ec43d"
      unitRef="usd">768000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzMtMi0xLTEtMA_257f69f1-005f-4bcf-bc7f-ee37a63546d3"
      unitRef="usd">802000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzQtMi0xLTEtMA_55323cb4-e60e-490c-b1e4-cda3e9ecac25"
      unitRef="usd">839000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzUtMi0xLTEtMA_36574bde-9799-4ffe-92fa-c5cfabece04c"
      unitRef="usd">592000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzYtMi0xLTEtMA_1f873cf2-36ea-4a8f-9da1-8d87217ddabf"
      unitRef="usd">466000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LongTermDebt
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjMvZnJhZzo1ODRiMTk0MTMxNjc0NmM3YTMyZTg1MmQxZTJlNTgxYi90YWJsZTo1MTM3NjMyZDEwMzU0YmU0ODM2ZDYzZjYyYWMyOTUwMS90YWJsZXJhbmdlOjUxMzc2MzJkMTAzNTRiZTQ4MzZkNjNmNjJhYzI5NTAxXzctMi0xLTEtMA_b37c3158-bd13-408d-8f63-5f6c5b59e622"
      unitRef="usd">4624000</us-gaap:LongTermDebt>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzk0OQ_1ab63aaf-1423-47f3-bba7-f651c41eb247">FINANCE LEASES&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has six finance lease obligations with two financing companies, collateralized by Gamma Knife and PBRT equipment having an aggregate net book value of $18,093,000, the individual customer contracts, and related accounts receivable of $1,892,000 at December&#160;31, 2020. These obligations have imputed interest rates ranging between 4.73% and 13.00%, are predominantly payable in 36 to 84 monthly installments, and mature between November 2021 and September 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2019, the Company had ten finance lease obligations with three financing companies, collateralized by Gamma Knife and PBRT equipment, having an aggregate net book value of $22,860,000, the individual customer contracts, and related accounts receivable of $4,600,000. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the end of each lease term, the Company has a bargain purchase option to purchase the equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments, together with the present value of the net minimum lease payments under finance leases at December&#160;31, 2020, are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Present Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;of Minimum&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease Payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,590,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,576,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,771,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,919,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,945,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,974,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <ams:NumberOfFinancingLeases
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzE2NDkyNjc0NDI2MjI_09fa34ac-caab-434d-b0dc-7fda052c8bae"
      unitRef="lease">6</ams:NumberOfFinancingLeases>
    <ams:FinanceLeaseObligations
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzE5NA_173003dd-d222-44f5-8afd-fc11529c997d"
      unitRef="usd">18093000</ams:FinanceLeaseObligations>
    <ams:FinanceLeaseAccountsReceivable
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzE2NDkyNjc0NDI4MTc_619b7fc8-240c-43e3-ba61-d8e712cd4e46"
      unitRef="usd">1892000</ams:FinanceLeaseAccountsReceivable>
    <ams:FinanceLeaseObligationInterestRate
      contextRef="icfa5f63042e644d5b31c703f3ac54c9a_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzMzOQ_b1cc98d0-0c63-4e86-b31d-4d14ba7ede98"
      unitRef="number">0.0473</ams:FinanceLeaseObligationInterestRate>
    <ams:FinanceLeaseObligationInterestRate
      contextRef="ibf0485b3300f4c709015ee46dc45d199_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzM0Ng_d04735b9-f406-4d31-b0ab-0d6266d5011e"
      unitRef="number">0.1300</ams:FinanceLeaseObligationInterestRate>
    <ams:FinanceLeaseObligationsMonthlyInstallments
      contextRef="i279a2dc09a1e4d058baa0f82d26d3fec_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzM2NQ_a6cf93f1-481b-41ff-bbf3-38245d71e599">P36Y</ams:FinanceLeaseObligationsMonthlyInstallments>
    <ams:FinanceLeaseObligationsMonthlyInstallments
      contextRef="i201f554e454a461689418aeaf993818a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzM3MQ_87d22d54-c50b-41a1-af48-a893efc8efe7">P84Y</ams:FinanceLeaseObligationsMonthlyInstallments>
    <ams:NumberOfFinancingLeases
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzE2NDkyNjc0NDI2NTQ_39668c9a-7cec-4453-8270-56e63e37c35e"
      unitRef="lease">10</ams:NumberOfFinancingLeases>
    <ams:FinanceLeaseObligations
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzY5MQ_c3441839-293e-4101-85d3-e43831aec3c9"
      unitRef="usd">22860000</ams:FinanceLeaseObligations>
    <ams:FinanceLeaseAccountsReceivable
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzE2NDkyNjc0NDI4MDc_01201402-cec6-4172-b22e-103d2bdb6a5a"
      unitRef="usd">4600000</ams:FinanceLeaseAccountsReceivable>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90ZXh0cmVnaW9uOjRhZjQ5ZDAzZjBlZDRjYzI4MzQxMzY1ODBiZTY1YWRjXzk1Mw_0e59b0cb-097c-47c2-b483-797b4b7485c5">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments, together with the present value of the net minimum lease payments under finance leases at December&#160;31, 2020, are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Present Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;of Minimum&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease Payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,590,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,576,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,771,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,919,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,945,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,974,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzItMS0xLTEtMA_d3385ac3-a3a7-486d-a8a7-ba77024b99a8"
      unitRef="usd">6590000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzMtMS0xLTEtMA_ea7a251e-333c-4bd7-be02-9cfa7adc2c94"
      unitRef="usd">1576000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzQtMS0xLTEtMA_336471c1-7573-4682-99e3-7cfd4b9e2390"
      unitRef="usd">1083000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzUtMS0xLTEtMA_ba3a8183-fa0c-4f57-bdda-242d92d3c6b9"
      unitRef="usd">522000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzgtMS0xLTEtMA_07a50c54-3a83-483e-926f-4a3b6739be83"
      unitRef="usd">9771000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzktMS0xLTEtMA_eceef4a8-1646-4971-85ab-39a9fd268c11"
      unitRef="usd">852000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzEwLTEtMS0xLTA_5aa2e8e9-816c-4edb-b2ff-15834319d39f"
      unitRef="usd">8919000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzExLTEtMS0xLTA_144983cd-f7c9-4618-992a-73af99a899e9"
      unitRef="usd">5945000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjYvZnJhZzo0YWY0OWQwM2YwZWQ0Y2MyODM0MTM2NTgwYmU2NWFkYy90YWJsZTplNjI2OWZhYTNlN2Y0Y2ZjYTc5ZTNmNDllYjlkMzk3MS90YWJsZXJhbmdlOmU2MjY5ZmFhM2U3ZjRjZmNhNzllM2Y0OWViOWQzOTcxXzEyLTEtMS0xLTA_2f9a6a15-4bff-4073-a108-916a98bda474"
      unitRef="usd">2974000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzI1OTA_9add1bf8-36cd-4f59-97e0-4ae7f581e09a">LEASES&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if a contract is a lease at inception. Under ASC 842, the Company is a lessor of equipment to various customers. Leases that commenced prior to ASC 842 adoption date were classified as operating leases under historical guidance. As the Company has elected the package of practical expedients allowing it to not reassess lease classification, these leases are classified as operating leases under ASC 842 as well. All of the Company&#x2019;s lessor arrangements entered into after ASC 842 adoption are also classified as operating leases. Some of these lease terms have an option to extend the lease after the initial term, but do not contain the option to terminate early or purchase the asset at the end of the term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Gamma Knife and PBRT contracts with hospitals are classified as operating leases under ASC 842. The related equipment is included in medical equipment and facilities on the Company&#x2019;s consolidated balance sheets (see further discussion at Note 2). As all income from the Company&#x2019;s lessor arrangements is solely based on procedure volume, all income is considered variable payments not dependent on an index or a rate. As such, the Company does not measure future operating lease receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lessee operating leases are accounted for as right-of-use (&#x201c;ROU&#x201d;) assets, other current liabilities, and lease liabilities on the consolidated balance sheets. Operating lease ROU assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company&#x2019;s operating lease contracts do not provide an implicit rate for calculating the present value of future lease payments, so the Company determined its incremental borrowing rate to be in the range of approximately 4.0% and 6.0% by using available market rates and expected lease terms. The operating lease ROU assets and liabilities also include any lease payments made and excludes lease incentives and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company&#x2019;s lessee operating lease agreements are for administrative office space and related equipment, and the agreement to lease clinic space for its stand-alone facility in Lima, Peru. These leases have remaining lease terms between 2 and 3 years, some of which include options to renew or extend the lease. As of December&#160;31, 2020, operating ROU assets and liabilities were $886,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2020, the Company elected to not renew its lease for a satellite office in Fairfield, California.  The Company previously included the renewal term in its assessment of the lease term for the ROU asset and liability. The Company accounted for this change as a lease reassessment under ASC 842. At the reassessment date, the remaining lease balance was not material to the Company's consolidated balance sheets and the Company wrote off the related ROU assets and liabilities of $67,000.  Also during the year ended December&#160;31, 2020, the Company agreed to a rent increase for its clinic space for its stand-alone facility in Lima, Peru.  The rent increase was effective as of January 1, 2020 and the Company increased the related ROU assets and liabilities by $135,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes maturities of lessee operating lease ROU assets and liabilities as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="icfa5f63042e644d5b31c703f3ac54c9a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzE2NDkyNjc0NDQyOTQ_8ed1db44-3d6e-462b-9734-7ed0c8f205c6"
      unitRef="number">0.040</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="ibf0485b3300f4c709015ee46dc45d199_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzE4MDY_5081b56e-b662-4029-aa2b-a090330302eb"
      unitRef="number">0.060</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="icfa5f63042e644d5b31c703f3ac54c9a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzU0OTc1NTgxNDI0OTg_ef033dee-3d5d-4081-aa34-c1ad75b1f054">P2Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="ibf0485b3300f4c709015ee46dc45d199_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzE2NDkyNjc0NDQzNDE_9561d5ec-e56a-4cd0-a226-9b77990eaf0d">P3Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzI0Nzk_21724a13-d867-4dd7-b25b-c6cd9044ccfa"
      unitRef="usd">886000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzI0Nzk_f23f1cf8-c53c-4dd8-b1b2-a6f040837acc"
      unitRef="usd">886000</us-gaap:OperatingLeaseLiability>
    <ams:LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzE2NDkyNjc0NDQ4Njc_6bf81729-3ea6-4ba3-ad60-134b781003b3"
      unitRef="usd">67000</ams:LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities>
    <ams:NonCashRightOfUseAssetsAndLeaseLiabilities
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzE2NDkyNjc0NDUxNTQ_eae76257-4d45-4418-bb30-7125b0936965"
      unitRef="usd">135000</ams:NonCashRightOfUseAssetsAndLeaseLiabilities>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90ZXh0cmVnaW9uOmJlMjhkOWYzNmU4ZTQzMTg5MzhkMTlmMTUyNTkzZTYzXzI1OTE_6f1824ec-9c59-493e-943e-21da368f2a62">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes maturities of lessee operating lease ROU assets and liabilities as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum payments under non-cancelable operating leases having initial terms of more than one year consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzItMS0xLTEtMA_7b19a2e5-0c3c-42be-9646-c05b2c9785dc"
      unitRef="usd">346000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzMtMS0xLTEtMA_cb34c068-3be7-47ee-966e-9e20b9460444"
      unitRef="usd">353000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzQtMS0xLTEtMA_83982e75-6c95-479d-9de5-1b67525d9010"
      unitRef="usd">248000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzUtMS0xLTEtMA_beda3f9a-5c60-4a95-b2a3-6ec76a33bfb5"
      unitRef="usd">8000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzgtMS0xLTEtMA_e9c5c06a-5c51-42e8-9ac5-2395f82f1736"
      unitRef="usd">955000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzktMS0xLTEtMA_eb9c9148-5d4d-4423-b473-9782ab0f8123"
      unitRef="usd">69000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNjkvZnJhZzpiZTI4ZDlmMzZlOGU0MzE4OTM4ZDE5ZjE1MjU5M2U2My90YWJsZTozMWI0MTA0MTNmOGI0YTQ2YTc1NzhhZjZmZWQ4ZThkZC90YWJsZXJhbmdlOjMxYjQxMDQxM2Y4YjRhNDZhNzU3OGFmNmZlZDhlOGRkXzEwLTEtMS0xLTA_64b00e18-cb8e-4721-897c-006e9d747f9e"
      unitRef="usd">886000</us-gaap:OperatingLeaseLiability>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkyNTU_524a81ff-ba82-4afb-bd9d-0686298effc0">I&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;NCOME&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; T&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;AXES&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020 and 2019 the Company recorded an income tax benefit of $1,737,000 and income tax expense of $128,000, respectively.  The decrease in the Company&#x2019;s provision for income taxes as of December&#160;31, 2020 is due to a loss on the write down of impaired assets.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the provision (benefit) for income taxes as of December&#160;31, 2020 and 2019 consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;YEARS ENDED DECEMBER 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,909,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(251,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,151,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(652,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,737,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of the Company&#x2019;s deferred tax liabilities and assets as of December&#160;31, 2020 and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DECEMBER 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(564,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,112,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(564,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,112,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &#x2013; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital loss carryover&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;921,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,519,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(678,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,514,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These amounts are presented in the financial statements as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DECEMBER 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,514,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,514,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The (benefit) provision for income taxes differs from the amount computed by applying the U.S. federal statutory tax rate (21% in 2020 and 2019) to income before taxes as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;YEARS ENDED DECEMBER 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computed expected federal income tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,844,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to Provision True-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain Tax Positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital loss carryforward expiration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred tax adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,737,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, the Company exhausted the remainder of its net operating loss carryforward for federal income tax return purposes. The Company has net operating loss carryforwards for state income tax purposes of approximately $2,219,000 that begin to expire in 2029. The Company has net operating loss carryforwards for its international subsidiaries of approximately $32,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Utilization of the net operating loss and credit carryforwards may be subject to an annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended (the &#x201c;Code&#x201d;), and similar state provisions. Any annual limitation may result in the expiration of net operating losses and credits before utilization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, the Company has a capital loss carryforward for federal income tax return purposes of approximately $2,586,000 which starts to expire in 2021. The Company has capital loss carryforwards for state income tax purposes of approximately $129,000 which starts to expire in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to uncertainty surrounding the realization of impairment losses, capital losses and foreign operating losses in future years, the Company has placed a valuation allowance against a portion of its net domestic and foreign deferred tax assets. The net valuation allowance decreased by $243,000 and $175,000 for the tax years ended December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2019, the Company released the valuation allowance related to GKPeru deferred tax assets, which resulted in an income tax benefit of $104,000. The Company concluded, based upon the preponderance of positive evidence (i.e. cumulative profit before tax adjusted for permanent items over the previous twelve quarters, a history of taxable income in recent periods, and the current forecast of income before taxes for GKPeru going forward) over negative evidence and the anticipated ability to use the deferred tax assets, that it was more likely than not that the deferred tax assets will be realized. If there are unfavorable changes to actual operating results or to projections of future income, the Company may determine that it is more likely than not such deferred tax assets may not be realizable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax return years 2016 through 2019 remain open to examination by the major domestic taxing jurisdictions to which the Company is subject. In 2019, the Company settled a New York State examination for tax years 2015 through 2017 with no material adjustments. Net operating losses generated on a tax return basis by the Company for calendar years 1999 through 2004, 2009, 2010, 2012, 2014, 2015, 2016, 2017 and 2018 remain open to examination by the major domestic taxing jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has adopted accounting standards which prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of uncertain tax positions taken or expected to be taken in a company's income tax return, and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. Additionally, these accounting standards specify that tax positions for which the timing of the ultimate resolution is uncertain should be recognized as long-term liabilities. The Company has made no reclassifications between current taxes payable and long term taxes payable under this guidance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the unrecognized tax benefit was $275,000 which, if recognized, will not affect the annual effective tax rate as these unrecognized tax benefits would increase deferred tax assets which would be subject to a full valuation allowance. A reconciliation of the beginning and ending amount of unrecognized tax benefit is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:0 1pt"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;YEARS ENDED DECEMBER 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's policy for deducting interest and penalties is to treat interest as interest expense and penalties as taxes. As of December&#160;31, 2020, the Company had $15,000 accrued for the payment of penalties and zero interest related to unrecognized tax benefits. The Company does not expect any material changes to our uncertain tax positions within the next 12 months.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzEwMA_32ea63fb-5c5c-457e-89c1-255d81534e6f"
      unitRef="usd">-1737000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzEwNA_082f93ad-b114-41f5-96e8-14fe988fb3b9"
      unitRef="usd">128000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkyNTA_18fe072d-36a2-4f9f-bb78-64c465646588">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the provision (benefit) for income taxes as of December&#160;31, 2020 and 2019 consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;YEARS ENDED DECEMBER 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,909,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(251,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,151,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(652,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,737,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzMtMS0xLTEtMA_0fa2e7ce-be55-455f-beba-0144ed1ddd28"
      unitRef="usd">209000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzMtMy0xLTEtMA_6c682b8d-882a-4a13-8adf-432f8e0c0182"
      unitRef="usd">443000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzQtMS0xLTEtMA_05840d2c-befe-4d26-8b86-a77db3f94ee2"
      unitRef="usd">88000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzQtMS0xLTEtMA_99de5bd3-62c0-4447-bd9e-fc1668ef640e"
      unitRef="usd">88000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzQtMy0xLTEtMA_04c8a0f3-586f-4446-8597-f679916fface"
      unitRef="usd">207000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzQtMy0xLTEtMA_110a55e1-28aa-4ef3-9acb-7fe78b6fd730"
      unitRef="usd">207000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzUtMS0xLTEtMA_ef74da8f-f61c-4ec7-83ec-2a142122c971"
      unitRef="usd">117000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzUtMy0xLTEtMA_9a82fb2a-aef9-4e29-b212-027d6e84f879"
      unitRef="usd">130000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzYtMS0xLTEtMA_4d624101-d11b-434e-aaab-d71efe034ea3"
      unitRef="usd">414000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzYtMS0xLTEtMA_993122a4-1f2a-472c-a180-9db7fa6d8f87"
      unitRef="usd">414000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzYtMy0xLTEtMA_5864aa83-65a6-4255-a9d2-231e71f47eb8"
      unitRef="usd">780000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzYtMy0xLTEtMA_d63a10a7-00d6-4768-968e-c42ba135ca4b"
      unitRef="usd">780000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzktMS0xLTEtMA_032bfb00-0965-4605-984c-c8b9b687a4fe"
      unitRef="usd">-1909000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzktMy0xLTEtMA_f6979472-4815-4a2d-b99c-449d6217c762"
      unitRef="usd">-311000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzEwLTEtMS0xLTA_4c173166-fd2f-4e61-8e9c-7214e02841e6"
      unitRef="usd">-266000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzEwLTMtMS0xLTA_f00feac1-3359-44b9-b58c-9178c1852d3f"
      unitRef="usd">-251000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzExLTEtMS0xLTA_13c29d03-ea33-4c73-86a8-cc70ad833b12"
      unitRef="usd">24000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzExLTMtMS0xLTA_9df9f0b8-2673-4a0d-9ae9-7838d3f8f613"
      unitRef="usd">-90000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzEyLTEtMS0xLTA_2667e9df-ff4b-48dc-acd7-fe5b3b8bc0a0"
      unitRef="usd">-2151000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzEyLTMtMS0xLTA_61506470-a6df-4085-b0bd-c76638a471b4"
      unitRef="usd">-652000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzE0LTEtMS0xLTA_00395d9b-dd64-46f5-a643-5af0788717a0"
      unitRef="usd">-1737000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5MjA0ZWZkZjBjM2M0Yzg5YWIzNTg1YWRlODU0NjUwYy90YWJsZXJhbmdlOjkyMDRlZmRmMGMzYzRjODlhYjM1ODVhZGU4NTQ2NTBjXzE0LTMtMS0xLTA_93518051-48bb-41be-a4ac-769ccb9a1be2"
      unitRef="usd">128000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkyNTE_31a636c1-f0c5-4eee-a05a-60d0ee6fde25">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of the Company&#x2019;s deferred tax liabilities and assets as of December&#160;31, 2020 and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DECEMBER 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(564,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,112,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(564,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,112,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &#x2013; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital loss carryover&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;921,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,519,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(678,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,514,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzMtMS0xLTEtMA_3ebe448c-0124-45a6-ae37-8ed47588df34"
      unitRef="usd">564000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzMtMy0xLTEtMA_96d5cf28-771b-47dd-a236-47fee9b3677e"
      unitRef="usd">3112000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzUtMS0xLTEtMA_42a02325-3703-4b36-b232-db8121301a2b"
      unitRef="usd">564000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzUtMy0xLTEtMA_7b5009ea-63d2-482a-b100-76c786330525"
      unitRef="usd">3112000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzgtMS0xLTEtMA_a1648294-c826-4815-80b5-7095bc9631e1"
      unitRef="usd">99000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzgtMy0xLTEtMA_32849272-e88d-4f42-bbed-ad2986be421f"
      unitRef="usd">117000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzktMS0xLTEtMA_88eb7d92-903b-449e-ac9c-8ca7e7e681de"
      unitRef="usd">43000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzktMy0xLTEtMA_a685bdff-df89-44fd-95d6-1a995fb7edee"
      unitRef="usd">248000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzEwLTEtMS0xLTA_e0281856-e018-41df-b82c-8111f4aeec58"
      unitRef="usd">5000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzEwLTMtMS0xLTA_837a20d7-5b10-44b7-9b97-3e6acc3c8d17"
      unitRef="usd">4000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzExLTEtMS0xLTA_111fbfd4-125c-4623-8b3c-28fa5c4f0322"
      unitRef="usd">50000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzExLTMtMS0xLTA_744aec86-8970-4576-9769-903aaa736831"
      unitRef="usd">229000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzEyLTEtMS0xLTA_97f53847-f965-4899-8be1-bff10d55af1a"
      unitRef="usd">627000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzEyLTMtMS0xLTA_b81b23c7-ae3c-4bc8-9f0a-d51d0ed519a7"
      unitRef="usd">921000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzE0LTEtMS0xLTA_22845cb7-924d-4506-a6c1-726be61cc7d0"
      unitRef="usd">824000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzE0LTMtMS0xLTA_1dbb3c59-10fa-4310-a6e0-81d3615dae0f"
      unitRef="usd">1519000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzE2LTEtMS0xLTA_79521325-e013-45e2-9130-c94fc879ff7e"
      unitRef="usd">678000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzE2LTMtMS0xLTA_89fffff4-2c7b-45b9-917f-bbffd108c872"
      unitRef="usd">921000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzE4LTEtMS0xLTA_8fe2bd4b-6d7e-4d6e-8079-c786b1f68556"
      unitRef="usd">146000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzE4LTMtMS0xLTA_e55074b1-e48e-411f-8e93-66895872f305"
      unitRef="usd">598000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzIwLTEtMS0xLTA_292cef21-df40-4ef1-82b7-2fef84f0f845"
      unitRef="usd">418000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo0ZmQzYjA1YWVjYWM0YjQzOTBjZTlmYzRhMTMyYzJiZC90YWJsZXJhbmdlOjRmZDNiMDVhZWNhYzRiNDM5MGNlOWZjNGExMzJjMmJkXzIwLTMtMS0xLTA_f79a16cd-2e7b-4103-a16d-3b97a6df65f8"
      unitRef="usd">2514000</us-gaap:DeferredTaxLiabilities>
    <ams:ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkyNTI_55ba8041-1713-40ee-b1a5-1048c1213a11">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These amounts are presented in the financial statements as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DECEMBER 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,514,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,514,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ams:ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5ZjAyNmE2NzAzMDY0Yjk5YjI5YTBlZjc4NDEyNWZmNy90YWJsZXJhbmdlOjlmMDI2YTY3MDMwNjRiOTliMjlhMGVmNzg0MTI1ZmY3XzItMS0xLTEtMA_52bf260f-89ae-4597-8bab-b1e2b1305960"
      unitRef="usd">418000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5ZjAyNmE2NzAzMDY0Yjk5YjI5YTBlZjc4NDEyNWZmNy90YWJsZXJhbmdlOjlmMDI2YTY3MDMwNjRiOTliMjlhMGVmNzg0MTI1ZmY3XzItMy0xLTEtMA_d0d90b42-7bff-4161-bed6-63e22b21a4d2"
      unitRef="usd">2514000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5ZjAyNmE2NzAzMDY0Yjk5YjI5YTBlZjc4NDEyNWZmNy90YWJsZXJhbmdlOjlmMDI2YTY3MDMwNjRiOTliMjlhMGVmNzg0MTI1ZmY3XzMtMS0xLTEtMA_74cbec7a-91a6-401d-b015-b013af3a0bab"
      unitRef="usd">418000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTo5ZjAyNmE2NzAzMDY0Yjk5YjI5YTBlZjc4NDEyNWZmNy90YWJsZXJhbmdlOjlmMDI2YTY3MDMwNjRiOTliMjlhMGVmNzg0MTI1ZmY3XzMtMy0xLTEtMA_3839a29e-3031-4a45-9436-c0873b3cc765"
      unitRef="usd">2514000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkyNTM_784dd8ce-8554-47b1-964c-e725d99bb613">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The (benefit) provision for income taxes differs from the amount computed by applying the U.S. federal statutory tax rate (21% in 2020 and 2019) to income before taxes as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;YEARS ENDED DECEMBER 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computed expected federal income tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,844,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to Provision True-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain Tax Positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital loss carryforward expiration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred tax adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,737,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzIxOTQ_7c83725e-d843-4a51-aff3-1fbfda2e4390"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzIxOTQ_9bcf070c-de98-4614-8999-941c09750173"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzItMS0xLTEtMA_d44194e7-c3fd-466a-bcb9-3fa9029e849d"
      unitRef="usd">-1844000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzItMy0xLTEtMA_380af34c-9c6b-4bca-87c9-7b988ba4a5e2"
      unitRef="usd">167000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzMtMS0xLTEtMA_ecdd2cba-acd6-443a-bcea-56be0a4e18d5"
      unitRef="usd">-199000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzMtMy0xLTEtMA_5f088dc8-2c24-4944-aa78-cbaa9f8e624a"
      unitRef="usd">-80000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzQtMS0xLTEtMA_3e3b5030-b697-4a7f-9ace-5eae5eb91121"
      unitRef="usd">6000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzQtMy0xLTEtMA_37f7298f-635f-49a9-ae72-1601a3cd1b8d"
      unitRef="usd">29000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <ams:EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzYtMS0xLTEtMA_a8bb5b92-a964-4e94-bf15-d09fc07a756d"
      unitRef="usd">22000</ams:EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount>
    <ams:EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzYtMy0xLTEtMA_b29d0e11-9dde-4732-a8f7-db4a475f4daf"
      unitRef="usd">39000</ams:EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount>
    <ams:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzctMS0xLTEtMA_3e1663e5-5de5-4db7-8215-8983900e254d"
      unitRef="usd">16000</ams:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount>
    <ams:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzctMy0xLTEtMA_35721ee2-6efd-44ec-bfb3-82b9d6e08c03"
      unitRef="usd">80000</ams:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount>
    <ams:EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzgtMS0xLTEtNTg2NA_ce37750f-6c1e-42cd-89b0-6bec381a0b20"
      unitRef="usd">246000</ams:EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount>
    <ams:EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzgtMy0xLTEtNTg2NA_9b7cfab5-8bdf-4577-b977-6941bae33eda"
      unitRef="usd">0</ams:EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzgtMS0xLTEtMA_0a34f3ad-fc96-4354-914d-73bbf4e76e80"
      unitRef="usd">-243000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzgtMy0xLTEtMA_74b8c31b-ad7a-4627-a8bf-c46ae84c1369"
      unitRef="usd">-175000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzktMS0xLTEtMA_2f298cfb-1f2d-4e6d-83af-213a906b02c7"
      unitRef="usd">259000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzktMy0xLTEtMA_71ccccd1-1649-4305-9eca-964e3f607639"
      unitRef="usd">68000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzExLTEtMS0xLTA_a7fde81f-152a-4ff2-99fa-598772f84d65"
      unitRef="usd">-1737000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZToxN2VkMTIzZmRiNTE0YTM1YmU3ZDM5YmMyYmI3YTYwNS90YWJsZXJhbmdlOjE3ZWQxMjNmZGI1MTRhMzViZTdkMzliYzJiYjdhNjA1XzExLTMtMS0xLTA_501322a7-4edf-4270-8399-3429131a07c4"
      unitRef="usd">128000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzU0MDE_d5a68f0e-0e98-4683-837b-dadb384755b6"
      unitRef="usd">2219000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i3dfd28bb44084d2ab54958e2d4bfab65_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzU1MzU_fbb104ae-a235-40b9-a07a-dc984c0a19e9"
      unitRef="usd">32000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="ibeda16fd19d5413fa54b8ddbc438d749_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzU5OTc_1799e22f-ddf2-4986-8645-4cbe84db8603"
      unitRef="usd">2586000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="i087b2dc2b4b54227989cfb9e793c3951_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzYxMjI_6c0a6470-477c-4bb7-830e-6dafe4c8274c"
      unitRef="usd">129000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzY0NDQ_24d9b032-4d3d-4627-a453-0bf68024c6b4"
      unitRef="usd">-243000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzY0NjE_85c6e639-34f0-4329-aaa3-1a04a6761169"
      unitRef="usd">-175000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie9aab6c477354d8aabfd59fedcdc7f0c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzY3MDc_2d3bfc8f-36f1-4d30-9fd6-97938e155d52"
      unitRef="usd">-104000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzg2MDc_de99fc34-6fc7-4a35-a35e-87a074babbb6"
      unitRef="usd">275000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkyNTQ_9e252b47-de2a-46c1-a7c0-0f12792b126e">A reconciliation of the beginning and ending amount of unrecognized tax benefit is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:0 1pt"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;YEARS ENDED DECEMBER 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTozYjQzNWU1MzI1ODc0YTllOWM0M2NhMWY5ZjE4NDNhZS90YWJsZXJhbmdlOjNiNDM1ZTUzMjU4NzRhOWU5YzQzY2ExZjlmMTg0M2FlXzItMS0xLTEtMA_36ef86a8-7eea-4ac6-8868-db44c62e35b4"
      unitRef="usd">259000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i88d4659da27e48458ba86016aae09e94_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTozYjQzNWU1MzI1ODc0YTllOWM0M2NhMWY5ZjE4NDNhZS90YWJsZXJhbmdlOjNiNDM1ZTUzMjU4NzRhOWU5YzQzY2ExZjlmMTg0M2FlXzItMy0xLTEtMA_fec6055c-b19f-4dfc-abe8-db8d7ac89910"
      unitRef="usd">87000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTozYjQzNWU1MzI1ODc0YTllOWM0M2NhMWY5ZjE4NDNhZS90YWJsZXJhbmdlOjNiNDM1ZTUzMjU4NzRhOWU5YzQzY2ExZjlmMTg0M2FlXzQtMS0xLTEtMA_126c4d65-668f-4b91-a1d0-d597f7f6312d"
      unitRef="usd">16000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTozYjQzNWU1MzI1ODc0YTllOWM0M2NhMWY5ZjE4NDNhZS90YWJsZXJhbmdlOjNiNDM1ZTUzMjU4NzRhOWU5YzQzY2ExZjlmMTg0M2FlXzQtMy0xLTEtMA_4ba1b21a-12f3-4539-a789-52265279662d"
      unitRef="usd">172000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTozYjQzNWU1MzI1ODc0YTllOWM0M2NhMWY5ZjE4NDNhZS90YWJsZXJhbmdlOjNiNDM1ZTUzMjU4NzRhOWU5YzQzY2ExZjlmMTg0M2FlXzYtMS0xLTEtMA_3d897135-243c-4172-9717-447870b98779"
      unitRef="usd">275000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90YWJsZTozYjQzNWU1MzI1ODc0YTllOWM0M2NhMWY5ZjE4NDNhZS90YWJsZXJhbmdlOjNiNDM1ZTUzMjU4NzRhOWU5YzQzY2ExZjlmMTg0M2FlXzYtMy0xLTEtMA_eed87b1b-cfdc-4cae-8d28-469035be1085"
      unitRef="usd">259000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzIvZnJhZzpiODFlN2JmZWRlMTI0NjIyYmUzNDZkMjc5YjQyOWIxZC90ZXh0cmVnaW9uOmI4MWU3YmZlZGUxMjQ2MjJiZTM0NmQyNzliNDI5YjFkXzkwNDg_5e713321-2942-465d-858d-1c7b513cc7d4"
      unitRef="usd">15000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg3NjI_04bdade5-0507-403c-a9c2-e553e6cca5e2">STOCK-BASED COMPENSATION EXPENSE&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Incentive Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2010 shareholders approved an amendment and restatement of the Company&#x2019;s stock incentive plan, renaming it the Incentive Compensation Plan (the &#x201c;Plan&#x201d;), and among other things, increasing the number of shares of the Company&#x2019;s common stock reserved for issuance under the Plan to 1,630,000. The Plan provides that the shares reserved under the Plan are available for issuance to officers of the Company, other key employees, non- employee directors, and advisors. The Plan is a successor to the Company&#x2019;s previous plans, and any shares awarded and outstanding under those plans were transferred to the Plan. No further grants or share issuances will be made under the previous plans. On June 21, 2019, the Company&#x2019;s shareholders approved an amendment and restatement of the Plan in order to extend the term of the Plan by two years to February 22, 2022. As of December&#160;31, 2020, approximately 437,000 shares remain available for grant under the Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Plan, a total of 456,000 restricted stock units have been granted, consisting of 43,000 of annual automatic grants to non-employee directors and the corporate secretary, 293,000 of deferred retainer fees to non-employee members of the Board, 20,000 grants issued in lieu of commission, to two (2) employees of the Company and 100,000 restricted stock units issued to the CEO during 2020, see further discussion below. Of the total restricted stock units granted under the Plan 210,000 of them are fully vested but not yet deemed issued and outstanding, 233,000 are fully vested and outstanding, and 13,000 are outstanding as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in restricted stock units, consisting primarily of annual automatic grants, deferred compensation to non-employee directors, and restricted stock units awards to the CEO, under the Incentive Compensation Plans during 2020 and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2020, total compensation expense recorded in the consolidated statements of operations related to restricted stock units in lieu of retainer fees was $80,000. For the year ended December&#160;31, 2020, total compensation expense recorded in the consolidated statements of income for annual restricted stock units awarded was $7,000, with an offsetting tax benefit of $1,000, as this expense is deductible for income tax purposes. As of December&#160;31, 2020, there was $2,000 of total unrecognized compensation cost related to annual restricted stock units which is expected to be recognized over a period of 0.5 years. During 2020 and 2019, shares of restricted stock units totaling 3,000 and 4,000 each, respectively, with a fair value of approximately $9,000 and $11,000, respectively, vested and became unrestricted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Certain Executive Equity Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective May 4, 2020, the Company appointed Raymond C. Stachowiak as Interim President and Chief Executive Officer (&#x201c;Interim CEO&#x201d;). As part of his Offer Letter, the Interim CEO was granted 50,000 restricted stock awards that vested in full on August 3, 2020.  The Interim CEO was granted additional restricted stock awards totaling 10,000 common shares per month, which vest in full at the end of each 30-day period following issuance. On October 1, 2020 the Interim CEO was appointed the CEO.  For the year ended December&#160;31, 2020, 100,000 restricted stock awards were issued to the CEO and 90,000 became fully vested. Additionally, Ernest R. Bates, Senior Vice President, Sales and Business Development, International Operations, was awarded 10,000 restricted stock awards, which vested in full on December 31, 2020. For the year ended December&#160;31, 2020, total compensation expense recorded in the consolidated financial statements of operations related to executive equity awards was $195,000.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2017, the Company entered into a Performance Share Award Agreement with three executive officers of the Company (the &#x201c;Award Agreements&#x201d;) for 161,766 restricted stock awards which vest upon the achievement of certain performance metrics. The Award Agreements expired on March 31, 2020. Based on the guidance in ASC 718 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 718&#x201d;), the Company concluded these were performance-based awards with vesting criteria tied to performance metrics. As of December 31, 2017, the Company achieved one of the certain performance metrics under the Award Agreements and recognized stock compensation expense of approximately $108,000 related to these awards. The unrecognized stock-based compensation expense for these awards was approximately $421,000 and unvested restricted stock awards of approximately 129,000 were returned to the plan as of March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, stock compensation expense recorded in the consolidated financial statements is summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock-Based&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Award Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;and Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs Issued in Lieu of Retainer Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annual RSU Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Executive Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in stock options outstanding under the Incentive Compensation Plans during 2020 and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;of Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contractual&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Term (Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.44&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.61&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.48&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average grant-date fair value of the options granted during the years 2020 and 2019 was $0.78 and $1.54, respectively. There were no options exercised and accordingly, no intrinsic value of options exercised during the year ended December&#160;31, 2020. There were 16,000 options exercised during the year ended December&#160;31, 2019. Total stock-based compensation expense recognized for stock options for the years ended December 2020 and 2019 was $17,000 and $141,000, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no cash received from options exercised under any share-based payment arrangements for the year ended December&#160;31, 2020, and as a result, there was no actual tax benefit realized for tax deductions from option exercises in that year. The Company received approximately $42,000 from the exercise of 16,000 options under the share-based arrangements for the year ended December 31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of the Company&#x2019;s non-vested stock options as of December&#160;31, 2020 and 2019, and changes during the years ended December&#160;31, 2020 and 2019 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.413%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;of Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Grant-Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, there was approximately $12,000 of unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Plan. This cost is expected to be recognized over a period of approximately three  years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s stock-based awards to employees are calculated using the Black-Scholes options valuation model. The Black-Scholes model was developed for use in estimating the fair value of traded options which have no vesting restrictions and are fully transferable. In addition, the Black-Scholes model requires the input of highly subjective assumptions including the expected stock price volatility. The Company&#x2019;s stock-based awards have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the present value estimates. For these reasons, management believes that the existing models do not necessarily provide a reliable single measure of the fair value of its stock-based awards to employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s option grants issued during 2020 and 2019  were estimated using assumptions for expected life, volatility, dividend yield, forfeiture rate, and risk-free interest rate which are specific to each award as summarized in the following table. The estimated fair value of the Company&#x2019;s options is amortized over the period during which the optionee is required to provide service in exchange for the award, usually the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s option grants under the Plan in 2020 and 2019 was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected forfeiture rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Repurchase of Common Stock, Common Stock Warrants and Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of 1,000,000 shares of its own stock on the open market, which the Board reaffirmed in 2008. There were no shares of the Company repurchased during 2020 or 2019. There are approximately 72,000 shares remaining under this repurchase authorization.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ic40a5c6d28184e559db2655dfa2504c5_I20100630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzM1MA_be7949a7-2c29-4fa4-95e0-92b84677d6b2"
      unitRef="shares">1630000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <ams:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant
      contextRef="i4b2e49a8ba0e4110902423280570dd60_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzk0MQ_6168fbc5-face-423f-8d71-84f310ae812d"
      unitRef="shares">437000</ams:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i7da1cbcaab824c258a3e435ef167afeb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI4Mjk_5d2f774e-ab3c-46df-84fc-e3ad3424deb0"
      unitRef="shares">456000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i75ab1b400ca446ebafefb5497cfcbe7f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI4ODg_8ed6422e-83c8-472c-b6fb-bb7abb0243e8"
      unitRef="shares">43000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i439999ffc655418594f79bcae4f8e02b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI5NzM_0be675a3-1a0b-4a0a-9c83-a84d3aa12e79"
      unitRef="shares">293000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="i865f409e789f412d9649eea7a779efbf_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzMwNDQ_901df5ab-fbf9-4952-8165-88f08d7bbee3"
      unitRef="shares">20000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <ams:NumberOfEmployees
      contextRef="i8948e770c9f64598b68bf6a898112dab_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODA1NTY_9b6375d7-c364-4917-949e-716d8e25a2d2"
      unitRef="employee">2</ams:NumberOfEmployees>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="i5065887f6a4b4118b70267038309da91_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODA1NTk_0d933e8a-e6d9-4ac6-8f2f-5c2c70b6d0f9"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzMxNzU_dc71f903-304c-46b3-8c6b-d81f765b27a4"
      unitRef="shares">210000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <ams:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber
      contextRef="i8cf66345370f4da19371bd488b60d7d9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODA1Njc_d27d54a3-eacb-4860-9c9d-f97e7d557559"
      unitRef="shares">233000</ams:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="if1ed81d1b3e0406887e3f7c0a942518d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2NDAyMDY_a7f339d5-0fc5-40d4-bfb8-61e29ca08e37"
      unitRef="shares">13000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg3NjM_e0b37fc3-085d-458f-aab1-4b7a70cef17d">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in restricted stock units, consisting primarily of annual automatic grants, deferred compensation to non-employee directors, and restricted stock units awards to the CEO, under the Incentive Compensation Plans during 2020 and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i1182cb262dd5404e857585d6453d5008_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzEtMS0xLTEtMA_04930e4d-aa53-4e8f-91f8-f106d94a7686"
      unitRef="shares">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1182cb262dd5404e857585d6453d5008_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzEtMy0xLTEtMA_ee8901c4-f129-4db7-8395-aaf70407262d"
      unitRef="usdPerShare">2.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
      contextRef="i1182cb262dd5404e857585d6453d5008_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzEtNS0xLTEtMA_ff932b88-05d8-4be7-b41e-5d6b2aa933e0"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzItMS0xLTEtMA_83909586-047c-4616-9e9d-1569d92d4e7c"
      unitRef="shares">36000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzItMy0xLTEtMA_bce700ef-d8c8-489e-8171-3956c635e3aa"
      unitRef="usdPerShare">2.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
      contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzItNS0xLTEtMA_3c52b012-3246-4933-963e-dc9df30d086d"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzMtMS0xLTEtMA_fda1c38d-a36e-4947-8a06-b95485fd9673"
      unitRef="shares">37000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzMtMy0xLTEtMA_3edafa42-3f94-40fd-99f9-f62783faf8e7"
      unitRef="usdPerShare">2.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
      contextRef="i1b2c66ea20d241b4a1cd09d98ec097e5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzMtNS0xLTEtMA_4924cf69-6571-4200-a5ba-9ef4f0f5d41f"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i75a3e8aadc8a42998ea1f668ddc598aa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzQtMS0xLTEtMA_dd826dd4-44c2-42e3-b9da-84301d7827ac"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i75a3e8aadc8a42998ea1f668ddc598aa_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzQtMy0xLTEtMA_16ebbaa4-127f-4e30-ad91-85482b875249"
      unitRef="usdPerShare">3.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
      contextRef="i75a3e8aadc8a42998ea1f668ddc598aa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzQtNS0xLTEtMA_4ea9bac6-b6d0-4126-8af5-d978c0097bce"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzctMS0xLTEtMA_4cfb39dd-ed84-42fb-bef7-cc344bb4f1c1"
      unitRef="shares">144000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzctMy0xLTEtMA_9cd85730-6d52-439a-b035-6f17d77b897e"
      unitRef="usdPerShare">1.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
      contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzctNS0xLTEtMA_178b3edd-36f3-47b8-838e-ab1557ef2f63"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzgtMS0xLTEtMA_a624f8db-4a05-4c92-9981-bfbd23173e90"
      unitRef="shares">134000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzgtMy0xLTEtMA_dd00b3f7-1ea7-474a-8afc-a887bf8bec4a"
      unitRef="usdPerShare">1.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
      contextRef="i1cf1d78763c447a8a69167cd7ba2a22b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzgtNS0xLTEtMA_5bfc97ad-d1ea-44c0-ab62-bb3a09e67a33"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="if1ed81d1b3e0406887e3f7c0a942518d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzktMS0xLTEtMA_a7f339d5-0fc5-40d4-bfb8-61e29ca08e37"
      unitRef="shares">13000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if1ed81d1b3e0406887e3f7c0a942518d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzktMy0xLTEtMA_6dea4b8e-7434-48a0-9973-0f383e0f7058"
      unitRef="usdPerShare">1.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
      contextRef="if1ed81d1b3e0406887e3f7c0a942518d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpjYzBlNWU5Yzg3OWI0OThmOGMwMTdlMjM3NDE4OWJjZS90YWJsZXJhbmdlOmNjMGU1ZTljODc5YjQ5OGY4YzAxN2UyMzc0MTg5YmNlXzktNS0xLTEtMA_f044417c-d037-44b3-8331-d952f6d64576"
      unitRef="usdPerShare">2000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="i1abe365945b24f1187e85f47a39fb40b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzM2MzI_5f932f9a-74f3-493b-a550-f95a391098da"
      unitRef="usd">80000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzM3ODI_62506e20-7465-4f0d-8533-93c956b2305d"
      unitRef="usd">7000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <ams:OffsettingTaxBenefit
      contextRef="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzM4MjA_94bbbc41-59e2-4f17-a005-f3ef0589b6e0"
      unitRef="usd">1000</ams:OffsettingTaxBenefit>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i8cf66345370f4da19371bd488b60d7d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzM4OTk_d4a4f8bb-0958-4f86-a62b-ae34b820dc39"
      unitRef="usd">2000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzQwMzU_eb6cb7b2-86da-4a72-8c00-cb0377626364">P0Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2Mzg4Mzc_f6efad20-230d-437e-baa4-df3cf72af59d"
      unitRef="shares">3000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i4a54847db3184f809b995f6ca5865dd9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2Mzg4NDE_8b1a9810-c5df-4aa0-87a0-1a01dd477915"
      unitRef="shares">4000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="idbcaedd8aa454d92b0aa841fffee4980_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzQxNjE_ef5a7870-5202-4d76-b414-fbfe40e1fc0a"
      unitRef="usd">9000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i4a54847db3184f809b995f6ca5865dd9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzQxNjU_fc05d938-5970-4e6b-9e98-7d9c753cc281"
      unitRef="usd">11000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="icdcf8f1e671343ef84efbcc784e706a6_D20200401-20200630"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2Mzc2Nzk_93d71a0e-3335-4a87-b764-0878b0537d3a"
      unitRef="shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8a5840910bb84c9ab051118c87f6190d_D20200803-20200803"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2Mzc4OTQ_a19cd1f2-1acc-4823-8a5b-64f9495d49fa"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8a5840910bb84c9ab051118c87f6190d_D20200803-20200803"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODA1OTg_1cc632c0-e48f-42b7-a283-feb6c592ec1d">P30D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="i5065887f6a4b4118b70267038309da91_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2NDAzOTE_0d933e8a-e6d9-4ac6-8f2f-5c2c70b6d0f9"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i5065887f6a4b4118b70267038309da91_D20200101-20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODQxNjc_9136f2cb-281d-48ff-ae99-d78001e38547"
      unitRef="shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="idcb7ef47ef694053b29237a21986aa43_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2MzgzMzM_098e5d19-3b35-4269-827c-200dac9170d8"
      unitRef="shares">10000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6bdba3f703e740a8b387f2723b455d9a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODQ0OTA_a37ce1e3-7336-4e67-a957-69179663b290"
      unitRef="usd">195000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i54f1ddba4c6143a2b7471da1ecaeeeaa_D20170104-20170104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzQzNzc_62789bdf-8dfc-4c12-87a2-929289f07518"
      unitRef="shares">161766</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i32da477d172646529ddc5afd23e6ed4d_D20170104-20170104"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzQ4NjA_2ca8dbb5-4d03-4132-9e7d-0cfc49abe17d"
      unitRef="usd">108000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ibe8c67bc767f4ff48911673917d29035_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzUwNzQ_2ce6e273-38c5-4250-b672-12255f5ebc94"
      unitRef="usd">421000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9f9e8e77770741a39de67b6d254f0f78_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzUxMzM_15dc86dd-e4e9-431d-9a96-422d84df19f0"
      unitRef="shares">129000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODQ3OTg_15cc6c78-e962-40e8-b4e8-94990fb76972">As of December&#160;31, 2020, stock compensation expense recorded in the consolidated financial statements is summarized as follows: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock-Based&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Award Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;and Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs Issued in Lieu of Retainer Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annual RSU Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Executive Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i8b626e312a7d4b85bdb7b11f21a56788_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzMtNC0xLTEtNjMxNQ_20d6f33b-6325-404b-8958-d0a7db75aadf"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8b626e312a7d4b85bdb7b11f21a56788_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzMtNi0xLTEtNjMxNQ_c3d60331-cfe9-456b-80ac-3be395dbf49b"
      unitRef="usd">17000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ifa091c4ef68c4bb68bd7b854b530cc2c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzQtNC0xLTEtNjMxNQ_04a99f17-2d1f-48aa-9708-66dfcede5ee1"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifa091c4ef68c4bb68bd7b854b530cc2c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzQtNi0xLTEtNjMxNQ_ad71d586-e284-4aba-afc4-67b743a29bc7"
      unitRef="usd">80000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i0e761c88d6f049ee8b2df4c059245e51_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzUtNC0xLTEtNjMxNQ_474f6a91-6625-47a3-90ea-4866fd2ad935"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0e761c88d6f049ee8b2df4c059245e51_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzUtNi0xLTEtNjMxNQ_2ad40ca1-50d7-4638-ab85-a509657e3925"
      unitRef="usd">7000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ie00f50be40664dab98b855706c8871d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzYtNC0xLTEtNjMxNQ_0c9761d5-a3d1-42ed-8b1f-61b5164dac19"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie00f50be40664dab98b855706c8871d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzYtNi0xLTEtNjMxNQ_4314a814-7940-462e-9045-eb543638d1d7"
      unitRef="usd">195000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzctNC0xLTEtNjMxNQ_ff1cd4f2-1a44-4f51-9214-f5936330c34a"
      unitRef="shares">103000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTpmYjJiY2ZmZWJlZDk0MzA5ODYwOTI0MGY2ZmI3OWIzZi90YWJsZXJhbmdlOmZiMmJjZmZlYmVkOTQzMDk4NjA5MjQwZjZmYjc5YjNmXzctNi0xLTEtNjMxNQ_f1531553-def1-48cf-a719-0d0aba35e52c"
      unitRef="usd">299000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg3NjQ_7fd8cf48-6331-4e96-b5ed-716a498f4dff">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in stock options outstanding under the Incentive Compensation Plans during 2020 and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;of Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contractual&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Term (Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.44&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.61&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.48&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i88d4659da27e48458ba86016aae09e94_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzItMi0xLTEtMA_a26eda31-96cd-4d86-ba55-01fa4b307e62"
      unitRef="shares">613000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i88d4659da27e48458ba86016aae09e94_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzItNC0xLTEtMA_522c327e-0ce0-470c-9775-4d29193d16cf"
      unitRef="usdPerShare">2.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="id87939e5af644ee294503aa4bedb6bbc_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzItNi0xLTEtMA_cb2a1ce9-1382-4ded-b4a4-aae0dcc36c6d">P3Y1M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i88d4659da27e48458ba86016aae09e94_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzItOC0xLTEtMA_7d44a33f-1203-4fda-abcb-bca153c829fe"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzMtMi0xLTEtMA_b8668a31-4883-4a86-a2a8-c208dd599a35"
      unitRef="shares">18000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzMtNC0xLTEtMA_2d046973-8860-4747-a9d8-079d8e063672"
      unitRef="usdPerShare">2.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <ams:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzMtNi0xLTEtMA_9db70f1e-dea9-4794-9df3-4b56167efd9d">P7Y</ams:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzQtMi0xLTEtMA_333b409e-5b93-47d3-8267-1d91d23ff74f"
      unitRef="shares">16000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzQtNC0xLTEtNzk3_aa1c30cb-d6cc-4769-9e1d-3d83ae1c6a05"
      unitRef="usdPerShare">2.59</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzUtMi0xLTEtMA_f77a5d1a-f4de-4b4e-ac23-3c7d1edb42dd"
      unitRef="shares">165000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzUtNC0xLTEtMA_f1abec16-3853-4448-ad44-995389437bfa"
      unitRef="usdPerShare">3.07</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzctMi0xLTEtMA_ad0dbcc8-5ab4-4d96-bfda-4e8f4f87ed95"
      unitRef="shares">450000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzctNC0xLTEtMA_7fcd053f-f654-4cd4-b858-41ac50ac20a5"
      unitRef="usdPerShare">2.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzctNi0xLTEtMA_6c2e5558-1276-4c8c-b996-4b11806567f3">P2Y5M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzctOC0xLTEtMA_47e55676-ce0d-462f-a5f1-2a53e28c7026"
      unitRef="usd">27000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzgtMi0xLTEtMA_99f879e4-1830-4390-91b1-30e03af15cc6"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzgtNC0xLTEtMA_87fd5776-144c-4783-8caa-1906bfbd91d8"
      unitRef="usdPerShare">1.88</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <ams:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzgtNi0xLTEtMA_46f26a20-bbd0-49ff-b653-1e5a5cd5d1cf">P7Y</ams:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzEwLTItMS0xLTA_e9cd83f4-9d61-48f1-b2ce-de75613b6483"
      unitRef="shares">43000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzEwLTQtMS0xLTA_07d523a3-7b6a-4521-98df-22c1c36ba95f"
      unitRef="usdPerShare">2.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzEyLTItMS0xLTA_0edadffd-fb21-430a-9dd2-435940eb7b2f"
      unitRef="shares">417000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzEyLTQtMS0xLTA_d3328896-e4cd-46cd-86e5-824ec81298ee"
      unitRef="usdPerShare">2.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzEyLTYtMS0xLTA_7505a701-1dfb-4923-8686-e47c62a31cf5">P1Y7M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzEyLTgtMS0xLTA_cd79d8d0-a5ba-40a7-a8cf-45b0f7a5e874"
      unitRef="usd">2000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE0LTItMS0xLTA_2ee43c2d-a7e2-4c00-9278-eace6b8286d2"
      unitRef="shares">425000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE0LTQtMS0xLTA_17df1ee9-e7a6-4c25-96e4-558f7bb7afcb"
      unitRef="usdPerShare">2.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE0LTYtMS0xLTA_8fc6c016-dc58-4bef-acc9-5ce0520a33db">P2Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE0LTgtMS0xLTA_e78b794f-0bb3-45b5-8395-caaf0634dc7a"
      unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE2LTItMS0xLTA_7c1a410f-db19-4970-850f-54bcdade2e44"
      unitRef="shares">405000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE2LTQtMS0xLTA_292ea7cb-d228-4749-9113-0705530a48c4"
      unitRef="usdPerShare">2.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE2LTYtMS0xLTA_a0f579d1-18b8-4adc-8607-80c1509f3467">P1Y5M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTowNjhmNDNmMWFiNzQ0OTdlODE0YjY0MTM0NzM3N2FjMS90YWJsZXJhbmdlOjA2OGY0M2YxYWI3NDQ5N2U4MTRiNjQxMzQ3Mzc3YWMxXzE2LTgtMS0xLTA_63685c88-c4fe-4bbe-a702-66811577326b"
      unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzU2NTY_2e3f2176-5a72-4a5e-ab02-36cf3a9223fb"
      unitRef="usdPerShare">0.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzU2NjA_b32c13ec-5dd7-4b41-9117-2cc65686d96a"
      unitRef="usdPerShare">1.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzI3NDg3NzkwODA2MTY_60505490-e016-4059-a34d-4d7c68100978"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzU2OTc_be5c46e7-f165-4a95-94c1-160277225fd3"
      unitRef="shares">16000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8b626e312a7d4b85bdb7b11f21a56788_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzYwMzA_18f6c5b4-2a31-4cc7-b869-43757b6f6173"
      unitRef="usd">17000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i613b14d7d6ca4d3f82337708f6ffc78f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzYwMzQ_eb0adf79-9af5-4ca8-8ebb-79494fe2175e"
      unitRef="usd">141000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="id87939e5af644ee294503aa4bedb6bbc_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2Mzk5MDM_406cb5d3-99d1-4354-9dfb-fa24994650f8"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzEwOTk1MTE2Mzk5MDM_f1e86171-1769-43cd-be98-8c479c942cc7"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzYwOTU_612a7b69-5783-4f84-9a35-839c5e2c805a"
      unitRef="usd">42000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzYxMTk_91ee1cd9-b727-4c7e-b35f-df24635423df"
      unitRef="shares">16000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg3NjU_3d9c2d57-d10b-4955-ac1c-1621a71c3d05">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of the Company&#x2019;s non-vested stock options as of December&#160;31, 2020 and 2019, and changes during the years ended December&#160;31, 2020 and 2019 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.413%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;of Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Grant-Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i88d4659da27e48458ba86016aae09e94_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzEtMi0xLTEtMA_3974a1d8-5fe8-4497-bc1f-f62ada6d23c1"
      unitRef="shares">125000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i88d4659da27e48458ba86016aae09e94_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzEtNC0xLTEtMA_8eb82ce0-aead-4b3d-a6d6-df9f71741c72"
      unitRef="usdPerShare">1.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzItMi0xLTEtMA_052e8292-0a40-4877-880a-2b01d52753f9"
      unitRef="shares">18000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzItNC0xLTEtMA_c2469adc-d382-4298-ada1-438892f9ac7e"
      unitRef="usdPerShare">1.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzMtMi0xLTEtMA_b81c2558-0ced-48ec-b10d-566f67ad883c"
      unitRef="shares">118000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzMtNC0xLTEtMA_64d02e49-54ae-4f43-995c-926515acf196"
      unitRef="usdPerShare">1.22</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzYtMi0xLTEtMA_acc6f813-7a74-4c4d-994b-c81a9e52bb85"
      unitRef="shares">25000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzYtNC0xLTEtMA_e5862601-e9b3-4d86-a23b-872e55e0a191"
      unitRef="usdPerShare">1.40</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzctMi0xLTEtMA_18ff0001-f89e-4cfe-9a55-5a60775ebd16"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzctNC0xLTEtMA_e7384575-778e-4c41-8528-2f9f5bdbaadd"
      unitRef="usdPerShare">0.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzgtMi0xLTEtMA_aeea57d4-76dc-469c-9eb0-e63d32df562b"
      unitRef="shares">23000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzgtNC0xLTEtMA_b5100bf4-a750-4bec-a91d-37ef1ebd958e"
      unitRef="usdPerShare">1.22</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzEwLTItMS0xLTA_414e41b8-1f10-438f-b0ad-78edce2ab63d"
      unitRef="shares">12000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo4OGQ0YWMxZTQ4OTM0ZGMzODk0Y2YwZWZlNDYyOGIwNy90YWJsZXJhbmdlOjg4ZDRhYzFlNDg5MzRkYzM4OTRjZjBlZmU0NjI4YjA3XzEwLTQtMS0xLTA_f72eabe8-8ad9-4bd5-9b7a-981c683f7028"
      unitRef="usdPerShare">1.07</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i882bf9794e8244f388b36b7749f33ee3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzY3Nzc_1f9286fa-8e19-4f53-8aa2-800e5ec49ea2"
      unitRef="usd">12000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzY5Njg_f58eef60-738f-4047-b5cc-12b6ccedf820">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg3NjA_4bd5d5f4-4ea0-4d63-9e8f-855dfc4959a5">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s option grants under the Plan in 2020 and 2019 was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected forfeiture rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzEtMS0xLTEtMA_e6c014ca-f052-48ed-a7a6-767521c5949e">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzEtMy0xLTEtMA_60a625c1-01a4-494e-b6a7-110244ad0406">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <ams:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzItMS0xLTEtMA_66e1982a-da2f-49f2-9ce0-be8438f2d7ff"
      unitRef="number">0.000</ams:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate>
    <ams:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzItMy0xLTEtMA_c8c44961-995a-4f87-b5a5-aed889d631e9"
      unitRef="number">0.000</ams:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzMtMS0xLTEtMA_20c3e040-9146-44b3-93ea-b54c637496e9"
      unitRef="number">0.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzMtMy0xLTEtMA_0c775a5f-ca1f-4c72-b8d4-6ab4697c1486"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzQtMS0xLTEtMA_b16cab71-4010-4293-ba0b-0f9a7580ff54"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzQtMy0xLTEtMA_2c38c03d-0ff5-4cac-b095-8b9302ff1fef"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzUtMS0xLTEtMA_f8b7b5d5-5b4f-48ea-a2dc-6b400911c6da"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90YWJsZTo3MmFiNzI3MDI4MzU0OTFmODBmZDgyNzZhMDRmYWQ5Zi90YWJsZXJhbmdlOjcyYWI3MjcwMjgzNTQ5MWY4MGZkODI3NmEwNGZhZDlmXzUtMy0xLTEtMA_c001c507-b78e-407a-b94d-5ac8d43de266"
      unitRef="number">0.019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="ia2672c01483e420db7e4c638ebae606e_I20011231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg1Mjk_6d081961-8deb-49b1-a557-6b8c3ac2b7c3"
      unitRef="shares">1000000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzUvZnJhZzoxNTRhMjQxZmMzMmY0NTdlOTZkOTVmNWJkODZiZjg0MC90ZXh0cmVnaW9uOjE1NGEyNDFmYzMyZjQ1N2U5NmQ5NWY1YmQ4NmJmODQwXzg3MDU_b8851ac9-dd4b-43bc-8d73-2fcdfd5e780c"
      unitRef="shares">72000</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzgvZnJhZzoyYWZjYzIyNzgyODg0ZWJhYWEzYzgxMzE2NTEwOWFkYS90ZXh0cmVnaW9uOjJhZmNjMjI3ODI4ODRlYmFhYTNjODEzMTY1MTA5YWRhXzY4Nw_ce34cc31-40a3-4bf9-8ff7-75dd1d36d12f">R&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ETIREMENT&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; P&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;LAN&lt;/span&gt;The Company has a defined-contribution retirement plan (the &#x201c;Retirement Plan&#x201d;) that allows for a matching safe harbor contribution. For 2020, the Board of Directors elected to match participant deferred salary contributions up to a maximum of 4% of the participant&#x2019;s annual compensation. Discretionary profit sharing contributions are allowed under the Retirement Plan in years that the Board does not elect a safe harbor match. The Company has accrued approximately $37,000 for the estimated safe harbor matching contribution for the year ended December&#160;31, 2020. The Company contributed $38,000 to the Retirement Plan for the safe harbor match for the year ended December&#160;31, 2019.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzgvZnJhZzoyYWZjYzIyNzgyODg0ZWJhYWEzYzgxMzE2NTEwOWFkYS90ZXh0cmVnaW9uOjJhZmNjMjI3ODI4ODRlYmFhYTNjODEzMTY1MTA5YWRhXzI3Mg_13170196-fe04-4f14-9cf1-151cd1626b1b"
      unitRef="number">0.04</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzgvZnJhZzoyYWZjYzIyNzgyODg0ZWJhYWEzYzgxMzE2NTEwOWFkYS90ZXh0cmVnaW9uOjJhZmNjMjI3ODI4ODRlYmFhYTNjODEzMTY1MTA5YWRhXzQ5Ng_d11e39af-f244-4a4f-a120-7a7addceeab3"
      unitRef="usd">37000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xNzgvZnJhZzoyYWZjYzIyNzgyODg0ZWJhYWEzYzgxMzE2NTEwOWFkYS90ZXh0cmVnaW9uOjJhZmNjMjI3ODI4ODRlYmFhYTNjODEzMTY1MTA5YWRhXzU5OA_e4bf388e-9cd5-4592-b1bf-c49aa6b95b6b"
      unitRef="usd">38000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:OperatingLeasesOfLessorDisclosureTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90ZXh0cmVnaW9uOmI5NzIzMWQ0MGEyMjRjNjdhMTQ5ZmRlZjI1NzJkNGYxXzEwODM_5555d5e6-0a83-43d0-9e87-16bc62b284ba">O&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;PERATING&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; L&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;EASES&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases office space and equipment under operating leases expiring at various dates through 2021 and 2024. On August 13, 2016, the Company entered into a 7 year operating lease for an office space located in San Francisco, CA. The Company also owns and operates a stand-alone Gamma Knife facility in Lima, Peru where it leases approximately 1,600 square feet for approximately $7,800 per month with a lease expiration date in January 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum payments under non-cancelable operating leases having initial terms of more than one year consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payments for repair and maintenance agreements incorporated in operating lease agreements are not included in the future minimum operating lease payments shown above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net rent expense was $404,000 and $380,000 for the years ended December&#160;31, 2020 and 2019, respectively, and includes the above operating leases as well as month-to-month rental and certain executory costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:OperatingLeasesOfLessorDisclosureTextBlock>
    <ams:LeaseExpirationPeriod
      contextRef="ib40f3f2ed22f45ceb3ad41a1918f4939_D20160813-20160813"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90ZXh0cmVnaW9uOmI5NzIzMWQ0MGEyMjRjNjdhMTQ5ZmRlZjI1NzJkNGYxXzE5NQ_ce36e54b-1c61-4417-a303-1fdb23c365ef">P7Y</ams:LeaseExpirationPeriod>
    <us-gaap:AreaOfLand
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90ZXh0cmVnaW9uOmI5NzIzMWQ0MGEyMjRjNjdhMTQ5ZmRlZjI1NzJkNGYxXzQ4MA_3c8f1500-e2bf-45ae-aede-42147b531ba4"
      unitRef="sqft">1600</us-gaap:AreaOfLand>
    <ams:OperatingLeaseMonthlyLeaseExpense
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90ZXh0cmVnaW9uOmI5NzIzMWQ0MGEyMjRjNjdhMTQ5ZmRlZjI1NzJkNGYxXzUwMQ_c1b0c9e5-6772-45fe-9829-9ba6a28ca3ae"
      unitRef="usd">7800</ams:OperatingLeaseMonthlyLeaseExpense>
    <ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90YWJsZTpiODc2ZDY1Nzk3NjA0Yjk4OTI2ZGY0NjI2ZTY0NTIyZC90YWJsZXJhbmdlOmI4NzZkNjU3OTc2MDRiOTg5MjZkZjQ2MjZlNjQ1MjJkXzItMS0xLTEtMA_be22b986-e988-4d8f-ab36-0b42b22663a5"
      unitRef="usd">350000</ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths>
    <ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90YWJsZTpiODc2ZDY1Nzk3NjA0Yjk4OTI2ZGY0NjI2ZTY0NTIyZC90YWJsZXJhbmdlOmI4NzZkNjU3OTc2MDRiOTg5MjZkZjQ2MjZlNjQ1MjJkXzMtMS0xLTEtMA_37093f2f-5c1e-4a54-b224-c8d527f6cb6a"
      unitRef="usd">355000</ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo>
    <ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90YWJsZTpiODc2ZDY1Nzk3NjA0Yjk4OTI2ZGY0NjI2ZTY0NTIyZC90YWJsZXJhbmdlOmI4NzZkNjU3OTc2MDRiOTg5MjZkZjQ2MjZlNjQ1MjJkXzQtMS0xLTEtMA_bc454b63-3ec7-4d8f-8e92-c5087f5bc4ed"
      unitRef="usd">259000</ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree>
    <ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90YWJsZTpiODc2ZDY1Nzk3NjA0Yjk4OTI2ZGY0NjI2ZTY0NTIyZC90YWJsZXJhbmdlOmI4NzZkNjU3OTc2MDRiOTg5MjZkZjQ2MjZlNjQ1MjJkXzUtMS0xLTEtMA_155bc612-19ed-40e3-bb11-9bfee884baf9"
      unitRef="usd">8000</ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour>
    <ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90YWJsZTpiODc2ZDY1Nzk3NjA0Yjk4OTI2ZGY0NjI2ZTY0NTIyZC90YWJsZXJhbmdlOmI4NzZkNjU3OTc2MDRiOTg5MjZkZjQ2MjZlNjQ1MjJkXzEwLTEtMS0xLTA_a7bb2658-d036-4248-a879-5cf705005f32"
      unitRef="usd">972000</ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue>
    <us-gaap:OperatingLeaseExpense
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90ZXh0cmVnaW9uOmI5NzIzMWQ0MGEyMjRjNjdhMTQ5ZmRlZjI1NzJkNGYxXzkxNw_78a59d8e-f355-4983-8028-703c5a1c1ac4"
      unitRef="usd">404000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i12fcbae54afa43f4b9d8ce86016330fc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODEvZnJhZzpiOTcyMzFkNDBhMjI0YzY3YTE0OWZkZWYyNTcyZDRmMS90ZXh0cmVnaW9uOmI5NzIzMWQ0MGEyMjRjNjdhMTQ5ZmRlZjI1NzJkNGYxXzkyMQ_07c40f8c-9845-4fe5-b408-7d0630587750"
      unitRef="usd">380000</us-gaap:OperatingLeaseExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzM3Nzg_efd511c9-c460-4e7b-aba9-e1654fe3b63a">C&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;OMMITMENTS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;AND&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; C&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ONTINGENCIES&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 20, 2018, the Company signed Second Amendments to two System Build Agreements for the Company&#x2019;s second and third Mevion PBRT units. The Company and Mevion have agreed to upgrade the second and third PBRT units for which the Company has purchase commitments. The Company is actively seeking sites for these units but, to date, has not entered into agreements with any party for either placement of a PBRT unit or the related financing. The Company projects that it will be required to commence delivery of the second and third PBRT units no later than 2023. In the event the Company is unable to enter into customer agreements within the requisite time frame or receive an extension from Mevion, the Company could forfeit its deposits, which are described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of December&#160;31, 2020, the Company had commitments to perform three (3) Cobalt-60 reloads and install four (4) Leksell Gamma Knife Icon Systems (&#x201c;Icon&#x201d;) at existing customer sites, and purchase two (2) Linear Accelerator ("LINAC") systems, one to be placed at an existing customer site and one at a new customer site. The Company also has a commitment to upgrade the Gamma Knife unit at its stand-alone facility in Ecuador to a Perfexion. The Cobalt-60 reloads, Icon upgrades, and LINAC purchases are scheduled to occur between 2021 and 2022. The Company expects to upgrade the equipment in Ecuador in the second quarter of 2021. Total Gamma Knife and LINAC commitments as of December&#160;31, 2020 were $12,210,000.  There are no significant cash requirements, pending financing, for these commitments in the next 12 months. There can be no assurance that financing will be available for the Company&#x2019;s current or future projects, or at terms that are acceptable to the Company.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 21, 2017, the Company entered into a Maintenance and Support Agreement (the &#x201c;Mevion Service Agreement&#x201d;) with Mevion, which provides for maintenance and support of the Company&#x2019;s PBRT unit at Orlando Health. The Mevion Service Agreement began September 5, 2017, was amended in 2018, and renews annually over a five (5) year period. The agreement requires an annual prepayment of $1,572,000 for the current contractual period. This payment portion was recorded as a prepaid contract and will be amortized over the &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU4MTM_78bf16e5-2777-43c0-8b8e-f765c5397ed5"&gt;one&lt;/span&gt;-year service period. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of December&#160;31, 2020, the Company had commitments to service and maintain its Gamma Knife and PBRT equipment. The service commitments are carried out via contracts with Mevion, Elekta and Mobius Imaging, LLC. In addition, in April 2019, the Company signed agreements to service the Icon upgrades which will be installed at various dates between 2021 and 2022.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company&#x2019;s commitments to purchase two LINAC systems also include a 9-year and 5-year agreement to service the equipment, respectively. Total service commitments as of December&#160;31, 2020 were $10,493,000. The Gamma Knife and certain other service contracts are paid monthly, as service is performed. The Company believes that cash flow from cash on hand and operations will be sufficient to cover these payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the following commitments for each of the equipment systems, with expected timing of payments as follows as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.968%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.968%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.968%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.968%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amounts committed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022-2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024-2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After 5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt (includes interest)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,251,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,854,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,543,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases (includes interest)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,771,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,590,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,659,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Future equipment purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,210,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,035,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment service contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,493,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,030,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,585,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,999,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,879,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition working capital payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Commitments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,894,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,715,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,747,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,072,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,360,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ams:NumberOfCobalt60Reloads
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU3ODc_cfaaf55f-f3e1-4c1a-8a66-ee037f2b025a"
      unitRef="reload">3</ams:NumberOfCobalt60Reloads>
    <ams:NumberOfLeksellGammaKnifeIconSystemInstalls
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU3ODk_f99c2e47-e71b-4981-968d-f440fb5d036e"
      unitRef="install">4</ams:NumberOfLeksellGammaKnifeIconSystemInstalls>
    <ams:NumberOfPurchaseCommitments
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU3OTI_8ebd52e1-1d87-44b8-9235-97031fa52227"
      unitRef="purchase">2</ams:NumberOfPurchaseCommitments>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="i5e5ea45669af4723953be698788c51f5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzE1NTQ_0b1a28d4-23bd-48ad-9a4c-b2de8dcff59c"
      unitRef="usd">12210000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="i588196b8c9c6489fab6078ddb17065d6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzE1NTQ_70ea43c0-2502-47d5-96d4-a0c9e829f15b"
      unitRef="usd">12210000</us-gaap:LongTermPurchaseCommitmentAmount>
    <ams:LongTermPurchaseCommitmentRenewalTerm
      contextRef="ie52549c616fe4dc18135044ebe97c162_D20170905-20170905"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU3ODA_d4409c55-5a4d-4596-a591-f4f68cd61e3d">P5Y</ams:LongTermPurchaseCommitmentRenewalTerm>
    <ams:PurchaseAgreementAnnualPrepayment
      contextRef="i160dbde260894a5d8df523d1c2359928_I20170905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU3OTU_61130d42-cebb-4be0-b441-186f76738a17"
      unitRef="usd">1572000</ams:PurchaseAgreementAnnualPrepayment>
    <ams:LongTermServiceCommitmentPeriod
      contextRef="i303d240dda61403d9ec1de771f26041e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU4MjM_272228a1-c5a1-45af-b762-2b2bd05b5fea">P9Y</ams:LongTermServiceCommitmentPeriod>
    <ams:LongTermServiceCommitmentPeriod
      contextRef="i922a42f468f946e8b4a7d5f99e207fbf_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU4MzA_11b9e6da-48cb-423d-8706-065af180dd74">P5Y</ams:LongTermServiceCommitmentPeriod>
    <ams:LongTermServiceCommitmentAmount
      contextRef="i5e5ea45669af4723953be698788c51f5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzM0Mjc_b8b9f34f-8ac1-4b7d-b902-86df965b2ddb"
      unitRef="usd">10493000</ams:LongTermServiceCommitmentAmount>
    <us-gaap:LongTermPurchaseCommitmentTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzM3Nzk_58aa2138-489b-4e9c-844f-c174780b71af">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the following commitments for each of the equipment systems, with expected timing of payments as follows as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.968%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.968%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.968%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.968%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amounts committed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022-2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024-2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After 5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt (includes interest)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,251,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,854,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,543,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases (includes interest)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,771,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,590,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,659,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Future equipment purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,210,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,035,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment service contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,493,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,030,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,585,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,999,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,879,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition working capital payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Commitments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,894,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,715,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,747,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,072,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,360,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongTermPurchaseCommitmentTextBlock>
    <us-gaap:ContractualObligation
      contextRef="i8e9d39e86c2548f0bf5e350d4df09116_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzItMi0xLTEtMA_4d5ed67c-592a-42d0-af73-c0af4c80d214"
      unitRef="usd">5251000</us-gaap:ContractualObligation>
    <us-gaap:ContractualObligationDueInNextTwelveMonths
      contextRef="i8e9d39e86c2548f0bf5e350d4df09116_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzItMy0xLTEtMA_bffc4a95-3184-461a-aa36-24034baa4bc9"
      unitRef="usd">1373000</us-gaap:ContractualObligationDueInNextTwelveMonths>
    <us-gaap:ContractualObligationDueInSecondAndThirdYear
      contextRef="i8e9d39e86c2548f0bf5e350d4df09116_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzItNC0xLTEtMA_339ae8a1-84d9-49e4-98b3-a41a644ec96a"
      unitRef="usd">1854000</us-gaap:ContractualObligationDueInSecondAndThirdYear>
    <us-gaap:ContractualObligationDueInFourthAndFifthYear
      contextRef="i8e9d39e86c2548f0bf5e350d4df09116_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzItNS0xLTEtMA_7834ae2d-44dd-48af-b7fb-40630205528d"
      unitRef="usd">1543000</us-gaap:ContractualObligationDueInFourthAndFifthYear>
    <us-gaap:ContractualObligationDueAfterFifthYear
      contextRef="i8e9d39e86c2548f0bf5e350d4df09116_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzItNi0xLTEtMA_66f925b6-4a75-41ee-b713-23fab5e54064"
      unitRef="usd">481000</us-gaap:ContractualObligationDueAfterFifthYear>
    <us-gaap:ContractualObligation
      contextRef="i18863b680ebc4002ab41bd4bd5d80267_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzMtMi0xLTEtMA_bd7f15a2-849a-4caf-bb1a-f317e2fab84c"
      unitRef="usd">9771000</us-gaap:ContractualObligation>
    <us-gaap:ContractualObligationDueInNextTwelveMonths
      contextRef="i18863b680ebc4002ab41bd4bd5d80267_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzMtMy0xLTEtMA_2d1d4cd9-7aed-4738-8d16-94079a9e4c19"
      unitRef="usd">6590000</us-gaap:ContractualObligationDueInNextTwelveMonths>
    <us-gaap:ContractualObligationDueInSecondAndThirdYear
      contextRef="i18863b680ebc4002ab41bd4bd5d80267_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzMtNC0xLTEtMA_37c4df6b-a6c4-41f7-8e82-e22f9cf25d34"
      unitRef="usd">2659000</us-gaap:ContractualObligationDueInSecondAndThirdYear>
    <us-gaap:ContractualObligationDueInFourthAndFifthYear
      contextRef="i18863b680ebc4002ab41bd4bd5d80267_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzMtNS0xLTEtMA_ef687377-7e96-484c-8ec7-2fd6d36bac4a"
      unitRef="usd">522000</us-gaap:ContractualObligationDueInFourthAndFifthYear>
    <us-gaap:ContractualObligationDueAfterFifthYear
      contextRef="i18863b680ebc4002ab41bd4bd5d80267_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzMtNi0xLTEtMA_0a2492d9-de57-47a1-b44d-4154a70e6412"
      unitRef="usd">0</us-gaap:ContractualObligationDueAfterFifthYear>
    <us-gaap:ContractualObligation
      contextRef="i0c1a379a87884628a8b8200736f37e34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzQtMi0xLTEtMA_3679221c-8995-436e-a18a-e5e49fe41a28"
      unitRef="usd">46210000</us-gaap:ContractualObligation>
    <us-gaap:ContractualObligationDueInNextTwelveMonths
      contextRef="i0c1a379a87884628a8b8200736f37e34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzQtMy0xLTEtMA_08f8e2f8-d3be-40b2-a8c2-9a8b6414787c"
      unitRef="usd">2175000</us-gaap:ContractualObligationDueInNextTwelveMonths>
    <us-gaap:ContractualObligationDueInSecondAndThirdYear
      contextRef="i0c1a379a87884628a8b8200736f37e34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzQtNC0xLTEtMA_c0ac10ad-e775-4bec-908c-b98c6e8ccd75"
      unitRef="usd">44035000</us-gaap:ContractualObligationDueInSecondAndThirdYear>
    <us-gaap:ContractualObligationDueInFourthAndFifthYear
      contextRef="i0c1a379a87884628a8b8200736f37e34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzQtNS0xLTEtMA_460e91f9-47b8-4ee9-8d79-c4e237a14c04"
      unitRef="usd">0</us-gaap:ContractualObligationDueInFourthAndFifthYear>
    <us-gaap:ContractualObligationDueAfterFifthYear
      contextRef="i0c1a379a87884628a8b8200736f37e34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzQtNi0xLTEtMA_e5c70e2b-1f1f-465b-81e1-5326f106334f"
      unitRef="usd">0</us-gaap:ContractualObligationDueAfterFifthYear>
    <us-gaap:ContractualObligation
      contextRef="if7d6fa8d4f2d4414a11cd4e62eebfcc7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzUtMi0xLTEtMA_74498637-2b72-4244-9776-daa4541b186a"
      unitRef="usd">10493000</us-gaap:ContractualObligation>
    <us-gaap:ContractualObligationDueInNextTwelveMonths
      contextRef="if7d6fa8d4f2d4414a11cd4e62eebfcc7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzUtMy0xLTEtMA_18c49cc1-15fd-4a6f-97db-5b086e888d4b"
      unitRef="usd">2030000</us-gaap:ContractualObligationDueInNextTwelveMonths>
    <us-gaap:ContractualObligationDueInSecondAndThirdYear
      contextRef="if7d6fa8d4f2d4414a11cd4e62eebfcc7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzUtNC0xLTEtMA_a3128e2b-7129-4fe1-bac6-bbf3a7c5ada4"
      unitRef="usd">2585000</us-gaap:ContractualObligationDueInSecondAndThirdYear>
    <us-gaap:ContractualObligationDueInFourthAndFifthYear
      contextRef="if7d6fa8d4f2d4414a11cd4e62eebfcc7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzUtNS0xLTEtMA_a856cf03-aab4-426b-a7ab-aceca02fcba9"
      unitRef="usd">2999000</us-gaap:ContractualObligationDueInFourthAndFifthYear>
    <us-gaap:ContractualObligationDueAfterFifthYear
      contextRef="if7d6fa8d4f2d4414a11cd4e62eebfcc7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzUtNi0xLTEtMA_10eeb730-26f8-4f09-ab4b-e4bc288d9a08"
      unitRef="usd">2879000</us-gaap:ContractualObligationDueAfterFifthYear>
    <us-gaap:ContractualObligation
      contextRef="i735df263f1544be9ab7b0ae62cd61c55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtMi0xLTEtODYz_e395b618-98a4-4361-abdf-e6497f9c5137"
      unitRef="usd">197000</us-gaap:ContractualObligation>
    <us-gaap:ContractualObligationDueInNextTwelveMonths
      contextRef="i735df263f1544be9ab7b0ae62cd61c55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtMy0xLTEtODYz_f383b7e3-14cc-4e16-ad92-2c3b7235d6b7"
      unitRef="usd">197000</us-gaap:ContractualObligationDueInNextTwelveMonths>
    <us-gaap:ContractualObligationDueInSecondAndThirdYear
      contextRef="i735df263f1544be9ab7b0ae62cd61c55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtNC0xLTEtODYz_594a5687-9f53-4831-a7fc-0f5ba4364c68"
      unitRef="usd">0</us-gaap:ContractualObligationDueInSecondAndThirdYear>
    <us-gaap:ContractualObligationDueInFourthAndFifthYear
      contextRef="i735df263f1544be9ab7b0ae62cd61c55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtNS0xLTEtODYz_e0434b01-106c-4dec-b0cf-68bd87248f2f"
      unitRef="usd">0</us-gaap:ContractualObligationDueInFourthAndFifthYear>
    <us-gaap:ContractualObligationDueAfterFifthYear
      contextRef="i735df263f1544be9ab7b0ae62cd61c55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtNi0xLTEtODYz_b53ac318-170c-4ade-a2e3-d4ca3676d1db"
      unitRef="usd">0</us-gaap:ContractualObligationDueAfterFifthYear>
    <us-gaap:ContractualObligation
      contextRef="iaf60e6023f1042189106a9ed43c03bcb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtMi0xLTEtMA_bf65c6b7-bc45-4551-874c-04141846d395"
      unitRef="usd">972000</us-gaap:ContractualObligation>
    <us-gaap:ContractualObligationDueInNextTwelveMonths
      contextRef="iaf60e6023f1042189106a9ed43c03bcb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtMy0xLTEtMA_cb161a42-0788-4c6d-897c-5d43d8fa0170"
      unitRef="usd">350000</us-gaap:ContractualObligationDueInNextTwelveMonths>
    <us-gaap:ContractualObligationDueInSecondAndThirdYear
      contextRef="iaf60e6023f1042189106a9ed43c03bcb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtNC0xLTEtMA_c2d26947-1b7b-4d62-9622-15481fffbdc6"
      unitRef="usd">614000</us-gaap:ContractualObligationDueInSecondAndThirdYear>
    <us-gaap:ContractualObligationDueInFourthAndFifthYear
      contextRef="iaf60e6023f1042189106a9ed43c03bcb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtNS0xLTEtMA_bb94f430-0387-4702-ab0b-39bdfd3f973a"
      unitRef="usd">8000</us-gaap:ContractualObligationDueInFourthAndFifthYear>
    <us-gaap:ContractualObligationDueAfterFifthYear
      contextRef="iaf60e6023f1042189106a9ed43c03bcb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzYtNi0xLTEtMA_5515dfc6-30b2-4634-a890-7d591e9a34bd"
      unitRef="usd">0</us-gaap:ContractualObligationDueAfterFifthYear>
    <us-gaap:ContractualObligation
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzgtMi0xLTEtMA_330fb0f1-498c-4200-91da-92c7958b819e"
      unitRef="usd">72894000</us-gaap:ContractualObligation>
    <us-gaap:ContractualObligationDueInNextTwelveMonths
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzgtMy0xLTEtMA_c590230f-f7a3-415d-8325-13e202c026ea"
      unitRef="usd">12715000</us-gaap:ContractualObligationDueInNextTwelveMonths>
    <us-gaap:ContractualObligationDueInSecondAndThirdYear
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzgtNC0xLTEtMA_9e7ad867-361f-4a95-989f-b6a646faf658"
      unitRef="usd">51747000</us-gaap:ContractualObligationDueInSecondAndThirdYear>
    <us-gaap:ContractualObligationDueInFourthAndFifthYear
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzgtNS0xLTEtMA_91ee44ce-4809-43d1-96df-b3fc2a674e93"
      unitRef="usd">5072000</us-gaap:ContractualObligationDueInFourthAndFifthYear>
    <us-gaap:ContractualObligationDueAfterFifthYear
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90YWJsZTpjNjRjYmU3NjgxYjA0NmNmYjdiMWNjMzAzN2I4MTgwYS90YWJsZXJhbmdlOmM2NGNiZTc2ODFiMDQ2Y2ZiN2IxY2MzMDM3YjgxODBhXzgtNi0xLTEtMA_e672a814-0778-43e1-922b-21d203d111a9"
      unitRef="usd">3360000</us-gaap:ContractualObligationDueAfterFifthYear>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODcvZnJhZzpmZmNhOTA5NjNmNDk0NDhhOThkYWMxYzJhMzMzYjhlNS90ZXh0cmVnaW9uOmZmY2E5MDk2M2Y0OTQ0OGE5OGRhYzFjMmEzMzNiOGU1XzEzNDI_f7083f99-d16f-4fff-9b8c-7009f1d0faa3">R&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ELATED&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; P&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ARTY&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; T&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;RANSACTIONS&lt;/span&gt;The Company&#x2019;s Gamma Knife business is operated through its 81% indirect interest in its GKF subsidiary. The remaining 19% of GKF is owned by a wholly owned U.S. subsidiary of Elekta, which is the manufacturer of the Gamma Knife. Since the Company purchases its Gamma Knife units from Elekta, there are significant related party transactions with Elekta such as equipment purchases, commitments to purchase equipment, deposits for such equipment purchases, and costs to maintain the equipment. The Company believes that all its transactions with Elekta are arm&#x2019;s-length transactions. At December&#160;31, 2020, the Company had commitments to purchase three (3) Cobalt-60 reloads, one (1) Perfexion upgrade, and install four (4) Leksell Gamma Knife Icon Systems (&#x201c;Icon&#x201d;) and service the related equipment, as discussed in Note 12 &#x2013; Commitments and Contingencies.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i5032e2b4fc36495cbac498a4109a1461_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODcvZnJhZzpmZmNhOTA5NjNmNDk0NDhhOThkYWMxYzJhMzMzYjhlNS90ZXh0cmVnaW9uOmZmY2E5MDk2M2Y0OTQ0OGE5OGRhYzFjMmEzMzNiOGU1XzEwMQ_d7dab15b-c4f4-456f-b1ed-459d39044c9b"
      unitRef="number">0.81</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i24a2c7db33474c15b8617c78beae2b0f_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODcvZnJhZzpmZmNhOTA5NjNmNDk0NDhhOThkYWMxYzJhMzMzYjhlNS90ZXh0cmVnaW9uOmZmY2E5MDk2M2Y0OTQ0OGE5OGRhYzFjMmEzMzNiOGU1XzE1OQ_7dcf8d42-c104-49c1-bfd5-b805df2b60d6"
      unitRef="number">0.19</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <ams:NumberOfCobalt60Reloads
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODcvZnJhZzpmZmNhOTA5NjNmNDk0NDhhOThkYWMxYzJhMzMzYjhlNS90ZXh0cmVnaW9uOmZmY2E5MDk2M2Y0OTQ0OGE5OGRhYzFjMmEzMzNiOGU1XzI3NDg3NzkwNzE1MDE_c85b53c2-f31f-4310-9fca-ed587546b951"
      unitRef="reload">3</ams:NumberOfCobalt60Reloads>
    <ams:NumberOfPerfexionUpgrades
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODcvZnJhZzpmZmNhOTA5NjNmNDk0NDhhOThkYWMxYzJhMzMzYjhlNS90ZXh0cmVnaW9uOmZmY2E5MDk2M2Y0OTQ0OGE5OGRhYzFjMmEzMzNiOGU1XzI3NDg3NzkwNzE1MDQ_a37becce-3fb0-4837-b84b-1c5ef38d4704"
      unitRef="upgrade">1</ams:NumberOfPerfexionUpgrades>
    <ams:NumberOfLeksellGammaKnifeIconSystemInstalls
      contextRef="i6687a8b13ec24af5990e629224319cec_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODcvZnJhZzpmZmNhOTA5NjNmNDk0NDhhOThkYWMxYzJhMzMzYjhlNS90ZXh0cmVnaW9uOmZmY2E5MDk2M2Y0OTQ0OGE5OGRhYzFjMmEzMzNiOGU1XzI3NDg3NzkwNzE1MDc_f9432f46-c54e-44df-a6b5-2ab7e32157ac"
      unitRef="install">4</ams:NumberOfLeksellGammaKnifeIconSystemInstalls>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301943164568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 22, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-08789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">American Shared Hospital Services<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-2918118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Two Embarcadero Center<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 410,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94111-4107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">788-5300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock No Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s definitive Proxy Statement for the 2021 Annual Meeting of Shareholders are incorporated by reference into Part III of this report.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000744825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301853810120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,961<span></span>
</td>
<td class="nump">$ 1,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $100,000 at December 31, 2020 and December 31, 2019</a></td>
<td class="nump">4,303<span></span>
</td>
<td class="nump">6,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">272<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,950<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">10,850<span></span>
</td>
<td class="nump">10,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">PROPERTY AND EQUIPMENT, net</a></td>
<td class="nump">30,418<span></span>
</td>
<td class="nump">41,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">LAND</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">GOODWILL</a></td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">INTANGIBLE ASSETS</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">RIGHT OF USE ASSETS</a></td>
<td class="nump">886<span></span>
</td>
<td class="nump">1,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">OTHER ASSETS</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">455<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">43,653<span></span>
</td>
<td class="nump">53,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">683<span></span>
</td>
<td class="nump">557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">405<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">2,045<span></span>
</td>
<td class="nump">1,779<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationCurrent', window );">Asset retirement obligations</a></td>
<td class="nump">1,270<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_WorkingCapitalPaymentLiabilityCurrent', window );">Working capital payment due</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease liabilities</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,157<span></span>
</td>
<td class="nump">1,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of finance leases</a></td>
<td class="nump">5,945<span></span>
</td>
<td class="nump">3,709<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">12,380<span></span>
</td>
<td class="nump">8,214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">LONG-TERM LEASE LIABILITIES, less current portion</a></td>
<td class="nump">581<span></span>
</td>
<td class="nump">827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">LONG-TERM DEBT, less current portion</a></td>
<td class="nump">3,440<span></span>
</td>
<td class="nump">1,954<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">LONG-TERM FINANCE LEASES, less current portion</a></td>
<td class="nump">2,974<span></span>
</td>
<td class="nump">8,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">DEFERRED REVENUE, less current portion</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">DEFERRED INCOME TAXES</a></td>
<td class="nump">418<span></span>
</td>
<td class="nump">2,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES (See Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, no par value (10,000,000 authorized; Issued and outstanding shares &#8211; 5,714,000 at December 31, 2018 and 5,710,000 at December 31, 2017</a></td>
<td class="nump">10,753<span></span>
</td>
<td class="nump">10,753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">7,024<span></span>
</td>
<td class="nump">6,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,497<span></span>
</td>
<td class="nump">8,555<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity- American Shared Hospital Services</a></td>
<td class="nump">19,274<span></span>
</td>
<td class="nump">26,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests in subsidiaries</a></td>
<td class="nump">4,376<span></span>
</td>
<td class="nump">5,778<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">23,650<span></span>
</td>
<td class="nump">31,811<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 43,653<span></span>
</td>
<td class="nump">$ 53,783<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_WorkingCapitalPaymentLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working Capital Payment Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_WorkingCapitalPaymentLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301849646776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_BalanceSheetParentheticalAbstract', window );"><strong>Balance Sheet Parenthetical [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">5,791,000<span></span>
</td>
<td class="nump">5,817,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">5,791,000<span></span>
</td>
<td class="nump">5,817,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_BalanceSheetParentheticalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_BalanceSheetParentheticalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301853886872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 17,837<span></span>
</td>
<td class="nump">$ 20,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DirectOperatingMaintenanceSuppliesCosts', window );">Maintenance and supplies</a></td>
<td class="nump">2,385<span></span>
</td>
<td class="nump">2,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">6,789<span></span>
</td>
<td class="nump">7,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Other direct operating costs</a></td>
<td class="nump">4,197<span></span>
</td>
<td class="nump">3,726<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Costs and expenses</a></td>
<td class="nump">13,371<span></span>
</td>
<td class="nump">13,685<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">4,466<span></span>
</td>
<td class="nump">6,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expense</a></td>
<td class="nump">4,608<span></span>
</td>
<td class="nump">4,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1,057<span></span>
</td>
<td class="nump">1,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Loss on write down of impaired assets and associated removal costs</a></td>
<td class="nump">8,264<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="num">(9,463)<span></span>
</td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">(Loss) income before income taxes</a></td>
<td class="num">(9,453)<span></span>
</td>
<td class="nump">1,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="num">(1,737)<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(7,716)<span></span>
</td>
<td class="nump">1,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: net loss (income) attributable to non-controlling interests</a></td>
<td class="nump">658<span></span>
</td>
<td class="num">(771)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income attributable to American Shared Hospital Services</a></td>
<td class="num">$ (7,058)<span></span>
</td>
<td class="nump">$ 659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net (loss) income per share attributable to American Shared Hospital Services:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">(Loss) income per common share - basic (in dollars per share)</a></td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">(Loss) income per common share - diluted (in dollars per share)</a></td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectOperatingMaintenanceSuppliesCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs of maintenance supplies used that are directly related to goods produced and sold, or services rendered, during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectOperatingMaintenanceSuppliesCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301854513208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Sub-Total ASHS</div></th>
<th class="th"><div>Non-controlling Interests in Subsidiaries</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning at Dec. 31, 2018</a></td>
<td class="nump">$ 31,048<span></span>
</td>
<td class="nump">$ 10,711<span></span>
</td>
<td class="nump">$ 6,495<span></span>
</td>
<td class="nump">$ 7,896<span></span>
</td>
<td class="nump">$ 25,102<span></span>
</td>
<td class="nump">$ 5,946<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,714,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation expense (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="nump">16,000<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Cash distributions to non-controlling interests</a></td>
<td class="num">$ (939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(939)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">659<span></span>
</td>
<td class="nump">659<span></span>
</td>
<td class="nump">771<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end at Dec. 31, 2019</a></td>
<td class="nump">31,811<span></span>
</td>
<td class="nump">$ 10,753<span></span>
</td>
<td class="nump">6,725<span></span>
</td>
<td class="nump">8,555<span></span>
</td>
<td class="nump">26,033<span></span>
</td>
<td class="nump">5,778<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,817,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation expense (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Cash distributions to non-controlling interests</a></td>
<td class="num">$ (761)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(761)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="num">(7,716)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,058)<span></span>
</td>
<td class="num">(7,058)<span></span>
</td>
<td class="num">(658)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">NCI investment in acquisition</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted common shares returned to plan (in shares)</a></td>
<td class="num">(129,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end at Dec. 31, 2020</a></td>
<td class="nump">$ 23,650<span></span>
</td>
<td class="nump">$ 10,753<span></span>
</td>
<td class="nump">$ 7,024<span></span>
</td>
<td class="nump">$ 1,497<span></span>
</td>
<td class="nump">$ 19,274<span></span>
</td>
<td class="nump">$ 4,376<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,791,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301853725000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (7,716)<span></span>
</td>
<td class="nump">$ 1,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash from operating activities (excluding assets acquired and liabilities assumed):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">6,970<span></span>
</td>
<td class="nump">7,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NonCashLeaseExpense', window );">Non cash lease expense</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Loss on write down impaired assets</a></td>
<td class="nump">8,184<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(2,162)<span></span>
</td>
<td class="num">(444)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_InterestExpenseLeaseFinancing', window );">Accrued interest on lease financing</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest expense associated with lease liabilities</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Receivables</a></td>
<td class="nump">2,966<span></span>
</td>
<td class="num">(1,187)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">762<span></span>
</td>
<td class="nump">260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue', window );">Accounts payable, accrued liabilities and deferred revenue</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_IncreaseDecreaseInLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(353)<span></span>
</td>
<td class="num">(332)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements', window );">Net insurance proceeds receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash from operating activities</a></td>
<td class="nump">9,745<span></span>
</td>
<td class="nump">8,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payment for purchase of property and equipment</a></td>
<td class="num">(455)<span></span>
</td>
<td class="num">(990)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payment for acquisition, net of cash acquired</a></td>
<td class="num">(2,084)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfMachineryAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) investing activities</a></td>
<td class="num">(2,389)<span></span>
</td>
<td class="num">(990)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="num">(1,726)<span></span>
</td>
<td class="num">(1,980)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_RepaymentsOfLongTermFinanceLeaseObligations', window );">Principal payments on finance leases</a></td>
<td class="num">(3,199)<span></span>
</td>
<td class="num">(4,142)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_ProceedsFromFinancingFromAcquisition', window );">Proceeds from financing from acquisition</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions to non-controlling interests</a></td>
<td class="num">(761)<span></span>
</td>
<td class="num">(939)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="num">(30)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrants and options exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermCapitalLeaseObligations', window );">Principal payments on short-term financing</a></td>
<td class="num">(519)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) financing activities</a></td>
<td class="num">(4,810)<span></span>
</td>
<td class="num">(7,070)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash, cash equivalents and restricted cash</a></td>
<td class="nump">2,546<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of year</a></td>
<td class="nump">1,779<span></span>
</td>
<td class="nump">1,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of year</a></td>
<td class="nump">4,325<span></span>
</td>
<td class="nump">1,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL CASH FLOW DISCLOSURE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">938<span></span>
</td>
<td class="nump">1,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">339<span></span>
</td>
<td class="nump">397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities', window );">Lease reassessment right of use assets and lease liabilities</a></td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NonCashRightOfUseAssetsAndLeaseLiabilities', window );">Right of use assets and lease liabilities</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">1,362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_InterestCapitalizedToPropertyAndEquipment', window );">Interest capitalized to property and equipment</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Acquisition of equipment with finance leases</a></td>
<td class="nump">496<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing', window );">Acquisition of equipment with long-term debt financing</a></td>
<td class="nump">1,184<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AcquisitionOfInsuranceWithShortTermFinancing', window );">Acquisition of insurance with short-term financing</a></td>
<td class="nump">634<span></span>
</td>
<td class="nump">$ 526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_PaymentsForWorkingCapital', window );">First working capital payment related to acquisition, withholding taxes</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition', window );">Estimated subsequent working capital payment for acquisition</a></td>
<td class="nump">$ 154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AcquisitionOfEquipmentWithLongTermDebtFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AcquisitionOfEquipmentWithLongTermDebtFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AcquisitionOfInsuranceWithShortTermFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition Of Insurance With Short-Term Financing</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AcquisitionOfInsuranceWithShortTermFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid and deferred revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_IncreaseDecreaseInLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_IncreaseDecreaseInLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from insurance settlements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_InterestCapitalizedToPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of interest capitalized to property and equipment in noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_InterestCapitalizedToPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_InterestExpenseLeaseFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Lease Financing</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_InterestExpenseLeaseFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Reassessment, Right-Of-Use Assets And Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NonCashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NonCashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NonCashRightOfUseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of Right of use assets and lease liabilities that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NonCashRightOfUseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_PaymentsForWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Working Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_PaymentsForWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_ProceedsFromFinancingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Financing From Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_ProceedsFromFinancingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_RepaymentsOfLongTermFinanceLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Long-term Finance Lease Obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_RepaymentsOfLongTermFinanceLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Subsequent Working Capital Payment Accrued For Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from proceeds received from lessor related to a long-term capital lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfMachineryAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of machinery and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfMachineryAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301848893192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text">B<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">USINESS AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ASIS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">RESENTATION</span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These consolidated financial statements include the accounts of American Shared Hospital Services and its subsidiaries (the &#8220;Company&#8221;) as follows: the Company wholly-owns the subsidiaries American Shared Radiosurgery Services (&#8220;ASRS&#8221;), PBRT Orlando, LLC (&#8220;Orlando&#8221;), OR21, Inc., and MedLeader.com, Inc. (&#8220;MedLeader&#8221;); the Company is the majority owner of Long Beach Equipment, LLC (&#8220;LBE&#8221;); ASRS is the majority-owner of GK Financing, LLC (&#8220;GKF&#8221;) which wholly-owns the subsidiary Instituto de Gamma Knife del Pacifico S.A.C. (&#8220;GKPeru&#8221;). GKF is the majority owner of the subsidiaries Albuquerque GK Equipment, LLC (&#8220;AGKE&#8221;) and Jacksonville GK Equipment, LLC (&#8220;JGKE&#8221;).  GKF formed HoldCo GKC S.A. (&#8220;HoldCo&#8221;) to acquire Gamma Knife Center Ecuador S.A. (&#8220;GKCE&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company (through ASRS) and Elekta AG (&#8220;Elekta&#8221;), the manufacturer of the Gamma Knife (through its wholly-owned United States subsidiary, GKV Investments, Inc.), entered into an operating agreement and formed GKF. During 2020 GKF provided Gamma Knife units to fifteen medical centers in the United States in the states of Arkansas, California, Florida, Illinois, Indiana, Massachusetts, Mississippi, Nebraska, New Mexico, New York, Ohio, Oregon, Tennessee, and Texas. GKF also owns and operates single-unit Gamma Knife facilities in Lima, Peru and Guayaquil, Ecuador. The Company through its wholly-owned subsidiary, Orlando, provided proton beam radiation therapy (&#8220;PBRT&#8221;) and related equipment to a customer in the United States. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company formed the subsidiary GKPeru and acquired GKCE for the purposes of expanding its business internationally; Orlando and LBE to provide PBRT equipment and services in Orlando, Florida and Long Beach, California, respectively; and AGKE and JGKE to provide Gamma Knife equipment and services in Albuquerque, New Mexico and Jacksonville, Florida, respectively. AGKE began operations in the second quarter of 2011 and JGKE began operations in the fourth quarter of 2011. Orlando treated its first patient in April 2016. GKPeru treated its first patient in July 2017. LBE is not expected to generate revenue within the next two years.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 12, 2020, GKF, through HoldCo, purchased approximately 98% of the total outstanding shares of GKCE, from GKCE&#8217;s majority shareholders (the &#8220;Acquisition&#8221;). As of December 31, 2020, the Company had acquired approximately 99.3% of the total outstanding shares of GKCE and intends to acquire the remaining 0.7% at a later date. The base purchase price for the Acquisition, including acquisition of the minority shares was approximately $2,000,000. This purchase price was paid with $575,000 in cash and a $1,425,000 loan from the United States International Development Finance Corporation (&#8220;DFC&#8221;).  The purchase price is subject to certain post-closing adjustments, including adjustment for GKCE's working capital and excess cash.  The DFC loan is denominated in U.S. dollars, which is also the currency of Ecuador.  See &#8220;Note 4. GKCE Acquisition&#8221; for further discussion.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to develop its design and business model for The Operating Room for the 21st Century</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through its 50% owned OR21, LLC (&#8220;OR21&#8221;). The remaining 50% of OR21 is owned by an architectural design company. OR21 is not expected to generate significant revenue within the next two years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MedLeader was formed to provide continuing medical education online and through videos for doctors, nurses, and other healthcare workers. This subsidiary is not operational at this time.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All significant intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks and uncertainties as a result of the COVID-19 pandemic and the extent and duration of the future impact on the Company's business is highly uncertain and difficult to predict. The COVID-19 pandemic has adversely impacted, and is likely to further adversely impact, nearly all aspects of the Company&#8217;s business and markets, including its employees, operations, contractors, customers, government and third party payors and others. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition will depend on future developments that are highly uncertain and difficult to predict.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301847199208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">ACCOUNTING POLICIES</a></td>
<td class="text">A<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OLICIES</span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of estimates in the preparation of financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In preparing the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates reflected in the Company&#8217;s consolidated financial statements include the estimated useful lives of fixed assets and its salvage values, revenues and costs of sales for turn-key and revenue sharing arrangements.&#160; Actual results could differ from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company expenses advertising costs as incurred. Advertising costs were $237,000 and $144,000 during the years ended December&#160;31, 2020 and 2019. Advertising costs are recorded in other direct operating costs and sales and administrative costs in the consolidated statements of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company considers all liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. Restricted cash is not considered a cash equivalent for purposes of the consolidated statements of cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Restricted cash represents the minimum cash that must be maintained in GKF to fund operations, per the subsidiary&#8217;s operating agreement, the minimum cash that must be maintained by GKF per it&#8217;s financing agreement with DFC, and the minimum cash that must be maintained in Orlando per the subsidiary&#8217;s financing agreement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business and credit risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company maintains its cash balances, which exceed federally insured limits, in financial institutions. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents. The Company monitors the financial condition of the financial institutions it uses on a regular basis.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s revenue was provided by eighteen and seventeen customers in 2020 and 2019. One customer accounted for approximately 35% and 30% of the Company&#8217;s total revenue in 2020 and 2019. At December&#160;31, 2020, four customers each individually accounted for 11%, 11%, 11% and 20% of total accounts receivable, respectively. At December&#160;31, 2019, three customers each individually accounted for 12%, 15% and 30% of total accounts receivable, respectively. The Company performs credit evaluations of its customers and generally does not require collateral. The Company has not experienced significant losses related to receivables from individual customers or groups of customers in any particular geographic area.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s radiosurgery devices have been purchased through Elekta, to date. However, there are other manufacturers that also make radiosurgery devices.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts receivable and doubtful accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Accounts receivable are recorded at net realizable value. An allowance for doubtful accounts is estimated based on historical collections plus an allowance for probable losses. Receivables are considered past due based on contractual terms and are charged off in the period that they are deemed uncollectible. Recoveries of receivables previously charged off are offset against bad debt expense when received.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-controlling interests</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company reports its non-controlling interests as a separate component of shareholders&#8217; equity. The Company also presents the consolidated net income and the portion of the consolidated net income allocable to the non-controlling interests and to the shareholders of the Company separately in its consolidated statements of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Property and equipment are stated at cost less accumulated depreciation. Depreciation for Gamma Knife, IGRT, and other equipment is determined using the straight-line method over the estimated useful lives of the assets, which for medical and office equipment is generally 3 &#8211; 10 years, and after accounting for salvage value on the equipment where indicated. Salvage value is based on the estimated fair value of the equipment at the end of its useful life.  The Company acquired a building as part of the Acquisition in June 2020.  Depreciation for buildings is determined using the straight-line method over 20 years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation for PBRT and related equipment is determined using the modified units of production method, which is a function of both time and usage of the equipment. This depreciation method allocates costs considering the projected volume of usage through the useful life of the PBRT unit, which has been estimated at 20 years. The estimated useful life of the PBRT unit is consistent with the estimated economic life of 20 years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes interest incurred on property and equipment that is under construction, for which deposits or progress payments have been made. When a rate is not readily available, imputed interest is calculated using the Company&#8217;s incremental borrowing rate. The interest capitalized for property and equipment is the portion of interest cost incurred during the acquisition periods that could have been avoided if expenditures for the equipment had not been made. The Company capitalized interest of $119,000 and $110,000 in 2020 and 2019, respectively, as costs of medical equipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases Gamma Knife and radiation therapy equipment to its customers under arrangements accounted for as operating leases. At December&#160;31, 2020, the Company held equipment under operating lease contracts with customers with an original cost of $75,241,000 and accumulated depreciation of $45,416,000. At December&#160;31, 2019, the Company held equipment under operating lease contracts with customers with an original cost of $92,135,000 and accumulated depreciation of $55,148,000.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company recognized a loss on the write down of impaired assets of $8,264,000.  The impaired assets included six (6) Gamma Knife units and the Company's deposits towards purchase of proton beam systems and related capitalized interest.  See further discussion under Note 2 - Long-lived asset impairment and Note 3 - Property and Equipment for further discussion.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company&#8217;s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels. Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company&#8217;s own assumptions about the assumptions that market participants would use in pricing the asset or liability.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s assets and liabilities as of December&#160;31, 2020 and 2019 were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:38.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company recognizes revenues under ASC 842 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 842&#8221;) and ASC 606 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 606&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rental income from medical services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company recognizes revenues under ASC 842 when services have been rendered and collectability is reasonably assured, on either a fee per use or revenue sharing basis. The terms of the contracts do not contain any guaranteed minimum payments. The Company&#8217;s contracts are typically for a 10-year term and are classified as either fee per use or retail. Retail arrangements are further classified as either turn-key or revenue sharing. Revenues from fee per use contracts is determined by each hospital&#8217;s contracted rate. Revenues are recognized at the time the procedures are performed, based on each hospital&#8217;s contracted rate and the number of procedures performed. Under revenue sharing arrangements, the Company receives a contracted percentage of the reimbursement received by the hospital. The amount the Company expects to receive is recorded as revenue and estimated based on historical experience. Revenue estimates are reviewed periodically and adjusted as necessary. Under turn-key arrangements, the Company receives payment from the hospital in the amount of the hospital&#8217;s reimbursement from third party payors, and the Company is responsible for paying all the operating costs of the equipment. Operating costs are determined primarily based on historical treatment protocols and cost schedules with the hospital. The Company records an estimate of operating costs which are reviewed on a regular basis and adjusted as necessary to more accurately reflect the actual operating costs. For turn-key sites, the Company also shares a percentage of net operating profit. The Company records an estimate of net operating profit based on estimated revenues, less estimated operating costs. The operating costs and estimated net operating profit are recorded as other direct operating costs in the consolidated statement of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2020 and 2019, the Company recognized revenues of approximately $16,204,000 and $19,396,000 under ASC 842, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company has stand-alone facilities in Lima, Peru and Guayaquil, Ecuador, where a contract exists between the Company&#8217;s facilities and the individual patient treated at the facility. Under ASC 606, the Company acts as the principal in this transaction and provides, at a point in time, a single performance obligation, in the form of a Gamma Knife treatment. Revenue related to a Gamma Knife treatment is recognized on a gross basis at the time when the patient receives treatment. There is no variable consideration present in the Company&#8217;s performance obligation and the transaction price is agreed upon per the stated contractual rate. GKPeru's payment terms are typically prepaid for self-pay patients and insurance provider payments are paid net 30 days. GKCE's patient population is primarily covered by a government payor and payments are paid approximately 30 to 60 days upon invoice. The Company did not capitalize any incremental costs related to the fulfillment of its customer contracts.  Accounts receivable earned by GKPeru were not significant for the year ended December&#160;31, 2020 and 2019. GKCE's accounts receivable were $467,000 for the year ended December&#160;31, 2020. As of December&#160;31, 2020 and 2019, the Company recognized revenues of approximately $1,633,000 and $1,209,000 under ASC 606, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company measures all stock-based compensation awards at fair value and records such expense in its consolidated financial statements over the requisite service period of the related award. See Note 9 for additional information on the Company&#8217;s stock-based compensation programs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Costs of revenue &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's costs of revenue consist primarily of maintenance and supplies, depreciation and amortization, and other operating expenses (such as insurance, property taxes, sales taxes, marketing costs and operating costs from the Company&#8217;s retail sites). Costs of revenues are recognized as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company markets its services through its preferred provider status with Elekta and a direct sales effort led by its Senior Vice President of Sales and Business Development, its President and Chief Financial and Operating Officer and its Chief Executive Officer (&#8220;CEO&#8221;). </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically provides the equipment, as well as planning, installation, reimbursement and marketing support services.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for uncertainty in income taxes as required by the provisions of ASC 740 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 740&#8221;), which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to estimate and measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement. It is inherently difficult and subjective to estimate such amounts, as this requires the Company to determine the probability of various possible outcomes. The Company considers many factors when evaluating and estimating the Company&#8217;s tax positions and tax benefits, which may require periodic adjustments and may not accurately anticipate actual outcomes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 for further discussion on income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Functional currency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Based on guidance provided in accordance with ASC 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 830&#8221;), the Company analyzes its operations outside the United States to determine the functional currency of each operation. Management has determined that these operations are initially accounted for in U.S. dollars since the primary transactions incurred are in U.S. dollars and the Company provides significant funding towards the startup of the operation. When Management determines that an operation has become predominantly self-sufficient, the Company will change its accounting for the operation to the local currency from the U.S. dollar. The Company analyzed it&#8217;s Gamma Knife site in Peru under ASC 830 as of December&#160;31, 2020 and 2019 and concluded the functional currency was the U.S. dollar. As facts and circumstances change, the Company will revisit this conclusion.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Retirement Obligations &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Based on the guidance provided in ASC 410 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Retirement Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 410&#8221;), the Company analyzed its existing lease agreements and determined an asset retirement obligation (&#8220;ARO&#8221;) exists to remove the respective units at the end of the lease terms. As of December&#160;31, 2020, four (4) of the Company's Gamma Knife customers notified the Company of their intent to terminate their contracts at the contract lease term.  The Company recorded an ARO liability for these four (4) sites, using estimates from Elekta.  No liability has been recorded as of December&#160;31, 2020 for the remaining Gamma Knife sites, or as of December&#160;31, 2019, because it is uncertain these units will be removed and the Company historically has not removed the Gamma Knife equipment at the end of the lease term. The Company will re-evaluate the need to record additional ARO liabilities on a periodic basis when facts and circumstances change that could affect this conclusion.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the year. The fully vested restricted stock units not issued and outstanding, are also included therein. Diluted earnings per share reflect the potential dilution that could occur if common shares were issued pursuant to the exercise of options or warrants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Company reported a loss for the year ended December&#160;31, 2020, the potentially dilutive effects of approximately 13,000, of the Company's unvested restricted stock awards were not considered for the reporting periods. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2020, the Company&#8217;s Award Agreements (as defined below) expired and the unvested performance share awards were returned to the Company&#8217;s stock incentive plan - see Note 9 for further discussion.  Based on the guidance provided in accordance with ASC 260, the weighted average common shares for basic earnings per share, for the year ended December 31, 2019 excluded the weighted average impact of the unvested performance share awards. These awards were legally outstanding but not deemed participating securities and therefore were excluded from the calculation of basic earnings per share. The unvested shares were also excluded from the denominator for diluted earnings per share because they were considered contingent shares not deemed probable as of December 31, 2019.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the computations of basic and diluted earnings per share for the years ended December&#160;31, 2020 and 2019.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.440%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.411%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.411%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for basic and diluted (loss) earnings per share</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,058,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic and diluted (loss) earnings per share &#8211; weighted-average shares</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,182,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,919,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities Employee stock options and restricted stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted (loss) earnings per share &#8211; adjusted weighted-average shares</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,182,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,930,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings per common share- basic</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.14)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings per common share- diluted</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.14)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, options outstanding to purchase 406,000 shares of common stock at an exercise price range of $2.25 - $3.90 per share and 13,000 restricted stock units were not included in the calculation of diluted earnings per share because they would be anti-dilutive.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, options outstanding to purchase 387,000 shares of common stock at an exercise price range of $2.68 - $3.90 per share and 3,000 restricted stock units were not included in the calculation of diluted earnings per share because they would be anti-dilutive.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business segment information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Based on the guidance provided in accordance with ASC 280 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 280&#8221;), the Company analyzed its subsidiaries which are all in the business of leasing radiosurgery and radiation therapy equipment to healthcare providers, and concluded there are two reportable segments, domestic and foreign. The Company provides Gamma Knife and PBRT equipment to fifteen hospitals in the United States and owns and operates two single-unit facilities in Lima, Peru and Guayaquil, Ecuador as of December&#160;31, 2020. The Company determined two reportable segments existed due to similarities in economics of business operations and geographic location. The operating results of the two reportable segments are reviewed by the Company&#8217;s CEO and President, Chief Operating and Financial Officer, who are also deemed the Company&#8217;s Chief Operating Decision Makers (&#8220;CODMs&#8221;).  As of December&#160;31, 2019, the Company had one reportable segment.  Following the Company's acquisition of GKCE in June 2020, the Company concluded it had two reportable segments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenues, profit or loss, and net property and equipment allocations for the Company's two reportable segments as of December&#160;31, 2020 consists of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.143%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,204,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,396,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,837,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,605,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit or (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,082,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,058,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.143%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,223,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,593,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,195,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,887,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,418,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,480,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long lived asset impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company assesses the recoverability of its long-lived assets when events or changes in circumstances indicate their carrying value may not be recoverable. Such events or changes in circumstances may include: a significant adverse change in the extent or manner in which a long-lived asset is being used, significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset, an accumulation of costs significantly in excess of the amount originally expected for the acquisition or development of a long-lived asset, current or future operating or cash flow losses that demonstrate continuing losses associated with the use of a long-lived asset, or a current expectation that, more likely than not, a long-lived asset will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company performs impairment testing at the asset group level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. The Company assesses recoverability of a long-lived asset by determining whether the carrying value of the asset group can be recovered through projected undiscounted cash flows over their remaining lives. If the carrying value of the asset group exceeds the forecasted undiscounted cash flows, an impairment loss is recognized, measured as the amount by which the carrying amount exceeds estimated fair value. An impairment loss is charged to the consolidated statement of operations in the period in which management determines such impairment. As of December&#160;31, 2020, the Company determined circumstances existed indicating its assets could be impaired, concluded an impairment existed, and recognized a loss on the write down of impaired assets of $8,264,000.  No such impairment has been noted as of  December&#160;31, 2019.  See Note 3 - Property and Equipment for further discussion. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and intangible assets - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded goodwill of $1,265,000 and an intangible asset with a fair value of $78,000 as part of the Acquisition in June 2020.  The intangible asset identified was GKCE's trade name and the Company assigned an indefinite useful life to the asset.  Based on the guidance provided in accordance with ASC 350 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 350&#8221;), the Company does not amortize the intangible asset because it has an indefinite life.  The Company assesses goodwill at the reporting unit level, which has been determined to be GKCE. Each reporting period, the Company assesses whether events or circumstances continue to support an indefinite useful life for the intangible asset.  Per ASC 350, the Company tests goodwill and intangibles for impairment annually or as events or circumstances change that indicate the fair value may be below the carrying amount.  As of December&#160;31, 2020, there has been no change to the Company's assessment of the value of intangible assets or goodwill. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company records acquisitions according to ASC 805 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 805&#8221;) using the acquisition method of accounting. Under the acquisition method of accounting, all assets acquired, including goodwill and other intangible assets, should be stated at fair value at the time of acquisition. The allocation of purchase price consideration is preliminary, pending the completion of the fair value of certain tangible, intangible assets, and residual goodwill.  During the measurement period, which can be no more than one year from the Closing Date, the Company expects to continue to obtain information to assist in determining the final fair value of assets acquired.  See Note 4 - GKCE Acquisition for further discussion on acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Accounting pronouncement issued and adopted &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2018, the FASB issued ASU No. 2018-03 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Recognition and Measurement of Financial Assets and Financial Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2018-03&#8221;), which clarifies certain aspects of ASU 2016-1. These are: equity securities without a readily determinable fair value &#8211; discontinuation, equity securities without a readily determinable fair value &#8211; adjustments, forward contracts and purchased options, presentation requirements for certain fair value option liabilities, fair value option liabilities denominated in a foreign currency, and transition guidance for equity securities without a readily determinable fair value. In August 2018, the FASB issued ASU No. 2018-13 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Fair Value Measurement (Topic 820): Disclosure Framework &#8211; Changes to the Disclosure Requirements to Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2018-13&#8221;), which amended the effective date and other certain measurement aspects of ASU 2018-03. The new guidance is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The Company adopted ASU 2018-03 and ASU 2018-13 on January 1, 2020. There was no significant impact on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting pronouncement issued and not yet adopted &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2019, the FASB issued ASU 2019-12 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2019-12&#8221;) which removes specific exceptions to the general principles in Topic 740 and eliminates the need for an organization to analyze whether the following apply in a given period: exception to the incremental approach for intraperiod tax allocation; exceptions to accounting for basis differences when there are ownership changes in foreign investments; exception in interim period income tax accounting for year-to-date losses that exceed anticipated losses.  The new guidance is effective for fiscal years and interim periods beginning after December 15, 2020.  The Company is currently evaluating ASU 2019-12 to determine the impact it may have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301850296168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">P<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ROPERTY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> E</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">QUIPMENT</span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consists of the following:</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.193%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment and facilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,657,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,132,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits towards purchase of proton beam systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,157,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,941,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,739,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,461,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net property and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,418,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,480,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, approximately $3,195,000 of the net property and equipment balance is outside of the United States. As December&#160;31, 2020, the Company recognized a loss on the write down of impaired assets of $8,264,000.  The impaired assets included six (6) Gamma Knife units and related removal costs, and two (2) deposits towards the purchase of proton beam systems and related capitalized interest.  The six (6) Gamma Knife units that were impaired consisted of two (2) units that had been taken out of service in prior years, one (1) unit that was taken out of service in 2020 and three (3) units that have already been, or the Company anticipates will be, taken out of service in 2021</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">totaling $3,051,000.  In addition to this impairment write-off of $3,051,000 were estimated costs of de-install and removal (ARO) of four (4) of the Gamma Knife units of $1,350,000 (of which, the Company has paid $80,000) as of December&#160;31, 2020. Total impairment related to the Gamma Knife business was $4,401,000 for the year ended December&#160;31, 2020.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the carrying value of its long-lived assets for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value may not be recoverable.  The Company has reviewed its Gamma Knife equipment, in light of available information as of December&#160;31, 2020 and based on current customer prospects, the probability of future contract extensions or renewals, and the high turnover rate in contract terminations compared to the Company's historical contract termination rate, the Company determined that these six (6) Gamma Knife units were more-than temporarily impaired.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to December&#160;31, 2020, the Company had $2,250,000 in deposits toward the purchase of two MEVION S250i PBRT systems from Mevion. The Company reviews the carrying value of its deposits for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value may not be recoverable. The Company has reviewed the deposits, in light of available information, as of December&#160;31, 2020 and based on its current customer prospects, the impact that the COVID-19 pandemic has had on medical centers undertaking large capital expenditure projects for a limited patient base, and the length of time required to negotiate and implement a proton therapy project, the Company determined that its deposits of $2,250,000, related capitalized interest and other charges of $1,613,000 were other-than temporarily impaired.  Total impairment related to the proton therapy business was $3,863,000.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301848948200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GKCE ACQUISITION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">GKCE ACQUISITION</a></td>
<td class="text">GKCE ACQUISITION<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">On June 18, 2019, the Company entered into a Stock Purchase Agreement to acquire Gamma Knife Center Ecuador S.A. (&#8220;GKCE&#8221;) from GKCE&#8217;s selling majority shareholders. GKCE is a well-established Gamma Knife operation founded in 2009 as a private clinic to introduce advanced stereotactic radiosurgery into Ecuador and continues to operate the only Gamma Knife unit in the country. The Company acquired GKCE for the continued expansion of its business internationally. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">On June 12, 2020 (the &#8220;Closing Date&#8221;), the Company acquired approximately 98% of the total outstanding shares of GKCE.  As of December&#160;31, 2020, the Company acquired approximately 99.3% of the total outstanding shares of GKCE and intends to acquire the remaining 0.7% at a later date. The fair value of the non-controlling interests (&#8220;NCI&#8221;) on the Closing Date was approximately $58,000, which was consistent with the purchase price in the executed NCI agreements. The total purchase consideration for 100% of the outstanding shares of GKCE was $2,883,000, including $2,000,000 of base purchase price, subject to certain price adjustments for current assets and liabilities and tax withholding. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The base purchase price of $2,000,000 was paid with $575,000 of cash and a $1,425,000 loan from the United States International Development Finance Corporation (&#8220;DFC&#8221;). The DFC loan is denominated in U.S. dollars, which is also the currency of Ecuador. The price adjustments will be paid by the Company in the post-closing period with the adjustments related to the amount of working capital that GKCE had as of the Closing Date.  The first price adjustment for working capital as of the Closing Date was approximately $515,000, which was paid by the Company in August 2020.  As of December&#160;31, 2020, the Company owed the withholding taxes related to this payment totaling approximately $43,000. The Company estimates an additional contingent consideration of approximately $368,000 will be remitted to the seller based on the collection of Closing Date accounts receivable balances, net of related costs, during the three-month, six-month and twelve-month periods after the Closing Date. As of December&#160;31, 2020, $214,000 of the contingent considerations had been paid and $154,000 is estimated to be paid for the twelve-month period after the Closing Date. The Company reviewed historical patient treatments, invoice, and collection data from GKCE to determine an appropriate estimate of the contingent consideration at the Closing Date. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The acquisition has been accounted for according to ASC 805 using the acquisition method of accounting.  Under the acquisition method of accounting, all assets acquired, including goodwill and other intangible assets, should be stated at fair value at the time of acquisition.  The allocation of purchase price consideration is preliminary, pending the completion of the fair value of certain tangible, intangible assets, and residual goodwill.  During the measurement period, which can be no more than one year from the Closing Date, the Company expects to continue to obtain information to assist in determining the final fair value of assets acquired.  The assets acquired were recorded based on valuations derived from estimated fair value assessments and assumptions used by the Company.  Thus, the provisional measurements of fair value discussed below are subject to change.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">As of December&#160;31, 2020, accounting for the Closing Date accounts receivable balances, allowance on the uncollected accounts receivable balances, and related liabilities, was not complete.  The accounting for these amounts will be complete following the twelve-month period after the Closing Date, per the terms of the Stock Purchase Agreement. The Company expects to finalize the valuation as soon as practicable, but no later than one year from the Closing Date.  While the Company believes its estimates and assumptions underlying the valuations are reasonable, different estimates and assumptions could result in different valuations assigned to the individual assets acquired, and the resulting amount of goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">After the Acquisition date, the Company received additional information regarding the amounts recorded as accounts receivable as of June 12, 2020.  After reviewing the information obtained, the Company booked an additional $27,000 of accounts receivable as of December&#160;31, 2020.  As a result, related liabilities were increased by $13,000 and the contingent consideration increased by $14,000.  There was no impact to goodwill or net loss as of December&#160;31, 2020. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:105%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:105%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:105%"> 4 - GKCE ACQUISITION (CONTINUED)</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The fair value of assets acquired and liabilities assumed were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 12, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expense and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,374,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(491,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consideration allocated to assets acquired and liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First working capital payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(515,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated subsequent working capital payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(368,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base purchase consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The Company has allocated the purchase price of GKCE to the tangible assets, liabilities, and intangible asset acquired, based on their estimated fair values.  Goodwill represents the excess of the purchase price consideration over the fair value of the identifiable tangible and intangible assets assumed.  The Company believes the amount of goodwill resulting from the acquisition is primarily attributable to expected synergies from an assembled and trained workforce and enhanced opportunities for growth and innovation.  The goodwill resulting from the acquisition is not tax deductible.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The preliminary value of the acquired tangible assets acquired are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Life (in Years)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The Company also acquired intangible assets with a fair value of $78,000.  The intangible asset identified was GKCE's trade name and the Company assigned an indefinite useful life to the asset.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The Company incurred costs related to the acquisition of approximately $93,000 for the three-month period ended June 30, 2020 and $69,000 for the three-month period ended September&#160;30, 2020.  All acquisition related costs were expensed as incurred and have been recorded in selling and administrative expense in the Company's consolidated statement of operations. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:105%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:105%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:105%"> 4 - GKCE ACQUISITION (CONTINUED)</span>The revenue and earnings of GKCE have been included in the Company&#8217;s consolidated results since the Closing Date and are not material to the Company&#8217;s consolidated financial results.  Historical financial statements and pro forma results of the operations of GKCE as if the Acquisition occurred earlier than the Closing Date have not been presented, as the applicable significance thresholds are not exceeded by the Acquisition and the corresponding requirements to provide historical financial statements and corresponding pro forma financial information are not applicable to the Acquisition. In addition, the Company believes that the financial impact of the Acquisition to the Company&#8217;s consolidated financial statements is not material and such historical financial information and pro forma financial information would not be meaningful for investors and financial statement users.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301850296168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG TERM DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">LONG TERM DEBT</a></td>
<td class="text">LONG TERM DEBT<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists primarily of seven notes with three financing companies collateralized by the Gamma Knife equipment having an aggregate net book value of $11,023,000, the individual customer contracts, and related accounts receivable of $1,718,000 at December&#160;31, 2020. These notes are predominantly payable in 36 to 84 fully amortizing monthly installments, mature between January 2021 and September 2027. The notes accrue interest at fixed annual rates between 3.67% and 6.90%.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2019, the Company had six notes with two financing companies collateralized by the Gamma Knife equipment having an aggregate net book value of $13,130,000, the individual customer contracts, and related accounts receivable of $1,848,000. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are contractual maturities of long-term debt by year at December&#160;31, 2020, excluding debt issuance costs of $27,000:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.331%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.751%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,624,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301848954616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCE LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">FINANCE LEASES</a></td>
<td class="text">FINANCE LEASES<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has six finance lease obligations with two financing companies, collateralized by Gamma Knife and PBRT equipment having an aggregate net book value of $18,093,000, the individual customer contracts, and related accounts receivable of $1,892,000 at December&#160;31, 2020. These obligations have imputed interest rates ranging between 4.73% and 13.00%, are predominantly payable in 36 to 84 monthly installments, and mature between November 2021 and September 2024. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2019, the Company had ten finance lease obligations with three financing companies, collateralized by Gamma Knife and PBRT equipment, having an aggregate net book value of $22,860,000, the individual customer contracts, and related accounts receivable of $4,600,000. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of each lease term, the Company has a bargain purchase option to purchase the equipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments, together with the present value of the net minimum lease payments under finance leases at December&#160;31, 2020, are summarized as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Present Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of Minimum</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Payments</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Year ending December 31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,590,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,771,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,919,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,945,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,974,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301848650504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract is a lease at inception. Under ASC 842, the Company is a lessor of equipment to various customers. Leases that commenced prior to ASC 842 adoption date were classified as operating leases under historical guidance. As the Company has elected the package of practical expedients allowing it to not reassess lease classification, these leases are classified as operating leases under ASC 842 as well. All of the Company&#8217;s lessor arrangements entered into after ASC 842 adoption are also classified as operating leases. Some of these lease terms have an option to extend the lease after the initial term, but do not contain the option to terminate early or purchase the asset at the end of the term.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Gamma Knife and PBRT contracts with hospitals are classified as operating leases under ASC 842. The related equipment is included in medical equipment and facilities on the Company&#8217;s consolidated balance sheets (see further discussion at Note 2). As all income from the Company&#8217;s lessor arrangements is solely based on procedure volume, all income is considered variable payments not dependent on an index or a rate. As such, the Company does not measure future operating lease receivables.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lessee operating leases are accounted for as right-of-use (&#8220;ROU&#8221;) assets, other current liabilities, and lease liabilities on the consolidated balance sheets. Operating lease ROU assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company&#8217;s operating lease contracts do not provide an implicit rate for calculating the present value of future lease payments, so the Company determined its incremental borrowing rate to be in the range of approximately 4.0% and 6.0% by using available market rates and expected lease terms. The operating lease ROU assets and liabilities also include any lease payments made and excludes lease incentives and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company&#8217;s lessee operating lease agreements are for administrative office space and related equipment, and the agreement to lease clinic space for its stand-alone facility in Lima, Peru. These leases have remaining lease terms between 2 and 3 years, some of which include options to renew or extend the lease. As of December&#160;31, 2020, operating ROU assets and liabilities were $886,000.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company elected to not renew its lease for a satellite office in Fairfield, California.  The Company previously included the renewal term in its assessment of the lease term for the ROU asset and liability. The Company accounted for this change as a lease reassessment under ASC 842. At the reassessment date, the remaining lease balance was not material to the Company's consolidated balance sheets and the Company wrote off the related ROU assets and liabilities of $67,000.  Also during the year ended December&#160;31, 2020, the Company agreed to a rent increase for its clinic space for its stand-alone facility in Lima, Peru.  The rent increase was effective as of January 1, 2020 and the Company increased the related ROU assets and liabilities by $135,000.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes maturities of lessee operating lease ROU assets and liabilities as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955,000&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886,000&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301847540248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">I<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NCOME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AXES</span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and 2019 the Company recorded an income tax benefit of $1,737,000 and income tax expense of $128,000, respectively.  The decrease in the Company&#8217;s provision for income taxes as of December&#160;31, 2020 is due to a loss on the write down of impaired assets.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision (benefit) for income taxes as of December&#160;31, 2020 and 2019 consist of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YEARS ENDED DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,909,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(251,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,151,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(652,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,737,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the Company&#8217;s deferred tax liabilities and assets as of December&#160;31, 2020 and 2019 are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.193%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(564,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,112,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(564,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,112,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8211; net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryover</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,519,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(678,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets net of valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,514,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts are presented in the financial statements as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.193%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes (non-current)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,514,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,514,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The (benefit) provision for income taxes differs from the amount computed by applying the U.S. federal statutory tax rate (21% in 2020 and 2019) to income before taxes as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YEARS ENDED DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computed expected federal income tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,844,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to Provision True-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain Tax Positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryforward expiration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred tax adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,737,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company exhausted the remainder of its net operating loss carryforward for federal income tax return purposes. The Company has net operating loss carryforwards for state income tax purposes of approximately $2,219,000 that begin to expire in 2029. The Company has net operating loss carryforwards for its international subsidiaries of approximately $32,000.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of the net operating loss and credit carryforwards may be subject to an annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), and similar state provisions. Any annual limitation may result in the expiration of net operating losses and credits before utilization.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company has a capital loss carryforward for federal income tax return purposes of approximately $2,586,000 which starts to expire in 2021. The Company has capital loss carryforwards for state income tax purposes of approximately $129,000 which starts to expire in 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to uncertainty surrounding the realization of impairment losses, capital losses and foreign operating losses in future years, the Company has placed a valuation allowance against a portion of its net domestic and foreign deferred tax assets. The net valuation allowance decreased by $243,000 and $175,000 for the tax years ended December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, the Company released the valuation allowance related to GKPeru deferred tax assets, which resulted in an income tax benefit of $104,000. The Company concluded, based upon the preponderance of positive evidence (i.e. cumulative profit before tax adjusted for permanent items over the previous twelve quarters, a history of taxable income in recent periods, and the current forecast of income before taxes for GKPeru going forward) over negative evidence and the anticipated ability to use the deferred tax assets, that it was more likely than not that the deferred tax assets will be realized. If there are unfavorable changes to actual operating results or to projections of future income, the Company may determine that it is more likely than not such deferred tax assets may not be realizable.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax return years 2016 through 2019 remain open to examination by the major domestic taxing jurisdictions to which the Company is subject. In 2019, the Company settled a New York State examination for tax years 2015 through 2017 with no material adjustments. Net operating losses generated on a tax return basis by the Company for calendar years 1999 through 2004, 2009, 2010, 2012, 2014, 2015, 2016, 2017 and 2018 remain open to examination by the major domestic taxing jurisdictions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted accounting standards which prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of uncertain tax positions taken or expected to be taken in a company's income tax return, and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. Additionally, these accounting standards specify that tax positions for which the timing of the ultimate resolution is uncertain should be recognized as long-term liabilities. The Company has made no reclassifications between current taxes payable and long term taxes payable under this guidance.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the unrecognized tax benefit was $275,000 which, if recognized, will not affect the annual effective tax rate as these unrecognized tax benefits would increase deferred tax assets which would be subject to a full valuation allowance. A reconciliation of the beginning and ending amount of unrecognized tax benefit is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:0 1pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEARS ENDED DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's policy for deducting interest and penalties is to treat interest as interest expense and penalties as taxes. As of December&#160;31, 2020, the Company had $15,000 accrued for the payment of penalties and zero interest related to unrecognized tax benefits. The Company does not expect any material changes to our uncertain tax positions within the next 12 months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301848650504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION EXPENSE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCK-BASED COMPENSATION EXPENSE</a></td>
<td class="text">STOCK-BASED COMPENSATION EXPENSE<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive Compensation Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2010 shareholders approved an amendment and restatement of the Company&#8217;s stock incentive plan, renaming it the Incentive Compensation Plan (the &#8220;Plan&#8221;), and among other things, increasing the number of shares of the Company&#8217;s common stock reserved for issuance under the Plan to 1,630,000. The Plan provides that the shares reserved under the Plan are available for issuance to officers of the Company, other key employees, non- employee directors, and advisors. The Plan is a successor to the Company&#8217;s previous plans, and any shares awarded and outstanding under those plans were transferred to the Plan. No further grants or share issuances will be made under the previous plans. On June 21, 2019, the Company&#8217;s shareholders approved an amendment and restatement of the Plan in order to extend the term of the Plan by two years to February 22, 2022. As of December&#160;31, 2020, approximately 437,000 shares remain available for grant under the Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Plan, a total of 456,000 restricted stock units have been granted, consisting of 43,000 of annual automatic grants to non-employee directors and the corporate secretary, 293,000 of deferred retainer fees to non-employee members of the Board, 20,000 grants issued in lieu of commission, to two (2) employees of the Company and 100,000 restricted stock units issued to the CEO during 2020, see further discussion below. Of the total restricted stock units granted under the Plan 210,000 of them are fully vested but not yet deemed issued and outstanding, 233,000 are fully vested and outstanding, and 13,000 are outstanding as of December&#160;31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in restricted stock units, consisting primarily of annual automatic grants, deferred compensation to non-employee directors, and restricted stock units awards to the CEO, under the Incentive Compensation Plans during 2020 and 2019 are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Units</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, total compensation expense recorded in the consolidated statements of operations related to restricted stock units in lieu of retainer fees was $80,000. For the year ended December&#160;31, 2020, total compensation expense recorded in the consolidated statements of income for annual restricted stock units awarded was $7,000, with an offsetting tax benefit of $1,000, as this expense is deductible for income tax purposes. As of December&#160;31, 2020, there was $2,000 of total unrecognized compensation cost related to annual restricted stock units which is expected to be recognized over a period of 0.5 years. During 2020 and 2019, shares of restricted stock units totaling 3,000 and 4,000 each, respectively, with a fair value of approximately $9,000 and $11,000, respectively, vested and became unrestricted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Certain Executive Equity Awards</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective May 4, 2020, the Company appointed Raymond C. Stachowiak as Interim President and Chief Executive Officer (&#8220;Interim CEO&#8221;). As part of his Offer Letter, the Interim CEO was granted 50,000 restricted stock awards that vested in full on August 3, 2020.  The Interim CEO was granted additional restricted stock awards totaling 10,000 common shares per month, which vest in full at the end of each 30-day period following issuance. On October 1, 2020 the Interim CEO was appointed the CEO.  For the year ended December&#160;31, 2020, 100,000 restricted stock awards were issued to the CEO and 90,000 became fully vested. Additionally, Ernest R. Bates, Senior Vice President, Sales and Business Development, International Operations, was awarded 10,000 restricted stock awards, which vested in full on December 31, 2020. For the year ended December&#160;31, 2020, total compensation expense recorded in the consolidated financial statements of operations related to executive equity awards was $195,000.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2017, the Company entered into a Performance Share Award Agreement with three executive officers of the Company (the &#8220;Award Agreements&#8221;) for 161,766 restricted stock awards which vest upon the achievement of certain performance metrics. The Award Agreements expired on March 31, 2020. Based on the guidance in ASC 718 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 718&#8221;), the Company concluded these were performance-based awards with vesting criteria tied to performance metrics. As of December 31, 2017, the Company achieved one of the certain performance metrics under the Award Agreements and recognized stock compensation expense of approximately $108,000 related to these awards. The unrecognized stock-based compensation expense for these awards was approximately $421,000 and unvested restricted stock awards of approximately 129,000 were returned to the plan as of March 31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, stock compensation expense recorded in the consolidated financial statements is summarized as follows: </span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.302%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock-Based</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards Issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Award Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">and Vested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs Issued in Lieu of Retainer Fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual RSU Awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Stock Options</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in stock options outstanding under the Incentive Compensation Plans during 2020 and 2019 are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:49.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term (Years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.61</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.48</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant-date fair value of the options granted during the years 2020 and 2019 was $0.78 and $1.54, respectively. There were no options exercised and accordingly, no intrinsic value of options exercised during the year ended December&#160;31, 2020. There were 16,000 options exercised during the year ended December&#160;31, 2019. Total stock-based compensation expense recognized for stock options for the years ended December 2020 and 2019 was $17,000 and $141,000, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no cash received from options exercised under any share-based payment arrangements for the year ended December&#160;31, 2020, and as a result, there was no actual tax benefit realized for tax deductions from option exercises in that year. The Company received approximately $42,000 from the exercise of 16,000 options under the share-based arrangements for the year ended December 31, 2019. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of the Company&#8217;s non-vested stock options as of December&#160;31, 2020 and 2019, and changes during the years ended December&#160;31, 2020 and 2019 is presented below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:74.439%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.413%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant-Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, there was approximately $12,000 of unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Plan. This cost is expected to be recognized over a period of approximately three  years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based awards to employees are calculated using the Black-Scholes options valuation model. The Black-Scholes model was developed for use in estimating the fair value of traded options which have no vesting restrictions and are fully transferable. In addition, the Black-Scholes model requires the input of highly subjective assumptions including the expected stock price volatility. The Company&#8217;s stock-based awards have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the present value estimates. For these reasons, management believes that the existing models do not necessarily provide a reliable single measure of the fair value of its stock-based awards to employees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s option grants issued during 2020 and 2019  were estimated using assumptions for expected life, volatility, dividend yield, forfeiture rate, and risk-free interest rate which are specific to each award as summarized in the following table. The estimated fair value of the Company&#8217;s options is amortized over the period during which the optionee is required to provide service in exchange for the award, usually the vesting period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s option grants under the Plan in 2020 and 2019 was estimated using the following assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected forfeiture rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Repurchase of Common Stock, Common Stock Warrants and Stock Options</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of 1,000,000 shares of its own stock on the open market, which the Board reaffirmed in 2008. There were no shares of the Company repurchased during 2020 or 2019. There are approximately 72,000 shares remaining under this repurchase authorization.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301849479624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLAN<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">RETIREMENT PLAN</a></td>
<td class="text">R<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ETIREMENT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">LAN</span>The Company has a defined-contribution retirement plan (the &#8220;Retirement Plan&#8221;) that allows for a matching safe harbor contribution. For 2020, the Board of Directors elected to match participant deferred salary contributions up to a maximum of 4% of the participant&#8217;s annual compensation. Discretionary profit sharing contributions are allowed under the Retirement Plan in years that the Board does not elect a safe harbor match. The Company has accrued approximately $37,000 for the estimated safe harbor matching contribution for the year ended December&#160;31, 2020. The Company contributed $38,000 to the Retirement Plan for the safe harbor match for the year ended December&#160;31, 2019.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301848898824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Leases, Operating [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock', window );">OPERATING LEASES</a></td>
<td class="text">O<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PERATING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> L</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">EASES</span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases office space and equipment under operating leases expiring at various dates through 2021 and 2024. On August 13, 2016, the Company entered into a 7 year operating lease for an office space located in San Francisco, CA. The Company also owns and operates a stand-alone Gamma Knife facility in Lima, Peru where it leases approximately 1,600 square feet for approximately $7,800 per month with a lease expiration date in January 2024.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum payments under non-cancelable operating leases having initial terms of more than one year consisted of the following:</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31, </span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments for repair and maintenance agreements incorporated in operating lease agreements are not included in the future minimum operating lease payments shown above.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net rent expense was $404,000 and $380,000 for the years ended December&#160;31, 2020 and 2019, respectively, and includes the above operating leases as well as month-to-month rental and certain executory costs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessor's operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph Note 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph Note 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLessorDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301851253432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">C<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OMMITMENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ONTINGENCIES</span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 20, 2018, the Company signed Second Amendments to two System Build Agreements for the Company&#8217;s second and third Mevion PBRT units. The Company and Mevion have agreed to upgrade the second and third PBRT units for which the Company has purchase commitments. The Company is actively seeking sites for these units but, to date, has not entered into agreements with any party for either placement of a PBRT unit or the related financing. The Company projects that it will be required to commence delivery of the second and third PBRT units no later than 2023. In the event the Company is unable to enter into customer agreements within the requisite time frame or receive an extension from Mevion, the Company could forfeit its deposits, which are described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2020, the Company had commitments to perform three (3) Cobalt-60 reloads and install four (4) Leksell Gamma Knife Icon Systems (&#8220;Icon&#8221;) at existing customer sites, and purchase two (2) Linear Accelerator ("LINAC") systems, one to be placed at an existing customer site and one at a new customer site. The Company also has a commitment to upgrade the Gamma Knife unit at its stand-alone facility in Ecuador to a Perfexion. The Cobalt-60 reloads, Icon upgrades, and LINAC purchases are scheduled to occur between 2021 and 2022. The Company expects to upgrade the equipment in Ecuador in the second quarter of 2021. Total Gamma Knife and LINAC commitments as of December&#160;31, 2020 were $12,210,000.  There are no significant cash requirements, pending financing, for these commitments in the next 12 months. There can be no assurance that financing will be available for the Company&#8217;s current or future projects, or at terms that are acceptable to the Company.&#160;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 21, 2017, the Company entered into a Maintenance and Support Agreement (the &#8220;Mevion Service Agreement&#8221;) with Mevion, which provides for maintenance and support of the Company&#8217;s PBRT unit at Orlando Health. The Mevion Service Agreement began September 5, 2017, was amended in 2018, and renews annually over a five (5) year period. The agreement requires an annual prepayment of $1,572,000 for the current contractual period. This payment portion was recorded as a prepaid contract and will be amortized over the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZWIxZWZjOTlkYzRmNDA4OTAzYjQ3NjlhZGM0YjkwL3NlYzowOGViMWVmYzk5ZGM0ZjQwODkwM2I0NzY5YWRjNGI5MF8xODQvZnJhZzo4NjVjZDg4MTczOGQ0ZjZkYmZmOGExYzhiN2ZhMjY1Yi90ZXh0cmVnaW9uOjg2NWNkODgxNzM4ZDRmNmRiZmY4YTFjOGI3ZmEyNjViXzI3NDg3NzkwNzU4MTM_78bf16e5-2777-43c0-8b8e-f765c5397ed5">one</span>-year service period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2020, the Company had commitments to service and maintain its Gamma Knife and PBRT equipment. The service commitments are carried out via contracts with Mevion, Elekta and Mobius Imaging, LLC. In addition, in April 2019, the Company signed agreements to service the Icon upgrades which will be installed at various dates between 2021 and 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s commitments to purchase two LINAC systems also include a 9-year and 5-year agreement to service the equipment, respectively. Total service commitments as of December&#160;31, 2020 were $10,493,000. The Gamma Knife and certain other service contracts are paid monthly, as service is performed. The Company believes that cash flow from cash on hand and operations will be sufficient to cover these payments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following commitments for each of the equipment systems, with expected timing of payments as follows as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.078%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.968%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.968%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.968%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.968%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.973%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts committed</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022-2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024-2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After 5&#160;years</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (includes interest)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,251,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,543,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases (includes interest)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,771,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,590,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,659,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Future equipment purchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,210,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,035,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment service contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,493,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,585,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,999,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition working capital payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commitments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,894,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,715,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,747,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,072,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,360,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301848884888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text">R<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ELATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ARTY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">RANSACTIONS</span>The Company&#8217;s Gamma Knife business is operated through its 81% indirect interest in its GKF subsidiary. The remaining 19% of GKF is owned by a wholly owned U.S. subsidiary of Elekta, which is the manufacturer of the Gamma Knife. Since the Company purchases its Gamma Knife units from Elekta, there are significant related party transactions with Elekta such as equipment purchases, commitments to purchase equipment, deposits for such equipment purchases, and costs to maintain the equipment. The Company believes that all its transactions with Elekta are arm&#8217;s-length transactions. At December&#160;31, 2020, the Company had commitments to purchase three (3) Cobalt-60 reloads, one (1) Perfexion upgrade, and install four (4) Leksell Gamma Knife Icon Systems (&#8220;Icon&#8221;) and service the related equipment, as discussed in Note 12 &#8211; Commitments and Contingencies.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301849508360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates in the preparation of financial statements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of estimates in the preparation of financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In preparing the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates reflected in the Company&#8217;s consolidated financial statements include the estimated useful lives of fixed assets and its salvage values, revenues and costs of sales for turn-key and revenue sharing arrangements.&#160; Actual results could differ from those estimates.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising costs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company expenses advertising costs as incurred. Advertising costs were $237,000 and $144,000 during the years ended December&#160;31, 2020 and 2019. Advertising costs are recorded in other direct operating costs and sales and administrative costs in the consolidated statements of operations.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company considers all liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. Restricted cash is not considered a cash equivalent for purposes of the consolidated statements of cash flows.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted cash</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Restricted cash represents the minimum cash that must be maintained in GKF to fund operations, per the subsidiary&#8217;s operating agreement, the minimum cash that must be maintained by GKF per it&#8217;s financing agreement with DFC, and the minimum cash that must be maintained in Orlando per the subsidiary&#8217;s financing agreement.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_BusinessAndCreditRiskPolicyTextBlock', window );">Business and credit risk</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business and credit risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company maintains its cash balances, which exceed federally insured limits, in financial institutions. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents. The Company monitors the financial condition of the financial institutions it uses on a regular basis.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s revenue was provided by eighteen and seventeen customers in 2020 and 2019. One customer accounted for approximately 35% and 30% of the Company&#8217;s total revenue in 2020 and 2019. At December&#160;31, 2020, four customers each individually accounted for 11%, 11%, 11% and 20% of total accounts receivable, respectively. At December&#160;31, 2019, three customers each individually accounted for 12%, 15% and 30% of total accounts receivable, respectively. The Company performs credit evaluations of its customers and generally does not require collateral. The Company has not experienced significant losses related to receivables from individual customers or groups of customers in any particular geographic area.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s radiosurgery devices have been purchased through Elekta, to date. However, there are other manufacturers that also make radiosurgery devices.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts receivable and doubtful accounts</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts receivable and doubtful accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Accounts receivable are recorded at net realizable value. An allowance for doubtful accounts is estimated based on historical collections plus an allowance for probable losses. Receivables are considered past due based on contractual terms and are charged off in the period that they are deemed uncollectible. Recoveries of receivables previously charged off are offset against bad debt expense when received.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NoncontrollingInterestsPolicyTextBlock', window );">Non-controlling interests</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-controlling interests</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company reports its non-controlling interests as a separate component of shareholders&#8217; equity. The Company also presents the consolidated net income and the portion of the consolidated net income allocable to the non-controlling interests and to the shareholders of the Company separately in its consolidated statements of operations.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Property and equipment are stated at cost less accumulated depreciation. Depreciation for Gamma Knife, IGRT, and other equipment is determined using the straight-line method over the estimated useful lives of the assets, which for medical and office equipment is generally 3 &#8211; 10 years, and after accounting for salvage value on the equipment where indicated. Salvage value is based on the estimated fair value of the equipment at the end of its useful life.  The Company acquired a building as part of the Acquisition in June 2020.  Depreciation for buildings is determined using the straight-line method over 20 years.</span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation for PBRT and related equipment is determined using the modified units of production method, which is a function of both time and usage of the equipment. This depreciation method allocates costs considering the projected volume of usage through the useful life of the PBRT unit, which has been estimated at 20 years. The estimated useful life of the PBRT unit is consistent with the estimated economic life of 20 years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes interest incurred on property and equipment that is under construction, for which deposits or progress payments have been made. When a rate is not readily available, imputed interest is calculated using the Company&#8217;s incremental borrowing rate. The interest capitalized for property and equipment is the portion of interest cost incurred during the acquisition periods that could have been avoided if expenditures for the equipment had not been made. The Company capitalized interest of $119,000 and $110,000 in 2020 and 2019, respectively, as costs of medical equipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases Gamma Knife and radiation therapy equipment to its customers under arrangements accounted for as operating leases. At December&#160;31, 2020, the Company held equipment under operating lease contracts with customers with an original cost of $75,241,000 and accumulated depreciation of $45,416,000. At December&#160;31, 2019, the Company held equipment under operating lease contracts with customers with an original cost of $92,135,000 and accumulated depreciation of $55,148,000.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company recognized a loss on the write down of impaired assets of $8,264,000.  The impaired assets included six (6) Gamma Knife units and the Company's deposits towards purchase of proton beam systems and related capitalized interest.  See further discussion under Note 2 - Long-lived asset impairment and Note 3 - Property and Equipment for further discussion.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value of financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company&#8217;s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels. Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company&#8217;s own assumptions about the assumptions that market participants would use in pricing the asset or liability.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company recognizes revenues under ASC 842 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 842&#8221;) and ASC 606 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 606&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rental income from medical services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company recognizes revenues under ASC 842 when services have been rendered and collectability is reasonably assured, on either a fee per use or revenue sharing basis. The terms of the contracts do not contain any guaranteed minimum payments. The Company&#8217;s contracts are typically for a 10-year term and are classified as either fee per use or retail. Retail arrangements are further classified as either turn-key or revenue sharing. Revenues from fee per use contracts is determined by each hospital&#8217;s contracted rate. Revenues are recognized at the time the procedures are performed, based on each hospital&#8217;s contracted rate and the number of procedures performed. Under revenue sharing arrangements, the Company receives a contracted percentage of the reimbursement received by the hospital. The amount the Company expects to receive is recorded as revenue and estimated based on historical experience. Revenue estimates are reviewed periodically and adjusted as necessary. Under turn-key arrangements, the Company receives payment from the hospital in the amount of the hospital&#8217;s reimbursement from third party payors, and the Company is responsible for paying all the operating costs of the equipment. Operating costs are determined primarily based on historical treatment protocols and cost schedules with the hospital. The Company records an estimate of operating costs which are reviewed on a regular basis and adjusted as necessary to more accurately reflect the actual operating costs. For turn-key sites, the Company also shares a percentage of net operating profit. The Company records an estimate of net operating profit based on estimated revenues, less estimated operating costs. The operating costs and estimated net operating profit are recorded as other direct operating costs in the consolidated statement of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2020 and 2019, the Company recognized revenues of approximately $16,204,000 and $19,396,000 under ASC 842, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company has stand-alone facilities in Lima, Peru and Guayaquil, Ecuador, where a contract exists between the Company&#8217;s facilities and the individual patient treated at the facility. Under ASC 606, the Company acts as the principal in this transaction and provides, at a point in time, a single performance obligation, in the form of a Gamma Knife treatment. Revenue related to a Gamma Knife treatment is recognized on a gross basis at the time when the patient receives treatment. There is no variable consideration present in the Company&#8217;s performance obligation and the transaction price is agreed upon per the stated contractual rate. GKPeru's payment terms are typically prepaid for self-pay patients and insurance provider payments are paid net 30 days. GKCE's patient population is primarily covered by a government payor and payments are paid approximately 30 to 60 days upon invoice. The Company did not capitalize any incremental costs related to the fulfillment of its customer contracts.  Accounts receivable earned by GKPeru were not significant for the year ended December&#160;31, 2020 and 2019. GKCE's accounts receivable were $467,000 for the year ended December&#160;31, 2020. As of December&#160;31, 2020 and 2019, the Company recognized revenues of approximately $1,633,000 and $1,209,000 under ASC 606, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-based compensation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company measures all stock-based compensation awards at fair value and records such expense in its consolidated financial statements over the requisite service period of the related award. See Note 9 for additional information on the Company&#8217;s stock-based compensation programs.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Costs of revenue</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Costs of revenue &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's costs of revenue consist primarily of maintenance and supplies, depreciation and amortization, and other operating expenses (such as insurance, property taxes, sales taxes, marketing costs and operating costs from the Company&#8217;s retail sites). Costs of revenues are recognized as incurred.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Sales and Marketing</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company markets its services through its preferred provider status with Elekta and a direct sales effort led by its Senior Vice President of Sales and Business Development, its President and Chief Financial and Operating Officer and its Chief Executive Officer (&#8220;CEO&#8221;). </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically provides the equipment, as well as planning, installation, reimbursement and marketing support services.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.</span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for uncertainty in income taxes as required by the provisions of ASC 740 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 740&#8221;), which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to estimate and measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement. It is inherently difficult and subjective to estimate such amounts, as this requires the Company to determine the probability of various possible outcomes. The Company considers many factors when evaluating and estimating the Company&#8217;s tax positions and tax benefits, which may require periodic adjustments and may not accurately anticipate actual outcomes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 for further discussion on income taxes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional currency</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Functional currency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Based on guidance provided in accordance with ASC 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 830&#8221;), the Company analyzes its operations outside the United States to determine the functional currency of each operation. Management has determined that these operations are initially accounted for in U.S. dollars since the primary transactions incurred are in U.S. dollars and the Company provides significant funding towards the startup of the operation. When Management determines that an operation has become predominantly self-sufficient, the Company will change its accounting for the operation to the local currency from the U.S. dollar. The Company analyzed it&#8217;s Gamma Knife site in Peru under ASC 830 as of December&#160;31, 2020 and 2019 and concluded the functional currency was the U.S. dollar. As facts and circumstances change, the Company will revisit this conclusion.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetRetirementObligationsPolicyPolicyTextBlock', window );">Asset Retirement Obligations</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Retirement Obligations &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Based on the guidance provided in ASC 410 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Retirement Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 410&#8221;), the Company analyzed its existing lease agreements and determined an asset retirement obligation (&#8220;ARO&#8221;) exists to remove the respective units at the end of the lease terms. As of December&#160;31, 2020, four (4) of the Company's Gamma Knife customers notified the Company of their intent to terminate their contracts at the contract lease term.  The Company recorded an ARO liability for these four (4) sites, using estimates from Elekta.  No liability has been recorded as of December&#160;31, 2020 for the remaining Gamma Knife sites, or as of December&#160;31, 2019, because it is uncertain these units will be removed and the Company historically has not removed the Gamma Knife equipment at the end of the lease term. The Company will re-evaluate the need to record additional ARO liabilities on a periodic basis when facts and circumstances change that could affect this conclusion.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the year. The fully vested restricted stock units not issued and outstanding, are also included therein. Diluted earnings per share reflect the potential dilution that could occur if common shares were issued pursuant to the exercise of options or warrants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Company reported a loss for the year ended December&#160;31, 2020, the potentially dilutive effects of approximately 13,000, of the Company's unvested restricted stock awards were not considered for the reporting periods. </span></div>On March 31, 2020, the Company&#8217;s Award Agreements (as defined below) expired and the unvested performance share awards were returned to the Company&#8217;s stock incentive plan - see Note 9 for further discussion.  Based on the guidance provided in accordance with ASC 260, the weighted average common shares for basic earnings per share, for the year ended December 31, 2019 excluded the weighted average impact of the unvested performance share awards. These awards were legally outstanding but not deemed participating securities and therefore were excluded from the calculation of basic earnings per share. The unvested shares were also excluded from the denominator for diluted earnings per share because they were considered contingent shares not deemed probable as of December 31, 2019.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Business segment information</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business segment information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Based on the guidance provided in accordance with ASC 280 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span> (&#8220;ASC 280&#8221;), the Company analyzed its subsidiaries which are all in the business of leasing radiosurgery and radiation therapy equipment to healthcare providers, and concluded there are two reportable segments, domestic and foreign. The Company provides Gamma Knife and PBRT equipment to fifteen hospitals in the United States and owns and operates two single-unit facilities in Lima, Peru and Guayaquil, Ecuador as of December&#160;31, 2020. The Company determined two reportable segments existed due to similarities in economics of business operations and geographic location. The operating results of the two reportable segments are reviewed by the Company&#8217;s CEO and President, Chief Operating and Financial Officer, who are also deemed the Company&#8217;s Chief Operating Decision Makers (&#8220;CODMs&#8221;).  As of December&#160;31, 2019, the Company had one reportable segment.  Following the Company's acquisition of GKCE in June 2020, the Company concluded it had two reportable segments.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long lived asset impairment</a></td>
<td class="text">Long lived asset impairment &#8211; The Company assesses the recoverability of its long-lived assets when events or changes in circumstances indicate their carrying value may not be recoverable. Such events or changes in circumstances may include: a significant adverse change in the extent or manner in which a long-lived asset is being used, significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset, an accumulation of costs significantly in excess of the amount originally expected for the acquisition or development of a long-lived asset, current or future operating or cash flow losses that demonstrate continuing losses associated with the use of a long-lived asset, or a current expectation that, more likely than not, a long-lived asset will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company performs impairment testing at the asset group level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. The Company assesses recoverability of a long-lived asset by determining whether the carrying value of the asset group can be recovered through projected undiscounted cash flows over their remaining lives. If the carrying value of the asset group exceeds the forecasted undiscounted cash flows, an impairment loss is recognized, measured as the amount by which the carrying amount exceeds estimated fair value. An impairment loss is charged to the consolidated statement of operations in the period in which management determines such impairment. As of December&#160;31, 2020, the Company determined circumstances existed indicating its assets could be impaired, concluded an impairment existed, and recognized a loss on the write down of impaired assets of $8,264,000.  No such impairment has been noted as of  December&#160;31, 2019.  See Note 3 - Property and Equipment for further discussion.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and intangible assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and intangible assets - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded goodwill of $1,265,000 and an intangible asset with a fair value of $78,000 as part of the Acquisition in June 2020.  The intangible asset identified was GKCE's trade name and the Company assigned an indefinite useful life to the asset.  Based on the guidance provided in accordance with ASC 350 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other</span> (&#8220;ASC 350&#8221;), the Company does not amortize the intangible asset because it has an indefinite life.  The Company assesses goodwill at the reporting unit level, which has been determined to be GKCE. Each reporting period, the Company assesses whether events or circumstances continue to support an indefinite useful life for the intangible asset.  Per ASC 350, the Company tests goodwill and intangibles for impairment annually or as events or circumstances change that indicate the fair value may be below the carrying amount.  As of December&#160;31, 2020, there has been no change to the Company's assessment of the value of intangible assets or goodwill.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Acquisitions</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company records acquisitions according to ASC 805 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 805&#8221;) using the acquisition method of accounting. Under the acquisition method of accounting, all assets acquired, including goodwill and other intangible assets, should be stated at fair value at the time of acquisition. The allocation of purchase price consideration is preliminary, pending the completion of the fair value of certain tangible, intangible assets, and residual goodwill.  During the measurement period, which can be no more than one year from the Closing Date, the Company expects to continue to obtain information to assist in determining the final fair value of assets acquired.  See Note 4 - GKCE Acquisition for further discussion on acquisitions.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting pronouncement issued and adopted and issued and not yet adopted</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Accounting pronouncement issued and adopted &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2018, the FASB issued ASU No. 2018-03 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Recognition and Measurement of Financial Assets and Financial Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2018-03&#8221;), which clarifies certain aspects of ASU 2016-1. These are: equity securities without a readily determinable fair value &#8211; discontinuation, equity securities without a readily determinable fair value &#8211; adjustments, forward contracts and purchased options, presentation requirements for certain fair value option liabilities, fair value option liabilities denominated in a foreign currency, and transition guidance for equity securities without a readily determinable fair value. In August 2018, the FASB issued ASU No. 2018-13 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Fair Value Measurement (Topic 820): Disclosure Framework &#8211; Changes to the Disclosure Requirements to Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2018-13&#8221;), which amended the effective date and other certain measurement aspects of ASU 2018-03. The new guidance is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The Company adopted ASU 2018-03 and ASU 2018-13 on January 1, 2020. There was no significant impact on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting pronouncement issued and not yet adopted &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2019, the FASB issued ASU 2019-12 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2019-12&#8221;) which removes specific exceptions to the general principles in Topic 740 and eliminates the need for an organization to analyze whether the following apply in a given period: exception to the incremental approach for intraperiod tax allocation; exceptions to accounting for basis differences when there are ownership changes in foreign investments; exception in interim period income tax accounting for year-to-date losses that exceed anticipated losses.  The new guidance is effective for fiscal years and interim periods beginning after December 15, 2020.  The Company is currently evaluating ASU 2019-12 to determine the impact it may have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetRetirementObligationsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetRetirementObligationsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_BusinessAndCreditRiskPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for business and credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_BusinessAndCreditRiskPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NoncontrollingInterestsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NoncontrollingInterestsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301943139624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s assets and liabilities as of December&#160;31, 2020 and 2019 were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:38.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text">The following table illustrates the computations of basic and diluted earnings per share for the years ended December&#160;31, 2020 and 2019.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.440%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.411%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.411%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for basic and diluted (loss) earnings per share</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,058,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic and diluted (loss) earnings per share &#8211; weighted-average shares</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,182,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,919,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities Employee stock options and restricted stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted (loss) earnings per share &#8211; adjusted weighted-average shares</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,182,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,930,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings per common share- basic</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.14)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings per common share- diluted</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.14)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock', window );">Schedule of Domestic and Foreign Break out Percentages</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenues, profit or loss, and net property and equipment allocations for the Company's two reportable segments as of December&#160;31, 2020 consists of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.143%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,204,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,396,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,837,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,605,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit or (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,082,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,058,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.143%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,223,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,593,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,195,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,887,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,418,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,480,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the presentation of foreign and domestic break out on the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301847379688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consists of the following:</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.193%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment and facilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,657,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,132,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits towards purchase of proton beam systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,157,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,941,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,739,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,461,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net property and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,418,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,480,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301942619048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GKCE ACQUISITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of purchase price consideration</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The fair value of assets acquired and liabilities assumed were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 12, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expense and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,374,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(491,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consideration allocated to assets acquired and liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First working capital payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(515,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated subsequent working capital payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(368,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base purchase consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Schedule of tangible assets acquired as part of business combination</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The preliminary value of the acquired tangible assets acquired are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Life (in Years)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Tangible Assets Acquired As Part Of Business Combination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301848907848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG TERM DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are contractual maturities of long-term debt by year at December&#160;31, 2020, excluding debt issuance costs of $27,000:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.331%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.751%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,624,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301848884888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCE LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments for Finance Leases</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments, together with the present value of the net minimum lease payments under finance leases at December&#160;31, 2020, are summarized as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Present Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of Minimum</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Payments</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Year ending December 31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,590,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,771,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,919,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,945,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,974,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301848778712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Maturities of Lessee Operating Lease</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes maturities of lessee operating lease ROU assets and liabilities as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955,000&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886,000&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum payments under non-cancelable operating leases having initial terms of more than one year consisted of the following:</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31, </span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301849779928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision (benefit) for income taxes as of December&#160;31, 2020 and 2019 consist of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YEARS ENDED DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,909,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(251,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,151,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(652,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,737,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the Company&#8217;s deferred tax liabilities and assets as of December&#160;31, 2020 and 2019 are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.193%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(564,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,112,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(564,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,112,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8211; net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryover</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,519,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(678,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets net of valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,514,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Amounts Presented in Financial Statements</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts are presented in the financial statements as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.193%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes (non-current)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,514,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,514,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The (benefit) provision for income taxes differs from the amount computed by applying the U.S. federal statutory tax rate (21% in 2020 and 2019) to income before taxes as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YEARS ENDED DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computed expected federal income tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,844,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to Provision True-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain Tax Positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryforward expiration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred tax adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,737,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text">A reconciliation of the beginning and ending amount of unrecognized tax benefit is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:0 1pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEARS ENDED DECEMBER 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301850481192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION EXPENSE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in restricted stock units, consisting primarily of annual automatic grants, deferred compensation to non-employee directors, and restricted stock units awards to the CEO, under the Incentive Compensation Plans during 2020 and 2019 are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Units</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award</a></td>
<td class="text">As of December&#160;31, 2020, stock compensation expense recorded in the consolidated financial statements is summarized as follows: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.302%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock-Based</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards Issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Award Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">and Vested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs Issued in Lieu of Retainer Fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual RSU Awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Compensation, Stock Options, Activity</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in stock options outstanding under the Incentive Compensation Plans during 2020 and 2019 are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:49.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term (Years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.61</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.48</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of Nonvested Share Activity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of the Company&#8217;s non-vested stock options as of December&#160;31, 2020 and 2019, and changes during the years ended December&#160;31, 2020 and 2019 is presented below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:74.439%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.413%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant-Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s option grants under the Plan in 2020 and 2019 was estimated using the following assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected forfeiture rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301848884888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Leases, Operating [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Operating Leases</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes maturities of lessee operating lease ROU assets and liabilities as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955,000&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886,000&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum payments under non-cancelable operating leases having initial terms of more than one year consisted of the following:</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31, </span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301848778712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentTextBlock', window );">Schedule of Long-term Purchase Commitment</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following commitments for each of the equipment systems, with expected timing of payments as follows as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.078%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.968%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.968%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.968%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.968%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.973%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts committed</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022-2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024-2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After 5&#160;years</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (includes interest)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,251,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,543,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases (includes interest)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,771,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,590,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,659,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Future equipment purchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,210,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,035,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment service contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,493,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,585,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,999,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition working capital payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commitments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,894,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,715,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,747,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,072,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,360,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301854481512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS AND BASIS OF PRESENTATION - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 12, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">GKCE acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionPercentageOfSharesAcquired', window );">Asset acquisition, percentage of shares acquired</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="nump">99.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionPercentageOfSharesRemaining', window );">Asset acquisition, percentage of shares remaining</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionConsiderationTransferred', window );">Base purchase consideration</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_PaymentsForAssetAcquisitions', window );">Payments for asset acquisitions</a></td>
<td class="nump">575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionTransactionCosts', window );">Asset acquisition, transaction costs</a></td>
<td class="nump">$ 1,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ams_Or21LlcMember', window );">OR21 LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ams_ArchitecturalDesignCompanyMember', window );">Architectural Design Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionPercentageOfSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Percentage Of Shares Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionPercentageOfSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionPercentageOfSharesRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Percentage Of Shares Remaining</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionPercentageOfSharesRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_PaymentsForAssetAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Asset Acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_PaymentsForAssetAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ams_Or21LlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ams_Or21LlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ams_ArchitecturalDesignCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ams_ArchitecturalDesignCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301845770552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTING POLICIES - Narrative (Details)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 12, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>segment </div>
<div>unit </div>
<div>customer </div>
<div>site </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 237<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Interest costs capitalized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Original cost of operating lease contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,418<span></span>
</td>
<td class="nump">41,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,739<span></span>
</td>
<td class="nump">55,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Loss on write down of impaired assets and associated removal costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,264)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,837<span></span>
</td>
<td class="nump">$ 20,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_PercentageOfTaxBenefitRealizedUponSettlement', window );">Percentage of tax benefit realized upon settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406<span></span>
</td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">GKCE acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill</a></td>
<td class="nump">$ 1,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">GKCE acquisition | Purchased intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Purchased intangible assets</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,837<span></span>
</td>
<td class="nump">$ 20,605<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=ams_CustomerOneMember', window );">Customer One | Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=ams_CustomerOneMember', window );">Customer One | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=ams_CustomerTwoMember', window );">Customer Two | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=ams_CustomerThreeMember', window );">Customer Three | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=ams_CustomerFourMember', window );">Customer Four | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue recognized, including assessed tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,204<span></span>
</td>
<td class="nump">$ 19,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member', window );">Accounting Standards Update 2014-09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,633<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_ProtonBeamRadiationTherapyPBRTMember', window );">Proton Beam Radiation Therapy (&#8220;PBRT&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_GammaKnifeAndRadiationTherapyMember', window );">Gamma Knife And Radiation Therapy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Original cost of operating lease contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,241<span></span>
</td>
<td class="nump">92,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,416<span></span>
</td>
<td class="nump">$ 55,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_GammaKnifeCenterEcuadorSAGKCEMember', window );">Gamma Knife Center Ecuador S.A. (&#8220;GKCE&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedParties', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_GammaKnifeUnitMember', window );">Gamma Knife Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfImpairedAssetUnits', window );">Number of impaired asset units | unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfCustomersWithIntentToTerminateContract', window );">Number of customers with intent to terminate contract | customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetRetirementObligationNumberOfSites', window );">Number of sites | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_StockOptionExercisePrice', window );">Stock options exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.90<span></span>
</td>
<td class="nump">$ 3.90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Medical and Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_StockOptionExercisePrice', window );">Stock options exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="nump">$ 2.68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Medical and Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetRetirementObligationNumberOfSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Retirement Obligation, Number Of Sites</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetRetirementObligationNumberOfSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfCustomersWithIntentToTerminateContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Customers With Intent To Terminate Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfCustomersWithIntentToTerminateContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfImpairedAssetUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Impaired Asset Units</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfImpairedAssetUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_PercentageOfTaxBenefitRealizedUponSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents the percentage of tax benefit realized upon ultimate settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_PercentageOfTaxBenefitRealizedUponSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_StockOptionExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The range of exercise prices of common stock that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_StockOptionExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amount of receivables arising from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ams_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ams_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ams_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ams_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ams_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ams_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ams_CustomerFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ams_CustomerFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_ProtonBeamRadiationTherapyPBRTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_ProtonBeamRadiationTherapyPBRTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_GammaKnifeAndRadiationTherapyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_GammaKnifeAndRadiationTherapyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_GammaKnifeCenterEcuadorSAGKCEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_GammaKnifeCenterEcuadorSAGKCEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_GammaKnifeUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_GammaKnifeUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301932285816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTING POLICIES - Schedule of Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash, cash equivalents, restricted cash, Carrying Value</a></td>
<td class="nump">$ 3,961<span></span>
</td>
<td class="nump">$ 1,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">43,653<span></span>
</td>
<td class="nump">53,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash</a></td>
<td class="nump">4,325<span></span>
</td>
<td class="nump">1,779<span></span>
</td>
<td class="nump">$ 1,792<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total, Fair Value</a></td>
<td class="nump">4,325<span></span>
</td>
<td class="nump">1,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Debt obligations, Fair Value</a></td>
<td class="nump">4,662<span></span>
</td>
<td class="nump">3,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total, Fair Value</a></td>
<td class="nump">4,662<span></span>
</td>
<td class="nump">3,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ams_CarryingValuesMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash, cash equivalents, restricted cash, Carrying Value</a></td>
<td class="nump">4,325<span></span>
</td>
<td class="nump">1,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">4,325<span></span>
</td>
<td class="nump">1,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt obligations, Carrying Value</a></td>
<td class="nump">4,624<span></span>
</td>
<td class="nump">3,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">4,624<span></span>
</td>
<td class="nump">3,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash</a></td>
<td class="nump">4,325<span></span>
</td>
<td class="nump">1,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total, Fair Value</a></td>
<td class="nump">4,325<span></span>
</td>
<td class="nump">1,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Debt obligations, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Debt obligations, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Debt obligations, Fair Value</a></td>
<td class="nump">4,662<span></span>
</td>
<td class="nump">3,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total, Fair Value</a></td>
<td class="nump">$ 4,662<span></span>
</td>
<td class="nump">$ 3,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ams_CarryingValuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ams_CarryingValuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301846178728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTING POLICIES - Schedule of EPS (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Numerator for basic and diluted (loss) earnings per share</a></td>
<td class="num">$ (7,058)<span></span>
</td>
<td class="nump">$ 659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Denominator for basic and diluted (loss) earnings per share &#8211; weighted-average shares (in shares)</a></td>
<td class="nump">6,182<span></span>
</td>
<td class="nump">5,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities Employee stock options and restricted stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Denominator for diluted (loss) earnings per share &#8211; adjusted weighted-average shares (in shares)</a></td>
<td class="nump">6,182<span></span>
</td>
<td class="nump">5,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">(Loss) earnings per common share - basic (in dollars per share)</a></td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">(Loss) earnings per common share - diluted (in dollars per share)</a></td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301958228136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTING POLICIES - Schedule of Domestic and Foreign Break out Percentages (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 17,837<span></span>
</td>
<td class="nump">$ 20,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(7,058)<span></span>
</td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">30,418<span></span>
</td>
<td class="nump">41,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">17,837<span></span>
</td>
<td class="nump">20,605<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ams_NetIncomeLossMember', window );">Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(7,058)<span></span>
</td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">30,418<span></span>
</td>
<td class="nump">41,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ams_DomesticMember', window );">Domestic | Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">16,204<span></span>
</td>
<td class="nump">19,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ams_DomesticMember', window );">Domestic | Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(7,082)<span></span>
</td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ams_DomesticMember', window );">Domestic | Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">27,223<span></span>
</td>
<td class="nump">38,593<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ams_ForeignMember', window );">Foreign | Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">1,633<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ams_ForeignMember', window );">Foreign | Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">24<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ams_ForeignMember', window );">Foreign | Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">$ 3,195<span></span>
</td>
<td class="nump">$ 2,887<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ams_NetIncomeLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ams_NetIncomeLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ams_DomesticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ams_DomesticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ams_ForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ams_ForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301854934248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Gross property and equipment</a></td>
<td class="nump">$ 76,157<span></span>
</td>
<td class="nump">$ 96,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Accumulated depreciation</a></td>
<td class="num">(45,739)<span></span>
</td>
<td class="num">(55,461)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Net property and equipment</a></td>
<td class="nump">30,418<span></span>
</td>
<td class="nump">41,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_MedicalEquipmentAndFacilitiesMember', window );">Medical equipment and facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Gross property and equipment</a></td>
<td class="nump">75,657<span></span>
</td>
<td class="nump">92,132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Gross property and equipment</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">594<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Gross property and equipment</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">1,965<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember', window );">Deposits towards purchase of proton beam systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Gross property and equipment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_MedicalEquipmentAndFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_MedicalEquipmentAndFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301854578888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>unit </div>
<div>deposit</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">$ 30,418<span></span>
</td>
<td class="nump">$ 41,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Loss on write down of impaired assets and associated removal costs</a></td>
<td class="num">(8,264)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">$ 3,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_GammaKnifeUnitMember', window );">Gamma Knife Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfImpairedAssetUnits', window );">Number of impaired asset units | unit</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of long-lived assets to be disposed of</a></td>
<td class="nump">$ 3,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetRetirementObligationNumberOfRemovedAssetUnits', window );">Number of removed asset units | unit</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligation', window );">Asset retirement obligation liability</a></td>
<td class="nump">$ 1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties', window );">Increase (decrease) in accounts payable</a></td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Tangible asset impairment charges</a></td>
<td class="nump">4,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_ProtonBeamRadiationTherapyPBRTMember', window );">Proton Beam Radiation Therapy (&#8220;PBRT&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Tangible asset impairment charges</a></td>
<td class="nump">$ 3,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember', window );">Deposits towards purchase of proton beam systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfDeposits', window );">Number of deposits | deposit</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember', window );">Two MEVION S250i Proton Beam Radiation Therapy Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedCapitalizedInterestCosts', window );">Accumulated capitalized interest costs</a></td>
<td class="nump">$ 1,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LongTermPurchaseCommitmentDepositsForAssets', window );">Long term purchase commitment deposits for assets</a></td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_UnitsRemovedFromServiceInPriorYearsMember', window );">Units removed from service in prior years | Gamma Knife Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfImpairedAssetUnits', window );">Number of impaired asset units | unit</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_UnitsRemovedFromServiceInCurrentYearMember', window );">Units removed from service in current year | Gamma Knife Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfImpairedAssetUnits', window );">Number of impaired asset units | unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember', window );">Units that will be removed from service in future years | Gamma Knife Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfImpairedAssetUnits', window );">Number of impaired asset units | unit</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetRetirementObligationNumberOfRemovedAssetUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Retirement Obligation, Number Of Removed Asset Units</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetRetirementObligationNumberOfRemovedAssetUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LongTermPurchaseCommitmentDepositsForAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term Purchase commitment deposits for the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LongTermPurchaseCommitmentDepositsForAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Deposits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfImpairedAssetUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Impaired Asset Units</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfImpairedAssetUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedCapitalizedInterestCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated interest costs capitalized as part of property, plant and equipment cost basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedCapitalizedInterestCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_GammaKnifeUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_GammaKnifeUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_ProtonBeamRadiationTherapyPBRTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_ProtonBeamRadiationTherapyPBRTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_UnitsRemovedFromServiceInPriorYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_UnitsRemovedFromServiceInPriorYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_UnitsRemovedFromServiceInCurrentYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_UnitsRemovedFromServiceInCurrentYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301940800920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GKCE ACQUISITION - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 12, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_PaymentsForWorkingCapital', window );">First working capital payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_PaymentsToAcquireAsset', window );">Payments to acquire asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition', window );">Estimated subsequent working capital payment for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">GKCE acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionPercentageOfSharesAcquired', window );">Asset acquisition, percentage of shares acquired</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionPercentageOfSharesRemaining', window );">Asset acquisition, percentage of shares remaining</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Fair value of noncontrolling interest</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionPercentageOfOutstandingShares', window );">Percentage of outstanding shares</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionTotalConsiderationTransferred', window );">Consideration allocated to assets acquired and liabilities assumed</a></td>
<td class="nump">$ 2,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionConsiderationTransferred', window );">Base purchase consideration</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_PaymentsForAssetAcquisitions', window );">Payments for asset acquisitions</a></td>
<td class="nump">575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionTransactionCosts', window );">Asset acquisition, transaction costs</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_PaymentsForWorkingCapital', window );">First working capital payment</a></td>
<td class="nump">515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAdditionalConsiderationTransferred', window );">Additional consideration transferred</a></td>
<td class="nump">368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionLiabilitiesAssumed', window );">Liabilities assumed</a></td>
<td class="nump">491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration', window );">Increase in amount of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">GKCE acquisition | Purchased intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Purchased intangible assets</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionAdditionalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Additional Consideration Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionAdditionalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Liabilities Assumed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionPercentageOfOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Percentage Of Outstanding Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionPercentageOfOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionPercentageOfSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Percentage Of Shares Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionPercentageOfSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionPercentageOfSharesRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Percentage Of Shares Remaining</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionPercentageOfSharesRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Total Consideration Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_PaymentsForAssetAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Asset Acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_PaymentsForAssetAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_PaymentsForWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Working Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_PaymentsForWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_PaymentsToAcquireAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_PaymentsToAcquireAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Subsequent Working Capital Payment Accrued For Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301940681256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GKCE ACQUISITION - Schedule of Purchase Price Consideration (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 12, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_PaymentsForWorkingCapital', window );">First working capital payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (43)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">GKCE acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">854<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionPrepaidExpenseAndOther', window );">Prepaid expense and other</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment, additions</a></td>
<td class="nump">723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill</a></td>
<td class="nump">1,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAssetsAcquired', window );">Total assets acquired</a></td>
<td class="nump">3,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(193)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="num">(141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(66)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionEmployeeCompensationAndBenefits', window );">Employee compensation and benefits</a></td>
<td class="num">(91)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionLiabilitiesAssumed', window );">Total liabilities assumed</a></td>
<td class="num">(491)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionTotalConsiderationTransferred', window );">Consideration allocated to assets acquired and liabilities assumed</a></td>
<td class="nump">2,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_PaymentsForWorkingCapital', window );">First working capital payment</a></td>
<td class="num">(515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAdditionalConsiderationTransferred', window );">Estimated subsequent working capital payment</a></td>
<td class="num">(368)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionConsiderationTransferred', window );">Base purchase consideration</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">GKCE acquisition | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment, additions</a></td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">GKCE acquisition | Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment, additions</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">GKCE acquisition | Medical equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment, additions</a></td>
<td class="nump">319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">GKCE acquisition | Purchased intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Purchased intangible assets</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Accounts Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionAdditionalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Additional Consideration Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionAdditionalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Cash And Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Deferred Income Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionEmployeeCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Employee Compensation And Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionEmployeeCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Income Taxes Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Liabilities Assumed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionPrepaidExpenseAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Prepaid Expense And Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionPrepaidExpenseAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Total Consideration Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_PaymentsForWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Working Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_PaymentsForWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_MedicalEquipmentAndOtherFixedAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_MedicalEquipmentAndOtherFixedAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301849786744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GKCE ACQUISITION - Schedule of Tangible Assets Acquired as Part of Business Combination (Details) - GKCE acquisition<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 12, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment, additions</a></td>
<td class="nump">$ 723<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment, additions</a></td>
<td class="nump">$ 385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property equipment, useful life</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment, additions</a></td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">Medical equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment, additions</a></td>
<td class="nump">$ 302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property equipment, useful life</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember', window );">Other fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment, additions</a></td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property equipment, useful life</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_AssetAcquisitionAxis=ams_GKCEAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_OtherFixedAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_OtherFixedAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301854642504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG TERM DEBT - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>note</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>note</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfDebtInstruments', window );">Number of notes | note</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_GammaKnifeUnitMember', window );">Gamma Knife Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCollateralAmount', window );">Aggregate net book value</a></td>
<td class="nump">11,023<span></span>
</td>
<td class="nump">$ 13,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedParties', window );">Accounts receivable</a></td>
<td class="nump">$ 1,718<span></span>
</td>
<td class="nump">$ 1,848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LongTermDebtMonthlyInstallments', window );">Monthly installments</a></td>
<td class="text">36 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingVariableInterestRate', window );">Long-term debt percentage rate</a></td>
<td class="nump">3.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LongTermDebtMonthlyInstallments', window );">Monthly installments</a></td>
<td class="text">84 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingVariableInterestRate', window );">Long-term debt percentage rate</a></td>
<td class="nump">6.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LongTermDebtMonthlyInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long Term Debt, Monthly Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LongTermDebtMonthlyInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfDebtInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Debt Instruments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfDebtInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amount of receivables arising from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCollateralAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets pledged to secure a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCollateralAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_GammaKnifeUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ams_GammaKnifeUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301931935736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG TERM DEBT (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Principal</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 1,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 4,624<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301942898920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCE LEASES - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfFinancingLeases', window );">Number of financing leases | lease</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_FinanceLeaseObligations', window );">Net book value of finance lease obligations</a></td>
<td class="nump">$ 18,093<span></span>
</td>
<td class="nump">$ 22,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_FinanceLeaseAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">$ 1,892<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_FinanceLeaseObligationInterestRate', window );">Finance lease obligation interest rate</a></td>
<td class="nump">4.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_FinanceLeaseObligationsMonthlyInstallments', window );">Monthly installments</a></td>
<td class="text">36 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_FinanceLeaseObligationInterestRate', window );">Finance lease obligation interest rate</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_FinanceLeaseObligationsMonthlyInstallments', window );">Monthly installments</a></td>
<td class="text">84 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_FinanceLeaseAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_FinanceLeaseAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_FinanceLeaseObligationInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate of capital lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_FinanceLeaseObligationInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_FinanceLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_FinanceLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_FinanceLeaseObligationsMonthlyInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Obligations, Monthly Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_FinanceLeaseObligationsMonthlyInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfFinancingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Financing Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfFinancingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301942911144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCE LEASES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 6,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">1,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">1,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total finance lease payments</a></td>
<td class="nump">9,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="nump">852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Gross minimum lease payments</a></td>
<td class="nump">8,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less current portion</a></td>
<td class="nump">5,945<span></span>
</td>
<td class="nump">$ 3,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Noncurrent portion finance lease liability</a></td>
<td class="nump">$ 2,974<span></span>
</td>
<td class="nump">$ 8,177<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301849404664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use asset</a></td>
<td class="nump">$ 886<span></span>
</td>
<td class="nump">$ 1,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liability</a></td>
<td class="nump">886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities', window );">Lease reassessment right of use assets and lease liabilities</a></td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NonCashRightOfUseAssetsAndLeaseLiabilities', window );">Right of use assets and lease liabilities</a></td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">$ 1,362<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Lessee, discount rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Operating&#8203; lease &#8203;remaining &#8203;lease &#8203;term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Lessee, discount rate</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Operating&#8203; lease &#8203;remaining &#8203;lease &#8203;term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Reassessment, Right-Of-Use Assets And Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NonCashRightOfUseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of Right of use assets and lease liabilities that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NonCashRightOfUseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301940694920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Summary of Maturities of Lessee Operating Lease (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 886<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301854578328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="num">$ (1,737)<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory income tax rate, percent</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State and local operating loss carryforwards</a></td>
<td class="nump">$ 2,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Decrease in net valuation allowance</a></td>
<td class="num">(243)<span></span>
</td>
<td class="num">$ (175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Amount accrued for income tax penalties and interest accrued</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ams_PeruDeferredTaxAssetsMember', window );">Peru</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">International operating loss carryforwards</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Domestic operating loss carryforwards</a></td>
<td class="nump">2,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State and local operating loss carryforwards</a></td>
<td class="nump">$ 129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ams_PeruDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ams_PeruDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301847189912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">$ 443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">414<span></span>
</td>
<td class="nump">780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(1,909)<span></span>
</td>
<td class="num">(311)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(266)<span></span>
</td>
<td class="num">(251)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">24<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Total deferred</a></td>
<td class="num">(2,151)<span></span>
</td>
<td class="num">(652)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">$ (1,737)<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301940703208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">$ (564)<span></span>
</td>
<td class="num">$ (3,112)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(564)<span></span>
</td>
<td class="num">(3,112)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances', window );">Accruals and allowances</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other &#8211; net</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Capital loss carryover</a></td>
<td class="nump">627<span></span>
</td>
<td class="nump">921<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">824<span></span>
</td>
<td class="nump">1,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(678)<span></span>
</td>
<td class="num">(921)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets net of valuation allowance</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (418)<span></span>
</td>
<td class="num">$ (2,514)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301931934232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Amounts Presented in Financial Statements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes (non-current)</a></td>
<td class="num">$ (418)<span></span>
</td>
<td class="num">$ (2,514)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (418)<span></span>
</td>
<td class="num">$ (2,514)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301851327816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Computed expected federal income tax</a></td>
<td class="num">$ (1,844)<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="num">(199)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible expenses</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount', window );">Return to Provision True-up</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount', window );">Uncertain Tax Positions</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount', window );">Capital loss carryforward expiration</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(243)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherTaxExpenseBenefit', window );">Other deferred tax adjustments</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">$ (1,737)<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Capital Loss Carryforward Expiration, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Return To Provision True-Up, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301943152088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Unrecognized Tax Benefits Roll Forward (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of year</a></td>
<td class="nump">$ 259<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions based on tax positions of prior years</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of year</a></td>
<td class="nump">$ 275<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301840724648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION EXPENSE - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 03, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 04, 2017 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>employee </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2010 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2001 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">417,000<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">613,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grant date weighted-average fair value, granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.78<span></span>
</td>
<td class="nump">$ 1.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost related to non-vested shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Number of shares authorized to be repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Remaining number of shares authorized to be repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,000<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Options granted in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,000<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grant date weighted-average fair value, granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.96<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 141,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ams_IncentiveCompensationPlanMember', window );">Incentive Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant', window );">Remaining shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">456,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ams_IncentiveCompensationPlanMember', window );">Incentive Compensation Plan | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber', window );">Shares vested and outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Employee benefits and share-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_OffsettingTaxBenefit', window );">Offsetting tax benefit | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of options vested in period | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ams_IncentiveCompensationPlanMember', window );">Incentive Compensation Plan | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued for services (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfEmployees', window );">Number of employees | employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ams_IncentiveCompensationPlanMember', window );">Incentive Compensation Plan | Non Employee Directors and Corporate Secretary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ams_ExecutiveEquityAwardsMember', window );">Executive Equity Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ams_ExecutiveEquityAwardsMember', window );">Executive Equity Awards | Chief Executive Officer | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Options granted in period (in shares)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ams_ExecutiveEquityAwardsMember', window );">Executive Equity Awards | Chief Executive Officer | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued for services (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ams_ExecutiveEquityAwardsMember', window );">Executive Equity Awards | Senior Vice President | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued for services (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ams_PerformanceShareAwardAgreementMember', window );">Performance Share Award Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 421,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ams_PerformanceShareAwardAgreementMember', window );">Performance Share Award Agreement | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Options granted in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Amount of nonvested options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ams_RetainerFeesMember', window );">Retainer Fees | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Employee benefits and share-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ams_RetainerFeesMember', window );">Retainer Fees | Incentive Compensation Plan | Non Employee Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Employees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_OffsettingTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of offsetting tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_OffsettingTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares available for grant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for employee benefit and equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeBenefitsAndShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ams_IncentiveCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ams_IncentiveCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ams_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ams_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_NonEmployeeDirectorsAndCorporateSecretaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_NonEmployeeDirectorsAndCorporateSecretaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ams_ExecutiveEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ams_ExecutiveEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ams_SeniorVicePresidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ams_SeniorVicePresidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ams_PerformanceShareAwardAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ams_PerformanceShareAwardAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ams_RetainerFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ams_RetainerFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_NonEmployeeDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_NonEmployeeDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301854672904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION EXPENSE - Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Restricted Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(103,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Grant Date Weighted- Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grant Date Weighted-Average Fair Value, Granted (in dollars per share)</a></td>
<td class="nump">$ 0.78<span></span>
</td>
<td class="nump">$ 1.54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Restricted Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding beginning balance (in shares)</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">144,000<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(134,000)<span></span>
</td>
<td class="num">(37,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding ending balance (in shares)</a></td>
<td class="nump">13,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Grant Date Weighted- Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Grant Date Weighted-Average Fair Value, Outstanding (in dollars per share)</a></td>
<td class="nump">$ 3.03<span></span>
</td>
<td class="nump">$ 2.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grant Date Weighted-Average Fair Value, Granted (in dollars per share)</a></td>
<td class="nump">1.96<span></span>
</td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Grant Date Weighted-Average Fair Value, Vested (in dollars per share)</a></td>
<td class="nump">1.98<span></span>
</td>
<td class="nump">2.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Grant Date Weighted-Average Fair Value, Outstanding (in dollars per share)</a></td>
<td class="nump">1.97<span></span>
</td>
<td class="nump">3.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract', window );"><strong>Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue', window );">Intrinsic Value, Outstanding (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue', window );">Intrinsic Value, Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue', window );">Intrinsic Value, Vested (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue', window );">Intrinsic Value, Outstanding (in dollars per share)</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average intrinsic value of award granted under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average intrinsic value of award vested under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301854669640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION EXPENSE - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested in period (in shares)</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested in period (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ams_RSUsIssuedInLieuOfRetainerFeesMember', window );">RSUs Issued in Lieu of Retainer Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested in period (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ams_AnnualRSUAwardsMember', window );">Annual RSU Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested in period (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ams_ExecutiveCompensationMember', window );">Executive Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested in period (in shares)</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ams_RSUsIssuedInLieuOfRetainerFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ams_RSUsIssuedInLieuOfRetainerFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ams_AnnualRSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ams_AnnualRSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ams_ExecutiveCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ams_ExecutiveCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301854524056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION EXPENSE - Share-based Compensation, Stock Options, Activity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding beginning balance (in shares)</a></td>
<td class="nump">417,000<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">613,000<span></span>
</td>
<td class="nump">417,000<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">613,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(16,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(43,000)<span></span>
</td>
<td class="num">(165,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding ending balance (in shares)</a></td>
<td class="nump">417,000<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">613,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405,000<span></span>
</td>
<td class="nump">425,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 2.78<span></span>
</td>
<td class="nump">$ 2.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted (in dollars per share)</a></td>
<td class="nump">1.88<span></span>
</td>
<td class="nump">2.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited (in dollars per share)</a></td>
<td class="nump">2.54<span></span>
</td>
<td class="nump">3.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Ending balance (in dollars per share)</a></td>
<td class="nump">$ 2.79<span></span>
</td>
<td class="nump">$ 2.78<span></span>
</td>
<td class="nump">$ 2.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.80<span></span>
</td>
<td class="nump">$ 2.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Term (Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (Years)</a></td>
<td class="text">1 year 7 months 9 days<span></span>
</td>
<td class="text">2 years 5 months 8 days<span></span>
</td>
<td class="text">3 years 1 month 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Term (Years) Granted</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term (Years), Exercisable</a></td>
<td class="text">1 year 5 months 23 days<span></span>
</td>
<td class="text">2 years 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 27,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301849955880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION EXPENSE - Schedule of Nonvested Share Activity (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Outstanding beginning balance (in shares)</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Vested (in shares)</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(118)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Outstanding ending balance (in shares)</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted Average Grant-Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Grant Date Weighted-Average Fair Value, Outstanding (in dollars per share)</a></td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grant Date Weighted-Average Fair Value, Granted (in dollars per share)</a></td>
<td class="nump">0.78<span></span>
</td>
<td class="nump">1.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Nonvested, Vested (in dollars per share)</a></td>
<td class="nump">1.22<span></span>
</td>
<td class="nump">1.22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Grant Date Weighted-Average Fair Value, Outstanding (in dollars per share)</a></td>
<td class="nump">$ 1.07<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301847209672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION EXPENSE - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate', window );">Expected forfeiture rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to forfeiture during a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301849653432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLAN (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employer matching contribution, percent of employee gross pay</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Cost of contribution</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301931951832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING LEASES (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Leases, Operating [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo', window );">2022</a></td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree', window );">2023</a></td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour', window );">2024</a></td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue', window );">Total Future Minimum Payments Due</a></td>
<td class="nump">$ 972<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301850089096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASES - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 13, 2016</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Leases, Operating [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LeaseExpirationPeriod', window );">Lease expiration period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of facility | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_OperatingLeaseMonthlyLeaseExpense', window );">Monthly lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 404,000<span></span>
</td>
<td class="nump">$ 380,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LeaseExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period on which lease or group of leases is set to expire.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LeaseExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_OperatingLeaseMonthlyLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Monthly Lease Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_OperatingLeaseMonthlyLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301965377640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 05, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>reload </div>
<div>install </div>
<div>purchase</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfCobalt60Reloads', window );">Number of Cobalt-60 reloads | reload</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfLeksellGammaKnifeIconSystemInstalls', window );">Number of Leksell Gamma Knife Icon System installs | install</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfPurchaseCommitments', window );">Number of purchase commitments | purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ams_GammaKnifePerfexionSystemMember', window );">Gamma Knife Perfexion System</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Long-term purchase commitment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ams_LINACSystemMember', window );">LINAC system</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Long-term purchase commitment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LongTermServiceCommitmentAmount', window );">Service commitment, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ams_LINACSystemMember', window );">LINAC system | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LongTermServiceCommitmentPeriod', window );">Service commitment, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ams_LINACSystemMember', window );">LINAC system | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LongTermServiceCommitmentPeriod', window );">Service commitment, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_MevionMedicalSystemsIncMember', window );">Mevion Medical Systems Inc | Maintenance and Support Agreement (the &#8220;Mevion Service Agreement&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_LongTermPurchaseCommitmentRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_PurchaseAgreementAnnualPrepayment', window );">Purchase agreement annual prepayment</a></td>
<td class="nump">$ 1,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermPurchaseCommitmentPeriod', window );">Commitment period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LongTermPurchaseCommitmentRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Purchase Commitment, Renewal Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LongTermPurchaseCommitmentRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LongTermServiceCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Service Commitment, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LongTermServiceCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_LongTermServiceCommitmentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Service Commitment, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_LongTermServiceCommitmentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfCobalt60Reloads">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Cobalt-60 Reloads</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfCobalt60Reloads</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfLeksellGammaKnifeIconSystemInstalls">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Leksell Gamma Knife Icon System Installs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfLeksellGammaKnifeIconSystemInstalls</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfPurchaseCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Purchase Commitments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfPurchaseCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_PurchaseAgreementAnnualPrepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents the amount of purchase agreement annual prepayment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_PurchaseAgreementAnnualPrepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermPurchaseCommitmentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermPurchaseCommitmentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ams_GammaKnifePerfexionSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ams_GammaKnifePerfexionSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ams_LINACSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ams_LINACSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_MevionMedicalSystemsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ams_MevionMedicalSystemsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301940750584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Schedule of Long-term Purchase Commitment (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Total amounts committed</a></td>
<td class="nump">$ 72,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInNextTwelveMonths', window );">2021</a></td>
<td class="nump">12,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInSecondAndThirdYear', window );">2022-2023</a></td>
<td class="nump">51,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInFourthAndFifthYear', window );">2024-2025</a></td>
<td class="nump">5,072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueAfterFifthYear', window );">After 5&#160;years</a></td>
<td class="nump">3,360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=us-gaap_LongTermDebtMember', window );">Long-term debt (includes interest)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Total amounts committed</a></td>
<td class="nump">5,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInNextTwelveMonths', window );">2021</a></td>
<td class="nump">1,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInSecondAndThirdYear', window );">2022-2023</a></td>
<td class="nump">1,854<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInFourthAndFifthYear', window );">2024-2025</a></td>
<td class="nump">1,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueAfterFifthYear', window );">After 5&#160;years</a></td>
<td class="nump">481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=ams_FinanceLeasesMember', window );">Finance leases (includes interest)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Total amounts committed</a></td>
<td class="nump">9,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInNextTwelveMonths', window );">2021</a></td>
<td class="nump">6,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInSecondAndThirdYear', window );">2022-2023</a></td>
<td class="nump">2,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInFourthAndFifthYear', window );">2024-2025</a></td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueAfterFifthYear', window );">After 5&#160;years</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=us-gaap_EquipmentMember', window );">Future equipment purchases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Total amounts committed</a></td>
<td class="nump">46,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInNextTwelveMonths', window );">2021</a></td>
<td class="nump">2,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInSecondAndThirdYear', window );">2022-2023</a></td>
<td class="nump">44,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInFourthAndFifthYear', window );">2024-2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueAfterFifthYear', window );">After 5&#160;years</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=ams_EquipmentServiceContractsMember', window );">Equipment service contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Total amounts committed</a></td>
<td class="nump">10,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInNextTwelveMonths', window );">2021</a></td>
<td class="nump">2,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInSecondAndThirdYear', window );">2022-2023</a></td>
<td class="nump">2,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInFourthAndFifthYear', window );">2024-2025</a></td>
<td class="nump">2,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueAfterFifthYear', window );">After 5&#160;years</a></td>
<td class="nump">2,879<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=ams_AcquisitionWorkingCapitalPaymentsMember', window );">Acquisition working capital payments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Total amounts committed</a></td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInNextTwelveMonths', window );">2021</a></td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInSecondAndThirdYear', window );">2022-2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInFourthAndFifthYear', window );">2024-2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueAfterFifthYear', window );">After 5&#160;years</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=ams_OperatingLeasesMember', window );">Operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Total amounts committed</a></td>
<td class="nump">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInNextTwelveMonths', window );">2021</a></td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInSecondAndThirdYear', window );">2022-2023</a></td>
<td class="nump">614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInFourthAndFifthYear', window );">2024-2025</a></td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueAfterFifthYear', window );">After 5&#160;years</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInFourthAndFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in fourth and fifth fiscal years following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInFourthAndFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInSecondAndThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in second and third fiscal years following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInSecondAndThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=ams_FinanceLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=ams_FinanceLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=ams_EquipmentServiceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=ams_EquipmentServiceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=ams_AcquisitionWorkingCapitalPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=ams_AcquisitionWorkingCapitalPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=ams_OperatingLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=ams_OperatingLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140301850087144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Textual)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>reload </div>
<div>upgrade </div>
<div>install</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfCobalt60Reloads', window );">Number of Cobalt-60 reloads | reload</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfPerfexionUpgrades', window );">Number of Perfexion upgrades | upgrade</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ams_NumberOfLeksellGammaKnifeIconSystemInstalls', window );">Number of Leksell Gamma Knife Icon System installs | install</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=ams_GkfSubsidiaryMember', window );">GKF Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling Interest, Ownership Percentage by Parent</a></td>
<td class="nump">81.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=ams_UsSubsidiaryOfElektaMember', window );">U.S. Subsidiary Of Elekta</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling Interest, Ownership Percentage by Parent</a></td>
<td class="nump">19.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfCobalt60Reloads">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Cobalt-60 Reloads</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfCobalt60Reloads</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfLeksellGammaKnifeIconSystemInstalls">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Leksell Gamma Knife Icon System Installs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfLeksellGammaKnifeIconSystemInstalls</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ams_NumberOfPerfexionUpgrades">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Perfexion Upgrades</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ams_NumberOfPerfexionUpgrades</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ams_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=ams_GkfSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=ams_GkfSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=ams_UsSubsidiaryOfElektaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=ams_UsSubsidiaryOfElektaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>80
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M\?^3U?K=7K]%XL)8E6^"@4&>RO5?_KP9B+V *#@0P#8![$T [1X("#<!8=.
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M7H#G<Z7L]L8UL/M>=/$_4$L#!!0    ( +6%AE(=%00.<P<  )4=   8
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M[\\'__Y.YJ1JV4-*1^JN,TSL=I2J5B8VW9Y@8J.%A*'5*K$P!;.^ 3R[CB3
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M>^ZF.!F%R<3;'>=N6@5^[$>-U0>LJ,&*G"G.N%02\27LW(K/E6K<Q(R=J3[
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MW>^T\E*9EUC0(<O^3!?E^J;1;X %7<;;K'QDN^]TKU!'[9>P3.B_8+>7;3=
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MBU(?DT>@\*?L6\6-"P0R&8W'.W6?6[?2E7'9TW6#Z&6'$P,%G6*RDL8Z5D(
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M115_W4-&^,O,\.)TZ2\0E]HA2OXQ\PQ#$_!]I<'R]0MM$&^4C_X+4$L#!!0
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M>1O5>?-E4!+ME T9)")ID<"\*=JCW3I/00*^I@:-G\G$3<'3'4I(D8-K@\>
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MU"16^55A=BM4DQIZ?R,O.4LFD*<GMBF7M-@O4:>@-5>8.@23UR32E5MFMNL
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M!'UJ$N?T4>/-Z_>\(;:8%TMMSM?N\&M?UY-*'>9V*Q^N"% 8G*$W''"9RC"
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M_Q$G_M!66_K#28NJ;:L-_7,-7L?4^ !\OZP 6<D'G,#]):T?_P]02P,$%
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MF\]KZ3]XW^'+1%JZU/FO*G/ST\Y11V0TE77N[O7R)VK\&;*\5.?6_Q7+0#N
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MR'<64F"<\7/T*58O=QNH&87O+*U)AGVI3?FZ*K2A?9"C(JFHM)%& 0#KOG6
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M#H<=8<(=-!R<KOR];Z(=X.4?YU@=R# !OD^U=NL#*VC_$7#V-U!+ P04
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MC3YG^,FB +$IQ /&NMA'42$,UX5QZ&=(:Q7#T<9 TD3.Y]8\:N H!=:<G?Z
M2^-(#]XI!' Q1*'*41H%R^%W5+\K+NDW9)PJQP"(F'4O6^BL.WSQ4A0&]$"5
MNR8J<:Y56#YP3J][\H.0'A!02 1H#O^S^R=26[&01:WBBI6I7J/;K6% DGL!
M;RXA^>/U70*RX9 VO2J6B+6629VCTX->#\Q?SG0VHP&PA-, -4BFI?8SDC*/
MB08X!40&N*A'E=4>W 3K"AE3T+'^[)\TD:3FZQRPHM_K)6<^XT94J3,X.#T=
MLJ*ZRHJ:!L);? /_</"8U&OI>0"E=_P5RB'Z/U/6@].#!3+_"K6&U"5ELMI:
MM%@ZI^ 5QJ[0<JP+[;7B9R\?R2&8^; \6[EC552FH1KJ/Y<Z9V=VCDZ.HL:9
M=#.2+$6G?S :\(?"R(I9"!WS -D)#K[W$"XG[IH)!2!>0(\Q)]I[!S0/' $(
MMG,3G!Q1<?/N.J*"E887O S05JXJ4V*-8$9ZZ-YW10X D]9%4""Y%<YPVI.?
MLA7J'_B&96Z[=:F+0HP5&S]>M1(L &ANG'^=!80"26F3KS'7E&5501IZUD*6
M2%2H [9 .#F3<XUX\S-()L+-3.9(K0%@S30(^:6M\UMJ$Q@VA>X6LS.;^D>;
MZ?2$^9?U%)8D[GDA*9DE.@!>-$"(H%0;[M&XYBH40U ?AVVH.:)<:M,\$ E]
M1["#0W(=4,9$/T5Q[1P&C3?$#H]/&?(A\D!SVC?"AI54<5.91WZ"?BXVK""P
MY5^943U"\S(%Y7%<8+X5B'/ 9J4( -'T#* $;_/:DEN0@&9 2*]+;-6 "/0C
M_^14AE*]"-\"[L#L"1+P-EB>#$YGT!_%7%Z7Q&U/.<+B6*F*P8 :=/I'/!>B
M%3U/?HH)$^OL#E6?U+093JL6T-"#3,"#A[XE0S(&=0@6L)OAQ$(Z71BB2NX:
M4C"@$,EU,X2:Y0I6!:I0!!",/"0/QBGJ_U=^P#JW6VFJC8X0![YR[*L0?L6^
MP"?+D#?B\OY:G/:.1.UBL)L22N5GX"7$)XL@MGZ ILN^:"SXHBA2)0BM0+/P
M3(W)">/H,P,B+=9B64TU0I0G N1FIBXP[M"W473!_$91#\X URE>/BD5?%(4
M)DN9ME%BVG[%C(<\T,CC=G4 ,.%*RL$HYX6*8OQ68Q'+8E3_8)<I:"?49)W7
M@*)H?5?<K).M5!)Z46[!&:61 S- RQB;%U$::G_@V0"(5DK:=9UK8F*C\7^<
M R2IA8H])_6T8U);5[Q/1_NPR7+8NB"_1K1&!2<:R:QM^T:(@]_;+Z&KM\AD
MB#YX2MR%0D)V0QQ@HYVS,>MD;L8:9#K'I8P*OG-U.>?9-0ILUP=4I';L!DBS
MA79,Q0TG$R<U5LBU@\TSB<)S!P$M5*OY :]/G^.R-?H3\WP'%R-6E]1_!%:O
MJT E"/OGIQ*TF,,;'=<!U<[*^ C@Q!2;>KK8#JP[CC@%AJ!BJ2"\F$HQA0+]
M HA2]7]JT[E12-> )=#I_W+3GQ"#_80S_'=N:3<G*?/&M<<\X9W "Q*E*_Z8
MZ4*UT@7"KZ$O=+03:];T#=0A&Q:KZ)H&FB7!73I '"F5Z\E$46_\M+2,F X8
MHBXX^=*<IF#(S6FU[@8TD-2"*66+:ZE(TT8)15('DUJ^-?]<IN!=-B@]WZ(0
M!AY"<=W6-(G#JJFTB3$CFE+.8YNW \/<%;;VLU$E+KY18',IIBTTL14T8[[A
M0JW&JS,XB=W%T\MOI3+EN R..]B56LQH4,TPRLP]G3XUA,GM3U;PC5FCU$9:
M%1)6:#")22>524A4[-8 N>YIM3^*3U]NQ4B\%ELG0_O7GSY^N?OX<'OS:L?6
M>).PM_9N"-1(Y-(%4G!O-HXBKN-NC+9E"H3!"L2T'3$:TGX.8+8=A]/0R'VV
MBAHW3/\*22GU!@.>?%5K[MF'I[S3^Q6'],_H]P>54XN&Z_*.;AB^1+K)MPNS
M..%^^WUT=/]@<,RROQB_G5=@R?!@>#)JVP*;!3*D(_;[9X2#5[#1! Y587<1
M!^SW1WW^?*,@O?DTKC%N__B8/]\"_9J58B(&9P36J[ X56J"S+1_%D2QHKOB
MM3^*8Z[;720W1DPD+PU^1Z0C!-@KX\YO<Y,7]TS@AK"+ T-2,8=:ZB V="CR
MQ,3]L/UY):Y:AP+M#$)%XM% LVI@V]NP;/O,)9Z'!/;<ZM%:Q3.</;7&-.BU
MN0.#5-K5L^#)9H05(!OXA'*!CWTR/-T+1?'9SM0L D%OGV;!(""9B29HK37=
MH7B*8KO.IDK7/A&8KK6.M2,5SV;G3TTSF&TU;%VE]U9#^65E3*CA&/=5I>P4
MD41"D*%!I1*&,=:\)3HG4 #+9VR!JF9\8FOF<V,]'K&2""#"J37+L O55646
M<MWQ?X?FV!CA>124IQKZ!U GGL*D;4#;VRE!MER;,F>#'=]AQ'XG&0].3>I"
M_(K'Q?M0WO\%'8E[M2:T3J*TP5^R6H_)<" ^$3=.]"-56-*E?Q*^,2ELJMH1
M)X/A5N+0T52R8AL[=)XD-P#88>9DIVTE2H0FQA5<@FGWH\-0Y["/D:5*=3+I
M$%L;/%.#S@KZ/@WM9\U^*]!O\>0*%VCC&#BT)C*E(XRMHZY&X+=/7)BOUX<%
MZR./V. JNFN@4C?LA5)'!Q#'9R^;>J_F/M3J7FHQ<._;4*QU",.%-I1!ZIZ2
MA;CP3"X4;_!3@P60BI<LU%GFN&_#NRJ\P$P%-9P9!K?]R ?5IM Y$S3NL0EB
MX*5TV>)>VE?LNA([;-PREL "=)?J^)*$+QS3VW1=>\FWE.OA?-?[00*)0 ]<
MJ E,[75/CO:$Y?M3?O!F3G>68^.]*>GG3 '>+ Z [Q-C?'S !=(E]L7_ %!+
M P04    " "UA892][TH6K8#  !/"   &0   'AL+W=O<FMS:&5E=',O<VAE
M970Q,2YX;6R]5MMNXS80_96!D'USK9MC.X%M($[2;;>;-DC2%D71!UH:6<12
MI):D?-FO[PQEN\EBDX>BZ(O%R\SA.7,A/=L:^\G5B!YVC=)N'M7>MY=Q[(H:
M&^&&ID5-.Y6QC? TM>O8M19%&9P:%6=),HX;(76TF(6U>[N8F<XKJ?'>@NN:
M1MC]$I79SJ,T.BX\R'7M>2%>S%JQQD?TO[;WEF;Q":64#6HGC0:+U3RZ2B^7
M([8/!K])W+IG8V E*V,^\>3'<AXE3 @5%IX1!'TV>(U*,1#1^'S C$Y'LN/S
M\1']^Z"=M*R$PVNC?I>EK^?1-((2*]$I_V"V/^!!SSGC%4:Y\ O;WC:;1%!T
MSIOFX$P,&JG[K]@=XO#,89J\XI ='++ NS\HL+P17BQFUFS!LC6A\2!(#=Y$
M3FI.RJ.WM"O)SR\^_O+S>WBZ?;B#F]OETRSVA,D[<7'P7_;^V2O^:09W1OO:
MP:TNL7P)$!.9$Z/LR&B9O8EX@\40\G0 69(E;^#E)X5YP,M?Q5MYN)&N4,9U
M%N'/JY7SEJKAKS? 1R?P40 ?_>OPO>G/+7?I6E'@/**><F@W&'T%"A^-7G_G
MT394;22E,-01SCMHK:0^DFH/I@*'&]2@C4='%>1K\+5%A$IJH0NIU^36M$)+
MVJ:248+PA))?L(35GFP1W@OJ2OA)RPH!/W>RI<[S4(L-.PMJG_7:XIK\0--5
MP6T&&Z$ZY,//TG209/D@29)! ).ZE!M9=D(=:A@M\PYA=P."*ZFAF41);5F8
M3I,<BP7*C5BI ^1@DDX9$02EC_::%8$<ZV((3S6%ZR!84%HI?*5I6*ZGB+1B
M'Y"DAGP,WL!T!%6G:$<TQGKYA54U7+BT)+7S0BD63.2HT[E,5NBW2"']('1'
MMQ6?F@;BC]CZG@PM30*1(XVBL!V?2<%%YYEX)7>L46L.A15L=03.A^/)NX X
M'EXD[X9PY5CX5U+3BSZBUR%]>TI("4[N7F1Z:_ZW/.>#-$_^XSQ/1R'/?20K
M(FVV@0LEX8C%!X2\2,_*R$^]; H2MT=AOUDK \!=H;J208.Q=*ZC:#$\]Q&S
MR"9,X1+^8!#4P?8%T+V5%-^6>(1".(-TD)X')U[(8#*>'B<Y3)/L.!G!-+\X
M3L[A_*+?(:GTA%8D $;C<5@Z@]%@G(W"^%LW4_SLDJ<XK\-3QEFFJ/;W_6GU
M]%I>]8_$/^;]4WLG[)J*'A16Y)H,)^<1V/[YZB?>M.')6!E/20W#FEY\M&Q
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MQCF3\^52 8XL+<#[N3&NN2$&[3?=U_\#4$L#!!0    ( +6%AE+;$#OO0 X
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M%3&4%W-E+;9XAB3+$%$FYI5EM>ZPIH3.UO&H+0(2.LO$3"'-I6V/=$4<BNL
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MY!I^+=-]*<V*7X6<F;(T2_ZX4"@QEA;@^=R8,GPA!O6[L6__#5!+ P04
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M#=R6XK#D_P'DQ(#WE]:&[40"[/Y93/\%4$L#!!0    ( +6%AE*X-_6C(P@
M +(3   9    >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;*U8;U/COA'^*CLI
MTX$90Q(G)N0.F D<]_O1\N?FH.V+3E\HMI*H9UL^24Z@G[Z[*]EQ<D [G;X
MR[:T?Y[=?7;C\XTV/^Q*2@<O15[:B][*N>I3OV_3E2R$/=&5+/'-0IM".+PU
MR[ZMC!09'RKR?CP8G/8+H<K>Y3D_^V8NSW7M<E7*;P9L713"O%[)7&\N>L->
M\^"[6JX</>A?GE=B*9^D^TOUS>!=OY62J4*65ND2C%Q<]&;#3U=CVL\;_JKD
MQG;60)[,M?Y!-[?916] !LE<IHXD"+RLY;7,<Q*$9OP,,GNM2CK873?2O[+O
MZ,M<6'FM\[^IS*TN>F<]R.1"U+G[KC>_R^!/0O)2G5O^#QN_-XE[D-;6Z2(<
M1@L*5?JK> DX= Z<#=XY$(<#,=OM%;&57X03E^=&;\#0;I1&"W:53Z-QJJ2@
M/#F#;Q6><Y?7C_?WM\_W-P_/3S![^ +7CP_/MP^_W3Q<W]X\G?<=JJ"-_32(
MN_+BXG?$#6.XUZ5;6;@I,YGM"NBC;:V!<6/@5?RAQ"\R/8'1,()X$ \^D#=J
M'1ZQO-%[#NNB4 [3RED090;7:*XJE[),E;3P1=DTU[8V$OX^FUMG,&O^\8'6
M<:MUS%K'_R^8/Q1'E?K)5B*5%STL12O-6O8NKV%?"72UP&,)"*8LYM(@F 3H
M\"P"MY*(05&)\A6L6I8R@R>9:D1FAB!E'BBGP6TT/+U:)PNXJE6.KY=&2O\:
MN:$KYX]_.(N'D\\6K!=$,+N5,AG<RS65XK>K[\]0EPKI!)X[^FECV+(2:PF"
M5&2DO:Z61F22M?PB=2N.+=FL5+K:\6LE+%2U2?$J(=TFP*YV90-'Y(B$E#\P
M*Q 1)UO_\+#7,J]=1%9EPLF(I9?: 4J4!LU5);X26W0VRJV %%3"N%<6)O$1
M1J'*,82T"?0"Q-8/"'@:F:.&#!:J%)B?Y7+7X,KH?R*Y87A6P@$>VZ@\ASF=
M^UDKXY$C=S&Y)5)5CKZ95]+UGV L-9!FLD*45'FC$[@M^9A<D[UN%[>Z%/-<
MDCH&P4/@V0OO]K!097 .C21\P2'+P\((_(^.&\Q11<$O0;ZX0/\+HXN0&KLI
MF^H:<Q$Q72"F0+9GLM(HUD8A$80AWVUJU!P1F5,;.H&9)1C:<FCX)=I+FZR;
M+>1>)0TU0MR&+L'AZ @WST7NCD\'%"V-79$15:5U H.QT+6!P_$1W,D?V(IR
M^$U@\X,_EVHAX18#$&K*PB%533SX3 ]Y.?Q\!!A6^:(L$=063L[)B-6T24W5
M>1BC&B0*86"6IMCWC'"(YV'O[O9A=MT[ NM51:!+CA5F"F=@1GH8[K=4L2(Z
M09N@Q#Z[\WJO@G.KN2!$![G] NYBP.DN?.00LC([%CDI6XA4Y0K+!;/E)JU%
M1B6AJ4@P FBH+AO%>_!''M:@+^#$"+1H6<X)FF^R.O=5HM,4 S67;B,E)_R0
MS^$BWG50OE2^Y'9=HERNV->.O2'10Z']K+'\$33,.Y*/8C6FR X86U.[:2?>
MSE78(-O P3".XN$@&@P&;"@^(N>P@(G,U4*E HU*A5TUK,!"(\SD,J-8M]P2
M=6BNJSYX46(Q K;W@MM[HPNE4QJA.F&Q:PHB&F:C5FQ+2F(M5,XT\5Z[P! 8
M)D,#B]I1#VX8+J)G*!7Q*P+=D9<"T[QR#?5T1)Y0L_M3C40>,UK#R6YE[U(U
MW./PBDS#UE,,GNJJTL9M6QP<TNE0H:%#/6'757B@W=16+1-^0U:>A-"1M<I"
M*RGVU-F@+A#S/BS;MH!N/YH<CVCX76+:KWQNOF<0HKX4]+QR/G62!HL-52BU
M=\8@3 )D"N*/8R\NRQKI"WO%FO@;HXF$?)@<P2NQ"Y*@TIG7W7)[DUYT.)Q'
MKV4E7IL&=S",DDE,F=IF0!-Q+! >M?A0*QT;2W.<\"$?R7!L$-J0Y4PSK$-E
MK0AVH\VY@L[]"_>R(Z22R.5_97\;$"85'$3\8^;:+V(.6<L)'JGF\$YI<PD9
MH\C"VL%:B=81NYM'-[G\X80?D?1<U19N"['DNKV[N^;V++),.=Z,9LTJHW**
M[/3-&:_3DSN.T<8=^@SIV^ 9VIKO&&N!@4([: JR_P5W;NM\KZ=VFYBGO]"I
M?#M199K7R+,"IL><?R0]"<LV_?:\:,&/,%\L<38/=@WKOAF,CWEV$(VGHY9G
M?PEY*@VG@^;);BN_"2:%FA.5"31_C4A?LXTRW4\6,MOM-SBO*!RY NDQCR]P
M@O$#$=_RL!P&.?RMCDT?4\"V(;/U IN "A"E31U8V=36WA0L<00H.*($XT+G
MJ(UG@@Y2/,(*S(O 6-ONUXX8G+N^65*'507)P.V-4O+>"W\7^$\A5EC$-9WP
M%I XSC'*KV,:36DUIE4"LP5UV(1IRL*=+I?'U#)P_ILCAX=$HI9&]&_=$1P@
M)\;)D$GI (;1:#)JUV?)N%TGX^;Y^,SO_JH\@>>2)XJWA$^CR<1O/HV2*?=H
MB*/39,JK)/9<R&41?X:OON5ML=R.*^/3IL?C^>$DX=48K1LE.R*:Z\TV'K_D
MX3:/4=9@U$A-SI*PFDZG874V\:M9ZB=U)F!M^(=1*BI%P6GC.9Q.>'-SW;>I
MN3[Z%$41 ;EIZ FCQ-MR.O2PG^V(\:G0_?%^ 'CP;-K&*(XFPR3<8$0GXTES
M$PV"B@,81:-3K^:M'_7]SG<4G&^7_+6($@_SSW]2:9^V'Z1F_CO,=KO_FG4O
M#)*S12<7>'1P,DEZ8/P7(G_C=,5?9>;:X3#-RY5$RC6T =\OM';-#2EH/]-=
M_AM02P,$%     @ M86&4E]#QO;Z 0  > 0  !D   !X;"]W;W)K<VAE971S
M+W-H965T,3DN>&ULK93;CM,P$(9?Q<HUJM.T"VB51DH/B)78I6H+""$NW&3:
M6.M#L*=D]^W7AS24BRXWW#0>>_YO_G$GR3MM'FT#@.1)"F5G28/8WE)JJP8D
MLR/=@G(G!VTD0Q>:([6M 58'D10T2].W5#*NDB(/>VM3Y/J$@BM8&V)/4C+S
M/ >ANUDR3LX;&WYLT&_0(F_9$;: 7]JU<1$=*#67H"S7BA@XS))R?#N?^OR0
M\)5#9R_6Q'>RU_K1!W?U+$F](1!0H2<P]_@-"Q#"@YR-7STS&4IZX>7Z3/\0
M>G>][)F%A1;?>(W-+'F?D!H.["1PH[N/T/=SXWF5%C;\DB[F3EQR=;*H92]V
M#B17\<F>^GNX%*17!%DOR(+O6"BX7#)D16YT1XS/=C2_"*T&M3/'E?]3MFC<
M*7<Z+#:K3^5NM23K<K/[3G:;\F%;+G9WGQ^V.47']UFTZEGSR,JNL,89N=<*
M&TM6JH;Z;P!UQ@9WV=G=/'N5N(1J1";C-R1+L_05WF3H=A)XDVO=@F (-5DS
M@\]D9YBR+$R')3_*O47CHI^OU)D.=::ASO2_W.H_6.0,(Y%&KN*B5WHQ#1+,
M,<R\)94^*8R#,>P.KU49I^E/>GPG[YDY<G<Y @Y.FH[>W23$Q#F/ >HVS-9>
MHYO4L&S<IP&,3W#G!ZWQ'/@"P\>F> %02P,$%     @ M86&4B]1SO3@'0
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MIZS1)7FY+,C?X$@'_N/Y!H=RKQ5#V%&U%!AQ9.&G#M-.L_<DCV.M'0>QE"1
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M513;:8A*=ZHFHJ44EN#C: Q.9Y"Y[2TN?/V<EF7VU;I&](:@?YMX""J3<A@
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M01.X:"%#%<@7:(V?ET! :889C&;F!M*+@60 :ER;B*R@^?KWWP9AT#]#A*]
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MS$3E"W=&28O@8PBHZ&(U;)K:O=, HS/%%(LUN=K+"H%1(?6<\[^8 7-M"UH
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MIN?;B@7]+U$:!;K?":&'C7$P_H&7_P%02P,$%     @ M86&4KX]XJ4  P
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MOO0\,5O1F(@+OJ:).K+@:4RDVDV7GEBGE,SSH#CRD.^'7DQ8TAH.\L_NT^&
M;V3$$GJ? K&)8Y+^?D\COKUJP=;S!U_8<B6S#[SA8$V6=$+EX_H^57M>F67.
M8IH(QA.0TL55ZQI>CG$O"\@57QG=BLHVR)8RY?Q'MG,SOVKYF2,:T9G,4A#U
M]D1'-(JR3,K'SR)IJSQG%EC=?L[^,5^\6LR4"#KBT;]L+E=7K5X+S.F";"+Y
MA6__H<6"@BS?C$<B?P7;0NNWP&PC)(^+8.4@9LGNG?PJ"E$)@)T# :@(0$T#
M<!& FP9TBH!.7IG=4O(ZC(DDPT'*MR#-U"I;MI$7,X]6RV=)UO>)3-51IN+D
M\'HTNGO\_'#S^6]P?W=[,[KY, %_@8FZO.:;B *^ !\)2\%7$FTH>#NFDK!(
MO%.2Q\D8O'WS#KP!+ $/*[X1))F+@2>5J2RU-RL,O-\90 <,C.GL F#8!LA'
MOB5\U#@<]BWAX^;AO7JXIRI9EA.5Y41Y/GRHG$)0*2X=F7"9">>9.@<RC8A8
MM<%,O0+Z<\.>2$03*=IJUH1,V4S2>7ZP#48D37^S9+GKD:T!NQ,%^8DR#CP-
M<3^$ ^^I6F93!#NH7XIJ:^B4:^@XU_!P]W!]"ZXGDP\/$YNQ7718.6<'AP'>
M<V:J MSM8;NUH+06-&A4NWIUCYF815QL4@J^74]5E163OCLZ&9:G"L_125N!
M0DN!4+!7'U,$N]U^730.S?9V^\A>PVZYL*Z[O5R2J%I"VQ*Z399@BFI+J+GK
ME>YZS@[?,C)E$9.,GM;F?GF^OK,:8SJ5@$\CMB39'4T<*TS?+$P8HKW"F"+L
M=P-[8:"OF>^?WK@BQQ&#%I7#8>6N!(_,S&&HU5-J,L-3T0PUF^'_!N?B3$<&
MQ*(Z/"%0\QF>!FAH([1ISE0YS&E"0S>B*P/L:IK&,'1SV!S0!MVQ$#A$G?T"
MF"K<Z?D'"J#Q"AOP%1PL0^'0 EB+0U/E<*@1"WM.AYH@;7"3K#?9#-S2)QH!
MZ&J91BKLO_9=&FDJ(C<53[A/(PLKS3FQJ [/"=*L1&Y6-J)YD>.80U/E<%CY
M4NQ&[[ENQ4@#&KD!_=*;,3+YZN_7QB6IV]3\14?XVZAU)EX-;RY)W9O&+PK^
M<+:1JT4:QRA\]=G6*$5NE)XRVR8ZC?*[)'7'&JW(C=9FET;ON#>7I.Y-8QFY
ML7RN><::S=C-YI?.,S91NU\8IZ1N4Z,8GP'%V(2LX<TEJ7O3$,;H#^<9NUI4
M>5Z!7WN>L08G=H/SA'G&QW'JE-0=:YQB-TZ;71K!<6\N2=V;1C%VH_AL\ZQY
MC-T\?O$\V[[E&C]&+:K#/T:Q1C$^ XJ+',$1AZ;*XM"K/,_-GKY_(NF2)0)$
M=*'"_(NNBD]W#[1W.Y*O\T>\4RXEC_/-%25SFF8"=7S!N7S>R9X:EW\K#/\#
M4$L#!!0    ( +6%AE*BR-./>@,  (,*   9    >&PO=V]R:W-H965T<R]S
M:&5E=#,T+GAM;*56VV[C-A#]E8$:% ZPL43YGMH&$MMM ^QFC?6F?2CZP$BT
MS88259**=_^^0TK6*KZHWO;%%LFYG3/#X8QW4KWH+6,&OB0BU1-O:TQVZ_LZ
MVK*$ZK;,6(HG:ZD2:G"I-K[.%*.Q4TJ$'P9!WT\H3[WIV.TMU70L<R-XRI8*
M=)XD5'V]9T+N)A[Q]AN?^&9K[(8_'6=TPU;,/&5+A2N_LA+SA*6:RQ046T^\
M.W([(T[!2?S&V4[7OL%">9;RQ2X>XHD7V(B88)&Q)BC^O;(9$\):PCC^+HUZ
ME4^K6/_>6__9@4<PSU2SF12_\]AL)][0@YBM:2[,)[G[E96 >M9>)(5VO[ K
M90,/HEP;F93*&$'"T^*??BF)J"F0_AF%L%0(#Q6Z9Q0ZI4+' 2TB<[#FU-#I
M6,D=*"N-UNR'X\9I(QJ>VC2NC,)3CGIF>C>;?7QZ_/SP^ LL/[Y_F#TL5G #
M*ZR6.!<,Y!H6RQ6TYLQ0+O0UGCVMYM"ZNH8K\$%OJ6(:> I/*3?Z76WC\U;F
MFJ8Q;EZ]68]]@W%;[WY4QGA?Q!B>B9&$\$&F9JMAD<8L?FO 1\ 5ZG"/^CYL
MM#AG41LZY!V$01B<"&AVL3H9-833J9+0<?8ZYY(013)/#4\WL)2"1QPI_./N
M61N%5?YG@X-NY:#K''3/.'C,$Z:HD0KPXMNRYQ%@+B#F(C<LAI:0&I/+J$HQ
M" T94T4J3R6K<-5SKFR7>)W>#(+><.R_UAD\ENKW1I7,&Q2]"D6OD:8Y2R5>
M 8OCMH&4?F6NWTA*S=SWT@(__C ,"?D)=JY-L/B&OB+!&[:_ "VL^.+S^A2%
M16#].CED&!XP>"S4&Y$S% XJS(-&"A?K-?9/>ZT=1NR@H%F4*VZPYAHX'5;V
MAXV<-MJ'19()^97AGI'1"\C,=G+M*$>FC.*19;TX_!<&AT?D! ?T'4L0<IJ\
M405N]%T%<WF9T/@O;.4H^A_K971)O1P+]4:=X#1D$GQ['X)&T*WWQ^ BF22R
M#!A?A.+B6 BQ%(*J&@,GT90>!_4.0MJD>X#GA%C0/I=#4GOPR/\%5"7V<DCD
M,DC'8B<@^;7G'/OVQDTY&MP;4;QQU6XU2=VY^>%@_]Y.6&Y,^&:F&,\^4+7A
M>/4$6Z/)H#W SJN*B:=8&)FYH>%9&AQ!W.<6IT2FK ">KZ4T^X5U4,V=TW\
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MA^03ZB?U/!;R]!/L\EA# ]Z6"Q;ER5)!%-#LV_V9&U%*@&9+ LH34#6AUY*
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MPDL!HPHPNA0050"[=*]<NPW<FFBRF$MQ1-+,!FOFP4;?HB%>+#.)<J<E_,H
MIQ<__;*Z0=>KWS]O[C:?-K]]0#^B#T1*8K8/O5Q331A7KV#T\]T:O7SQ"KU
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M@7F_%.9.W&]L@&8^'O\'4$L#!!0    ( +6%AE)&^0#;2 (  #8&   9
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MS96>,W99Z,$.PB3H\RWGZAB88=/]*K+_4$L#!!0    ( +6%AE)"-UX") ,
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ME9[7MU?=D:PT%\"<276=F.9:W?C ]03U?LF8_.CH.Z7]AAB] U!+ P04
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MZ?S]DG>LVO@;_:.R^#[PS36^^4"["?A]J91][3@'Y2MR\B]02P,$%     @
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MS36K>MR:FS!(:V"^KX70#P-[UVKOUK-_4$L#!!0    ( +6%AE)K6TTW50(
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M=S]"(EDT0L5$BYWM)39"8V=BAPDVCR"- 'Z/A=#GB7%0MJ/SWU!+ P04
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M 2*R59#JE5GYP].1.[V0[)!,K4],JADX6>X)#@C7 NK^EC'Y>J$-Y!\^%O\
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ME+%"^+7)J4+W"[K]L_W^PWY<=3K'.Q3ZL@!;^8;^@"'<DEC $Z$IGGD)KHM
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MDEJET=D(-&61.D<?$./H82-21?E2=7UM>%@T/\QSWNQSDB,YYY!<HJ#U$9$
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MMJ!E*C_SS>^LZ5!0Y8MY*NI/L&GN]0<@+H7D61.L6I E^?:;?F\&8B< 04L
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MSO"HR.+)*0PM,GO-+X3&1\,V5_A,@S03<#P60C\;YN6H'O[^;U!+ P04
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MX!.41E!$Y2BD<A13.0JJ'$55CL(J1W&5H\#*4605*+(*%%D%BJP"15:!(JM
MD56@R"I09!4HL@H4626*K!)%5HDBJT215:+(*E%DE2BR2A19)8JL$D56A2*K
M0I%5H<BJ4&15*+(J%%D5BJP*15:%(JM"D56CR*I19-4HLFH4636*K!I%5HTB
MJT:15:/(JE%D+5!D+5!D+5!D+5!D+?Y3UF=KEW\</SSSUM3=(9\-?[N:O0%0
M2P$"% ,4    " "UA892!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( +6%AE*HL/C#[P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M +6%AE*97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ M86&4O&HX?MB!@  .QH  !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M +6%AE(=%00.<P<  )4=   8              " @:8.  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    " "UA892CBWV\ZH"  !R!P  &
M            @(%/%@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ M86&4K\#QQ#B!   OQ$  !@              ("!+QD  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( +6%AE+/32(H3 4  /05
M   8              " @4<>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    " "UA892>V[";FT(   H(P  &               @(')(P
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ M86&4GO-N8$B
M"0  718  !@              ("!;"P  'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( +6%AE(WET?)+R$  %5K   8              "
M@<0U  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "UA892
MB%%!4G<&   4$   &               @($I5P  >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ M86&4GGM"@$\"P  T!X  !D
M     ("!UET  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +6%AE+;$#OO0 X  "<K   9              "
M@>Z#  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ M86&
M4L'JS&KK 0  3P0  !D              ("!99(  'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"% ,4    " "UA892\02@3>X#  !E"   &0
M        @(&'E   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0
M   ( +6%AE*X-_6C(P@  +(3   9              " @:R8  !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ M86&4E]#QO;Z 0  > 0
M !D              ("!!J$  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"% ,4    " "UA892+U'.]. =   59   &0              @($WHP
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( +6%AE+#WOXE
M#P4  *T-   9              " @4[!  !X;"]W;W)K<VAE971S+W-H965T
M,C$N>&UL4$L! A0#%     @ M86&4C$YP"7J @  # 8  !D
M ("!E,8  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "U
MA892Y)I9"]L#  #]"   &0              @(&UR0  >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( +6%AE*FVMS/FP(  'H%   9
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M970R."YX;6Q02P$"% ,4    " "UA892W\VH? 4#  "'!@  &0
M    @(%FXP  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (
M +6%AE)I_50>CP,  (T'   9              " @:+F  !X;"]W;W)K<VAE
M971S+W-H965T,S N>&UL4$L! A0#%     @ M86&4KX]XJ4  P  ]@@  !D
M             ("!:.H  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"
M% ,4    " "UA892T$".Z4((   ;*0  &0              @(&?[0  >&PO
M=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( +6%AE(\!N%DB 0
M &(8   9              " @1CV  !X;"]W;W)K<VAE971S+W-H965T,S,N
M>&UL4$L! A0#%     @ M86&4J+(TX]Z P  @PH  !D              ("!
MU_H  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " "UA892
M T.?A3D$   2$P  &0              @(&(_@  >&PO=V]R:W-H965T<R]S
M:&5E=#,U+GAM;%!+ 0(4 Q0    ( +6%AE*7L)K/2@,  +\+   9
M      " @?@" 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%
M  @ M86&4O"&?%HW!0  WQ0  !D              ("!>08! 'AL+W=O<FMS
M:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " "UA892+:L^1HP$   %$0
M&0              @('G"P$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+
M 0(4 Q0    ( +6%AE*#YER%H@0  +(2   9              " @:H0 0!X
M;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ M86&4M_V,V,%
M P  *0L  !D              ("!@Q4! 'AL+W=O<FMS:&5E=',O<VAE970T
M,"YX;6Q02P$"% ,4    " "UA892M?^==E8#   K"P  &0
M@(&_& $ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( +6%
MAE)&^0#;2 (  #8&   9              " @4P< 0!X;"]W;W)K<VAE971S
M+W-H965T-#(N>&UL4$L! A0#%     @ M86&4D(W7@(D P  3 H  !D
M         ("!RQX! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
M    " "UA892HFNP:<\"  !/"   &0              @($F(@$ >&PO=V]R
M:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( +6%AE+9M#Z[+@,  /X*
M   9              " @2PE 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL
M4$L! A0#%     @ M86&4MP>.<UM @  =@8  !D              ("!D2@!
M 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " "UA892!$AX
M2? #  !1#@  &0              @($U*P$ >&PO=V]R:W-H965T<R]S:&5E
M=#0W+GAM;%!+ 0(4 Q0    ( +6%AE)+T2H:*P,  "H*   9
M  " @5PO 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @
MM86&4LEZ@;MD P  9PL  !D              ("!OC(! 'AL+W=O<FMS:&5E
M=',O<VAE970T.2YX;6Q02P$"% ,4    " "UA892:UM--U4"  !2!0  &0
M            @(%9-@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4
M Q0    ( +6%AE*S;MT@G@,  )H*   9              " @>4X 0!X;"]W
M;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ M86&4B"'Z17) @
MZ08  !D              ("!NCP! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX
M;6Q02P$"% ,4    " "UA892*<<%.UH(  !6+@  &0              @(&Z
M/P$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( +6%AE);
M[CY4$@0   01   9              " @4M( 0!X;"]W;W)K<VAE971S+W-H
M965T-30N>&UL4$L! A0#%     @ M86&4B<FU3J' P  /@X  !D
M     ("!E$P! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +6%AE*]"T>M/P(  'X%   9              "
M@;U> 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ M86&
M4LJ@+6MZ @  : 8  !D              ("!,V$! 'AL+W=O<FMS:&5E=',O
M<VAE970V,2YX;6Q02P$"% ,4    " "UA8928X.(4><#  !S#@  &0
M        @('D8P$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0
M   ( +6%AE*Q3V+^^P0  *<8   9              " @0)H 0!X;"]W;W)K
M<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ M86&4K#)-@;0 @  ! @
M !D              ("!-&T! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q0
M2P$"% ,4    " "UA892\N][JP8#   M$   #0              @ $[< $
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +6%AE*7BKL<P    !,"   +
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4!08     2 !( *\3  #+?0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>166</ContextCount>
  <ElementCount>461</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>78</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>17</UnitCount>
  <MyReports>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/STATEMENTSOFOPERATIONS</Role>
      <ShortName>STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATION</Role>
      <ShortName>BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/ACCOUNTINGPOLICIES</Role>
      <ShortName>ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/PROPERTYANDEQUIPMENT</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2114104 - Disclosure - GKCE ACQUISITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/GKCEACQUISITION</Role>
      <ShortName>GKCE ACQUISITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2119105 - Disclosure - LONG TERM DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/LONGTERMDEBT</Role>
      <ShortName>LONG TERM DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2123106 - Disclosure - FINANCE LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/FINANCELEASES</Role>
      <ShortName>FINANCE LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2127107 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2131108 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2139109 - Disclosure - STOCK-BASED COMPENSATION EXPENSE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSE</Role>
      <ShortName>STOCK-BASED COMPENSATION EXPENSE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2147110 - Disclosure - RETIREMENT PLAN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/RETIREMENTPLAN</Role>
      <ShortName>RETIREMENT PLAN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2149111 - Disclosure - OPERATING LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/OPERATINGLEASES</Role>
      <ShortName>OPERATING LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2153112 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2157113 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/RELATEDPARTYTRANSACTIONS</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/ACCOUNTINGPOLICIESTables</Role>
      <ShortName>ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ashs.com/role/ACCOUNTINGPOLICIES</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/PROPERTYANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ashs.com/role/PROPERTYANDEQUIPMENT</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2315303 - Disclosure - GKCE ACQUISITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/GKCEACQUISITIONTables</Role>
      <ShortName>GKCE ACQUISITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ashs.com/role/GKCEACQUISITION</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - LONG TERM DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/LONGTERMDEBTTables</Role>
      <ShortName>LONG TERM DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ashs.com/role/LONGTERMDEBT</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2324305 - Disclosure - FINANCE LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/FINANCELEASESTables</Role>
      <ShortName>FINANCE LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ashs.com/role/FINANCELEASES</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2328306 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ashs.com/role/LEASES</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2332307 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ashs.com/role/INCOMETAXES</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2340308 - Disclosure - STOCK-BASED COMPENSATION EXPENSE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables</Role>
      <ShortName>STOCK-BASED COMPENSATION EXPENSE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSE</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2350309 - Disclosure - OPERATING LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/OPERATINGLEASESTables</Role>
      <ShortName>OPERATING LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ashs.com/role/OPERATINGLEASES</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2354310 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - BUSINESS AND BASIS OF PRESENTATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails</Role>
      <ShortName>BUSINESS AND BASIS OF PRESENTATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - ACCOUNTING POLICIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails</Role>
      <ShortName>ACCOUNTING POLICIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - ACCOUNTING POLICIES - Schedule of Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails</Role>
      <ShortName>ACCOUNTING POLICIES - Schedule of Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - ACCOUNTING POLICIES - Schedule of EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails</Role>
      <ShortName>ACCOUNTING POLICIES - Schedule of EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - ACCOUNTING POLICIES - Schedule of Domestic and Foreign Break out Percentages (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails</Role>
      <ShortName>ACCOUNTING POLICIES - Schedule of Domestic and Foreign Break out Percentages (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ashs.com/role/PROPERTYANDEQUIPMENTTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - PROPERTY AND EQUIPMENT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - GKCE ACQUISITION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails</Role>
      <ShortName>GKCE ACQUISITION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - GKCE ACQUISITION - Schedule of Purchase Price Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails</Role>
      <ShortName>GKCE ACQUISITION - Schedule of Purchase Price Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - GKCE ACQUISITION - Schedule of Tangible Assets Acquired as Part of Business Combination (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails</Role>
      <ShortName>GKCE ACQUISITION - Schedule of Tangible Assets Acquired as Part of Business Combination (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2421411 - Disclosure - LONG TERM DEBT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails</Role>
      <ShortName>LONG TERM DEBT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2422412 - Disclosure - LONG TERM DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/LONGTERMDEBTDetails</Role>
      <ShortName>LONG TERM DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ashs.com/role/LONGTERMDEBTTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2425413 - Disclosure - FINANCE LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/FINANCELEASESNarrativeDetails</Role>
      <ShortName>FINANCE LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2426414 - Disclosure - FINANCE LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/FINANCELEASESDetails</Role>
      <ShortName>FINANCE LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ashs.com/role/FINANCELEASESTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2429415 - Disclosure - LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/LEASESNarrativeDetails</Role>
      <ShortName>LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2430416 - Disclosure - LEASES - Summary of Maturities of Lessee Operating Lease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails</Role>
      <ShortName>LEASES - Summary of Maturities of Lessee Operating Lease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2433417 - Disclosure - INCOME TAXES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - INCOME TAXES - Schedule of Components of Income Tax Expense (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Components of Income Tax Expense (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2435419 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - INCOME TAXES - Schedule of Amounts Presented in Financial Statements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Amounts Presented in Financial Statements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2437421 - Disclosure - INCOME TAXES - Schedule of Effective Income Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Effective Income Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2438422 - Disclosure - INCOME TAXES - Schedule of Unrecognized Tax Benefits Roll Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Unrecognized Tax Benefits Roll Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION EXPENSE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2442424 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION EXPENSE - Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2443425 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION EXPENSE - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2444426 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Share-based Compensation, Stock Options, Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION EXPENSE - Share-based Compensation, Stock Options, Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2445427 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Schedule of Nonvested Share Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION EXPENSE - Schedule of Nonvested Share Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2446428 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION EXPENSE - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2448429 - Disclosure - RETIREMENT PLAN (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/RETIREMENTPLANDetailsTextual</Role>
      <ShortName>RETIREMENT PLAN (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ashs.com/role/RETIREMENTPLAN</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2451430 - Disclosure - OPERATING LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/OPERATINGLEASESDetails</Role>
      <ShortName>OPERATING LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ashs.com/role/OPERATINGLEASESTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2452431 - Disclosure - OPERATING LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails</Role>
      <ShortName>OPERATING LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2455432 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2456433 - Disclosure - COMMITMENTS AND CONTINGENCIES - Schedule of Long-term Purchase Commitment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Schedule of Long-term Purchase Commitment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ams-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2458434 - Disclosure - RELATED PARTY TRANSACTIONS (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ashs.com/role/RELATEDPARTYTRANSACTIONS</ParentRole>
      <Position>64</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="ams-20201231.htm">ams-20201231.htm</File>
    <File>ams-20201231.xsd</File>
    <File>ams-20201231_cal.xml</File>
    <File>ams-20201231_def.xml</File>
    <File>ams-20201231_lab.xml</File>
    <File>ams-20201231_pre.xml</File>
    <File>ams-20201231xex311.htm</File>
    <File>ams-20201231xex312.htm</File>
    <File>ams-20201231xex321.htm</File>
    <File>ashs-2020consentexhibit231.htm</File>
    <File>ashs10-kexhibit41.htm</File>
    <File>ashsex1011dfullyexecuted.htm</File>
    <File>exhibit211.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>86
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ams-20201231.htm": {
   "axisCustom": 1,
   "axisStandard": 20,
   "contextCount": 166,
   "dts": {
    "calculationLink": {
     "local": [
      "ams-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ams-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "ams-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ams-20201231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ams-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ams-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 599,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 1,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 6
   },
   "keyCustom": 79,
   "keyStandard": 382,
   "memberCustom": 46,
   "memberStandard": 30,
   "nsprefix": "ams",
   "nsuri": "http://www.ashs.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.ashs.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114104 - Disclosure - GKCE ACQUISITION",
     "role": "http://www.ashs.com/role/GKCEACQUISITION",
     "shortName": "GKCE ACQUISITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119105 - Disclosure - LONG TERM DEBT",
     "role": "http://www.ashs.com/role/LONGTERMDEBT",
     "shortName": "LONG TERM DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123106 - Disclosure - FINANCE LEASES",
     "role": "http://www.ashs.com/role/FINANCELEASES",
     "shortName": "FINANCE LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127107 - Disclosure - LEASES",
     "role": "http://www.ashs.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131108 - Disclosure - INCOME TAXES",
     "role": "http://www.ashs.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139109 - Disclosure - STOCK-BASED COMPENSATION EXPENSE",
     "role": "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSE",
     "shortName": "STOCK-BASED COMPENSATION EXPENSE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147110 - Disclosure - RETIREMENT PLAN",
     "role": "http://www.ashs.com/role/RETIREMENTPLAN",
     "shortName": "RETIREMENT PLAN",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149111 - Disclosure - OPERATING LEASES",
     "role": "http://www.ashs.com/role/OPERATINGLEASES",
     "shortName": "OPERATING LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153112 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157113 - Disclosure - RELATED PARTY TRANSACTIONS",
     "role": "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - ACCOUNTING POLICIES (Policies)",
     "role": "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies",
     "shortName": "ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - ACCOUNTING POLICIES (Tables)",
     "role": "http://www.ashs.com/role/ACCOUNTINGPOLICIESTables",
     "shortName": "ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "role": "http://www.ashs.com/role/PROPERTYANDEQUIPMENTTables",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - GKCE ACQUISITION (Tables)",
     "role": "http://www.ashs.com/role/GKCEACQUISITIONTables",
     "shortName": "GKCE ACQUISITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - LONG TERM DEBT (Tables)",
     "role": "http://www.ashs.com/role/LONGTERMDEBTTables",
     "shortName": "LONG TERM DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324305 - Disclosure - FINANCE LEASES (Tables)",
     "role": "http://www.ashs.com/role/FINANCELEASESTables",
     "shortName": "FINANCE LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328306 - Disclosure - LEASES (Tables)",
     "role": "http://www.ashs.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332307 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://www.ashs.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340308 - Disclosure - STOCK-BASED COMPENSATION EXPENSE (Tables)",
     "role": "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables",
     "shortName": "STOCK-BASED COMPENSATION EXPENSE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2350309 - Disclosure - OPERATING LEASES (Tables)",
     "role": "http://www.ashs.com/role/OPERATINGLEASESTables",
     "shortName": "OPERATING LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermPurchaseCommitmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354310 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "role": "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermPurchaseCommitmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6422158328d64dee80e1ac0f4c7ef41f_I20200612",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "ams:AssetAcquisitionPercentageOfSharesAcquired",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - BUSINESS AND BASIS OF PRESENTATION - Narrative (Details)",
     "role": "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails",
     "shortName": "BUSINESS AND BASIS OF PRESENTATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i410be01cd1af4746a125e7746f1d7df8_I20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "us-gaap:AdvertisingCostsPolicyTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - ACCOUNTING POLICIES - Narrative (Details)",
     "role": "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
     "shortName": "ACCOUNTING POLICIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "us-gaap:AdvertisingCostsPolicyTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - ACCOUNTING POLICIES - Schedule of Fair Value (Details)",
     "role": "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails",
     "shortName": "ACCOUNTING POLICIES - Schedule of Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - ACCOUNTING POLICIES - Schedule of EPS (Details)",
     "role": "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails",
     "shortName": "ACCOUNTING POLICIES - Schedule of EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - ACCOUNTING POLICIES - Schedule of Domestic and Foreign Break out Percentages (Details)",
     "role": "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails",
     "shortName": "ACCOUNTING POLICIES - Schedule of Domestic and Foreign Break out Percentages (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ams:ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i714b56581adc46f6942c585891e61544_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - PROPERTY AND EQUIPMENT (Details)",
     "role": "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails",
     "shortName": "PROPERTY AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - PROPERTY AND EQUIPMENT - Narrative (Details)",
     "role": "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails",
     "shortName": "PROPERTY AND EQUIPMENT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i3035febde0194678b2773c7062226a54_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "ams:PaymentsForWorkingCapital",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - GKCE ACQUISITION - Narrative (Details)",
     "role": "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
     "shortName": "GKCE ACQUISITION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "ams:PaymentsToAcquireAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "ams:PaymentsForWorkingCapital",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - GKCE ACQUISITION - Schedule of Purchase Price Consideration (Details)",
     "role": "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails",
     "shortName": "GKCE ACQUISITION - Schedule of Purchase Price Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612",
      "decimals": "-3",
      "lang": "en-US",
      "name": "ams:AssetAcquisitionCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - STATEMENTS OF OPERATIONS",
     "role": "http://www.ashs.com/role/STATEMENTSOFOPERATIONS",
     "shortName": "STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DirectOperatingMaintenanceSuppliesCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ams:ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "ib43ee360e2d64e0da8930fe7071f63f8_D20200612-20200612",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAdditions",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - GKCE ACQUISITION - Schedule of Tangible Assets Acquired as Part of Business Combination (Details)",
     "role": "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails",
     "shortName": "GKCE ACQUISITION - Schedule of Tangible Assets Acquired as Part of Business Combination (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ams:ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i205b91ae82344e9d8e528defe6019354_D20200612-20200612",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ams:NumberOfDebtInstruments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "note",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - LONG TERM DEBT - Narrative (Details)",
     "role": "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails",
     "shortName": "LONG TERM DEBT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ams:NumberOfDebtInstruments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "note",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422412 - Disclosure - LONG TERM DEBT (Details)",
     "role": "http://www.ashs.com/role/LONGTERMDEBTDetails",
     "shortName": "LONG TERM DEBT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ams:NumberOfFinancingLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - FINANCE LEASES - Narrative (Details)",
     "role": "http://www.ashs.com/role/FINANCELEASESNarrativeDetails",
     "shortName": "FINANCE LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ams:NumberOfFinancingLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426414 - Disclosure - FINANCE LEASES (Details)",
     "role": "http://www.ashs.com/role/FINANCELEASESDetails",
     "shortName": "FINANCE LEASES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429415 - Disclosure - LEASES - Narrative (Details)",
     "role": "http://www.ashs.com/role/LEASESNarrativeDetails",
     "shortName": "LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "icfa5f63042e644d5b31c703f3ac54c9a_I20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430416 - Disclosure - LEASES - Summary of Maturities of Lessee Operating Lease (Details)",
     "role": "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails",
     "shortName": "LEASES - Summary of Maturities of Lessee Operating Lease (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433417 - Disclosure - INCOME TAXES - Narrative (Details)",
     "role": "http://www.ashs.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - INCOME TAXES - Schedule of Components of Income Tax Expense (Benefit) (Details)",
     "role": "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails",
     "shortName": "INCOME TAXES - Schedule of Components of Income Tax Expense (Benefit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435419 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i88d4659da27e48458ba86016aae09e94_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY",
     "role": "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i88d4659da27e48458ba86016aae09e94_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ams:ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxLiabilitiesNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - INCOME TAXES - Schedule of Amounts Presented in Financial Statements (Details)",
     "role": "http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails",
     "shortName": "INCOME TAXES - Schedule of Amounts Presented in Financial Statements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437421 - Disclosure - INCOME TAXES - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "role": "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails",
     "shortName": "INCOME TAXES - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i882bf9794e8244f388b36b7749f33ee3_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438422 - Disclosure - INCOME TAXES - Schedule of Unrecognized Tax Benefits Roll Forward (Details)",
     "role": "http://www.ashs.com/role/INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails",
     "shortName": "INCOME TAXES - Schedule of Unrecognized Tax Benefits Roll Forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Narrative (Details)",
     "role": "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails",
     "shortName": "STOCK-BASED COMPENSATION EXPENSE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442424 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity (Details)",
     "role": "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION EXPENSE - Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i1182cb262dd5404e857585d6453d5008_I20181231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443425 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details)",
     "role": "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails",
     "shortName": "STOCK-BASED COMPENSATION EXPENSE - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "ifa091c4ef68c4bb68bd7b854b530cc2c_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444426 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Share-based Compensation, Stock Options, Activity (Details)",
     "role": "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION EXPENSE - Share-based Compensation, Stock Options, Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i882bf9794e8244f388b36b7749f33ee3_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445427 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Schedule of Nonvested Share Activity (Details)",
     "role": "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION EXPENSE - Schedule of Nonvested Share Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i88d4659da27e48458ba86016aae09e94_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446428 - Disclosure - STOCK-BASED COMPENSATION EXPENSE - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)",
     "role": "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails",
     "shortName": "STOCK-BASED COMPENSATION EXPENSE - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448429 - Disclosure - RETIREMENT PLAN (Details Textual)",
     "role": "http://www.ashs.com/role/RETIREMENTPLANDetailsTextual",
     "shortName": "RETIREMENT PLAN (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451430 - Disclosure - OPERATING LEASES (Details)",
     "role": "http://www.ashs.com/role/OPERATINGLEASESDetails",
     "shortName": "OPERATING LEASES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "ams:LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "ib40f3f2ed22f45ceb3ad41a1918f4939_D20160813-20160813",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ams:LeaseExpirationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452431 - Disclosure - OPERATING LEASES - Narrative (Details)",
     "role": "http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails",
     "shortName": "OPERATING LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "ib40f3f2ed22f45ceb3ad41a1918f4939_D20160813-20160813",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ams:LeaseExpirationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ams:NumberOfCobalt60Reloads",
      "reportCount": 1,
      "unitRef": "reload",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455432 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)",
     "role": "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "ams:NumberOfPurchaseCommitments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "purchase",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongTermPurchaseCommitmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractualObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456433 - Disclosure - COMMITMENTS AND CONTINGENCIES - Schedule of Long-term Purchase Commitment (Details)",
     "role": "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Schedule of Long-term Purchase Commitment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongTermPurchaseCommitmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractualObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ams:NumberOfCobalt60Reloads",
      "reportCount": 1,
      "unitRef": "reload",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458434 - Disclosure - RELATED PARTY TRANSACTIONS (Details Textual)",
     "role": "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i6687a8b13ec24af5990e629224319cec_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "ams:NumberOfPerfexionUpgrades",
      "reportCount": 1,
      "unique": true,
      "unitRef": "upgrade",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - BUSINESS AND BASIS OF PRESENTATION",
     "role": "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATION",
     "shortName": "BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - ACCOUNTING POLICIES",
     "role": "http://www.ashs.com/role/ACCOUNTINGPOLICIES",
     "shortName": "ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - PROPERTY AND EQUIPMENT",
     "role": "http://www.ashs.com/role/PROPERTYANDEQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ams-20201231.htm",
      "contextRef": "i2d04da4440b146829c3c7dd402b496e5_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 78,
   "tag": {
    "ams_AccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Line Items]",
        "terseLabel": "Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "AccountingPoliciesLineItems",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ams_AccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Table]",
        "terseLabel": "Accounting Policies [Table]"
       }
      }
     },
     "localname": "AccountingPoliciesTable",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ams_AcquisitionOfEquipmentWithLongTermDebtFinancing": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Acquisition Of Equipment With Long term Debt Financing",
        "verboseLabel": "Acquisition of equipment with long-term debt financing"
       }
      }
     },
     "localname": "AcquisitionOfEquipmentWithLongTermDebtFinancing",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AcquisitionOfInsuranceWithShortTermFinancing": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition Of Insurance With Short-Term Financing",
        "label": "Acquisition Of Insurance With Short-Term Financing",
        "terseLabel": "Acquisition of insurance with short-term financing"
       }
      }
     },
     "localname": "AcquisitionOfInsuranceWithShortTermFinancing",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AcquisitionWorkingCapitalPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition Working Capital Payments",
        "label": "Acquisition Working Capital Payments [Member]",
        "terseLabel": "Acquisition working capital payments"
       }
      }
     },
     "localname": "AcquisitionWorkingCapitalPaymentsMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_AnnualRSUAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual RSU Awards",
        "label": "Annual RSU Awards [Member]",
        "terseLabel": "Annual RSU Awards"
       }
      }
     },
     "localname": "AnnualRSUAwardsMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_ArchitecturalDesignCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Architectural Design Company [Member]",
        "terseLabel": "Architectural Design Company"
       }
      }
     },
     "localname": "ArchitecturalDesignCompanyMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_AssetAcquisitionAccountsPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 2.0,
       "parentTag": "ams_AssetAcquisitionLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Accounts Payable",
        "label": "Asset Acquisition, Accounts Payable",
        "negatedTerseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AssetAcquisitionAccountsPayable",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionAccountsReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 4.0,
       "parentTag": "ams_AssetAcquisitionAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Accounts Receivable",
        "label": "Asset Acquisition, Accounts Receivable",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AssetAcquisitionAccountsReceivable",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionAdditionalConsiderationTransferred": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 1.0,
       "parentTag": "ams_AssetAcquisitionConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Additional Consideration Transferred",
        "label": "Asset Acquisition, Additional Consideration Transferred",
        "negatedTerseLabel": "Estimated subsequent working capital payment",
        "terseLabel": "Additional consideration transferred"
       }
      }
     },
     "localname": "AssetAcquisitionAdditionalConsiderationTransferred",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 1.0,
       "parentTag": "ams_AssetAcquisitionTotalConsiderationTransferred",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Assets Acquired",
        "label": "Asset Acquisition, Assets Acquired",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "AssetAcquisitionAssetsAcquired",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ams_AssetAcquisitionCashAndCashEquivalents": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 6.0,
       "parentTag": "ams_AssetAcquisitionAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Cash And Cash Equivalents",
        "label": "Asset Acquisition, Cash And Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "AssetAcquisitionCashAndCashEquivalents",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionConsiderationTransferred": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Consideration Transferred",
        "label": "Asset Acquisition, Consideration Transferred",
        "terseLabel": "Base purchase consideration",
        "totalLabel": "Base purchase consideration"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferred",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration",
        "label": "Asset Acquisition, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration",
        "terseLabel": "Increase in amount of contingent consideration"
       }
      }
     },
     "localname": "AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionDeferredIncomeTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 3.0,
       "parentTag": "ams_AssetAcquisitionLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Deferred Income Taxes",
        "label": "Asset Acquisition, Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "AssetAcquisitionDeferredIncomeTaxes",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_AssetAcquisitionEmployeeCompensationAndBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 4.0,
       "parentTag": "ams_AssetAcquisitionLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Employee Compensation And Benefits",
        "label": "Asset Acquisition, Employee Compensation And Benefits",
        "negatedLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "AssetAcquisitionEmployeeCompensationAndBenefits",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionIncomeTaxesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 1.0,
       "parentTag": "ams_AssetAcquisitionLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Income Taxes Payable",
        "label": "Asset Acquisition, Income Taxes Payable",
        "negatedTerseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AssetAcquisitionIncomeTaxesPayable",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionLiabilitiesAssumed": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 2.0,
       "parentTag": "ams_AssetAcquisitionTotalConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Liabilities Assumed",
        "label": "Asset Acquisition, Liabilities Assumed",
        "negatedTotalLabel": "Total liabilities assumed",
        "terseLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "AssetAcquisitionLiabilitiesAssumed",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionPercentageOfOutstandingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Percentage Of Outstanding Shares",
        "label": "Asset Acquisition, Percentage Of Outstanding Shares",
        "terseLabel": "Percentage of outstanding shares"
       }
      }
     },
     "localname": "AssetAcquisitionPercentageOfOutstandingShares",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ams_AssetAcquisitionPercentageOfSharesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Percentage Of Shares Acquired",
        "label": "Asset Acquisition, Percentage Of Shares Acquired",
        "terseLabel": "Asset acquisition, percentage of shares acquired"
       }
      }
     },
     "localname": "AssetAcquisitionPercentageOfSharesAcquired",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ams_AssetAcquisitionPercentageOfSharesRemaining": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Percentage Of Shares Remaining",
        "label": "Asset Acquisition, Percentage Of Shares Remaining",
        "terseLabel": "Asset acquisition, percentage of shares remaining"
       }
      }
     },
     "localname": "AssetAcquisitionPercentageOfSharesRemaining",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ams_AssetAcquisitionPrepaidExpenseAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 5.0,
       "parentTag": "ams_AssetAcquisitionAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Prepaid Expense And Other",
        "label": "Asset Acquisition, Prepaid Expense And Other",
        "terseLabel": "Prepaid expense and other"
       }
      }
     },
     "localname": "AssetAcquisitionPrepaidExpenseAndOther",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionTotalConsiderationTransferred": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 3.0,
       "parentTag": "ams_AssetAcquisitionConsiderationTransferred",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Total Consideration Transferred",
        "label": "Asset Acquisition, Total Consideration Transferred",
        "terseLabel": "Consideration allocated to assets acquired and liabilities assumed",
        "totalLabel": "Consideration allocated to assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "AssetAcquisitionTotalConsiderationTransferred",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetAcquisitionTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Transaction Costs",
        "label": "Asset Acquisition, Transaction Costs",
        "terseLabel": "Asset acquisition, transaction costs"
       }
      }
     },
     "localname": "AssetAcquisitionTransactionCosts",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_AssetRetirementObligationNumberOfRemovedAssetUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Retirement Obligation, Number Of Removed Asset Units",
        "label": "Asset Retirement Obligation, Number Of Removed Asset Units",
        "terseLabel": "Number of removed asset units"
       }
      }
     },
     "localname": "AssetRetirementObligationNumberOfRemovedAssetUnits",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ams_AssetRetirementObligationNumberOfSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Retirement Obligation, Number Of Sites",
        "label": "Asset Retirement Obligation, Number Of Sites",
        "terseLabel": "Number of sites"
       }
      }
     },
     "localname": "AssetRetirementObligationNumberOfSites",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ams_AssetRetirementObligationsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for asset retirement obligations.",
        "label": "Asset Retirement Obligations Policy [Policy Text Block]",
        "terseLabel": "Asset Retirement Obligations"
       }
      }
     },
     "localname": "AssetRetirementObligationsPolicyPolicyTextBlock",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ams_BalanceSheetParentheticalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Parenthetical [Abstract]",
        "terseLabel": "Balance Sheet Parenthetical [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetParentheticalAbstract",
     "nsuri": "http://www.ashs.com/20201231",
     "xbrltype": "stringItemType"
    },
    "ams_BusinessAndCreditRiskPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for business and credit risk.",
        "label": "Business And Credit Risk [Policy Text Block]",
        "terseLabel": "Business and credit risk"
       }
      }
     },
     "localname": "BusinessAndCreditRiskPolicyTextBlock",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ams_CarryingValuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying Values [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingValuesMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ams_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ams_CustomerFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Four",
        "label": "Customer Four [Member]",
        "terseLabel": "Customer Four"
       }
      }
     },
     "localname": "CustomerFourMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_CustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer One [Member]",
        "terseLabel": "Customer One"
       }
      }
     },
     "localname": "CustomerOneMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_CustomerThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Three [Member]",
        "terseLabel": "Customer Three"
       }
      }
     },
     "localname": "CustomerThreeMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_CustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Two",
        "label": "Customer Two [Member]",
        "terseLabel": "Customer Two"
       }
      }
     },
     "localname": "CustomerTwoMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_DepositsTowardsPurchaseOfProtonBeamSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits Towards Purchase of Proton Beam Systems [Member]",
        "verboseLabel": "Deposits towards purchase of proton beam systems"
       }
      }
     },
     "localname": "DepositsTowardsPurchaseOfProtonBeamSystemsMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document and Entity Information [Abstract]",
        "label": "Document and Entity Information [Abstract]",
        "terseLabel": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.ashs.com/20201231",
     "xbrltype": "stringItemType"
    },
    "ams_DomesticMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic [Member]",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "DomesticMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Capital Loss Carryforward Expiration, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Capital Loss Carryforward Expiration, Amount",
        "terseLabel": "Capital loss carryforward expiration"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationCapitalLossCarryforwardExpirationAmount",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Return To Provision True-Up, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Return To Provision True-Up, Amount",
        "terseLabel": "Return to Provision True-up"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUpAmount",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount",
        "terseLabel": "Uncertain Tax Positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_EmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee [Member]",
        "terseLabel": "Employee"
       }
      }
     },
     "localname": "EmployeeMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_EquipmentServiceContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment Service Contracts",
        "label": "Equipment Service Contracts [Member]",
        "terseLabel": "Equipment service contracts"
       }
      }
     },
     "localname": "EquipmentServiceContractsMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_ExecutiveCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive Compensation",
        "label": "Executive Compensation [Member]",
        "terseLabel": "Executive Compensation"
       }
      }
     },
     "localname": "ExecutiveCompensationMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_ExecutiveEquityAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive Equity Awards",
        "label": "Executive Equity Awards [Member]",
        "terseLabel": "Executive Equity Awards"
       }
      }
     },
     "localname": "ExecutiveEquityAwardsMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_FinanceLeaseAccountsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Accounts Receivable",
        "label": "Finance Lease, Accounts Receivable",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "FinanceLeaseAccountsReceivable",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_FinanceLeaseObligationInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate of capital lease obligation.",
        "label": "Finance Lease, Obligation Interest Rate",
        "terseLabel": "Finance lease obligation interest rate"
       }
      }
     },
     "localname": "FinanceLeaseObligationInterestRate",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ams_FinanceLeaseObligations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Obligations",
        "label": "Finance Lease Obligations",
        "terseLabel": "Net book value of finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseObligations",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_FinanceLeaseObligationsMonthlyInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Obligations, Monthly Installments",
        "label": "Finance Lease Obligations, Monthly Installments",
        "terseLabel": "Monthly installments"
       }
      }
     },
     "localname": "FinanceLeaseObligationsMonthlyInstallments",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ams_FinanceLeasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Leases",
        "label": "Finance Leases [Member]",
        "terseLabel": "Finance leases (includes interest)"
       }
      }
     },
     "localname": "FinanceLeasesMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_ForeignMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_GKCEAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GKCE Acquisition",
        "label": "GKCE Acquisition [Member]",
        "terseLabel": "GKCE acquisition"
       }
      }
     },
     "localname": "GKCEAcquisitionMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_GammaKnifeAndRadiationTherapyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gamma Knife And Radiation Therapy",
        "label": "Gamma Knife And Radiation Therapy [Member]",
        "terseLabel": "Gamma Knife And Radiation Therapy"
       }
      }
     },
     "localname": "GammaKnifeAndRadiationTherapyMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_GammaKnifeCenterEcuadorSAGKCEMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gamma Knife Center Ecuador S.A. (\u201cGKCE\u201d)",
        "label": "Gamma Knife Center Ecuador S.A. (\u201cGKCE\u201d) [Member]",
        "terseLabel": "Gamma Knife Center Ecuador S.A. (\u201cGKCE\u201d)"
       }
      }
     },
     "localname": "GammaKnifeCenterEcuadorSAGKCEMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_GammaKnifePerfexionSystemMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gamma Knife Perfexion System [Member]",
        "terseLabel": "Gamma Knife Perfexion System"
       }
      }
     },
     "localname": "GammaKnifePerfexionSystemMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_GammaKnifeUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gamma Knife Unit [Member]",
        "terseLabel": "Gamma Knife Unit"
       }
      }
     },
     "localname": "GammaKnifeUnitMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_GkfSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GKF Subsidiary [Member]",
        "terseLabel": "GKF Subsidiary"
       }
      }
     },
     "localname": "GkfSubsidiaryMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_IncentiveCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Compensation Plan [Member]",
        "terseLabel": "Incentive Compensation Plan"
       }
      }
     },
     "localname": "IncentiveCompensationPlanMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_IncomeTaxDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Line Items]",
        "terseLabel": "Income Tax Disclosure [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureLineItems",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ams_IncomeTaxDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Table]",
        "terseLabel": "Income Tax Disclosure [Table]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTable",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ams_IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid and deferred revenue.",
        "label": "Increase Decrease In Accounts Payable, Accrued Liabilities And Deferred Revenue",
        "negatedLabel": "Accounts payable, accrued liabilities and deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_IncreaseDecreaseInLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Lease Liabilities",
        "label": "Increase (Decrease) In Lease Liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInLeaseLiabilities",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_IncreaseDecreaseInOtherReceivableInsuranceSettlements": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due from insurance settlements",
        "label": "Increase Decrease in Other Receivable Insurance Settlements",
        "negatedLabel": "Net insurance proceeds receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivableInsuranceSettlements",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_InterestCapitalizedToPropertyAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of interest capitalized to property and equipment in noncash transaction.",
        "label": "Interest Capitalized To Property And Equipment",
        "terseLabel": "Interest capitalized to property and equipment"
       }
      }
     },
     "localname": "InterestCapitalizedToPropertyAndEquipment",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_InterestExpenseLeaseFinancing": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Expense, Lease Financing",
        "label": "Interest Expense, Lease Financing",
        "terseLabel": "Accrued interest on lease financing"
       }
      }
     },
     "localname": "InterestExpenseLeaseFinancing",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_LINACSystemMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LINAC system [Member]",
        "terseLabel": "LINAC system"
       }
      }
     },
     "localname": "LINACSystemMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_LeaseExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period on which lease or group of leases is set to expire.",
        "label": "Lease Expiration Period",
        "terseLabel": "Lease expiration period"
       }
      }
     },
     "localname": "LeaseExpirationPeriod",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ams_LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Reassessment, Right-Of-Use Assets And Lease Liabilities",
        "label": "Lease Reassessment, Right-Of-Use Assets And Lease Liabilities",
        "terseLabel": "Lease reassessment right of use assets and lease liabilities"
       }
      }
     },
     "localname": "LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ashs.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/OPERATINGLEASESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due",
        "label": "Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due",
        "totalLabel": "Total Future Minimum Payments Due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/OPERATINGLEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/OPERATINGLEASESDetails": {
       "order": 1.0,
       "parentTag": "ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Next Twelve Months",
        "label": "Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Next Twelve Months",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueNextTwelveMonths",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/OPERATINGLEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/OPERATINGLEASESDetails": {
       "order": 4.0,
       "parentTag": "ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Four",
        "label": "Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/OPERATINGLEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/OPERATINGLEASESDetails": {
       "order": 3.0,
       "parentTag": "ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Three",
        "label": "Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/OPERATINGLEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/OPERATINGLEASESDetails": {
       "order": 2.0,
       "parentTag": "ams_LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Two",
        "label": "Lessee, Operating Lease, Liability, Payments, Net Of Sublease Income, Due Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/OPERATINGLEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_LongTermDebtMonthlyInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Debt, Monthly Installments",
        "label": "Long Term Debt, Monthly Installments",
        "terseLabel": "Monthly installments"
       }
      }
     },
     "localname": "LongTermDebtMonthlyInstallments",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ams_LongTermPurchaseCommitmentDepositsForAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term Purchase commitment deposits for the assets.",
        "label": "Long Term Purchase Commitment Deposits For Assets",
        "terseLabel": "Long term purchase commitment deposits for assets"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentDepositsForAssets",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_LongTermPurchaseCommitmentRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Purchase Commitment, Renewal Term",
        "label": "Long-term Purchase Commitment, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentRenewalTerm",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ams_LongTermServiceCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Service Commitment, Amount",
        "label": "Long-Term Service Commitment, Amount",
        "terseLabel": "Service commitment, amount"
       }
      }
     },
     "localname": "LongTermServiceCommitmentAmount",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_LongTermServiceCommitmentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Service Commitment, Period",
        "label": "Long-Term Service Commitment, Period",
        "terseLabel": "Service commitment, period"
       }
      }
     },
     "localname": "LongTermServiceCommitmentPeriod",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ams_MaintenanceAndSupportAgreementTheMevionServiceAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maintenance And Support Agreement (The \u201cMevion Service Agreement\u201d)",
        "label": "Maintenance And Support Agreement (The \u201cMevion Service Agreement\u201d) [Member]",
        "terseLabel": "Maintenance and Support Agreement (the \u201cMevion Service Agreement\u201d)"
       }
      }
     },
     "localname": "MaintenanceAndSupportAgreementTheMevionServiceAgreementMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_MedicalEquipmentAndFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical Equipment and Facilities [Member]",
        "verboseLabel": "Medical equipment and facilities"
       }
      }
     },
     "localname": "MedicalEquipmentAndFacilitiesMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_MedicalEquipmentAndOtherFixedAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Equipment And Other Fixed Assets",
        "label": "Medical Equipment And Other Fixed Assets [Member]",
        "terseLabel": "Medical equipment"
       }
      }
     },
     "localname": "MedicalEquipmentAndOtherFixedAssetsMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_MedicalEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Equipment",
        "label": "Medical Equipment [Member]",
        "terseLabel": "Medical equipment"
       }
      }
     },
     "localname": "MedicalEquipmentMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_MevionMedicalSystemsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mevion Medical Systems Inc [Member]",
        "terseLabel": "Mevion Medical Systems Inc"
       }
      }
     },
     "localname": "MevionMedicalSystemsIncMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_NetIncomeLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss)",
        "label": "Net Income (Loss) [Member]",
        "terseLabel": "Net Income (Loss)"
       }
      }
     },
     "localname": "NetIncomeLossMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_NonCashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Cash Lease Expense",
        "label": "Non-Cash Lease Expense",
        "terseLabel": "Non cash lease expense"
       }
      }
     },
     "localname": "NonCashLeaseExpense",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_NonCashRightOfUseAssetsAndLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of Right of use assets and lease liabilities that were incurred during a noncash or partial noncash transaction.",
        "label": "Non-Cash Right Of Use Assets And Lease Liabilities",
        "terseLabel": "Right of use assets and lease liabilities"
       }
      }
     },
     "localname": "NonCashRightOfUseAssetsAndLeaseLiabilities",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ashs.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_NonEmployeeDirectorsAndCorporateSecretaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Employee Directors And Corporate Secretary [Member]",
        "verboseLabel": "Non Employee Directors and Corporate Secretary"
       }
      }
     },
     "localname": "NonEmployeeDirectorsAndCorporateSecretaryMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_NonEmployeeDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Employee Directors [Member]",
        "terseLabel": "Non Employee Directors"
       }
      }
     },
     "localname": "NonEmployeeDirectorsMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_NoncontrollingInterestsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent.",
        "label": "Noncontrolling Interests [Policy Text Block]",
        "verboseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestsPolicyTextBlock",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ams_NumberOfCobalt60Reloads": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Cobalt-60 Reloads",
        "label": "Number Of Cobalt-60 Reloads",
        "terseLabel": "Number of Cobalt-60 reloads"
       }
      }
     },
     "localname": "NumberOfCobalt60Reloads",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual"
     ],
     "xbrltype": "integerItemType"
    },
    "ams_NumberOfCustomersWithIntentToTerminateContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Customers With Intent To Terminate Contract",
        "label": "Number Of Customers With Intent To Terminate Contract",
        "terseLabel": "Number of customers with intent to terminate contract"
       }
      }
     },
     "localname": "NumberOfCustomersWithIntentToTerminateContract",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ams_NumberOfDebtInstruments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Debt Instruments",
        "label": "Number Of Debt Instruments",
        "terseLabel": "Number of notes"
       }
      }
     },
     "localname": "NumberOfDebtInstruments",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ams_NumberOfDeposits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Deposits",
        "label": "Number Of Deposits",
        "terseLabel": "Number of deposits"
       }
      }
     },
     "localname": "NumberOfDeposits",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ams_NumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Employees",
        "label": "Number Of Employees",
        "terseLabel": "Number of employees"
       }
      }
     },
     "localname": "NumberOfEmployees",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ams_NumberOfFinancingLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Financing Leases",
        "label": "Number Of Financing Leases",
        "terseLabel": "Number of financing leases"
       }
      }
     },
     "localname": "NumberOfFinancingLeases",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ams_NumberOfImpairedAssetUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Impaired Asset Units",
        "label": "Number Of Impaired Asset Units",
        "terseLabel": "Number of impaired asset units"
       }
      }
     },
     "localname": "NumberOfImpairedAssetUnits",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ams_NumberOfLeksellGammaKnifeIconSystemInstalls": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Leksell Gamma Knife Icon System Installs",
        "label": "Number Of Leksell Gamma Knife Icon System Installs",
        "terseLabel": "Number of Leksell Gamma Knife Icon System installs"
       }
      }
     },
     "localname": "NumberOfLeksellGammaKnifeIconSystemInstalls",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual"
     ],
     "xbrltype": "integerItemType"
    },
    "ams_NumberOfPerfexionUpgrades": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Perfexion Upgrades",
        "label": "Number Of Perfexion Upgrades",
        "terseLabel": "Number of Perfexion upgrades"
       }
      }
     },
     "localname": "NumberOfPerfexionUpgrades",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual"
     ],
     "xbrltype": "integerItemType"
    },
    "ams_NumberOfPurchaseCommitments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Purchase Commitments",
        "label": "Number Of Purchase Commitments",
        "terseLabel": "Number of purchase commitments"
       }
      }
     },
     "localname": "NumberOfPurchaseCommitments",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ams_OffsettingTaxBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of offsetting tax benefit.",
        "label": "Offsetting Tax Benefit",
        "terseLabel": "Offsetting tax benefit"
       }
      }
     },
     "localname": "OffsettingTaxBenefit",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_OperatingLeaseMonthlyLeaseExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Monthly Lease Expense",
        "label": "Operating Lease, Monthly Lease Expense",
        "terseLabel": "Monthly lease expense"
       }
      }
     },
     "localname": "OperatingLeaseMonthlyLeaseExpense",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_OperatingLeasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases",
        "label": "Operating Leases [Member]",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeasesMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_Or21LlcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OR21 LLC [Member]",
        "terseLabel": "OR21 LLC"
       }
      }
     },
     "localname": "Or21LlcMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_OtherFixedAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Fixed Assets",
        "label": "Other Fixed Assets [Member]",
        "terseLabel": "Other fixed assets"
       }
      }
     },
     "localname": "OtherFixedAssetsMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_PaymentsForAssetAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Asset Acquisitions",
        "label": "Payments For Asset Acquisitions",
        "terseLabel": "Payments for asset acquisitions"
       }
      }
     },
     "localname": "PaymentsForAssetAcquisitions",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_PaymentsForWorkingCapital": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 2.0,
       "parentTag": "ams_AssetAcquisitionConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Working Capital",
        "label": "Payments For Working Capital",
        "negatedTerseLabel": "First working capital payment",
        "terseLabel": "First working capital payment",
        "verboseLabel": "First working capital payment related to acquisition, withholding taxes"
       }
      }
     },
     "localname": "PaymentsForWorkingCapital",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_PaymentsToAcquireAsset": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Acquire Asset",
        "label": "Payments To Acquire Asset",
        "terseLabel": "Payments to acquire asset"
       }
      }
     },
     "localname": "PaymentsToAcquireAsset",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_PercentageOfTaxBenefitRealizedUponSettlement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents the percentage of tax benefit realized upon ultimate settlement.",
        "label": "Percentage Of Tax Benefit Realized Upon Settlement",
        "terseLabel": "Percentage of tax benefit realized upon settlement"
       }
      }
     },
     "localname": "PercentageOfTaxBenefitRealizedUponSettlement",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ams_PerformanceShareAwardAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance Share Award Agreement [Member]",
        "terseLabel": "Performance Share Award Agreement"
       }
      }
     },
     "localname": "PerformanceShareAwardAgreementMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_PeruDeferredTaxAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Peru Deferred Tax Assets",
        "label": "Peru Deferred Tax Assets [Member]",
        "terseLabel": "Peru"
       }
      }
     },
     "localname": "PeruDeferredTaxAssetsMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_ProceedsFromFinancingFromAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Financing From Acquisition",
        "label": "Proceeds From Financing From Acquisition",
        "terseLabel": "Proceeds from financing from acquisition"
       }
      }
     },
     "localname": "ProceedsFromFinancingFromAcquisition",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_ProtonBeamRadiationTherapyPBRTMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proton Beam Radiation Therapy (\u201cPBRT\u201d)",
        "label": "Proton Beam Radiation Therapy (\u201cPBRT\u201d) [Member]",
        "terseLabel": "Proton Beam Radiation Therapy (\u201cPBRT\u201d)"
       }
      }
     },
     "localname": "ProtonBeamRadiationTherapyPBRTMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_PurchaseAgreementAnnualPrepayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents the amount of purchase agreement annual prepayment.",
        "label": "Purchase Agreement Annual Prepayment",
        "terseLabel": "Purchase agreement annual prepayment"
       }
      }
     },
     "localname": "PurchaseAgreementAnnualPrepayment",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_RSUsIssuedInLieuOfRetainerFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RSUs Issued In Lieu Of Retainer Fees",
        "label": "RSUs Issued In Lieu Of Retainer Fees [Member]",
        "terseLabel": "RSUs Issued in Lieu of Retainer Fees"
       }
      }
     },
     "localname": "RSUsIssuedInLieuOfRetainerFeesMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_RepaymentsOfLongTermFinanceLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments Of Long-term Finance Lease Obligations",
        "label": "Repayments Of Long-term Finance Lease Obligations",
        "negatedTerseLabel": "Principal payments on finance leases"
       }
      }
     },
     "localname": "RepaymentsOfLongTermFinanceLeaseObligations",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_RetainerFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retainer Fees [Member]",
        "terseLabel": "Retainer Fees"
       }
      }
     },
     "localname": "RetainerFeesMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule Of Components Of Deferred Tax Assets and Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Amounts Presented in Financial Statements"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ams_ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the presentation of foreign and domestic break out on the statement of financial position.",
        "label": "Schedule of Domestic and Foreign Break out Percentages [Table Text Block]",
        "terseLabel": "Schedule of Domestic and Foreign Break out Percentages"
       }
      }
     },
     "localname": "ScheduleOfDomesticAndForeignBreakOutPercentagesTableTextBlock",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ams_ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Tangible Assets Acquired As Part Of Business Combination",
        "label": "Schedule Of Tangible Assets Acquired As Part Of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of tangible assets acquired as part of business combination"
       }
      }
     },
     "localname": "ScheduleOfTangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ams_SeniorVicePresidentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Vice President",
        "label": "Senior Vice President [Member]",
        "terseLabel": "Senior Vice President"
       }
      }
     },
     "localname": "SeniorVicePresidentMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to forfeiture during a period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Foreiture Rate",
        "verboseLabel": "Expected forfeiture rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForeitureRate",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number",
        "terseLabel": "Shares vested and outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ams_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining number of shares available for grant.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Remaining Number Of Shares Available For Grant",
        "terseLabel": "Remaining shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingNumberOfSharesAvailableForGrant",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ams_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Granted, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Term (Years) Granted"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ams_StockOptionExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The range of exercise prices of common stock that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Stock Option, Exercise Price",
        "terseLabel": "Stock options exercise price (in dollars per share)"
       }
      }
     },
     "localname": "StockOptionExercisePrice",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ams_SubsequentWorkingCapitalPaymentAccruedForAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsequent Working Capital Payment Accrued For Acquisition",
        "label": "Subsequent Working Capital Payment Accrued For Acquisition",
        "terseLabel": "Estimated subsequent working capital payment for acquisition"
       }
      }
     },
     "localname": "SubsequentWorkingCapitalPaymentAccruedForAcquisition",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ams_TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two MEVION S250i Proton Beam Radiation Therapy Systems [Member]",
        "terseLabel": "Two MEVION S250i Proton Beam Radiation Therapy Systems"
       }
      }
     },
     "localname": "TwoMEVIONS250iProtonBeamRadiationTherapySystemsMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_UnitsRemovedFromServiceInCurrentYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Units Removed From Service In Current Year",
        "label": "Units Removed From Service In Current Year [Member]",
        "terseLabel": "Units removed from service in current year"
       }
      }
     },
     "localname": "UnitsRemovedFromServiceInCurrentYearMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_UnitsRemovedFromServiceInPriorYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Units Removed From Service In Prior Years",
        "label": "Units Removed From Service In Prior Years [Member]",
        "terseLabel": "Units removed from service in prior years"
       }
      }
     },
     "localname": "UnitsRemovedFromServiceInPriorYearsMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_UnitsThatWillBeRemovedFromServiceInFutureYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Units That Will Be Removed From Service In Future Years",
        "label": "Units That Will Be Removed From Service In Future Years [Member]",
        "terseLabel": "Units that will be removed from service in future years"
       }
      }
     },
     "localname": "UnitsThatWillBeRemovedFromServiceInFutureYearsMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_UsSubsidiaryOfElektaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U.S. Subsidiary Of Elekta [Member]",
        "terseLabel": "U.S. Subsidiary Of Elekta"
       }
      }
     },
     "localname": "UsSubsidiaryOfElektaMember",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "ams_WorkingCapitalPaymentLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Working Capital Payment Liability, Current",
        "label": "Working Capital Payment Liability, Current",
        "terseLabel": "Working capital payment due"
       }
      }
     },
     "localname": "WorkingCapitalPaymentLiabilityCurrent",
     "nsuri": "http://www.ashs.com/20201231",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r544",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r544",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r168",
      "r245",
      "r249",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r272",
      "r273",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r464",
      "r510",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://www.ashs.com/role/FINANCELEASESNarrativeDetails",
      "http://www.ashs.com/role/LEASESNarrativeDetails",
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r272",
      "r273",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r464",
      "r510",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://www.ashs.com/role/FINANCELEASESNarrativeDetails",
      "http://www.ashs.com/role/LEASESNarrativeDetails",
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r168",
      "r245",
      "r249",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r252",
      "r272",
      "r273",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r464",
      "r510",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://www.ashs.com/role/FINANCELEASESNarrativeDetails",
      "http://www.ashs.com/role/LEASESNarrativeDetails",
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r252",
      "r272",
      "r273",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r464",
      "r510",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://www.ashs.com/role/FINANCELEASESNarrativeDetails",
      "http://www.ashs.com/role/LEASESNarrativeDetails",
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r166",
      "r167",
      "r245",
      "r248",
      "r511",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails",
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r166",
      "r167",
      "r245",
      "r248",
      "r511",
      "r527",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails",
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r169",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Relationship to Entity [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "Accounting Standards Update 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r21",
      "r170",
      "r171"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net of allowance for doubtful accounts of $100,000 at December 31, 2020 and December 31, 2019"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableRelatedParties": {
     "auth_ref": [
      "r20",
      "r93",
      "r428",
      "r431",
      "r504"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.",
        "label": "Accounts Receivable, Related Parties",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r13",
      "r484",
      "r499"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedCapitalizedInterestCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated interest costs capitalized as part of property, plant and equipment cost basis.",
        "label": "Accumulated Capitalized Interest Costs",
        "terseLabel": "Accumulated capitalized interest costs"
       }
      }
     },
     "localname": "AccumulatedCapitalizedInterestCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r106",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r349",
      "r350",
      "r351",
      "r352",
      "r466",
      "r467",
      "r468",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income to net cash from operating activities (excluding assets acquired and liabilities assumed):"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r276",
      "r304",
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Allocated share-based compensation expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r27",
      "r176",
      "r191"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "verboseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AreaOfLand": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of land held.",
        "label": "Area of Land",
        "terseLabel": "Area of facility"
       }
      }
     },
     "localname": "AreaOfLand",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r75",
      "r212"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "verboseLabel": "Loss on write down impaired assets"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetRetirementObligation": {
     "auth_ref": [
      "r220"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.",
        "label": "Asset Retirement Obligation",
        "terseLabel": "Asset retirement obligation liability"
       }
      }
     },
     "localname": "AssetRetirementObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetRetirementObligationCurrent": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.",
        "label": "Asset Retirement Obligation, Current",
        "terseLabel": "Asset retirement obligations"
       }
      }
     },
     "localname": "AssetRetirementObligationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r90",
      "r148",
      "r157",
      "r163",
      "r184",
      "r374",
      "r380",
      "r394",
      "r483",
      "r498"
     ],
     "calculation": {
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails",
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets:",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails",
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r47",
      "r90",
      "r184",
      "r374",
      "r380",
      "r394"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r386"
     ],
     "calculation": {
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total, Fair Value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r278",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "terseLabel": "Fair value of noncontrolling interest"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r365"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "GKCE ACQUISITION"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r85",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r30",
      "r77"
     ],
     "calculation": {
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash, cash equivalents, restricted cash, Carrying Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails",
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r11",
      "r78",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r11",
      "r78",
      "r85",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r70",
      "r77",
      "r83"
     ],
     "calculation": {
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of year",
        "periodStartLabel": "CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of year",
        "terseLabel": "Cash, cash equivalents, restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails",
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r70",
      "r395"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r88",
      "r90",
      "r118",
      "r119",
      "r120",
      "r122",
      "r124",
      "r130",
      "r131",
      "r132",
      "r184",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r42",
      "r224",
      "r490",
      "r505"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "COMMITMENTS AND CONTINGENCIES (See Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r100",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r19",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, no par value (10,000,000 authorized; Issued and outstanding shares \u2013 5,714,000 at December 31, 2018 and 5,710,000 at December 31, 2017"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r84",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r137",
      "r138",
      "r168",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r137",
      "r138",
      "r168",
      "r392",
      "r393",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r137",
      "r138",
      "r168",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r242",
      "r243",
      "r246"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "DEFERRED REVENUE, less current portion"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Contractual Obligation",
        "totalLabel": "Total amounts committed"
       }
      }
     },
     "localname": "ContractualObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueAfterFifthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation, to be Paid, after Year Five",
        "terseLabel": "After 5\u00a0years"
       }
      }
     },
     "localname": "ContractualObligationDueAfterFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueInFourthAndFifthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in fourth and fifth fiscal years following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation, to be Paid, Year Four and Five",
        "terseLabel": "2024-2025"
       }
      }
     },
     "localname": "ContractualObligationDueInFourthAndFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "ContractualObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueInSecondAndThirdYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in second and third fiscal years following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation, to be Paid, Year Two and Three",
        "terseLabel": "2022-2023"
       }
      }
     },
     "localname": "ContractualObligationDueInSecondAndThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "verboseLabel": "Costs of revenue:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Costs of revenue"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r92",
      "r345",
      "r355"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "verboseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r345"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r92",
      "r345",
      "r355",
      "r357"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "verboseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r92",
      "r345",
      "r355"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "verboseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r489",
      "r506"
     ],
     "calculation": {
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "verboseLabel": "Debt obligations, Carrying Value"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCollateralAmount": {
     "auth_ref": [
      "r495"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets pledged to secure a debt instrument.",
        "label": "Debt Instrument, Collateral Amount",
        "terseLabel": "Aggregate net book value"
       }
      }
     },
     "localname": "DebtInstrumentCollateralAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r41",
      "r95",
      "r233",
      "r236",
      "r237",
      "r238",
      "r405",
      "r406",
      "r408",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r92",
      "r346",
      "r355"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "verboseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r34",
      "r407"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r92",
      "r346",
      "r355"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r75",
      "r92",
      "r346",
      "r355",
      "r356",
      "r357"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "verboseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r15",
      "r16",
      "r336",
      "r485",
      "r497"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r324",
      "r325"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedLabel": "Deferred income taxes (non-current)",
        "terseLabel": "DEFERRED INCOME TAXES"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r92",
      "r346",
      "r355"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "verboseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.",
        "label": "Deferred Tax Assets, Capital Loss Carryforwards",
        "verboseLabel": "Capital loss carryover"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r337"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r339"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets net of valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Domestic operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "State and local operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "verboseLabel": "Other \u2013 net"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r342",
      "r343",
      "r344"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Returns and Allowances",
        "terseLabel": "Accruals and allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r338"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r325",
      "r339"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofAmountsPresentedinFinancialStatementsDetails",
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r271"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Cost of contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/RETIREMENTPLANDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Employer matching contribution, percent of employee gross pay"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/RETIREMENTPLANDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r75",
      "r213"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r75",
      "r146"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DirectOperatingMaintenanceSuppliesCosts": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of maintenance supplies used that are directly related to goods produced and sold, or services rendered, during the reporting period.",
        "label": "Direct Operating Maintenance Supplies Costs",
        "verboseLabel": "Maintenance and supplies"
       }
      }
     },
     "localname": "DirectOperatingMaintenanceSuppliesCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r278",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "verboseLabel": "Net (loss) income per share attributable to American Shared Hospital Services:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r54",
      "r107",
      "r108",
      "r109",
      "r110",
      "r111",
      "r115",
      "r118",
      "r122",
      "r123",
      "r124",
      "r127",
      "r128",
      "r492",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "(Loss) earnings per common share - basic (in dollars per share)",
        "verboseLabel": "(Loss) income per common share - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails",
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r54",
      "r107",
      "r108",
      "r109",
      "r110",
      "r111",
      "r118",
      "r122",
      "r123",
      "r124",
      "r127",
      "r128",
      "r492",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "(Loss) income per common share - diluted (in dollars per share)",
        "verboseLabel": "(Loss) earnings per common share - diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails",
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r85",
      "r125",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r327",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal statutory income tax rate, percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeBenefitsAndShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for employee benefit and equity-based compensation.",
        "label": "Employee Benefits and Share-based Compensation",
        "terseLabel": "Employee benefits and share-based compensation"
       }
      }
     },
     "localname": "EmployeeBenefitsAndShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost related to non-vested shares"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Future equipment purchases"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r104",
      "r112",
      "r114",
      "r129",
      "r188",
      "r232",
      "r239",
      "r312",
      "r313",
      "r314",
      "r351",
      "r352",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r516",
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment, ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r268",
      "r387",
      "r437",
      "r438",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r253",
      "r255",
      "r260",
      "r268",
      "r387",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r253",
      "r255",
      "r260",
      "r268",
      "r387",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r268",
      "r387",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": {
     "auth_ref": [
      "r386",
      "r387"
     ],
     "calculation": {
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations measured on a recurring basis.",
        "label": "Obligations, Fair Value Disclosure",
        "verboseLabel": "Debt obligations, Fair Value"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r268",
      "r437",
      "r438",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r85",
      "r390",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r414",
      "r420",
      "r422"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest expense associated with lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r413",
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/FINANCELEASESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ashs.com/role/FINANCELEASESDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "totalLabel": "Gross minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r413"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ashs.com/role/FINANCELEASESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current portion of finance leases",
        "verboseLabel": "Less current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ashs.com/role/FINANCELEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments for Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r413"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.ashs.com/role/FINANCELEASESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "LONG-TERM FINANCE LEASES, less current portion",
        "verboseLabel": "Noncurrent portion finance lease liability"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ashs.com/role/FINANCELEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/FINANCELEASESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ashs.com/role/FINANCELEASESDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total finance lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/FINANCELEASESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "verboseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/FINANCELEASESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/FINANCELEASESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/FINANCELEASESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/FINANCELEASESDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r180",
      "r181",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r85",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Functional currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "negatedTerseLabel": "Loss on write down of impaired assets and associated removal costs",
        "terseLabel": "Loss on write down of impaired assets and associated removal costs"
       }
      }
     },
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails",
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r201",
      "r202",
      "r482"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "verboseLabel": "GOODWILL"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r203"
     ],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 1.0,
       "parentTag": "ams_AssetAcquisitionAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r85",
      "r204",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and intangible assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r56",
      "r90",
      "r148",
      "r156",
      "r159",
      "r162",
      "r164",
      "r184",
      "r394"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r75",
      "r211"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment of long-lived assets to be disposed of"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r85",
      "r210",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long lived asset impairment"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r96",
      "r148",
      "r156",
      "r159",
      "r162",
      "r164"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "(Loss) income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r328",
      "r334",
      "r341",
      "r353",
      "r359",
      "r361",
      "r362",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r92",
      "r113",
      "r114",
      "r147",
      "r326",
      "r354",
      "r360",
      "r509"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "totalLabel": "Income tax expense (benefit)",
        "verboseLabel": "Income tax (benefit) expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails",
      "http://www.ashs.com/role/INCOMETAXESScheduleofComponentsofIncomeTaxExpenseBenefitDetails",
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails",
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r51",
      "r85",
      "r322",
      "r323",
      "r334",
      "r335",
      "r340",
      "r347",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "verboseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r321",
      "r327"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "verboseLabel": "Computed expected federal income tax"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "verboseLabel": "Non-deductible expenses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "verboseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r72",
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "verboseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
        "label": "Increase (Decrease) in Accounts Payable, Related Parties",
        "terseLabel": "Increase (decrease) in accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r206",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r206",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IndefinitelivedIntangibleAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 3.0,
       "parentTag": "ams_AssetAcquisitionAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.",
        "label": "Indefinite-lived Intangible Assets Acquired",
        "terseLabel": "Purchased intangible assets"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r205",
      "r208"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest and Other Income",
        "verboseLabel": "Interest and other income"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r404"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Interest costs capitalized"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r52",
      "r145",
      "r403",
      "r407",
      "r493"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r68",
      "r71",
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r7",
      "r32"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "LAND"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOperatingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases, Operating [Abstract]",
        "terseLabel": "Leases, Operating [Abstract]"
       }
      }
     },
     "localname": "LeasesOperatingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "FINANCE LEASES"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/FINANCELEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments.",
        "label": "Lessee, Operating Lease, Discount Rate",
        "terseLabel": "Lessee, discount rate"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Summary of Maturities of Lessee Operating Lease",
        "verboseLabel": "Schedule of Future Minimum Rental Payments for Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASESTables",
      "http://www.ashs.com/role/OPERATINGLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Operating\u200b lease \u200bremaining \u200blease \u200bterm"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r37",
      "r90",
      "r158",
      "r184",
      "r375",
      "r380",
      "r381",
      "r394"
     ],
     "calculation": {
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r90",
      "r184",
      "r394",
      "r488",
      "r503"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r39",
      "r90",
      "r184",
      "r375",
      "r380",
      "r381",
      "r394"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r386"
     ],
     "calculation": {
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total, Fair Value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r14",
      "r227",
      "r486",
      "r500"
     ],
     "calculation": {
      "http://www.ashs.com/role/LONGTERMDEBTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt, Fiscal Year Maturity [Abstract]",
        "verboseLabel": "Principal"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r98",
      "r226"
     ],
     "calculation": {
      "http://www.ashs.com/role/LONGTERMDEBTDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r98",
      "r226"
     ],
     "calculation": {
      "http://www.ashs.com/role/LONGTERMDEBTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "verboseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r98",
      "r226"
     ],
     "calculation": {
      "http://www.ashs.com/role/LONGTERMDEBTDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r98",
      "r226"
     ],
     "calculation": {
      "http://www.ashs.com/role/LONGTERMDEBTDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r98",
      "r226"
     ],
     "calculation": {
      "http://www.ashs.com/role/LONGTERMDEBTDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r98",
      "r226"
     ],
     "calculation": {
      "http://www.ashs.com/role/LONGTERMDEBTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term debt (includes interest)"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "verboseLabel": "LONG-TERM DEBT, less current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingVariableInterestRate": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.",
        "label": "Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate",
        "terseLabel": "Long-term debt percentage rate"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "LONG TERM DEBT"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.",
        "label": "Long-term Purchase Commitment, Amount",
        "terseLabel": "Long-term purchase commitment amount"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Long-term Purchase Commitment [Line Items]",
        "terseLabel": "Long-term Purchase Commitment [Line Items]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule setting forth key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.",
        "label": "Long-term Purchase Commitment [Table]",
        "terseLabel": "Long-term Purchase Commitment [Table]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.",
        "label": "Long-term Purchase Commitment [Table Text Block]",
        "terseLabel": "Schedule of Long-term Purchase Commitment"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermPurchaseCommitmentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Long-term Purchase Commitment, Period",
        "terseLabel": "Commitment period"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r46",
      "r90",
      "r184",
      "r394",
      "r487",
      "r502"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "verboseLabel": "Non-controlling interests in subsidiaries"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Cash distributions to non-controlling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Noncontrolling Interest, Ownership Percentage by Parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r70",
      "r73",
      "r76"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r49",
      "r50",
      "r53",
      "r76",
      "r90",
      "r103",
      "r107",
      "r108",
      "r109",
      "r110",
      "r113",
      "r114",
      "r121",
      "r148",
      "r156",
      "r159",
      "r162",
      "r164",
      "r184",
      "r394",
      "r491",
      "r507"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Numerator for basic and diluted (loss) earnings per share",
        "totalLabel": "Net (loss) income attributable to American Shared Hospital Services",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails",
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails",
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r49",
      "r50",
      "r113",
      "r114",
      "r377",
      "r383"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: net loss (income) attributable to non-controlling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting pronouncement issued and adopted and issued and not yet adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "auth_ref": [
      "r80",
      "r81",
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "terseLabel": "Acquisition of equipment with finance leases"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r240",
      "r368",
      "r379"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "NCI investment in acquisition"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r239",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "verboseLabel": "Non-controlling Interests in Subsidiaries"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Office equipment",
        "verboseLabel": "Medical and Office equipment"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r148",
      "r156",
      "r159",
      "r162",
      "r164"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating (loss) income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r415"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Rent expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/OPERATINGLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r413"
     ],
     "calculation": {
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease, liability",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASESNarrativeDetails",
      "http://www.ashs.com/role/LEASESSummaryofMaturitiesofLesseeOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r413"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r413"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "LONG-TERM LEASE LIABILITIES, less current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "RIGHT OF USE ASSETS",
        "verboseLabel": "Operating lease, right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ashs.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": {
     "auth_ref": [
      "r409",
      "r410",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessor's operating leases.",
        "label": "Lessor, Operating Leases [Text Block]",
        "terseLabel": "OPERATING LEASES"
       }
      }
     },
     "localname": "OperatingLeasesOfLessorDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/OPERATINGLEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r342"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "International operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r2",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "verboseLabel": "BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r38"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "OTHER ASSETS"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of other commitment.",
        "label": "Other Commitments [Axis]",
        "terseLabel": "Other Commitments [Axis]"
       }
      }
     },
     "localname": "OtherCommitmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation.",
        "label": "Other Commitments [Domain]",
        "terseLabel": "Other Commitments [Domain]"
       }
      }
     },
     "localname": "OtherCommitmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESScheduleofLongtermPurchaseCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities.",
        "label": "Other Cost of Operating Revenue",
        "verboseLabel": "Other direct operating costs"
       }
      }
     },
     "localname": "OtherCostOfOperatingRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "verboseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherTaxExpenseBenefit": {
     "auth_ref": [
      "r91",
      "r326",
      "r347"
     ],
     "calculation": {
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other income tax expense (benefit).",
        "label": "Other Tax Expense (Benefit)",
        "verboseLabel": "Other deferred tax adjustments"
       }
      }
     },
     "localname": "OtherTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "verboseLabel": "Sub-Total ASHS"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Payment for acquisition, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Payment for purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Distributions to non-controlling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r252",
      "r254",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "RETIREMENT PLAN"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/RETIREMENTPLAN"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r278",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r28",
      "r29"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermCapitalLeaseObligations": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from proceeds received from lessor related to a long-term capital lease obligation.",
        "label": "Proceeds from Long-term Capital Lease Obligations",
        "verboseLabel": "Principal payments on short-term financing"
       }
      }
     },
     "localname": "ProceedsFromLongTermCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfMachineryAndEquipment": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sale of machinery and equipment.",
        "label": "Proceeds from Sale of Machinery and Equipment",
        "verboseLabel": "Proceeds from sale of equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfMachineryAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r63",
      "r307"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from stock options exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "verboseLabel": "Proceeds from warrants and options exercised"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r49",
      "r50",
      "r69",
      "r90",
      "r103",
      "r113",
      "r114",
      "r148",
      "r156",
      "r159",
      "r162",
      "r164",
      "r184",
      "r373",
      "r376",
      "r378",
      "r383",
      "r384",
      "r394",
      "r494"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net (loss) income",
        "totalLabel": "Net (loss) income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY",
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAdditions": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails": {
       "order": 2.0,
       "parentTag": "ams_AssetAcquisitionAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Additions",
        "terseLabel": "Property, plant and equipment, additions"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAdditions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r215",
      "r414",
      "r420"
     ],
     "calculation": {
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedLabel": "Accumulated depreciation",
        "terseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r48",
      "r216",
      "r420"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "netLabel": "Property and equipment, net",
        "terseLabel": "PROPERTY AND EQUIPMENT, net",
        "totalLabel": "Net property and equipment",
        "verboseLabel": "Original cost of operating lease contracts"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails",
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r12",
      "r214",
      "r412"
     ],
     "calculation": {
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Gross property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r33",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails",
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r219",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r31",
      "r85",
      "r216",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r12",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r12",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails",
      "http://www.ashs.com/role/LONGTERMDEBTNarrativeDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r262",
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r262",
      "r427",
      "r428",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r262",
      "r427",
      "r431",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r425",
      "r426",
      "r428",
      "r432",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Principal payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r11",
      "r77",
      "r83"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "verboseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r239",
      "r315",
      "r501",
      "r520",
      "r525"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r104",
      "r112",
      "r114",
      "r188",
      "r312",
      "r313",
      "r314",
      "r351",
      "r352",
      "r516",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r143",
      "r144",
      "r155",
      "r160",
      "r161",
      "r165",
      "r166",
      "r168",
      "r244",
      "r245",
      "r465"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails",
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r143",
      "r144",
      "r155",
      "r160",
      "r161",
      "r165",
      "r166",
      "r168",
      "r244",
      "r245",
      "r465"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Revenue recognized, including assessed tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r86",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r137",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofDomesticandForeignBreakoutPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofTangibleAssetsAcquiredasPartofBusinessCombinationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of purchase price consideration"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/GKCEACQUISITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r1",
      "r90",
      "r183",
      "r184",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r386",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LONGTERMDEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Share Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r33",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r94",
      "r429",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/RELATEDPARTYTRANSACTIONSDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r278",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r283",
      "r294",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Share-based Compensation, Stock Options, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r43",
      "r88",
      "r130",
      "r131",
      "r229",
      "r230",
      "r231",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r333",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r85",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Business segment information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r85",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "Sales and Marketing"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Options granted in period (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average intrinsic value of award granted under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share",
        "verboseLabel": "Intrinsic Value, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Grant date weighted-average fair value, granted (in dollars per share)",
        "verboseLabel": "Grant Date Weighted-Average Fair Value, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value",
        "periodEndLabel": "Intrinsic Value, Outstanding (in dollars per share)",
        "periodStartLabel": "Intrinsic Value, Outstanding (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Amount of nonvested options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Grant Date Weighted-Average Fair Value, Outstanding (in dollars per share)",
        "periodStartLabel": "Grant Date Weighted-Average Fair Value, Outstanding (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)",
        "terseLabel": "Shares vested in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average intrinsic value of award vested under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share",
        "verboseLabel": "Intrinsic Value, Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Grant Date Weighted-Average Fair Value, Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "verboseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "verboseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "verboseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r284",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "Outstanding ending balance (in shares)",
        "periodStartLabel": "Outstanding beginning balance (in shares)",
        "terseLabel": "Shares outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Number of Options, Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Grant Date Weighted-Average Fair Value, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r285",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding ending balance (in shares)",
        "terseLabel": "Outstanding beginning balance (in shares)",
        "verboseLabel": "Outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Options",
        "verboseLabel": "Restricted Stock Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price, Ending balance (in dollars per share)",
        "periodStartLabel": "Weighted Average Exercise Price, Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Grant Date Weighted- Average Fair Value",
        "verboseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r275",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEDisclosureofSharebasedCompensationArrangementsbySharebasedPaymentAwardDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted Average Exercise Price, Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted Average Exercise Price, Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted Average Exercise Price, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Intrinsic Value",
        "verboseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedCompensationRestrictedStockandRestrictedStockUnitsActivityDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r299",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected life (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Term (Years), Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares",
        "periodEndLabel": "Outstanding ending balance (in shares)",
        "periodStartLabel": "Outstanding beginning balance (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "periodEndLabel": "Grant Date Weighted-Average Fair Value, Outstanding (in dollars per share)",
        "periodStartLabel": "Grant Date Weighted-Average Fair Value, Outstanding (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant-Date Fair Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of options vested in period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted Average Grant-Date Fair Value, Nonvested, Vested (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSEScheduleofNonvestedShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance at end (in shares)",
        "periodStartLabel": "Balance at beginning (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r88",
      "r90",
      "r118",
      "r119",
      "r120",
      "r122",
      "r124",
      "r130",
      "r131",
      "r132",
      "r184",
      "r232",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r45",
      "r100",
      "r101",
      "r102",
      "r104",
      "r112",
      "r114",
      "r129",
      "r188",
      "r232",
      "r239",
      "r312",
      "r313",
      "r314",
      "r351",
      "r352",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r516",
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/BUSINESSANDBASISOFPRESENTATIONNarrativeDetails",
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r129",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "terseLabel": "Shares issued for services (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r232",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "negatedTerseLabel": "Restricted common shares returned to plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r18",
      "r19",
      "r232",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock awards (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r18",
      "r19",
      "r232",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Stock-based compensation expense (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r18",
      "r19",
      "r232",
      "r239",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Options exercised in period (in shares)",
        "verboseLabel": "Options exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails",
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSESharebasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r18",
      "r19",
      "r239",
      "r277",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r45",
      "r232",
      "r239"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Number of shares authorized to be repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
        "terseLabel": "Remaining number of shares authorized to be repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r19",
      "r24",
      "r25",
      "r90",
      "r178",
      "r184",
      "r394"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total equity- American Shared Hospital Services"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r90",
      "r100",
      "r101",
      "r102",
      "r104",
      "r112",
      "r184",
      "r188",
      "r239",
      "r312",
      "r313",
      "r314",
      "r351",
      "r352",
      "r371",
      "r372",
      "r382",
      "r394",
      "r396",
      "r397",
      "r401",
      "r517",
      "r518"
     ],
     "calculation": {
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end",
        "periodStartLabel": "Balance at beginning",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r89",
      "r239",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION EXPENSE"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "SUPPLEMENTAL CASH FLOW DISCLOSURE"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "auth_ref": [
      "r0",
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.",
        "label": "Tangible Asset Impairment Charges",
        "terseLabel": "Tangible asset impairment charges"
       }
      }
     },
     "localname": "TangibleAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts receivable and doubtful accounts"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Purchased intangible assets"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONNarrativeDetails",
      "http://www.ashs.com/role/GKCEACQUISITIONScheduleofPurchasePriceConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r180",
      "r181",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r106",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r349",
      "r350",
      "r351",
      "r352",
      "r466",
      "r467",
      "r468",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r320",
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails",
      "http://www.ashs.com/role/INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r329"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Amount accrued for income tax penalties and interest accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "verboseLabel": "Additions based on tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136",
      "r139",
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates in the preparation of financial statements"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r339"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Decrease in net valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "verboseLabel": "Effect of dilutive securities Employee stock options and restricted stock (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "verboseLabel": "Effect of dilutive securities"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r117",
      "r124"
     ],
     "calculation": {
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Denominator for diluted (loss) earnings per share \u2013 adjusted weighted-average shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "verboseLabel": "Denominator for basic and diluted (loss) earnings per share \u2013 weighted-average shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/ACCOUNTINGPOLICIESScheduleofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "terseLabel": "Restricted stock units (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ashs.com/role/STOCKBASEDCOMPENSATIONEXPENSENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 17
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2646-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e4975-111524"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5093-111524"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2611-110228"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32059-109318"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "Note 1",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "Note 3",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888252"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r541": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r542": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r543": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r544": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r545": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r546": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r547": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r548": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r549": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>87
<FILENAME>0000744825-21-000030-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000744825-21-000030-xbrl.zip
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M"F<?"RPQXY81%\<5:;4 #BG'R1UQFN7KPV*0=4U>7/&G_FFW9W[ D#M#UG7
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M)HWH!KG0:<D69\^(_JC1- _.!'%U%EFW3D1N:/M "#KK]L%F!?NF/ 9.&SD
M>P?,(/&-^Z>A\Z_1V0S2LK9/0]0'(BJL=EG7Y*6!WAODHJ'OPPJMHZD:.$=>
M)CN5ZZS1"@\'+])N9:/TQ:C[K<.]H>TOT-:HDQZ\_[B!PP]&4^<(SDTQ"%S5
MV]ME=6ZW+0Z\,__V_0.PH,ZSSKD)SGK917E4[K!7?L[3XJPHMP2<]UZ)85&Z
MH"O]"&09=GP+8Z<T]#'3\$P6Z!1LMMRA5_A-=#JC<K-@<)(5WKYP+NAR[T3T
M1K?W;S78$KXD<=D/0,4=7??$+X*#/)7#@7&O]#[H\KTN?[YHO-9S,XN<U)S
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MU*/A2H2F6O!>X+J[9>AEY9"Y>5XOH,"!FKK+%@2@\^RXYU"XMUH*9VF4.]J
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M-=ZH>.2=%EC&YGN7J;I)XA<;>5H3'?$CXX[MO1<[^)>@'2[3*(A'B2<*0B,
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MM1FY( '[#$*$2Z$S8L\K90N\ZNP(-9ZA[D-<$71.\&X?YW:,2HK)U\O?A';
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MB$S)'K(?O%43/+S*P?^ZW@^#&7'%ZTF;4/H=ZF1[?KHF6-W Z.32NF;)M](
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M Z$_(8],Z-N3:(1)ESK.<Y\4X++!4:>2&<@6*?)1F/%)9:P3]U<XTK8S*@(
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M]P/8(;/0[!G4=@;GQD9/EZPMEL\GN&ZT07Q[@)77EBL]VR:PS%7_H.GH%KO
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M^0P0*9EX\,F!&#D@)'>TJB@_B+Z1L6$F35T'7[R30B":_I$,,FXLGT>/>%"
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M36POT,<I=#_+(S6(0).F^B1-# X^'%L@85/] ]]:/3EZL4BB?L.K=5;D.L.
M]>;0*KEQB(D&/%^9ODK'V>*, A255+%^M^N-T3)FMXW1:=*Y'R8+0(\!SSS>
M$$3*.1Z3(Z8RG<$9!U,^M9U:!YD:/2>;IV3.'"<"AG8+QT("#NF?11IF(R$#
MTX%K65WQKL;!4,C@O&1 )U+@G6!Q$>6*T3Q>8,Q0YT>?7%XXMPPA4_"*-L!,
M7SS-S#7Z5-C@<S6<Q$Q84B+XEN@B;LEI4H"=)50>91H/<P2J+R&SA%N"++'R
M+.6+'<3EA2?,T_CS;8 [5\0=?J)8^*BP4D6=S_0](%[#<!1VJH.P**!.*@<F
M:<'\85?QV0&EU=3:!H8)J$5?+G&\W9))@CJ0P^C",*=SBD*Q!H?F0@L_;2N9
M\/.4W.WN #)N,$M5SQ(I4(KOE06BDM_L3B.G:TF]M#M=;MQ!:+U+3K:X .4/
MV?6:%EF^K'&9QB+3CJ.E0*DGL0VSFH(QONHM=8*O^>U-#IJ)R)U$8YA;%E$/
M<4P:/=")/#K)5_/&2F6"2:7P7>H[VW/S.#*Y271R Y7,=6E0KJ03B3OESN+>
M.TD&,+7>P0YGQ0;L#3 AL:R>5@R&UILT4E))NJ_]"E?DD9$04NH;*GS:]%SV
MEPF2)LDC-)C^@M5W\*%,E!)_0'=1>)*-(7M1<.K E;W:I>0>:K.>\WR>8PCE
MYZ-*"\FL>T1G3:,+NKQMNFSY&>E3M^BH.9WNWH#&"3<S/Q=IOY!4%'^"I0B&
M0Q6AQDM2U_DF9DS65N1\6_>?=!G-A/7\W[WM\NKQQ-*]DC[R[%-NXF5)1+7.
M%:UDNK&!T[O<_T*_,@^$:;S&[M.F16TT3OQ*UH&X675NQ9K+87V&3.^B_^FJ
M>W%RZG4OWGJ]B[>GYQ>]=[V3#<Z4<<\D7>C O+]F7]V""8=1-D[YQT3W42(9
MW*S>L:YD&MM: IO\6^5J#^D%2EPNY:K/LQP;9XQ%+"J, 8_95RJ5 C#32]\-
MLXPXH1#TJ[GSS.MDG$^.($O(7EAK@5QI!<6H<I;2KIE>K&E!5_R/7S-I2O.]
MCDVV(R@$HH^^=Y:Q+I5WSDQC\CE,P+!14^U[XVJ3PH4QEQ/5716%T@#>-046
MYDH-V?PL#S.X2958=)2M,@(!(M=>' .3OE=[KIMCE:I(AT4 ^P+_<Q&G8)FS
MTG6L9E(\ Z?,^]_)," NP]]/3GTR#SA@&DEIJ"&!M$D='"P"B: C";XQ'C.!
M+$4;G$])H:E"1XSR&$0VJ)3H*ZPTND3(?A[G]D@HNR/S78I']8MHEHYHU1<M
M39,IX&8*M)M,@774U_4&Q.GYQ[/+?YV>]C?OJ.GFI@B*X6HZ;4VV[)ZM"@S$
MY!Z-<!5[6^V=U]Y,)0BTQNRO111M<W2$2*SKV<4-Y?$#KYZ%T\ GI<SW-UGX
MQ=LZ>/"U]T5P'X#=$/E:A[>\B\2$S/$N@P>AYFH^T6Z)(KG-&L!2B=]FCA5[
M5/$!ARYJ@K%J47%2RL^,P<Z\+5+%VKC6/0*]&:LQV.:S2!\"U1"M\[!)WJ!Q
M8'+ 6MLX"_;,_YR>?+KN_7'J7;X#6_OTJ@__\*X_G'HGE^<?NQ?_6N<A+3;;
MN(2?+%S2;C9!F_,J0%(1>8$%!M,M5!JS/9R A'(^)]]K8QB,:.75%S4L2#03
MR@!.LTK<5$,TS#U&0=-@-L,*)NO[ODG0YX8FWA(>09+:U!+E29 =$P52Y29:
MSK_UH-!9*HUO1)QQ?-PZW'D2<<;N7FM_=>*,1_RVW_D&;! [K8/.TW@;OG]G
M#W9:.WO[7Y,-8KT@Z^IQ\R^"J;*P'2^0.*![\QW'OW;+_U$[&(_B3G@$K.^:
MC+X>[/ JN)\F6+G=0EMO.('S+_C\=87AJ7/U0W=*_6P=[*['U*R=&)U,L/3U
MU)@Q7.^4/F9+;=1PTR"\\7X'XRVX">Z"EW%X+-@2AR_AZ*@?NZD0]SW> )?F
M @JM\G<F_?J9;X?3-,;<\JN6]P;#!2]Y.^SOO=SMT%<QYAK]@7<%%CQA7N@7
MHAX_%3YV':(([?U%UA1E/)*'3I Z"X[*2EQ 0%9*&=B[.RW/.T]+;=MVB2,A
MG#HS3X@\"[YF,\ #"DF<!_?>'G_$)"W:NJ+.SJ+O_YG0U;R-,H2QY(I7GYRE
MZA8#9]&]T^G5.@O]ZT\"S'KJ,=0%0CW-3-J^>Y>BJZTH-'WM>^=7/6KZX^GU
MWTZNG2O4<D4.I6F$E%0TA%%+BIZ%F#H^;GM%G(>1-Z'$A5P7EX<.<FH'!MV+
MI5JDNDY)-/+V=WXF8 ,*>MJ"G/+8,*AY5@R"U#N%SN;WWKLB'LDE_E2N:JDA
M3!F?GYKYB9?T8DP@MR]=G?2AK[H\($.*C6%+L)3P&03<"F[D [8MITL^)[51
MU0->YS+6)N?'*GX,*_RS^0X)2 '6S[Q!H!68@C<:WX' AV!.6V]:W18O2R\>
MA= 9#$DCVC4T#$U^$+0M28.$QCXR5&IW.,0L1<RKW@ICSFMZ[3O/T3[!J[-N
M,0HQ7<4^1E^?P$IEI01+D8:/::)A=? YG+V8TGC.::HHT\3S-B_T63%F*6]W
M*GLZ#W.^YK$;%89?T4I>0 437#>/: (%WREF<U:1WM"LW-ZI0<K5>\?'QXX"
MF+.;Y'G44?#H08L$2O<6JZNKVG6^!9(D4RUX?+QKM)P9S/'Q/H'^:"T55$\R
MRKP9(B+)+!B"&-(FYYL7Z8P4$P9>_5$(4Z?'S*_M'OG\#RI%)#WE/FP5</M
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M$?HF1\M34N1T0I?15UMXY@EG@0!,ID(NQZ:=U8$#Q;0WM$F$_<Z5'K=0C2X
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M!CV)T(Z<T!;,\I('QLM._>8 $+GI^?V,LVLRK/).<DIS9Z:%#&^J))$0/)F
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MVUGSZG1NWIX^_7>!@31<3A5G;-1\C((X6_]-_=9J5=_C,[S^((9?VTM^)FO
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M\>Z3S&U[CV5K9(@EO("IP*H60Q<_4@B%I1F";$^$@MK9.FEP2TPU\;P0^]Z
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MR'H-9,U&(;/N192L')CE+="+SA=/=:-MK2Z3SC$OV9N!;;9O*;;X (Z0/5N
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MXPR["JG5YU*%U.J-U$;GFA2;V+#%N:9CZD:1M&C:I;+LUM.2%FL@>#8*JG6
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M[-57M],;IO.T.S=JL,YBAD$M <\]AUY>JQU&P+)APK>C8<OL1>A&66^K%^
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M6LL?L@#T:*?1;(S/A3_^L=\:GZ#+T]#1-Y(;A6+.&?4'\!&HN7*RG)C![T,
MQ/<#!2:>"J!H?L/]H<3M$^J7'H0\IX$TC'^-U&<>G! /LW&TN7QA\2IXUCA7
M3<1^@RU:?E#N]N@7_C;<L/\E\*E0I(GTG(%2[H[?,>93L>I14*2S2: AO+6C
M <T8BEA=6*,9H1__U'<=R\W#0R8@CTE@/7DAJ"E?ZF:X7%PJ+R^=%H[T>WY=
M^>Q0#&X43Y>;%7(I>A&3:5&C_)N,W4CQ)[9)!K_+69>$B1SY5&R(Q);>B*?\
M"4^5C* RA>4FT&YN5!1'E9.(E\ERRK>&'(8LDO\*P#Q*2)'C+QA[]_Y,Q,$J
M#Z9/%$<)9'F\7'E(2/HJ)[9*"KN]N7"GE,YR9VNF9<1H>;6Q0!V9HQ/Z](:1
MI)/=,KH>&\=SK/$\=?..;7B'&VS=$,0]8M>[(Y"4DCLVR],0HQ5TDDUPN-3=
MVH#UP6Q?Z,4R1 L(8-I*$Z^88_*,1I#3-6SB^8B9[IWO%T=J5V,M=B?^NOC]
M'HX17]XSI=/)<CQHWG5*5MN]$8G ^<)RF/N6K*Q?[VW&!-&(R#H9/R-=@KM3
M'HW=PHDH9$9N1TUR?G<GR3AY-*<\#Y7VS\B!#'*&PPWYTI\G\;5(6I1N/$W[
M*#)]BJ&&3%8KV)U*J,[7@X>AJ.(@C)\'0639D"I(ZIYE))\(HF]$$2K\8#/#
M#_2:V4ENPW+NF$E%+BY(XB0"JBX?Z"P@L!X6#R.T,98(;Q(NX-%,L?_;7?'Q
M9B*:?YNA6B9^I(FX+*+@0?*G!7X8?R4B0-.?4:\GPD5_#N+K'@_ \A-P9<"Y
M+""09V3!S;DBD''UXV?GV3:S7E7<)+PUD@]@"T>">G+[:$VE5RXLA=J/UI]%
M:=X5>?8[Y&K?T0;3<$CDCDUM6%FC%&\0^%<(S](FE)<T-SGS+#3I9"M9AMHP
MB_)5A&4:V\:E#=\M]F_LV1J9'M-K4%*WD]=-4QN,:4I5P)7Q+>L!P>1_E=S
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M,V<I/Q,S. F_@"TGA&!35&UL3MI\EOMZPIW-OBCU^TO^J>3D<G+R5QD:65Z
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M1+_]Y=P>__J3'O_RS:.#;^9Q]Z?Y-_="V^0^0PQ3$X$NYPB,2@,T><@(U[W
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M*UR@C=$UK]%N=E+0N#D(U"G!<[7(5*ER6S=,E_L8668 5KC+P!['NH^X:>-
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M9&' U--,N74J 6_D#@G[[B0<6X#%D8L2B$L)Q-94KRW3IV'HZRXR"3$1;&>
MF*A-XQN6:7G$- V7B9+.1/7:VG1V?DU\H]AYE>Q<ZDGNZX'HK(5LS,!<"<P
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MXBX F=)LN7)>.HFT@BI9W^ MDN&+M;YEK'L=6/<<).>,<',C7"7DC-J@@_&
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MF+.4,XSMQC9FFPCBS+)KSK+(:VVTQH;+0!EV$E')F'6$$!$XSRS[C%EV__O
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M4RE3:3%IK4LT@,Q6;@Y:8VWHUWXW3J;;W6U?F$8K.XH?H/3\F+9V$.T-%C0
M3*4!U/( -+4>^*@)(:*1L4QO;"^F'FEF]+5E]&4:/#*C+XG1)ZP;A@3D$61
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M HR!$6 ]YD!Z10 1,D*P4XJFSN9TDXC9SOR,M!EI,](^'&DYET)+@XBWF.K
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M";9]6=J'_'??L8WNHXJ</5\%<GTZ<<U*;O^[)-C^@$091Q_N)(L@2B ,@7I
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MROO'H>":5#ZV^.6@F%)BL]TBS[#[BCGE3W:T9^GAWD&\YRLYCERC!%(F2@Y
M80(!-3#UH:&1:RAF//X6B! ;VW(3\]F-%@;QQ]/[9M!N*54+^%[[Y^T[*/YR
MHQP-95!ZB)DAU'&G J>.&$6<C[\Q-EL2/3AZ.Y%K653'. X'@V$5&R'UZ7K-
MQ*]4K=C[^N.P_O5,0X&MY0@(K4740:P#4D;(Q)PC(R@7GL*-;7Z#Z/^:4-!+
MY^$PP6\ ./_3'9N1>^TKW7'=<3W]TM'8BSO!>'U1ZUYW>WZ0<CQT7LXR@,:]
M=NI]+?0[@Q8<W2A7=LL-E830HW9$,EP#M7?MUF>0$G8&^W&P/<MH^OB2XD(2
M+YQ(3AH=QX61X.9;9I1(N#5P?0V2 =_&&?^5,@J.P]MA_=Z#PN!_\;IK[=>_
M_C@3B#J/G "$I/9;V,@(@%P"!ZVVGFAGR7JTXW@[D1@R68AY0,FU2/.KSW#=
M3#4E+"I)_WPZ$UDRNGK'>2,JF1%"K@=^JLM.HYTZ>B0O6*]P!5WV"[@I_AJ5
MPZGUO#UO-?Z;6O;U!\6S+Z*<'<=5?7I$F?:@U%K3?_/-[E;M7?JWAH8/3CF+
M_99VB8/C8_[;;Z=_(JM_C1 3!V/+CIFZL-0./B]]/PT79U;F!\YNQSBLI3!1
M>:=P/1677!<%OZVM-"D9S*# J[(83#E:7!WMX-<R)3*^HS4<]&"T21N/(Q[.
MLZP3DRHPF+@?RAH70]=5":2I4\I@V->;-=^H]$)J7J=O4^Y3^==P0&1R^2J/
M'GQ>FF1+<;-3797-P8E0-'^<Z1Q,4FNUBZ8V[7YO.-S)WII#,A6UA1KQ*<DV
M4;COXIY(9$M+,G+XW9CL2KHAC'I[VW/O^LV$Y$-0'\FX[\;K=5AN"7?<.O')
MB1EG\VNJQEZDU;SJY.\O._ LJH$P> @!TJEJ-^88*(<#$,8S+P+A,.J'Z]TZ
MX7;_R5V9A--,<UM'V#MTR9$OJFR9J!/3INHSW=H_BYHP[7Z<@.O^Z\W/5.A!
MMM*C<[:F,[3:E^/,+,GX0S*SB-R*['FOS*QY'HO@%D7W2_B:[SN&5!YL'NR3
M#98O(DGQH4F(2\;1(OZ_A+P1@@UF/M^DRN3A%4UK=EK#0+B;8UXPS6KCQ2T!
MSDM 7O,2U%.5U=>\ +NZT[E.*DZA04RLQ,]RS;7]F@JVMAP8##;JHCZ$!R>9
M+W_ZY=!<JM986 7>%#;#=%7*I2B%WMI0WKW'+KEU20:";*$GW)J4?X^]]=,U
M?\PS\B#S(.\<Y-R $(K_K2D@S!;X2AO*FP<Q^]1T'T2<_(S7^8P%';:U]*_8
M$FS-V6QW9B?*(JIY5AOA*97S7JL!:\\!;_[QJ"E6I]9)3UVKN<T1)"*P4 QC
MCQ4Q5#%GD*$.*>PA# %YOH!8T[3E?M9[?/*#RI6C$ 'R3$WE'__^H_NI?GEQ
M5/_*/N(_X='?^_&^#_'Z'7;\VZ<O1_5]_.FW?7STQ7TY_/)7\[ QN.<_?YR;
M"]<\OOB(XGR^?-K[$WVL'[*C9%K?^TH_71RBP_JGKQ_K'_$1/KP^^OO#]7]^
M'/8.3^'W=_7]WN'.F:74(@0=0(H&0+6&0',H@*;2(\L]$M!M;---@F]V/)EM
M?WD(*,[!*XN4R#)BO5#$(EY#$Q G2B+J")%(*T.QQH)@+B2\'V+]\)VV^__L
MO7M3&[FV/OQ5NO*>\YZ9*L36K=72S"FJ&""SV7N 7,AD)_]0NH*)L3EN.P0^
M_6])W;;;8 (D)C:DIS()V-VZ+CWKJK4 :EJP6BI874[ B@2)22$MDB$6\-.4
M(*WCM2W%K0_<,*MX- M+2NCO+5RU</5$X(I:KQ7S*L^!"PMAM2BHE-I+17)9
MF%M"*%NX6D6XVI_*5LH((4EA$9&.QVNEL4JUIDAHGZO"&"4I;N&JA:N5F-L#
MX JHNM RYG&RE.N0*X6]H(I2SHBRWK;ZX%/#K*F()156@4J'J/;QEJO@R,#?
MB#K.G/!,8ENT^F"+6"LPMP<@%L=!..:-!"F+*V<TM: 9 G/.C;-8DP4A%H#2
M-2C:'(Y]N,F%VR+3 Y'IH"%-4<58R"DJ<@7(I*1&VH8"@ J#DL^\XS1?/61:
MD%ONJ;@.YH9LW#77>SD[GR/F/GC^SP:0?X!+H7(63^+OMR=W6UH0?A (OVZZ
M"W+F"?<@&3H9#( P(#%HN I9!9J -WEDJ L"X8<>CL>6'>]P,K<@UX+<#_5"
MM/BV,'R;JK],8ZVIM,@64<B4DB'- >YR:G,=J,*%M0LSV;4(UR+<TT:XQW5<
MM BW*(1K."4$%2SG02#B&" <<P$90CTJB#&6ZIC,G[4(UR)<BW _RM?1PMS"
M8*[AQPB&N1@JDKNB0#P$A@S#"F%M8ZXB;',O6D6U!;D6Y'Z,>Z0"N1;1'HAH
M#?\'#CP8S!UBH*$B3HA&.I8_%T(HA_.B,#P\,42KG2/C@8S)EU?))I9ZZXK!
ME%Q_%/-=K/#=L':4[2A_WNN C4Q*[97 MHWV2N#C';5M;X99W\! TEW\&^>M
MC9QZIJK!8ASUMUEX)T:/>R3%.YA27ZM&/$B-L$T/OBJ\,[3 B!2$(ZX#1L:Q
M'!F)59YR""_0P]6&>+9 ]2R<[2U0_2"@FEIP*:?&2JJ1"S'1/2X\,D831*FC
MA!C! +5:H&J!:B7F]L-]YE\UMK9H]6/0JN%6)UQ))B1(5)99Q 6A2 JFD7;&
M8@$;K& _-_B:$+3%JA:KG@A6_0#O=XM5/PBKII*5MD'DV%,4\G@OV8<"R5A/
MADJ0H/.\H$KI%JM:K%J!N:V6$SM:0=,=OU3J*)7^:R'IVR&IX=SVQ+F0LQR1
M8 7B4G,DB0I(,*N=-5QAD:X="\I7")+:RWUM.%$;3O2#?08-.;&-F?Q>$#YN
MN@8<T86F6B"3>X*X,C&]%BBR@,"@P,+_@84V-+R%N1;F?H#'H86YQ<+<5/TM
M1&$$53DHO06HOU(!S!&FD<P+I:26I""ZA;D6YEJ8^U'^BA;K%HIUS=M^A<:!
M!(*8SB7BK&!(::N0IWFN!;?:*[4@4U^+="W2/6VD^P'>CA;I%HMTC<P-5ADF
M%4561PLB-PXIBW/$M2V\,)R(PK5(UR)=BW0_QE?20+H6UAX(:PW'B%#6\4+F
MB!8$8$WG#-163!%CG&*0R /WBW*,M+?^GMD=L':4/]LHG]>MO^^L"DI4>RNP
M;>,IW@I<D?.W^"*<"T3'MHV?K(V?+-AFT44XYZS&,]7GGZ?*'AR3M."%H;GA
M4A#-*=4X4 &*O JYBRH[46W1E2>BY.]<)@4_*?J;1X;EELJB0%IHCWBA)-+6
MYHCGG"NJ:"B,?+%!UHI"+4C+?T+VR1:R5FEN#X"L'/"(YT041A5<:Z,,4RPH
MP:PSTA7Z?I#5EK5;#;3:FZ"5M\Q3*@52SBO$!=9(*?B+4(6I5<9XYA<=0-/B
M58M7CXU7BGGK@K;>.,,Y%\HXRXD/G@,S)LZV>/64\.K=!*\(8YKF7"--"@-X
MY6-2?Y6CH HIG-0%H%:+5RU>K<3<'H!74E(#-*RXEY3SP*0T3)BBX"HPYCUK
M5<(G!UIV EJ*A+Q@@B ="$/<8X*4S#EB6AEJ"#=$YZU*V$+6"LSM(8$G3E#E
M"<<@7/% K&;"N4(!8'DC,%,+@JRV$.?BH>G3!)J8<D(RJQ 3*EZ@$ HIRADB
MA7 %YM;YW*T>-/UD&3L?=EGW9LC!SQ4*^.#Y/QM$_@%^A;; R8)0^*KI,\#8
M4TJY!0K2!'$=]5N1>Z0*;#&VRIMXC6TA*/S0T['B*5Y:E/OI4.YQ71$MP"T.
MX*9N!J(% V'2 *(%$#.#D,CD-$?,>0^[6%">FT4G &TAKH6X59KXRG@O6HA;
M',1-/1/&>YDK[)$.O$!<R)B)3W)DG;":%85G3+00UT)<"W$_RN'1XMSB<&[J
MS)!!FX+('#E+:$RY HCGA4->6P)R7* ^%ZVNVJ)<BW(_QD?25N/\1DB;.D&"
MMTIXGR,LE4 \IP89B@.BSFI,7;">TR<&:0NYF+O *U:/>$VS'64[RA\YRI_A
M8N#WEN-\"I?0VC96LXV?['+@-Y?C;..GGK9NL!AO?5OE;JEZ!&VZ\7-!'7&$
MQ-LS'$6S/9)4.R15"#HW(@2KVN#T%JE68FXKXW%OD>I'(57CVI\VP1+OD:-,
M(,ZP12;"E=:YE$8I*]IK?RU2K<C<?KCCO"URMQ)P-?6MP]YA@;5 GF*#.!8F
MWE(6*->N@#V6C!/Z8H.MX2)OP:H%JR<"5C_ !=Z"U8\"JZF#7##A+(C'J."A
M0%P6&FG+%<+4"6$T<9J[%JQ:L%J!N:V6)[LMR;E@3)IZN(GCT8N=(R*H1\!@
M%%(AYRCDA::^("!?)0&*2[Q"F-1>\[MW)$$U\'D^S#;J:&$+]&S _'%=#VUA
ME$7B.)NY**@E#LS9E#H"<<-!$9:B0*ZPAL+.*<_E(P69+^  /8WXS!9*6RA=
M%=]("Z4+AM*I"Z2P@1:88D1,01&G"D3B7.0HUJZW6EJ::]9":0NE+90^(^=-
MBZ<+QM.ICR8G-N<%ELCH:/;$UB)CJ$4B2$P-\$7MQ(+,GBV:MFC:HNGRO4LM
MFBX83:=.I*+P04G/$%5"(9['/+=4:10<$!A1V%+/6C1MT;1%TV?C_FJKK'X/
M=$Y]78"<!A?2(<>C8N^$0)H8C@2C3%&5^Z)0"_)UK0QT)D_9/X8:.H5_7>?S
MQGAJ^Z,S.!RV^CV2=*<W2@[5C?^%QZ[=#RTHG)OS?ME)Y1@'O@M/?O:_7W3<
M\&1\9AIOU1/&TU>T@;F-AK>_TIB6]7"^!C_^Z-,XII<H(VRRS]6"-?X^F=R<
M/=?''IF!UY^0#C#>WW3W0E^6+_XQ,ZVS3F_<OLS7HZ/QM@4XTX-C>#B2@DAL
M:QFS/XR$DO5#MA4QKC<L9U?B:\---#8E@$37,.RN/B_];^,??G>=\KRK+W_K
M]%+GZ:7?Z[9JJHF+=(VF$W%47]?KI]1Z0?*XA+4;N.ZX7MWUM+K7CFG]IEQ7
M^/:O\3KY[YG#\Q4W\\SIOO/\WEL62$O]N+M_H^IJVOW-\6XOM'-YK[[W=M[L
M;FWN/\H([CG][.T2Y__/S3<[VTN=_3^7./N#MZ]V#S?_^FEW?^?-W[M;.V]O
MH.TRJB^_V'B<4WCG2J2^#PYW'F<C[CGW;(ES/SQ8ZLRWEKGM^V\/_MK=WCQ<
M&@A6:_!RB6NPN[^YO[6[-!3$RT3!BOYA^_=V]@^OX>!MBLSRA.?Y(+XDV*0U
M;"Z5>=(L.<3)[]DRA<BMK8-W^X>[^W\N=2U>+9,._MK=VMUYF_VR=1 7XMW.
M]J_SE-EK*G]E2Z)YR!UQAC"/.=="<:LL-=I@QSB3HK)\P3O>;4:[%1=4*N%Q
M\(7DRD7[EZ0I*[W$3C ]L:/5IH99PQEUF#O-.<>&<"&ILLP6SG%,#8=6\Z-M
MBJ$U@@F*/U06M%G#V!O_V<-HWGC;/^XE.\,K4,#LY2%T\D>W;S\]42/9Q_^<
M8'OV=T^_5Z.#L[VK_=/7EQ]/]_)]ND/W#]]T]Z+1Z^I?IWLPOOVSW8N]/U^>
M?7R_E__G:A?OG6Z2(V<+GMOH<LU#0-SD DF,&1)$<$],\-X4+S)?6GT>32^#
MD;_5%I&(OJ&YGH[*82=<+@EBZQW/!M,M_S%'?;ZY)$/9X8G/MOIGT/GE>%17
MT,&@&FB9C7K.#[+-MUN9Y/1QA,OI8%.+O\5+$AU[C^&GFQ3E4A?PE\@V*/Z]
M7J#T&_G]UTSW7%HT@<6*+=J8!,.@?Y;,9-%$7&87G>%)M@6'HP]8MSIK"NLW
M7M/U^]CR?OAQ?_#J]^#1K-.SL,[5'IQY%ZUH&?3QN6.73,]C*>AAL'!QXGN3
M\6<G^K//C(>/!CX^YETZ#M&&ZNVP\@5=9IW8FB[[/1")+S-=IJN;:QDP<P^D
M"(WK#' ^.X>?1J7/^H-QYUEYHN/=SLS$RYWK::A#/S@KH]T7WDQLNB)JU\]Z
M_6'Z0'=Z69S,\4@/-+!Q&-19I]<Y&YUEY_KR+-J*UYNS3@M1_%XV6M,#Z.CR
M/&X6C#CTXQ"_)B$((0LMHSAB*=<A5PI[016EG!%E?0K[&@L&#6<:[)W]S8T&
MEUX/;KC2?%EZ?P"+ G)/[S@!X"',_2",3_+/)S*P_>UCMG_UZ<O>]H?+O2M[
M9+ 5!;,2T9S26'2((PFKCA@LM=$V-R('>8'@ZYXD%%<\D5*BU[C=M@N$V0F=
M2,+EF#!OD"405W<]>Y/^A=> OHY]HJC41A@-TFMSVQJ.!CWTR5_.H>_88GW:
M$DXTNYT2)1PCY^.8X2R[S%QF7MN3[*1?IKN&-Z@8G@'2\8VVXQ G)QR&-DQG
M: BHDGXX'_2M!VJLGX0!1%*-)Q6.'SP?S^M]>DQ+&AOLC<X,S +.:J/I2;/K
MV;N$+-?/>G-5UU([#73RG<]Q>,TNH<'HAM/'?HP* ]\Y,Z-!F=H8OY56+'X[
M'GZ% ?JL/^H-9[KQ7\Y]7.]A?_QNA6 V.E'2CHZ''"?J@>O >8[MCU?II .\
M=9"0/K8UZ/B>G>[#Y(WQAGSN^(MJ'IV^JR$G4:6++*WJL0<#*4L]N!ROVH2:
M[K%<->I5M-5< F!.Z?=Z$>KEN[&_L^M9M](9P)#U . =FN\/H._QMH_[3XM6
MGO=[92?ZVR**PJ-IB[O=]&1_C&ZPG^5P@NK^_T:=\]C7>G9P[8FX8HU#<#Z
ME1P <YR[^$/@.L,T9J"_83_ZQ6KV5 ZSTIX 179]+0_=I(PF3QRX^.9DY^)
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M"B1 /D><!8Y, <2B%6PB]L1JJ8 ZU!I38CYUS.BC:TG$ +0'0:=[^2SL!J^
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M\%LF7T%YRZ@S?:&3>1H$3MT9@,+2K;TR8\-U.;(GR0G3*Z/*6(FZ30-PZ/1
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M)SMGY]W^I??UG9_Q1<NJSO/L1:_O$+KFK/2S!.(%"UU7?M!WNCRY%P;72)N
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M?OI3[J2BU!(1I)"<207BNP)6*(/P4AN!6Z'FB9WRJ5"CG<RQ= &9/"9KB^4
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M9Z)8I%6D1:/O0J/+&32BE@=+-&!0(0&-<IPCI1Q'0>C@B>;&Y1C02"S$,;E
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MD<+6YNWO1:?;C:17]F$OH-$^]#NXZ$#'+D$Q/ @CF%UCXT-L/M%2SXW/Q_G
M?^[T1V5<8>!69VDJ,(,PZL)( E!T\\#!<D7O4MD EVP8WX,5T14Y5 .,KH5S
MH"S8DVH9!]%)5*9C$9^"58;7Z@?BCE:DW''P! PYV5 G^P'+'-<%&*U/M.+\
M.<R@WNC86N-)^"0MQOBTQTN8W4X%"AU?KL_'CYO8,6?1S240P] /SCJ].%_
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MQG-9@<3+S;=_C$>\^?8=G-WU]"W";'6X:AK_F\H/F7 DKNU> S !BJJ[HQV
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M@WXT;">#<!08ZLBZH?[24.Y_OS8[/;MM1H,^"S@!:!FYNJ]#L2M+;HSP[%_
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M0%)P%=UKN8"? BN*%QMRC8KYU[3JNBO7Z::JC@N_EYTOV5=LG_##=1*2/,?
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M_,5V!G9T!L)@S\),SN)P0 >/=4>&OM+NYPSA3%]FO?X0M/CDJO[L!Q%2:X=
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M=FN7;3.YE"*FUZS\G*)8T3F4K:/+^4KW&)MT!C/KV_V4KIB8]8G;OX<,SJB
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M8-8YC'W@RF7&#5O.\\')$YPQ_&2=G7'\9.Q(Y*?B#??3ZY9J6ZCM[?%!]9R
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M,T[_-7DP;1 AX/NO& L3T^_-_\J#3.;KVT6:'WQ!E53@-[%"8S\O._<N_T5
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M4(- $K"!\"NVM4MG$ZK.[[_ZH(_J^C5-E7R'L:<U#/WQ9X(LO[LII3M2/'I
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MA-8,DP+SW6OF,4-ZY]-VYTNEZ)PS/HK<2(\,--Q$C+^ !*GK7<*"55+ WVF
M)(U5_^_ C6>D^"X ICNY8B0#-CY+@# PZL&+#X>91I#PO.7!5A;#(%KKL6$
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MVT&M9AQD6<D.%/AK0<26C3LP>_XU5VA&PC8M-H;KJ!3V)DDNC'92NR2M-IJ
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M@BG=&<!W8#YB*'V#I<R5+I+R[_"B0Z=NKX(U@#5XCXO=O>T#'')+>FU1E,'
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M+7);PC<TUW>Z[<V?&6Z6/UBY(=3=YN#F1QHA'F:P?!G&\SQ2S6?RU1DV?^G
M>B).S-D';I%!@ IW\ 0SX:JOW5VZTJW@])=QS5J9\SJ7SO\%R.&L')9%!'&U
MN'5O6.S:WOEI?)B5?CG;)L>H?]'2\07LF6$:SB+;9?&&\NO5,*6,T-]"*.XQ
M$7?:9K\@$K]#YY9?+-6S;,JBG:1@<!%J5>!."["ME",$K!PKI-)ZS;I8K7WJ
MR)")^V3_^,_F/OUV\NWKGZUO6]]Q_6)3[&[MG^WN[>#Z^_S)3F;HOOC6G&;B
M_M:LG_QY#%>V]D_^AF=\O*AO?<_)=0+&</8-/MD_S@S=C9-_+NK]QMN2B;MQ
M7/_9^'A <9"),8<DH[D_"W=(9Y[!@$$^G!+6AK3LCLNW!LI5[DMP#PA9.<Q?
MN&/!+5]^37%S!H'J<D&S2AQ^ MQK3N">9T'FY$CD4\ZX$Q)P#UN/F(O,B. 2
M-^[5&S*;Y7D58>\EM*#_]/G+R-#/N5M_#7L%?!KU"G@7X]T4UU^T=EWJ/6Y2
M3V_;*G:-P'1V9T"+#?$\)JD]=TYJ%Q3 *G>"8>^IKY30YPS&'Z>54,RM,9E>
MG0:2<O\KBXS"&DD9DH\ABAC)*C90K:!AR7K6DG&ATK.>8&M/ZEDV*!*$EBA2
MS1&WSB*;/$=2.95+EXWS:F[/EZHU\D/NR\V2Z!^4JFG2S8?PRCV29^\YX>-,
MU0E')8G7.LB$N8E1.QI23JDPE(LH?DFAM!H%8)7^= ^0_3*M/W'%D[2&@,*4
MG7C*,F1P;D6OI4R!VF"8F,>7O_8-1%\J.ES7GAX3&BKMZ6$V]J3V!%N78V\)
M$C@HQ"73R((^C*S 1@H5F:%B7BNR)^Z5^<Q=45=DW'/3+BKGTY-CY$P-*F*<
M!':18REYL,YHV%)"80G0"<9*I4$]?Z#=O^:!\@;.S@#(R@)!G,: M",)2>($
MR5+BR0W$J94':DWQX;H.]9C@4.E0#[.U)W4HS@BWFG"D#,>@0]$(QA$7*#K!
M&6A4@00UG_2P<D$]Y,;\P[8*BC#;G\$W1O%S<$B]X%2S.S&S5(K6<T)C/ZUH
MI41\X$7C#<X13X(@0W.'-6$ C!GVC!>--Y;IK*KRS58,]JM\LU]HH8^)G)46
M^C"X-ZF%)B(8$8*A$!,8F-HG9!4Q" =LG64B"NI?O:%F-L/;*N+>9"WY-:*K
M52276[1)8<D-/%T1,:IR?D!"NL_^*(9!:RX=73&PX;@V<]=!4&$*VJF7RT%W
M"&/^>*!2@*W%-9(YMY-'(Y$3,2!%I.5&)QY2FN:1NT%(GX@H[>U1UEI[.<>Q
MI+'KE$M=ZPSZO;YMY[T[1J>\T\Z55=.^Z-H'L*UZM3"CO7HM$]N/L=C]BJ#L
MJK#^@:K?C=G00MZI^-UL&'6W>O*;/Q/D :K4\08GMV--JP;[S =[.UJ!9U2Z
M>_O"PN54F_Z*'7!TB\=GQYS#%U90(<^%XE499B?-5HBJ]9R:J*_%+V/EU:NZ
MHILPJ?8PKOPXMW_&KF_V5G^@'\ DB-7NJ';'8X[S4SRQS39(Q\J/--,B9\?&
MP+96?JQ[L7M2^]=^M-W>--E9M:.G-LKA83<>VO[J;Y4=D+]FN]?T*S_2OVUK
M,.LD&9H%H^&,KN&E@7X3S_9U9^"X/W#)3#G5(U?ED2\LF6"Z<YE^T$R"%Y9X
M/IM61@<NA0F6JL@U%]I9+3&1UD9LHN&Y'1'13Q/B']JKNU?.TV?2=JB,:77.
M&L=',)[&2?WKNV;C(O=ZA6NVMF$\^[B^5X?GU5F#OCNN?YZ*:1UOTMWW\!VZ
M_W/_:^[B\E$TZ!=>W_O4;, 8ZA<?6?W"L_VO]9__7.STZ\.85GWSP%(9@V4$
M&>D#XD%+Y*P0")-DN6-814E?O9'DF1:=W'N_KQQZ+AR3?R:1]P^Q6Z#&4O",
M/B!FC2SFH4$Z\H84SH8*R19$LE%6$B"9H-0S6&6$?<2(*^R142HWI*2&&!:(
M].G5&[JAQ?.#L26I@BN[XV?&YX-6AIDH;)*<QT@-%YA9.+5B<-*Y@F2 Z&%\
M?K3'Q[04&)/_+0RZY]%V9^YW]^O][A;>[Y?^G3'W2?9.T&K'WV['7^DNWE%+
M?#2(,$UAG\> '+<<96P/WC/I97CUAFT0/K>[6Z5*5*K$+TGCEF(2+9W;Z#K2
M7/K#"G=3I4LLB"R[5[J$"IQ;QA(B-'>S3L$BZ[Q#SELBF-?4I+AL-LT5JM@M
MGJTVE%AQ@'H/F^1VQ-=5)=U]G$*$)N]L%-PFRUGBS@3M8P&"C.%4:EIFI&F9
M)_4.%3+1&Y5YO.]V>KT*"1="POJX?\AI*77V#W&M 0GAY$.66HT\Q3H$88S-
ME"1$KUC1W9)0X-X[?^4@\_8ZW:Q77%-0F^\>NB>R+>XGFMMU?"9\5;ZB):+:
MF*\HI_9+HQC2L-2(*ZZ0A95'6,&_$4LF%2U\1>KY8=J2F%Q6=OO/]!7=:9__
MPE=D3WKW]A,--=A;^HBJC7Z[C7ZEOIC@%$XDHA"M@8UN.#(A@2+CA"12Q11,
M>/5&;5PI+_=R$57JQ#-2)X;F_=HS1ZR+-3_2;NYFS[_L)(]_K;!!GRO?2K+_
MK:*&K51MBV.Q-UX >;G^E6:[T('W<=Q>9XPYCDU$PADXYE0 '9=*A4@P)%"6
MDN()['4YTU[_]QJ'0*OPRSJ=K<_!5!_A566M/P2F7?+-7'QG!]82S[!W*$CO
M =6D02:2@%C0S$;BI<4BV^O"K% PILKMN)5^7<7B7_IA<#=#JPJ;WG6^WW6Z
M*3:KP.ES,[3N&3D=BL6@>Z715%K+0EK+EW%++"EE12 6)1XBXHY'9#UE*),(
MD1@<IR%D2VPV7^GM3;'5BS!4;LYU.GV?@RDV [HJ8VR)L#86.DW$NNB)1$P+
MACCG&MG .3)&,&TX4R[9G'2+J]#IRS#%JL/@&1T&JQ+S6J@B_DFIPV]QCV55
MEJ_\BS[[>[R$CD@WE-^;RF'PX.7WU"6C#(^:<IZ8UHY)IQ0WB;$865%K\K1N
M@JK\_G[:M)\HOP\X..\U$M9QQ$/FN<W5)K#^B2>M8C#BU1LNGFF_HDHY7"?E
M\$[E]W?!LZK\?DV0;,POH)(/6+"$DA2 9#YPY+30B!/K!;:>8EN$:)5^?C#V
M;/T"CYU2797?K_R.O])=I*=1"-CBA"H).UY[Y PH,-P1HK$44B66=SQ?3OE]
MI4J\$%5BK4VBJ@;_7O R5H//%:"+!&3Q$8?<[S$A*Q(<)E:P2+57F$J EZ4T
MS:Z2]I^B!/]EI^P_PQZ,50G^DH#P<-Q'9$S2RD2.B&88<68P,L01Q'#$S"8B
MO)>YU6+%T/C<]+KU2^6\@XOHGLA6E>"O$:J-^8NT2D$H4.\(YSFE7S.DO;6(
M&"Q=<KE<20.J;>A[^XM6#].>;4K_TMLI5B7X:[K1K]07+A.5EF+D7 #UQ:2$
MG!0,D2BL\$$$DGE9EU:"7ZD3STB=6/7*D%%W3!#:>#.^5]^\ZS>KXIPJU^9A
MBG/6R:=2%>?<5RG9/OMK;Z=?_YP5D\V#:'S0+&4Z()G)#1-!COK,$Z2$),Q)
MKMFK-WQVVXNJ.&>5=OU+C9.MBS^E*LYY:%C[> EK6 5!F65(.6D1%Y0@HT-"
ME'KBF736B*()AN K%#*KLG"JZISJ-*BJ<ZKJG.H>577.7:MS**X\!@^<A"&E
M5E8[PJ*GW"9A#(Z2&DHY(\9'GU/1GMA/4%7GW%.=/A_W$N 8;$@IH.1 D^8,
M6V1"H/"3,!Q'IQP%=9J354M"J[3#%Z@=WL%7<#= J\ISU@;*KCP#@3&JM9$H
M\MSH-W?[U3(*I"F/7A-J=(Q%?<Z]*117#\>>K6?@L?,MJOJ<U=_R^Y=;7@DL
MK(+U)2$YQ UEL.5U1@#E);6,^)1[-VU(4A7H5,K$G0MT[J9$X*H^9RWAY? 2
M7GS(W9("1E8XBSBV"EGM$^+"X:2LB%IQT"A6S#1ZYBY,!M,2.@/7BBOGPZQ&
M^:2C? G>T:&Y:/-D5/Q%%7_1#6T;LHQ4'M*[* %XW$-*8^3,TX"LBA1QCS$R
M5&D4K8_2::IEH*_><#J;Y7CM/0N54?-<C)K5)C : ZW*0[I4*+ORD!(5$HG1
MH*ALYC.A AD9.1)")^6<LLF[RD/ZC#RDJ\Q@-'_#S_.0DFK+WW++7WE(=?+2
MPW*CX#-5F8L)6>\-$CYB0;%E+!1;GHK*0UHI$T],8701NYU@>T</"#63WE%2
MJ1,+8\N5>S0J[6#)$\+.L>P4%4@S(Y"W-F')>/#*CN7VKHQ&43E(JU&^R%%6
M#M*G3R$=+ELY1S>MW+/UH*Y!CFGE0;VGGD#'/:C*$\L)3B@X8A W"B,MX%?!
MG0\V1!HY?_6&XV5Z4!?:9BON8KT_9*P<2B]L-BTV!VL*ERN?QEHY:1\*+:^<
MM+"JT:K<"9Q2C3B8T,@0PA!66 B&+=<^)YULZ)<(E8O<8]'W6@O06+M$V,K-
M^W"@<>7FM3@)90)!1#L #1L\TA(KI+$G IO$N%0Y$9;K57#S5@K-RU%H'L3X
MJQS%:X!.5XYBR:067FOD><J-PEU$5F&*0!@($4HQ*MVR'<6/HM44#K7_Z6=Y
M@?^&YH\WU^ 5_C@:ZXGM'C;;91T^GL2SXT&OWTSGC[]_:=Z_>T>Q=C8\G&NV
M/)UKAYDU% 7;C[5DF]W:C[P/:IU4Z\.W.^5^*;\$%X'R '-9?)25B%[A:JO9
M=BB2$FMGME?[KW5@^IEG_VS_WZ#9/]]I]_K=0<$(M NOVMT[LNW;4"H7'V[!
M3+Z#B7P>:?G?_CG"_N3OMOUJ!KO'VZ3Q?ON\L?4.GED_A^<1@ ;1. &(^+I/
M]D\^\L;)GR>[6Q_/_KGX0AM[^P<TLD2)DDA814%A$0 )#B"!29^8A?. )8 $
M/*N95B%6=Y&F1V_J7DG38TC3\>:!8]1GE0*)$!0<,)QDFUDAZKT44LM@I,WJ
M[PQ2J->U;NR=1OCE1VR=;]0 "[L9#>&?1^5:W&F\NVZ3M0<G9W".]6+[FNSU
M._[[3J\WB&&KP-Y25 IYZQ4?3JHT<?W)%.\N)%E;.62-B^\PIDU:!_B16&#!
M#48QY\9P+ RRC ?$@_*@E&!LE'[UIMVY#CZCDR^.YK6 (^L]K!,L0^O\=:W=
MJ35'VN/5L7G]PJE#LQ;; ?XZBEB5:L\H;'4/P;PG["T6>*G$<A'LVMWS!RX*
MSV54*!$IX"0T AGNP9*7F"I%J4B! 7;)F<&1>TD5,2!5G;YM@;X)*X,*JPAD
MY^HL@]OFGR-@I.\<MD&E#%D6RN]?/CO_Y4KSFWS>HHK@=%Z1DU1&1JA5@3LM
M7'#*$0*J@Q52:;U, MO-5JOCX5@-L\_U[7(J7K"\[I_5+S8/B$[2"\=1KJ]&
MW'N%G)8&<::$<C))HK*\SB:,^;7N-NTO( R.TZ""])8'EC1E3"D,8TC)*YV6
M"5Z5 -Q" #X>1(=M2,H@8Q, EK<:Z>@<4H8;L.]!JQ<1!("3F1(PI6]=FO6%
M\;PFQG(^AP'(%A#CH)5A)@J;).<Q4L,%9M9R%X.3SI5GL!Z)L;ZG<OBAV_$Q
MAMZ[;N>D.G0G97C[;'?O.ZGO;=,ZC*^^53_@6'HG D,F.] Y$YDR.SF0'LJ-
MX5+@I!?R<3ZN)5 M]B*+G0AHOD2!>J6*,\L'Y*(!!/-<&6\X6(QJIN)__2CS
MMG>4%:,(2 9J$4S_#&UL -I0%TZ]\UJAFP]UK-/2&5"S8QS3$VK4C;; Z]+D
MZ-5LQM)!J_\Z7S<$)3 ^RE!:K6]_UEQLQ]3LP_< .D?:6_X [C[P0_7M:N27
M ^^!!0,WM?UB-(7Q4<MG87Z1RU>VIZ?=SD^0VCX@^4*G^F.:)-7^N.E W]W[
M<B"S>NU@.XC<HXPG#0!H69',[46D7F-A<X7K;(VN$)\LMR/9R<9N9:$^#_GX
M6=_[?F!(C,0'@YRB"A0^!3#&1$(A42[AN*0LI%];J"429D$91\+;(F#MRF2=
M5!GS\[(P-=L#6P+UF!(Y5-P4!<WNM--KYB_\UHTMF[7/W\^:H7\T"F&.736,
M&>&K2ZSK=5J#_OQ+QK13#Z\2NT^DG+Y#-6JF)FCLWZ/+HH=3>PA+ ,?"=V03
MC/<WVSJSY[U7_S.IA(,&/KR_%ANYL=#T!#R1#EZD=P/.Y-21+#JW,2-D6=]1
M7'JYTD60$(;=LJ>]^-OHA]]';9J:[>+AQ46_#^\U%(\\&U/!P4(*RH^O)FH#
MEY,US+L?/GGX\4;QT51,L_S,Z V#YW^,-\A_WS:O?R(42N=2@"^:9_$(RZ]F
MYAMLCI9[J0_7MWIV??O3SMO-QH.,X):O7_O\A.__G\U/VUM/^O;_><*WW_W\
M86=O\Z\7N_K;G_[>>;O]^1K</LU4/,PNO*4D[&T_S$+<5@R>\-WW=I_TS=\^
MY;(W/N_^M;.UN??$(/CN">=@I['9>+OS@E%P#Y:_OMW8F\+!>2EA-ZFCCSQW
M] EADPYA\XG$IGA\S=2*-$/R^U,)4&F_[+[]7_3'YN?MK=K;W?J'[<;GS;V=
MW49M^Y_\\W;M7V]W&WL[C2_;6_^>9<Q-F;RE5\)2K+SGW 3IN',A=T)C6%#A
M)$LA4Y\OO81@RK/BCV(8M.)N:G3:/V)O%$C;S+&>9O^\,-KVX(E_M#K^^XOS
MI1S"F+\<L& \#4*A0'!FK!8"64\\(I(2JXAG 8M7M=CS]C2[%;J#^&H]PF*;
MM=[@!$9W/DH1[?5M?] ;_39T'A>;3_V>W=1M5,K(5#*!+2Z9[?B^S",H/>#^
M*+N.>M>33V]RGE_E(C1[M=-N[,4B@=7%5N?LMU^Y$88F]+T]"=-^@\[IT%]@
MS(86\B[N L4W.#.W<A<L]ID@=[OK38,E>(.3V_DV5F2P;!F.F-7D49AC6XTP
MO#;TA]^B4&B!JKU[^)R>SN<Z9Z8*AH"YT+$JPP14G5[)*ZVU6L^KB1JE6Z_\
MB@[SP5=^G$7".LH9ZRL_U)Q27RMRZN>9=HO0YRS2?W.USH39=7Y79\(,ZG%]
MITK2VQ(BW<2LL^@T/TM6':T#E\($2U7DF@OM;!% MS9B$PTO&/BN)98MSJIS
MC^K*2_$I3\S=]'GX(FL>7Q^65O+=]Q]Q+G_\MO<1Q@3/>E^_@&?A?;I_!F-N
M-;;VSW??[YPUSJ=+*P_YMZU/1_L7[^ [AZ)^\0G>K0[W^'3\[?B/UK>3+[AQ
MO,/WCS?9/Q?;_7HSEU7"?S</F%'<DJ"12%$C,/X5<IXDE"2UP<I F2>OWI#E
MD)/? <X>E"OB%]CQL'BQ<N!\^PKTA=]_37'R)L[SNX#E[ + 90#B\Z_P>VR,
M;+R]Q$@=G:8^8F2C#8@[%A @HT0AF:2(XL0KFHL#Z=H Y))X'$M8R]S/*PYM
M[\LJ\Z>F;GSV.N2CYF'>DXILLD3Z?;?3JQ3)Q4!R9UR1Q()&30U%V'*,N%8*
M:8TMH@Z3(*@2+!D 25TUN7ENVN#SXJ5?=>J'%TKP\-C(-J;^><JER81H@6F*
M.#4:@6F<"[VT-C09ZU6<PPWQY!3U=[:%UTW#^[LP@Y[:@[B&"MZ_5ES#NX=U
M_'?E*[PO$-;'53RGB:=":(1]!#M81X\<P0$)*9-4-FC-/ #A'!WOWXM:P6OD
M"7S.ZMVL5UQM2%L5]>[>T%6I=<M&LS&U3O* :>0&P:)'Q!//]?O"(T.E(,+Z
M1(PLO'IT25Z]1U#K1KEB,-AX,P2NWC>7TE3I 7HX+H%!_&9'[E,/<CF=?F8+
M^4J?@3=F(]RM$?K+MB56LQ%ZE7#PQ,?N_K@18;V721.&E%4<<<\#'+O<(:^)
M-5%0Y[1X]6:I^0:5(5$9$NO8#+U*#%A%+!LS(:+0DH*-B*+)_4N#ELA2YI!6
M- H1L865+IIFK!*25;'_*O;_$.K</4GKJMC_6N&@']?IB$X)1)&@I$T$G2Y%
M9*P02%B)E1+1!9)=*;B*_3\WG>Y%Q/Y7IHE(%?M_%&0;U_ 4TUPH@932&=DX
M05I0C6@R*7.)6Q#\.5U&JMA_%?M?<05OP=C_HVMX5>S_*8'P<,)M%Z,5*G"D
M9/"(2^.1B0ZC*%E@-"0AJ7OUAK(J]/^,M+L7X;%[$.VN"OVO')B-:75.@+2X
MQ)%5 B/NHD?6D("8BHF M6J$CJL:^J_BXROQHB\]/IYKW5:B6O\>/:#7Z/B:
MJ8\OIQ5R%4!?^<-K^^ROO9W+9LB<\,B)TX@D@G,50D*YH1)2.@8?J76@DN>2
M_>57[#]L+^3'K=I_F;WC[S0':XJ9\U7^NP%G%:1?)[S\>(F72=%H7=1(VV!
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MORNV@0?&FWL2-E9XL^IX<Z4G>9V;4DN2Z1DMXDGG +D5R,:@M0F2D6@JO'E
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M1(EE0-1RV']?JG;(*B[<-86HHVY<?Q?7XX+49#<$SP5WDB%87U7J43H:BKS
M6B4!'\< 6T282H]Z:I#BE1ZUGB#UKC/H5ABU$$9-L',3 3@D"47$Q( XC@PY
M1P@R+L6H<V)',J_>S*Y(65DU:A;I[-+:%JS^S1?RA2Z!XW?N/>8Z6F??_;[G
MSO10?W7=9&XW@Q&&3L:8F<G=S\U/>:<YJ ZU!S_4JL-LH<-L^ZPXR(H#;?/
M*N>H%!H%S"3BE&MDM3)(^*2PP%@D1E^],7.85^]VGBVT@^YUX%VG3)_+\;JR
M0>V1\!<I(-UX:IO=(I<H<]WV8SL'M&OV$ S/\EM-V!;=TTRQ7N8G3:<SC7W5
M%A3-_7Q):Q#*KQ?![,DP^O0=+L/JO:/,%FU=YT?<N'_8^['G%< $IK/=S_D3
M.36E=F9[*TM/, F,53+-]Y^-LP.EK3!!1Y28$(@;S9#&5".%F1>6>&(]SZVT
M^>SJ\+R)5I4<H%KOJ?4^KW\\P,ISG+1'1G-8[Q0%<AS#>@<L&19:*8$S&< <
MHOOQXO[>C602P\1?8E[GC@NY 6'S1VR=OR[^/D3+7G&O ORNIQ(!DIS%5BO_
MMTC8 OA#9>961AS;*F[DX?@"# ?\B7[0[Q2L0+U^;Q%B\F7E%+U(@G,ZJZ!I
M<8H"_H $YS/663Y":57%>[YLWO.EED%75 POK=ZSHF*HJ!@JWO.*\Z#B/*@X
M#UXJ"CX"[WE%A?!LJ!#H8U$AY.Z4S7[A$-UL%VR.H-7'MF_&%21)W]WZ.&)Q
MY(WCOX^_;1WR^IZ_V'W_$:[[]GW_Y-O)[OOMG_L71\T&_794/]XG^\UI%L=#
MVOC:^+Z[=?BS<5'GV;G3./G4_':RS_?WWAWOOM]AWTZVS^'^S7\NZJQQ<7@0
M4Q"$>(,\EQCQJ!RRSAH4B10\1>8DNT:'@&E@"0LMK(^<T>B44,%;*EE0AB4Q
M38?P=B$ZA%_??7(T6@ABN&7*.WB':!R+CBO&B>!,T5S$^23;K%[?V9L Q2?9
M;4\(-)N-IU()Z%.J1>7J-S(5QC:H!7>DA+B%4*]X)(?D<L#=]E5A7"9H!Z#6
MD_0,/1AD#+7/$>8@U#8!K4,9PLH,L6>=VN?S7C^>U/X8-%OP\56$;.0R'M[G
MDHV[5]XH>W'[1\UNJ-7CCSRK'_[XM%>$$'I3+ #MRZ\<V1_#(%Q!%3\X/>S:
M$$L^VNF[7MVN&,E5]]5QGNW+]I;^ZB2:?'HSDW&7+FQX1OQ>$-TW,PW!\/UR
MG^#B*6[0?YU'E>N(7Q=W+TB_)\@MKF:GK$*&!V3"\O/B9K&9>X9D*GY?$NYV
M4LU>O4=M.)^%:QGNF)HY?@GCF1SP:;=S''U_2$,.EYTU6ZV:R]?]WZ#9+6<N
MOV[,P<\06_!NW?-1+>Y-T]CNU/*3NV4];\ZUWJCME%'/^"./MS\Y;X-VX;F$
MQQ634$Z!!VGOP!DS/1?#\&DQR#R_M3Y(>2UU05^H%;%;'YMY\;/+OU]V68%/
M.R=#T9@46=\9@"S"G":8TZ(U;XB%G[TW:L.;P[<!SL!NT\&,N-CJG,T/P]XU
M,K RFWRSJ,6>':]Y/;4IPOA>R(MW&KLY]);976*L_6MNT _DLF.7D_DRUE,A
MY[>,&@&_[3C;ZDO\J7C2*A7=/;9FN,,:6X>@'7X_:UQ\8;M;_L G"],K$DHL
M$L0]L4A;*5&,F*E$':8BEZA<B^S]NU;.*I*X5JY@;QBIZ_4M $?J#+HW+/KP
M:P^YZG_%[[W8:A4\+P7-RPX\JSQT=LJG5Y)P)0G?#Y(QGD:N4%0D-S77!!FI
M TI@J24G<JY2G-5"X]^UX4Q/4.KDR1X>\;W:OX;-8?(?+SO"V)P%TNP5(=Q+
M="^.R#+F>WG&9F5AOB2-OO:0HO1A^(PQN[,2G9'H[.T<Z.B"H( ?)&B%.'<:
M&<H$,@HSDJR@E*I7;^@LT8$SQW9KF]['5H[GPY']KU=_[30VW[[Z=ZU7BL_K
M@@,$3A101@HE)V39*4[T6>)3DC[!%?E+M3:<A!,?SZ"**EL=71U?TSKBN%P7
M&I4ME8-Q.JEQ"JEM/[ A:UV9ENP#'(,PT-PZIGSP%&J^+K?*\'E#V2]FX'('
ME%EC/7\4PZ!5*F(=[P%?7>R?Q=B>($ZCDR^8$ZU\>2"/O](56]O8>(>ZU%"7
MRT1(6?T"#2#?'V[;R5D4XY-Q-=3QL]_>H#74SC*EUB(90"**:+F0TMC$%65&
M,!>ET4IK+TA::L;77YWVX5[LGES?[YLGG<%8FZ67M^FW26/OXP%VQ%(=.*+,
M!<2U#<A8[I&C(>K@$^"L7RC#66A-C'3:&R^Y-LDZB94.P1&%I0BR6MU'7%V%
M8:<QCQ$5F"*N B"XA,6VF3Y+4Y.(<*_>$/J:DMGI7M?^L%'+8)3;8!5IKX5/
MH)F:/K=G\[9W-#(N"^!X#29#2;ES::*^'K.6QR%FB%1MD*/L=B[2O$H#')X#
M=\]'!3S.]GJ#;I&L6QBUE[>]M&WM#]LLF:GF>1T 9HN$5?AXF*([,I1?Y[_E
MCET%9U79WRZ_*1QEI_V1!3MVRXVIQ.U?LT>OHDFXVZ[].6B=UVC9E$?=2,E9
M'T^7AK/B\^#TM-/M7WE[)EH'#ITUGV/W1V9]O/S2I<98^#Y&=GMIC\-B_&B&
MH5?E9.IQO>'CACZ*Z:6]\I# TNUV6W!)I_:?",?SL+/:O &!Y!S:_/?3?ND
M$Z.YR.G,]J1,<VRVATZQ/!20H7@VZB@'T]?YD5T9()$_KDSCF=&2**C@ (Y$
MILB#)YHP@3F/+AKEB:1% JS"!@LT^N%VS*5SP?!3'JIMY0]?' Y.6T6;!P&L
M'^.%0,+RD)MA262%(6 5):E]D"2R\.J-F(Z#_+ODK#LM"&%+:;IT7(U +XO#
MJ,?@:2XR.!]Y[Q;*D)8XN!"IQ-IP*X(.25 6B <%W!BJLZ$SDHL[U B-Y.-2
M^#>+ 7^X'.\+/C6G#:$O!Y(0A@.GR$<'-K2+&#G.P2[2,BFIF+9$9>I1,:>V
MY_(8&AT[15,]^+"0D4MA:O9&!2&U#'!90C+R=$%Q[V;H*>R90J2:X?(6!0Y=
M'GPG^;J+3*;X8]B7<N(XR;"!FC_143.$V/[MI2XJ/*M^H+1+1$8 6*7 NLT*
MDG:Y D))X04S*@;QZ@T8@</3&Q5;OS<\-4:K5GF)9WJ)1]-T65V5L_.S<3UM
M9Q:G]:796D+JZ.()Z[/0 +O=9I;M0;_VHVDOMT!O4H78;L7O?5L&BCJN.>C5
M=D[L8:%V_O77VR)(D1.&^\6785B;I]UF:UBC,"/2-1:9&'NQ_,4)"W^HN8QV
MXM 36CHU)GG19YOW#Q-ZI;=:ZMK#A)UO*6A[L_3SJ:##N-.P=$T,O4BEJV=8
M2/(+NGB&6: <AV EX?"SB9Z$J!1)<,QR$F=:I0LH74.-\DKG6A'B^"?&VN/Z
M 5644C@E42XFR]S="3DE*:*.NH"%$RG:5V_,M+I50F[>(C<MJZ'4<IJXU,EP
M&;7C%FS<9$RD6"67JF5]D&6]V#P@Q)DH@T5<>]"+0#]%6F&)L(05)AIVFN(S
MM.CALEXJSE.P>GD:3):,C3R5,T^'M?--WBA@+]YQ5<?U8W_@M#.)\82T]8 :
M3@7D#*9(RY",%(Z&D!U7^#4W;*;>7:H3TRK'J%BP4^177(G32)G(JD:A8A?^
MIZ)6L7?YM:RCEQ'P&"9=\BZVFO%''/J,"C=8:G7.RK2$XM<B96683C&L<\S]
MY$<J0V^0^V(TASO"CS3XL3+QZ_SS#YB-.=^5\+)3,+\?"&TM)4P#[!F O6@\
MTAS$U!/%E<9.$9NF4RI7/?OK_V_O2IO:RK'H7WGEJJGJKD*T]B69<A4-),-,
M8SI 9H;^0FG%#[PP?G:GX=>/]&QLLS4DV&T']"'$VY.>EG.D>W3?O?<2 MVD
MEJ]N!^6_1;NUFY*.N]Z)%#<[?IJ>\=4[\_%I53KB*KNIC/CS:>0#74T*_W,6
M?S(9P#H'\2?Q2B$7'L1?;!(AEI$:0/'%WVPN=E*L((M,N_!-$;*>"%WU-64\
M'67K@:=RQX^!K%7XIO'>4M<;KQOS,S+6,Q)#O/JN>2C)PAOM!PS^-*;PV^H,
MFCJ#Y<YH-+=28(J"C7<L=4R46[WR#9$1OQ]ZSZ6O0>D+BNR^UM$EDST*DE=&
MX;P9%C],@P>5M7="-?SQFZCHB8BC7].#KRU*YZO.)B2]<D1YR2UF5 9H O.$
M04==@ HA_H(@G+/G6:>GO <F=DZM]WSWJMXDQ.9YZ_SP_*3[.=['V1\GYUNP
MU6UU3\Y=K+]UOG^]==W">[&\LR\G1W=#;.[CUL=6^=NQQ0<['\K]G4_X!/\6
MZ]C[XP3O7^_O[).36.;!SL_M.C=0.8T731WSC@L+F,(:4.P@T$$08*$.U$KH
M,$IZ\P9F:,VBVF<FR4RR:";9&?F]WAJG'OM.Z.5JEC(C!$NU8H @20'E2 .M
M"0>80D*-UM18E=Q\B'CXN"'32Z:75T8OX\>\MWKN.#W^>U*?D&>"^2J":6W/
M$H<1I7UR@Y#4*4"5IT!)0X"F2'-*O54I<1C:D.SA.+N98#+!O#*"22ETANU(
M,!_*,&QG@OD6@IDEU!&24.VQ Y2Z^D&NY&<5#* IJC.&C&'I:D=EFG<PF6#>
M ,'4RGRFEF^FEIGVPGE0F!D.J!8,4.1]I!9$ "9!&^99I)B4(4"NF_*RH'R"
M:\TS'\KQTW&3D/F+DL:?>X[TYK,4(BDY,5Q";VPL#&M#D7'4..8DQ%QD+7DM
M^&Q_7DLV3@3$-(ZVF-* VK15,DB#0)#P.'*:I+;15!M"+(31%IA_,$-O#:"7
MQ=>%X'$FOF*''+5. :%3+E!!)) .<: H%$HK3RU2C2;?8.KA( 49CQF/6:U\
M,2+GU4IAHX7&#=#<TKCC#P)(+S'P& =E V:.Q!T_WN"+R2&>$?D*$9GEO9<C
M<B;O^<"E($( X54TQ.,.-2+2"H"#XX[P.,&I;C097F2&T8S'M<3CM1_TG:[:
M60C[:T X,QRAQE3AN%%UGHFX4=4H!0.)6U;$J!;0<XIPHUD_R8[?KQ$(WX*/
MZ(=Q+*_9<VC36(O+\ U]%J<]]_#BN^8T:)$FT4Q+CTA3CJ661F((!>&!"$]H
M%L#6@L<^S0M@A N%,8I;"*48H(1[H)'4P#-/5? TA81L-"E_-"S@2@\+,_96
MC;VL@"T$D#,%#,H@/0X2.&(\H-!@H*7%( ZMB9L**J2PR=Y&@F4\9CQF!6PY
MB)Q3P"S4%D'M@!?IS-MX"Q24%A@E+??26B=87"+I!B09DJ\>DE]K<F?U:Q%H
MG*E?E$.O4%#1YC824.\5D$ZD1'@>DVB&4POIP@SO#,77!,6L?KT,A#.KT3,K
MH,<&H( "H)P9()%'@!', X*<$!K6$81OP0UL=Q9^Z6Y0L^S_M4Q2"\+QH*6C
M 3L:+36-D'74<^R]"=9F_Z_U(++/\_*7H%1)3@3 1F! ,:5 "<&!TYHRB@R2
M];,XCP<7S,=I;QI[6?Y:""!G\A>2EBIK$4 L.$ U#Q&0S@!FH(S&MHQ#;)+\
M!4EV ,MXS/+7DA Y)W]I@K!,>WV!<+2Z0]SFQTG-@3&!:&&9=KIV &-R(>I7
M1N0K1&26P%Z.R)D$IB7C-D "M#8T;EJ3<Z;0\8_U5D,<K-$J(5*I[)*9$9F5
ML,5C<69 (AA'2Q (, \RKHY0@0A* SPU%L?=JM)0)BQ*L6Y8? N>8%OV?Z.R
M*L=)M/J#BSITN;XL4Y3?F]CCV2=LF20G"',!<Q(0H]1XI8TP4$>22^GU+&-9
M%%L+3CN9BF('.R?7IYXH9CB20$E-DU<8BJSF O"<*A&498BD5'=*Y//N#+VL
MB2T%CU=S> Q$$B,\ 8A:"ZA''&BG,, V?HSC.'.3\?@V\/CU_B=9#GLQ&&_D
ML!J,+*7BY5( %1@!5)*X.(I@ 0S,Z+A64LOE.AY^9S"N 1BS$O9R,![-[U0A
M)=1 !!#D<66,0P4,M %P:9P4F,J U](3)8-QY6#,(MC+8#AO,!I&M"718$0"
M1AAJYX'&<;_JJ-6$"^Y02M*X?C!\"PYA!^,DD[VS262P[ 6V3"[3@4//(8YD
M!BE&4L6%22OO4FIY8JS)@M>:\-=\%+# F8TF-#"6,D 90T *&G?T%%$D*7=$
ML493B1Q1(0,ORUU+E;O2\U8&<:0I!E!(":(U[8!4*=U+'$HG@X9QC]%H$I8=
MP#(:L^*U9,4KX1$[S!45 $6S+)K8' /%,0;16),HSF3C+&\T.5I(MH*,QU>(
MQRQZ+4ST2KM5HVB@! )(9 H]!#'0!AI E''!D: $T8VFS&A\[6C,@M=*!*\(
MP6@A,A<L!R3%YZ"<4*"E@D XII!7FE#CUCCZU]?D(/YVWZ>_J(PEI>#-I2^V
M]+>@M![WDV/A=K_;+8??[EOXA-3ZU'63<1EWQ#L2A\;U1Z;CQV/SO&3KKRVQ
MSB*[YM5L0CB70DN#B+>8ZL"4BGL2K#"F!"GK;5:JUV+C<78K7!^!P<"  %72
M HHA! HY#12V0C%I)%*^T11X0ZI%FN.+ ,XR<H)ERLN4]SU07CXC6 @/SIT1
M,!6M9QA $)JDH,L.2((9B",;1]!"S'V*VX W!%KD4ZF9!]<$\YD'OU\>S*<S
M+V;"N=,9Y85VD@M > K%E1+7*ZD",%QSRH,.G,E&DZ$-01?R=$!FPO5"?6;"
M[Y<)\[G8RYEP=BZFD/>46@^HA I0XA!0W$4F),%BS07UBD0FW( +]>/*1+@F
MH,]$^+T283Z7?!D%SL5EY0)KB2B 0LA(@3Y2(,8&8.0PC(2(4(H,0S8(7Z3S
MW"HIL#Y6^FFH8W7Q?U?^WKQI5&O4C:"QX_=IJI>]43WCFG^O?S9NHQG\U)RV
MM_X\_KES/BIP!-ME?QQ'XMW =V(QO_OW7THW;-\ ;>ZJ23_ V27:Q%:/AH]?
M,M=FZU.V[K^>+W"=.0D4A-SNCOF_Z8YK2$+I#?+!*N4L#11*!8FA@BL=WQL%
M3Y$4C9NKVM/SYDM]YH$9>'T!=,+\.]WYHJ^JQD^W.J-;]L!\S]_MM#@GTW#/
MNKN>7[&+.OJR\N]N7KQW9779T5?ORE[=T/JB]UT].(OE3\:(7=Z;7O50C+^>
MU;P)Q[5/SB\G-4^^WJR_N@.6\7=*;BKX^-=P$_WMF>>CWWH,.IWJRYM*XN'0
M*S?3:*&5RV?5O;][N+>]U5K*'3RS^<71"MO_CZW#W9V5MOX?*VS]P=&O>\=;
MO[S9T=\]_/?>]N[1'1I_C@_&K74<WUJL'UBOOX:#IMQ^BWY3;RY]I7NXDY9#
M#L^<H,>[RYD?SYV=*VS[\<%*6[Z]RF%O'1W\LK>S=;QB;OZPPC[8:VVUMO?>
M,#D?Q^'?WVT=']TS.AZW2!XU=.[:*Q-VK4VME5 K7B&UX@FUKFAJU=47B!2U
MUR]Z7_S]EAEZ6VS!#E*G*:70(,HE5I98X1R%V%#%/3O=26(+1!"!F>IR6TPY
M3&:H=[_JP?#J>!#O>6S"5SME93O]:C3PQ[&ZGSM]>[%R'<5.=)3+[F_=5CN6
MRUKGK5C'!6SMM./[]L7)?_;_.+G^9WO_>C_6V>ZTCA3\[;]M:+O_[NG_J-%!
MO/($[[+]G0N\CT_@P?$G>/!QEQU\/&R?7'\XW^_NQBM;Y<''S^B_U[O7K9V]
MTR"@)$$IX! /@(80@#+2@CAT*B '@]9D+(*5O9%W6TG"@@0CY8272D#JO3"(
M&4(U"]K%-TPU"E]9?9E,]L'(-YJ']]6&\>R[HSE,S.8G2[]]-Y)"HK#QPGE*
MM23*!:X="P9I87T(BP;X\S"V^\L*E[ QS'Y=(<5L'1Z?K+3QQRML_.%6ZVAK
M^W@O[F6F:]0]>>VI=6G><#@?5<,R7*U([WH8ID_#[KCMDYMWO..KFN[%^ZKX
MJ+M=7?RK5P9?F%$5ZZJJHJR*?AU^P[MBV![T1V?MHAQ6Q:/"?&_4-7YP1YMG
MD3A\7!J")9PJ9HVV-$7F1%#IN'Z@A[5Y?'?)V"][_4$YO-I+"J.OA@=?>GY0
MM<O+7_T@R8[ZS/]\%1>4^'(JP@/\]E:/+_N?3IUP.M$S2/HFH"RN( 9Y%U\I
M1Q2DU"K3:$IT3T+_6U'V7#GP=AA?C/LYOJ@'_>._/A35R%2E*_7@:K-(LVC@
MN[KLI> L7S<E,-4X;AD,(510&V]4<B2LD,;K.%-@R%-BH5,"'7PZ%<X&Z2@&
M%L$X)91%P 3'@)$PA:\R'#J>@G ^,"7ZH1[\Q :Q@UUAK@I=?&GW.YVKR2>?
M-X\VYR9'NF*WXR^&>B/^KK3M=.TPSI=(>:.0SM &?I!^E#Z;8Y[-XJCL65]_
M/"&HXG(TL.T4^&<\">=H*DVQJ@B#?G=:6;QPX(LXX$45Z;D,I=6]83$8;S:+
MR[3;+(9SV\WB2SEL3ZZ.]Q]O5%>%GZ:@F]:]$:?O]+&88MB??C/[\4:<J/61
M296.%,>%/5B2[B7YJAJ7D^ SC/_J)D]_/@;730\8WRG][S[UH!X6NM.I>^+1
M9NBZ![HWS XZOG<6OYW__6:Q-2QVO/4)FN-3,X(VBH2YC5N=W];NT9;'!<'[
MXH='@1][O:\7<TZ[U_IP WW=K=ZU:DHY"-M]HSM##@_KFM;)(_FO1O@>:>V<
MD=;UQ9=61/O^SNZIE<PP8C$()#G6$02!"E8#[Y@4C'*C&&HTR3VT_UB,>Q5P
M6(Q',$[9?N_/!GIT>3:()L R1SKR>?!_Q%H_C^O*8ST;ZT^GF@CCK?6 ! -3
M2%<169T:@"SS@432%RFI\/W%_L=BVJ_%9!#']%3VJF'BF= ?#?YDX"<_6^;
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M><F^GFD4!<VUU2YNC2[I)QVOH'6CKC:::M"0H3$%B$V;.IJM;Q';V+;=53J
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M\8@),A?V/4':"W:=$2(Z&_,"T2.)MU!?8@6X;?&<1T$%" A0@ +%)T'A-"A
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M&Z1L4QWD<_KHA2++"OU)3P]6E+X)SL\)2>$H.4_4?4>Z&]^_S(D!12!ER^\
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MI>$_1SM_KYW"2F*E??WA_P!02P,$%     @ M86&4K@<TH.F+0  S-@! !0
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M3(;#HC9>U;K(_9B0+2TQJKI0FBK]Z7%N"VD7S 5^B\.;>+?FE\^7[\M3<R@
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M8+6&C$U I?[ H"JEH9U!ZIGS-Q!9?WRKN%OBN?)&*LV0RJ<5W!")7 P)8:K
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M ;Q4*FF5FA@ -T'L@ZHW%FJ#T*W5IRJ7V%0LW B'M/:(S+2/G'E!+A &56)
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M2T@CL@P.IE.<'23:3:9S7;_'2:*QX1.>E,7A__R7$\PT80A9@V7)6\TT%,E
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M$<:R6(1A#A4X&3VW;1J=[XH3C[2,?#I*K"/XOJN9P/DY_'4T+'B(-=_J*%U
M'D\^'M2Z'9>;H :CI?&2K%='LRU)L CH&2<;5^10+"[;?ZMKFSS^J-T7/MY6
M&^-VHNRY(-PW>#7.^A)/!*AG_<B\D?7J!R/S6;A:H,ZZ@(F[3G7\5HV])[K<
M4%B[3%-^]?64AE@L3$6YE(5B2M6Z.D$7%D!:!I+7J'IM5.KB:?>76/4-V[Z8
M?WVK89<9JA7@E1G2 6)+0[ #QJ>Q#'O7;U?^;*F<7:XX-Z J*P0ZVM&T7/C9
MM+=EVM%4CMI($1W91'O%GT>LR.= GW5TTH V)Z4,$UX#NSJ0(50A0V00?6':
MVL)B\([16LR-,LXYU21U826:W1LGO>MMW+?0>[8W:<*S\>@5POD'R(MLX-//
M.($O7]^_^G!Z90\K*ROC&99B:KX-)_N,C"M)7^H8N9*^2^7++L_:'Y4WD6XS
MOY(FO@SQ$IY((7-O(K,H@<@I(PM!6Y:]XR8I$R!TR27H\*C]TGW?LFUP\GB0
M_^_%95GF-^/)._S]AB4^&8_HRS0/ )C.]\/$;1 IUU#$2-) &\D_5L"\MB4H
M0AQDDP">M5#NB__23C4-RI#4M^6D'.3QEQO%8[M@:NFZK +U-+Y*0UV.&RFB
M@;VY$AN7*FCM-;,%Z161J)D/()A(,8?$);TY30ZS=T>.1QR1)^;&.O)OP(EO
MD_TX@U&&29[^^B7##,EXL%Q>@I36&D>V$%.02BVR1"NJMX;4"B&C!H6B2:!Y
M)W2[-UJV5^3JA.H>M="@(NA#(,DHNSK\-1JP6%OQU9-[<MQ#)%LZ0,8JF0BE
MR3E')W1[3I7-M-!B5?F=<%T?XW#C.7KRIIVH_:FUT@RT1\:Y3BEI#J519MM-
M%'MCEFXLV@9UPN9I;Z]@BKDFQI$H%L7,)I,:8#3?-%]]_?:9R[;'\QE\F\8H
M5]_O5K>WQ^?4TFQM,:DG,GLWY\IR#]+GHN@&BU63N6D%&FK#UVPAU";/FL6@
M Q.F=M.*@B;;Q%5_.>1]S"Q_WMQ=1[]-HI*FL\DPS3#/\U;G%>$^?/SU<O<'
M:3&B(1DY3KL_@&<>B"N:C M11 Y\N<E.7P%*#Z!Z@F;=3Z[X.R%-?6FM[RAH
M^+_CR769C?D;9VV)69)[FW0]>;69LZ@QL82""R1_PQ3>@4,=@]F7'__2K;4>
MA-IC'<Z*IE+XI-S"=,GH+J#ZSB&Z%\WN,XJV5=.XE8Q[SE6Y'QS*C#D7PSAR
M1>YHKIOKW!TM7J-,G,?>\E9VK/@'DI!VHO=U1-OSS>(5DI/15:I'SB8**30+
M*&E;T:&PZ"VM:TBFE0"K$BRU7UAYCWAGX-TFK_0D['%?DNHY'. *S.GOXTLP
M5O"<(T],%I_)XDB.18>%%!.\-R$F&?(::KL>>%_4MIFD&KUMIZ2!Z^Q2K$T?
M!3#GR4K4Z 4C#)Z60Q6]B]$XWJ6^]8JA]T9U&TJKQYOXFW#>C"\F5T>T$4S1
MRC(K1#U%Q<A"\HH)&[G,EI14[!JZ^S;ROJAN0UDUB.*]TS+KU==7.$J?SV'R
MC_FV[I''Z))F7-$?&K)AH1 ^<+DH65S -N[P8\!>NI/31 $-2M7?Q7>%[BK[
MH0.^EB?.CP%\FM/C?M7Z*&=ZT$F#@[9'<6H5LQ4::.$TGFGCZ<7AZ%DN@>S&
M5(3Q3<)UGX8SCQS:/BUEUE%%BWN$VHOELJCU.[R*+/9!<(A2,023R)7 P&*B
MS98\3*^Y4<F*)OGF*]'L_@RV7Z4MG^QO+?%V81(WBN-?%YOA8,@I899K2=R?
M&[B$,!J+3F:A>.QRHKII9,0=0'M&AE[DWK-7>-GRZW\NAM.%:.L:"!@2@4@L
M>3>?)%G>Y/HP##9*R0T/179P+5:-_=(MREYD=E>'&U=87(7GDJI=$*VV&3MI
M\RD,OWZD_X JMQ!=XQ?S$ID3*G-K#,N F3A+[(VU**/SJ@BG4@+HDL&_2V7>
M8Y'M2I?K2*SOU)F_'A[= '1U=)N,2=H5%F-)-?(-:'ZT]GBE.(#RP>@NAVXK
M!]]QA=(>)#[N4UP-C*5OU5+?KJJ6^NKKXNCJ#*:+&QK%E?+>"28B$5<[*UG0
M(C#N47OM0M:J287C-7&^]'UX%^JYRZ:MVX(] O<;V!OQ'%T@MSS[V0#STQP'
M->7">KSK39$-3@$V@0XE>X%6,V$%[<DV6!9Y(B_(< %%6FU%DYCY9\.]1XZ5
MGCOUUM%?B[RN"62L<*97D60NHRC),1MK:ZS" _-<&%:$]5Z8[" V::&Y#&3W
M)PS-M;><TK6-Z.^UI_[]IR6!O:5OY[^8_[P*Y .6'^K?OWXXOA;>[[___B>8
M?I[^*8W/?YI+[>#P\.37=Z?'[WY^?_+V^/#XZ./']!GSQ1F.RQL83OX&9Q?X
M&F<P/)O>1C4=GG\Y>\Q07FOXG[Y-X/;$+I]QBP=]3@7_F"'1@L0^S'_^<6B-
M-:X>.BN9-)E$4#LT),LS#Q"BXX.UGK3=FWL]W'4#[[=#B,.S>=^A7Q"F%Q/,
M)Z,/M1=1;3A!'W@W'DVNOGT%T^&- O=6&Z=1&F:AYK++[&C9(Q\A^QQ*=L45
MT^2HN==9;'W\NL 0IXNF<+32IY"B8D6&6+>"S&+2])K3&UZX(/&TN?N]#6/W
M"^'3,>O.N>SF"FG@<![2JD)SK7_54A._P=D\M7=V")/)5YKX7&8#ES!S04XU
MY!J+8J5GT87 8M&"HQ"!0Y/LC4[H=D^F;52X?(G7N_Q;I"_.YTO. M18O\!2
MS?#6#CGYT%&S $7D5,LBZB9% A>/?]%JWD""#:JKW%CRKF?%>5"(U2,0H3!-
MDV$@R%7P$B5/,EM7FK1Y7H'E>]X5ME5-@[?^-<;9?&GZ,IS!V5N2!G[K.#H=
M@+)60*#9UNI@.@9@,5MDTG)MA(2BVEA7#\/:/8>VUMRXF=@;D.+&; ?.!0P@
M"TOS8P5:!%G4Y."1_Z"D]CHFWN3P^0:&EZ_N307:HOC6?!'\YM(-I[45%RV!
MUQ-5WIB8:/>+MM92('>11<3 I*QQ"D'XDMI4+G@,V?>\=?2KM@:\JL;MDH'[
M+?/ST@"^_8,;GQQ(CED$PITY)_!%)A9<"DQI:Z1.P2G=9)_9"O53&:N]L6"%
MF[(;%39S7U:(9N"B#DIC82X;6G"E!EJS76(EYPB"A^R$V.EZMF^\Z4?T;5VA
MA^9>,%J9?63U2+P&%Q@&-97#$Z4+#Q9+FPJ3W>!]S[M> P4VR,6YAO:PF.9R
MN67E>P5<2<6BRHEIHY%63&L8&90Y%FZXS$V.:3?$^Z1F>&_J'^]>=VT]M%7K
MKL_T9N7H6=&&WKFL:%T7&%DQM#<G)X,&M_L5;2\)U*,F&NR ?2SEBX@J*43"
M8LFH$RXRG91D7G'##+<!<LK$>=MTL=IV!JT[<3^_W?-IE+]JM=MEU^\[LW_U
M]?K+OPQQ0L@^?WV+O^'9(C0XB<1I#BQ#) $+F9D/IF9+")Z,\3[+)J<=W>#M
M.J;RB:ES'X'[4V&#O?@:VJ5<%E65[^"]"KSI +9EZ.5::)\FZ+*%VN]C5C.=
M/3G1C'#!F."8P"29YB:P$+)E7&%)2=H@>9/XRF= L$<B*Y\=O]9154M>'8^^
M7,RF<PF(J^HRQ0FGLB"#N*9*U/9 7GK+7'#$]ZB=:A,.\ "F)SP0Z5^;]_%F
M2U4T""):!>VJ2+O/*:D<(K-6$32K:9/'DIF @,%:#SJT#<*[B^E[8\DFJMC1
M6J*N.H) L*8>*L>@#!&8'.((2C"?M*+_8:V,L"N6J.^3)9NHHL6QQ' $HS2$
ML^/1E'S!>0G:>:4,#2H(X6F2J)B.*%B4W#,I712HH+;$:L*0U7B^<^^K!R4U
MX,Z\^WJIU2M'^2-.?ALFFO))68%V6HL93U?_ZJK@3H>Y-.T6U>-DGLA9ZX,E
M=Q-,GE;%;?*5^IM3$B**J!2KQ;/IM;; ?(F*<1#<&JV-L$UVTN=/U\=<O^?.
MUG4TVW<USYO1Z->I78!:JFQ8R2'5-I2TE60R)R5Y'"$K=&%Y1UY=$G+%V$_0
ME^C)-#7N4<Q/FT%W]/YCF]RY&P,WS)J[#_Y2OEST/GIAI2E9Z9@,N4V&C&3Z
M2COPZ!_,EUL]DW[$3^3#Z6R88)3?C"<X_#1Z-4'XQ_AB]I[L2Z(G?,)I&P6M
M]>B&*MQ<!$M*=L447V]GDTG:1/!.*/*:,:MHN17Y026OA6*+FCUW"EQ\NQMT
M"K)-M%%;5=LR M2")IPS'R5:*+IXWJ5%\@./V+YCR[Q,W1M:B0_'H_EE^]^'
ML\]7Y72/_DAG%[DZ,.3GT/_S*?PQ4%FEZIXPZ22MJ]%;%GU2#&7,PEON56@2
M<+X!UAV7QNF)"G<;M+154H.SR'<X.Q[18H%OQ]/I@,LB3="91>L<T]8X!C)P
M%H7Q2=OHO&O2J/,6BOW@PN:";> RW=LFG;Y>&&8XSYSY,/ST>792?ITNSDL.
MR@PG)*"+\XLSF&%^C5\FF!9]T.E?'IR/)[/A_\Z_'1297))$8=KI!1EQ$%BP
M)C/00<0"A=.NT((Z[:>V'WQ\9A3HN03_?=6K8G(V>5680Q&8+K5,O92:!:&
M!Z@G>EV<KGN&;QT(U8(/?4GKJ8.3:GN"CS.B9!WD9QQ_FL"7SV1$+FZ</=A4
MK.9,^$+K;3'S*G>:&9I@C!BU]%V.OSOU)+H7Q7,JX[:6:L=]B[CG7E0?%]2Y
M">GJB+(#J+Z;D=V+9O?-R'K2UKB5J'?&@^2<1]3 :J(ITXZV(F]\S3CU/&HC
M #&^4/T_T)-LE^I?1\(]'Z]>'1A<17-8U")'01[4O%FY("M;:,^XE)&;*#)X
MZ+#'WQYUMWUV>A+SN!<9]=R1[/),YZJS?(E%%NU8TDHQ+7R]+B>[11J!WNM
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MR!P+I.3 JRT7L3L/W0/FM!5TST$>RT!/QS,XJV40AS3VX@"Y7B,5G-3=UR
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M5EG+WXOT!*F0%Q609"<*F>=?/FP0N8NL)X,)JD$GE0]7,'X'7_#.(I54-)G
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MDD5O G,:E W.^N";7$OORR8V!/>',XEM!#]P6/%N,IZ_V/AU-,5$_W(>[,A
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MU?UVRFTJ_,D@DALP@*PS?O5YA.7A"/1]*:.$TWM88%VME(U,!$NP0"CF(5$
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M1XC<B<LUV'86T>Q>9)<-?/EWAA77,G"+;[-"]%$HF;A/.B;T6JBDP!>A%6#
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M.*12=AE^4KW:@Y==U=CG$6[:3<ATT9S(WNI;%Q'S$TRUQQ4F$0$("P9(!&/
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M4@EW#3>I6K20>U=1V=SBICKH0[XXSW-9M(J8G'-NTBMRK>E,IOR"!%&"8I$
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ME!WI5;M7]OO ;S,J9-,OHBD7>".Y3+^:BH'7ZV7*OR]4P%F$<0Q0:-(]0\(
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M^X\1I]5S1J:KE7I@?/?MFH]2I)PN-XD233> ]Z;D897L5;O@**0A42(&C*C
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MFBQBIP-R.V"GZ[(3-I;8<9^%'?!9_B@38R]7UV7<QZ8F0["(51*'G") 8A$
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M[!MA;IYC"=*3&Y1.VX.'>3Q^O' R.V.;8B4Q6X#U7MJIQ#@42#B5H(G*(E3
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M]LRKX0ZW^V!+S)!;!4?'G-2OMV5@UPFWOL\]I^5</U"8A[Y?TKL%P51*'"<
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M-1#P%=(FJP@P8#Z,M7)"4K(X01+'BRJ-2\N=%98J:FHY7#[<76G&^X8W&,L
M,'GF73T5>:$-8.-BFIZ,8KU<TBPW1Z75COQ4[1E[OR^,ADCZ"0+<QWHQXTP
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M)OA78#9K,UEF0@\OX 6GGY0I98WL9*5RE:KN/5L/8;BF.!V*T E&9%:>7[\
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MC$'UNP"G@@18GX1V4V6-AO@$'%K3(MZ]\QL#QY&7I$)DT)!9\RTTI 8-L4?
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M[QD3=ZN/NZW:%>@LX;H:QD,B#6C H8=UL"*- DAB/X:<1)2RE(9<&/=*[R/
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M01R)*/5Q&IF>:38?/#?_1<L&M'! 2V=^0OD*K.Y#R+X0C&PK#+6W.D4\I^J
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MX\4$\B0.N$>CE.'4BAEE J'G9BVJ=MKK@YP#VJ!/,>D(R]0+4@^F(0DA8E1
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M&]NR:B5!0\LK<! :O)+Z56F;NJS05<_X]7[&+]TZBQDW9\V8Q\Q/1*+QQF^
M%:G&^!/3PK$QXN"346Z,#V"3@6."T?H2<CR(;YF.TJZV^F!U$?+$3SPN89*2
M6&U28K5)\4,.X\3WN4PYEA&R(^)X/<#<%NR*4>(@)-!2VO)N'('8OJ2Z@&;D
MQ= 2E1[T&N=5'TRK<?38B>DTSBMU2J-QX;H!>0NT^TR'7BA(_KQ>?1?Y5O"Z
MY6+9Y&LAF2<$#F(8"#_51304IB)*($<1B47"4I*PGJVSW$MK\^W\G]$M:X09
MC\(T37%$H1<AK+L@(T@89S!,$B] 0L2^3'HUR)K#?/^%>V*-,-46221O.WGS
M3Q+9IX'LM:T[7.VY=1TT?)]H2IPG>(P@ZO0)'./A?39!8\3A^KD8[W=YMA)Y
MWMC!'/(!$))4(A1!&A,"42H%3,- 0J891;CP192&-B>D;8/-;?=0R]J,&@S(
MO&C%V<QDNT)O9+O;'SAKBVF"B$NSUSK>I+;+1/-C V1T3]_Z?;(M;)BR2B=5
MM_OT5NF'(8E$#"FC$J(P8,J<X 1Z-/2"*&"$)I:U^P:CSLVN[(4N7(AS)><&
MR:4#)L'0/70-[=C.G@M4>Y3M6Z#DMF3?9.")R_4ML#@MU;>YN6<:1Y%<]I%D
M&]V(H,$#L/\T8AF'OB1Z,Q @B @.8,I#"5.$L(=D*$5LQ/MO/.+<;%,I\!70
M(A<-05Y37_2T2]W &V9SN(1SBB/'(4C:)W.8HN,TEZ-ST&E3.4PQ.,GD,+ZQ
M1R)'6;F:K;Y]62\SEHFRZ<F"I%QB/P@A(5@'81.UN?*4-R2C",<\E4EDUINJ
M98S9V9>]F*"6LV*$,#0I;7@:)#L,1VELL]$#(+O#Y78(VDZ&+]PYW;%NN^BO
MSF0[+NWG0-P(*38;3816M5KXE!&:+0L>M$5,/8(%"J&@GO(=U+<-J2\X1'X:
MI9[ZFK%$=3?OQ[5NQV"TYK6-:?3>ON[>?1AYO'>X& /P2G"P)7^"Y4%H.]>A
M%7(SKV$P@M-\^;68189Y0\0K\.MFG3N,,IO@X=)%:!UO4N_ 1/-CQ\#HG@'[
MD;OG%^5TZ)W/AR>R^:;>:L$9DR3DD,M$&1*I; @)U79$1HA+$2:A9+YE*OG9
M@6S>_6G2QXN^1>L5^+')M@+P]8\5R JIU5=!"@>MQ[[C%&"+S<8@T*;888"#
MA* 2T?&.XB($SK<1IR--OW>XJ.W9#</EJ_L6FJ@/;9OERF_1S77SPGGY>6"8
MP]BCH=H=0)]@JDQ#@&'*< @I3B1C/@]BEEC%)]K'F]WNX2!NGX;97>@:V@5W
MF(UM(!IP%>VS_RAE'8=\SQ 7MX4D[4-.7$5BI/]I"8G9;?9AAU_)\S/Y]U4F
MQ1>QD>)/3;#W,]^*YXJAC=(D2GTI84HBW2^"(T@X$= +8Y2FL2\Q,3K;-1AK
M;H:D$!<4\H*]P*"4V#P.T05P=SS"(6PCVY(VQ!S2X5F TA*IZ'K"9!$+0U6:
MD0O36X9%,#YF*YV[5EB<SV*[D-1+4)@02&240.0' <1)K M9913H$Q&6^#:.
MQ85QYF8';@3=@BS/=T4B7P^7XA*>=I&) 2B-'I10 -W5 !4"7@$EHOMHQ 4,
MQ@A$' _U)C&("_I>"C]<NGQB.KPJ$ZV1#=O6X>IAO5Q6O687+*!^P)6W03SB
M0>5@Z/"H%T""DI1Q+TT%3B=APNNMPMR,UZ]%[<:-;@1=:P#WA'B'8\>)B._Z
MOQE12(F?T C&G!5]RV*HO$\"&9)QR#E-) X<]^Q\TW=C%GT[9_]6F*V@\Y[I
MD1=GE_GM#2 ZFW+.B_QP\$S.@O>POQ9_#<K#P;/DC.UPN"0]>_U52?L/XF6]
MV>K3Z*_B6U$-O)"I# (2^%#R0.V^&/5@*G2%KO!)A"-!$\^(CJ-[J+GY,(=:
MFLU>5I!7PEHV\+N,K]E:X@:UD6W^ ;"#F.!K%V#V_?8ZL7#:5^_R:-/VS^O4
M^J1/7O<=_:Q%M=\K6!'K$^>?ORMSE1>)+8+?_LET)G]!(+"0TN,>(S[D,HT@
MDIBKY9ZEL&@)["DS0H51NX)>H\_-IGS2I2?9\\MN6W2I5$.*_'+ P@'Z9N9E
M-$Q'MCB5W"6#ZM4^,^7G%6@*#TKI*XX4=X:H%VHN;9.= ).:JU[8'%NP?@\9
MVB>OS.O_36R?UORNJ&HLC&:9QXDQX:%(."0!\B&B0ADRDDB("<,1X@D2=M;,
M;-BYF;%::KW65Q4LI>"@(;E=\JSE/!ANP9VC._:VV0FP YK3F> T3@.ZUI'?
MJ,F<"1J7&\D9W6U_=JY]""%>DU/OK6.UF]1Q^'OY=:=&4G\M\P-O=D*W&WE4
MTR<6L? #Y/D)C +N*3L64F71)(4Q0B3D5!:)?(8'["X$FIN%4Z]K:'[:[F1*
MNH_DIP9Z9&-7JG,%CICP7_EQM5;%R1ZXEZ#6#)2J70&E'-#:@4*]B>?,G-%P
MZKF;B+MPTCFT2M5P"7A+/H>3829+^G )2C,SQ.ES^SGP1Y'2,OIQDRWU5KLD
M(VF$5:_Y_]Z5R_&^S),@%*$4)3 .1 R1SPBDNNFU[WFI+Y*$1(C9'?4-E&A^
MYW:W4@I6%+%SK47V7<=#V6[3HW9FZ&R9^?\3SL#(:V7![US8\^7I$5BI"KC>
M;C<9W95QU^T:W-235,W;&$=CCA!VN:48*M*D>PU'^!UO0EP]MB^YJ[;NFY?U
MIFJ=3;;B@X[1;'Y^6'.Q\'D0"J9L*XL$T5RO"*:(Q5"@A$N)HX"ES([KM76\
MN>TM*I+35S)?@4)J!3.H) =:=%L^V';<VXWF"&B.;!1= -F#0M8(GL&,LNVC
M3$PP:Z3R*=^LV6T]ZY%.>FXK_[+JM;/@ 4-4! %DB4AT$PD?I@E'4$343W@@
MB4QBRSK%EN'FYZGM&\-O]N)>@94H?#>R7*Y_%,<F4GTD?+VC6[E; E+?HB[Y
MOY33>^5Y'B!;<*.>4)SKAOX5T&\K4*O&\6]];%GNU#9Y9KZ=JPD9V4;M9^*A
M,1-$JG4&7+^:B \;P;,MT'6F5Z#2PV$%E %:3LN?VL:;MO;)0/.3PB>3>_J9
MK=^RU7I3F,;R\/?^QTJY'$_9RQ>AWCCEWW\3[]6.N?@04B]._30)H9?XNMHZ
M8I#X,8<A9B3% 0L0QC:'319CS\UG^JPF6W?/7B^7.LA4:W %]CJ @Q(ZL;!4
MP\XJV<R-F9$:"?&1;99KL*VM50_87!HOF^$GM64]<#DV;7T>T<_2&<4$;W9B
M08FDG 4^1%A&$ 4Z0RA!*<3(YXG'44K54[?FM#2F UO9N,FX:<K(^$LEIIT!
M,X;<S'J- >0,SI2V:T!%T<;0G<6RA<JEN3(>>U);98O(L:&ROG_2D_1%%!//
M3P("0ZKL%4I\'Q*IC!:E)$Y#%GK$$R9&:Z <\[1A'W=;S22IUIKL>?>\/P#4
MYWR3'-".>Y;^%S-W1L>OTTS+),?E_R>?DK_YT?BX)^)_B8-PQ^?? [WLN@C[
MD?Q9\L3>;Y_$9A%XJ1\A3F%<!$!C3B!%C,$8>UX4)SY-A.5I]OF!YA?Z+,0"
M__V_I8'O_UW'//NQ)ASA:>8P#\=HY/7B%9%C30-=".F>->$\"&.0)AR-]":<
M">>UO429<.'JX8VX'S=DE1-6]OK,M_DB#H(PQGX((^XK/Y4BY:=2))3;JOZ
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MR%9J$J4$IXPC*&@>0:PS\]7&S'RU*&+6"YAI)5V3YXX-,C8;L"F17PD*K*3
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M*2TAI8+ E$894KE$L?1J%'IJP+'1RRMY@148K"7N:-N<Q-S5!Q,.R=Y=,N>
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MKRE"-)4LSF/(8J6@68)L#W6:0)$0KLR'E*=:3E;V$6\Y1>OQ_U^<HM,>E-Z
M[WD]JNIC; E^ 4K1P>O)V!*^+XP]>MOUA?50'>["8>[7[ZX+;FU=[[R>-USO
MNRYJONJ U^D!_BMY8R%\5K\MU73Z%_;TQ/Y[5FAU;;2\_[E<J2<;MF2(<#FA
MFC.)F8)*101BEB>0BBB#@A ATIPG*G9VR7N,.[95?&,MU\*#4GI0B@^L_*!2
M !2U!NYTY3,=IQ>$GD#N>3FH\;TYC>]UK_BZ+P8]X3S04A 0;Z^EH -J+0N!
MS],&6P8ZJ+B]"'2YW7\)>,^FU@]^_TVIU2VSC0.^J54AV'2[PG]*4[-M2SB/
M(=9F[T83J2 R6P06BPPIG;H2_\G1QD;WM<"@E!B\$MFE^GP'N$\3>U 0>Z;S
M,_'SHA1G7%J(Y/0S!J,/9W6V2</]IH['5]9W=&WVNDI^?%D4L\<J9KUR,97_
M6,>T7_U0"U$LS;8JSJDD.F$PYK& .$D1Y(E 4,6,()PG*$+<,UW+6PB?+V*@
M=D.5A$ U(G;W;7>8$\(SC%(:01ZGAM-QAB&)<@VQ^;LDHI2SQ"L M]\9&21,
M;V\^S'0\EUH,.C,X(CG520QC%=GD1D;MS&#S1\)4FJ4RBIA?7^F>YF;09M%7
M;_*5.!XJ]_KN][P^!\C[6V?V-?HM-\E] 8^M.Z,<]$S;7XIA#[P[H[1W&M[]
M2=TLBSM5=EXV1LOJ9^G=,L:*??[:,)9)G"DN4BB8[3J:X1@2'&F8)1%#FF/&
MB%>>VJD!Q[9"U?*"4F"P+;'W3L09<S<&#(EDSWQW'HC>K.6*3$B..CGFH(SD
MBL N_SC?U[%R+EM^L__9?+?O;&I#WC<'Y/8?+F?R]5]L7=GDZ8I%6<]75;^;
M/T]?I&'*JQ_BFUT[;8'?*ZV5^8YT2E.L8P*Q(,@>@C-(4<ZABF*94F6VH%J[
MG+"^C?AC.Z;]HE:@DM%:&L)H=U'^"M1&R?* =K$)9+'_[EGH=]A7Q(UJQSOQ
M/1/WAW*6RS:06QJ]BE4J_]%.^^[?O;JA @$T*(!W#0Y_LI4H:BA @T5921U4
M: 0L<?PFLQBT8/*P&@Q;?OE-9F>OF//;2-%M.7W_LBQF:KDT6TA>S,H=Y%;;
M\G7I@Y1F41[E.9292B%66$!"6095+#2*M-22>9GP;L..S9#_RW]_N *7'_[G
MZ_7]]</US1>_9<D1:K?E)#R ?9\GU *#+8G!1F3P:R]5)OQ@"LFSCB,/RH]^
M:.SRFN?='8\IQ#<E7Z;J1G^9S[Z7Y75*S\6EV41\+\R.PE8DV7PL-*4)PPF&
M48)BB#.40\X9A4(R\S^$(\R)ESO<:_BQ\5,CO0UR6<M?>0!!HX&G[]5O.AS]
MKKV!W+?/U0'?7HOF=$,NJ!_53X)A?:B=T-GSGW9[2K@V8Y_KX.2?O[#5RV+_
M(\M2DK!8<<@R,T68"@P9YA@B&F&FB6V!Z-0B_0P91D=\+T]/;/'3?I>UP#:R
MNPSUL[KM]MLZOTW9J3F**38R)Q*F1 J(&<\ABU@.%=%$1B36B&&_H_.>9VF8
ML_-M OWTLK)VWR_%K'AZ>3);_]E6N>)E6:M[9]H\\TV[S)O; M;S7/2\BAUM
M0K=6X:+YBOI=S<Z L>^&=:?$>/,>=HXXN;2U<WW4^?EFGS=I-Y=5ULV$1['*
M9)[!".<,8D4(I$3%,-:"J3R3&4F<8Q1/#S>V=>MSR#RD ^@*05(D-(=Q;C#%
M FM(TA1#K46<2<[C+%)-3,I#MS2QCB"_#D)Y&.#LH<J3"9KY=0#Q]@4D_%O:
M\UIQ(-]H^YV][ '![LE<YR'Y=AE</HB>E;5U'""/5*T##WFS_*SC"K4E9;7<
MU6T7=_7T/)W_5&HKNJ:N;I*B&.<ZEI!*VZP^IAQRRF*8<V66.7N('%&?O=K1
MD<:VLM4Q1GX6^W$<W>SR(.CT[4,Z%(^W"=EKHO)ZJ!]S$IV01O7QP08UG4_J
MO&L@G[ZA0[+F?-8\]F.Q4,),4]/_,M)9G M)H:360,."0\HC9:SA#.6*:IHD
M3EWDVX<9&SD824$C*EC+ZI$.>!S0T_97&)AZ9HG#" 4D!3<DVA+WCM\\7)[>
M205>I>6=OKI#>^7ZB?7KIU">YUA1&.4H@1A)!6G"<VC^FA*AD(H2I_5^_]%C
M^X8;Z3SZ +^&ZO27VAV GK_.]9<9]GL\K&];*]_7-PS7O?>@H*\:]AZ^PO_[
MVJYO/BM[<1;&4IH)8[N7;JH)DSD5!A>81JF&6-C4J QIJ&2,LUC3".?.#J13
M@XWM&]RNNFU+G[Z2N';=>J2XGL3Z]"<;$L&>/^+SP//ZL%U1:?G43SYBL(_?
M59EM.G"^9^!VAI]8L2B;-95^@&K+>E<L?_NT4.IZ9CYAM5S94+L)0R3"0F=0
M<&+CWS(.6900J"/&:18AC7$T4.="5YG'=_IGI83:B F*6DZP,((.U(W0>:[=
M? VCFK\!?18=<PVMUE670+"E]P6PF@.K.FAT+P.W1] XT'>>1M$CT%GH/T8[
M0-\Y"-;YSWM@OX5KN5A-;GZ?&1/Q6_%<=H+23))8ZA0R)1C$#"M(4IK8^)',
MO"09):E3@/7>D\=FLZZ%\^JBM0]8.TN?!4//;.J,@#/7'=6VA9/,/5M\9/ZT
MRT7[#QV$,X[JTGS;QR_HR7A<'B.)^HSCTWRA56&#F99-)]"=>KY-IO7MHA!J
MDA.*99XQR'E.C2U)<TB$1E#D:8IY+DF>A;8E ZLP/M-RKS9V(R\H!;X M89#
MM<0._<X$LDG?\#T8@8FZ=*V'L07#=KOK$R_9@#9K3_,XJ D;6H=Q6;0]S9"W
M@=N7'-W6VH^JJGQ[OS*V\^5,?C:?PO1Z)N9/ZH']N/IA-5#OU4SI8C5)"<)1
MDN<PEQ)#S&4.F<QR&"6ISI)<9#G+_=9)G^''M\:54ONM4UYXNZTQ?6'8\_K0
MB U*N<MD\U)R4(D.C.R@%AZ\J\4/T SL'-1"LK'7^(,R:1=D=EFPTS/.V+'7
M'5P5B2,5YP2*E.40"R4A1=K KR3C*$]5CIP2<0X\>\2[=J\>N(=@\]BYCZ_;
MK3L.W7;OSJUM_?;O0_:Q;='GX![^[(ZUQFS1\\5353[59NI9^V:W0::.\X1J
MG4+";;E,6\: IHK"F'(2DTS%9L)=SXE=!AS;%[PE<Y.Q:J7>=,!T/R=VPOOT
M67%H%'O^]$\"&#@:Q >>EH-CI\<,=GCLH]3V ;+7?1U3<>>SQP>U>/JH^&J3
M1'JGGNN,Q!MM=D S43Q;T^(?BBT^%=_5A&4)3A)BR(1% N(X89 JK&%.HH1$
M$D52Q9Z)GEWD&-]NQ;R(J6>^9J<)<-NU] YJS^1CY8=6 6 UV.1G7@ K++#2
M!LS+/ >LH)F9G009-C?S'*SVLC//>IB_X72SB-'GJ6ABT5FJE& 9C))(&BKC
M"#)E=C?<]I63/-$<._?[>_7DL9E"-W<Q I\_?W"W>%X#==JTZ:Q^W]N76O/
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M *3K8/73;!HWT0C8K$S$D"98GW$UA++O.@Q?8S L,BDP+*F6D+I+S3 3 FH
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M*I:FY9((#(M*.88D+@A*LL;0AGGOK:J2EWB$IF9RI#4M6C\::<)C>T1&7.6
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MY!15)DSX2*0) H,BQ$9,RF3+@XVTWBRC9Y$Z^*7YES6']=382#"RE<?U0GR
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MLJL\PL?Q% [QR\7(B 2TY!$$*U68+'%BE5#(D N):JVII+>5WU.FYAXI [>
MK;=M]"3]QC:.SS"/14%?4&2K!FJ+&[WGO4OH-Y-HRYUI7R99BHQ>M,+5$KF"
M:,,.F\G#;QPX,[*G7A_98GH2<O/0.89BG%>50#'JQ#!T9\:A164>'7:E\%OA
M(T2GI+E[0+HC=JY>V<B4G9< SVYB;@P])6<^3JO)5;/IZ=Q/%VN21J"9#=QY
M CD$(H4.Q&$41IRU.4N:@^DTP+/K^QII6=X_;GH1<#M5>G?96XP$Y88SCVY:
MMI%(+=%TXH^(\C& E8EZVB7V?>P=C?0,VA\<O0FR,2NRPK6/:[R73IP*O;?D
M92(Y9T!P&TI<D)&$;*03GAK="11/O:>1)CO]6XV]!-I ;+3=[3_Z:XIO^#H^
MO]Y,1]EIIY-QA(=R0S+F2+R1FF0O,.Z3,CJH4G74F<)&>N'LA[&Z>FFQ"O/@
M[=NCWS^='G[Z]?/1Q\.WA^]/=BCKV?*0O4MWGB*LI_*<S1!Z=$\_SR;C>+/;
MH\C1HPX5"0Y#'*E=)L'B1@,)P>,SP^VG2@OKATG:.Q4S_C(=YW'TJYKB.R^Y
M+F2SQE (N+G&:"R1&71I<VF(L4EST!)\KC)#I1MYP\;=/>'E7IJF?\V\#FMS
MR6,O5N?J816LSW9"ZUNAG$6BP0F";/-R2RD2F[DB/AKCJ(^^TJ36>E;H]T5)
M>"Z6XS/<LQ<C9XSU(DGB5>E!CWMF&1KI2=+& V4A\KM=$OIA\#89S5J5Y^C_
MKE790](-.,<'Z1O,E^CI3[^LG/N5:'Y<&\,8H@6;&+%E<H9$XDGPV1(3)75&
M"\%YE9[_3] U;&JO$I+ZU$4#T-HTL;S;7_@.4Y8%#UXX$F6(R)3)Q&((291R
M02O@!F.(&@#K1-VPF<!*,.M?+\V"[5Y'U:U,CX*4+K%(2?0<HUA*-7%.)10I
MY<[&I+**+X?!;D0/FX=\46A6T.+ .<O+^=Z%%WSS>'D\7OQY=P6&&-"NZT!"
M]IK(X"BNP,2),Q$D%_C+[)[PWKN^:]C<9<]@JB+@!DS<Z=PG0(:.EE]AOI$9
MKHT(N ["!#:K  2+Z("BN<DF%O\3A<6R((XYG7/6&"A7R6%VHF[8_&4EH]6_
M7H;OOA=GTR4^$7_[Y;(CUWT/P0?G(2IBE,%(1P;T$$S,!"RP@/*TEJ<.]JG;
MVX9MD5'!0E40<A/=;R][M7V>E#3;C89M=SEC@2NKG",F);2^SEKB:1"K<0Q"
M&@>2U1F8V9' 8=MD5+)55;33P-[XP8_G_^$G%W#C;N7A% 5V<7;#0Q14)4VE
M(YE37VZR"Q*T-B2XZ(-*%DRJ$FMVHJX3WMPKPUO_>FD ;,?P#:87@%O\[,MT
M79!U9_5D!EQ0;PF-( I#LK3:];B8LDH86#.NJ^23GZ2L6P:6OC*4]:N0!A!6
M;B3!=+%2S#%,RHS7K1E!(S,-S$5BH)2*EF2SBS819;WRTJ@H1)U.\=WHZX:V
MUY;PKZ&<)C"W6![E$S^!>YSH#-%; ;AZ(F"@S!FQ94(C1BT4G,T)ZDRY?)BD
M;LAZ;0< /:F@ 3"=P"JL^16F,/<3=#0/TMEX.BXR*KU@WG\O*^@^E^ AE/N;
M1(2,2X9*2AS/D20E&5<K$539-W<CMQL(7]OQP NHK@& 7DV9N<N'3X%%'30!
MXP,&/L:5VQ>XVI(6GBN4JJXT'VH[0=U ]MH2_;V(OP$8?9C-H=P@O\!W3Y&/
MZU+9DGI>?3M9C\&^YQT($;SCB62!X8Y,+A''RI $$(I[D$+3*CC;F>)N0'PM
MAP0OJ\ 62N2/83F>KP<D70]G7S-UK]! .J6C5L26*6W20"2K:]69,RX4!65-
ME]8BSWQM-X"]EM.!VG)OP/B]]_-RY:R,C%[=0KN70_08[S"#MCR7T0;(&PD:
M. F6 @K1TF1T#1/W!%W=</9:SA)J**,!;)W E]5<*SB?S:]D=6_!4,43=U2C
ME\DH"BP*XM&#($;EK"QX96R5@<:=J.N&L]=V@M"_8AI V^'9N1_/5S9Z_FZ\
M.)\M_.0HEQ$:'S'DV4QON>>J>JJT89I@:&.)9,ZB%%>%!%XGJV(*=3H^[T)L
M-RR^MM.%ZFIK )J_SF;IK_&D!.*'J++IEW&8P';.,K<\68&K+#M6"J 2\1 E
ML<J8**((.E69G-V=Q&YENZ_M^*&2BAH WV49U=O961A/;[JN(Q4I))L#$9))
M#'\8PT!=.2(M-X+Z8!*M<O3P,$G=P/7:3AMZ4D$#8/H$?]V0T7PVQ2\CW#@'
MOKM8.&B,H3'^D3$B5R(88G5DQ%FTTU:+,DZ\!L2>2V@WX+VVPXBJZGH=]^96
MG:'ZN36W>52%.W/;B*Q_8RXRKZ*2F6CO,Y'&1>(Y<Z2$D=RZZ$6NLC8KWMN]
MZA-V5;1R/>+V>KKM;^#+1(IT-#V&>#&?(R5O_&*\[B)V(Y7CK&.0$PE!XHI0
MJEP#$XD89G)TE%*5JMR;ZI6+9N_K/0=]#_?(?VD]-[ 'WVB&=R=?5)B+*()W
MX\G%$M(=-KV,WM@R@4T#!DU) #+,<5^A,0HT- %$E1LR.]+;[/7 ?H!;3W<#
M'U1<L_AN=E;FPA6N-D<T;^;@_SRZ6%[W!;F[%JW*,1:1TAS+6DR4.(%+4V;/
MDF')@M5/;-Q[$]'LC<%=D/>R*GD=/F$/ YHZ/+2"G_@B@Y@> 2!7+GEM$7&6
MEYF>"HA/0A"+@#!,8<S*JR0,^O<8UT-P[S406;61Q>T^*2%Q<7F/@&<!@RW%
M#4F1.6?!>9,[M>7?_OAF';+G*/?V+.']Q3CPW)=C/_VRGE!B,+[F22FBLR\;
M+2NU*VC[ G5.,:H 0I=>1IU&O%R]=< ^W'WH;K:O(%O0_F7/\ A**QL(SQ2(
MI"X1RSPEJ[R(EIZYU-N(GQOO'6YHRXX:NZOS'<0WL-9_\]_'9Q=GEV-EC XI
M(N 34QR=G#*1F#%)E$)7*S#\R_4V9NS6FP?6_"YZF_4AQ*&U/Y[>)%QGZGWR
M)&K/B/0\XJ['."JOI%BSB4"[9,*Z:?_FFX<;S=.+]G<68@-IE,VUC\]^OKQ5
M,OCFQ\W?K"PC"R$R'A#-KO2N5*[,)%&9& S'LDW<.7 UW-[N) Z#H[X]B,JJ
M:0QTFYDGECF?L]6XY$096E&*NC)3Q(#PA@=+-:^2EKM/RK"122VE/X*M'30P
M](P@?W;F_WTZSO 62KN!]_'"I]G\Y*!,P-G88>F5Y!BNH>-F4#HY,A(\6$+1
MO6/)90UW79GM$X.>?E4[@-E%D[-Z8FT&);]/Q\L-_<%["3[!>O"[%!"(3<R4
MP8G:.(C4=)HUN>W9PZ;JJ^!@1\$UL,4\V![BS8]3?,3:@&9A8F*""%$F8SF9
MB?-<$\\I0%92B5AE2GH'VH9)OM?R9/I61LOX*@QMUI_0C(&QI<'E.J! JYG0
M5HH4I.(L&-RI7Q1?U[0-NV?UCH>N>-M1.0W@[2CG<80K1BY#5N3")1^(#[;T
M$->9!&<-P<5*E5#&&%&E-F,K-8UB:E>=S_I6P*!-K59S<N:SY6SZ!OS9L4_C
M]>BDKS#WYS\^OSD^O73PA.9E?1'(N13 ,8I. ^[X'+^4(5#!;9<IJUW>-:S#
M5 LP523=C"N-@KK+TH8=%EVB5@6B@7M<"CP0YZ0FR1JJHE#.NR[#B3J\:MC*
MA)JXZ5O.#6Q<!^F_+C;C23_,YH^4XJYV_4BU8S$%DEE Z4%I:4J%)U;J[ 1R
MZ*ZKC_MMTOX,*H=I6%S+.:^GH ;05];D43Y(L_,;$Y$I%TY**XG.@-+B($L?
M>D98#,E%RE&(57*-VX@9N ZBGN[OMI;=5Q$-@.E:."=+/TU^GA:_GR>_!-S"
M-.4;IKC6RN .3H2/Z!*F,N++:H5X\"Z!] )8E7%(G:@;%F[[@^"N[>I=(XW#
M#%V)RWR<DAZRUH6?DHC%(-D%]!Z=3U D&7RN7(3V"'7#>O8O"K/=--("S/Y"
M/J[2+519"A8C5\/*L&4I)/'2 J%4QA@E]1FJ7 &_1<4PS?NK.58["[@!=%Q6
MXY>.D-=-(@_F\U(PL7()WORX_LQF N^*XVNVIZG$2)_\V658)(67OLS83-J7
M>W5&DN"D(TQ);GE@*)0JWGT-9@9VW';'UMV[&$,KN@&P7X]E.5G.XI_EU&MQ
M?/+[QJY[KB% N0YE*-IU[VV9'\2(Q&V#998<U95*$QZA:ECX#0^:>_4,?6EP
MZ(H\_U^S^5L,RF9G^+S5ZM8ZA\0QV(JR9)1THB1(B"0"HPS0@U6Y2Z_WCD69
M=U\_S*"3&E79>XIV8&"4A7*4;_&P63? $Z24,9X!*M"S+1,;Y<JSS58"CY2&
MWHIV'Z1BN +>?=4ZZUO& ^?J+RD_FEX6MJ:D N,8_SK@:/3D:M*PQO4#Z#0P
MKT7T=YI>;\W,WWOP<#KO25&SOJ36B,I/_YIMB->,IA1H)#S;A'MI-"08R*A4
M9ZUR(7+79:+1O0</5ZE=3^6[2:T5E:/V+A%K("AOF"?&HN\DP3*"-%NTWR)8
M$X(R]*D+G0\\>I@3M\IJWU%RC2C^P^QB?IG:"EYE*331C)7L$X0RGD$0I@/E
M2:."<Y?;XO>?/,Q!5UVU[RBW!J+4M[-IN9L^7X_K&"_^?//C#4SCUS,__W/E
M]EB@(9@H"17XA_1)$9>1'V]2%CP;!W4"U:<(&V;B7:VT7J]J:!)6E]Q<Q>4A
M:28]+C%EB506A47!DI0=>D4Q,V6K%)D]1=BP*9!^8? DQO;020,86PV"V<RV
M^@27Q7/6,>I+_Q;P*J*'#8Z$B/8<@S8KJ1)1LRH7RK92TQJ:]E'XW13OWM)O
M $+WQ]%>^FZ2>H6^.M%48K#O5[X;<A24!L,3$S14&87X$$'#GGU6!5(O.FAA
M@L1!_.^+\6(U7V]EJSVX,M4GDFC-2BCH5&)$0,#IP#E5U&7>P8/>]NQAAJ_V
M[?ST(KG&-+]9$(:)1+52)'G H)^A8((7#D-!D9D1,7K?Y:+@]J</V--D;VT]
MHOH=1#=T!?._OWU_@X'+'%]4*DJ320@YEI(-C_+ ]6"%H-X+ZY3LDC'9^O!V
M5+^+MF9]BJX!]^%PFB"/I^,EK!KJW^UN_N;'.M<P\8OU$8*@0EAK&&'!EI&7
MFA,G2Y,Y"])*XY(473H@/=NK>":=PXQ:KA5:UU12^QB\9N[&H;C/R;(R=95I
MAA9;.TT"C>B]*<I\YEIJ5J7,;P=:AXV@JF+G>3C=6Y$-8/5T[A,4\A>7-10F
M 2L#EW1PI;J1.F(I4R0S;2U3R?A0923'74*:1MG^FK];-K^/&H;VM^_M$!_'
M4SA< O[.1DFS1YEP+PR1B:,C"HH3GSA&IUI2FV@7I_OA5PPT'[Y*X-63(!LP
M*P?I&\R7Z$E.OVS&[Z)4 GCI)8E4 9'.HB.I="0F2XI1"1AAJDQ*OD]*2PTH
M=]3PO;M=>XF[ <#<RV===VAF(Q<AXK)11 M>.B!Q(#XF2JRV.IE8^I]4&9KW
M&%$M]2#K!T2]J: !.#UX>??W!>2+R<=QAE&BS&69,RX)*/W%M2<.=WUB?0PH
M+O0;H8JGTX&VEMK"] .NOA72 ,8.2^\L6"S?SA;+Q5M_/E[ZR?@?D$8Q,2,L
M>$*Y\KC_IT1LIHD8B\X;BE#2%&H ZR&"6KK'W ^:>A%] Q!Z<%64B07CJ4>#
M_!'\ H['7[XNCS*NE77.+R,)*-N+LXM5,[!W@ S$=1,!_)<'9V70Z3]6WXZ2
M-I[;2(F@KHQ<RYHX[R+AW*AHC0'GJHP]JL]:2[?(*AO)8> P:".;?67231S&
M"P;,HWK0B\$PFU'B;8I$A)R"!2M,KE+S4I6KEJYR#+LP^@=! YO&KWX\_3A;
M+(ZFJX*/HWPU#&SUQ?6(X;=?_?P++$9"9,6L01RJ<AIHJ"-!.$J2-)92W!(3
MK]*IX+F$ME0_V ]NJZIJX+3?IXN2J#S*:R8VLZM7%_)&WI76?2X0(TKNP89$
M H^2,!:]D)S%Y+H<MS[\AI:*+?9#2H^2;, T?00D'8[05OLBHI5-/H7YV5%^
M.YNNY^Y0%3".@T1B0B]$RJR(958BX+U7*KCH4I4#UZ=):^F,M1_ST[,Z&@#8
MIKKQ XKODH4_QLNOET7_A],XN4C(:EE"^+]TZK^/A-;4:0!BJ-&E_YXB@05-
MO!"*XAI2D5?)\^Q :U.'&?U@L+;&&@#E_7+)&TVZ49 C_'DVW AB<VG0G33N
MZAZW=G#21>.X]75&ZSY%6#>XO:Z3D#YUT0"VGE@^[[]O63XIRFQ"#,1I&8ET
M"9T&D)RH'+.0)N><JJ1\=J"U&P)?U3%*;8T-WU[XZECH*"/Q;V *>;P\AG4*
M]O?SV?0$ELO)JC_("(,7:XTSA.=2Q\!I)H[10+*-.@FG>:)=NL4^YYW=,/4J
M3D^JBKN1^/&JI4-9)26Q/UV>SHJ7.IZBW;YR5),7D6?O"8TL$*D]<I9T)(SF
M!#XJ$*;+0(_GO;4;E%[%T4EED0]=@U1"YF-88OA<UL%1F(R_K/1TR?+)>(F;
MOV;H4:;"AQ/H6&I0Q&N-@;4VR@9AJ?"=RI$ZO:T;>%[% 44E$3?@7QV@E%(9
M0C_^!B<0+^;CXB6N-VE(ZTW\[/QBK;?[<^P/SHJ<1PG0A^11$YX<Q_T;!,HT
M1)*$$"XYS62EKHI]4-\-IZ_JO.#EM3JP_5MU0SM:]4%]_QT=AO$"/L_'$49.
M&;36O/1R3K@(([4DN%0&.]'(49XN2]/!XCWT_&[8>14Y^][$V(!5NS3)QW ^
MFR]+%'P"7U;]^D;,^F""!,)=Q/@7?"J@]N@F!B^D55JF*H=!#Y/4#4.O(IO?
ML_P;0-*OLUGZ:SR9K"Z&X>O?H2U%:<%\/$LC;G-@ CE()FPFZ7J/N[[A-"J5
M:"D,K'*P^ A1W=#TJM+XO>F@ 3Q=7ZR8;+M8<<GB*,J(KJ/T1,B2 A9)%[8<
M@D$(@U&)PBVY3@U=)_JZ5?^^JD1]#<WT!KA_^>6>H)'K/U>_6OVF_*MCR#^5
MOW\_/KSU?+_XNOA;G)VM'WWP]NW1[Y].#S_]^OGHX^';P_<G)_$KI(L)S/('
M/Y[_AY]<P#M8^O%D<9N/Q?CL?/+4P?6S'O_+-0-W6=N\Y1YL^F(&OF/8C\[P
MSWT-,;A$XT%8;(X6C374XTX7%3K-TCM%0E2"4.>5TZ5;)]2Y\/$@2?L:KRN)
M7I5Q?!S[,)ZLHHO?P"\N$-]'T^,2<103C1_X-)O.+[]]XQ?CS14ASEB$K"-N
M^R:@/RDXL8(JHJAV/L64J=(U9-,;!P.W1>\'=7=-X##Z;6!7OF+\S8^K+_\^
MACD2]?7'1_@&DW5;B<@B1?))\J%45_-$K%.E!PPKSH:UB5=)<W0C;UA(#H2=
MAQ#<GR);@N=&CNM!5O?XV]S#5<PXI9PA#")'CU@YXAQZ*51 CI%KQVF5J_3/
MHK(1L/8(DX>0V+O.6@+DX?3\8KE828Q=-A?.AAF1&/&Q-$PI4V(MMQB0.0/9
M!VF$K#)M_!&:&@%;_TAX"'-[JJ51A%W..;,I1I%<(%H+9$5+W" @)\*\ Z>U
M]=)5Z:?X"$W#-L,;%F&[J*51A(D-*]$[K:!TBG1"X6)1OK208L1&*?"_4+J<
MOA3"1 O#@(=%V"YJ:0%AJYLY8S\YG&)P=K&ZK[/JF"N]<(Q9% H((@,P$CBU
MY0Y:8"!\F:E<!5W;Z6G$=@T;-_2@J@80=SKWTT4NXV&FZ03FW\811724MW"W
M*+.I%MM_M5G%D;' @A"D#)5">6I/; Z"4,^H5E(JIJL8P3Z9&-CSZP-5]SLE
M#:/BH>=!^/G\![*ZLA577:(\2"Z2(CFY6 Y_</$G=#DX>K0N"3#NKB7=/A%B
MR[,'GB \F)9G/8J\ 8O8Q_9R?;ZDI3(2N"+:<U^&<ACB)"22;'(YF6RRJAMY
M],%%(YYD&WG"%X=% VMBP_/EB8$4-KJ(]B!S#-ZDT8F$*"VN[>@S9<A(G7$J
MM\EH)$?S\GBX6[JWNW(:@-9;O_B*LBE_E1X%W_RD[$,'RUM;R<A$2)0)1WPJ
M8Z@TMR08AV%=EHP"8X[Z*L4-G:@;^&1O#_7?[6?6NRZ::(BREM H@2_#"1V)
M5. :,T")]T$2YS-+T?!@ZZ29UZ\?-F;N$20[2'-W,S-;^DD_]^ROC?/UP3=U
M J"T-V8N$XG,$\\,(Y8#IY$G;7*56W];:'G]&95^]K)]U=3 AO8.PG)E1%<]
MUE8=!*YO?BQ&7FC-2HV%UAJY"<Z3D#00KBF&5=QG42<@>)RL8;>PO;4^JZ:"
M)C:P&_(9&0R7G>>9Q%5W=C37)&!,31)-@DLK0Z1UNH%<TS"LL>H;++L*MX%-
M;6VNKZL6QXLXF15C?248894*$??X@%A'P7B$>CD.X;S,NG+,YECGFM53E+W^
ME$*?P5M?*FQ@^RO!PYT XAB0E7%<0MH$&+=_<..3(TXA,8=\)DJ1V<PC<28Z
M(J167$9GA*RR.^Y%=0OQ7V\(VA(2OHPZ&\#N@Z(<F2"=D)")20HW!BX][BTF
MDIQ2\(RZ9%B=RNR'*&HAG*R%N7[4T,#^?&-3>4Q6&8+FR092IJ&4\6.*^#)M
MV^+RR:6M4^95DEO=R!NF%W9[.W4%939@\JY8>5RL*SG>BJ&L\%1P08)(D4@E
M 2V[5@0=[A0R592G*D< .]+;3'S;&W0>.IZJJ,?68N%M.X1-N(Y3L"3+TLX^
M"=R!& 22%7H@T7 GZPP^>9RL9B+F6O#K42N][=LO= /R_>>3.G<?;SRXZJW'
MAQBH?]_1!.V4LXXH7NI_!6[,03#T%$URW*0HP-?L\ECAON,G6!Y.4>I0>EB/
M5!16LI1)<#Z5?CZ)!(N.1P;E#--"45\EFKU%1;/W#I^C_7OM(G:6<P,^UQ]0
MFNY#.L!]T7^!JVY0I9'.XNABN5CZ:>EW^*[TXX%T;4=73NR5_ *$$*@,Q!OI
MB PH1!?1HPU>@"M#YJ6MDMOKA_R! ]@ZL!Q LTTX98_Q?8/MXGU&C- V[(^8
M,\"T!:++K0\96,G8>TVRH9Q%Q5QP59RUW<@=UI . :UGH+LG+;>+Y@TW]^1]
MD/[K8K%<%6I?RIAG!SII2U:MT*0,I39&.8)B,!FHUE%4B8WWI'M8B]PJOBOI
M_34#?>2TYRHF7P[0#6Z1I7>EQ[6=G8O!&$-1Y T!O$'#70M5_2#Z60IN%\E'
M^2%61V!BHDQ9E"+%/8FC?V=-20E3)I1V45GUDI['0W0V:)*'1&Y/"FW@9.AN
M_]25SS3"_<F&F $%EDO[5 \8T3)-A%6>!2>-BE7&H&ZE9M@*C0;<@?UUU$"N
MX2X3ETYY0.H] )#(R@0_H*7ID_&$6J8,M1Q$G?OJ#] S["%C@V#;14\][L0O
ME#M_-SN#Q7(<4;P?9G/4PO3-'/R?LXOE]0R'19WL^K->737_OKL0ZF?HI8B"
M"8O+N$P9EQ($"<P+XI*$*$.,DM$:9J+_#/WV1J#K>X&XHG2T(A?/!!=N3I)X
MSB5Q3'CJ?+DSV.52\ ./;S8!_QSEWIIKT(,8!]P:%_/EZ 05L&I)\BO,OLS]
M^5=<?NL.7M;KF+6DA-E<1MNJ6.RW) IY"VCA);==(@-\R0VTXW=WD?XH%<-
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M9C+@'D(8]Q@'QQB(IV5EJ! 21)6$JW*6_S_E)/LY"-KY)/LY2FK9$[YQ+A8
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MHV!H$%&//;HT_*AU^3\+\N]&XQ.M(FJ,FH)M3A$WA=P0E"[@N9>6>Y:]XUM
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MN%U!-@0KA>*RB4^TEIIQ+Z8!4/ HT#Y8YKT;AY5;N$]9SYH/&=10K".LK;G
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M;5YQ7UR\0=)1.*_7]25]WH][?WD28A D- .)D_=.3#N(ABRT=+Z(1'P+(5O
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M.L#BAE*_":;HR&NH]3ZUZUW3:7*159E9QY"Q:'F3U\(-](S3+-X464-(OE\
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MY1N2YGJ&%)-U+FR"E'AM.'=TZW$GP-NLO58EL-1F\]%SE&V'MA-X#&VCBP[
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M?+A&IP"#+7J%E=:@<E X1X-VUP-)2 ]%LDI\-*F$+L41W8$P9HIRA,7NVOP
M]8UL];?Q[_G7;[N@*:THLK*)HLTLN,JM W&18$/QI6"H4MJ^[/[#R"-;_A"[
M+?M0XMC6GR]N"8Y5HY2*(*O64B_)"HEJ ,,S#RY&KSK177>S_NV1Q\E(>[/^
MP4H<.>_\2?Q[,U_0:3L7G"FKJTJU0";D1$:D" $%YU E!)NL=OHNE>F^%XK7
M8XU3@SI8)C"(BD>&S*X[_*MEBN<;)SCU7L:RGOGJ;-:I@"J1HV:(&5#P9"I&
M95VP(?HN1QB/?'Z2EWT'VF_9KS(G@H<W]&5-Y^<WYS&G>7<4<[I8;^+Y^7J6
M,*'*U4'RK;4R9@^I<J(5%2^G7%*[7M@#(QV&G.1A>W^XZ5OI$\'2_<HPSLJ1
MY2>)X#1R+,7VA%58 =;QYCZ7$IP+>V#G@2$FN0WM#RO'*G4"%S./5PZ>?%U^
M6VQF5LI(SJO6P::Q^&4+:#&"PX)$+D0CAF$X>T*P2>8UQT%K$)N,?0+_Z%P^
MT(+^BN?MES,96&B/%;((Q+L[+.Q0A8"0E<E!A.Q<)_J?+H.-0R<PN$_J7]$C
M(V<WD>M#X)/%XEL\?[^BBRN6A%D)43O/P;>D5M%<)4%L]1JZ$$^#M-%WR1<?
M1,V3 W5"C'MQB.E7P1.)99L'E\#V?;PDAYI(@734:GMXKYF$:&F<%\*0%6&8
MVKBG!.L$,/^B #:(3282R[:W4_>FDG0)O"HL*"W8N1;).P*1%2C%BG+DM.Q4
M+_?$,)W $EX46/I6[E1QLDW?M'?%M>-+65T!(X,'C"A F<!PMS%))X[!R1X)
M,O[_X.0 Y;ZP9TXWS>4?]ZJ#O(#:9^ A'T<=K(!1WDTQ7++*7H-JM7JF) /)
M"@O.2*=JX5V;&H339BH/1*_.^(6J6F=.'+VUK9Q:0R*EH: TK(SH2AF&L^KG
M<KVDIU;[X&B/AZ%[FV<"&?YEB[G;VFO%!=(AZI U1Q+;K@1;+5+A--(Y@U)Q
M5HEU&,J7!X09F66L3VO?97XY5O43A,^VF$T5BAF# E%3X@4F>(&UY]<J.6^5
M=Y[4( _S'A9G7 @=;^8G<'. SB> G-W*>DUI5XR(I(0CG\'Z+, 8SET31@=5
M^"I)^<*YYY"1[4:4:2'F$ ,_$K4.U/;(V[_?YI?UK5?T6[OR)1\I&^% RL">
M-V0'*-NU(9K,*RO$I+H<#3SPZ7$+SWLT?A^JFX"G:$W%+V[5+%?C'#F5 %U[
M^<>1%W@+6L&'ZA/+S]M4,82;N"/'N,7D _B(8_0\LH.X%OWZ#&-QF>E?(Q[;
M6]-6X6Z)IT*MVDW'"%0<LDZPFDXM")X89EQRPIX=1Y\J'1D=)YGGLIXW0_QG
MN?K26LC&B_DFGN_(P7?/L%+!+*J':JH&(VN":!%Y;UB3UA9ER%U"2L?AQB5A
M[QDM0ZAX4K2YNPF@RMEH$R'PG^W9>8$4I "MG2!E%9+O0JC]X,?'N14="!''
MJV\"J<?CV_^;8W>GM'$^:G"F/=QR5C.:&=*!7"574(1,0Z0C'60;F8%[P+.3
MO@TS :SM NRW>/XNG<\_7=II9JV2 3E#CZV8VRB!@,KQG**A9-AKAC 0)^(#
MTDSU+.Y F]\C,CW6 +UU".D91:^_T>GB7C\\(S (M*U.0,?FV1%B8L].B%Z2
MC<+)@:B%NXHX5?\U(-Z.-]547=GES#Y27B[*R:*<?9ZO2NO\-).9G'>.$P%)
MLIU&\(:3E<K)(7E!QGAG!MG.[R/DR(T+1@/BD>::-!1;R['-9Y[;;_.Z^7PY
M-XR51&OJX5,JS==S;F(X656.9/)")?0#W2]W%W+D#@BC0?%(<TT8BB>5Q[B9
ME3&\$4I8(2CV\*81$J58#"B9!,E"5>8NCYM[ ^&/XHW<.FXD^!UAHBE61'WX
M]<W)V:^OWY]\./OOV8>3WS^>O#H[???[(:TY'OW4T55+W83LJ0[I,6[+&W9>
M%47.R4((N?'TA-9&FG]H'SCJY4HH!]GE/R784&R[#[5NT-);AF>&UJ43C,$,
M0:NVLE0.2HO[5V[#ZF!R33=Z15%7SMUC+?62'-2V%+%-E%UTC^[JSH<'<UX_
MF\!SN;):/2*YMIEL)[HH%,3V),4AIU/:2VD%OD17MJME?5>[,15?G4+*8FOR
MG#_Z7-L]EFLG/2)!1N-D*#98[X?0QD'23MR][8.LN^YM>.N-3&+S[J\%?^?S
M_.**(1NE,Z[6UB-.@?')03(B0C!)FQQ1&M4;==4/(X\+H6>P\K(/E4\%*]M+
MN*1*HE(*((;(>YJ0 5-Q[>[=FX2DO.J2?>Z'EC&+)X^TWD,8.$"58Q/R?FD=
MR]?S,H^K[]L+U*AC3I?G;2IE,"W'2SI<OO0QULB*V.FETP.?GH"A#S'1LC]]
MC6SN/]8WTK^KOY[3ETW<SD(7DIIC*(LM6]D$VD:!P6NA$6!D74TN7:S^^ CC
M49OU9?R>M#>!<\)'(N/-"5<PZ*)K'11B#F!J08BF6K!6:HH%8Q5=^$_[2N#?
M3*/<X/E2BT$,-0'@O9TOEJOYYOOI@K])Z\WUTGQ/J]Q,^8E^^?[^TABSZ&RQ
MRD90K>C/M'=4D:P&RCJ@XWALZR 8W$/&26Z6#@3'\GDL-1%JK;M,<Z&4BLEF
M(-,*3GU@5QY%@18G@JZ^U0YU"'_'T/8]-]'\<3CI2YD3P<-UUX0_+CZM8J'U
MK"CK.;5#<(KU86K2$),@")3X7SBXNVCW0,2] 2;)%-\?)HY3Z$10T8574&!!
M+U/K::T2F!0#)!\<9&&D<CI63@WWP$E?9(Z#W<\/CIR^E3[\[</V%^U'BFOZ
MYS_^!U!+ P04    " "UA892_)YD_7L'  "P'   %@   &%M<RTR,#(P,3(S
M,7AE>#,Q,2YH=&W566UOXS82_GZ_@G5P^P+X3;&SV3C9 &F2HD%[NT76A\5]
M.E#2R")"B2I)V7%_?1^24NS$SL5[;>_6"ZQCF4-RYIF99X;4V7=7GRZG__KE
MFN6VD.R7?W[_\\TEZ_0&@R^CR\'@:GK%?IS^XV<V[@\C-M6\-,(*57(Y&%Q_
M[+!.;FTU&0P6BT5_,>HK/1M,;P=NJ?% *F6HG]JT<W[F?L$G\?3\;V??]7KL
M2B5U0:5EB29N*66U$>6,?4G)W+%>KY&Z5-52BUENV>'P,&)?E+X3<Q[&K;"2
MSMMUS@;A^6S@-SF+5;H\/TO%G(GT0T<<#X?O>90E]&X\&H]/^ G^'J;X=D+C
M\>AX].\(2@X@'N88NY3TH5.(LI>3VW\R/NP?'U7V="%2FT^BX?#O'2]Z?I:I
MTF(_C?GA:UAF<S&N9UC/J@K3L9*E>]OC4LS*B3>Q$Y9JQ1,EE9X<#/V_4S?2
MRW@AY'+R>BH*,NPC+=BM*GCYNFO@EIXA+;(@:,1O%#;QCXM@ C XE:*DUJ3H
MT!EQ?9^+6%@VBOK18PMVTST!^*3_<N7'6Y6_O+Z=WOQP<WDQO?GT<5?M_T^Z
MWG39+5\6JDS999]]MCS)U4+PNWZ7<<.27%#&Z)Z2VHHY,95E(B&-O^RBP(8)
M+]GGG&MDRH_*5,)RR3Z3GD/(=!DDK<B6S.;<OCHX>G_ZC6,1]5\=1.^&IS<L
MYS!6TUS0 J;97!C&R[*&=9HJI2U3)?M!Z8)%P]Y/+%,:,L0J;*M21F6*25>4
M4!&3#DN.HJXCB^%.R &KDV\=J\,&J^^Y@0F HUBRNU(M)*4SZ@;(&JQ2A6U+
M!5+%JER4@'+)ZM+JFJ U:-8S+H#AK,"3%H BXPE^0J 5( &K@MR&0 F,C>%Z
MZ40*?D?>#0]K&OR60AEL*3U=8P\GD @->H98B>G0)$5$+W*1Y,S4[F,U?T&:
MFD6< 84P$CSN2L)"V!P&FHH2K^":_Q,U)^?7>+D.PSXX=?224XEEH@1LS@,K
MF$ 5H ^%8;TV+DKD!?R%NHSOB:Q=5L 5:YATX4:AY9)50-(%@0L.*5=>;@ V
M3[9&(*6^X'>=1"TA -<JX.^W,UZ?A)N<95(M3.MW33-A++H%Z[A-94%O:-E=
M<Y]IE=G0=A\\.&X\.'UD[FO3>*=A9!? +94["&X8B,B##?!$+,E3&L'#L10F
M=^).K$#RN@1VSZDPB52FQCR7UEK)@'JE54(I?C;L#4!."5X+2%[?)SDO9\0N
MD#&WM81$-.*]Z.@-O?53HZ,T/(5'X2IX&;SMUF<NK=:"(#C%Z;+S1MFCC3)L
MU%+W>FA PO'_/E0L_C:X^XH,NAZ8[PGL9=]T';<FO#:[3W$D%Q-P;G8*M*EJ
MC04J5[B,ST=(4>G7<55_E<GK;*!)<N^XAC=7X'<;IG"# ED-78R2(O6]N*EC
M(U+!M7 &B,#NGI]*MU)M'./Z.#>>GGWVHMF'0NC"_:2*(V*26G)'.C#+*[%B
M;LP(=6"]?.%;3$X0O%"Y@KT//!!O#8R=4VHC/G9/QIW#!*$U%ZGS/C<XNCG6
MX0:1XZJR"PFNT]8]"!C!8R&%73HNW[:M"U;O2>^D$&>/1->JNB>W^\:@JM85
M@L3XVI,D2J=> 5_?9U2BI$C$"D:H<D'H1-"[A'A L(I*[D?#EC01<3WGLO;Y
MY."B+$-]16M?HI':K).O#MX?1L>G9A=^"(_;2Z</ $Q$;IM0H&-5V^<UV(7!
M^(,TN>XC>[D%8W';U_B8IH $]/'^<QM\XSY,VZP.\&S"[#KK4/Q,&-KJS*](
M9L?A*DEJ[=!L"'/+BH4R%K^[4S?6,0D6^;4&UV+9-\\HD2$DD&)/I!NET;N1
M/Q&4C\]=;X-&.3</E<4EIP\A2CUK>3 :1EFB[[\CV1P/GLAW_S \^Q(V1_]E
M4^A/P6D;:]U5^KAL7G?Y*I.<T[ZBRFPT %"*H_Q;I<T#I?L?L%B!LZ EVF0I
M3(H5RH4;205T\M/?(!A !\;1#?ZZ]J.M)_1K+:"RC]:Z3/R9X>T^]7L7."2Y
M BLR=Y%@??>;" *^#1$_]%T+XG>.65>$$$JS/URW!Z:O\EK3(H43PY9$XRDF
M&GK(LRT>;DHYA.$L5-QN('8#5C=U :@!B3>CH;6MA\I]R;ZV%;L -V<:P=P%
M@N0S#S[PUPJ-L[J!W40Y5W).CN)*/FMN1W23K%144BT)HXM<A0SECT(!KJ--
M[G_]%;36_\8!O4#C)0.F[_RMVHLWQ+&R5A63=UYEZUO-1B!&])'N077)*T.3
M]LLI:*^2?#D1I5? 3SJ=.Z9$N6HNF8%#<_-^<M(_'AZ[RW>K\3]MEV_NY?O^
M7GY@T\VQ\?O^R?#YX6$_>G;L3UIVX%4.:L-\4_'R0V?4:2=4/'5]^.2PNF?1
MXTMV29E]BDF ^G\?&=[85P=C%'#_N?U6^R%0&E#^@[U#9^V.&#51Y/.B@M7N
MR,I:<_<)P.V@Q?K\TK\(N'YX$? I- I_",^!3ZJUK'WVK=5:1C]Y\86CF[\(
MG(0[A3EMO I;^<ASP' UA<=P5&TWI[SP]JSY#._R_%O%\]\!4$L#!!0    (
M +6%AE)MT_#6D0<  .L<   6    86US+3(P,C Q,C,Q>&5X,S$R+FAT;=59
M;6_;.!+^?K^"Z^#Z OA-?DD3)PV035)LL'MMT?6BN$\'2AI91"A12U)VO+_^
M'I+R2V)GX^[A[IH"=2QS.!P^,_/,D#K_X?K3U?2?GV]8;@O)/O_VXR^W5ZS5
MZ?6^#J]ZO>OI-?MI^H]?V*C;C]A4\]((*U3)9:]W\['%6KFUU:376RP6W<6P
MJ_2L-_W2<ZI&/:F4H6YJT];%N?L%G\33B[^=_]#IL&N5U 65EB6:N*64U4:4
M,_8U)7/'.IU&ZDI52RUFN66#_B!B7Y6^$W,>QJVPDBY6>LY[X?F\YQ<YCU6Z
MO#A/Q9R)]'U+Q*/Q:18?'Z<G\>GH)(GCX^&8LG$_/AFFV0D-_A7!R![$PQQC
MEY+>MPI1=G)RZT]&@^Z[<67/%B*U^23J]__>\J(7YYDJ+=;3F!^^!C6[RKB>
M09]5%:9#DZ5[V^%2S,J)WV(KJ%J))THJ/3GJ^W]G;J23\4+(Y>3U5!1DV$=:
ML"^JX.7KMH%;.H:TR(*@$7]06,0_+L(6WD&/%"6MMA0-W"9N[G,1"\N&47?P
M< >'V9X ?-+_=>-'>XV_NODRO?UP>W4YO?WT\5#K_T^VWK;9E>9BQG[NLBF?
M\05O,VY8I<F(%""V69(+RE@F2EXF@DO&RY2IBC2W+C54EHF$-/ZRRP(F)+QD
MO^9<(W=^4J82%C-^)3V'D($NTE9D2V9S;E\=C4_.OG-THNZKH^BX?W;+<CXG
MIFDN:(&MV5P8 %'6V)VF2FG+5,D^*%VPJ-_YF65*0X888!(J952FF'1-"14Q
MZ:!R&+4=??0/0@Y8G7[O6 T:K'[D!EL ',62W95J(2F=43M UF"5*BQ;*M L
MM')1 LHEJTNK:X+5(%[/P0"&LP)/VH5=QA/\A$ K0 M6!;D=@1(8&\/UTHD4
M_(Z\&]8Z#7Y+80R6E)[ L8832(0&84.LQ'18DB*B%[E(<F9J][&9OR!-C1*W
M@4(8"69WF; 0-L<&346)-W#+_XF:D_-KO-R&X24X=?B<4VF+&38PM0-+8%AO
MC8L2>0%_H5+C>R)KEQ5PQ18F;;A1:+GT!.2"P 6'E!LO-P";1TLCD%+? K2=
M1"TA -<V-*5*X^U)N,E9)M7"K/RN:2:,1?]@'>FI+-@-*]M;[C,K8W:L?0D>
M'#4>G#[8[FO3>*=AY&TJ=Q#<,A"1!QO@B5B2IS2"AV,I3.[$G5B!Y'4)[)Y3
M81*I3(UY+JVUD@'U2JN$4OQLV!N G!*\%I"\N4]R7LZ(72)COM02$M&0=Z+Q
M&WKKIT;C-#R%1^%J>AF\[?0SEU9;01"<XFPY>*'LP4(9%EI1]W9H0,+Q_TNH
M6/QM</<UZO?,;=\3V/.^:3MN37AM#I_B2"XFX-RL%&A3U1H**E>XC,]'2%'I
M];BJO\GD;3;0)$,[T?#F!OQVPQ1N4""K88M14J2^.S=UC"Y%<"W<!D1@=\]/
MI=-4&\>X/LZ-IV>?O6C_81#Z<C^IXHB8I);<D0ZVY8W8,#=FA#JP7;[P+28G
M"%ZH7,%^"3P0[PV,@U-J)SX.3\:#PP2A-4?3B:G<X##G6(<;1(ZKRBXDN$Y7
M[D' "!X+*>S2<?F^95VP>D]Z)X4X>R"Z5=4]N=TW&ZIJ72%(C*\]2:)TZ@WP
M]7U&)4J*1*Q@A"H7A$X$O4N(!P2KJ.3+:-B2)B)NYES6/I\<7)1EJ*]BCHV:
M/77RU=')('IW9@[AA_"XOW3Z ,!$Y+8)!3I6M7W:@D,8C*^ER74?V?,M&(M7
M?8V/:0I(P![O/[? =^[#=)75 9Y=F%UG'8J?"4-[G?D-R>PX7"5)K1V:#6'N
MT5@H8_&[.X=#CTF@Y/<:7 NU;YXP(D-((,4>23=&HW<C?R(H'YZ[W@:+<F[6
ME<4EIP\A2CUK>3 :1EFB[[\CV1P/'LFW_V-X7DK8C/]B4^A/P>DJUMJ;]''9
MO.WR328YIWU#E=EI & 41_FW2ILUI?L?H*S 6= 2[;(4)L4*Y<*-I (V^>EO
M$ R@ ^/H!G]=^[&J)_1[+6"RC]:Z3/R9X>U+ZO<N<4AR!59D[B+!^NXW$01\
M&R)>]UT+XG>.63>$$$JS/URO#DS?Y+6F10HGACV)QE-,-+3.LST>;DHYA.$L
M5-QV('8#5C=U :@!B=]&0VM[#Y4O)?M6K=@EN#G3".8V$"2?>?"!OU9HG-4.
M[";*N9)S<A17\EES.Z*;9*6BDFI)&%WD*F0H?Q *<!WM<O_K;Z"U[QS/2_1=
M,D!Z["_5HN<,CI6UJI@<>Y.M[S0;@1C!1[H#TR6O#$U67\[ >I7DRXDHO0%^
MTMG<$26J57/K#!R:J_C3T^[)>.ANXZW&_W2EOKFH[_J+^IY-=\=.HNYP^/1P
MOQL].?9G:J/C[NC=86I[WN1@-K9O*EZ^;PU;JPD53UT;/AE4]RQZ>.LN*;./
M,0E0_^\CP[\+>74T0OWVGX^ON=<ATL#Q)SOMNWT>B$X3/SXC*NS7G579:J,O
M";K'<,7ZXO/FI<"5?RGP:?T:P%'SAS5Q? I-PP$0'P37+OX]GWY;^?WD"Z^M
MW'_TS@QG/']C. F7#W/:>8NV,=*S17\SA<>PM+:[4YYY\=9\AM> _H7DQ;\!
M4$L#!!0    ( +6%AE*C"!@D' 4  +P4   6    86US+3(P,C Q,C,Q>&5X
M,S(Q+FAT;>U86T\;.11^WU]Q&K24E3*W9 +D A(;Z';5+B!(A?9IY8P]&0N/
M/;4=0O;7[[$GPYV62K2EJ^9AE+%]CL_YOG.Q9_1J_V@\^?OX  I;"CC^\/O[
M/\?0"J+HK#N.HOW)/KR=_/4>TC!.8**)--QR)8F(HH/#%K0*:ZM!%"T6BW#1
M#96>19.3R*E*(Z&482&UM+4[<B/X9(3N_C)Z%02PK[)YR:2%3#-B&86YX7(&
M9Y29<PB"U:JQJI::SPH+G;B3P)G2Y_R"U/.66\%V&SVCJ'X?17Z3T531Y>Z(
M\@O@=*?%X[R7] CM]^(X3FF?]&F^U=N,.ZS?SY,^2_])T,@(E]<RQBX%VVF5
M7 8%<_L/TDZXU:OL<,&I+09)'/_:\DMW1[F2%O?3*%__K=7<4V;9I0V(X#,Y
M\"ZU:M%F.E-"Z<%:[']#-Q/DI.1B.7@]X24S<,@6<*)*(E^W#=(0&*9Y7B\T
M_%^&-J%Y_G51F[R%>@27K'$AZ3BC#RX+/N46NITPN6WQE3=?SZ3T09/V*LW%
M^EJR&0\WVS73]RR[HH3H&;)B5>6U?W40'[;XE&5SC8F &HFD<'"9%43.&,9K
M67)C,$%>"+1I+X8W/+<%G%K-F&W#87CV0FP[(Z; G+=*MF$_'(?(?"_MOW#F
MWQ/:L/X'EAW!L/BLK_6VAT^U>^CK )<4I0?=S>_FR*1@D#%M><XSXDHZ&&8A
M5QIC9<J$6@ W^,<593.?EMRZ(FT56)3[?/B#48*)I=/G):JYKK ;@,HA4V4E
MED[O@N->)W/!(.F2($DWIK]Y??50CZZ&4.;.IE<;[F7632?];@H;;M'ZVG:G
M$P]O+O!#R;!6C4J\KTD7$P,EQP6I+-.PV75O$]="(-ENMOP@N?/ZU&*',N@=
M92%,"L3E-G X()5UX$P94(8A02'G I_HMID3:1O@;AGN[*&*U<*9D@8[V-PR
M(% 1;1L;]J2<$P$GK%)N4,(;I4M(XN#=+8_K^6M?,P<SD1YGZTP6#!G4X8\6
MIB=D62H$"LL#TI 5:L')>=CVT(P+SG+$% /#\@L&1SE2@F0Z8,>:\!F\0[[(
MC"Q(+7"LF>'.H_9*]@V71&8<\74R1Q73R"@BUFA"#O9*-#PC$DX+HI'2M\I4
MW*+$*=,7N,BT@:%=34B@Y[8@N,&*\2DSGDI'P;E4"XR*&?NR@E$12M&H0+ <
MFWKG#C?!=R0GN0JG;[_[;5@ZVV'/P> @7Z5*/A=8@'RU<:SX8N.F-?LXY]K5
M;6L<,]<E88-@L=%8>3;H4ZL.,MD?NN#Y'[#9>9%L<HD]I*P++19)2U"2XBC<
MI)IPC5Q7F-Z.U;:;)D( BJ$QF*LX42'-IBX#^576HT+J[S,^_W'57-1!H>I2
M@$7Y237@LV5UJJQ5Y: FUY(IMIG5@JG2E.D 81:D,FS0_!E2;BI!E@,N/5A>
M:'CAJDQ&Q.HB@5&UNI'T^^%6O.4N)19O(I8VZE?WE=#?5R)+[\^EVV$_?GPZ
M#I-'YYY);>1-KLU&]PWVK9U6M]4(K$)C$$/BX6OT?6)II[ITBX<W[EPNL.["
M5[/R[=/-X[*^EFX-C7_"@UWN*J:>%Z-5P/F"5%EW4.,4&G=_)  ?!@TOXH^<
M"Q["L[&Y49S6"?I<<7AKZ<\POW,H^QG@GX;N+EP8VO=.L-=G5M?!KL^SC\9\
MY!O)O<O_ U^P;G2Q.Q_!\"KGN^9 ,T%<BMW[+';-A>][\;4(F2(A>,WYTB]I
MJV?]7<]_8=S]#U!+ P04    " "UA892E4B+*_X"   J!P  '@   &%S:',M
M,C R,&-O;G-E;G1E>&AI8FET,C,Q+FAT;=55VV[;.!!][U=,'?0&6!8I*;:L
MN 9<NVF+3;M!XB+8IP5-439;B11(.J[[]3N4Y*0;HVB!/A35 Z'AS!R>N9&3
MQXN_Y\M_+E_#QE4E7'Y\=?%N#KT@#&_B>1@NE@MXNWQ_ <F 4%@:IJQT4BM6
MAN'K#SWH;9RKLS#<[7:#73S09ATNKT(/E82EUE8,<I?WIA._@ZM@^?31Y'$0
MP$+S;264 VX$<R*'K95J#3>YL)\A"#JKN:[W1JXW#B(24;C1YK.\9:W>25>*
MZ0%G$K;R)&P.F:QTOI].<GD+,G_9DTE.3V.^2B@3/"'),$VC/.5QPHMQ6J3C
MZ%^*)$,T;WVLVY?B9:^2*M@(?WXVBFIWMI.YVV24D">]QFXZ*;1R>)A!Y_:W
MQ3A&8F:-8"OMG*ZR*$&P;LOIN@'OM6 '!ZY+;;(3TGQG7A,4K)+E/GOV1F":
M)7O6M\+(HM59^55DU,,VXJXCC:ZE5.(0!(UC9#[7ROK,ZP+>J5S4 A<4K\1:
M6B<,UN)RNRHEAQGG>JN<K\NY--7_0[P+_R<8SXQD)?+%[@F.2),'I).'I.DI
MDKX1P#O>3H/;")"*:U-KPWP_PFH/1A3(7G&O:BS:B#J#:X=MYCO%PO-S;2JX
M#F+XH <0QW$0D>1T'/>!J1PZ97JGI",R/"7]>SD>)\GP7DXIC=-[<1334?2-
M=92.QBWR88NDA(Q?^/SKK4':&(2#O)D"F-5&ED]/Z)"<X1&^Z_MH4;*F"EWD
M/A&ZE*U'(153'/.+=;B+D-6U8,:[=*F8*;5%DZOV+$Q'$R4EP5^>QJS"HG"&
M2=HP7_^WVM;2H?VU,+>2"PN%-@W.'F'!-TP."\%%M1*F)1O3ABT9''7)@Q'P
M_4[],#GQQ06LE&N5?=I:)XO]SX_ KS54,P5/3Y+1F6U6>*^MA5G.*@L7%Y=_
M2@376+!SXXMON>[#')E@F91DWPW@-Q,^[NWO,NW\XB$"U[I]<[)V#F[%T3U\
M\.JN5W+OPE8X*5MW[/*#J[M;VU>D><^F_P%02P,$%     @ M86&4J\DQG?K
M#P  ?T8  !4   !A<VAS,3 M:V5X:&EB:70T,2YH=&WM'&ESW+;U>W\%HDQJ
M:88Z5I(/R8IG%,FI,[43CZ7$DT\=+ GNPN82&X#<]>;7]QT "7*YBI4FC==M
M9ZI()(#W\.Z+OOCB^H>KVY]?/Q?3:E:(US]^\_*[*[&S?WCX]N3J\/#Z]EJ\
MN'WU4IP>'(W$K96ETY4VI2P.#Y]_OR-VIE4U/S\\7"Z7!\N3 V,GA[=O#O&H
MT\/"&*<.LBK;>7:!3^"GDMFSOUU\L;\OKDU:SU19B=0J6:E,U$Z7$_$V4^Z]
MV-_WJZ[,?&7U9%J)XZ/CD7AK['N]D/R^TE6AGH5S+@[Y[XM# G(Q-MGJV46F
M%T)G7^_H<38>G9T^2A\>GZG3Q^/'\NSAZ=F3?/SX;'1V]%"J?XT R4-8SGM<
MM2K4USLS7>Y/%<(_?WP\KYXN=59-ST='1U_MT+IG%[DI*P!F83/_RF>LG52I
M#]6^+/2D/*?[[/#6\#HUA;'G7Q[1_Y[BF_U<SG2Q.G]PJV?*B>_54KPQ,UD^
M2!SP8-\IJW->Z/2O"G "].C/I<<7SBETJ0+^HV-$^OF'J1[K"K@YZB(<H3J7
M60:LV"<\ST\.'L')&] ?N/F?<=!,V@EP8FRJRLS@)MUS4N"^LG\10:^52ZV>
MHTH(DXL;E=86% 0 O%$3[0 Q$.W7M76U!.0J@RMH\>@8UU=3%>]Y_B&=RG*B
MQ&5:X>O1V<GIO:FBRPPH<GX"Y/[3B7(Z2)1+A\A?JU3-QLJ*DU&"ZGN4B,L9
M')C*4MQ,)1+FA7%S7<D":& 7.E4N$5)< 5MS8TLM16KLW%A)!-O]^Y=/CH^/
MGE[>O+BA7T=/]Q(QE9DPI1)I(1U!=2TU;<N!&FAB[T][0,<)">8E4]G?OWSX
MY*D E&8S.,)5)GV?B-*(N;1B(8M:-1C&2P*F!T+< KS<%(59HJ%+@8I2EW"\
MR+HR9&K;@P)(+%51X']397$;W*T@JXDJQO98Z!*H-B-B$33M.B=K!.7J&8C-
M"DA6K(0L,Y$9N'II*C&OD=0DHF.%\.>%JA0<]%8)5:: E 3:K$R-*\!D9T2_
ML$Z@Y"'R@3NCQT\!GJUT6BCBBRXC9L9T%;MXD"?=QAV!CH1TV(F_6^4JHL1X
M5<BEZYS&CUIA64YU.@52@M0L@!>Z@&W&1H#H&#@R!Z$I4X58*K:8#J_=N=QE
M6=9 ]3>*R 8$_A:H+T9'^_\$HKT)1] ^C\Y2)1Z7\ 2H&I[@7?S3.J#,F 3(
M"4@QD,9YPI=,<OC#+K53L/:76@,U-D%WJ')34X BK)_OGP^+W\>!O8>=^HML
M]3]4J:PLMM"@Q@X$V7"'8@7IIF5U-35@WE:X3SL'-FITE "J^']! D%'Q.P^
M$)\^(Z\8WQO$=PNYR>[QE;1@C+QOA)\/D\=G1\F3T2AB3%\7@;M6P=,*;%Z)
ML14H^R4X!N_-HA<;N N2 X:O+L#ZSZ5F"UJ"]W .-%R."_5IJ#&=>(Z1@4X_
M0AY^,A5>^0T^<ELH$#]2=(+,9H_5F-S6S,ZM6>B,_1,L26CU1C. 7BT^#G^/
M[3^) 5P:,Z8,C0.&4 M388!BA9(@F+1\37RFJL!X2T@0.@@U*CP+]T&$-8?'
M@%P,)D&LBIKD$>53%3X @V,S<!II92SXJTLXZAW;*2_(7GAC# D[64$,,U.*
MV!VO;0!:-8>=F!%D %S,X2&3 U #&GY8);@!L =/YN#T&D\5O]3&UC.Z/!Y9
M89HK&U3'F)IZ#XC)Z@&%<AUZ>J",8%:#>J4 A,,+HEE &A9P%-( U>WNF5R1
MA]4E6&HT]1Z/%H,:7D(<F+T#CI:4/D/LMM35M-%[Q!\?9%8N)5D&59IZ,NWB
M"X<7"MV$]^P0D@>$@&DYV 4(#YD E7RO(/HF4?0K6_![%%;.43I9-N%^<+ C
M/@TSU0<,Q-0!)MS' 'WR^HO7)L$%$D@QH4J'%65-:9&.:,%:'=1VLUZ#2 /-
M2J]&R&=@U;!>)1P"Y+FFI&#18H+/-S*G51_T#0L3I-:+]<<+\RZ_\@>'@UIT
M, $I7%<&-@M/0RD&M.>U>.P#'4[9ULW!\X6R'9LT;%- V@=IR!I9SVI,M@1F
M5+C%$6DF2%)*/5'S,DDR[%D+9_!"P!J4T$=M[<L6 *=;!%QEB0!(E9X7FD6B
MNXE/A U,6,3&$Q<M=8FY'_KU<,$$I2F#!-CJ<=W!'I4:*05I%' +! P@ O)@
MY2>8\<R0',VE'#Y"FSC5Y7L'21.8OQ=FJ8"PE/[&M&UX$A-Y@'R[^D =)  #
M6(TVMP-P@(I!<<CZ#!'%BUJ==LQ<2Q/=]24(>*^3U@3@#QQ2K;W\ U%*-!2(
MI2>[PJP:,YX-EZ/H>ZS 9LX+F;(;*LU,EZS!0'!C@T0$K2BSONS",8Y$##>#
M-2 Y)<7UNC=T#M #\="@OB7;[B$,#\1W;.!1>(=!$B49;D*^ON,\.DH!X+7U
M5\\[M.M>'*"6FQ4MZ;(!#5&J]"(XM"D86\CS([[W[9J[(W08*Q^C>/\.+JZ>
M?[124E#32!96J&S[#BC6!C);Z+G$9>OH6;Z1N6A5R>M[VRBYU '4<W.5:OCU
MCABL>P*Z*$A+VK MB1ZQ_07A#X]8J(/@81Q"[@'="0C3$BMU>()3%4$'?H(#
M] X KP#NA, FJ/%.3\K6CG8J'&MI$B@M_H6%L#8B(G73I9Z!8QNV.$M3@SN$
MRX)'Q@3*4J;MT^Y?%5(,\6'Y\3AV8MC6@P8E&XAZ*>Q$!F'RUT2:[)U5=H"5
M2S6OFN@U5C#9B"?2 0D(IJ&A*0#(-=85Q4*"[J6K;IC7/ TM&JJ-S<Q"%GM)
MI"X;Y3YNG<P--X[.J7():KO63 F[O)H<M5ODV)D"?-A]^R_\<VK;AL1$[8_A
M,N_W90X.Y5P62[ER.W]2S^<OJ)<,:[G7R,B@]26!ZL%>4^I2@LR;VJVORN^4
MTR$!C-*\[TIOY!W'P^5_2U+1A)$&-O!"T3+4-)O;K<6= [;BGO?>QH+*M<9B
M UB8K2VI_/!;%0\.,""8\U=U'/J2HF0J+:@_I5ED(8H&P0JL[70!QD;:K!L]
M=#H0:Z^;1@;Z.WB1UPB[4!,*5.5"Z@+K<(U0S>5JYJ6S0=4WDQA-#BNY+6+J
MTA]:U3:^&V;IU<!=*&<E'+T?!AW+U!Q9CPO@;0[Q6TD^'_2$>TU897&0J+ S
MG2M&P5% /Q5Y83 #GEN#P4)%1:"LAC1DU9Y :[GSYU41[\AY%>MU+IF8H<5C
M-:F6BS#N$#U3:H918Z$6LJRV4NE>:J!$QNS\?/6.ZXJ4%_L6)(@/2/P*E0V9
M6RH(;AR$>(YKBE(4$6$XIZ5P@,0^Y[PPTA/+M5*'KRFY!)$NM!SK@OJ\6RD:
MWQOQVH*$SS%P2L25*2']=IX>;U1&;SXKL:$L&KOKT;5=/6[:V0D:DX@(MB4"
MS95@GH8FD2HC%6Y]!Y:"XHC:DH7! BUE^]S\8 ,$<4/MS:M5?C<D$N5[2C?
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M*H,%GP!02P$"% ,4    " "UA892S;%@>XQ[ @"2!!P $
M@ $     86US+3(P,C Q,C,Q+FAT;5!+ 0(4 Q0    ( +6%AE):FHQ8HQ8
M )#Z   0              "  ;I[ @!A;7,M,C R,#$R,S$N>'-D4$L! A0#
M%     @ M86&4K@<TH.F+0  S-@! !0              ( !BY(" &%M<RTR
M,#(P,3(S,5]C86PN>&UL4$L! A0#%     @ M86&4DJ__/(<9@  =#@$ !0
M             ( !8\ " &%M<RTR,#(P,3(S,5]D968N>&UL4$L! A0#%
M  @ M86&4D37)GEG( $ J=X+ !0              ( !L28# &%M<RTR,#(P
M,3(S,5]L86(N>&UL4$L! A0#%     @ M86&4BA4ID9'J0  =[0' !0
M         ( !2D<$ &%M<RTR,#(P,3(S,5]P<F4N>&UL4$L! A0#%     @
MM86&4OR>9/U[!P  L!P  !8              ( !P_ $ &%M<RTR,#(P,3(S
M,7AE>#,Q,2YH=&U02P$"% ,4    " "UA892;=/PUI$'  #K'   %@
M        @ %R^ 0 86US+3(P,C Q,C,Q>&5X,S$R+FAT;5!+ 0(4 Q0    (
M +6%AE*C"!@D' 4  +P4   6              "  3< !0!A;7,M,C R,#$R
M,S%X97@S,C$N:'1M4$L! A0#%     @ M86&4I5(BRO^ @  *@<  !X
M         ( !AP4% &%S:',M,C R,&-O;G-E;G1E>&AI8FET,C,Q+FAT;5!+
M 0(4 Q0    ( +6%AE*O),9WZP\  ']&   5              "  <$(!0!A
M<VAS,3 M:V5X:&EB:70T,2YH=&U02P$"% ,4    " "UA892]!^<]4 !   +
M @  '               @ '?& 4 87-H<V5X,3 Q,61F=6QL>65X96-U=&5D
M+FAT;5!+ 0(4 Q0    ( +6%AE*7R6 Z; ,  &$;   .              "
I 5D:!0!E>&AI8FET,C$Q+FAT;5!+!08     #0 - &4#  #Q'04    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
